data_1rwu_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1rwu _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 N--CA 1.495 1.816 0 N-CA-C 109.989 -0.374 . . . . 1.02 109.989 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -69.44 114.64 3.72 Favored 'Trans proline' 0 C--N 1.313 -1.312 0 O-C-N 123.861 1.453 . . . . 0.41999999999999998 110.979 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -102.53 101.13 11.28 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.694 -0.629 . . . . 0.41999999999999998 110.222 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.4 m -75.5 93.04 2.93 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.631 -0.877 . . . . 1.1100000000000001 108.631 178.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -110.75 159.25 17.8 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.468 -0.77 . . . . 0.70999999999999996 110.752 -178.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.513 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -134.82 101.25 4.85 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.348 -0.612 . . . . 0.54000000000000004 109.348 179.766 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.502 ' CG2' HG21 ' A' ' 60' ' ' ILE . 3.5 t -79.68 95.62 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.477 -0.764 . . . . 1.0700000000000001 109.59 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.536 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 43.9 mtm -97.73 142.0 30.05 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.538 -0.726 . . . . 1.27 110.178 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 166.42 -147.69 12.46 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.586 -1.406 . . . . 0.38 109.586 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.503 ' HB2' HG23 ' A' ' 82' ' ' ILE . 0.0 OUTLIER -75.8 151.1 37.59 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.326 -1.102 . . . . 0.97999999999999998 110.106 179.816 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.6 105.04 2.98 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.564 -0.71 . . . . 0.47999999999999998 110.31 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.6 HD11 ' HD2' ' A' ' 25' ' ' PRO . 2.6 mm? -111.13 129.69 23.74 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.592 -0.693 . . . . 1.1100000000000001 109.761 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.6 ' HD2' HD11 ' A' ' 24' ' ' LEU . 43.3 Cg_endo -70.49 -30.5 18.81 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 O-C-N 123.701 1.369 . . . . 0.46000000000000002 110.606 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -83.6 -2.81 56.9 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.463 -0.773 . . . . 0.64000000000000001 110.791 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.476 HD22 HG22 ' A' ' 58' ' ' VAL . 0.8 OUTLIER -58.48 -52.62 64.85 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.043 -1.035 . . . . 1.3300000000000001 110.284 179.997 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.8 m -62.23 -33.2 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.48 -0.762 . . . . 1.0600000000000001 110.467 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -67.45 -46.26 73.59 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.511 -0.743 . . . . 0.48999999999999999 109.937 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.603 ' HG2' ' HA ' ' A' ' 77' ' ' LEU . 3.2 tp60 -72.24 -34.32 68.2 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.446 -0.784 . . . . 0.73999999999999999 110.328 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.499 HG22 HD21 ' A' ' 77' ' ' LEU . 2.8 t -60.41 -53.21 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.561 -0.712 . . . . 0.83999999999999997 110.432 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.9 p -70.81 -31.47 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 121.329 -0.857 . . . . 1.0900000000000001 110.846 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.73 -46.27 54.39 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.301 -0.874 . . . . 0.52000000000000002 110.932 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.471 HG22 ' HB2' ' A' ' 76' ' ' GLU . 7.6 p -75.51 -30.28 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.247 -0.908 . . . . 0.34000000000000002 111.048 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.454 HG12 ' HB2' ' A' ' 43' ' ' TYR . 4.0 p -75.2 -30.75 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.045 -1.034 . . . . 0.83999999999999997 110.209 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -79.04 -42.0 27.52 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.383 -0.823 . . . . 0.63 110.32 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.9 mtm180 -62.87 -30.06 71.23 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.269 -0.895 . . . . 3.0299999999999998 111.053 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.588 ' CG ' HD12 ' A' ' 73' ' ' LEU . 68.6 m-70 -97.5 -41.05 8.36 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.342 -0.849 . . . . 0.63 110.72 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -120.8 145.56 41.58 Favored Pre-proline 0 N--CA 1.497 1.922 0 O-C-N 121.439 -0.788 . . . . 0.59999999999999998 110.019 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.96 142.53 51.77 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 O-C-N 123.598 1.315 . . . . 0.46000000000000002 110.985 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 98.09 147.76 22.74 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.724 -1.35 . . . . 0.40000000000000002 109.724 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -94.48 139.9 30.53 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.573 -0.957 . . . . 0.66000000000000003 109.949 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.506 ' HB3' ' O ' ' A' ' 61' ' ' THR . 76.5 m-85 -131.81 164.41 26.09 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.444 -0.785 . . . . 0.85999999999999999 110.67 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.428 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 0.5 OUTLIER -142.79 158.14 60.16 Favored Pre-proline 0 N--CA 1.498 1.935 0 O-C-N 121.424 -0.798 . . . . 1.2 111.713 -179.314 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.537 ' HA ' ' HA ' ' A' ' 60' ' ' ILE . 55.2 Cg_endo -96.69 120.58 0.19 Allowed 'Trans proline' 0 C--N 1.317 -1.119 0 C-N-CA 122.382 2.055 . . . . 0.51000000000000001 110.258 179.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.491 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 27.6 m -81.41 99.48 8.74 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.021 -1.049 . . . . 1.0700000000000001 109.397 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.492 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 10.8 p -75.89 144.35 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.419 -0.801 . . . . 1.04 111.469 -178.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 O-C-N 121.834 -0.541 . . . . 0.89000000000000001 109.665 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 41.3 t80 . . . . . 0 N--CA 1.497 1.894 0 CA-C-O 121.074 0.464 . . . . 1.01 109.797 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -130.35 142.26 50.54 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.281 -0.887 . . . . 0.94999999999999996 111.311 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.536 ' HA ' ' HA ' ' A' ' 20' ' ' MET . 16.0 m -110.51 117.23 32.99 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.705 -0.85 . . . . 0.79000000000000004 108.705 179.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.492 ' HA ' ' HA ' ' A' ' 47' ' ' VAL . 2.8 m -110.09 150.78 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.187 -0.946 . . . . 0.46000000000000002 111.829 -178.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.497 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 0.3 OUTLIER -104.41 104.6 14.5 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.396 -0.965 . . . . 1.1200000000000001 108.396 178.476 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.537 ' HA ' ' HA ' ' A' ' 45' ' ' PRO . 14.5 tt -93.1 130.73 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.305 -0.872 . . . . 0.92000000000000004 111.849 -178.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.506 ' O ' ' HB3' ' A' ' 43' ' ' TYR . 37.7 m -96.44 133.91 40.27 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.633 -0.877 . . . . 0.95999999999999996 108.633 178.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.452 HG12 ' CG2' ' A' ' 35' ' ' VAL . 32.3 mt -144.14 139.39 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 120.939 -1.1 . . . . 1.05 111.137 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -112.63 57.21 0.66 Allowed 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.877 0.846 . . . . 0.40000000000000002 109.161 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.21 130.74 44.06 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.965 -1.085 . . . . 0.85999999999999999 110.22 -179.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 32.8 p -70.08 -7.57 42.4 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.868 -0.52 . . . . 1.04 111.053 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.703 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 13.1 t-80 -129.75 157.89 40.92 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.198 -0.939 . . . . 0.47999999999999998 110.104 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.458 HG21 HD11 ' A' ' 67' ' ' ILE . 16.0 mm -69.7 -51.4 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.413 -0.805 . . . . 1.21 110.504 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.418 ' HB2' ' CE1' ' A' ' 66' ' ' HIS . 1.7 mt-10 -71.58 -14.69 62.16 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.472 -0.768 . . . . 1.1499999999999999 111.647 -179.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.703 ' HB2' ' HB3' ' A' ' 66' ' ' HIS . 39.4 tt0 -62.09 -46.0 91.02 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.013 -1.055 . . . . 0.58999999999999997 110.306 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.8 p -60.73 -27.22 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 121.158 -0.964 . . . . 0.94999999999999996 110.609 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -67.82 -50.24 57.86 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.298 -0.876 . . . . 0.83999999999999997 109.856 179.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.9 p -63.5 -37.33 86.9 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.512 -0.742 . . . . 1.02 109.597 179.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.588 HD12 ' CG ' ' A' ' 38' ' ' HIS . 5.5 mp -60.03 -39.96 87.69 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.538 -0.726 . . . . 1.3600000000000001 109.561 178.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.619 ' CD1' ' HB ' ' A' ' 86' ' ' VAL . 0.6 OUTLIER -63.03 -45.79 90.61 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.531 -0.73 . . . . 0.68999999999999995 109.084 178.654 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -60.7 -37.67 82.43 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.56 -0.713 . . . . 0.67000000000000004 109.943 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.471 ' HB2' HG22 ' A' ' 34' ' ' VAL . 0.3 OUTLIER -63.26 -41.38 99.03 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.516 -0.74 . . . . 0.56999999999999995 110.566 179.801 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.603 ' HA ' ' HG2' ' A' ' 30' ' ' GLN . 0.3 OUTLIER -84.47 -28.59 26.68 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.382 -0.824 . . . . 0.83999999999999997 110.557 179.818 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.529 ' N ' ' HG ' ' A' ' 77' ' ' LEU . . . -107.08 58.98 0.4 Allowed Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.806 -1.317 . . . . 0.29999999999999999 109.806 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.12 4.17 26.56 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.606 -0.938 . . . . 1.0 110.389 178.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.403 HD12 ' HG ' ' A' ' 24' ' ' LEU . 2.2 mp -63.4 152.65 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.383 -0.823 . . . . 1.1699999999999999 110.125 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -69.74 -11.87 61.19 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.333 -0.854 . . . . 0.79000000000000004 111.063 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.503 HG23 ' HB2' ' A' ' 22' ' ' GLN . 22.3 mm -82.94 175.23 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.134 -0.979 . . . . 1.1799999999999999 109.903 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 76.0 t -63.16 112.04 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.373 -0.829 . . . . 1.0900000000000001 111.395 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.96 136.76 54.94 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 109.109 -0.7 . . . . 1.27 109.109 178.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.412 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 2.6 ttt -151.3 161.57 42.46 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.12 -0.987 . . . . 2.8399999999999999 110.724 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.619 ' HB ' ' CD1' ' A' ' 74' ' ' TYR . 8.1 p -141.71 153.04 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.431 -0.793 . . . . 0.44 110.565 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.513 ' HB3' ' HB2' ' A' ' 18' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.496 1.835 0 CA-C-O 117.944 -1.027 . . . . 1.0600000000000001 109.705 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.1 t . . . . . 0 N--CA 1.494 1.774 0 N-CA-C 110.306 -0.257 . . . . 1.1399999999999999 110.306 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.31 125.68 11.57 Favored 'Trans proline' 0 C--N 1.313 -1.301 0 O-C-N 123.925 1.487 . . . . 0.46999999999999997 110.483 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.45 ' HB2' HG21 ' A' ' 62' ' ' ILE . 29.5 m-85 -105.91 99.31 8.91 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.535 -0.728 . . . . 0.45000000000000001 110.355 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.1 m -76.93 92.72 3.69 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.072 -1.084 . . . . 1.1799999999999999 108.072 178.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.436 ' HA ' HD22 ' A' ' 87' ' ' LEU . 3.0 m-85 -99.86 107.33 19.32 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.434 -0.792 . . . . 0.46999999999999997 110.723 -178.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 0.1 OUTLIER -82.07 88.79 6.41 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.524 -0.735 . . . . 0.47999999999999998 109.292 179.547 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.568 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . 21.3 t -79.95 95.02 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.537 -0.727 . . . . 1.1000000000000001 109.617 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.8 ttt -107.96 125.91 52.07 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.573 -0.704 . . . . 1.6599999999999999 110.431 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.482 ' HA3' ' HD3' ' A' ' 84' ' ' ARG . . . -153.82 -160.24 9.64 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.28 -1.528 . . . . 0.27000000000000002 109.28 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.481 ' HB2' HG23 ' A' ' 82' ' ' ILE . 0.0 OUTLIER -67.02 168.06 10.69 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.38 -1.07 . . . . 1.24 110.253 179.73 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.76 103.62 0.58 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.408 -0.808 . . . . 0.46999999999999997 110.417 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -125.1 123.03 25.39 Favored Pre-proline 0 N--CA 1.496 1.835 0 O-C-N 121.469 -0.769 . . . . 0.64000000000000001 110.32 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.04 -22.41 19.51 Favored 'Trans proline' 0 N--CA 1.489 1.227 0 O-C-N 123.892 1.47 . . . . 0.58999999999999997 111.163 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.49 -0.67 30.36 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.307 -0.87 . . . . 0.56000000000000005 111.524 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.3 mt -53.64 -58.44 7.19 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.19 -0.944 . . . . 1.1100000000000001 110.871 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.437 ' HA ' ' CG ' ' A' ' 45' ' ' PRO . 8.9 p -64.9 -30.35 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.429 -0.794 . . . . 1.0900000000000001 111.177 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -67.08 -56.44 10.03 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.317 -0.865 . . . . 0.46999999999999997 110.649 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.664 ' HG2' ' HA ' ' A' ' 77' ' ' LEU . 0.7 OUTLIER -68.98 -38.02 79.09 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.327 -0.858 . . . . 1.3400000000000001 110.846 -179.898 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.558 HG12 HD12 ' A' ' 60' ' ' ILE . 3.2 t -57.63 -54.52 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.398 -0.814 . . . . 1.1000000000000001 110.596 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.3 p -66.09 -34.16 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.329 -0.857 . . . . 0.97999999999999998 111.284 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.88 -52.77 11.9 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.094 -1.004 . . . . 1.26 111.06 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.442 ' CG2' ' HB3' ' A' ' 76' ' ' GLU . 8.0 p -68.26 -27.26 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.3 -0.875 . . . . 0.53000000000000003 111.34 -179.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.458 HG22 HD12 ' A' ' 62' ' ' ILE . 2.9 p -79.92 -34.14 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.01 -1.056 . . . . 1.0600000000000001 110.703 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -80.92 -23.71 38.7 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.058 -1.027 . . . . 1.52 110.585 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 31.7 mtm180 -76.59 -43.8 37.1 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.318 -0.864 . . . . 1.48 110.793 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.598 ' CB ' HD13 ' A' ' 73' ' ' LEU . 90.1 m-70 -93.19 -45.65 7.77 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.365 -0.834 . . . . 1.8700000000000001 110.843 -179.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.92 148.84 37.83 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 121.337 -0.852 . . . . 1.0600000000000001 110.072 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.02 140.28 34.39 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 O-C-N 123.884 1.465 . . . . 0.87 110.572 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.96 154.45 9.41 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.729 -1.348 . . . . 0.52000000000000002 109.729 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.94 143.56 26.68 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.399 -1.06 . . . . 0.66000000000000003 110.002 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.459 ' HB3' ' O ' ' A' ' 61' ' ' THR . 51.0 m-85 -127.65 172.73 10.51 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.516 -0.74 . . . . 1.0800000000000001 110.517 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -142.23 154.38 64.24 Favored Pre-proline 0 N--CA 1.497 1.9 0 O-C-N 121.43 -0.794 . . . . 1.1899999999999999 110.82 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.537 ' HA ' ' HA ' ' A' ' 60' ' ' ILE . 53.4 Cg_endo -93.91 164.39 2.16 Favored 'Trans proline' 0 C--N 1.317 -1.11 0 C-N-CA 121.69 1.593 . . . . 0.46999999999999997 110.354 179.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 22.7 m -120.28 95.98 4.96 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.688 -0.856 . . . . 1.0900000000000001 108.688 178.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 9.9 p -75.78 143.8 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.538 -0.726 . . . . 1.0800000000000001 111.239 -178.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.409 ' HB2' ' HB3' ' A' ' 57' ' ' SER . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.671 0 O-C-N 121.722 -0.612 . . . . 0.64000000000000001 110.102 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 121.075 0.464 . . . . 0.94999999999999996 109.96 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -111.1 129.83 55.8 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.54 -0.725 . . . . 0.71999999999999997 110.483 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.409 ' HB3' ' HB2' ' A' ' 48' ' ' LYS . 0.4 OUTLIER -97.56 99.31 10.7 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.522 -0.736 . . . . 0.57999999999999996 109.451 179.341 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.521 HG11 ' HB ' ' A' ' 19' ' ' VAL . 1.0 OUTLIER -103.81 120.93 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.394 -0.816 . . . . 0.45000000000000001 110.746 -179.216 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.471 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 11.6 t -100.92 114.49 28.41 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.452 -0.78 . . . . 0.87 109.114 178.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.558 HD12 HG12 ' A' ' 31' ' ' VAL . 11.2 tt -93.47 132.7 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.268 -0.895 . . . . 1.0600000000000001 111.344 -178.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.459 ' O ' ' HB3' ' A' ' 43' ' ' TYR . 22.7 m -99.03 135.52 40.31 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.808 -0.812 . . . . 0.60999999999999999 108.808 178.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.487 HG23 HG22 ' A' ' 70' ' ' VAL . 3.1 tt -162.37 131.75 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.128 -0.983 . . . . 1.1000000000000001 111.003 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -105.28 101.19 10.75 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.407 -0.808 . . . . 0.64000000000000001 109.359 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -115.72 146.56 41.78 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.427 -0.795 . . . . 1.0900000000000001 110.64 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 47.3 p -79.35 -2.87 43.58 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.661 -0.649 . . . . 0.96999999999999997 111.136 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.506 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 8.6 t-160 -129.81 147.4 51.58 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.189 -0.944 . . . . 0.79000000000000004 110.746 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -78.95 -41.42 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.638 -0.664 . . . . 1.4299999999999999 109.843 179.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -65.47 -32.5 74.14 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.472 -0.767 . . . . 0.52000000000000002 110.661 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.506 ' HB2' ' HB3' ' A' ' 66' ' ' HIS . 0.6 OUTLIER -59.91 -55.81 29.53 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.361 -0.837 . . . . 0.63 110.531 -179.936 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.487 HG22 HG23 ' A' ' 62' ' ' ILE . 13.3 p -61.16 -29.89 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.351 -0.843 . . . . 1.02 110.452 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.416 ' N ' HG11 ' A' ' 70' ' ' VAL . 3.1 mm-40 -67.69 -43.85 79.13 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.229 -0.919 . . . . 0.46999999999999997 109.365 178.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 54.7 m -60.52 -38.63 85.02 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.604 -0.685 . . . . 1.0600000000000001 109.168 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.598 HD13 ' CB ' ' A' ' 38' ' ' HIS . 7.7 mp -63.71 -38.39 90.92 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.68 -0.638 . . . . 1.04 109.777 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.609 ' CD1' ' HB ' ' A' ' 86' ' ' VAL . 0.2 OUTLIER -59.3 -47.92 83.56 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 108.973 -0.751 . . . . 1.0600000000000001 108.973 178.693 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.14 -31.29 72.41 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.606 -0.684 . . . . 0.55000000000000004 110.214 179.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.442 ' HB3' ' CG2' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -66.14 -51.38 58.4 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.442 -0.787 . . . . 0.66000000000000003 110.236 179.501 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.664 ' HA ' ' HG2' ' A' ' 30' ' ' GLN . 0.4 OUTLIER -76.43 -25.41 54.4 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.431 -0.793 . . . . 1.04 110.536 179.685 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.615 ' HA2' ' HG2' ' A' ' 84' ' ' ARG . . . -101.11 39.23 2.81 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 110.051 -1.22 . . . . 0.27000000000000002 110.051 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.62 4.23 45.64 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.521 -0.988 . . . . 2.4199999999999999 110.635 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.7 mp -60.14 153.03 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.303 -0.873 . . . . 1.1200000000000001 110.064 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.5 -27.79 67.87 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.479 -0.763 . . . . 1.3 109.932 179.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.481 HG23 ' HB2' ' A' ' 22' ' ' GLN . 0.9 OUTLIER -68.26 171.99 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.526 -0.734 . . . . 1.1499999999999999 110.179 179.36 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 97.5 t -81.5 110.8 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.294 -0.879 . . . . 1.23 110.639 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.615 ' HG2' ' HA2' ' A' ' 78' ' ' GLY . 8.3 tpp180 -121.59 131.85 54.35 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.689 -0.632 . . . . 0.44 109.802 179.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.456 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 6.0 mtm -129.82 171.41 12.73 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.382 -0.823 . . . . 1.8799999999999999 110.516 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.609 ' HB ' ' CD1' ' A' ' 74' ' ' TYR . 8.8 p -138.62 156.03 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.548 -0.72 . . . . 0.41999999999999998 110.619 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.436 HD22 ' HA ' ' A' ' 17' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.5 2.029 0 CA-C-O 118.81 -0.614 . . . . 1.1000000000000001 110.398 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.2 t . . . . . 0 N--CA 1.495 1.82 0 N-CA-C 110.244 -0.28 . . . . 1.02 110.244 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.43 117.82 5.35 Favored 'Trans proline' 0 C--N 1.315 -1.212 0 O-C-N 123.893 1.47 . . . . 0.45000000000000001 110.811 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.636 ' HB2' ' HB ' ' A' ' 62' ' ' ILE . 16.7 m-85 -103.29 99.67 9.53 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.589 -0.694 . . . . 0.38 110.429 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.9 m -75.56 92.94 2.95 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.504 -0.925 . . . . 1.0900000000000001 108.504 178.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.458 ' HA ' ' CD2' ' A' ' 87' ' ' LEU . 3.4 m-85 -102.72 108.0 19.1 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.343 -0.848 . . . . 0.56000000000000005 110.9 -178.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.546 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 0.0 OUTLIER -78.3 89.72 4.34 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.532 -0.73 . . . . 1.4099999999999999 109.296 179.404 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.644 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . 24.8 t -78.57 96.5 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.487 -0.758 . . . . 1.04 109.906 -179.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.587 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 1.0 OUTLIER -97.21 149.71 21.72 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.541 -0.724 . . . . 1.73 110.124 -179.772 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 170.21 -151.44 16.61 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.848 -1.301 . . . . 0.40000000000000002 109.848 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.456 ' HB2' HG21 ' A' ' 82' ' ' ILE . 1.0 OUTLIER -79.38 151.45 30.95 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.545 -0.973 . . . . 0.89000000000000001 110.327 179.92 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.412 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -76.21 96.99 4.02 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.604 -0.685 . . . . 0.54000000000000004 110.199 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.4 155.53 76.45 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.469 -0.769 . . . . 1.3 110.45 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.56 -22.96 20.46 Favored 'Trans proline' 0 C--N 1.314 -1.263 0 O-C-N 123.927 1.488 . . . . 0.59999999999999998 110.803 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -70.32 -18.09 63.08 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.337 -0.852 . . . . 0.64000000000000001 111.035 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.408 ' O ' HG22 ' A' ' 31' ' ' VAL . 1.7 mm? -57.87 -66.28 0.5 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.305 -0.872 . . . . 1.1000000000000001 110.414 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.5 p -62.99 -29.5 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.449 -0.782 . . . . 1.0700000000000001 110.965 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -64.59 -57.66 8.5 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.338 -0.851 . . . . 0.46000000000000002 110.324 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.53 ' HG2' ' HA ' ' A' ' 77' ' ' LEU . 4.9 tp60 -69.33 -30.32 68.33 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.353 -0.842 . . . . 1.1799999999999999 110.821 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.549 HG23 HD12 ' A' ' 60' ' ' ILE . 2.3 t -59.79 -54.52 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.248 -0.907 . . . . 0.93000000000000005 110.242 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.417 ' O ' ' HG2' ' A' ' 36' ' ' GLN . 9.5 p -70.77 -32.74 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.339 -0.85 . . . . 1.01 111.15 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.58 -51.42 16.96 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.204 -0.935 . . . . 0.62 110.756 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.463 HG23 ' HB2' ' A' ' 76' ' ' GLU . 4.0 p -66.71 -29.22 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.467 -0.771 . . . . 0.39000000000000001 111.213 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.578 ' HA ' HD21 ' A' ' 73' ' ' LEU . 4.7 p -80.09 -31.93 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.035 -1.041 . . . . 0.38 110.711 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.484 ' HG3' ' N ' ' A' ' 37' ' ' ARG . 1.6 pt20 -82.42 -21.91 35.54 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.055 -1.028 . . . . 1.4099999999999999 110.685 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.484 ' N ' ' HG3' ' A' ' 36' ' ' GLN . 26.9 mtm180 -79.24 -41.84 27.29 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.278 -0.889 . . . . 0.90000000000000002 110.704 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.56 ' CD2' HD13 ' A' ' 73' ' ' LEU . 93.7 m-70 -95.9 -43.62 7.75 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.391 -0.818 . . . . 0.57999999999999996 110.683 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -98.01 150.64 36.96 Favored Pre-proline 0 N--CA 1.497 1.894 0 O-C-N 121.324 -0.86 . . . . 0.93999999999999995 109.924 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.36 140.09 29.88 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.678 1.357 . . . . 0.34999999999999998 110.673 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.63 154.02 14.18 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 110.045 -1.222 . . . . 0.40000000000000002 110.045 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -95.07 148.32 22.48 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.466 -1.02 . . . . 0.45000000000000001 109.914 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -135.1 175.9 9.16 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.467 -0.771 . . . . 1.0 110.723 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.425 HG21 ' HD2' ' A' ' 45' ' ' PRO . 0.2 OUTLIER -142.7 158.06 60.61 Favored Pre-proline 0 N--CA 1.498 1.95 0 O-C-N 121.398 -0.814 . . . . 1.3100000000000001 111.239 -178.973 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.5 ' HA ' ' HA ' ' A' ' 60' ' ' ILE . 54.4 Cg_endo -96.24 118.26 0.18 Allowed 'Trans proline' 0 C--N 1.318 -1.029 0 C-N-CA 122.121 1.881 . . . . 0.28000000000000003 110.431 179.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.479 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 31.9 m -76.24 104.71 6.9 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.086 -1.009 . . . . 1.0900000000000001 109.283 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.532 ' CB ' HG11 ' A' ' 58' ' ' VAL . 14.3 p -76.2 142.58 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.411 -0.806 . . . . 1.05 111.656 -178.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.424 ' HD2' HG21 ' A' ' 46' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.721 0 O-C-N 121.755 -0.591 . . . . 1.1100000000000001 109.787 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 33.3 t80 . . . . . 0 N--CA 1.497 1.908 0 CA-C-O 121.063 0.459 . . . . 0.89000000000000001 109.845 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.412 ' HB2' ' HA ' ' A' ' 23' ' ' ALA . 2.6 m170 -117.27 135.69 53.64 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.428 -0.795 . . . . 0.91000000000000003 110.904 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.587 ' HA ' ' HA ' ' A' ' 20' ' ' MET . 26.8 m -108.64 102.54 11.59 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 109.139 -0.689 . . . . 0.88 109.139 179.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.532 HG11 ' CB ' ' A' ' 47' ' ' VAL . 3.1 m -103.65 146.79 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.306 -0.871 . . . . 1.01 110.834 -179.022 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.546 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 7.3 t -108.98 114.15 27.66 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.852 -0.796 . . . . 0.88 108.852 179.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.549 HD12 HG23 ' A' ' 31' ' ' VAL . 8.8 tt -93.08 132.77 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.269 -0.894 . . . . 0.72999999999999998 111.763 -178.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 56.2 m -86.7 117.4 25.43 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.565 -0.902 . . . . 1.04 108.565 178.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.636 ' HB ' ' HB2' ' A' ' 15' ' ' PHE . 38.3 mm -114.29 132.93 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.068 -1.02 . . . . 0.78000000000000003 111.048 -178.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -108.18 62.1 0.61 Allowed 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.521 0.677 . . . . 0.39000000000000001 109.216 178.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.464 ' CB ' ' HB3' ' A' ' 69' ' ' GLN . . . -91.67 133.83 35.24 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.306 -0.871 . . . . 0.79000000000000004 110.686 -179.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 31.8 p -70.67 -17.83 62.84 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.608 -0.682 . . . . 0.94999999999999996 110.691 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -129.84 159.88 35.22 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.332 -0.855 . . . . 0.62 110.127 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.2 tt -74.62 -17.01 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.378 -0.826 . . . . 1.3899999999999999 110.783 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.9 -30.22 40.04 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.188 -0.945 . . . . 0.83999999999999997 110.25 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.464 ' HB3' ' CB ' ' A' ' 64' ' ' ALA . 0.4 OUTLIER -65.64 -47.97 73.77 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.395 -0.815 . . . . 0.57999999999999996 110.271 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.543 HG21 ' HB3' ' A' ' 15' ' ' PHE . 13.7 p -67.44 -28.82 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.367 -0.833 . . . . 1.0700000000000001 110.294 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.16 -52.94 56.57 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.354 -0.841 . . . . 0.83999999999999997 109.536 179.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.5 p -63.23 -35.66 81.05 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.503 -0.748 . . . . 1.01 109.487 179.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.578 HD21 ' HA ' ' A' ' 35' ' ' VAL . 3.6 mp -60.9 -39.58 89.84 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.634 -0.666 . . . . 1.01 109.557 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.582 ' CD1' ' HB ' ' A' ' 86' ' ' VAL . 0.3 OUTLIER -63.91 -48.69 75.6 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 109.143 -0.688 . . . . 0.66000000000000003 109.143 178.761 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.76 -36.71 83.95 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.549 -0.719 . . . . 0.68000000000000005 110.2 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.463 ' HB2' HG23 ' A' ' 34' ' ' VAL . 23.5 mt-10 -65.04 -47.38 77.6 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.586 -0.696 . . . . 0.35999999999999999 110.459 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.53 ' HA ' ' HG2' ' A' ' 30' ' ' GLN . 0.3 OUTLIER -76.84 -29.11 55.76 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.246 -0.909 . . . . 1.0600000000000001 110.433 179.718 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.47 ' N ' ' HG ' ' A' ' 77' ' ' LEU . . . -102.36 48.19 1.08 Allowed Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.503 -1.439 . . . . 0.25 109.503 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.9 ttmt -106.46 4.0 27.85 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.47 -1.017 . . . . 2.1800000000000002 110.808 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.0 mp -69.57 153.13 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.218 -0.926 . . . . 1.1200000000000001 110.105 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.12 -26.45 68.31 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.399 -0.813 . . . . 1.3799999999999999 110.239 179.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.456 HG21 ' HB2' ' A' ' 22' ' ' GLN . 1.0 OUTLIER -64.13 174.72 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.606 -0.684 . . . . 1.1899999999999999 110.583 179.671 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 75.4 t -63.71 117.49 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.392 -0.818 . . . . 1.1000000000000001 110.546 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.94 132.81 54.74 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.728 -0.607 . . . . 0.94999999999999996 110.049 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.469 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -154.22 160.54 41.89 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.215 -0.928 . . . . 2.29 110.318 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.644 ' HA ' ' HA ' ' A' ' 19' ' ' VAL . 8.2 p -141.48 157.23 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.406 -0.809 . . . . 0.35999999999999999 110.763 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.458 ' CD2' ' HA ' ' A' ' 17' ' ' TYR . 77.4 mt . . . . . 0 N--CA 1.501 2.08 0 CA-C-O 117.674 -1.155 . . . . 1.1299999999999999 110.554 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.7 t . . . . . 0 N--CA 1.495 1.784 0 N-CA-C 110.227 -0.286 . . . . 1.0600000000000001 110.227 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.94 122.56 8.92 Favored 'Trans proline' 0 C--N 1.315 -1.197 0 O-C-N 123.83 1.437 . . . . 0.46999999999999997 110.883 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.453 ' HB2' HG23 ' A' ' 62' ' ' ILE . 20.3 m-85 -106.38 99.78 9.34 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.652 -0.655 . . . . 0.46999999999999997 110.281 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.1 p -73.64 99.22 3.03 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.248 -1.019 . . . . 1.0800000000000001 108.248 178.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -113.91 159.54 19.77 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.384 -0.822 . . . . 0.93999999999999995 111.031 -178.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.588 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 0.7 OUTLIER -137.35 102.46 4.8 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.822 -0.807 . . . . 0.97999999999999998 108.822 179.204 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.513 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . 15.6 t -81.14 99.74 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 CA-C-O 121.463 0.649 . . . . 1.0600000000000001 110.193 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 35.7 mtt -94.77 155.01 17.01 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.479 -0.763 . . . . 1.9399999999999999 109.961 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 157.5 -150.12 20.98 Favored Glycine 0 N--CA 1.497 2.722 0 N-CA-C 110.194 -1.163 . . . . 0.34999999999999998 110.194 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.466 ' HB2' HG21 ' A' ' 82' ' ' ILE . 1.1 tm0? -76.93 160.81 28.89 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.51 -0.994 . . . . 0.73999999999999999 110.642 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -86.43 92.28 8.79 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.628 -0.67 . . . . 0.55000000000000004 110.053 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.59 150.31 72.62 Favored Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 121.504 -0.748 . . . . 1.0800000000000001 110.386 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -71.86 -24.06 21.56 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 O-C-N 123.861 1.453 . . . . 0.48999999999999999 111.461 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.82 -18.31 64.8 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.216 -0.927 . . . . 0.59999999999999998 111.044 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.428 HD21 HD12 ' A' ' 77' ' ' LEU . 0.7 OUTLIER -60.8 -63.18 1.39 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.225 -0.922 . . . . 1.3999999999999999 110.365 -179.956 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.6 p -65.38 -31.58 54.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.421 -0.799 . . . . 1.1000000000000001 110.63 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -63.4 -53.71 48.16 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.339 -0.851 . . . . 0.51000000000000001 110.188 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.517 ' HB3' ' HA ' ' A' ' 77' ' ' LEU . 1.1 tp-100 -68.55 -34.87 76.6 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.426 -0.796 . . . . 0.89000000000000001 110.658 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.7 t -57.28 -46.94 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.342 -0.849 . . . . 1.0600000000000001 109.997 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.414 ' O ' HG11 ' A' ' 35' ' ' VAL . 77.4 t -71.17 -37.25 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.493 -0.754 . . . . 1.1000000000000001 110.681 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.43 -54.32 11.05 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.181 -0.95 . . . . 1.03 110.839 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.496 HG23 ' HB2' ' A' ' 76' ' ' GLU . 9.9 p -62.79 -33.02 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.43 -0.794 . . . . 0.41999999999999998 111.395 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.513 ' HA ' HD21 ' A' ' 73' ' ' LEU . 3.2 p -77.21 -29.61 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.032 -1.043 . . . . 1.01 110.343 179.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -74.26 -35.19 63.77 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.235 -0.916 . . . . 1.4299999999999999 109.977 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.48 -23.87 61.1 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.493 -0.755 . . . . 1.6100000000000001 110.811 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -101.51 -46.0 5.12 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.206 -0.934 . . . . 0.66000000000000003 110.546 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -103.15 151.09 38.44 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.484 -0.76 . . . . 1.1100000000000001 109.841 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -69.94 -41.26 4.2 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 O-C-N 123.857 1.451 . . . . 0.85999999999999999 111.115 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -85.81 145.24 20.77 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.634 -1.386 . . . . 0.55000000000000004 109.634 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.9 152.03 27.0 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.446 -1.032 . . . . 0.80000000000000004 109.962 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.489 ' HB3' ' O ' ' A' ' 61' ' ' THR . 45.2 m-85 -136.9 159.79 40.82 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.529 -0.732 . . . . 0.83999999999999997 110.573 -179.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.457 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 22.8 m -142.32 151.51 58.35 Favored Pre-proline 0 N--CA 1.499 1.984 0 O-C-N 121.445 -0.784 . . . . 0.54000000000000004 111.301 -179.054 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.676 ' HA ' ' HA ' ' A' ' 60' ' ' ILE . 54.1 Cg_endo -96.51 135.84 0.5 Allowed 'Trans proline' 0 C--N 1.32 -0.958 0 C-N-CA 122.03 1.82 . . . . 0.47999999999999998 110.508 178.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 32.1 m -95.03 108.43 20.5 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.16 -0.963 . . . . 1.01 109.17 179.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.47 ' HA ' HG12 ' A' ' 58' ' ' VAL . 7.7 p -75.9 141.58 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.444 -0.785 . . . . 1.1100000000000001 111.54 -178.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.7 mtmp? . . . . . 0 N--CA 1.495 1.782 0 O-C-N 121.885 -0.509 . . . . 1.5 109.905 179.611 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 30.2 t80 . . . . . 0 N--CA 1.497 1.904 0 CA-C-O 121.137 0.494 . . . . 0.70999999999999996 110.111 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 1.2 m170 -125.06 145.26 50.0 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.281 -0.887 . . . . 1.1699999999999999 111.333 -179.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.0 t -119.22 106.09 12.0 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.54 -0.911 . . . . 0.67000000000000004 108.54 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.484 ' HA ' ' O ' ' A' ' 46' ' ' THR . 2.1 m -103.29 146.4 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.272 -0.892 . . . . 1.02 111.176 -178.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.588 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 16.9 p -103.89 110.67 22.89 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.64 -0.874 . . . . 0.73999999999999999 108.64 178.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.676 ' HA ' ' HA ' ' A' ' 45' ' ' PRO . 13.8 tt -93.12 128.34 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 CA-C-O 121.902 0.858 . . . . 0.93999999999999995 111.459 -178.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.489 ' O ' ' HB3' ' A' ' 43' ' ' TYR . 22.5 m -97.18 126.83 42.62 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.193 -1.04 . . . . 0.77000000000000002 108.193 178.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.453 HG23 ' HB2' ' A' ' 15' ' ' PHE . 11.0 tt -153.9 141.03 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.124 -0.985 . . . . 1.3799999999999999 111.466 -178.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -117.22 102.99 9.74 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.723 -0.843 . . . . 0.73999999999999999 108.723 178.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.565 ' HB3' ' HB3' ' A' ' 69' ' ' GLN . . . -109.86 141.01 43.17 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.485 -0.759 . . . . 1.0700000000000001 111.312 -178.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.2 p -74.29 -5.23 40.95 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.788 -0.57 . . . . 0.94999999999999996 111.269 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.716 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 49.5 t60 -129.73 146.54 51.49 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.969 -1.082 . . . . 0.65000000000000002 110.188 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -67.64 -30.01 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.52 -0.738 . . . . 1.6499999999999999 110.749 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.05 -11.66 43.49 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.274 -0.891 . . . . 0.93000000000000005 111.068 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.716 ' HB2' ' HB3' ' A' ' 66' ' ' HIS . 8.8 tt0 -61.52 -46.54 89.54 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.22 -0.925 . . . . 1.1599999999999999 109.874 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.1 p -70.48 -28.92 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.638 -0.664 . . . . 0.82999999999999996 110.01 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.99 -50.06 45.35 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.485 -0.759 . . . . 0.56000000000000005 109.604 179.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.6 p -61.81 -40.78 96.43 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.527 -0.733 . . . . 1.0800000000000001 109.51 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.513 HD21 ' HA ' ' A' ' 35' ' ' VAL . 2.8 mp -60.45 -37.59 81.44 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.682 -0.636 . . . . 1.1699999999999999 109.694 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.532 ' CD1' ' HB ' ' A' ' 86' ' ' VAL . 0.4 OUTLIER -62.97 -45.03 94.36 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.564 -0.71 . . . . 1.0 109.179 178.662 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.46 -36.15 79.61 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.498 -0.751 . . . . 0.52000000000000002 109.988 179.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.496 ' HB2' HG23 ' A' ' 34' ' ' VAL . 0.5 OUTLIER -67.55 -49.07 65.01 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.544 -0.722 . . . . 0.47999999999999998 110.279 179.497 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.517 ' HA ' ' HB3' ' A' ' 30' ' ' GLN . 0.3 OUTLIER -72.62 -27.23 62.02 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.423 -0.798 . . . . 0.95999999999999996 110.533 179.622 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.459 ' N ' ' HG ' ' A' ' 77' ' ' LEU . . . -107.44 38.96 3.07 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.678 -1.369 . . . . 0.31 109.678 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.91 4.09 54.54 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.31 -1.112 . . . . 1.49 110.732 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.4 mp -72.17 155.07 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.321 -0.862 . . . . 1.24 109.982 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -68.71 -15.78 63.62 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.41 -0.806 . . . . 0.91000000000000003 110.235 178.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.466 HG21 ' HB2' ' A' ' 22' ' ' GLN . 49.7 mm -71.33 170.14 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.544 -0.723 . . . . 1.27 109.985 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 76.1 t -62.42 115.06 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.342 -0.849 . . . . 1.1699999999999999 110.818 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -121.19 140.74 51.61 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.857 -0.527 . . . . 1.0800000000000001 109.595 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.1 mtp -158.54 154.05 26.05 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.062 -1.024 . . . . 2.0099999999999998 110.29 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.532 ' HB ' ' CD1' ' A' ' 74' ' ' TYR . 5.9 p -142.5 157.44 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.32 -0.863 . . . . 0.93999999999999995 110.801 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.577 ' HB3' ' HB2' ' A' ' 18' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.497 1.899 0 CA-C-O 117.955 -1.022 . . . . 1.0600000000000001 109.878 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.0 t . . . . . 0 N--CA 1.495 1.802 0 CA-C-O 120.559 0.219 . . . . 0.81999999999999995 110.455 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -71.65 127.23 12.89 Favored 'Trans proline' 0 C--N 1.315 -1.213 0 O-C-N 123.911 1.48 . . . . 0.34999999999999998 110.389 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -108.5 99.69 9.05 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.482 -0.761 . . . . 0.5 110.467 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.5 m -74.18 92.9 2.25 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.169 -1.049 . . . . 1.0700000000000001 108.169 178.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -105.09 106.69 17.3 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.379 -0.826 . . . . 0.72999999999999998 110.897 -178.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.577 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 0.0 OUTLIER -79.27 92.49 5.14 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.533 -0.729 . . . . 1.7 109.532 179.525 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.556 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . 15.7 t -79.02 96.09 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.462 -0.774 . . . . 1.0600000000000001 109.516 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.639 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 44.4 ttp -98.05 148.71 23.24 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.601 -0.687 . . . . 1.52 110.295 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 166.83 -152.35 21.17 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.664 -1.374 . . . . 0.28999999999999998 109.664 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.484 ' HB3' HD12 ' A' ' 24' ' ' LEU . 20.7 tp60 -74.01 138.9 44.39 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.423 -1.045 . . . . 1.3400000000000001 110.394 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.53 ' HB1' ' HB2' ' A' ' 56' ' ' HIS . . . -68.35 115.24 7.56 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.665 -0.647 . . . . 1.1799999999999999 110.378 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.484 HD12 ' HB3' ' A' ' 22' ' ' GLN . 0.2 OUTLIER -131.86 150.91 77.5 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.623 -0.673 . . . . 1.3 110.2 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -73.0 -24.87 16.89 Favored 'Trans proline' 0 C--N 1.313 -1.335 0 O-C-N 123.839 1.442 . . . . 0.65000000000000002 111.079 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.15 -7.32 58.1 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.244 -0.91 . . . . 0.81000000000000005 111.643 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.85 -60.03 4.48 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.033 -1.042 . . . . 1.72 110.374 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.2 p -62.97 -31.36 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 121.439 -0.788 . . . . 1.21 110.567 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -68.32 -56.42 8.65 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.372 -0.83 . . . . 0.46999999999999997 109.913 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.604 ' HG2' ' HA ' ' A' ' 77' ' ' LEU . 0.1 OUTLIER -63.19 -38.62 91.9 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.338 -0.851 . . . . 1.3 110.269 179.524 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.513 HG11 HD12 ' A' ' 60' ' ' ILE . 2.4 t -56.57 -52.0 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.542 -0.723 . . . . 1.1100000000000001 110.216 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 40.1 t -63.68 -40.88 90.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.47 -0.769 . . . . 0.94999999999999996 111.244 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.13 -50.77 29.93 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.309 -0.869 . . . . 0.62 111.134 -179.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.521 HG23 ' HA ' ' A' ' 73' ' ' LEU . 8.9 p -69.1 -28.05 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.485 -0.759 . . . . 0.29999999999999999 111.521 -179.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.508 ' CG2' HG12 ' A' ' 62' ' ' ILE . 1.9 p -83.21 -27.05 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.034 -1.041 . . . . 0.39000000000000001 110.784 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -78.89 -39.7 34.27 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.235 -0.915 . . . . 0.63 110.429 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 14.4 ptt180 -69.56 -20.1 63.67 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.344 -0.847 . . . . 1.24 111.33 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -106.16 -45.77 4.23 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.15 -0.969 . . . . 1.0800000000000001 110.768 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -103.68 149.84 37.52 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.401 -0.812 . . . . 1.0700000000000001 109.997 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.33 140.4 36.88 Favored 'Trans proline' 0 C--N 1.314 -1.241 0 O-C-N 123.802 1.422 . . . . 0.66000000000000003 110.636 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.06 172.92 49.25 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.706 -1.357 . . . . 0.56000000000000005 109.706 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -100.99 144.69 29.62 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.439 -1.036 . . . . 0.56999999999999995 110.338 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.452 ' HB3' ' O ' ' A' ' 61' ' ' THR . 83.5 m-85 -129.08 165.46 21.18 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.509 -0.745 . . . . 0.89000000000000001 110.325 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.431 HG21 ' HD2' ' A' ' 45' ' ' PRO . 0.2 OUTLIER -142.57 156.79 63.21 Favored Pre-proline 0 N--CA 1.499 1.992 0 O-C-N 121.371 -0.831 . . . . 1.3700000000000001 111.165 -179.417 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.499 ' HA ' ' HA ' ' A' ' 60' ' ' ILE . 53.2 Cg_endo -96.54 132.78 0.41 Allowed 'Trans proline' 0 C--N 1.32 -0.952 0 C-N-CA 122.233 1.955 . . . . 0.53000000000000003 110.292 178.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.432 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 36.2 m -93.89 92.11 7.24 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.955 -1.09 . . . . 1.1599999999999999 109.502 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.495 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 11.3 p -76.55 140.69 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.474 -0.766 . . . . 1.03 111.638 -178.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.1 ptpt . . . . . 0 N--CA 1.493 1.715 0 O-C-N 121.785 -0.572 . . . . 2.0699999999999998 109.498 179.089 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 23.0 t80 . . . . . 0 N--CA 1.498 1.926 0 CA-C-O 121.181 0.515 . . . . 0.60999999999999999 110.021 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.53 ' HB2' ' HB1' ' A' ' 23' ' ' ALA . 1.6 m80 -130.16 148.14 51.97 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.373 -0.829 . . . . 0.57999999999999996 111.174 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.639 ' HA ' ' HA ' ' A' ' 20' ' ' MET . 89.3 p -113.34 126.12 55.03 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 109.155 -0.683 . . . . 0.69999999999999996 109.155 179.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.495 ' HA ' ' HA ' ' A' ' 47' ' ' VAL . 1.5 m -116.59 141.37 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.241 -0.912 . . . . 0.70999999999999996 111.116 -178.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.577 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 1.3 t -103.08 106.41 16.92 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.387 -0.821 . . . . 1.1799999999999999 108.87 178.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.513 HD12 HG11 ' A' ' 31' ' ' VAL . 6.2 tt -93.7 132.1 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.273 -0.892 . . . . 0.96999999999999997 111.264 -178.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.452 ' O ' ' HB3' ' A' ' 43' ' ' TYR . 85.9 m -87.12 127.79 35.12 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 108.635 -0.876 . . . . 1.0800000000000001 108.635 178.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.508 HG12 ' CG2' ' A' ' 35' ' ' VAL . 44.5 mt -137.85 103.36 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 120.995 -1.065 . . . . 1.0900000000000001 111.176 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -85.08 80.51 9.23 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.298 -0.876 . . . . 0.45000000000000001 109.17 178.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -101.74 136.74 41.07 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.515 -0.741 . . . . 0.95999999999999996 110.311 -179.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 39.9 p -68.8 -14.8 63.26 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.45 -0.781 . . . . 1.0600000000000001 111.063 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -130.85 159.74 36.47 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.246 -0.909 . . . . 0.60999999999999999 110.764 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 8.4 tp -76.5 -27.15 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.532 -0.73 . . . . 1.1299999999999999 110.367 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.32 -26.9 63.04 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.203 -0.936 . . . . 0.64000000000000001 110.558 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -63.84 -53.46 50.41 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.393 -0.817 . . . . 2.3100000000000001 110.231 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.4 p -65.73 -27.59 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.662 -0.649 . . . . 0.93000000000000005 110.441 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.18 -48.31 73.89 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.316 -0.865 . . . . 0.46000000000000002 109.286 178.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 82.7 m -64.36 -34.59 78.52 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.741 -0.599 . . . . 1.0600000000000001 109.436 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.521 ' HA ' HG23 ' A' ' 34' ' ' VAL . 5.2 mp -63.14 -40.29 97.14 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.67 -0.644 . . . . 1.0800000000000001 109.714 179.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.631 ' CD1' ' HB ' ' A' ' 86' ' ' VAL . 0.7 OUTLIER -64.77 -43.86 91.9 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.604 -0.685 . . . . 0.45000000000000001 109.457 178.886 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -65.98 -32.87 74.6 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.474 -0.766 . . . . 0.75 110.735 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.507 ' CB ' HG23 ' A' ' 34' ' ' VAL . 0.3 OUTLIER -70.49 -55.52 8.76 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.333 -0.854 . . . . 0.51000000000000001 110.378 179.972 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.604 ' HA ' ' HG2' ' A' ' 30' ' ' GLN . 0.3 OUTLIER -70.27 -28.19 65.02 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.361 -0.837 . . . . 0.87 110.199 179.677 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.507 ' N ' ' HG ' ' A' ' 77' ' ' LEU . . . -107.59 55.78 0.51 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.428 -1.469 . . . . 0.26000000000000001 109.428 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -106.07 4.18 28.95 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.702 -0.881 . . . . 1.97 110.6 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.7 mp -63.44 145.05 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.35 -0.844 . . . . 1.1299999999999999 110.195 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.73 -5.93 41.08 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.509 -0.744 . . . . 1.6200000000000001 111.603 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.48 HD12 ' HA ' ' A' ' 82' ' ' ILE . 47.3 mm -80.77 -106.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.031 -1.043 . . . . 1.21 109.887 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.464 HG23 HG23 ' A' ' 82' ' ' ILE . 63.5 t -123.93 112.16 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 120.915 -1.116 . . . . 1.04 110.389 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.06 122.02 38.31 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.37 0.605 . . . . 0.81000000000000005 109.727 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.488 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 1.3 ttm -146.88 158.6 43.96 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.25 -0.906 . . . . 3.0099999999999998 110.174 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.631 ' HB ' ' CD1' ' A' ' 74' ' ' TYR . 9.8 p -141.45 154.13 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.429 -0.795 . . . . 0.44 110.837 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.499 1.989 0 CA-C-O 118.823 -0.608 . . . . 1.0800000000000001 110.407 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.5 t . . . . . 0 N--CA 1.496 1.836 0 CA-C-O 120.612 0.244 . . . . 1.01 110.459 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.66 129.6 14.79 Favored 'Trans proline' 0 C--N 1.314 -1.261 0 O-C-N 123.879 1.462 . . . . 0.41999999999999998 110.637 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -109.6 99.7 8.86 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.596 -0.69 . . . . 0.5 110.217 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.2 m -73.95 92.58 2.12 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.257 -1.016 . . . . 1.05 108.257 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.437 ' CZ ' HG21 ' A' ' 70' ' ' VAL . 2.9 m-85 -103.55 103.74 13.72 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.461 -0.774 . . . . 0.54000000000000004 110.949 -178.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.643 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 0.1 OUTLIER -82.3 97.45 8.31 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.344 -0.847 . . . . 3.7599999999999998 109.741 179.404 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.56 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . 15.9 t -79.95 96.89 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.427 -0.795 . . . . 1.05 109.37 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 60.2 mtm -101.36 127.3 48.05 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.571 -0.705 . . . . 1.28 110.254 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -157.15 -158.81 9.12 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.875 -1.29 . . . . 0.40000000000000002 109.875 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.428 ' HB2' ' CG2' ' A' ' 82' ' ' ILE . 0.0 OUTLIER -68.78 177.49 2.53 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.364 -1.08 . . . . 1.55 110.559 -179.979 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.423 ' HA ' ' CG ' ' A' ' 56' ' ' HIS . . . -79.4 91.03 5.04 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.427 -0.796 . . . . 0.52000000000000002 110.459 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -133.81 132.29 21.48 Favored Pre-proline 0 N--CA 1.496 1.847 0 O-C-N 121.397 -0.814 . . . . 1.1000000000000001 110.249 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -76.43 -4.19 14.73 Favored 'Trans proline' 0 N--CA 1.489 1.216 0 O-C-N 123.702 1.369 . . . . 0.59999999999999998 112.057 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -80.14 -5.84 56.7 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 120.968 -1.082 . . . . 0.62 111.466 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.631 HD11 HG13 ' A' ' 58' ' ' VAL . 4.1 pp -66.13 -38.23 87.63 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.932 -1.105 . . . . 1.1699999999999999 111.083 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.8 p -76.53 -29.83 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.256 -0.902 . . . . 0.93000000000000005 110.855 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -69.27 -53.84 17.73 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.365 -0.834 . . . . 0.39000000000000001 110.116 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.644 ' HG2' ' HA ' ' A' ' 77' ' ' LEU . 0.6 OUTLIER -67.66 -38.78 84.25 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.34 -0.85 . . . . 0.71999999999999997 110.75 179.911 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.425 ' CG1' ' CD1' ' A' ' 60' ' ' ILE . 2.8 t -59.39 -56.87 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.362 -0.836 . . . . 0.68999999999999995 110.615 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.7 p -62.79 -33.71 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 121.292 -0.88 . . . . 1.05 111.549 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.85 -55.91 5.32 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.043 -1.036 . . . . 0.42999999999999999 110.823 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.562 HG22 ' HB2' ' A' ' 76' ' ' GLU . 6.2 p -65.53 -23.97 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.34 -0.85 . . . . 0.38 111.512 -179.324 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.45 ' HA ' HD21 ' A' ' 73' ' ' LEU . 1.8 p -86.0 -32.52 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 120.922 -1.111 . . . . 0.76000000000000001 111.078 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -78.73 -26.92 44.78 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.966 -1.084 . . . . 0.45000000000000001 110.558 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.86 -39.51 35.03 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.276 -0.89 . . . . 0.77000000000000002 110.609 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.648 ' HB2' HD11 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -86.69 -45.54 10.88 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.35 -0.844 . . . . 0.40999999999999998 110.571 -179.878 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -100.69 152.15 37.77 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.434 -0.791 . . . . 1.1100000000000001 109.993 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.42 140.58 36.92 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 O-C-N 123.844 1.444 . . . . 0.47999999999999998 110.584 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.22 162.41 26.2 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.749 -1.341 . . . . 0.52000000000000002 109.749 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.05 143.62 27.71 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.426 -1.043 . . . . 0.41999999999999998 110.088 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.427 ' HB3' ' O ' ' A' ' 61' ' ' THR . 82.8 m-85 -125.79 166.37 16.96 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.493 -0.754 . . . . 0.51000000000000001 110.448 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.459 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 3.9 m -140.76 152.36 65.58 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.408 -0.808 . . . . 0.77000000000000002 111.083 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.582 ' HA ' ' HA ' ' A' ' 60' ' ' ILE . 54.6 Cg_endo -96.06 123.42 0.27 Allowed 'Trans proline' 0 C--N 1.319 -0.999 0 C-N-CA 122.125 1.884 . . . . 0.25 110.545 179.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.487 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 58.6 m -75.3 92.72 2.79 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.213 -0.929 . . . . 0.98999999999999999 108.779 178.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.462 HG21 ' CG1' ' A' ' 58' ' ' VAL . 8.3 p -80.75 139.38 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 CA-C-O 121.863 0.84 . . . . 1.05 112.406 -178.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.465 ' HG2' ' O ' ' A' ' 57' ' ' SER . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.695 0 N-CA-C 108.709 -0.848 . . . . 1.1299999999999999 108.709 178.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 16.0 t80 . . . . . 0 N--CA 1.497 1.879 0 CA-C-O 121.144 0.497 . . . . 1.01 110.351 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.423 ' CG ' ' HA ' ' A' ' 23' ' ' ALA . 5.4 m170 -116.27 123.76 48.49 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.558 -0.713 . . . . 1.02 110.317 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.465 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 26.0 m -108.7 119.88 40.82 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.435 -0.791 . . . . 0.84999999999999998 108.913 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.631 HG13 HD11 ' A' ' 27' ' ' LEU . 1.7 m -124.81 151.62 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 120.957 -1.089 . . . . 1.01 111.221 -178.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.643 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 6.4 t -118.82 105.86 11.95 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.586 -0.696 . . . . 1.0 109.155 179.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.582 ' HA ' ' HA ' ' A' ' 45' ' ' PRO . 2.5 tp -93.29 129.93 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.238 -0.914 . . . . 0.40999999999999998 111.07 -179.027 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.427 ' O ' ' HB3' ' A' ' 43' ' ' TYR . 49.5 m -85.44 121.92 28.84 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.855 -0.794 . . . . 0.94999999999999996 108.855 178.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.43 HG12 ' CG2' ' A' ' 35' ' ' VAL . 68.2 mt -127.82 109.25 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 120.939 -1.101 . . . . 1.1200000000000001 110.986 -178.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -90.7 92.96 9.04 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.418 -0.801 . . . . 0.62 109.576 179.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -117.79 139.38 51.15 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.53 -0.731 . . . . 1.0600000000000001 110.39 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 34.5 p -74.86 -13.0 60.51 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.502 -0.749 . . . . 0.56000000000000005 110.729 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -129.14 148.15 51.06 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.338 -0.851 . . . . 0.51000000000000001 110.311 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -72.87 -21.7 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.511 -0.743 . . . . 1.3600000000000001 110.763 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.18 -23.86 57.76 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.144 -0.973 . . . . 0.5 110.844 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -71.21 -50.45 32.94 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.296 -0.877 . . . . 0.58999999999999997 110.268 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.437 HG21 ' CZ ' ' A' ' 17' ' ' TYR . 8.1 p -65.81 -31.52 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.56 -0.712 . . . . 0.92000000000000004 110.339 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.4 -47.22 77.04 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.361 -0.837 . . . . 0.46999999999999997 109.343 178.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 93.4 m -62.47 -34.7 77.35 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.705 -0.622 . . . . 1.0600000000000001 109.498 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.648 HD11 ' HB2' ' A' ' 38' ' ' HIS . 2.0 mp -61.96 -41.02 97.51 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.583 -0.698 . . . . 0.95999999999999996 109.593 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.529 ' CD1' ' HB ' ' A' ' 86' ' ' VAL . 2.7 t80 -64.64 -40.47 95.51 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.597 -0.689 . . . . 0.78000000000000003 109.323 178.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.57 -38.49 87.7 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.379 -0.826 . . . . 0.44 110.254 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.562 ' HB2' HG22 ' A' ' 34' ' ' VAL . 0.4 OUTLIER -71.12 -50.73 30.46 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.483 -0.76 . . . . 0.46999999999999997 110.721 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.644 ' HA ' ' HG2' ' A' ' 30' ' ' GLN . 0.2 OUTLIER -72.01 -27.71 62.91 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.316 -0.865 . . . . 1.01 110.574 179.944 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.487 ' N ' ' HG ' ' A' ' 77' ' ' LEU . . . -100.84 38.13 3.28 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.646 -1.382 . . . . 0.28000000000000003 109.646 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.54 3.72 27.36 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.545 -0.974 . . . . 0.71999999999999997 110.815 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.0 mt -67.36 155.91 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.15 -0.969 . . . . 1.02 109.911 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -62.25 -25.0 67.58 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.349 -0.844 . . . . 0.5 110.005 179.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.428 ' CG2' ' HB2' ' A' ' 22' ' ' GLN . 49.7 mm -73.54 163.89 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.555 -0.716 . . . . 1.0800000000000001 109.92 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 92.2 t -71.6 106.28 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.409 -0.807 . . . . 1.1100000000000001 110.843 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 1.4 tpm_? -121.99 114.03 20.4 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.598 -0.689 . . . . 0.47999999999999998 109.585 179.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.46 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -120.65 170.54 9.33 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.296 -0.877 . . . . 2.1699999999999999 110.38 -179.713 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.56 ' HA ' ' HA ' ' A' ' 19' ' ' VAL . 4.7 p -138.16 155.21 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.472 -0.768 . . . . 0.96999999999999997 110.629 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.498 1.937 0 CA-C-O 117.738 -1.125 . . . . 1.1100000000000001 110.43 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.5 t . . . . . 0 N--CA 1.496 1.835 0 N-CA-C 110.037 -0.357 . . . . 1.01 110.037 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -71.98 125.22 10.75 Favored 'Trans proline' 0 C--N 1.314 -1.282 0 O-C-N 123.869 1.458 . . . . 0.44 111.19 -179.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.526 ' HB3' HG21 ' A' ' 70' ' ' VAL . 23.4 m-85 -110.35 99.31 8.36 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.591 -0.693 . . . . 0.40000000000000002 110.249 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.4 m -78.99 92.32 4.94 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.21 -1.033 . . . . 1.1000000000000001 108.21 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.429 ' CE1' HG21 ' A' ' 70' ' ' VAL . 3.4 m-85 -99.66 107.91 20.14 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.496 -0.752 . . . . 0.93000000000000005 110.768 -178.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.648 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 0.0 OUTLIER -87.56 89.7 8.09 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.592 -0.693 . . . . 2.3100000000000001 109.944 179.825 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.553 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . 2.4 m -82.34 110.35 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.36 -0.837 . . . . 1.05 109.828 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 53.9 mtt -109.36 157.34 18.99 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.611 -0.681 . . . . 1.3600000000000001 110.282 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 169.36 -164.04 37.62 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 109.986 -1.246 . . . . 0.5 109.986 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.489 ' HB2' HG22 ' A' ' 82' ' ' ILE . 6.3 mt-30 -69.59 150.85 46.64 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.53 -0.982 . . . . 2.1000000000000001 110.017 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.416 ' HA ' ' CD2' ' A' ' 56' ' ' HIS . . . -53.74 111.7 0.78 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.583 -0.698 . . . . 1.1499999999999999 110.548 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.7 mt -132.21 129.72 21.75 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.585 -0.697 . . . . 1.3899999999999999 110.395 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.65 -21.65 18.91 Favored 'Trans proline' 0 C--N 1.315 -1.231 0 O-C-N 123.849 1.447 . . . . 0.80000000000000004 111.171 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -81.33 -4.25 55.08 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.271 -0.893 . . . . 1.46 111.298 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.98 -58.34 8.27 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.991 -1.068 . . . . 1.24 110.332 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.495 HG11 ' HG2' ' A' ' 45' ' ' PRO . 36.0 m -62.22 -29.67 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 O-C-N 121.497 -0.752 . . . . 1.1100000000000001 111.042 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.445 ' O ' HG12 ' A' ' 32' ' ' VAL . 31.9 t70 -70.22 -53.26 17.77 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.286 -0.884 . . . . 0.52000000000000002 110.427 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.591 ' HG2' ' HA ' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -69.17 -35.8 76.68 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.326 -0.859 . . . . 1.8500000000000001 110.352 179.6 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.403 ' O ' ' HB ' ' A' ' 35' ' ' VAL . 3.8 t -61.81 -51.47 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.574 -0.704 . . . . 1.0 110.562 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.445 HG12 ' O ' ' A' ' 29' ' ' ASP . 6.1 p -67.03 -32.63 58.77 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.232 -0.917 . . . . 1.0800000000000001 111.223 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.63 -50.93 14.02 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.079 -1.013 . . . . 1.0800000000000001 110.509 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.488 HG22 ' HA ' ' A' ' 73' ' ' LEU . 9.9 p -67.69 -30.37 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.366 -0.834 . . . . 0.40000000000000002 110.898 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.606 HG22 ' CG1' ' A' ' 62' ' ' ILE . 2.3 p -76.64 -38.2 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.073 -1.017 . . . . 0.98999999999999999 110.352 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -74.05 -22.45 59.53 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.054 -1.029 . . . . 0.56000000000000005 109.946 179.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.0 mtp-105 -68.48 -49.24 61.24 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.415 -0.803 . . . . 0.92000000000000004 110.154 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.413 ' CE1' ' HG2' ' A' ' 69' ' ' GLN . 2.0 m-70 -84.54 -45.78 12.25 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.39 -0.819 . . . . 0.40999999999999998 110.498 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.83 153.79 83.11 Favored Pre-proline 0 N--CA 1.497 1.897 0 O-C-N 121.351 -0.843 . . . . 0.34999999999999998 110.068 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -69.06 -34.54 16.68 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.922 1.485 . . . . 0.48999999999999999 111.395 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -108.86 -178.61 21.57 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 110.063 -1.215 . . . . 0.46000000000000002 110.063 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.14 148.68 22.8 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.553 -0.969 . . . . 0.52000000000000002 109.648 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -135.4 172.84 12.43 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.409 -0.807 . . . . 0.56000000000000005 111.188 -179.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.489 HG21 ' CD ' ' A' ' 45' ' ' PRO . 0.3 OUTLIER -142.39 156.53 63.89 Favored Pre-proline 0 N--CA 1.496 1.851 0 O-C-N 121.613 -0.68 . . . . 1.1100000000000001 110.513 -179.64 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.56 ' HB2' ' HB ' ' A' ' 58' ' ' VAL . 52.6 Cg_endo -94.64 121.94 0.34 Allowed 'Trans proline' 0 C--N 1.317 -1.125 0 C-N-CA 121.986 1.79 . . . . 0.33000000000000002 110.229 179.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.44 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 74.2 m -80.44 101.4 9.02 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.079 -1.013 . . . . 1.0900000000000001 109.572 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.473 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 12.1 p -76.52 141.2 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.408 -0.807 . . . . 1.0700000000000001 111.525 -179.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.458 ' HE2' ' HB3' ' A' ' 57' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.729 0 O-C-N 121.752 -0.593 . . . . 1.1599999999999999 109.691 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 14.9 t80 . . . . . 0 N--CA 1.495 1.793 0 CA-C-O 121.17 0.51 . . . . 1.27 110.231 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.416 ' CD2' ' HA ' ' A' ' 23' ' ' ALA . 0.6 OUTLIER -142.25 146.71 35.44 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.506 -0.746 . . . . 0.51000000000000001 110.31 179.824 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.458 ' HB3' ' HE2' ' A' ' 48' ' ' LYS . 37.5 m -119.69 114.22 21.85 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.282 -0.886 . . . . 0.90000000000000002 109.719 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.56 ' HB ' ' HB2' ' A' ' 45' ' ' PRO . 3.1 m -114.07 146.76 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.136 -0.977 . . . . 0.64000000000000001 110.952 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.648 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 45.5 t -112.97 111.1 21.6 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.687 -0.633 . . . . 0.76000000000000001 109.43 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.504 ' HA ' ' HA ' ' A' ' 45' ' ' PRO . 2.2 tp -92.74 129.79 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 C-N-CA 119.773 -0.771 . . . . 0.38 111.042 -179.15 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 82.7 m -82.34 137.83 34.67 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.934 -0.765 . . . . 1.05 108.934 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.606 ' CG1' HG22 ' A' ' 35' ' ' VAL . 2.3 mt -136.95 139.54 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.105 -0.997 . . . . 1.1499999999999999 111.017 -179.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -117.99 69.55 0.78 Allowed 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 121.457 0.646 . . . . 0.45000000000000001 109.299 179.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.482 ' HB2' ' HB2' ' A' ' 69' ' ' GLN . . . -99.59 135.78 40.5 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.489 -0.757 . . . . 0.94999999999999996 110.269 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 58.0 p -73.73 -13.05 60.9 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.492 -0.755 . . . . 1.1200000000000001 110.847 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 8.7 t60 -129.47 157.16 42.78 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.249 -0.907 . . . . 0.62 110.76 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.14 -24.88 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.534 -0.729 . . . . 1.6200000000000001 110.43 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -70.96 -31.26 67.77 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.319 -0.863 . . . . 0.94999999999999996 110.278 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.482 ' HB2' ' HB2' ' A' ' 64' ' ' ALA . 57.1 mt-30 -63.06 -52.74 61.59 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.472 -0.768 . . . . 0.42999999999999999 110.025 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.526 HG21 ' HB3' ' A' ' 15' ' ' PHE . 7.7 p -69.31 -26.98 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.371 -0.831 . . . . 0.92000000000000004 110.222 179.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.95 -52.27 64.72 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.345 -0.847 . . . . 0.70999999999999996 109.229 178.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.5 p -63.83 -35.75 81.65 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.474 -0.767 . . . . 1.1200000000000001 109.239 178.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.488 ' HA ' HG22 ' A' ' 34' ' ' VAL . 3.7 mp -57.3 -42.2 81.3 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.541 -0.724 . . . . 0.95999999999999996 109.693 178.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.462 ' CD1' ' HB ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -65.03 -44.22 89.82 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 109.102 -0.703 . . . . 0.64000000000000001 109.102 178.766 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -65.71 -33.84 76.81 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.548 -0.72 . . . . 0.63 110.616 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.481 ' HB2' HG22 ' A' ' 34' ' ' VAL . 0.2 OUTLIER -70.31 -54.3 13.19 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.452 -0.78 . . . . 0.44 110.629 -179.897 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.591 ' HA ' ' HG2' ' A' ' 30' ' ' GLN . 0.9 OUTLIER -73.13 -24.67 60.63 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.309 -0.87 . . . . 1.0600000000000001 110.177 179.588 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -103.68 43.67 1.63 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.492 -1.443 . . . . 0.34000000000000002 109.492 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.13 3.89 28.5 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.435 -1.038 . . . . 1.0600000000000001 110.842 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.2 mp -65.3 144.89 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.26 -0.9 . . . . 1.1200000000000001 110.292 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.8 -20.87 66.03 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.332 -0.855 . . . . 1.48 110.322 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.489 HG22 ' HB2' ' A' ' 22' ' ' GLN . 40.4 mm -70.46 170.13 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.431 -0.793 . . . . 1.1899999999999999 109.87 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 75.3 t -62.32 112.75 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.335 -0.853 . . . . 1.1899999999999999 110.544 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.31 161.64 21.67 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.733 -0.605 . . . . 1.4199999999999999 110.113 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.454 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 1.7 ttp -157.72 160.19 37.65 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.401 -0.812 . . . . 1.73 109.882 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.553 ' HA ' ' HA ' ' A' ' 19' ' ' VAL . 11.3 p -134.1 146.46 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.32 -0.863 . . . . 1.0600000000000001 110.524 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 34.8 mt . . . . . 0 N--CA 1.5 2.063 0 CA-C-O 117.646 -1.169 . . . . 1.03 110.488 -179.807 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.5 t . . . . . 0 N--CA 1.495 1.81 0 CA-C-O 120.611 0.243 . . . . 1.1100000000000001 110.54 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.17 129.54 15.23 Favored 'Trans proline' 0 C--N 1.315 -1.199 0 O-C-N 123.917 1.483 . . . . 0.52000000000000002 110.334 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.596 ' CB ' HG22 ' A' ' 70' ' ' VAL . 32.8 m-85 -108.29 100.76 10.03 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.595 -0.69 . . . . 0.42999999999999999 110.32 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.9 m -74.19 92.26 2.2 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.407 -0.96 . . . . 1.1200000000000001 108.407 178.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.512 ' CZ ' HG21 ' A' ' 70' ' ' VAL . 3.3 m-85 -102.8 104.41 14.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.441 -0.787 . . . . 0.85999999999999999 110.611 -178.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.609 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 0.0 OUTLIER -78.99 93.47 5.1 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.573 -0.704 . . . . 2.5499999999999998 109.484 179.605 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.575 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . 24.8 t -78.36 95.3 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.463 -0.773 . . . . 1.05 109.15 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.448 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 53.7 mtt -97.71 153.57 18.16 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.577 -0.702 . . . . 1.6100000000000001 110.535 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 168.4 -151.94 19.37 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.877 -1.289 . . . . 0.34000000000000002 109.877 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.522 ' HA ' ' HA ' ' A' ' 55' ' ' TYR . 5.9 mt-30 -78.19 170.26 16.91 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.458 -1.025 . . . . 1.1399999999999999 110.414 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.448 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -78.0 101.33 6.85 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.29 -0.881 . . . . 1.04 109.816 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.509 ' HG ' ' HD2' ' A' ' 25' ' ' PRO . 1.0 OUTLIER -130.33 136.37 28.89 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.49 -0.756 . . . . 1.6000000000000001 110.548 -179.404 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.509 ' HD2' ' HG ' ' A' ' 24' ' ' LEU . 47.3 Cg_endo -72.92 -20.48 22.18 Favored 'Trans proline' 0 C--N 1.316 -1.181 0 O-C-N 123.822 1.433 . . . . 0.56999999999999995 110.997 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -72.07 -13.74 61.67 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.351 -0.843 . . . . 0.91000000000000003 111.213 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.8 mt -56.83 -64.01 1.01 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.213 -0.929 . . . . 1.1799999999999999 110.577 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.6 p -60.94 -30.84 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 O-C-N 121.388 -0.82 . . . . 1.1100000000000001 111.021 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -64.35 -62.39 1.63 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.395 -0.816 . . . . 0.51000000000000001 110.389 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.526 ' CG ' ' HA ' ' A' ' 77' ' ' LEU . 5.5 tp60 -64.35 -32.53 74.18 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.354 -0.841 . . . . 0.75 110.724 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.513 HG22 HD23 ' A' ' 77' ' ' LEU . 2.3 t -59.03 -56.67 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.269 -0.894 . . . . 1.02 110.346 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.523 HG11 ' N ' ' A' ' 33' ' ' GLU . 8.6 p -68.49 -28.36 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.381 -0.824 . . . . 1.0700000000000001 111.548 -179.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.523 ' N ' HG11 ' A' ' 32' ' ' VAL . 1.0 OUTLIER -76.02 -55.97 5.1 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.031 -1.043 . . . . 0.52000000000000002 110.773 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.474 HG23 ' HA ' ' A' ' 73' ' ' LEU . 5.7 p -66.93 -25.8 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.428 -0.795 . . . . 0.40000000000000002 111.339 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.467 ' CG2' HG12 ' A' ' 62' ' ' ILE . 2.4 p -82.64 -35.02 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.013 -1.055 . . . . 0.44 110.828 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -76.73 -25.98 54.13 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.066 -1.021 . . . . 0.62 110.2 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 25.7 mtm-85 -75.96 -39.7 55.45 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.267 -0.896 . . . . 1.5700000000000001 110.533 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.572 ' CB ' HD11 ' A' ' 73' ' ' LEU . 0.5 OUTLIER -90.26 -45.71 8.89 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.285 -0.884 . . . . 0.79000000000000004 110.691 -179.818 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -98.52 150.95 37.22 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.56 -0.713 . . . . 1.03 110.149 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -71.3 140.72 37.6 Favored 'Trans proline' 0 C--N 1.313 -1.302 0 O-C-N 123.823 1.433 . . . . 0.48999999999999999 110.385 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.83 164.77 32.29 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.597 -1.401 . . . . 0.54000000000000004 109.597 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -99.98 139.56 35.47 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.376 -1.073 . . . . 0.51000000000000001 110.117 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.431 ' HB2' HG13 ' A' ' 35' ' ' VAL . 93.0 m-85 -119.21 170.59 8.95 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.527 -0.733 . . . . 0.54000000000000004 110.541 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.69 HG23 ' HD2' ' A' ' 45' ' ' PRO . 0.2 OUTLIER -142.44 153.91 62.97 Favored Pre-proline 0 N--CA 1.498 1.974 0 O-C-N 121.423 -0.798 . . . . 1.1000000000000001 110.836 -179.136 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.69 ' HD2' HG23 ' A' ' 44' ' ' THR . 52.6 Cg_endo -96.36 121.16 0.22 Allowed 'Trans proline' 0 C--N 1.321 -0.9 0 C-N-CA 122.015 1.81 . . . . 0.28999999999999998 110.104 178.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.439 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 53.2 m -78.81 97.6 6.0 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.129 -0.982 . . . . 1.05 109.686 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.527 HG22 HG11 ' A' ' 58' ' ' VAL . 11.5 p -76.53 139.22 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.515 -0.74 . . . . 1.1200000000000001 111.479 -179.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.3 pttt . . . . . 0 N--CA 1.494 1.772 0 O-C-N 121.684 -0.635 . . . . 2.3900000000000001 109.884 179.199 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 17.6 m-85 . . . . . 0 N--CA 1.496 1.83 0 CA-C-O 121.129 0.49 . . . . 1.23 110.394 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.448 ' HB2' ' HA ' ' A' ' 23' ' ' ALA . 0.2 OUTLIER -137.5 142.44 41.49 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.561 -0.712 . . . . 1.1399999999999999 110.417 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.448 ' HA ' ' HA ' ' A' ' 20' ' ' MET . 17.1 m -116.87 107.84 15.1 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.601 -0.687 . . . . 0.85999999999999999 109.445 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.543 ' HB ' ' HB2' ' A' ' 45' ' ' PRO . 3.1 m -108.23 149.8 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.336 -0.853 . . . . 1.03 110.85 -179.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.609 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 9.1 t -114.76 110.08 19.18 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.938 -0.764 . . . . 0.93999999999999995 108.938 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.522 ' HA ' ' HA ' ' A' ' 45' ' ' PRO . 6.6 tt -92.43 131.06 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.228 -0.92 . . . . 1.0600000000000001 111.423 -178.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 91.9 m -86.13 130.21 34.6 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.684 -0.858 . . . . 1.03 108.684 178.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.608 HD12 HG23 ' A' ' 70' ' ' VAL . 59.3 mt -139.75 99.16 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.004 -1.06 . . . . 1.1000000000000001 111.086 -179.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -84.02 97.97 9.58 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.277 -0.889 . . . . 0.38 108.925 178.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -119.05 138.79 52.61 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.533 -0.729 . . . . 0.95999999999999996 111.19 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 37.8 p -74.23 -9.93 59.1 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.619 -0.676 . . . . 0.97999999999999998 110.475 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.448 ' HD2' ' HB2' ' A' ' 68' ' ' GLU . 6.7 t60 -129.51 156.97 43.29 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.398 -0.814 . . . . 0.72999999999999998 110.201 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -82.37 -22.66 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.476 -0.765 . . . . 1.4399999999999999 111.075 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.448 ' HB2' ' HD2' ' A' ' 66' ' ' HIS . 39.5 mt-10 -77.33 -30.27 53.92 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.057 -1.027 . . . . 0.96999999999999997 110.928 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -61.74 -44.58 96.63 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.3 -0.875 . . . . 0.55000000000000004 110.214 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.608 HG23 HD12 ' A' ' 62' ' ' ILE . 9.2 p -71.77 -29.31 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.234 -0.917 . . . . 0.97999999999999998 110.238 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.83 -47.5 74.81 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.31 -0.869 . . . . 0.68000000000000005 109.32 179.036 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.484 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . 17.9 p -65.36 -35.17 80.16 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.654 -0.654 . . . . 1.1399999999999999 109.466 178.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.572 HD11 ' CB ' ' A' ' 38' ' ' HIS . 3.8 mp -61.86 -37.23 83.72 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.367 -0.833 . . . . 0.95999999999999996 109.942 179.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.54 ' CD1' ' HB ' ' A' ' 86' ' ' VAL . 0.8 OUTLIER -67.74 -52.78 33.46 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.386 -0.821 . . . . 0.79000000000000004 109.715 179.28 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.484 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 10.6 pt-20 -63.04 -28.03 69.81 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.375 -0.828 . . . . 0.64000000000000001 110.705 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.445 ' HB3' ' CG2' ' A' ' 34' ' ' VAL . 0.1 OUTLIER -71.29 -48.05 53.15 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.277 -0.889 . . . . 0.44 110.003 179.454 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.526 ' HA ' ' CG ' ' A' ' 30' ' ' GLN . 0.3 OUTLIER -76.94 -28.09 55.1 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.468 -0.77 . . . . 1.05 110.198 179.519 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.608 ' HA2' ' HG2' ' A' ' 84' ' ' ARG . . . -103.49 44.96 1.39 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.701 -1.36 . . . . 0.32000000000000001 109.701 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.1 3.83 36.39 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.626 -0.926 . . . . 1.1499999999999999 110.778 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.483 ' HB ' ' HD3' ' A' ' 84' ' ' ARG . 1.7 mp -73.87 154.87 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.276 -0.89 . . . . 1.04 110.03 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.0 -19.91 66.01 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.442 -0.786 . . . . 1.45 110.638 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.514 HG21 ' HB2' ' A' ' 22' ' ' GLN . 51.9 mm -70.19 169.27 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.395 -0.815 . . . . 1.1699999999999999 109.985 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 90.3 t -62.47 104.6 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.439 -0.788 . . . . 1.0900000000000001 110.445 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.608 ' HG2' ' HA2' ' A' ' 78' ' ' GLY . 0.1 OUTLIER -121.82 112.61 18.57 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.692 -0.484 . . . . 0.65000000000000002 109.692 179.911 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.464 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 0.2 OUTLIER -135.5 166.37 23.36 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.287 -0.883 . . . . 2.0 110.419 -179.611 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.575 ' HA ' ' HA ' ' A' ' 19' ' ' VAL . 5.1 p -139.2 157.06 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.393 -0.817 . . . . 0.46999999999999997 110.583 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 87' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.499 2.003 0 CA-C-O 118.843 -0.599 . . . . 1.0800000000000001 110.459 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.4 t . . . . . 0 N--CA 1.496 1.833 0 CA-C-O 120.551 0.215 . . . . 1.0800000000000001 110.441 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.69 123.47 9.04 Favored 'Trans proline' 0 C--N 1.314 -1.238 0 O-C-N 123.864 1.455 . . . . 0.40000000000000002 110.49 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.473 ' HB3' HG21 ' A' ' 70' ' ' VAL . 21.8 m-85 -104.42 99.47 9.17 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.508 -0.745 . . . . 0.44 110.587 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.8 m -75.7 93.35 3.09 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.085 -1.079 . . . . 1.1200000000000001 108.085 178.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.425 ' HA ' HD23 ' A' ' 87' ' ' LEU . 2.7 m-85 -101.91 109.74 21.56 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.306 -0.871 . . . . 0.90000000000000002 111.306 -178.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.607 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 0.0 OUTLIER -81.66 91.15 6.38 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.533 -0.729 . . . . 1.49 109.331 179.06 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.474 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . 38.4 t -79.25 96.96 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.666 -0.646 . . . . 1.05 109.955 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.438 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 58.6 mtm -102.17 148.4 25.46 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.405 -0.81 . . . . 1.28 110.028 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.42 ' HA3' ' O ' ' A' ' 83' ' ' VAL . . . 166.77 -142.35 7.55 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 110.035 -1.226 . . . . 0.25 110.035 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.484 ' HG3' HG22 ' A' ' 82' ' ' ILE . 0.0 OUTLIER -66.25 153.93 41.23 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.523 -0.987 . . . . 0.52000000000000002 110.57 -179.934 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -96.58 99.1 10.76 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.568 -0.708 . . . . 1.1499999999999999 110.232 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -128.71 155.82 78.55 Favored Pre-proline 0 N--CA 1.498 1.946 0 O-C-N 121.479 -0.763 . . . . 1.1000000000000001 110.546 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -72.56 -24.58 18.66 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 O-C-N 123.879 1.463 . . . . 0.47999999999999998 111.367 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.27 -5.62 45.57 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.182 -0.948 . . . . 0.56999999999999995 111.291 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.14 -55.66 29.83 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.107 -0.995 . . . . 1.55 110.266 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 26.8 m -66.99 -29.48 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.426 -0.796 . . . . 1.1000000000000001 110.69 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -66.83 -53.42 32.88 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.364 -0.835 . . . . 0.41999999999999998 110.33 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.632 ' HG2' ' HA ' ' A' ' 77' ' ' LEU . 0.3 OUTLIER -68.29 -34.29 75.89 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.25 -0.906 . . . . 1.9299999999999999 110.376 179.594 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.485 HG11 HD11 ' A' ' 60' ' ' ILE . 2.7 t -57.58 -56.09 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.405 -0.81 . . . . 1.0700000000000001 110.268 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.8 p -66.81 -32.98 60.45 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.352 -0.842 . . . . 1.1000000000000001 111.266 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.19 -54.93 7.21 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.14 -0.975 . . . . 0.84999999999999998 110.772 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.458 HG23 ' HA ' ' A' ' 73' ' ' LEU . 8.2 p -66.66 -29.68 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 121.412 -0.805 . . . . 0.35999999999999999 111.153 -179.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.499 ' HA ' ' CD2' ' A' ' 73' ' ' LEU . 2.4 p -78.08 -30.66 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.058 -1.026 . . . . 0.90000000000000002 110.304 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -73.67 -38.32 64.97 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.201 -0.937 . . . . 0.81000000000000005 110.063 179.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.27 -25.14 65.91 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.526 -0.734 . . . . 2.0499999999999998 111.199 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.439 ' CD2' HD13 ' A' ' 73' ' ' LEU . 1.1 m-70 -103.39 -45.62 4.82 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.291 -0.881 . . . . 1.3 110.792 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -106.65 149.51 38.49 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.424 -0.798 . . . . 1.1100000000000001 110.173 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -71.53 142.4 40.31 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 O-C-N 123.858 1.452 . . . . 0.81999999999999995 110.652 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.21 156.26 21.25 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.751 -1.34 . . . . 0.46000000000000002 109.751 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -89.97 140.49 29.58 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.463 -1.021 . . . . 0.55000000000000004 110.127 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.495 ' HB2' HG12 ' A' ' 35' ' ' VAL . 67.8 m-85 -121.76 169.07 11.11 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.556 -0.715 . . . . 0.95999999999999996 110.39 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.431 HG23 ' HD2' ' A' ' 45' ' ' PRO . 2.0 m -142.4 153.19 62.24 Favored Pre-proline 0 N--CA 1.497 1.92 0 O-C-N 121.374 -0.829 . . . . 1.1299999999999999 110.912 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.467 ' HB2' ' HB ' ' A' ' 58' ' ' VAL . 54.3 Cg_endo -95.94 125.06 0.31 Allowed 'Trans proline' 0 C--N 1.32 -0.957 0 C-N-CA 122.022 1.814 . . . . 0.45000000000000001 110.389 178.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.42 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 55.5 m -83.04 94.39 7.78 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.09 -1.006 . . . . 1.1000000000000001 109.468 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.528 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 14.1 p -76.76 141.66 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.453 -0.779 . . . . 1.1399999999999999 111.543 -178.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.43 ' HG2' ' O ' ' A' ' 57' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.777 0 O-C-N 121.724 -0.61 . . . . 0.68999999999999995 109.732 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 13.3 t80 . . . . . 0 N--CA 1.495 1.81 0 CA-C-O 121.168 0.509 . . . . 0.62 110.131 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -132.59 140.53 48.28 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.504 -0.747 . . . . 0.79000000000000004 110.383 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' A' ' 20' ' ' MET . 28.9 m -108.0 108.93 20.27 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.649 -0.657 . . . . 0.73999999999999999 109.387 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.528 ' HA ' ' HA ' ' A' ' 47' ' ' VAL . 2.9 m -109.86 152.75 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.143 -0.973 . . . . 0.93000000000000005 110.858 -179.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.607 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 1.7 t -116.59 111.27 19.65 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.613 -0.884 . . . . 1.1899999999999999 108.613 178.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.485 HD11 HG11 ' A' ' 31' ' ' VAL . 10.5 tt -92.21 127.9 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.218 -0.926 . . . . 1.1299999999999999 111.296 -178.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.47 ' O ' ' HB3' ' A' ' 43' ' ' TYR . 65.9 m -90.91 141.16 29.12 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 109.047 -0.723 . . . . 1.0800000000000001 109.047 179.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.458 HG21 ' HB2' ' A' ' 15' ' ' PHE . 7.8 tt -162.54 141.76 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.012 -1.055 . . . . 0.98999999999999999 110.998 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -108.0 87.56 2.53 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.509 -0.744 . . . . 0.70999999999999996 109.317 178.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -106.63 136.73 45.91 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.46 -0.775 . . . . 1.0800000000000001 110.524 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.2 p -66.98 -23.47 65.95 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.489 -0.757 . . . . 1.0800000000000001 110.843 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -131.47 157.88 42.34 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.193 -0.942 . . . . 0.68000000000000005 110.525 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.2 tt -75.73 -19.1 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.459 -0.776 . . . . 1.1299999999999999 110.676 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.43 -35.42 79.22 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.243 -0.911 . . . . 0.44 110.403 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -65.21 -48.94 71.61 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.457 -0.777 . . . . 1.1699999999999999 110.351 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.473 HG21 ' HB3' ' A' ' 15' ' ' PHE . 8.0 p -70.23 -25.23 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.448 -0.782 . . . . 1.0 110.485 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -68.7 -50.5 50.35 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.195 -0.94 . . . . 0.39000000000000001 109.584 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 20.6 p -61.47 -40.01 92.97 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 109.028 -0.73 . . . . 1.1200000000000001 109.028 178.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.499 ' CD2' ' HA ' ' A' ' 35' ' ' VAL . 3.1 mp -59.65 -39.07 83.16 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.665 -0.647 . . . . 0.92000000000000004 109.709 178.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.651 ' CD1' ' HB ' ' A' ' 86' ' ' VAL . 0.2 OUTLIER -60.36 -44.98 95.06 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.977 -0.749 . . . . 0.84999999999999998 108.977 178.653 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -69.07 -33.21 73.19 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.59 -0.693 . . . . 1.22 110.322 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.447 ' CB ' HG23 ' A' ' 34' ' ' VAL . 0.3 OUTLIER -64.74 -50.0 68.6 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.464 -0.773 . . . . 0.41999999999999998 109.883 179.48 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.632 ' HA ' ' HG2' ' A' ' 30' ' ' GLN . 0.4 OUTLIER -78.25 -26.57 47.32 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.42 -0.8 . . . . 1.0600000000000001 109.698 178.995 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.489 ' N ' ' HG ' ' A' ' 77' ' ' LEU . . . -105.94 56.25 0.52 Allowed Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.367 -1.493 . . . . 0.29999999999999999 109.367 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.18 4.31 28.83 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.643 -0.916 . . . . 1.8799999999999999 110.573 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.9 mp -60.06 155.27 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.404 -0.81 . . . . 1.1299999999999999 110.094 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.99 -3.93 53.35 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.205 -0.935 . . . . 1.26 111.547 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.484 HG22 ' HG3' ' A' ' 22' ' ' GLN . 39.2 mm -84.71 -104.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.105 -0.997 . . . . 1.02 109.975 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.42 ' O ' ' HA3' ' A' ' 21' ' ' GLY . 84.7 t -124.32 118.73 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 120.943 -1.098 . . . . 1.0800000000000001 110.263 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.33 113.63 19.66 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.517 -0.739 . . . . 1.55 109.488 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.426 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 3.1 mtm -139.95 157.12 46.19 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.361 -0.837 . . . . 1.3100000000000001 110.179 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.651 ' HB ' ' CD1' ' A' ' 74' ' ' TYR . 8.1 p -141.74 152.88 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.362 -0.837 . . . . 0.64000000000000001 110.787 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' A' ' 17' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.5 2.042 0 CA-C-O 117.52 -1.229 . . . . 1.1200000000000001 110.558 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.6 t . . . . . 0 N--CA 1.496 1.826 0 N-CA-C 110.41 -0.218 . . . . 0.84999999999999998 110.41 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.417 ' HA ' ' HA ' ' A' ' 63' ' ' ASN . 45.2 Cg_endo -71.27 126.44 12.32 Favored 'Trans proline' 0 C--N 1.315 -1.188 0 O-C-N 123.997 1.525 . . . . 0.45000000000000001 110.306 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.539 ' HB2' HG23 ' A' ' 62' ' ' ILE . 25.0 m-85 -107.01 99.75 9.29 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.557 -0.714 . . . . 0.48999999999999999 110.451 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.7 m -78.2 92.68 4.48 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.3 -1.0 . . . . 1.1200000000000001 108.3 178.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.473 ' CZ ' HD13 ' A' ' 87' ' ' LEU . 3.4 m-85 -100.53 105.9 17.37 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.535 -0.728 . . . . 0.78000000000000003 110.959 -178.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.589 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 0.0 OUTLIER -80.8 91.77 5.98 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.351 -0.843 . . . . 1.8899999999999999 109.358 179.341 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.625 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . 21.9 t -78.58 95.9 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.462 -0.774 . . . . 1.0800000000000001 109.736 -179.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 7.1 ttt -100.68 151.85 21.16 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.55 -0.719 . . . . 2.04 110.052 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 171.47 -165.08 38.02 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.95 -1.26 . . . . 0.32000000000000001 109.95 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -71.38 154.58 41.46 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.501 -0.999 . . . . 1.97 110.142 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.46 109.65 0.29 Allowed 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.747 -0.595 . . . . 1.1899999999999999 110.707 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.35 114.71 18.4 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.574 -0.704 . . . . 1.28 110.112 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.67 -26.0 20.04 Favored 'Trans proline' 0 N--CA 1.49 1.293 0 O-C-N 123.828 1.436 . . . . 0.54000000000000004 111.108 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -81.92 -6.42 59.09 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.216 -0.927 . . . . 0.68000000000000005 111.193 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.8 -50.29 74.05 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.985 -1.072 . . . . 1.3500000000000001 110.512 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.9 p -65.67 -34.08 67.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.392 -0.818 . . . . 1.0900000000000001 110.349 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -66.68 -46.79 74.52 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.338 -0.851 . . . . 0.62 109.812 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.53 ' HA ' ' CG ' ' A' ' 33' ' ' GLU . 3.3 tp60 -72.14 -30.79 65.37 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.476 -0.765 . . . . 1.8200000000000001 110.252 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.574 HG13 HD11 ' A' ' 60' ' ' ILE . 2.3 t -62.79 -46.26 96.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.412 -0.805 . . . . 1.0800000000000001 110.277 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.8 p -76.12 -35.06 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.36 -0.838 . . . . 1.0 111.583 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.53 ' CG ' ' HA ' ' A' ' 30' ' ' GLN . 0.5 OUTLIER -76.74 -35.17 57.93 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.709 -1.244 . . . . 0.52000000000000002 110.867 -179.733 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.461 ' CG2' ' CB ' ' A' ' 76' ' ' GLU . 6.9 p -78.43 -34.02 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.017 -1.052 . . . . 0.37 110.014 179.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.578 HG22 ' HB2' ' A' ' 43' ' ' TYR . 3.9 p -74.01 -31.52 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.271 -0.893 . . . . 1.03 109.607 178.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -75.59 -35.05 60.67 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.323 -0.861 . . . . 2.1299999999999999 109.649 178.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 28.1 mtm180 -66.42 -24.41 66.45 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.485 -0.759 . . . . 0.94999999999999996 110.788 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -104.96 -45.77 4.46 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.216 -0.927 . . . . 1.04 110.742 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -96.0 153.64 39.13 Favored Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.428 -0.795 . . . . 1.0700000000000001 109.886 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -69.03 -39.5 7.82 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 O-C-N 123.859 1.452 . . . . 1.1100000000000001 111.317 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -95.1 146.83 18.37 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.871 -1.292 . . . . 0.56000000000000005 109.871 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -77.96 159.97 28.5 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.454 -1.027 . . . . 0.62 109.936 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.578 ' HB2' HG22 ' A' ' 35' ' ' VAL . 40.5 m-85 -143.32 167.51 22.0 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.455 -0.778 . . . . 0.96999999999999997 110.717 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.431 HG21 ' HD2' ' A' ' 45' ' ' PRO . 2.0 m -142.33 155.51 64.47 Favored Pre-proline 0 N--CA 1.499 1.989 0 O-C-N 121.47 -0.769 . . . . 0.60999999999999999 110.99 -179.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.556 ' HA ' ' HA ' ' A' ' 60' ' ' ILE . 51.5 Cg_endo -95.95 137.62 0.67 Allowed 'Trans proline' 0 C--N 1.321 -0.881 0 C-N-CA 121.97 1.78 . . . . 0.56000000000000005 110.447 179.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 72.4 m -95.6 100.73 12.43 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.217 -0.927 . . . . 1.02 109.463 179.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.53 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 13.2 p -76.19 141.56 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.413 -0.805 . . . . 0.96999999999999997 111.485 -179.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.512 ' HE2' ' HB3' ' A' ' 57' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.765 0 N-CA-C 109.479 -0.563 . . . . 1.1200000000000001 109.479 179.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 1.6 t80 . . . . . 0 N--CA 1.495 1.79 0 CA-C-O 121.191 0.519 . . . . 1.0 110.536 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -145.13 152.55 40.22 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.492 -0.755 . . . . 0.51000000000000001 110.503 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.512 ' HB3' ' HE2' ' A' ' 48' ' ' LYS . 0.8 OUTLIER -124.47 110.05 14.02 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.397 -0.814 . . . . 1.01 109.758 -179.962 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.53 ' HA ' ' HA ' ' A' ' 47' ' ' VAL . 2.5 m -109.85 147.66 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.122 -0.986 . . . . 0.75 110.711 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.589 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 1.0 OUTLIER -115.24 114.73 25.61 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.965 -0.754 . . . . 1.1100000000000001 108.965 179.209 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.574 HD11 HG13 ' A' ' 31' ' ' VAL . 3.9 tt -92.18 128.4 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.232 -0.917 . . . . 1.01 110.843 -178.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.4 ' O ' ' HB3' ' A' ' 43' ' ' TYR . 26.3 m -93.88 135.09 35.56 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.707 -0.849 . . . . 0.59999999999999998 108.707 179.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.539 HG23 ' HB2' ' A' ' 15' ' ' PHE . 3.9 tt -162.46 118.61 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.171 -0.956 . . . . 1.04 111.165 -179.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.417 ' HA ' ' HA ' ' A' ' 14' ' ' PRO . 4.3 t30 -92.45 100.19 12.79 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.474 -0.766 . . . . 0.57999999999999996 109.005 178.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -115.01 139.55 49.76 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.509 -0.745 . . . . 1.0700000000000001 110.99 -178.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 47.6 p -73.47 -6.63 47.62 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.559 -0.713 . . . . 1.1200000000000001 110.817 179.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 20.8 m80 -129.4 136.31 49.8 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.322 -0.862 . . . . 1.8500000000000001 110.433 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.4 tt -72.11 -24.0 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.483 -0.761 . . . . 1.3899999999999999 109.699 178.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.14 -32.9 61.47 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.411 -0.806 . . . . 0.52000000000000002 110.412 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -60.96 -47.78 84.87 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.477 -0.764 . . . . 0.81999999999999995 110.277 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.496 HG23 ' HB3' ' A' ' 15' ' ' PHE . 11.2 p -71.85 -27.49 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.43 -0.794 . . . . 1.04 110.377 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.443 ' N ' HG13 ' A' ' 70' ' ' VAL . 7.1 mt-10 -71.36 -44.67 64.58 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.16 -0.962 . . . . 0.64000000000000001 109.132 178.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 95.4 m -63.11 -37.61 87.87 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 109.03 -0.73 . . . . 1.0600000000000001 109.03 178.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.509 ' CD2' ' HA ' ' A' ' 35' ' ' VAL . 2.7 mp -62.96 -39.19 93.9 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.716 -0.615 . . . . 1.0600000000000001 109.559 178.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.581 ' CD1' ' HB ' ' A' ' 86' ' ' VAL . 0.5 OUTLIER -60.37 -44.93 95.15 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.519 -0.738 . . . . 0.97999999999999998 109.068 178.497 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.47 -35.46 80.53 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.587 -0.696 . . . . 0.82999999999999996 110.525 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.461 ' CB ' ' CG2' ' A' ' 34' ' ' VAL . 0.2 OUTLIER -69.46 -51.68 33.9 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.48 -0.763 . . . . 0.46999999999999997 110.421 179.886 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.521 ' HA ' ' HG2' ' A' ' 30' ' ' GLN . 0.4 OUTLIER -69.38 -28.4 66.15 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.377 -0.827 . . . . 0.97999999999999998 110.335 179.729 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.468 ' N ' ' HG ' ' A' ' 77' ' ' LEU . . . -107.42 42.9 1.81 Allowed Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.609 -1.397 . . . . 0.33000000000000002 109.609 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.7 4.32 51.91 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.342 -1.093 . . . . 1.0800000000000001 110.694 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.6 mp -69.25 153.21 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.248 -0.907 . . . . 1.04 110.268 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -68.24 -17.47 64.31 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.481 -0.762 . . . . 0.57999999999999996 110.312 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 51.8 mm -70.75 170.12 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.547 -0.72 . . . . 1.23 110.043 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 78.4 t -62.4 114.9 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.37 -0.831 . . . . 1.1799999999999999 110.596 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 5.4 ppt_? -121.42 143.57 49.15 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.86 -0.525 . . . . 1.6100000000000001 110.117 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.416 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 1.6 ttp -156.42 159.04 38.34 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.166 -0.959 . . . . 1.49 110.486 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.625 ' HA ' ' HA ' ' A' ' 19' ' ' VAL . 9.2 p -141.02 156.61 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.44 -0.787 . . . . 0.41999999999999998 110.301 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.473 HD13 ' CZ ' ' A' ' 17' ' ' TYR . 67.3 mt . . . . . 0 N--CA 1.502 2.136 0 CA-C-O 117.655 -1.164 . . . . 1.1200000000000001 110.206 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.1 t . . . . . 0 N--CA 1.495 1.788 0 CA-C-O 120.614 0.245 . . . . 1.1000000000000001 110.48 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -72.4 125.93 11.16 Favored 'Trans proline' 0 C--N 1.315 -1.222 0 O-C-N 123.862 1.454 . . . . 0.41999999999999998 110.398 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.406 ' HB2' HG22 ' A' ' 62' ' ' ILE . 23.9 m-85 -106.16 99.6 9.18 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.556 -0.715 . . . . 0.41999999999999998 110.632 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.4 m -76.06 92.88 3.22 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 107.982 -1.118 . . . . 0.84999999999999998 107.982 178.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.443 ' HA ' HD22 ' A' ' 87' ' ' LEU . 2.6 m-85 -100.1 109.47 21.77 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.397 -0.815 . . . . 0.63 111.327 -177.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.551 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 0.1 OUTLIER -81.26 90.45 6.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.592 -0.693 . . . . 1.22 109.402 179.156 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.512 HG13 ' CD1' ' A' ' 77' ' ' LEU . 32.1 t -79.64 98.07 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.623 -0.673 . . . . 1.1000000000000001 109.945 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.457 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 36.7 mtm -106.15 147.55 28.89 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.575 -0.703 . . . . 1.3500000000000001 110.085 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 170.14 -141.5 6.63 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.088 -1.205 . . . . 0.31 110.088 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.425 ' HG3' HG23 ' A' ' 82' ' ' ILE . 0.0 OUTLIER -66.04 154.33 39.81 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.547 -0.973 . . . . 0.62 110.626 -179.817 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.606 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -93.08 97.93 11.0 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.491 -0.756 . . . . 0.71999999999999997 110.305 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.447 HD23 HD12 ' A' ' 80' ' ' ILE . 0.5 OUTLIER -130.44 154.23 81.53 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.523 -0.736 . . . . 1.1399999999999999 110.49 179.901 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.03 -19.94 22.44 Favored 'Trans proline' 0 C--N 1.313 -1.316 0 O-C-N 124.041 1.548 . . . . 0.46000000000000002 111.477 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -75.98 -5.08 44.64 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.084 -1.01 . . . . 0.62 111.358 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.48 HD22 HG23 ' A' ' 58' ' ' VAL . 2.4 mt -60.35 -59.92 4.63 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.067 -1.021 . . . . 1.27 110.219 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.515 HG11 ' HG2' ' A' ' 45' ' ' PRO . 33.6 m -64.99 -29.96 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.436 -0.79 . . . . 1.1200000000000001 110.796 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -67.28 -55.06 15.5 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.395 -0.816 . . . . 0.48999999999999999 110.229 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.49 ' CG ' ' HA ' ' A' ' 77' ' ' LEU . 16.0 tp60 -67.1 -34.85 78.51 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.319 -0.863 . . . . 0.84999999999999998 110.643 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.519 HG11 HD12 ' A' ' 60' ' ' ILE . 3.0 t -59.06 -57.78 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.409 -0.807 . . . . 1.0600000000000001 110.366 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.8 p -64.37 -33.07 60.36 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.323 -0.86 . . . . 1.0900000000000001 111.424 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.6 -55.01 8.59 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.134 -0.979 . . . . 0.63 110.913 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.443 ' CG2' ' CB ' ' A' ' 76' ' ' GLU . 10.0 p -68.58 -27.58 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.407 -0.808 . . . . 0.37 111.481 -179.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.553 ' HA ' HD21 ' A' ' 73' ' ' LEU . 2.4 p -80.64 -28.94 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.028 -1.045 . . . . 0.93999999999999995 110.732 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -79.59 -40.96 28.15 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.264 -0.897 . . . . 1.5900000000000001 110.143 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.3 mtm180 -66.62 -22.85 66.11 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.39 -0.819 . . . . 3.2400000000000002 111.299 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.446 ' CG ' HD12 ' A' ' 73' ' ' LEU . 39.4 m-70 -105.23 -45.79 4.4 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.208 -0.933 . . . . 1.6499999999999999 110.667 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -106.72 143.41 26.98 Favored Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 121.438 -0.789 . . . . 1.22 110.247 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -72.12 144.81 42.96 Favored 'Trans proline' 0 C--N 1.314 -1.27 0 O-C-N 123.827 1.435 . . . . 0.91000000000000003 110.786 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 91.66 148.35 21.9 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.532 -1.427 . . . . 0.56000000000000005 109.532 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -82.01 134.27 35.35 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.531 -0.982 . . . . 1.22 110.113 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.55 ' HB2' ' CG1' ' A' ' 35' ' ' VAL . 38.8 m-85 -123.95 157.49 34.22 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.623 -0.673 . . . . 0.88 110.402 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.407 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 1.4 m -142.36 153.38 62.59 Favored Pre-proline 0 N--CA 1.498 1.937 0 O-C-N 121.515 -0.741 . . . . 1.21 110.955 -179.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.515 ' HG2' HG11 ' A' ' 28' ' ' VAL . 55.3 Cg_endo -95.27 133.15 0.56 Allowed 'Trans proline' 0 C--N 1.32 -0.962 0 C-N-CA 121.898 1.732 . . . . 0.53000000000000003 110.579 179.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.421 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 51.5 m -89.93 93.99 9.63 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.187 -0.945 . . . . 1.04 109.289 179.06 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.498 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 14.4 p -76.46 137.26 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.498 -0.752 . . . . 1.1299999999999999 111.589 -178.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.425 ' HE2' ' HB3' ' A' ' 57' ' ' SER . 0.5 OUTLIER . . . . . 0 N--CA 1.494 1.733 0 O-C-N 121.728 -0.608 . . . . 1.3799999999999999 109.833 179.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 14.6 t80 . . . . . 0 N--CA 1.493 1.724 0 CA-C-O 121.156 0.503 . . . . 0.76000000000000001 110.178 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.606 ' HB2' ' HA ' ' A' ' 23' ' ' ALA . 0.1 OUTLIER -129.73 137.03 50.35 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.495 -0.753 . . . . 1.03 110.29 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.457 ' HA ' ' HA ' ' A' ' 20' ' ' MET . 6.1 m -110.18 105.46 14.54 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.598 -0.689 . . . . 0.80000000000000004 109.392 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.498 ' HA ' ' HA ' ' A' ' 47' ' ' VAL . 2.8 m -108.36 147.57 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.219 -0.926 . . . . 0.96999999999999997 110.84 -179.267 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.551 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 8.6 t -112.1 112.16 23.58 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.403 -0.81 . . . . 0.94999999999999996 108.843 179.117 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.519 HD12 HG11 ' A' ' 31' ' ' VAL . 9.6 tt -92.33 126.86 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.217 -0.927 . . . . 1.01 111.265 -178.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.411 ' O ' ' HB3' ' A' ' 43' ' ' TYR . 19.1 m -91.72 136.06 33.42 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.944 -0.762 . . . . 0.85999999999999999 108.944 179.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.457 HG21 HG21 ' A' ' 70' ' ' VAL . 5.9 tt -162.5 131.27 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.276 -0.89 . . . . 1.0600000000000001 110.72 -179.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -99.68 98.18 9.05 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.358 -0.838 . . . . 0.52000000000000002 109.698 179.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -113.67 139.69 48.84 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.451 -0.781 . . . . 1.02 110.227 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 33.9 p -66.54 -22.64 66.16 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.465 -0.772 . . . . 1.1000000000000001 110.864 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -131.64 157.65 43.15 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.146 -0.971 . . . . 0.78000000000000003 110.8 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.401 ' O ' HG12 ' A' ' 70' ' ' VAL . 3.3 tt -79.9 -16.75 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.529 -0.732 . . . . 1.1599999999999999 110.407 179.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.14 -33.09 71.37 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.125 -0.985 . . . . 0.48999999999999999 110.124 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.12 -48.75 64.59 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.353 -0.842 . . . . 1.6299999999999999 110.053 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.457 HG21 HG21 ' A' ' 62' ' ' ILE . 7.6 p -69.25 -25.02 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.387 -0.821 . . . . 1.1399999999999999 110.262 179.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -69.02 -51.04 43.33 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.252 -0.905 . . . . 0.40999999999999998 109.529 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 20.1 p -62.02 -38.26 87.98 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.526 -0.734 . . . . 1.0700000000000001 109.284 178.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.553 HD21 ' HA ' ' A' ' 35' ' ' VAL . 5.4 mp -61.33 -40.3 93.73 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 109.304 -0.628 . . . . 1.0 109.304 178.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.632 ' CD1' ' HB ' ' A' ' 86' ' ' VAL . 0.1 OUTLIER -59.16 -42.81 91.63 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.858 -0.793 . . . . 0.76000000000000001 108.858 178.387 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -68.5 -34.94 76.78 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.565 -0.709 . . . . 1.3500000000000001 110.336 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.443 ' CB ' ' CG2' ' A' ' 34' ' ' VAL . 0.3 OUTLIER -62.99 -48.59 78.17 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.488 -0.758 . . . . 0.48999999999999999 110.03 179.482 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.512 ' CD1' HG13 ' A' ' 19' ' ' VAL . 0.3 OUTLIER -79.38 -29.42 42.09 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.45 -0.781 . . . . 1.0700000000000001 110.132 179.387 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.495 ' N ' ' HG ' ' A' ' 77' ' ' LEU . . . -102.59 56.36 0.64 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.266 -1.533 . . . . 0.27000000000000002 109.266 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.3 tttt -106.22 4.59 29.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.698 -0.883 . . . . 2.0899999999999999 110.774 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.447 HD12 HD23 ' A' ' 24' ' ' LEU . 2.5 mp -59.78 154.99 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.335 -0.853 . . . . 1.1100000000000001 110.111 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.16 -4.55 55.74 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.285 -0.884 . . . . 1.52 111.505 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.465 HD11 ' HA ' ' A' ' 82' ' ' ILE . 48.9 mm -85.52 -103.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 120.921 -1.112 . . . . 1.23 110.175 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 88.3 t -123.99 118.75 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 120.822 -1.174 . . . . 1.05 110.298 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.47 111.24 16.59 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.614 -0.679 . . . . 1.24 109.543 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.459 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 0.4 OUTLIER -136.73 154.93 50.45 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.36 -0.838 . . . . 1.3500000000000001 110.392 -179.812 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.632 ' HB ' ' CD1' ' A' ' 74' ' ' TYR . 8.0 p -141.81 151.29 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.445 -0.784 . . . . 0.91000000000000003 110.572 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.443 HD22 ' HA ' ' A' ' 17' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.5 2.067 0 CA-C-O 117.545 -1.217 . . . . 1.0800000000000001 110.474 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.2 t . . . . . 0 N--CA 1.495 1.804 0 N-CA-C 110.438 -0.208 . . . . 1.0 110.438 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.73 120.26 6.57 Favored 'Trans proline' 0 C--N 1.315 -1.227 0 O-C-N 123.897 1.472 . . . . 0.40999999999999998 110.311 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -102.88 99.71 9.64 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.568 -0.707 . . . . 0.42999999999999999 110.606 -179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.7 p -74.45 101.15 4.04 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.545 -0.909 . . . . 0.56999999999999995 108.545 178.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.459 ' HA ' HD23 ' A' ' 87' ' ' LEU . 4.3 m-85 -114.77 160.04 19.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.395 -0.816 . . . . 1.0 111.024 -178.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.649 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 7.6 mttt -135.97 99.18 4.08 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.099 -0.704 . . . . 2.6899999999999999 109.099 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.472 ' O ' HG22 ' A' ' 58' ' ' VAL . 10.2 t -79.76 98.31 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.445 -0.784 . . . . 1.0900000000000001 109.399 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 63.0 mtm -106.66 157.77 17.45 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.32 -0.862 . . . . 1.3700000000000001 110.298 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 164.2 -160.59 33.58 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 110.089 -1.204 . . . . 0.35999999999999999 110.089 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.27 156.48 39.21 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.496 -1.003 . . . . 2.02 110.085 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -48.4 110.13 0.31 Allowed 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.776 -0.578 . . . . 0.59999999999999998 110.814 -179.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.405 ' HB3' ' HB2' ' A' ' 27' ' ' LEU . 0.2 OUTLIER -130.51 110.99 16.34 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.554 -0.716 . . . . 1.1200000000000001 109.966 -179.872 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.6 -30.48 11.95 Favored 'Trans proline' 0 C--N 1.315 -1.209 0 O-C-N 123.914 1.481 . . . . 0.58999999999999997 111.05 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -77.5 -7.12 55.75 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.228 -0.92 . . . . 0.68999999999999995 111.291 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.499 HD21 HG23 ' A' ' 58' ' ' VAL . 0.3 OUTLIER -58.24 -55.14 38.89 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.947 -1.095 . . . . 1.25 110.308 -179.952 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.536 HG21 ' HD2' ' A' ' 45' ' ' PRO . 11.9 p -61.04 -34.9 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 121.461 -0.774 . . . . 1.1200000000000001 110.559 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.422 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 10.1 m-20 -64.23 -49.46 71.84 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.479 -0.763 . . . . 0.53000000000000003 110.125 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.568 ' CG ' ' HA ' ' A' ' 77' ' ' LEU . 13.3 tp60 -71.64 -31.74 67.18 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.477 -0.764 . . . . 0.63 110.517 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.553 HG22 HD13 ' A' ' 60' ' ' ILE . 7.3 t -58.71 -52.48 59.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.324 -0.86 . . . . 1.05 110.043 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.9 p -73.32 -30.54 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.414 -0.804 . . . . 1.0700000000000001 111.198 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.422 ' HB2' ' O ' ' A' ' 29' ' ' ASP . 0.8 OUTLIER -73.64 -50.48 20.83 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.045 -1.034 . . . . 0.55000000000000004 110.484 179.958 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.449 HG23 ' HB2' ' A' ' 76' ' ' GLU . 9.8 p -67.45 -32.41 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.426 -0.796 . . . . 0.47999999999999998 110.706 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.635 ' HA ' HD21 ' A' ' 73' ' ' LEU . 2.5 p -77.17 -27.45 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.046 -1.034 . . . . 0.51000000000000001 110.02 179.112 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -74.18 -36.29 64.04 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.293 -0.88 . . . . 0.78000000000000003 109.602 178.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 52.7 mtm180 -73.1 -25.82 61.01 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.478 -0.764 . . . . 1.0700000000000001 110.758 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 43.0 m-70 -98.39 -45.8 6.01 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.368 -0.833 . . . . 0.81999999999999995 110.715 -179.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -102.8 151.84 38.39 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 121.481 -0.762 . . . . 1.1499999999999999 109.975 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -69.83 -41.1 4.47 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.855 1.45 . . . . 1.3 110.895 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -86.45 144.79 20.01 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.494 -1.442 . . . . 0.56999999999999995 109.494 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.08 149.06 29.36 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.37 -1.076 . . . . 0.59999999999999998 110.047 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.472 ' HB3' ' O ' ' A' ' 61' ' ' THR . 42.3 m-85 -132.43 161.13 34.46 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.572 -0.705 . . . . 0.71999999999999997 110.762 -179.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.44 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 3.7 m -142.6 153.49 61.91 Favored Pre-proline 0 N--CA 1.499 2.01 0 O-C-N 121.484 -0.76 . . . . 0.56000000000000005 111.016 -179.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.627 ' HA ' ' HA ' ' A' ' 60' ' ' ILE . 51.9 Cg_endo -95.1 148.75 1.59 Allowed 'Trans proline' 0 C--N 1.319 -0.997 0 C-N-CA 121.832 1.688 . . . . 0.55000000000000004 110.479 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.489 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 56.9 m -106.81 96.84 6.72 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.174 -0.954 . . . . 0.96999999999999997 109.142 179.04 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.469 HG22 HG11 ' A' ' 58' ' ' VAL . 12.4 p -75.49 139.38 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.364 -0.835 . . . . 0.68999999999999995 111.771 -178.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.758 0 N-CA-C 109.69 -0.485 . . . . 1.3700000000000001 109.69 179.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 22.3 t80 . . . . . 0 N--CA 1.497 1.885 0 CA-C-O 121.097 0.475 . . . . 1.01 110.169 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 4.1 p-80 -145.45 147.32 32.08 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.478 -0.764 . . . . 0.46000000000000002 110.54 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.8 m -125.81 117.71 23.98 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.389 -0.819 . . . . 0.79000000000000004 109.524 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.499 HG23 HD21 ' A' ' 27' ' ' LEU . 1.3 m -115.04 139.64 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.188 -0.945 . . . . 0.45000000000000001 111.388 -179.17 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.538 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 7.5 t -95.64 108.0 20.24 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.352 -0.981 . . . . 1.03 108.352 178.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.627 ' HA ' ' HA ' ' A' ' 45' ' ' PRO . 12.1 tt -92.4 125.79 44.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.256 -0.902 . . . . 1.0600000000000001 111.208 -178.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.472 ' O ' ' HB3' ' A' ' 43' ' ' TYR . 98.5 m -93.03 135.51 34.14 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.364 -0.976 . . . . 0.97999999999999998 108.364 178.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.502 HD12 HD22 ' A' ' 73' ' ' LEU . 12.6 tt -160.46 145.18 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.076 -1.015 . . . . 1.1200000000000001 111.059 -179.203 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -121.62 111.13 16.83 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.62 -0.675 . . . . 0.46000000000000002 109.305 179.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -121.46 141.47 50.98 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.47 -0.769 . . . . 1.04 110.762 -179.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 26.1 p -77.33 -4.5 45.42 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.506 -0.746 . . . . 0.79000000000000004 111.219 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.644 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 62.1 t60 -130.37 150.32 51.65 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.216 -0.927 . . . . 0.66000000000000003 110.191 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 7.5 mm -70.67 -48.39 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 121.47 -0.769 . . . . 1.1899999999999999 110.087 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.55 -18.46 65.38 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.454 -0.779 . . . . 0.75 111.236 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.644 ' HB2' ' HB3' ' A' ' 66' ' ' HIS . 0.3 OUTLIER -59.11 -58.87 6.75 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.263 -0.898 . . . . 1.3500000000000001 110.405 179.901 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.0 p -59.57 -26.98 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.416 -0.803 . . . . 1.0800000000000001 110.924 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.23 -45.66 62.8 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.265 -0.897 . . . . 0.81999999999999995 109.668 179.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 67.5 m -62.39 -41.17 98.44 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.573 -0.705 . . . . 1.0900000000000001 109.728 179.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.635 HD21 ' HA ' ' A' ' 35' ' ' VAL . 4.7 mp -65.08 -36.39 84.18 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.636 -0.665 . . . . 1.1899999999999999 110.047 179.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.614 ' CD1' ' HB ' ' A' ' 86' ' ' VAL . 0.3 OUTLIER -61.32 -46.09 91.74 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.46 -0.775 . . . . 0.56000000000000005 109.105 178.837 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.56 -33.82 76.8 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.522 -0.736 . . . . 1.1699999999999999 109.887 179.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.449 ' HB2' HG23 ' A' ' 34' ' ' VAL . 28.1 mt-10 -65.03 -43.47 92.31 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.411 -0.805 . . . . 0.42999999999999999 109.889 179.259 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.568 ' HA ' ' CG ' ' A' ' 30' ' ' GLN . 0.4 OUTLIER -80.73 -29.68 36.33 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.358 -0.839 . . . . 0.98999999999999999 109.964 178.943 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.502 ' N ' ' HG ' ' A' ' 77' ' ' LEU . . . -105.26 54.32 0.61 Allowed Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.475 -1.45 . . . . 0.29999999999999999 109.475 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.97 4.12 29.11 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.567 -0.961 . . . . 1.4299999999999999 110.563 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.7 mp -68.6 154.46 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.34 -0.85 . . . . 1.0900000000000001 110.175 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -66.16 -20.67 66.21 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.361 -0.837 . . . . 0.72999999999999998 110.155 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 43.3 mm -68.91 166.75 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.422 -0.798 . . . . 0.98999999999999999 109.895 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 76.6 t -62.47 114.39 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.287 -0.883 . . . . 1.1299999999999999 110.779 -179.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.25 137.16 54.81 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.774 -0.579 . . . . 1.5800000000000001 109.615 179.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.7 mtm -151.92 160.21 43.58 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.158 -0.964 . . . . 2.0299999999999998 110.523 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.614 ' HB ' ' CD1' ' A' ' 74' ' ' TYR . 5.4 p -142.14 155.23 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.463 -0.773 . . . . 0.45000000000000001 110.378 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.649 ' HB3' ' HB2' ' A' ' 18' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.494 1.764 0 CA-C-O 117.896 -1.05 . . . . 1.0900000000000001 109.824 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.9 t . . . . . 0 N--CA 1.495 1.782 0 N-CA-C 110.172 -0.307 . . . . 0.83999999999999997 110.172 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -72.37 129.88 15.48 Favored 'Trans proline' 0 C--N 1.314 -1.277 0 O-C-N 123.939 1.494 . . . . 0.41999999999999998 110.631 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.448 ' HB3' HG21 ' A' ' 70' ' ' VAL . 33.9 m-85 -112.01 100.89 9.24 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.583 -0.698 . . . . 0.46000000000000002 110.022 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 16.5 m -73.52 92.96 1.94 Allowed 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 108.497 -0.927 . . . . 1.1299999999999999 108.497 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.441 ' HA ' ' CD2' ' A' ' 87' ' ' LEU . 3.3 m-85 -103.82 102.16 11.98 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.464 -0.773 . . . . 0.71999999999999997 110.858 -178.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.646 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 0.0 OUTLIER -77.77 89.19 4.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.671 -0.643 . . . . 1.8799999999999999 109.89 179.805 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.634 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . 1.2 m -82.51 108.22 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 C-N-CA 119.358 -0.937 . . . . 0.92000000000000004 109.413 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.1 mtp -108.05 151.72 25.46 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.553 -0.717 . . . . 1.6100000000000001 110.567 -179.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 178.28 -159.81 25.51 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.82 -1.312 . . . . 0.40999999999999998 109.82 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.49 ' HA ' ' HA ' ' A' ' 55' ' ' TYR . 0.9 OUTLIER -70.44 -179.8 2.21 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.426 -1.044 . . . . 1.0700000000000001 110.503 179.973 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.61 100.01 2.2 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.392 -0.817 . . . . 1.1000000000000001 110.126 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.414 ' O ' HD21 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -122.94 108.56 32.53 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.516 -0.74 . . . . 1.47 109.923 -179.773 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -69.91 -15.44 36.54 Favored 'Trans proline' 0 N--CA 1.491 1.354 0 O-C-N 123.805 1.424 . . . . 0.76000000000000001 111.588 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -83.09 -0.41 48.93 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.201 -0.937 . . . . 1.1200000000000001 111.476 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.511 HD13 ' C ' ' A' ' 27' ' ' LEU . 3.1 pp -58.84 -35.11 72.37 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.906 -1.121 . . . . 1.27 110.906 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.463 ' N ' HD13 ' A' ' 27' ' ' LEU . 9.8 p -75.35 -32.9 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.066 -1.021 . . . . 1.1599999999999999 110.557 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -64.77 -48.75 73.39 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.442 -0.786 . . . . 0.63 110.085 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.716 ' HG2' ' HA ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -72.92 -37.3 67.25 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.474 -0.766 . . . . 1.3799999999999999 110.698 179.937 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.574 HG23 HD12 ' A' ' 60' ' ' ILE . 4.2 t -57.11 -47.09 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.31 -0.869 . . . . 0.91000000000000003 110.885 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.4 ' O ' HG11 ' A' ' 35' ' ' VAL . 8.2 p -76.33 -37.19 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.251 -0.905 . . . . 1.03 111.577 -179.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.484 ' CG ' ' HA ' ' A' ' 30' ' ' GLN . 0.2 OUTLIER -75.94 -31.37 59.05 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.828 -1.17 . . . . 0.56000000000000005 110.912 -179.869 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.468 HG23 ' HB2' ' A' ' 76' ' ' GLU . 5.4 p -79.98 -35.02 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.092 -1.005 . . . . 0.33000000000000002 110.14 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.55 ' HA ' HD21 ' A' ' 73' ' ' LEU . 9.7 p -73.99 -29.94 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.181 -0.95 . . . . 0.81999999999999995 109.446 178.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -77.08 -36.39 55.81 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.435 -0.791 . . . . 1.01 109.997 179.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.7 mtp-105 -65.92 -27.09 67.93 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.42 -0.8 . . . . 1.0600000000000001 111.085 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.507 ' CD2' HD12 ' A' ' 73' ' ' LEU . 17.3 m-70 -105.16 -45.86 4.4 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.334 -0.853 . . . . 0.60999999999999999 110.599 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -100.21 150.14 36.65 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.509 -0.745 . . . . 1.01 109.808 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -70.04 -38.46 7.16 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.759 1.4 . . . . 0.69999999999999996 111.15 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -85.78 145.3 20.82 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.918 -1.273 . . . . 0.48999999999999999 109.918 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.83 150.08 22.39 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.523 -0.987 . . . . 0.52000000000000002 109.864 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.471 ' HB2' HG23 ' A' ' 35' ' ' VAL . 51.9 m-85 -135.9 178.86 6.72 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.495 -0.753 . . . . 0.68999999999999995 110.779 -179.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.415 HG21 ' HD2' ' A' ' 45' ' ' PRO . 0.2 OUTLIER -141.0 157.0 68.18 Favored Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 121.476 -0.765 . . . . 0.82999999999999996 110.847 -179.064 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.608 ' HB2' ' CG2' ' A' ' 58' ' ' VAL . 51.7 Cg_endo -93.75 163.27 2.26 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 C-N-CA 121.784 1.656 . . . . 0.40999999999999998 110.366 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.408 ' C ' HG23 ' A' ' 58' ' ' VAL . 44.6 m -127.34 88.79 2.85 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.341 -0.85 . . . . 0.96999999999999997 109.063 178.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.527 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 11.4 p -83.11 142.74 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.401 -0.812 . . . . 1.01 111.651 -178.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.671 0 O-C-N 121.698 -0.626 . . . . 1.48 109.841 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.49 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 15.0 t80 . . . . . 0 N--CA 1.494 1.761 0 CA-C-O 121.164 0.507 . . . . 1.0600000000000001 110.183 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -139.57 136.91 34.92 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.589 -0.694 . . . . 1.1799999999999999 110.469 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.3 m -108.67 120.66 43.13 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.64 -0.663 . . . . 0.84999999999999998 109.318 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.608 ' CG2' ' HB2' ' A' ' 45' ' ' PRO . 3.2 p -127.01 145.27 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.257 -0.902 . . . . 1.03 111.485 -178.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.646 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 66.5 p -111.79 118.07 34.56 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.636 -0.665 . . . . 0.83999999999999997 109.51 179.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.575 ' HA ' ' HA ' ' A' ' 45' ' ' PRO . 7.0 tt -94.55 134.5 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.436 -0.79 . . . . 1.1100000000000001 111.249 -179.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 52.9 m -89.19 114.37 25.67 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.58 -0.896 . . . . 1.0800000000000001 108.58 178.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.414 ' O ' ' HB2' ' A' ' 15' ' ' PHE . 32.3 mm -122.42 99.32 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.171 -0.956 . . . . 1.0600000000000001 111.299 -178.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -88.59 86.25 6.97 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.108 -0.995 . . . . 0.45000000000000001 108.703 178.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.529 ' HB1' ' HB3' ' A' ' 69' ' ' GLN . . . -102.84 140.14 37.51 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.605 -0.685 . . . . 0.95999999999999996 111.042 -178.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 32.9 p -75.86 -6.84 52.71 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.667 -0.646 . . . . 1.03 110.981 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 4.2 t-160 -129.73 158.59 38.97 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.265 -0.897 . . . . 0.47999999999999998 110.454 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.422 ' O ' HG12 ' A' ' 70' ' ' VAL . 1.8 mt -73.68 -46.92 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.588 -0.695 . . . . 1.46 109.851 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.5 -21.28 66.63 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.495 -0.753 . . . . 0.72999999999999998 110.998 179.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.529 ' HB3' ' HB1' ' A' ' 64' ' ' ALA . 9.9 tt0 -61.04 -52.6 64.28 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.238 -0.914 . . . . 0.46000000000000002 110.44 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.448 HG21 ' HB3' ' A' ' 15' ' ' PHE . 7.4 p -69.73 -27.42 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.335 -0.853 . . . . 1.0900000000000001 110.332 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.56 -52.7 59.92 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.275 -0.89 . . . . 0.92000000000000004 109.533 179.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.8 p -62.65 -37.35 86.04 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.541 -0.724 . . . . 1.1499999999999999 109.298 178.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.55 HD21 ' HA ' ' A' ' 35' ' ' VAL . 2.0 mp -61.85 -39.77 93.01 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.666 -0.646 . . . . 0.97999999999999998 110.021 179.207 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.49 ' CD1' ' C ' ' A' ' 74' ' ' TYR . 0.0 OUTLIER -63.51 -45.97 88.21 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.552 -0.718 . . . . 0.93999999999999995 109.332 179.02 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -70.12 -30.04 67.13 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.542 -0.724 . . . . 0.73999999999999999 110.722 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.468 ' HB2' HG23 ' A' ' 34' ' ' VAL . 23.4 mt-10 -71.65 -51.39 23.34 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.377 -0.827 . . . . 0.42999999999999999 110.362 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.716 ' HA ' ' HG2' ' A' ' 30' ' ' GLN . 0.7 OUTLIER -71.54 -29.69 65.04 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.279 -0.888 . . . . 1.0 109.951 179.236 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.462 ' N ' ' HG ' ' A' ' 77' ' ' LEU . . . -102.61 46.03 1.28 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.362 -1.495 . . . . 0.23999999999999999 109.362 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.76 3.92 29.38 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.533 -0.981 . . . . 1.79 110.998 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.3 mp -60.96 145.88 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.288 -0.883 . . . . 1.0800000000000001 110.159 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -63.57 -21.19 66.21 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.474 -0.766 . . . . 0.81999999999999995 110.525 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.473 HG21 ' HB2' ' A' ' 22' ' ' GLN . 38.2 mm -71.59 172.4 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.405 -0.81 . . . . 1.1499999999999999 109.83 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 68.9 t -62.29 113.7 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.248 -0.908 . . . . 1.21 110.766 -179.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.87 154.26 37.31 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.782 -0.574 . . . . 1.28 110.368 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.478 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 4.4 ttp -156.18 159.86 39.35 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.336 -0.852 . . . . 1.3500000000000001 110.012 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.634 ' HA ' ' HA ' ' A' ' 19' ' ' VAL . 9.8 p -131.87 149.15 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 121.307 -0.871 . . . . 1.0900000000000001 110.891 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.441 ' CD2' ' HA ' ' A' ' 17' ' ' TYR . 37.6 mt . . . . . 0 N--CA 1.501 2.092 0 CA-C-O 117.653 -1.165 . . . . 1.0800000000000001 110.664 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 N--CA 1.497 1.885 0 N-CA-C 110.34 -0.244 . . . . 0.94999999999999996 110.34 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.93 119.75 6.24 Favored 'Trans proline' 0 C--N 1.314 -1.283 0 O-C-N 123.915 1.481 . . . . 0.5 110.634 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.656 ' HB2' ' HB ' ' A' ' 62' ' ' ILE . 15.6 m-85 -103.62 99.8 9.61 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.638 -0.664 . . . . 0.51000000000000001 110.231 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.9 m -75.03 96.05 3.13 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.395 -0.816 . . . . 1.1200000000000001 108.843 179.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.514 ' CZ ' HG22 ' A' ' 70' ' ' VAL . 4.6 m-85 -108.63 115.07 29.41 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.244 -0.91 . . . . 0.46999999999999997 110.848 -178.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.535 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 0.8 OUTLIER -83.64 91.04 7.37 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.478 -0.764 . . . . 1.3500000000000001 109.5 179.452 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.522 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . 11.0 t -79.3 95.4 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.51 -0.744 . . . . 1.3799999999999999 109.645 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.48 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 34.5 mtm -101.58 136.02 42.11 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.461 -0.774 . . . . 1.75 110.15 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -172.25 -156.97 13.04 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.565 -1.414 . . . . 0.45000000000000001 109.565 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.488 ' HB2' HG23 ' A' ' 82' ' ' ILE . 3.3 tp60 -67.68 168.79 10.61 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.458 -1.024 . . . . 0.72999999999999998 110.486 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -90.0 97.85 11.43 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.426 -0.796 . . . . 0.55000000000000004 109.969 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.428 ' CD1' ' HB3' ' A' ' 26' ' ' GLU . 0.8 OUTLIER -130.13 154.45 81.32 Favored Pre-proline 0 N--CA 1.498 1.939 0 O-C-N 121.562 -0.711 . . . . 1.1000000000000001 110.645 -179.837 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -73.06 -26.7 14.76 Favored 'Trans proline' 0 N--CA 1.49 1.316 0 O-C-N 123.877 1.461 . . . . 0.54000000000000004 111.68 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.428 ' HB3' ' CD1' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -68.82 -11.61 60.62 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.135 -0.978 . . . . 0.62 111.258 -179.804 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.14 -64.61 0.88 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.124 -0.985 . . . . 1.4299999999999999 110.441 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.508 HG12 ' HG2' ' A' ' 45' ' ' PRO . 26.9 m -66.77 -29.81 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 O-C-N 121.396 -0.815 . . . . 1.1299999999999999 110.956 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.452 ' N ' HG22 ' A' ' 28' ' ' VAL . 27.9 t70 -65.23 -56.63 11.69 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.314 -0.867 . . . . 0.67000000000000004 110.051 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.543 ' HG2' ' HA ' ' A' ' 77' ' ' LEU . 7.8 tp60 -68.3 -31.55 71.06 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.494 -0.754 . . . . 0.75 110.586 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.526 HG22 HD13 ' A' ' 60' ' ' ILE . 2.4 t -58.2 -52.33 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.37 -0.831 . . . . 0.96999999999999997 110.368 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.7 p -73.49 -32.53 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.303 -0.873 . . . . 1.1100000000000001 111.385 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.69 -49.05 27.66 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.029 -1.044 . . . . 1.1799999999999999 110.777 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.565 HG22 ' HB2' ' A' ' 76' ' ' GLU . 4.6 p -68.79 -34.05 62.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.457 -0.777 . . . . 0.44 111.012 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.538 HG21 HD11 ' A' ' 62' ' ' ILE . 4.7 p -74.16 -31.16 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.007 -1.058 . . . . 0.34999999999999998 110.051 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -73.31 -34.03 65.48 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.269 -0.894 . . . . 1.6699999999999999 109.754 178.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.3 mtt180 -68.96 -33.75 74.22 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.447 -0.783 . . . . 2.48 111.345 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 24.6 m-70 -99.1 -45.81 5.79 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.081 -1.012 . . . . 0.78000000000000003 110.781 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -101.74 150.28 37.2 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 121.449 -0.782 . . . . 1.1599999999999999 110.28 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.55 141.18 34.2 Favored 'Trans proline' 0 C--N 1.314 -1.281 0 O-C-N 123.803 1.423 . . . . 0.80000000000000004 110.762 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.55 165.23 36.41 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.71 -1.356 . . . . 0.54000000000000004 109.71 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -99.01 145.45 27.06 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.411 -1.052 . . . . 0.62 110.21 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.453 ' CD1' HG22 ' A' ' 61' ' ' THR . 78.2 m-85 -129.26 167.11 18.16 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.524 -0.735 . . . . 0.55000000000000004 110.108 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.12 157.61 68.72 Favored Pre-proline 0 N--CA 1.498 1.973 0 O-C-N 121.233 -0.917 . . . . 1.25 111.552 -178.55 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.621 ' HA ' ' HA ' ' A' ' 60' ' ' ILE . 54.8 Cg_endo -96.56 141.74 0.8 Allowed 'Trans proline' 0 C--N 1.319 -0.997 0 C-N-CA 122.131 1.887 . . . . 0.58999999999999997 110.395 179.148 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.452 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 45.2 m -95.64 93.66 7.27 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.21 -0.931 . . . . 1.1200000000000001 109.051 178.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.464 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 11.0 p -76.06 138.24 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.473 -0.767 . . . . 1.0900000000000001 111.598 -178.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.722 0 O-C-N 121.868 -0.52 . . . . 1.3899999999999999 109.705 179.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 22.2 t80 . . . . . 0 N--CA 1.494 1.764 0 CA-C-O 121.195 0.522 . . . . 1.03 109.905 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -132.72 139.09 47.46 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.431 -0.793 . . . . 0.64000000000000001 110.497 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.48 ' HA ' ' HA ' ' A' ' 20' ' ' MET . 57.7 m -107.89 116.22 31.56 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.605 -0.685 . . . . 0.79000000000000004 109.476 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.464 ' HA ' ' HA ' ' A' ' 47' ' ' VAL . 1.7 m -115.5 143.3 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.27 -0.894 . . . . 0.84999999999999998 111.13 -179.087 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.535 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 13.4 m -104.56 108.28 19.64 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.753 -0.832 . . . . 1.04 108.753 178.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.621 ' HA ' ' HA ' ' A' ' 45' ' ' PRO . 6.4 tt -92.84 132.13 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.326 -0.859 . . . . 1.1100000000000001 111.556 -178.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.453 HG22 ' CD1' ' A' ' 43' ' ' TYR . 13.2 t -87.69 125.12 34.21 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.755 -0.832 . . . . 0.81999999999999995 108.755 178.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.656 ' HB ' ' HB2' ' A' ' 15' ' ' PHE . 45.4 mm -121.37 125.0 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.217 -0.927 . . . . 1.1299999999999999 110.998 -178.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -101.94 64.01 0.94 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.411 -0.806 . . . . 0.62 109.21 178.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -94.68 132.86 38.97 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.353 -0.842 . . . . 0.55000000000000004 110.355 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 41.3 p -67.7 -22.66 65.26 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.603 -0.685 . . . . 1.03 110.613 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -130.42 160.28 34.51 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.411 -0.805 . . . . 1.1299999999999999 110.139 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -72.06 -16.86 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.412 -0.805 . . . . 1.5600000000000001 110.681 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.1 -33.89 72.44 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.089 -1.007 . . . . 0.84999999999999998 110.399 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -66.35 -48.29 70.7 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.464 -0.772 . . . . 1.1000000000000001 110.381 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.514 HG22 ' CZ ' ' A' ' 17' ' ' TYR . 8.1 p -68.34 -25.89 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.387 -0.821 . . . . 1.03 110.561 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -67.71 -51.28 51.38 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.207 -0.933 . . . . 0.69999999999999996 109.544 179.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.2 p -65.01 -34.95 79.66 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.532 -0.73 . . . . 1.1499999999999999 109.578 178.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.524 HD23 ' HA ' ' A' ' 35' ' ' VAL . 2.9 mp -60.62 -41.74 95.47 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.548 -0.72 . . . . 0.98999999999999999 109.844 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.534 ' CD1' ' HB ' ' A' ' 86' ' ' VAL . 2.0 t80 -65.15 -44.31 89.01 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.476 -0.765 . . . . 1.1599999999999999 109.487 178.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.22 -37.4 83.55 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.521 -0.737 . . . . 0.92000000000000004 110.53 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.565 ' HB2' HG22 ' A' ' 34' ' ' VAL . 26.5 mt-10 -69.01 -49.88 53.78 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.449 -0.782 . . . . 0.5 110.483 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.543 ' HA ' ' HG2' ' A' ' 30' ' ' GLN . 0.3 OUTLIER -74.09 -28.98 61.63 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.352 -0.842 . . . . 1.0900000000000001 110.3 179.633 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.47 ' N ' ' HG ' ' A' ' 77' ' ' LEU . . . -104.09 49.43 0.93 Allowed Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.314 -1.514 . . . . 0.32000000000000001 109.314 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -106.16 3.97 28.51 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.705 -0.88 . . . . 1.1399999999999999 110.791 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.495 HG21 HG12 ' A' ' 82' ' ' ILE . 2.3 mp -61.1 157.27 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.323 -0.86 . . . . 1.2 110.328 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.32 -4.12 40.4 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.131 -0.981 . . . . 1.1499999999999999 111.83 -179.512 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.495 HG12 HG21 ' A' ' 80' ' ' ILE . 17.8 mm -86.68 -125.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 120.962 -1.086 . . . . 1.2 110.402 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 98.9 t -119.51 117.2 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 120.711 -1.243 . . . . 1.02 110.485 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.484 ' HD2' ' HB ' ' A' ' 80' ' ' ILE . 0.0 OUTLIER -122.49 131.65 53.96 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.656 -0.653 . . . . 0.79000000000000004 110.283 179.779 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.485 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 1.8 ttp -143.05 158.56 43.49 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.413 -0.804 . . . . 1.76 109.683 179.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.534 ' HB ' ' CD1' ' A' ' 74' ' ' TYR . 9.8 p -141.62 152.21 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.294 -0.879 . . . . 0.95999999999999996 111.026 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.479 HD23 ' HA ' ' A' ' 17' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.501 2.078 0 CA-C-O 117.54 -1.219 . . . . 1.0700000000000001 110.482 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.2 t . . . . . 0 N--CA 1.495 1.785 0 CA-C-O 120.604 0.24 . . . . 1.04 110.633 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.493 ' HA ' ' HA ' ' A' ' 63' ' ' ASN . 46.2 Cg_endo -72.7 125.5 10.6 Favored 'Trans proline' 0 C--N 1.314 -1.248 0 O-C-N 123.94 1.495 . . . . 0.38 110.449 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.42 ' CB ' HG21 ' A' ' 70' ' ' VAL . 32.9 m-85 -103.14 99.45 9.32 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.558 -0.714 . . . . 0.46999999999999997 110.215 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.9 m -78.23 91.94 4.43 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.299 -1.0 . . . . 1.1200000000000001 108.299 178.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.4 ' HA ' ' CD2' ' A' ' 87' ' ' LEU . 3.1 m-85 -97.6 104.37 16.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.573 -0.704 . . . . 0.91000000000000003 110.352 -178.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.562 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 0.0 OUTLIER -78.22 89.12 4.28 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.693 -0.629 . . . . 2.4700000000000002 110.202 179.905 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.559 HG23 HG21 ' A' ' 58' ' ' VAL . 1.0 OUTLIER -83.89 101.67 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.308 -0.87 . . . . 1.04 109.397 179.337 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 36.8 mtm -109.44 151.43 26.69 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.588 -0.695 . . . . 1.6799999999999999 110.254 -179.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -177.67 -154.89 12.85 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.847 -1.301 . . . . 0.40999999999999998 109.847 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.463 ' HB2' HG21 ' A' ' 82' ' ' ILE . 0.1 OUTLIER -66.88 167.27 11.83 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.468 -1.019 . . . . 0.69999999999999996 110.353 179.968 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.29 102.61 1.42 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.37 -0.831 . . . . 0.66000000000000003 110.255 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.55 120.48 19.77 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.499 -0.751 . . . . 1.3400000000000001 110.091 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -71.9 -14.91 29.68 Favored 'Trans proline' 0 N--CA 1.49 1.323 0 O-C-N 123.871 1.458 . . . . 0.57999999999999996 111.465 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -82.28 -0.33 45.0 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.111 -0.993 . . . . 0.73999999999999999 111.456 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.442 HD12 ' N ' ' A' ' 28' ' ' VAL . 3.5 pp -57.87 -36.51 72.47 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 120.969 -1.082 . . . . 1.1799999999999999 111.045 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.442 ' N ' HD12 ' A' ' 27' ' ' LEU . 9.9 p -79.36 -30.91 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.161 -0.962 . . . . 1.1200000000000001 110.497 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -66.72 -50.92 61.25 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.403 -0.81 . . . . 0.40999999999999998 109.891 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.726 ' HG2' ' HA ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -68.81 -45.25 71.73 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.261 -0.9 . . . . 1.3700000000000001 110.525 179.765 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.551 HG22 HD12 ' A' ' 60' ' ' ILE . 2.9 t -53.76 -54.05 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.442 -0.786 . . . . 1.05 111.172 -179.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.9 p -66.77 -35.65 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 121.185 -0.947 . . . . 0.93999999999999995 111.63 -179.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -73.8 -51.06 17.62 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.059 -1.026 . . . . 0.5 110.896 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.407 ' CG2' ' HB3' ' A' ' 76' ' ' GLU . 9.5 p -66.25 -31.7 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.403 -0.81 . . . . 0.47999999999999998 111.162 -179.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.601 ' HA ' HD22 ' A' ' 73' ' ' LEU . 1.6 p -79.59 -28.23 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.145 -0.972 . . . . 0.98999999999999999 110.634 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -75.98 -37.76 58.2 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.226 -0.922 . . . . 1.04 110.524 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 13.3 mtm180 -71.87 -23.11 61.46 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.332 -0.855 . . . . 3.3599999999999999 110.93 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.52 ' CD2' HD11 ' A' ' 73' ' ' LEU . 19.8 m-70 -99.6 -45.78 5.67 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.298 -0.877 . . . . 0.64000000000000001 110.392 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -92.17 153.57 43.13 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.405 -0.809 . . . . 1.1100000000000001 109.695 179.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -68.05 -36.74 16.54 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 O-C-N 123.752 1.396 . . . . 0.82999999999999996 111.082 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -101.74 163.89 17.47 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 109.517 -1.433 . . . . 0.53000000000000003 109.517 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -88.55 154.63 20.19 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.354 -1.086 . . . . 0.66000000000000003 109.885 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.412 ' HD2' HG23 ' A' ' 35' ' ' VAL . 75.3 m-85 -137.65 172.77 12.46 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.471 -0.768 . . . . 0.57999999999999996 110.641 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.444 ' CG2' ' HD2' ' A' ' 45' ' ' PRO . 4.2 m -142.27 154.0 63.65 Favored Pre-proline 0 N--CA 1.498 1.943 0 O-C-N 121.416 -0.803 . . . . 0.67000000000000004 110.919 -179.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.45 ' HA ' ' HA ' ' A' ' 60' ' ' ILE . 55.1 Cg_endo -95.12 132.5 0.56 Allowed 'Trans proline' 0 C--N 1.319 -0.979 0 C-N-CA 121.823 1.682 . . . . 0.56999999999999995 110.421 178.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.436 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 35.8 m -90.24 99.35 12.39 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.067 -1.021 . . . . 0.87 109.202 179.019 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.5 ' HA ' HG12 ' A' ' 58' ' ' VAL . 12.4 p -76.63 135.18 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.544 -0.722 . . . . 1.1200000000000001 111.495 -178.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.401 ' HE2' ' HB3' ' A' ' 57' ' ' SER . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.802 0 O-C-N 121.789 -0.569 . . . . 1.0700000000000001 109.817 179.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 16.3 t80 . . . . . 0 N--CA 1.494 1.761 0 CA-C-O 121.139 0.495 . . . . 0.56999999999999995 110.38 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 4.0 m170 -120.62 126.04 49.27 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.561 -0.712 . . . . 1.1399999999999999 109.974 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.401 ' HB3' ' HE2' ' A' ' 48' ' ' LYS . 38.9 m -109.7 110.88 22.05 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.403 -0.811 . . . . 0.51000000000000001 109.593 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.559 HG21 HG23 ' A' ' 19' ' ' VAL . 3.6 m -119.74 151.34 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.21 -0.931 . . . . 0.93000000000000005 110.931 -179.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.562 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 79.3 p -117.8 118.08 31.06 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.478 -0.764 . . . . 0.79000000000000004 109.422 179.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.551 HD12 HG22 ' A' ' 31' ' ' VAL . 9.1 tt -93.17 130.68 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.33 -0.856 . . . . 1.0 110.922 -179.012 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 97.2 m -86.15 129.91 34.7 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 109.101 -0.703 . . . . 1.03 109.101 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.511 HG12 HG21 ' A' ' 35' ' ' VAL . 91.0 mt -141.65 96.6 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.103 -0.998 . . . . 1.03 110.848 -179.344 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.493 ' HA ' ' HA ' ' A' ' 14' ' ' PRO . 2.0 t30 -82.31 93.94 7.25 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.039 -1.038 . . . . 0.46000000000000002 109.353 178.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -117.45 140.21 49.89 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.598 -0.689 . . . . 1.0700000000000001 110.319 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 33.8 p -69.74 -15.37 63.13 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.546 -0.722 . . . . 1.0600000000000001 110.653 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -130.53 157.98 41.2 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.399 -0.813 . . . . 0.53000000000000003 109.901 179.466 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.2 tt -89.99 -3.23 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.29 -0.881 . . . . 1.1399999999999999 111.093 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -74.38 -43.68 55.42 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.106 -0.996 . . . . 0.41999999999999998 110.487 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.459 ' CG ' ' HB3' ' A' ' 38' ' ' HIS . 0.6 OUTLIER -67.01 -47.0 72.79 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.531 -0.73 . . . . 0.68000000000000005 110.848 -179.682 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.42 HG21 ' CB ' ' A' ' 15' ' ' PHE . 8.9 p -62.24 -31.13 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 121.446 -0.784 . . . . 0.93999999999999995 110.699 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -66.76 -46.89 73.93 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.326 -0.859 . . . . 0.52000000000000002 109.224 178.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.0 m -61.32 -34.38 75.16 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.679 -0.638 . . . . 1.0700000000000001 109.464 178.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.601 HD22 ' HA ' ' A' ' 35' ' ' VAL . 2.1 mp -65.64 -39.11 91.08 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.515 -0.741 . . . . 1.1499999999999999 109.914 179.202 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.467 ' CD1' ' C ' ' A' ' 74' ' ' TYR . 0.0 OUTLIER -63.12 -48.94 76.37 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.625 -0.672 . . . . 0.95999999999999996 109.779 179.419 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -71.26 -26.24 62.81 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.423 -0.798 . . . . 0.62 110.883 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.407 ' HB3' ' CG2' ' A' ' 34' ' ' VAL . 23.2 mt-10 -73.49 -50.18 22.88 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.216 -0.927 . . . . 0.39000000000000001 110.07 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.726 ' HA ' ' HG2' ' A' ' 30' ' ' GLN . 1.5 pp -76.17 -25.73 55.52 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.282 -0.886 . . . . 1.05 110.023 178.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -101.39 40.74 2.32 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.307 -1.517 . . . . 0.31 109.307 179.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.05 4.12 39.44 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.384 -1.068 . . . . 1.1899999999999999 110.842 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.0 mp -62.04 145.85 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.334 -0.854 . . . . 1.1100000000000001 110.116 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -60.96 -30.29 70.16 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.407 -0.808 . . . . 0.73999999999999999 110.302 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.463 HG21 ' HB2' ' A' ' 22' ' ' GLN . 1.0 OUTLIER -61.35 171.09 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.616 -0.678 . . . . 1.1599999999999999 110.611 179.724 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 78.9 t -63.67 118.16 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.43 -0.794 . . . . 1.1200000000000001 110.288 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.35 158.67 27.74 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.675 -0.641 . . . . 0.81999999999999995 110.369 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.509 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 1.1 ttp -157.76 158.53 35.46 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.511 -0.743 . . . . 1.3500000000000001 109.786 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.458 ' HA ' ' HA ' ' A' ' 19' ' ' VAL . 9.1 p -135.46 147.17 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.378 -0.826 . . . . 1.0 110.628 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.4 ' CD2' ' HA ' ' A' ' 17' ' ' TYR . 35.8 mt . . . . . 0 N--CA 1.5 2.061 0 CA-C-O 118.693 -0.67 . . . . 1.1000000000000001 110.466 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.615 ' HB3' ' HB3' ' A' ' 7' ' ' GLU . 2.4 mtm . . . . . 0 N--CA 1.496 1.831 0 CA-C-O 121.225 0.535 . . . . 2.5299999999999998 110.556 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.89 89.48 1.97 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.486 -0.759 . . . . 3.3100000000000001 110.033 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 27.0 p -120.62 -5.71 9.73 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.465 -0.772 . . . . 1.25 111.326 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.475 ' HA ' HD11 ' A' ' 8' ' ' LEU . 0.0 OUTLIER 56.35 41.92 28.4 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.172 -0.955 . . . . 2.6000000000000001 110.769 -179.771 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -163.8 -55.22 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.546 -0.721 . . . . 1.76 110.086 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -113.35 -21.17 11.05 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.38 -0.825 . . . . 1.1899999999999999 110.931 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.615 ' HB3' ' HB3' ' A' ' 1' ' ' MET . 0.6 OUTLIER -157.11 141.68 16.67 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.158 -0.964 . . . . 0.55000000000000004 110.822 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.475 HD11 ' HA ' ' A' ' 4' ' ' LYS . 1.3 tt -158.2 -55.92 0.07 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.583 -0.698 . . . . 1.76 110.269 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.455 ' CD1' ' HB3' ' A' ' 11' ' ' PHE . 0.6 OUTLIER -89.04 -13.96 37.51 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.693 -0.629 . . . . 0.88 111.178 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 55.03 52.17 12.27 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.354 -0.841 . . . . 0.55000000000000004 111.183 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.455 ' HB3' ' CD1' ' A' ' 9' ' ' LEU . 13.4 t80 -139.87 111.39 7.4 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.441 -0.787 . . . . 1.53 109.425 179.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.513 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 43.4 Cg_endo -69.89 107.54 1.91 Allowed 'Trans proline' 0 C--N 1.314 -1.264 0 O-C-N 123.884 1.465 . . . . 0.34999999999999998 110.911 -179.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.9 t -110.44 146.02 33.43 Favored Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 121.66 -0.65 . . . . 1.02 109.989 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -69.44 114.64 3.72 Favored 'Trans proline' 0 C--N 1.313 -1.312 0 O-C-N 123.861 1.453 . . . . 0.41999999999999998 110.979 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -102.53 101.13 11.28 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.694 -0.629 . . . . 0.41999999999999998 110.222 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.4 m -75.5 93.04 2.93 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.631 -0.877 . . . . 1.1100000000000001 108.631 178.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -110.75 159.25 17.8 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.468 -0.77 . . . . 0.70999999999999996 110.752 -178.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.513 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -134.82 101.25 4.85 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.348 -0.612 . . . . 0.54000000000000004 109.348 179.766 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.502 ' CG2' HG21 ' A' ' 60' ' ' ILE . 3.5 t -79.68 95.62 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.477 -0.764 . . . . 1.0700000000000001 109.59 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.536 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 43.9 mtm -97.73 142.0 30.05 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.538 -0.726 . . . . 1.27 110.178 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 166.42 -147.69 12.46 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.586 -1.406 . . . . 0.38 109.586 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.503 ' HB2' HG23 ' A' ' 82' ' ' ILE . 0.0 OUTLIER -75.8 151.1 37.59 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.326 -1.102 . . . . 0.97999999999999998 110.106 179.816 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.6 105.04 2.98 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.564 -0.71 . . . . 0.47999999999999998 110.31 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.6 HD11 ' HD2' ' A' ' 25' ' ' PRO . 2.6 mm? -111.13 129.69 23.74 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.592 -0.693 . . . . 1.1100000000000001 109.761 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.6 ' HD2' HD11 ' A' ' 24' ' ' LEU . 43.3 Cg_endo -70.49 -30.5 18.81 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 O-C-N 123.701 1.369 . . . . 0.46000000000000002 110.606 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -83.6 -2.81 56.9 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.463 -0.773 . . . . 0.64000000000000001 110.791 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.476 HD22 HG22 ' A' ' 58' ' ' VAL . 0.8 OUTLIER -58.48 -52.62 64.85 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.043 -1.035 . . . . 1.3300000000000001 110.284 179.997 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.8 m -62.23 -33.2 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.48 -0.762 . . . . 1.0600000000000001 110.467 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -67.45 -46.26 73.59 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.511 -0.743 . . . . 0.48999999999999999 109.937 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.603 ' HG2' ' HA ' ' A' ' 77' ' ' LEU . 3.2 tp60 -72.24 -34.32 68.2 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.446 -0.784 . . . . 0.73999999999999999 110.328 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.499 HG22 HD21 ' A' ' 77' ' ' LEU . 2.8 t -60.41 -53.21 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.561 -0.712 . . . . 0.83999999999999997 110.432 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.9 p -70.81 -31.47 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 121.329 -0.857 . . . . 1.0900000000000001 110.846 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.73 -46.27 54.39 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.301 -0.874 . . . . 0.52000000000000002 110.932 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.471 HG22 ' HB2' ' A' ' 76' ' ' GLU . 7.6 p -75.51 -30.28 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.247 -0.908 . . . . 0.34000000000000002 111.048 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.454 HG12 ' HB2' ' A' ' 43' ' ' TYR . 4.0 p -75.2 -30.75 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.045 -1.034 . . . . 0.83999999999999997 110.209 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -79.04 -42.0 27.52 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.383 -0.823 . . . . 0.63 110.32 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.9 mtm180 -62.87 -30.06 71.23 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.269 -0.895 . . . . 3.0299999999999998 111.053 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.588 ' CG ' HD12 ' A' ' 73' ' ' LEU . 68.6 m-70 -97.5 -41.05 8.36 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.342 -0.849 . . . . 0.63 110.72 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -120.8 145.56 41.58 Favored Pre-proline 0 N--CA 1.497 1.922 0 O-C-N 121.439 -0.788 . . . . 0.59999999999999998 110.019 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.96 142.53 51.77 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 O-C-N 123.598 1.315 . . . . 0.46000000000000002 110.985 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 98.09 147.76 22.74 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.724 -1.35 . . . . 0.40000000000000002 109.724 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -94.48 139.9 30.53 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.573 -0.957 . . . . 0.66000000000000003 109.949 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.506 ' HB3' ' O ' ' A' ' 61' ' ' THR . 76.5 m-85 -131.81 164.41 26.09 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.444 -0.785 . . . . 0.85999999999999999 110.67 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.428 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 0.5 OUTLIER -142.79 158.14 60.16 Favored Pre-proline 0 N--CA 1.498 1.935 0 O-C-N 121.424 -0.798 . . . . 1.2 111.713 -179.314 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.537 ' HA ' ' HA ' ' A' ' 60' ' ' ILE . 55.2 Cg_endo -96.69 120.58 0.19 Allowed 'Trans proline' 0 C--N 1.317 -1.119 0 C-N-CA 122.382 2.055 . . . . 0.51000000000000001 110.258 179.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.491 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 27.6 m -81.41 99.48 8.74 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.021 -1.049 . . . . 1.0700000000000001 109.397 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.492 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 10.8 p -75.89 144.35 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.419 -0.801 . . . . 1.04 111.469 -178.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.41 147.28 42.56 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.834 -0.541 . . . . 0.89000000000000001 109.665 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.66 97.73 0.73 Allowed 'Trans proline' 0 C--N 1.314 -1.265 0 O-C-N 123.767 1.404 . . . . 0.65000000000000002 110.307 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.1 t -86.33 -50.04 7.22 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.561 -0.712 . . . . 1.3300000000000001 110.998 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.41 -52.15 1.62 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.134 -0.979 . . . . 1.49 111.204 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 10.2 tttt -150.35 179.56 8.03 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.304 -0.872 . . . . 3.23 110.306 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.78 -27.94 73.48 Favored Glycine 0 N--CA 1.497 2.716 0 N-CA-C 109.355 -1.498 . . . . 0.56999999999999995 109.355 179.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -74.43 -31.74 62.4 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.505 -0.997 . . . . 0.94999999999999996 110.547 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -111.27 123.83 51.01 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.35 -0.844 . . . . 1.01 109.797 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -130.35 142.26 50.54 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.281 -0.887 . . . . 0.94999999999999996 111.311 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.536 ' HA ' ' HA ' ' A' ' 20' ' ' MET . 16.0 m -110.51 117.23 32.99 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.705 -0.85 . . . . 0.79000000000000004 108.705 179.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.492 ' HA ' ' HA ' ' A' ' 47' ' ' VAL . 2.8 m -110.09 150.78 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.187 -0.946 . . . . 0.46000000000000002 111.829 -178.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.497 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 0.3 OUTLIER -104.41 104.6 14.5 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.396 -0.965 . . . . 1.1200000000000001 108.396 178.476 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.537 ' HA ' ' HA ' ' A' ' 45' ' ' PRO . 14.5 tt -93.1 130.73 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.305 -0.872 . . . . 0.92000000000000004 111.849 -178.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.506 ' O ' ' HB3' ' A' ' 43' ' ' TYR . 37.7 m -96.44 133.91 40.27 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.633 -0.877 . . . . 0.95999999999999996 108.633 178.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.452 HG12 ' CG2' ' A' ' 35' ' ' VAL . 32.3 mt -144.14 139.39 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 120.939 -1.1 . . . . 1.05 111.137 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -112.63 57.21 0.66 Allowed 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.877 0.846 . . . . 0.40000000000000002 109.161 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.21 130.74 44.06 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.965 -1.085 . . . . 0.85999999999999999 110.22 -179.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 32.8 p -70.08 -7.57 42.4 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.868 -0.52 . . . . 1.04 111.053 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.703 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 13.1 t-80 -129.75 157.89 40.92 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.198 -0.939 . . . . 0.47999999999999998 110.104 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.458 HG21 HD11 ' A' ' 67' ' ' ILE . 16.0 mm -69.7 -51.4 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.413 -0.805 . . . . 1.21 110.504 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.418 ' HB2' ' CE1' ' A' ' 66' ' ' HIS . 1.7 mt-10 -71.58 -14.69 62.16 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.472 -0.768 . . . . 1.1499999999999999 111.647 -179.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.703 ' HB2' ' HB3' ' A' ' 66' ' ' HIS . 39.4 tt0 -62.09 -46.0 91.02 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.013 -1.055 . . . . 0.58999999999999997 110.306 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.8 p -60.73 -27.22 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 121.158 -0.964 . . . . 0.94999999999999996 110.609 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -67.82 -50.24 57.86 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.298 -0.876 . . . . 0.83999999999999997 109.856 179.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.9 p -63.5 -37.33 86.9 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.512 -0.742 . . . . 1.02 109.597 179.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.588 HD12 ' CG ' ' A' ' 38' ' ' HIS . 5.5 mp -60.03 -39.96 87.69 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.538 -0.726 . . . . 1.3600000000000001 109.561 178.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.619 ' CD1' ' HB ' ' A' ' 86' ' ' VAL . 0.6 OUTLIER -63.03 -45.79 90.61 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.531 -0.73 . . . . 0.68999999999999995 109.084 178.654 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -60.7 -37.67 82.43 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.56 -0.713 . . . . 0.67000000000000004 109.943 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.471 ' HB2' HG22 ' A' ' 34' ' ' VAL . 0.3 OUTLIER -63.26 -41.38 99.03 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.516 -0.74 . . . . 0.56999999999999995 110.566 179.801 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.603 ' HA ' ' HG2' ' A' ' 30' ' ' GLN . 0.3 OUTLIER -84.47 -28.59 26.68 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.382 -0.824 . . . . 0.83999999999999997 110.557 179.818 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.529 ' N ' ' HG ' ' A' ' 77' ' ' LEU . . . -107.08 58.98 0.4 Allowed Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.806 -1.317 . . . . 0.29999999999999999 109.806 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.12 4.17 26.56 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.606 -0.938 . . . . 1.0 110.389 178.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.403 HD12 ' HG ' ' A' ' 24' ' ' LEU . 2.2 mp -63.4 152.65 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.383 -0.823 . . . . 1.1699999999999999 110.125 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -69.74 -11.87 61.19 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.333 -0.854 . . . . 0.79000000000000004 111.063 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.503 HG23 ' HB2' ' A' ' 22' ' ' GLN . 22.3 mm -82.94 175.23 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.134 -0.979 . . . . 1.1799999999999999 109.903 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 76.0 t -63.16 112.04 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.373 -0.829 . . . . 1.0900000000000001 111.395 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.96 136.76 54.94 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 109.109 -0.7 . . . . 1.27 109.109 178.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.412 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 2.6 ttt -151.3 161.57 42.46 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.12 -0.987 . . . . 2.8399999999999999 110.724 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.619 ' HB ' ' CD1' ' A' ' 74' ' ' TYR . 8.1 p -141.71 153.04 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.431 -0.793 . . . . 0.44 110.565 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.513 ' HB3' ' HB2' ' A' ' 18' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.496 1.835 0 CA-C-O 117.944 -1.027 . . . . 1.0600000000000001 109.705 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.805 0 CA-C-O 121.022 0.439 . . . . 2.3300000000000001 110.28 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.04 -57.38 0.72 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.422 -0.799 . . . . 2.02 110.125 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 28.5 p -84.87 -175.11 5.63 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.533 -0.729 . . . . 1.55 110.276 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.16 71.48 0.56 Allowed 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.526 0.679 . . . . 2.71 110.21 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.07 82.68 1.85 Allowed 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.5 0.667 . . . . 2.1400000000000001 109.408 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -97.45 -24.52 15.56 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.492 -0.755 . . . . 2.1499999999999999 110.461 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.486 ' HG2' ' CG ' ' A' ' 66' ' ' HIS . 0.0 OUTLIER 64.59 99.63 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.68 -0.637 . . . . 0.81000000000000005 110.413 -179.906 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -124.37 22.43 8.49 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.456 -0.778 . . . . 1.97 110.463 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.46 ' O ' ' HB2' ' A' ' 10' ' ' GLU . 3.7 mp -123.52 -48.49 1.93 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.445 -0.784 . . . . 1.3300000000000001 109.939 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 9' ' ' LEU . 3.7 mp0 61.14 31.82 19.63 Favored 'General case' 0 N--CA 1.5 2.037 0 CA-C-O 121.112 0.482 . . . . 0.66000000000000003 110.698 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.439 ' O ' ' HA ' ' A' ' 65' ' ' THR . 29.8 m-85 -111.63 109.07 55.93 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.42 -0.8 . . . . 1.47 109.395 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.536 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 44.0 Cg_endo -70.37 110.26 2.63 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 O-C-N 124.019 1.536 . . . . 0.5 110.684 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.1 t -132.29 146.29 60.95 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.663 -0.648 . . . . 1.1399999999999999 110.306 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.31 125.68 11.57 Favored 'Trans proline' 0 C--N 1.313 -1.301 0 O-C-N 123.925 1.487 . . . . 0.46999999999999997 110.483 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.45 ' HB2' HG21 ' A' ' 62' ' ' ILE . 29.5 m-85 -105.91 99.31 8.91 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.535 -0.728 . . . . 0.45000000000000001 110.355 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.1 m -76.93 92.72 3.69 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.072 -1.084 . . . . 1.1799999999999999 108.072 178.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.436 ' HA ' HD22 ' A' ' 87' ' ' LEU . 3.0 m-85 -99.86 107.33 19.32 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.434 -0.792 . . . . 0.46999999999999997 110.723 -178.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 0.1 OUTLIER -82.07 88.79 6.41 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.524 -0.735 . . . . 0.47999999999999998 109.292 179.547 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.568 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . 21.3 t -79.95 95.02 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.537 -0.727 . . . . 1.1000000000000001 109.617 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.8 ttt -107.96 125.91 52.07 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.573 -0.704 . . . . 1.6599999999999999 110.431 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.482 ' HA3' ' HD3' ' A' ' 84' ' ' ARG . . . -153.82 -160.24 9.64 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.28 -1.528 . . . . 0.27000000000000002 109.28 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.481 ' HB2' HG23 ' A' ' 82' ' ' ILE . 0.0 OUTLIER -67.02 168.06 10.69 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.38 -1.07 . . . . 1.24 110.253 179.73 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.76 103.62 0.58 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.408 -0.808 . . . . 0.46999999999999997 110.417 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -125.1 123.03 25.39 Favored Pre-proline 0 N--CA 1.496 1.835 0 O-C-N 121.469 -0.769 . . . . 0.64000000000000001 110.32 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.04 -22.41 19.51 Favored 'Trans proline' 0 N--CA 1.489 1.227 0 O-C-N 123.892 1.47 . . . . 0.58999999999999997 111.163 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.49 -0.67 30.36 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.307 -0.87 . . . . 0.56000000000000005 111.524 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.3 mt -53.64 -58.44 7.19 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.19 -0.944 . . . . 1.1100000000000001 110.871 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.437 ' HA ' ' CG ' ' A' ' 45' ' ' PRO . 8.9 p -64.9 -30.35 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.429 -0.794 . . . . 1.0900000000000001 111.177 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -67.08 -56.44 10.03 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.317 -0.865 . . . . 0.46999999999999997 110.649 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.664 ' HG2' ' HA ' ' A' ' 77' ' ' LEU . 0.7 OUTLIER -68.98 -38.02 79.09 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.327 -0.858 . . . . 1.3400000000000001 110.846 -179.898 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.558 HG12 HD12 ' A' ' 60' ' ' ILE . 3.2 t -57.63 -54.52 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.398 -0.814 . . . . 1.1000000000000001 110.596 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.3 p -66.09 -34.16 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.329 -0.857 . . . . 0.97999999999999998 111.284 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.88 -52.77 11.9 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.094 -1.004 . . . . 1.26 111.06 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.442 ' CG2' ' HB3' ' A' ' 76' ' ' GLU . 8.0 p -68.26 -27.26 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.3 -0.875 . . . . 0.53000000000000003 111.34 -179.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.458 HG22 HD12 ' A' ' 62' ' ' ILE . 2.9 p -79.92 -34.14 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.01 -1.056 . . . . 1.0600000000000001 110.703 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -80.92 -23.71 38.7 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.058 -1.027 . . . . 1.52 110.585 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 31.7 mtm180 -76.59 -43.8 37.1 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.318 -0.864 . . . . 1.48 110.793 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.598 ' CB ' HD13 ' A' ' 73' ' ' LEU . 90.1 m-70 -93.19 -45.65 7.77 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.365 -0.834 . . . . 1.8700000000000001 110.843 -179.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.92 148.84 37.83 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 121.337 -0.852 . . . . 1.0600000000000001 110.072 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.02 140.28 34.39 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 O-C-N 123.884 1.465 . . . . 0.87 110.572 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.96 154.45 9.41 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.729 -1.348 . . . . 0.52000000000000002 109.729 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.94 143.56 26.68 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.399 -1.06 . . . . 0.66000000000000003 110.002 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.459 ' HB3' ' O ' ' A' ' 61' ' ' THR . 51.0 m-85 -127.65 172.73 10.51 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.516 -0.74 . . . . 1.0800000000000001 110.517 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -142.23 154.38 64.24 Favored Pre-proline 0 N--CA 1.497 1.9 0 O-C-N 121.43 -0.794 . . . . 1.1899999999999999 110.82 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.537 ' HA ' ' HA ' ' A' ' 60' ' ' ILE . 53.4 Cg_endo -93.91 164.39 2.16 Favored 'Trans proline' 0 C--N 1.317 -1.11 0 C-N-CA 121.69 1.593 . . . . 0.46999999999999997 110.354 179.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 22.7 m -120.28 95.98 4.96 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.688 -0.856 . . . . 1.0900000000000001 108.688 178.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 9.9 p -75.78 143.8 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.538 -0.726 . . . . 1.0800000000000001 111.239 -178.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.409 ' HB2' ' HB3' ' A' ' 57' ' ' SER . 0.8 OUTLIER -135.76 106.19 9.82 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.722 -0.612 . . . . 0.64000000000000001 110.102 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -76.7 -18.81 14.93 Favored 'Trans proline' 0 C--N 1.315 -1.235 0 O-C-N 124.115 1.587 . . . . 0.64000000000000001 110.916 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 88.1 p -60.66 -24.39 65.55 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.403 -0.81 . . . . 1.05 111.129 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 28.9 m -63.25 -56.11 19.28 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.292 -0.88 . . . . 1.03 110.322 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.49 166.26 32.53 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.475 -0.765 . . . . 2.4700000000000002 110.578 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.52 -51.66 5.91 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.737 -1.345 . . . . 0.82999999999999996 109.737 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -93.57 14.32 19.24 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.445 -1.032 . . . . 0.81999999999999995 111.068 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -132.26 129.75 40.01 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.209 -0.932 . . . . 0.94999999999999996 109.96 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -111.1 129.83 55.8 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.54 -0.725 . . . . 0.71999999999999997 110.483 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.409 ' HB3' ' HB2' ' A' ' 48' ' ' LYS . 0.4 OUTLIER -97.56 99.31 10.7 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.522 -0.736 . . . . 0.57999999999999996 109.451 179.341 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.521 HG11 ' HB ' ' A' ' 19' ' ' VAL . 1.0 OUTLIER -103.81 120.93 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.394 -0.816 . . . . 0.45000000000000001 110.746 -179.216 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.471 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 11.6 t -100.92 114.49 28.41 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.452 -0.78 . . . . 0.87 109.114 178.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.558 HD12 HG12 ' A' ' 31' ' ' VAL . 11.2 tt -93.47 132.7 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.268 -0.895 . . . . 1.0600000000000001 111.344 -178.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.459 ' O ' ' HB3' ' A' ' 43' ' ' TYR . 22.7 m -99.03 135.52 40.31 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.808 -0.812 . . . . 0.60999999999999999 108.808 178.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.487 HG23 HG22 ' A' ' 70' ' ' VAL . 3.1 tt -162.37 131.75 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.128 -0.983 . . . . 1.1000000000000001 111.003 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -105.28 101.19 10.75 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.407 -0.808 . . . . 0.64000000000000001 109.359 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -115.72 146.56 41.78 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.427 -0.795 . . . . 1.0900000000000001 110.64 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.536 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 47.3 p -79.35 -2.87 43.58 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.661 -0.649 . . . . 0.96999999999999997 111.136 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.506 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 8.6 t-160 -129.81 147.4 51.58 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.189 -0.944 . . . . 0.79000000000000004 110.746 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -78.95 -41.42 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.638 -0.664 . . . . 1.4299999999999999 109.843 179.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -65.47 -32.5 74.14 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.472 -0.767 . . . . 0.52000000000000002 110.661 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.506 ' HB2' ' HB3' ' A' ' 66' ' ' HIS . 0.6 OUTLIER -59.91 -55.81 29.53 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.361 -0.837 . . . . 0.63 110.531 -179.936 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.487 HG22 HG23 ' A' ' 62' ' ' ILE . 13.3 p -61.16 -29.89 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.351 -0.843 . . . . 1.02 110.452 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.416 ' N ' HG11 ' A' ' 70' ' ' VAL . 3.1 mm-40 -67.69 -43.85 79.13 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.229 -0.919 . . . . 0.46999999999999997 109.365 178.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 54.7 m -60.52 -38.63 85.02 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.604 -0.685 . . . . 1.0600000000000001 109.168 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.598 HD13 ' CB ' ' A' ' 38' ' ' HIS . 7.7 mp -63.71 -38.39 90.92 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.68 -0.638 . . . . 1.04 109.777 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.609 ' CD1' ' HB ' ' A' ' 86' ' ' VAL . 0.2 OUTLIER -59.3 -47.92 83.56 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 108.973 -0.751 . . . . 1.0600000000000001 108.973 178.693 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.14 -31.29 72.41 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.606 -0.684 . . . . 0.55000000000000004 110.214 179.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.442 ' HB3' ' CG2' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -66.14 -51.38 58.4 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.442 -0.787 . . . . 0.66000000000000003 110.236 179.501 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.664 ' HA ' ' HG2' ' A' ' 30' ' ' GLN . 0.4 OUTLIER -76.43 -25.41 54.4 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.431 -0.793 . . . . 1.04 110.536 179.685 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.615 ' HA2' ' HG2' ' A' ' 84' ' ' ARG . . . -101.11 39.23 2.81 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 110.051 -1.22 . . . . 0.27000000000000002 110.051 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.62 4.23 45.64 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.521 -0.988 . . . . 2.4199999999999999 110.635 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.7 mp -60.14 153.03 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.303 -0.873 . . . . 1.1200000000000001 110.064 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.5 -27.79 67.87 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.479 -0.763 . . . . 1.3 109.932 179.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.481 HG23 ' HB2' ' A' ' 22' ' ' GLN . 0.9 OUTLIER -68.26 171.99 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.526 -0.734 . . . . 1.1499999999999999 110.179 179.36 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 97.5 t -81.5 110.8 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.294 -0.879 . . . . 1.23 110.639 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.615 ' HG2' ' HA2' ' A' ' 78' ' ' GLY . 8.3 tpp180 -121.59 131.85 54.35 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.689 -0.632 . . . . 0.44 109.802 179.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.456 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 6.0 mtm -129.82 171.41 12.73 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.382 -0.823 . . . . 1.8799999999999999 110.516 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.609 ' HB ' ' CD1' ' A' ' 74' ' ' TYR . 8.8 p -138.62 156.03 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.548 -0.72 . . . . 0.41999999999999998 110.619 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.436 HD22 ' HA ' ' A' ' 17' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.5 2.029 0 CA-C-O 118.81 -0.614 . . . . 1.1000000000000001 110.398 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.496 1.851 0 CA-C-O 121.014 0.435 . . . . 2.9300000000000002 110.299 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.423 ' HE2' ' HA ' ' A' ' 7' ' ' GLU . 0.1 OUTLIER -67.49 144.09 55.86 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.544 -0.723 . . . . 1.1200000000000001 110.546 -179.836 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.7 m 53.11 42.48 32.19 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-O 121.072 0.463 . . . . 1.21 111.13 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 14.2 tttt -168.24 -67.34 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.114 -0.991 . . . . 1.6899999999999999 110.065 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.57 -46.68 3.94 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.232 -0.918 . . . . 1.6200000000000001 109.949 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -120.62 112.56 19.05 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.516 -0.74 . . . . 2.27 109.816 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.423 ' HA ' ' HE2' ' A' ' 2' ' ' LYS . 0.8 OUTLIER -144.18 -164.48 1.91 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.38 -0.825 . . . . 0.89000000000000001 110.76 -179.617 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.73 -32.3 52.73 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.294 -0.879 . . . . 1.53 110.864 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.5 mp -74.12 -58.45 3.29 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.356 -0.84 . . . . 1.4399999999999999 109.987 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 56.87 37.47 28.82 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.77 -0.581 . . . . 0.91000000000000003 111.153 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.403 ' O ' ' HA ' ' A' ' 65' ' ' THR . 87.4 t80 -105.44 109.25 62.99 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.298 -0.876 . . . . 0.96999999999999997 109.687 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.647 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 45.6 Cg_endo -70.64 108.63 2.29 Favored 'Trans proline' 0 C--N 1.314 -1.265 0 O-C-N 123.861 1.453 . . . . 0.41999999999999998 110.798 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.2 t -110.35 144.06 29.36 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.494 -0.754 . . . . 1.02 110.244 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.43 117.82 5.35 Favored 'Trans proline' 0 C--N 1.315 -1.212 0 O-C-N 123.893 1.47 . . . . 0.45000000000000001 110.811 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.636 ' HB2' ' HB ' ' A' ' 62' ' ' ILE . 16.7 m-85 -103.29 99.67 9.53 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.589 -0.694 . . . . 0.38 110.429 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.9 m -75.56 92.94 2.95 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.504 -0.925 . . . . 1.0900000000000001 108.504 178.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.458 ' HA ' ' CD2' ' A' ' 87' ' ' LEU . 3.4 m-85 -102.72 108.0 19.1 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.343 -0.848 . . . . 0.56000000000000005 110.9 -178.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.546 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 0.0 OUTLIER -78.3 89.72 4.34 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.532 -0.73 . . . . 1.4099999999999999 109.296 179.404 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.644 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . 24.8 t -78.57 96.5 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.487 -0.758 . . . . 1.04 109.906 -179.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.587 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 1.0 OUTLIER -97.21 149.71 21.72 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.541 -0.724 . . . . 1.73 110.124 -179.772 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 170.21 -151.44 16.61 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.848 -1.301 . . . . 0.40000000000000002 109.848 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.456 ' HB2' HG21 ' A' ' 82' ' ' ILE . 1.0 OUTLIER -79.38 151.45 30.95 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.545 -0.973 . . . . 0.89000000000000001 110.327 179.92 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.412 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -76.21 96.99 4.02 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.604 -0.685 . . . . 0.54000000000000004 110.199 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.4 155.53 76.45 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.469 -0.769 . . . . 1.3 110.45 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.56 -22.96 20.46 Favored 'Trans proline' 0 C--N 1.314 -1.263 0 O-C-N 123.927 1.488 . . . . 0.59999999999999998 110.803 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -70.32 -18.09 63.08 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.337 -0.852 . . . . 0.64000000000000001 111.035 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.408 ' O ' HG22 ' A' ' 31' ' ' VAL . 1.7 mm? -57.87 -66.28 0.5 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.305 -0.872 . . . . 1.1000000000000001 110.414 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.5 p -62.99 -29.5 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.449 -0.782 . . . . 1.0700000000000001 110.965 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -64.59 -57.66 8.5 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.338 -0.851 . . . . 0.46000000000000002 110.324 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.53 ' HG2' ' HA ' ' A' ' 77' ' ' LEU . 4.9 tp60 -69.33 -30.32 68.33 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.353 -0.842 . . . . 1.1799999999999999 110.821 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.549 HG23 HD12 ' A' ' 60' ' ' ILE . 2.3 t -59.79 -54.52 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.248 -0.907 . . . . 0.93000000000000005 110.242 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.417 ' O ' ' HG2' ' A' ' 36' ' ' GLN . 9.5 p -70.77 -32.74 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.339 -0.85 . . . . 1.01 111.15 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.58 -51.42 16.96 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.204 -0.935 . . . . 0.62 110.756 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.463 HG23 ' HB2' ' A' ' 76' ' ' GLU . 4.0 p -66.71 -29.22 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.467 -0.771 . . . . 0.39000000000000001 111.213 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.578 ' HA ' HD21 ' A' ' 73' ' ' LEU . 4.7 p -80.09 -31.93 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.035 -1.041 . . . . 0.38 110.711 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.484 ' HG3' ' N ' ' A' ' 37' ' ' ARG . 1.6 pt20 -82.42 -21.91 35.54 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.055 -1.028 . . . . 1.4099999999999999 110.685 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.484 ' N ' ' HG3' ' A' ' 36' ' ' GLN . 26.9 mtm180 -79.24 -41.84 27.29 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.278 -0.889 . . . . 0.90000000000000002 110.704 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.56 ' CD2' HD13 ' A' ' 73' ' ' LEU . 93.7 m-70 -95.9 -43.62 7.75 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.391 -0.818 . . . . 0.57999999999999996 110.683 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -98.01 150.64 36.96 Favored Pre-proline 0 N--CA 1.497 1.894 0 O-C-N 121.324 -0.86 . . . . 0.93999999999999995 109.924 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.36 140.09 29.88 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.678 1.357 . . . . 0.34999999999999998 110.673 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.63 154.02 14.18 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 110.045 -1.222 . . . . 0.40000000000000002 110.045 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -95.07 148.32 22.48 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.466 -1.02 . . . . 0.45000000000000001 109.914 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -135.1 175.9 9.16 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.467 -0.771 . . . . 1.0 110.723 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.425 HG21 ' HD2' ' A' ' 45' ' ' PRO . 0.2 OUTLIER -142.7 158.06 60.61 Favored Pre-proline 0 N--CA 1.498 1.95 0 O-C-N 121.398 -0.814 . . . . 1.3100000000000001 111.239 -178.973 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.5 ' HA ' ' HA ' ' A' ' 60' ' ' ILE . 54.4 Cg_endo -96.24 118.26 0.18 Allowed 'Trans proline' 0 C--N 1.318 -1.029 0 C-N-CA 122.121 1.881 . . . . 0.28000000000000003 110.431 179.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.479 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 31.9 m -76.24 104.71 6.9 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.086 -1.009 . . . . 1.0900000000000001 109.283 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.532 ' CB ' HG11 ' A' ' 58' ' ' VAL . 14.3 p -76.2 142.58 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.411 -0.806 . . . . 1.05 111.656 -178.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.424 ' HD2' HG21 ' A' ' 46' ' ' THR . 0.0 OUTLIER -142.91 135.96 13.88 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.755 -0.591 . . . . 1.1100000000000001 109.787 179.784 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.78 101.48 1.31 Allowed 'Trans proline' 0 C--N 1.316 -1.177 0 O-C-N 123.763 1.402 . . . . 0.63 110.071 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -87.58 -51.03 6.13 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.405 -0.81 . . . . 1.1799999999999999 110.931 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.8 m -119.73 -57.44 1.97 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.339 -0.851 . . . . 1.24 110.801 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.79 -179.43 6.79 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.355 -0.841 . . . . 2.0899999999999999 110.388 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.53 -32.45 71.35 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.542 -1.423 . . . . 0.42999999999999999 109.542 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -63.81 -34.99 79.16 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.631 -0.923 . . . . 2.0099999999999998 110.781 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -109.01 119.3 39.14 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.222 -0.924 . . . . 0.89000000000000001 109.845 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.412 ' HB2' ' HA ' ' A' ' 23' ' ' ALA . 2.6 m170 -117.27 135.69 53.64 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.428 -0.795 . . . . 0.91000000000000003 110.904 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.587 ' HA ' ' HA ' ' A' ' 20' ' ' MET . 26.8 m -108.64 102.54 11.59 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 109.139 -0.689 . . . . 0.88 109.139 179.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.532 HG11 ' CB ' ' A' ' 47' ' ' VAL . 3.1 m -103.65 146.79 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.306 -0.871 . . . . 1.01 110.834 -179.022 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.546 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 7.3 t -108.98 114.15 27.66 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.852 -0.796 . . . . 0.88 108.852 179.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.549 HD12 HG23 ' A' ' 31' ' ' VAL . 8.8 tt -93.08 132.77 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.269 -0.894 . . . . 0.72999999999999998 111.763 -178.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 56.2 m -86.7 117.4 25.43 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.565 -0.902 . . . . 1.04 108.565 178.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.636 ' HB ' ' HB2' ' A' ' 15' ' ' PHE . 38.3 mm -114.29 132.93 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.068 -1.02 . . . . 0.78000000000000003 111.048 -178.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -108.18 62.1 0.61 Allowed 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.521 0.677 . . . . 0.39000000000000001 109.216 178.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.464 ' CB ' ' HB3' ' A' ' 69' ' ' GLN . . . -91.67 133.83 35.24 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.306 -0.871 . . . . 0.79000000000000004 110.686 -179.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.647 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 31.8 p -70.67 -17.83 62.84 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.608 -0.682 . . . . 0.94999999999999996 110.691 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -129.84 159.88 35.22 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.332 -0.855 . . . . 0.62 110.127 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.2 tt -74.62 -17.01 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.378 -0.826 . . . . 1.3899999999999999 110.783 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.9 -30.22 40.04 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.188 -0.945 . . . . 0.83999999999999997 110.25 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.464 ' HB3' ' CB ' ' A' ' 64' ' ' ALA . 0.4 OUTLIER -65.64 -47.97 73.77 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.395 -0.815 . . . . 0.57999999999999996 110.271 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.543 HG21 ' HB3' ' A' ' 15' ' ' PHE . 13.7 p -67.44 -28.82 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.367 -0.833 . . . . 1.0700000000000001 110.294 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.16 -52.94 56.57 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.354 -0.841 . . . . 0.83999999999999997 109.536 179.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.5 p -63.23 -35.66 81.05 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.503 -0.748 . . . . 1.01 109.487 179.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.578 HD21 ' HA ' ' A' ' 35' ' ' VAL . 3.6 mp -60.9 -39.58 89.84 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.634 -0.666 . . . . 1.01 109.557 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.582 ' CD1' ' HB ' ' A' ' 86' ' ' VAL . 0.3 OUTLIER -63.91 -48.69 75.6 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 109.143 -0.688 . . . . 0.66000000000000003 109.143 178.761 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.76 -36.71 83.95 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.549 -0.719 . . . . 0.68000000000000005 110.2 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.463 ' HB2' HG23 ' A' ' 34' ' ' VAL . 23.5 mt-10 -65.04 -47.38 77.6 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.586 -0.696 . . . . 0.35999999999999999 110.459 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.53 ' HA ' ' HG2' ' A' ' 30' ' ' GLN . 0.3 OUTLIER -76.84 -29.11 55.76 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.246 -0.909 . . . . 1.0600000000000001 110.433 179.718 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.47 ' N ' ' HG ' ' A' ' 77' ' ' LEU . . . -102.36 48.19 1.08 Allowed Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.503 -1.439 . . . . 0.25 109.503 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.9 ttmt -106.46 4.0 27.85 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.47 -1.017 . . . . 2.1800000000000002 110.808 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.0 mp -69.57 153.13 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.218 -0.926 . . . . 1.1200000000000001 110.105 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.12 -26.45 68.31 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.399 -0.813 . . . . 1.3799999999999999 110.239 179.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.456 HG21 ' HB2' ' A' ' 22' ' ' GLN . 1.0 OUTLIER -64.13 174.72 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.606 -0.684 . . . . 1.1899999999999999 110.583 179.671 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 75.4 t -63.71 117.49 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.392 -0.818 . . . . 1.1000000000000001 110.546 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.94 132.81 54.74 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.728 -0.607 . . . . 0.94999999999999996 110.049 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.469 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -154.22 160.54 41.89 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.215 -0.928 . . . . 2.29 110.318 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.644 ' HA ' ' HA ' ' A' ' 19' ' ' VAL . 8.2 p -141.48 157.23 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.406 -0.809 . . . . 0.35999999999999999 110.763 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.458 ' CD2' ' HA ' ' A' ' 17' ' ' TYR . 77.4 mt . . . . . 0 N--CA 1.501 2.08 0 CA-C-O 117.674 -1.155 . . . . 1.1299999999999999 110.554 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.0 ttt . . . . . 0 N--CA 1.493 1.718 0 CA-C-O 121.249 0.547 . . . . 2.23 110.525 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.7 ptmt -134.64 169.79 16.79 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.517 -0.739 . . . . 1.9099999999999999 110.35 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.8 t -65.85 150.98 47.72 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.427 -0.796 . . . . 1.46 110.422 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.22 -48.28 0.92 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.387 -0.821 . . . . 1.3999999999999999 110.689 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.82 171.17 16.71 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.373 -0.829 . . . . 1.6899999999999999 110.463 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -118.47 -48.54 2.5 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.533 -0.729 . . . . 1.9299999999999999 110.408 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -158.06 144.22 17.34 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.376 -0.827 . . . . 0.71999999999999997 110.712 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -159.22 -60.23 0.07 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.557 -0.714 . . . . 1.5 110.475 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.43 HD12 ' HB3' ' A' ' 11' ' ' PHE . 0.6 OUTLIER -77.77 -24.89 48.83 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.435 -0.791 . . . . 1.1100000000000001 110.856 179.867 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 56.07 45.67 23.13 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.536 -0.728 . . . . 0.81000000000000005 111.638 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.43 ' HB3' HD12 ' A' ' 9' ' ' LEU . 53.9 t80 -117.53 109.5 41.81 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.38 -0.825 . . . . 0.83999999999999997 109.095 178.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.641 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 44.5 Cg_endo -70.14 112.29 3.11 Favored 'Trans proline' 0 C--N 1.313 -1.303 0 O-C-N 123.897 1.472 . . . . 0.56000000000000005 110.741 -179.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.7 t -132.89 145.28 56.41 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 121.731 -0.606 . . . . 1.0600000000000001 110.227 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.94 122.56 8.92 Favored 'Trans proline' 0 C--N 1.315 -1.197 0 O-C-N 123.83 1.437 . . . . 0.46999999999999997 110.883 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.453 ' HB2' HG23 ' A' ' 62' ' ' ILE . 20.3 m-85 -106.38 99.78 9.34 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.652 -0.655 . . . . 0.46999999999999997 110.281 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.1 p -73.64 99.22 3.03 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.248 -1.019 . . . . 1.0800000000000001 108.248 178.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -113.91 159.54 19.77 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.384 -0.822 . . . . 0.93999999999999995 111.031 -178.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.588 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 0.7 OUTLIER -137.35 102.46 4.8 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.822 -0.807 . . . . 0.97999999999999998 108.822 179.204 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.513 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . 15.6 t -81.14 99.74 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 CA-C-O 121.463 0.649 . . . . 1.0600000000000001 110.193 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 35.7 mtt -94.77 155.01 17.01 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.479 -0.763 . . . . 1.9399999999999999 109.961 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 157.5 -150.12 20.98 Favored Glycine 0 N--CA 1.497 2.722 0 N-CA-C 110.194 -1.163 . . . . 0.34999999999999998 110.194 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.466 ' HB2' HG21 ' A' ' 82' ' ' ILE . 1.1 tm0? -76.93 160.81 28.89 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.51 -0.994 . . . . 0.73999999999999999 110.642 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -86.43 92.28 8.79 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.628 -0.67 . . . . 0.55000000000000004 110.053 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.59 150.31 72.62 Favored Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 121.504 -0.748 . . . . 1.0800000000000001 110.386 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -71.86 -24.06 21.56 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 O-C-N 123.861 1.453 . . . . 0.48999999999999999 111.461 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.82 -18.31 64.8 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.216 -0.927 . . . . 0.59999999999999998 111.044 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.428 HD21 HD12 ' A' ' 77' ' ' LEU . 0.7 OUTLIER -60.8 -63.18 1.39 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.225 -0.922 . . . . 1.3999999999999999 110.365 -179.956 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.6 p -65.38 -31.58 54.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.421 -0.799 . . . . 1.1000000000000001 110.63 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -63.4 -53.71 48.16 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.339 -0.851 . . . . 0.51000000000000001 110.188 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.517 ' HB3' ' HA ' ' A' ' 77' ' ' LEU . 1.1 tp-100 -68.55 -34.87 76.6 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.426 -0.796 . . . . 0.89000000000000001 110.658 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.7 t -57.28 -46.94 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.342 -0.849 . . . . 1.0600000000000001 109.997 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.414 ' O ' HG11 ' A' ' 35' ' ' VAL . 77.4 t -71.17 -37.25 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.493 -0.754 . . . . 1.1000000000000001 110.681 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.43 -54.32 11.05 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.181 -0.95 . . . . 1.03 110.839 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.496 HG23 ' HB2' ' A' ' 76' ' ' GLU . 9.9 p -62.79 -33.02 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.43 -0.794 . . . . 0.41999999999999998 111.395 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.513 ' HA ' HD21 ' A' ' 73' ' ' LEU . 3.2 p -77.21 -29.61 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.032 -1.043 . . . . 1.01 110.343 179.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -74.26 -35.19 63.77 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.235 -0.916 . . . . 1.4299999999999999 109.977 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.48 -23.87 61.1 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.493 -0.755 . . . . 1.6100000000000001 110.811 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -101.51 -46.0 5.12 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.206 -0.934 . . . . 0.66000000000000003 110.546 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -103.15 151.09 38.44 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.484 -0.76 . . . . 1.1100000000000001 109.841 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -69.94 -41.26 4.2 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 O-C-N 123.857 1.451 . . . . 0.85999999999999999 111.115 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -85.81 145.24 20.77 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.634 -1.386 . . . . 0.55000000000000004 109.634 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.9 152.03 27.0 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.446 -1.032 . . . . 0.80000000000000004 109.962 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.489 ' HB3' ' O ' ' A' ' 61' ' ' THR . 45.2 m-85 -136.9 159.79 40.82 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.529 -0.732 . . . . 0.83999999999999997 110.573 -179.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.457 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 22.8 m -142.32 151.51 58.35 Favored Pre-proline 0 N--CA 1.499 1.984 0 O-C-N 121.445 -0.784 . . . . 0.54000000000000004 111.301 -179.054 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.676 ' HA ' ' HA ' ' A' ' 60' ' ' ILE . 54.1 Cg_endo -96.51 135.84 0.5 Allowed 'Trans proline' 0 C--N 1.32 -0.958 0 C-N-CA 122.03 1.82 . . . . 0.47999999999999998 110.508 178.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 32.1 m -95.03 108.43 20.5 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.16 -0.963 . . . . 1.01 109.17 179.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.47 ' HA ' HG12 ' A' ' 58' ' ' VAL . 7.7 p -75.9 141.58 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.444 -0.785 . . . . 1.1100000000000001 111.54 -178.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.7 mtmp? -140.09 149.19 57.58 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.885 -0.509 . . . . 1.5 109.905 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.99 100.14 1.17 Allowed 'Trans proline' 0 C--N 1.315 -1.212 0 O-C-N 123.747 1.393 . . . . 0.59999999999999998 109.825 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.9 p -89.83 -49.12 6.81 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.552 -0.717 . . . . 0.88 111.165 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.5 m -123.94 -60.32 1.45 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.309 -0.87 . . . . 1.52 110.563 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -144.87 179.82 7.08 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.394 -0.816 . . . . 2.3199999999999998 110.563 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.16 -31.57 79.65 Favored Glycine 0 N--CA 1.496 2.653 0 N-CA-C 109.862 -1.295 . . . . 0.63 109.862 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -71.45 -35.19 70.8 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.483 -1.01 . . . . 0.95999999999999996 110.952 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -105.36 127.4 52.95 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.142 -0.974 . . . . 0.70999999999999996 110.111 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 1.2 m170 -125.06 145.26 50.0 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.281 -0.887 . . . . 1.1699999999999999 111.333 -179.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.0 t -119.22 106.09 12.0 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.54 -0.911 . . . . 0.67000000000000004 108.54 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.484 ' HA ' ' O ' ' A' ' 46' ' ' THR . 2.1 m -103.29 146.4 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.272 -0.892 . . . . 1.02 111.176 -178.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.588 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 16.9 p -103.89 110.67 22.89 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.64 -0.874 . . . . 0.73999999999999999 108.64 178.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.676 ' HA ' ' HA ' ' A' ' 45' ' ' PRO . 13.8 tt -93.12 128.34 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 CA-C-O 121.902 0.858 . . . . 0.93999999999999995 111.459 -178.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.489 ' O ' ' HB3' ' A' ' 43' ' ' TYR . 22.5 m -97.18 126.83 42.62 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.193 -1.04 . . . . 0.77000000000000002 108.193 178.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.453 HG23 ' HB2' ' A' ' 15' ' ' PHE . 11.0 tt -153.9 141.03 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.124 -0.985 . . . . 1.3799999999999999 111.466 -178.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -117.22 102.99 9.74 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.723 -0.843 . . . . 0.73999999999999999 108.723 178.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.565 ' HB3' ' HB3' ' A' ' 69' ' ' GLN . . . -109.86 141.01 43.17 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.485 -0.759 . . . . 1.0700000000000001 111.312 -178.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.641 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 13.2 p -74.29 -5.23 40.95 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.788 -0.57 . . . . 0.94999999999999996 111.269 179.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.716 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 49.5 t60 -129.73 146.54 51.49 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.969 -1.082 . . . . 0.65000000000000002 110.188 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -67.64 -30.01 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.52 -0.738 . . . . 1.6499999999999999 110.749 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.05 -11.66 43.49 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.274 -0.891 . . . . 0.93000000000000005 111.068 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.716 ' HB2' ' HB3' ' A' ' 66' ' ' HIS . 8.8 tt0 -61.52 -46.54 89.54 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.22 -0.925 . . . . 1.1599999999999999 109.874 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.1 p -70.48 -28.92 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.638 -0.664 . . . . 0.82999999999999996 110.01 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.99 -50.06 45.35 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.485 -0.759 . . . . 0.56000000000000005 109.604 179.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.6 p -61.81 -40.78 96.43 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.527 -0.733 . . . . 1.0800000000000001 109.51 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.513 HD21 ' HA ' ' A' ' 35' ' ' VAL . 2.8 mp -60.45 -37.59 81.44 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.682 -0.636 . . . . 1.1699999999999999 109.694 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.532 ' CD1' ' HB ' ' A' ' 86' ' ' VAL . 0.4 OUTLIER -62.97 -45.03 94.36 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.564 -0.71 . . . . 1.0 109.179 178.662 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.46 -36.15 79.61 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.498 -0.751 . . . . 0.52000000000000002 109.988 179.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.496 ' HB2' HG23 ' A' ' 34' ' ' VAL . 0.5 OUTLIER -67.55 -49.07 65.01 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.544 -0.722 . . . . 0.47999999999999998 110.279 179.497 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.517 ' HA ' ' HB3' ' A' ' 30' ' ' GLN . 0.3 OUTLIER -72.62 -27.23 62.02 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.423 -0.798 . . . . 0.95999999999999996 110.533 179.622 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.459 ' N ' ' HG ' ' A' ' 77' ' ' LEU . . . -107.44 38.96 3.07 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.678 -1.369 . . . . 0.31 109.678 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.91 4.09 54.54 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.31 -1.112 . . . . 1.49 110.732 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.4 mp -72.17 155.07 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.321 -0.862 . . . . 1.24 109.982 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -68.71 -15.78 63.62 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.41 -0.806 . . . . 0.91000000000000003 110.235 178.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.466 HG21 ' HB2' ' A' ' 22' ' ' GLN . 49.7 mm -71.33 170.14 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.544 -0.723 . . . . 1.27 109.985 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 76.1 t -62.42 115.06 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.342 -0.849 . . . . 1.1699999999999999 110.818 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -121.19 140.74 51.61 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.857 -0.527 . . . . 1.0800000000000001 109.595 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.1 mtp -158.54 154.05 26.05 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.062 -1.024 . . . . 2.0099999999999998 110.29 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.532 ' HB ' ' CD1' ' A' ' 74' ' ' TYR . 5.9 p -142.5 157.44 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.32 -0.863 . . . . 0.93999999999999995 110.801 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.577 ' HB3' ' HB2' ' A' ' 18' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.497 1.899 0 CA-C-O 117.955 -1.022 . . . . 1.0600000000000001 109.878 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 ttt . . . . . 0 N--CA 1.496 1.845 0 CA-C-O 121.074 0.464 . . . . 2.27 110.368 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.534 ' HG3' ' HB ' ' A' ' 67' ' ' ILE . 0.0 OUTLIER -89.09 63.21 6.56 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.429 -0.795 . . . . 0.77000000000000002 110.271 179.962 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 10.7 p -136.58 -56.54 0.74 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.405 -0.809 . . . . 0.65000000000000002 109.89 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.33 49.0 0.83 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.594 -0.691 . . . . 1.9199999999999999 109.979 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -108.85 161.91 14.69 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.351 -0.843 . . . . 1.28 110.669 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -133.9 129.49 36.43 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.541 -0.725 . . . . 1.74 109.923 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 51.91 61.83 3.01 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-O 121.421 0.629 . . . . 1.99 110.679 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -146.04 -42.97 0.2 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.264 -0.898 . . . . 1.5700000000000001 110.901 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.5 mp -88.58 -53.26 4.73 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.352 -0.842 . . . . 1.1200000000000001 110.589 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 56.88 32.64 21.81 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.708 -0.62 . . . . 0.72999999999999998 110.662 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.449 ' O ' ' HA ' ' A' ' 65' ' ' THR . 92.2 t80 -111.74 118.8 46.09 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.35 -0.844 . . . . 0.81000000000000005 109.762 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.673 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 43.4 Cg_endo -69.67 108.43 2.06 Favored 'Trans proline' 0 C--N 1.315 -1.208 0 O-C-N 123.854 1.449 . . . . 0.42999999999999999 110.686 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.0 t -129.58 143.79 50.36 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.608 -0.682 . . . . 0.81999999999999995 110.455 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -71.65 127.23 12.89 Favored 'Trans proline' 0 C--N 1.315 -1.213 0 O-C-N 123.911 1.48 . . . . 0.34999999999999998 110.389 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -108.5 99.69 9.05 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.482 -0.761 . . . . 0.5 110.467 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.5 m -74.18 92.9 2.25 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.169 -1.049 . . . . 1.0700000000000001 108.169 178.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -105.09 106.69 17.3 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.379 -0.826 . . . . 0.72999999999999998 110.897 -178.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.577 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 0.0 OUTLIER -79.27 92.49 5.14 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.533 -0.729 . . . . 1.7 109.532 179.525 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.556 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . 15.7 t -79.02 96.09 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.462 -0.774 . . . . 1.0600000000000001 109.516 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.639 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 44.4 ttp -98.05 148.71 23.24 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.601 -0.687 . . . . 1.52 110.295 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 166.83 -152.35 21.17 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.664 -1.374 . . . . 0.28999999999999998 109.664 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.484 ' HB3' HD12 ' A' ' 24' ' ' LEU . 20.7 tp60 -74.01 138.9 44.39 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.423 -1.045 . . . . 1.3400000000000001 110.394 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.53 ' HB1' ' HB2' ' A' ' 56' ' ' HIS . . . -68.35 115.24 7.56 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.665 -0.647 . . . . 1.1799999999999999 110.378 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.484 HD12 ' HB3' ' A' ' 22' ' ' GLN . 0.2 OUTLIER -131.86 150.91 77.5 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.623 -0.673 . . . . 1.3 110.2 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -73.0 -24.87 16.89 Favored 'Trans proline' 0 C--N 1.313 -1.335 0 O-C-N 123.839 1.442 . . . . 0.65000000000000002 111.079 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.15 -7.32 58.1 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.244 -0.91 . . . . 0.81000000000000005 111.643 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.85 -60.03 4.48 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.033 -1.042 . . . . 1.72 110.374 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.2 p -62.97 -31.36 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 121.439 -0.788 . . . . 1.21 110.567 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -68.32 -56.42 8.65 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.372 -0.83 . . . . 0.46999999999999997 109.913 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.604 ' HG2' ' HA ' ' A' ' 77' ' ' LEU . 0.1 OUTLIER -63.19 -38.62 91.9 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.338 -0.851 . . . . 1.3 110.269 179.524 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.513 HG11 HD12 ' A' ' 60' ' ' ILE . 2.4 t -56.57 -52.0 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.542 -0.723 . . . . 1.1100000000000001 110.216 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 40.1 t -63.68 -40.88 90.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.47 -0.769 . . . . 0.94999999999999996 111.244 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.13 -50.77 29.93 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.309 -0.869 . . . . 0.62 111.134 -179.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.521 HG23 ' HA ' ' A' ' 73' ' ' LEU . 8.9 p -69.1 -28.05 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.485 -0.759 . . . . 0.29999999999999999 111.521 -179.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.508 ' CG2' HG12 ' A' ' 62' ' ' ILE . 1.9 p -83.21 -27.05 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.034 -1.041 . . . . 0.39000000000000001 110.784 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -78.89 -39.7 34.27 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.235 -0.915 . . . . 0.63 110.429 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 14.4 ptt180 -69.56 -20.1 63.67 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.344 -0.847 . . . . 1.24 111.33 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -106.16 -45.77 4.23 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.15 -0.969 . . . . 1.0800000000000001 110.768 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -103.68 149.84 37.52 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.401 -0.812 . . . . 1.0700000000000001 109.997 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.33 140.4 36.88 Favored 'Trans proline' 0 C--N 1.314 -1.241 0 O-C-N 123.802 1.422 . . . . 0.66000000000000003 110.636 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.06 172.92 49.25 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.706 -1.357 . . . . 0.56000000000000005 109.706 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -100.99 144.69 29.62 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.439 -1.036 . . . . 0.56999999999999995 110.338 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.452 ' HB3' ' O ' ' A' ' 61' ' ' THR . 83.5 m-85 -129.08 165.46 21.18 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.509 -0.745 . . . . 0.89000000000000001 110.325 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.431 HG21 ' HD2' ' A' ' 45' ' ' PRO . 0.2 OUTLIER -142.57 156.79 63.21 Favored Pre-proline 0 N--CA 1.499 1.992 0 O-C-N 121.371 -0.831 . . . . 1.3700000000000001 111.165 -179.417 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.499 ' HA ' ' HA ' ' A' ' 60' ' ' ILE . 53.2 Cg_endo -96.54 132.78 0.41 Allowed 'Trans proline' 0 C--N 1.32 -0.952 0 C-N-CA 122.233 1.955 . . . . 0.53000000000000003 110.292 178.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.432 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 36.2 m -93.89 92.11 7.24 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.955 -1.09 . . . . 1.1599999999999999 109.502 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.495 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 11.3 p -76.55 140.69 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.474 -0.766 . . . . 1.03 111.638 -178.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.1 ptpt -142.32 154.9 64.58 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.785 -0.572 . . . . 2.0699999999999998 109.498 179.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -71.36 99.61 0.93 Allowed 'Trans proline' 0 C--N 1.313 -1.331 0 O-C-N 123.845 1.445 . . . . 0.56999999999999995 110.209 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.5 p -89.94 -47.17 8.04 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.547 -0.72 . . . . 0.79000000000000004 110.955 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.24 -52.44 1.74 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.252 -0.905 . . . . 1.3700000000000001 110.872 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.3 mttt -151.2 176.79 10.86 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.399 -0.813 . . . . 3.0499999999999998 110.34 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.424 ' HA2' ' HE1' ' A' ' 56' ' ' HIS . . . -64.42 -28.42 73.08 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.309 -1.516 . . . . 0.54000000000000004 109.309 178.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -78.89 -28.57 44.08 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.475 -1.014 . . . . 1.77 110.552 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -111.35 118.1 34.93 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.359 -0.838 . . . . 0.60999999999999999 110.021 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.53 ' HB2' ' HB1' ' A' ' 23' ' ' ALA . 1.6 m80 -130.16 148.14 51.97 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.373 -0.829 . . . . 0.57999999999999996 111.174 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.639 ' HA ' ' HA ' ' A' ' 20' ' ' MET . 89.3 p -113.34 126.12 55.03 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 109.155 -0.683 . . . . 0.69999999999999996 109.155 179.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.495 ' HA ' ' HA ' ' A' ' 47' ' ' VAL . 1.5 m -116.59 141.37 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.241 -0.912 . . . . 0.70999999999999996 111.116 -178.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.577 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 1.3 t -103.08 106.41 16.92 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.387 -0.821 . . . . 1.1799999999999999 108.87 178.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.513 HD12 HG11 ' A' ' 31' ' ' VAL . 6.2 tt -93.7 132.1 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.273 -0.892 . . . . 0.96999999999999997 111.264 -178.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.452 ' O ' ' HB3' ' A' ' 43' ' ' TYR . 85.9 m -87.12 127.79 35.12 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 108.635 -0.876 . . . . 1.0800000000000001 108.635 178.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.508 HG12 ' CG2' ' A' ' 35' ' ' VAL . 44.5 mt -137.85 103.36 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 120.995 -1.065 . . . . 1.0900000000000001 111.176 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -85.08 80.51 9.23 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.298 -0.876 . . . . 0.45000000000000001 109.17 178.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -101.74 136.74 41.07 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.515 -0.741 . . . . 0.95999999999999996 110.311 -179.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.673 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 39.9 p -68.8 -14.8 63.26 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.45 -0.781 . . . . 1.0600000000000001 111.063 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -130.85 159.74 36.47 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.246 -0.909 . . . . 0.60999999999999999 110.764 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.534 ' HB ' ' HG3' ' A' ' 2' ' ' LYS . 8.4 tp -76.5 -27.15 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.532 -0.73 . . . . 1.1299999999999999 110.367 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.32 -26.9 63.04 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.203 -0.936 . . . . 0.64000000000000001 110.558 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -63.84 -53.46 50.41 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.393 -0.817 . . . . 2.3100000000000001 110.231 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.4 p -65.73 -27.59 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.662 -0.649 . . . . 0.93000000000000005 110.441 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.18 -48.31 73.89 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.316 -0.865 . . . . 0.46000000000000002 109.286 178.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 82.7 m -64.36 -34.59 78.52 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.741 -0.599 . . . . 1.0600000000000001 109.436 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.521 ' HA ' HG23 ' A' ' 34' ' ' VAL . 5.2 mp -63.14 -40.29 97.14 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.67 -0.644 . . . . 1.0800000000000001 109.714 179.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.631 ' CD1' ' HB ' ' A' ' 86' ' ' VAL . 0.7 OUTLIER -64.77 -43.86 91.9 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.604 -0.685 . . . . 0.45000000000000001 109.457 178.886 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -65.98 -32.87 74.6 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.474 -0.766 . . . . 0.75 110.735 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.507 ' CB ' HG23 ' A' ' 34' ' ' VAL . 0.3 OUTLIER -70.49 -55.52 8.76 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.333 -0.854 . . . . 0.51000000000000001 110.378 179.972 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.604 ' HA ' ' HG2' ' A' ' 30' ' ' GLN . 0.3 OUTLIER -70.27 -28.19 65.02 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.361 -0.837 . . . . 0.87 110.199 179.677 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.507 ' N ' ' HG ' ' A' ' 77' ' ' LEU . . . -107.59 55.78 0.51 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.428 -1.469 . . . . 0.26000000000000001 109.428 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -106.07 4.18 28.95 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.702 -0.881 . . . . 1.97 110.6 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.7 mp -63.44 145.05 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.35 -0.844 . . . . 1.1299999999999999 110.195 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.73 -5.93 41.08 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.509 -0.744 . . . . 1.6200000000000001 111.603 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.48 HD12 ' HA ' ' A' ' 82' ' ' ILE . 47.3 mm -80.77 -106.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.031 -1.043 . . . . 1.21 109.887 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.464 HG23 HG23 ' A' ' 82' ' ' ILE . 63.5 t -123.93 112.16 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 120.915 -1.116 . . . . 1.04 110.389 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.06 122.02 38.31 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.37 0.605 . . . . 0.81000000000000005 109.727 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.488 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 1.3 ttm -146.88 158.6 43.96 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.25 -0.906 . . . . 3.0099999999999998 110.174 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.631 ' HB ' ' CD1' ' A' ' 74' ' ' TYR . 9.8 p -141.45 154.13 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.429 -0.795 . . . . 0.44 110.837 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.499 1.989 0 CA-C-O 118.823 -0.608 . . . . 1.0800000000000001 110.407 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.769 0 CA-C-O 120.874 0.369 . . . . 3.2999999999999998 110.586 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.05 -62.87 1.44 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.301 -0.874 . . . . 1.6200000000000001 109.83 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 57.6 m -138.83 84.95 2.04 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.493 -0.754 . . . . 1.6200000000000001 109.602 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.71 -54.91 0.61 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.445 -0.784 . . . . 1.6799999999999999 110.498 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 52.54 55.19 9.44 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.701 -0.624 . . . . 1.72 110.303 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -102.14 73.14 1.35 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.399 -0.813 . . . . 1.3400000000000001 109.937 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -105.39 155.69 18.89 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.553 -0.717 . . . . 0.55000000000000004 110.224 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.91 -41.84 20.35 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.388 -0.82 . . . . 1.45 109.487 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.425 HD11 ' HB2' ' A' ' 11' ' ' PHE . 0.9 OUTLIER -94.37 -30.38 14.53 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.75 -0.594 . . . . 1.1699999999999999 110.345 179.287 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 46.27 67.43 0.76 Allowed 'General case' 0 N--CA 1.499 2.01 0 CA-C-O 121.509 0.671 . . . . 0.59999999999999998 110.877 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.425 ' HB2' HD11 ' A' ' 9' ' ' LEU . 87.4 t80 -94.93 125.26 51.56 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.482 -0.761 . . . . 0.72999999999999998 110.039 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.611 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 43.4 Cg_endo -70.79 112.05 3.17 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 O-C-N 124.051 1.553 . . . . 0.34000000000000002 110.424 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.5 t -121.5 141.56 33.71 Favored Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 121.556 -0.715 . . . . 1.01 110.459 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.66 129.6 14.79 Favored 'Trans proline' 0 C--N 1.314 -1.261 0 O-C-N 123.879 1.462 . . . . 0.41999999999999998 110.637 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -109.6 99.7 8.86 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.596 -0.69 . . . . 0.5 110.217 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.2 m -73.95 92.58 2.12 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.257 -1.016 . . . . 1.05 108.257 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.437 ' CZ ' HG21 ' A' ' 70' ' ' VAL . 2.9 m-85 -103.55 103.74 13.72 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.461 -0.774 . . . . 0.54000000000000004 110.949 -178.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.643 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 0.1 OUTLIER -82.3 97.45 8.31 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.344 -0.847 . . . . 3.7599999999999998 109.741 179.404 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.56 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . 15.9 t -79.95 96.89 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.427 -0.795 . . . . 1.05 109.37 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 60.2 mtm -101.36 127.3 48.05 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.571 -0.705 . . . . 1.28 110.254 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -157.15 -158.81 9.12 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.875 -1.29 . . . . 0.40000000000000002 109.875 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.428 ' HB2' ' CG2' ' A' ' 82' ' ' ILE . 0.0 OUTLIER -68.78 177.49 2.53 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.364 -1.08 . . . . 1.55 110.559 -179.979 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.423 ' HA ' ' CG ' ' A' ' 56' ' ' HIS . . . -79.4 91.03 5.04 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.427 -0.796 . . . . 0.52000000000000002 110.459 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -133.81 132.29 21.48 Favored Pre-proline 0 N--CA 1.496 1.847 0 O-C-N 121.397 -0.814 . . . . 1.1000000000000001 110.249 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -76.43 -4.19 14.73 Favored 'Trans proline' 0 N--CA 1.489 1.216 0 O-C-N 123.702 1.369 . . . . 0.59999999999999998 112.057 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -80.14 -5.84 56.7 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 120.968 -1.082 . . . . 0.62 111.466 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.631 HD11 HG13 ' A' ' 58' ' ' VAL . 4.1 pp -66.13 -38.23 87.63 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.932 -1.105 . . . . 1.1699999999999999 111.083 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.8 p -76.53 -29.83 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.256 -0.902 . . . . 0.93000000000000005 110.855 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -69.27 -53.84 17.73 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.365 -0.834 . . . . 0.39000000000000001 110.116 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.644 ' HG2' ' HA ' ' A' ' 77' ' ' LEU . 0.6 OUTLIER -67.66 -38.78 84.25 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.34 -0.85 . . . . 0.71999999999999997 110.75 179.911 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.425 ' CG1' ' CD1' ' A' ' 60' ' ' ILE . 2.8 t -59.39 -56.87 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.362 -0.836 . . . . 0.68999999999999995 110.615 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.7 p -62.79 -33.71 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 121.292 -0.88 . . . . 1.05 111.549 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.85 -55.91 5.32 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.043 -1.036 . . . . 0.42999999999999999 110.823 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.562 HG22 ' HB2' ' A' ' 76' ' ' GLU . 6.2 p -65.53 -23.97 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.34 -0.85 . . . . 0.38 111.512 -179.324 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.45 ' HA ' HD21 ' A' ' 73' ' ' LEU . 1.8 p -86.0 -32.52 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 120.922 -1.111 . . . . 0.76000000000000001 111.078 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -78.73 -26.92 44.78 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.966 -1.084 . . . . 0.45000000000000001 110.558 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.86 -39.51 35.03 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.276 -0.89 . . . . 0.77000000000000002 110.609 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.648 ' HB2' HD11 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -86.69 -45.54 10.88 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.35 -0.844 . . . . 0.40999999999999998 110.571 -179.878 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -100.69 152.15 37.77 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.434 -0.791 . . . . 1.1100000000000001 109.993 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.42 140.58 36.92 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 O-C-N 123.844 1.444 . . . . 0.47999999999999998 110.584 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.22 162.41 26.2 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.749 -1.341 . . . . 0.52000000000000002 109.749 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.05 143.62 27.71 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.426 -1.043 . . . . 0.41999999999999998 110.088 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.427 ' HB3' ' O ' ' A' ' 61' ' ' THR . 82.8 m-85 -125.79 166.37 16.96 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.493 -0.754 . . . . 0.51000000000000001 110.448 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.459 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 3.9 m -140.76 152.36 65.58 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.408 -0.808 . . . . 0.77000000000000002 111.083 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.582 ' HA ' ' HA ' ' A' ' 60' ' ' ILE . 54.6 Cg_endo -96.06 123.42 0.27 Allowed 'Trans proline' 0 C--N 1.319 -0.999 0 C-N-CA 122.125 1.884 . . . . 0.25 110.545 179.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.487 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 58.6 m -75.3 92.72 2.79 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.213 -0.929 . . . . 0.98999999999999999 108.779 178.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.462 HG21 ' CG1' ' A' ' 58' ' ' VAL . 8.3 p -80.75 139.38 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 CA-C-O 121.863 0.84 . . . . 1.05 112.406 -178.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.465 ' HG2' ' O ' ' A' ' 57' ' ' SER . 0.2 OUTLIER -142.57 109.39 5.67 Favored Pre-proline 0 N--CA 1.493 1.695 0 N-CA-C 108.709 -0.848 . . . . 1.1299999999999999 108.709 178.198 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -77.09 126.44 8.62 Favored 'Trans proline' 0 C--N 1.315 -1.191 0 O-C-N 123.766 1.403 . . . . 0.56999999999999995 111.021 -178.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 31.1 p -77.25 -44.95 28.04 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.444 -0.785 . . . . 0.88 109.802 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -122.86 -165.66 1.34 Allowed 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 109.347 -0.612 . . . . 1.49 109.347 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.63 118.31 31.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.265 -0.897 . . . . 3.4100000000000001 109.589 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 50.18 33.21 22.37 Favored Glycine 0 N--CA 1.497 2.762 0 N-CA-C 110.596 -1.002 . . . . 0.52000000000000002 110.596 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -108.22 -65.93 1.08 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.277 -1.131 . . . . 2.1000000000000001 110.817 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -142.5 136.97 29.9 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.51 -0.744 . . . . 1.01 110.351 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.423 ' CG ' ' HA ' ' A' ' 23' ' ' ALA . 5.4 m170 -116.27 123.76 48.49 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.558 -0.713 . . . . 1.02 110.317 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.465 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 26.0 m -108.7 119.88 40.82 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.435 -0.791 . . . . 0.84999999999999998 108.913 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.631 HG13 HD11 ' A' ' 27' ' ' LEU . 1.7 m -124.81 151.62 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 120.957 -1.089 . . . . 1.01 111.221 -178.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.643 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 6.4 t -118.82 105.86 11.95 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.586 -0.696 . . . . 1.0 109.155 179.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.582 ' HA ' ' HA ' ' A' ' 45' ' ' PRO . 2.5 tp -93.29 129.93 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.238 -0.914 . . . . 0.40999999999999998 111.07 -179.027 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.427 ' O ' ' HB3' ' A' ' 43' ' ' TYR . 49.5 m -85.44 121.92 28.84 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.855 -0.794 . . . . 0.94999999999999996 108.855 178.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.43 HG12 ' CG2' ' A' ' 35' ' ' VAL . 68.2 mt -127.82 109.25 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 120.939 -1.101 . . . . 1.1200000000000001 110.986 -178.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -90.7 92.96 9.04 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.418 -0.801 . . . . 0.62 109.576 179.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -117.79 139.38 51.15 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.53 -0.731 . . . . 1.0600000000000001 110.39 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.611 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 34.5 p -74.86 -13.0 60.51 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.502 -0.749 . . . . 0.56000000000000005 110.729 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -129.14 148.15 51.06 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.338 -0.851 . . . . 0.51000000000000001 110.311 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -72.87 -21.7 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.511 -0.743 . . . . 1.3600000000000001 110.763 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.18 -23.86 57.76 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.144 -0.973 . . . . 0.5 110.844 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -71.21 -50.45 32.94 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.296 -0.877 . . . . 0.58999999999999997 110.268 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.437 HG21 ' CZ ' ' A' ' 17' ' ' TYR . 8.1 p -65.81 -31.52 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.56 -0.712 . . . . 0.92000000000000004 110.339 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.4 -47.22 77.04 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.361 -0.837 . . . . 0.46999999999999997 109.343 178.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 93.4 m -62.47 -34.7 77.35 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.705 -0.622 . . . . 1.0600000000000001 109.498 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.648 HD11 ' HB2' ' A' ' 38' ' ' HIS . 2.0 mp -61.96 -41.02 97.51 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.583 -0.698 . . . . 0.95999999999999996 109.593 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.529 ' CD1' ' HB ' ' A' ' 86' ' ' VAL . 2.7 t80 -64.64 -40.47 95.51 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.597 -0.689 . . . . 0.78000000000000003 109.323 178.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.57 -38.49 87.7 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.379 -0.826 . . . . 0.44 110.254 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.562 ' HB2' HG22 ' A' ' 34' ' ' VAL . 0.4 OUTLIER -71.12 -50.73 30.46 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.483 -0.76 . . . . 0.46999999999999997 110.721 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.644 ' HA ' ' HG2' ' A' ' 30' ' ' GLN . 0.2 OUTLIER -72.01 -27.71 62.91 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.316 -0.865 . . . . 1.01 110.574 179.944 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.487 ' N ' ' HG ' ' A' ' 77' ' ' LEU . . . -100.84 38.13 3.28 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.646 -1.382 . . . . 0.28000000000000003 109.646 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.54 3.72 27.36 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.545 -0.974 . . . . 0.71999999999999997 110.815 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.0 mt -67.36 155.91 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.15 -0.969 . . . . 1.02 109.911 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -62.25 -25.0 67.58 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.349 -0.844 . . . . 0.5 110.005 179.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.428 ' CG2' ' HB2' ' A' ' 22' ' ' GLN . 49.7 mm -73.54 163.89 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.555 -0.716 . . . . 1.0800000000000001 109.92 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 92.2 t -71.6 106.28 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.409 -0.807 . . . . 1.1100000000000001 110.843 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 1.4 tpm_? -121.99 114.03 20.4 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.598 -0.689 . . . . 0.47999999999999998 109.585 179.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.46 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -120.65 170.54 9.33 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.296 -0.877 . . . . 2.1699999999999999 110.38 -179.713 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.56 ' HA ' ' HA ' ' A' ' 19' ' ' VAL . 4.7 p -138.16 155.21 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.472 -0.768 . . . . 0.96999999999999997 110.629 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.498 1.937 0 CA-C-O 117.738 -1.125 . . . . 1.1100000000000001 110.43 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.5 mtt . . . . . 0 N--CA 1.495 1.812 0 CA-C-O 121.223 0.535 . . . . 1.8700000000000001 110.372 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -162.61 -170.38 2.39 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.47 -0.769 . . . . 2.2999999999999998 110.007 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 85.1 m -111.51 -53.1 2.74 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.359 -0.838 . . . . 1.21 110.045 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.6 tptt -145.68 158.35 43.86 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.381 -0.825 . . . . 0.69999999999999996 110.069 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.445 ' O ' ' HB2' ' A' ' 6' ' ' ASN . 0.9 OUTLIER -102.01 12.94 36.07 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.418 -0.801 . . . . 1.3 110.734 179.8 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' A' ' 5' ' ' LEU . 22.5 m-80 62.25 -79.2 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.808 -0.557 . . . . 1.8400000000000001 111.41 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.423 ' HB2' ' O ' ' A' ' 6' ' ' ASN . 1.2 mt-10 62.96 176.37 0.15 Allowed 'General case' 0 N--CA 1.506 2.359 0 O-C-N 121.468 -0.77 . . . . 0.60999999999999999 110.965 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -98.07 -33.2 11.26 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.436 -0.79 . . . . 1.8300000000000001 110.039 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.2 mp -98.39 -41.88 7.61 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.424 -0.798 . . . . 1.28 110.008 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 58.65 60.09 2.66 Favored 'General case' 0 N--CA 1.5 2.025 0 CA-C-O 121.505 0.669 . . . . 0.53000000000000003 110.208 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.411 ' O ' ' HA ' ' A' ' 65' ' ' THR . 84.9 t80 -95.63 113.51 62.02 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.488 -0.757 . . . . 1.1799999999999999 109.705 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.655 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 44.7 Cg_endo -70.62 116.66 4.75 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 O-C-N 124.021 1.537 . . . . 0.41999999999999998 110.949 -179.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.5 t -119.51 142.94 33.6 Favored Pre-proline 0 N--CA 1.496 1.835 0 O-C-N 121.687 -0.633 . . . . 1.01 110.037 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -71.98 125.22 10.75 Favored 'Trans proline' 0 C--N 1.314 -1.282 0 O-C-N 123.869 1.458 . . . . 0.44 111.19 -179.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.526 ' HB3' HG21 ' A' ' 70' ' ' VAL . 23.4 m-85 -110.35 99.31 8.36 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.591 -0.693 . . . . 0.40000000000000002 110.249 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.4 m -78.99 92.32 4.94 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.21 -1.033 . . . . 1.1000000000000001 108.21 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.429 ' CE1' HG21 ' A' ' 70' ' ' VAL . 3.4 m-85 -99.66 107.91 20.14 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.496 -0.752 . . . . 0.93000000000000005 110.768 -178.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.648 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 0.0 OUTLIER -87.56 89.7 8.09 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.592 -0.693 . . . . 2.3100000000000001 109.944 179.825 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.553 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . 2.4 m -82.34 110.35 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.36 -0.837 . . . . 1.05 109.828 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 53.9 mtt -109.36 157.34 18.99 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.611 -0.681 . . . . 1.3600000000000001 110.282 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 169.36 -164.04 37.62 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 109.986 -1.246 . . . . 0.5 109.986 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.489 ' HB2' HG22 ' A' ' 82' ' ' ILE . 6.3 mt-30 -69.59 150.85 46.64 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.53 -0.982 . . . . 2.1000000000000001 110.017 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.416 ' HA ' ' CD2' ' A' ' 56' ' ' HIS . . . -53.74 111.7 0.78 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.583 -0.698 . . . . 1.1499999999999999 110.548 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.7 mt -132.21 129.72 21.75 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.585 -0.697 . . . . 1.3899999999999999 110.395 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.65 -21.65 18.91 Favored 'Trans proline' 0 C--N 1.315 -1.231 0 O-C-N 123.849 1.447 . . . . 0.80000000000000004 111.171 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -81.33 -4.25 55.08 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.271 -0.893 . . . . 1.46 111.298 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.98 -58.34 8.27 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.991 -1.068 . . . . 1.24 110.332 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.495 HG11 ' HG2' ' A' ' 45' ' ' PRO . 36.0 m -62.22 -29.67 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 O-C-N 121.497 -0.752 . . . . 1.1100000000000001 111.042 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.445 ' O ' HG12 ' A' ' 32' ' ' VAL . 31.9 t70 -70.22 -53.26 17.77 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.286 -0.884 . . . . 0.52000000000000002 110.427 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.591 ' HG2' ' HA ' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -69.17 -35.8 76.68 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.326 -0.859 . . . . 1.8500000000000001 110.352 179.6 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.403 ' O ' ' HB ' ' A' ' 35' ' ' VAL . 3.8 t -61.81 -51.47 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.574 -0.704 . . . . 1.0 110.562 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.445 HG12 ' O ' ' A' ' 29' ' ' ASP . 6.1 p -67.03 -32.63 58.77 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.232 -0.917 . . . . 1.0800000000000001 111.223 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.63 -50.93 14.02 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.079 -1.013 . . . . 1.0800000000000001 110.509 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.488 HG22 ' HA ' ' A' ' 73' ' ' LEU . 9.9 p -67.69 -30.37 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.366 -0.834 . . . . 0.40000000000000002 110.898 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.606 HG22 ' CG1' ' A' ' 62' ' ' ILE . 2.3 p -76.64 -38.2 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.073 -1.017 . . . . 0.98999999999999999 110.352 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -74.05 -22.45 59.53 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.054 -1.029 . . . . 0.56000000000000005 109.946 179.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.0 mtp-105 -68.48 -49.24 61.24 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.415 -0.803 . . . . 0.92000000000000004 110.154 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.413 ' CE1' ' HG2' ' A' ' 69' ' ' GLN . 2.0 m-70 -84.54 -45.78 12.25 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.39 -0.819 . . . . 0.40999999999999998 110.498 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.83 153.79 83.11 Favored Pre-proline 0 N--CA 1.497 1.897 0 O-C-N 121.351 -0.843 . . . . 0.34999999999999998 110.068 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -69.06 -34.54 16.68 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.922 1.485 . . . . 0.48999999999999999 111.395 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -108.86 -178.61 21.57 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 110.063 -1.215 . . . . 0.46000000000000002 110.063 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.14 148.68 22.8 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.553 -0.969 . . . . 0.52000000000000002 109.648 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -135.4 172.84 12.43 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.409 -0.807 . . . . 0.56000000000000005 111.188 -179.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.489 HG21 ' CD ' ' A' ' 45' ' ' PRO . 0.3 OUTLIER -142.39 156.53 63.89 Favored Pre-proline 0 N--CA 1.496 1.851 0 O-C-N 121.613 -0.68 . . . . 1.1100000000000001 110.513 -179.64 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.56 ' HB2' ' HB ' ' A' ' 58' ' ' VAL . 52.6 Cg_endo -94.64 121.94 0.34 Allowed 'Trans proline' 0 C--N 1.317 -1.125 0 C-N-CA 121.986 1.79 . . . . 0.33000000000000002 110.229 179.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.44 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 74.2 m -80.44 101.4 9.02 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.079 -1.013 . . . . 1.0900000000000001 109.572 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.473 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 12.1 p -76.52 141.2 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.408 -0.807 . . . . 1.0700000000000001 111.525 -179.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.458 ' HE2' ' HB3' ' A' ' 57' ' ' SER . 0.1 OUTLIER -142.27 149.55 52.05 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.752 -0.593 . . . . 1.1599999999999999 109.691 179.215 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -75.85 88.46 1.31 Allowed 'Trans proline' 0 C--N 1.314 -1.267 0 O-C-N 124.03 1.542 . . . . 0.76000000000000001 110.649 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.3 m -93.23 -44.83 8.14 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.49 -0.757 . . . . 1.1499999999999999 109.968 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.471 ' HB3' ' HB3' ' A' ' 55' ' ' TYR . 0.1 OUTLIER -112.85 161.12 17.31 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.531 -0.731 . . . . 1.51 110.092 179.651 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.42 158.25 15.52 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.363 -0.835 . . . . 2.4199999999999999 110.54 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.93 -138.28 13.98 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.68 -1.368 . . . . 0.88 109.68 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -98.07 67.43 1.91 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.452 -1.028 . . . . 0.95999999999999996 109.945 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.471 ' HB3' ' HB3' ' A' ' 51' ' ' SER . 14.9 t80 -145.47 139.4 26.82 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.445 -0.784 . . . . 1.27 110.231 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.416 ' CD2' ' HA ' ' A' ' 23' ' ' ALA . 0.6 OUTLIER -142.25 146.71 35.44 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.506 -0.746 . . . . 0.51000000000000001 110.31 179.824 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.458 ' HB3' ' HE2' ' A' ' 48' ' ' LYS . 37.5 m -119.69 114.22 21.85 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.282 -0.886 . . . . 0.90000000000000002 109.719 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.56 ' HB ' ' HB2' ' A' ' 45' ' ' PRO . 3.1 m -114.07 146.76 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.136 -0.977 . . . . 0.64000000000000001 110.952 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.648 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 45.5 t -112.97 111.1 21.6 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.687 -0.633 . . . . 0.76000000000000001 109.43 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.504 ' HA ' ' HA ' ' A' ' 45' ' ' PRO . 2.2 tp -92.74 129.79 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 C-N-CA 119.773 -0.771 . . . . 0.38 111.042 -179.15 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 82.7 m -82.34 137.83 34.67 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.934 -0.765 . . . . 1.05 108.934 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.606 ' CG1' HG22 ' A' ' 35' ' ' VAL . 2.3 mt -136.95 139.54 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.105 -0.997 . . . . 1.1499999999999999 111.017 -179.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -117.99 69.55 0.78 Allowed 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 121.457 0.646 . . . . 0.45000000000000001 109.299 179.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.482 ' HB2' ' HB2' ' A' ' 69' ' ' GLN . . . -99.59 135.78 40.5 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.489 -0.757 . . . . 0.94999999999999996 110.269 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.655 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 58.0 p -73.73 -13.05 60.9 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.492 -0.755 . . . . 1.1200000000000001 110.847 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 8.7 t60 -129.47 157.16 42.78 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.249 -0.907 . . . . 0.62 110.76 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.14 -24.88 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.534 -0.729 . . . . 1.6200000000000001 110.43 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -70.96 -31.26 67.77 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.319 -0.863 . . . . 0.94999999999999996 110.278 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.482 ' HB2' ' HB2' ' A' ' 64' ' ' ALA . 57.1 mt-30 -63.06 -52.74 61.59 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.472 -0.768 . . . . 0.42999999999999999 110.025 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.526 HG21 ' HB3' ' A' ' 15' ' ' PHE . 7.7 p -69.31 -26.98 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.371 -0.831 . . . . 0.92000000000000004 110.222 179.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.95 -52.27 64.72 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.345 -0.847 . . . . 0.70999999999999996 109.229 178.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.5 p -63.83 -35.75 81.65 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.474 -0.767 . . . . 1.1200000000000001 109.239 178.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.488 ' HA ' HG22 ' A' ' 34' ' ' VAL . 3.7 mp -57.3 -42.2 81.3 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.541 -0.724 . . . . 0.95999999999999996 109.693 178.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.462 ' CD1' ' HB ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -65.03 -44.22 89.82 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 109.102 -0.703 . . . . 0.64000000000000001 109.102 178.766 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -65.71 -33.84 76.81 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.548 -0.72 . . . . 0.63 110.616 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.481 ' HB2' HG22 ' A' ' 34' ' ' VAL . 0.2 OUTLIER -70.31 -54.3 13.19 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.452 -0.78 . . . . 0.44 110.629 -179.897 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.591 ' HA ' ' HG2' ' A' ' 30' ' ' GLN . 0.9 OUTLIER -73.13 -24.67 60.63 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.309 -0.87 . . . . 1.0600000000000001 110.177 179.588 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -103.68 43.67 1.63 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.492 -1.443 . . . . 0.34000000000000002 109.492 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.13 3.89 28.5 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.435 -1.038 . . . . 1.0600000000000001 110.842 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.2 mp -65.3 144.89 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.26 -0.9 . . . . 1.1200000000000001 110.292 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.8 -20.87 66.03 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.332 -0.855 . . . . 1.48 110.322 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.489 HG22 ' HB2' ' A' ' 22' ' ' GLN . 40.4 mm -70.46 170.13 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.431 -0.793 . . . . 1.1899999999999999 109.87 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 75.3 t -62.32 112.75 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.335 -0.853 . . . . 1.1899999999999999 110.544 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.31 161.64 21.67 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.733 -0.605 . . . . 1.4199999999999999 110.113 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.454 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 1.7 ttp -157.72 160.19 37.65 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.401 -0.812 . . . . 1.73 109.882 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.553 ' HA ' ' HA ' ' A' ' 19' ' ' VAL . 11.3 p -134.1 146.46 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.32 -0.863 . . . . 1.0600000000000001 110.524 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 34.8 mt . . . . . 0 N--CA 1.5 2.063 0 CA-C-O 117.646 -1.169 . . . . 1.03 110.488 -179.807 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.8 ptm . . . . . 0 N--CA 1.497 1.891 0 CA-C-O 121.312 0.577 . . . . 1.45 111.173 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.82 170.6 9.76 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.648 -0.657 . . . . 4.0800000000000001 110.866 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.419 ' O ' ' C ' ' A' ' 4' ' ' LYS . 26.4 p -129.3 -52.17 1.19 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.457 -0.777 . . . . 1.29 110.79 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.419 ' C ' ' O ' ' A' ' 3' ' ' THR . 5.6 ptmt 33.54 68.62 0.16 Allowed 'General case' 0 N--CA 1.509 2.496 0 CA-C-O 121.587 0.708 . . . . 1.5 111.236 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.519 HD22 ' HG3' ' A' ' 69' ' ' GLN . 0.4 OUTLIER -69.0 151.83 46.01 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.444 -0.785 . . . . 1.53 111.062 -179.461 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 51.61 61.43 3.23 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.333 0.587 . . . . 1.3500000000000001 111.178 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -129.02 -57.19 1.17 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.306 -0.871 . . . . 0.65000000000000002 110.021 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -110.11 -35.92 5.98 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.648 -0.658 . . . . 1.5800000000000001 110.413 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.4 mp -96.05 -56.15 2.74 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.401 -0.812 . . . . 1.47 110.331 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 54.77 33.71 20.21 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.801 -0.562 . . . . 0.73999999999999999 110.803 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.427 ' O ' ' HA ' ' A' ' 65' ' ' THR . 69.7 t80 -121.66 114.41 31.39 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.329 -0.857 . . . . 1.1200000000000001 109.8 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.572 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 44.3 Cg_endo -70.3 108.94 2.29 Favored 'Trans proline' 0 C--N 1.314 -1.272 0 O-C-N 123.911 1.479 . . . . 0.35999999999999999 110.51 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.5 t -129.65 142.43 45.27 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.658 -0.651 . . . . 1.1100000000000001 110.54 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.17 129.54 15.23 Favored 'Trans proline' 0 C--N 1.315 -1.199 0 O-C-N 123.917 1.483 . . . . 0.52000000000000002 110.334 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.596 ' CB ' HG22 ' A' ' 70' ' ' VAL . 32.8 m-85 -108.29 100.76 10.03 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.595 -0.69 . . . . 0.42999999999999999 110.32 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.9 m -74.19 92.26 2.2 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.407 -0.96 . . . . 1.1200000000000001 108.407 178.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.512 ' CZ ' HG21 ' A' ' 70' ' ' VAL . 3.3 m-85 -102.8 104.41 14.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.441 -0.787 . . . . 0.85999999999999999 110.611 -178.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.609 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 0.0 OUTLIER -78.99 93.47 5.1 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.573 -0.704 . . . . 2.5499999999999998 109.484 179.605 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.575 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . 24.8 t -78.36 95.3 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.463 -0.773 . . . . 1.05 109.15 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.448 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 53.7 mtt -97.71 153.57 18.16 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.577 -0.702 . . . . 1.6100000000000001 110.535 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 168.4 -151.94 19.37 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.877 -1.289 . . . . 0.34000000000000002 109.877 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.522 ' HA ' ' HA ' ' A' ' 55' ' ' TYR . 5.9 mt-30 -78.19 170.26 16.91 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.458 -1.025 . . . . 1.1399999999999999 110.414 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.448 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -78.0 101.33 6.85 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.29 -0.881 . . . . 1.04 109.816 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.509 ' HG ' ' HD2' ' A' ' 25' ' ' PRO . 1.0 OUTLIER -130.33 136.37 28.89 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.49 -0.756 . . . . 1.6000000000000001 110.548 -179.404 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.509 ' HD2' ' HG ' ' A' ' 24' ' ' LEU . 47.3 Cg_endo -72.92 -20.48 22.18 Favored 'Trans proline' 0 C--N 1.316 -1.181 0 O-C-N 123.822 1.433 . . . . 0.56999999999999995 110.997 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -72.07 -13.74 61.67 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.351 -0.843 . . . . 0.91000000000000003 111.213 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.8 mt -56.83 -64.01 1.01 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.213 -0.929 . . . . 1.1799999999999999 110.577 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.6 p -60.94 -30.84 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 O-C-N 121.388 -0.82 . . . . 1.1100000000000001 111.021 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -64.35 -62.39 1.63 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.395 -0.816 . . . . 0.51000000000000001 110.389 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.526 ' CG ' ' HA ' ' A' ' 77' ' ' LEU . 5.5 tp60 -64.35 -32.53 74.18 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.354 -0.841 . . . . 0.75 110.724 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.513 HG22 HD23 ' A' ' 77' ' ' LEU . 2.3 t -59.03 -56.67 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.269 -0.894 . . . . 1.02 110.346 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.523 HG11 ' N ' ' A' ' 33' ' ' GLU . 8.6 p -68.49 -28.36 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.381 -0.824 . . . . 1.0700000000000001 111.548 -179.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.523 ' N ' HG11 ' A' ' 32' ' ' VAL . 1.0 OUTLIER -76.02 -55.97 5.1 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.031 -1.043 . . . . 0.52000000000000002 110.773 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.474 HG23 ' HA ' ' A' ' 73' ' ' LEU . 5.7 p -66.93 -25.8 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.428 -0.795 . . . . 0.40000000000000002 111.339 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.467 ' CG2' HG12 ' A' ' 62' ' ' ILE . 2.4 p -82.64 -35.02 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.013 -1.055 . . . . 0.44 110.828 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -76.73 -25.98 54.13 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.066 -1.021 . . . . 0.62 110.2 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 25.7 mtm-85 -75.96 -39.7 55.45 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.267 -0.896 . . . . 1.5700000000000001 110.533 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.572 ' CB ' HD11 ' A' ' 73' ' ' LEU . 0.5 OUTLIER -90.26 -45.71 8.89 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.285 -0.884 . . . . 0.79000000000000004 110.691 -179.818 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -98.52 150.95 37.22 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.56 -0.713 . . . . 1.03 110.149 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -71.3 140.72 37.6 Favored 'Trans proline' 0 C--N 1.313 -1.302 0 O-C-N 123.823 1.433 . . . . 0.48999999999999999 110.385 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.83 164.77 32.29 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.597 -1.401 . . . . 0.54000000000000004 109.597 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -99.98 139.56 35.47 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.376 -1.073 . . . . 0.51000000000000001 110.117 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.431 ' HB2' HG13 ' A' ' 35' ' ' VAL . 93.0 m-85 -119.21 170.59 8.95 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.527 -0.733 . . . . 0.54000000000000004 110.541 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.69 HG23 ' HD2' ' A' ' 45' ' ' PRO . 0.2 OUTLIER -142.44 153.91 62.97 Favored Pre-proline 0 N--CA 1.498 1.974 0 O-C-N 121.423 -0.798 . . . . 1.1000000000000001 110.836 -179.136 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.69 ' HD2' HG23 ' A' ' 44' ' ' THR . 52.6 Cg_endo -96.36 121.16 0.22 Allowed 'Trans proline' 0 C--N 1.321 -0.9 0 C-N-CA 122.015 1.81 . . . . 0.28999999999999998 110.104 178.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.439 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 53.2 m -78.81 97.6 6.0 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.129 -0.982 . . . . 1.05 109.686 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.527 HG22 HG11 ' A' ' 58' ' ' VAL . 11.5 p -76.53 139.22 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.515 -0.74 . . . . 1.1200000000000001 111.479 -179.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.3 pttt -142.53 152.53 60.33 Favored Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.684 -0.635 . . . . 2.3900000000000001 109.884 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -77.16 81.49 2.6 Favored 'Trans proline' 0 C--N 1.313 -1.308 0 O-C-N 123.934 1.492 . . . . 0.75 110.49 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.474 ' HB2' ' HB2' ' A' ' 57' ' ' SER . 0.4 OUTLIER -90.15 -46.55 8.38 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.424 -0.797 . . . . 1.3600000000000001 110.07 179.829 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.423 ' HB3' ' CB ' ' A' ' 55' ' ' TYR . 0.1 OUTLIER -102.73 166.23 10.61 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.45 -0.781 . . . . 1.6599999999999999 110.202 179.767 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.39 160.07 14.74 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.422 -0.799 . . . . 2.0 110.586 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.44 -136.24 13.75 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.563 -1.415 . . . . 0.93000000000000005 109.563 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -99.23 64.88 1.39 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.578 -0.954 . . . . 1.02 110.01 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 17.6 m-85 -139.0 139.27 37.82 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.494 -0.754 . . . . 1.23 110.394 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.448 ' HB2' ' HA ' ' A' ' 23' ' ' ALA . 0.2 OUTLIER -137.5 142.44 41.49 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.561 -0.712 . . . . 1.1399999999999999 110.417 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.474 ' HB2' ' HB2' ' A' ' 50' ' ' SER . 17.1 m -116.87 107.84 15.1 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.601 -0.687 . . . . 0.85999999999999999 109.445 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.543 ' HB ' ' HB2' ' A' ' 45' ' ' PRO . 3.1 m -108.23 149.8 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.336 -0.853 . . . . 1.03 110.85 -179.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.609 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 9.1 t -114.76 110.08 19.18 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.938 -0.764 . . . . 0.93999999999999995 108.938 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.522 ' HA ' ' HA ' ' A' ' 45' ' ' PRO . 6.6 tt -92.43 131.06 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.228 -0.92 . . . . 1.0600000000000001 111.423 -178.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 91.9 m -86.13 130.21 34.6 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.684 -0.858 . . . . 1.03 108.684 178.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.608 HD12 HG23 ' A' ' 70' ' ' VAL . 59.3 mt -139.75 99.16 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.004 -1.06 . . . . 1.1000000000000001 111.086 -179.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -84.02 97.97 9.58 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.277 -0.889 . . . . 0.38 108.925 178.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -119.05 138.79 52.61 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.533 -0.729 . . . . 0.95999999999999996 111.19 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.572 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 37.8 p -74.23 -9.93 59.1 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.619 -0.676 . . . . 0.97999999999999998 110.475 179.008 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.448 ' HD2' ' HB2' ' A' ' 68' ' ' GLU . 6.7 t60 -129.51 156.97 43.29 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.398 -0.814 . . . . 0.72999999999999998 110.201 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -82.37 -22.66 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.476 -0.765 . . . . 1.4399999999999999 111.075 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.448 ' HB2' ' HD2' ' A' ' 66' ' ' HIS . 39.5 mt-10 -77.33 -30.27 53.92 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.057 -1.027 . . . . 0.96999999999999997 110.928 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.519 ' HG3' HD22 ' A' ' 5' ' ' LEU . 0.2 OUTLIER -61.74 -44.58 96.63 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.3 -0.875 . . . . 0.55000000000000004 110.214 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.608 HG23 HD12 ' A' ' 62' ' ' ILE . 9.2 p -71.77 -29.31 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.234 -0.917 . . . . 0.97999999999999998 110.238 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.83 -47.5 74.81 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.31 -0.869 . . . . 0.68000000000000005 109.32 179.036 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.484 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . 17.9 p -65.36 -35.17 80.16 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.654 -0.654 . . . . 1.1399999999999999 109.466 178.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.572 HD11 ' CB ' ' A' ' 38' ' ' HIS . 3.8 mp -61.86 -37.23 83.72 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.367 -0.833 . . . . 0.95999999999999996 109.942 179.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.54 ' CD1' ' HB ' ' A' ' 86' ' ' VAL . 0.8 OUTLIER -67.74 -52.78 33.46 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.386 -0.821 . . . . 0.79000000000000004 109.715 179.28 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.484 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 10.6 pt-20 -63.04 -28.03 69.81 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.375 -0.828 . . . . 0.64000000000000001 110.705 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.445 ' HB3' ' CG2' ' A' ' 34' ' ' VAL . 0.1 OUTLIER -71.29 -48.05 53.15 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.277 -0.889 . . . . 0.44 110.003 179.454 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.526 ' HA ' ' CG ' ' A' ' 30' ' ' GLN . 0.3 OUTLIER -76.94 -28.09 55.1 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.468 -0.77 . . . . 1.05 110.198 179.519 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.608 ' HA2' ' HG2' ' A' ' 84' ' ' ARG . . . -103.49 44.96 1.39 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.701 -1.36 . . . . 0.32000000000000001 109.701 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.1 3.83 36.39 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.626 -0.926 . . . . 1.1499999999999999 110.778 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.483 ' HB ' ' HD3' ' A' ' 84' ' ' ARG . 1.7 mp -73.87 154.87 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.276 -0.89 . . . . 1.04 110.03 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.0 -19.91 66.01 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.442 -0.786 . . . . 1.45 110.638 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.514 HG21 ' HB2' ' A' ' 22' ' ' GLN . 51.9 mm -70.19 169.27 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.395 -0.815 . . . . 1.1699999999999999 109.985 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 90.3 t -62.47 104.6 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.439 -0.788 . . . . 1.0900000000000001 110.445 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.608 ' HG2' ' HA2' ' A' ' 78' ' ' GLY . 0.1 OUTLIER -121.82 112.61 18.57 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.692 -0.484 . . . . 0.65000000000000002 109.692 179.911 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.464 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 0.2 OUTLIER -135.5 166.37 23.36 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.287 -0.883 . . . . 2.0 110.419 -179.611 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.575 ' HA ' ' HA ' ' A' ' 19' ' ' VAL . 5.1 p -139.2 157.06 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.393 -0.817 . . . . 0.46999999999999997 110.583 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 87' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.499 2.003 0 CA-C-O 118.843 -0.599 . . . . 1.0800000000000001 110.459 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.795 0 CA-C-O 120.981 0.419 . . . . 2.2000000000000002 110.767 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? 65.36 106.58 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.161 0 CA-C-O 121.431 0.634 . . . . 2.48 110.718 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 87.4 m -97.74 140.04 32.72 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.54 -0.725 . . . . 1.1799999999999999 109.883 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -138.26 128.13 25.35 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.572 -0.705 . . . . 1.04 110.408 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.571 HD11 HD12 ' A' ' 9' ' ' LEU . 0.5 OUTLIER 56.4 -172.06 0.08 Allowed 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 121.296 0.57 . . . . 1.9099999999999999 111.148 -179.886 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -136.42 78.23 1.7 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.435 -0.791 . . . . 2.3300000000000001 110.271 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 52.05 58.18 5.71 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.701 -0.625 . . . . 0.67000000000000004 110.798 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.41 HD12 HD23 ' A' ' 5' ' ' LEU . 2.9 mt -113.3 -44.18 3.27 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.378 -0.826 . . . . 1.3899999999999999 110.275 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.571 HD12 HD11 ' A' ' 5' ' ' LEU . 1.4 mp -81.18 -48.13 12.51 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.347 -0.846 . . . . 1.6399999999999999 109.936 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 60.38 50.26 6.22 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.341 0.591 . . . . 0.95999999999999996 111.082 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.456 ' O ' ' HA ' ' A' ' 65' ' ' THR . 7.3 m-85 -96.55 117.32 66.13 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 121.371 -0.831 . . . . 1.22 109.001 178.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.695 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 42.6 Cg_endo -68.13 106.17 1.32 Allowed 'Trans proline' 0 C--N 1.313 -1.312 0 O-C-N 123.779 1.41 . . . . 0.55000000000000004 111.107 -178.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.4 t -129.15 146.75 62.07 Favored Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 121.84 -0.537 . . . . 1.0800000000000001 110.441 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.69 123.47 9.04 Favored 'Trans proline' 0 C--N 1.314 -1.238 0 O-C-N 123.864 1.455 . . . . 0.40000000000000002 110.49 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.473 ' HB3' HG21 ' A' ' 70' ' ' VAL . 21.8 m-85 -104.42 99.47 9.17 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.508 -0.745 . . . . 0.44 110.587 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.8 m -75.7 93.35 3.09 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.085 -1.079 . . . . 1.1200000000000001 108.085 178.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.425 ' HA ' HD23 ' A' ' 87' ' ' LEU . 2.7 m-85 -101.91 109.74 21.56 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.306 -0.871 . . . . 0.90000000000000002 111.306 -178.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.607 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 0.0 OUTLIER -81.66 91.15 6.38 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.533 -0.729 . . . . 1.49 109.331 179.06 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.474 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . 38.4 t -79.25 96.96 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.666 -0.646 . . . . 1.05 109.955 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.438 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 58.6 mtm -102.17 148.4 25.46 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.405 -0.81 . . . . 1.28 110.028 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.42 ' HA3' ' O ' ' A' ' 83' ' ' VAL . . . 166.77 -142.35 7.55 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 110.035 -1.226 . . . . 0.25 110.035 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.484 ' HG3' HG22 ' A' ' 82' ' ' ILE . 0.0 OUTLIER -66.25 153.93 41.23 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.523 -0.987 . . . . 0.52000000000000002 110.57 -179.934 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -96.58 99.1 10.76 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.568 -0.708 . . . . 1.1499999999999999 110.232 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -128.71 155.82 78.55 Favored Pre-proline 0 N--CA 1.498 1.946 0 O-C-N 121.479 -0.763 . . . . 1.1000000000000001 110.546 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -72.56 -24.58 18.66 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 O-C-N 123.879 1.463 . . . . 0.47999999999999998 111.367 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.27 -5.62 45.57 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.182 -0.948 . . . . 0.56999999999999995 111.291 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.14 -55.66 29.83 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.107 -0.995 . . . . 1.55 110.266 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 26.8 m -66.99 -29.48 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.426 -0.796 . . . . 1.1000000000000001 110.69 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -66.83 -53.42 32.88 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.364 -0.835 . . . . 0.41999999999999998 110.33 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.632 ' HG2' ' HA ' ' A' ' 77' ' ' LEU . 0.3 OUTLIER -68.29 -34.29 75.89 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.25 -0.906 . . . . 1.9299999999999999 110.376 179.594 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.485 HG11 HD11 ' A' ' 60' ' ' ILE . 2.7 t -57.58 -56.09 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.405 -0.81 . . . . 1.0700000000000001 110.268 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.8 p -66.81 -32.98 60.45 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.352 -0.842 . . . . 1.1000000000000001 111.266 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.19 -54.93 7.21 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.14 -0.975 . . . . 0.84999999999999998 110.772 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.458 HG23 ' HA ' ' A' ' 73' ' ' LEU . 8.2 p -66.66 -29.68 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 121.412 -0.805 . . . . 0.35999999999999999 111.153 -179.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.499 ' HA ' ' CD2' ' A' ' 73' ' ' LEU . 2.4 p -78.08 -30.66 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.058 -1.026 . . . . 0.90000000000000002 110.304 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -73.67 -38.32 64.97 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.201 -0.937 . . . . 0.81000000000000005 110.063 179.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.27 -25.14 65.91 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.526 -0.734 . . . . 2.0499999999999998 111.199 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.439 ' CD2' HD13 ' A' ' 73' ' ' LEU . 1.1 m-70 -103.39 -45.62 4.82 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.291 -0.881 . . . . 1.3 110.792 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -106.65 149.51 38.49 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.424 -0.798 . . . . 1.1100000000000001 110.173 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -71.53 142.4 40.31 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 O-C-N 123.858 1.452 . . . . 0.81999999999999995 110.652 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.21 156.26 21.25 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.751 -1.34 . . . . 0.46000000000000002 109.751 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -89.97 140.49 29.58 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.463 -1.021 . . . . 0.55000000000000004 110.127 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.495 ' HB2' HG12 ' A' ' 35' ' ' VAL . 67.8 m-85 -121.76 169.07 11.11 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.556 -0.715 . . . . 0.95999999999999996 110.39 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.431 HG23 ' HD2' ' A' ' 45' ' ' PRO . 2.0 m -142.4 153.19 62.24 Favored Pre-proline 0 N--CA 1.497 1.92 0 O-C-N 121.374 -0.829 . . . . 1.1299999999999999 110.912 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.467 ' HB2' ' HB ' ' A' ' 58' ' ' VAL . 54.3 Cg_endo -95.94 125.06 0.31 Allowed 'Trans proline' 0 C--N 1.32 -0.957 0 C-N-CA 122.022 1.814 . . . . 0.45000000000000001 110.389 178.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.42 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 55.5 m -83.04 94.39 7.78 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.09 -1.006 . . . . 1.1000000000000001 109.468 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.528 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 14.1 p -76.76 141.66 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.453 -0.779 . . . . 1.1399999999999999 111.543 -178.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.43 ' HG2' ' O ' ' A' ' 57' ' ' SER . 0.1 OUTLIER -142.46 149.62 51.65 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.724 -0.61 . . . . 0.68999999999999995 109.732 179.293 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -75.04 84.63 1.64 Allowed 'Trans proline' 0 C--N 1.315 -1.197 0 O-C-N 123.9 1.474 . . . . 0.78000000000000003 110.472 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -91.18 -46.47 8.07 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.484 -0.76 . . . . 1.47 109.964 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 13.9 m -110.21 163.27 13.79 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.542 -0.724 . . . . 0.96999999999999997 110.188 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.56 158.99 15.18 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.462 -0.774 . . . . 2.1299999999999999 110.265 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.52 -135.78 12.76 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.579 -1.408 . . . . 0.68999999999999995 109.579 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -103.37 57.76 0.75 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.414 -1.051 . . . . 1.9399999999999999 110.199 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -135.4 130.21 34.51 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.376 -0.827 . . . . 0.62 110.131 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -132.59 140.53 48.28 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.504 -0.747 . . . . 0.79000000000000004 110.383 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' A' ' 20' ' ' MET . 28.9 m -108.0 108.93 20.27 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.649 -0.657 . . . . 0.73999999999999999 109.387 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.528 ' HA ' ' HA ' ' A' ' 47' ' ' VAL . 2.9 m -109.86 152.75 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.143 -0.973 . . . . 0.93000000000000005 110.858 -179.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.607 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 1.7 t -116.59 111.27 19.65 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.613 -0.884 . . . . 1.1899999999999999 108.613 178.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.485 HD11 HG11 ' A' ' 31' ' ' VAL . 10.5 tt -92.21 127.9 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.218 -0.926 . . . . 1.1299999999999999 111.296 -178.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.47 ' O ' ' HB3' ' A' ' 43' ' ' TYR . 65.9 m -90.91 141.16 29.12 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 109.047 -0.723 . . . . 1.0800000000000001 109.047 179.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.458 HG21 ' HB2' ' A' ' 15' ' ' PHE . 7.8 tt -162.54 141.76 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.012 -1.055 . . . . 0.98999999999999999 110.998 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -108.0 87.56 2.53 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.509 -0.744 . . . . 0.70999999999999996 109.317 178.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -106.63 136.73 45.91 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.46 -0.775 . . . . 1.0800000000000001 110.524 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.695 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 40.2 p -66.98 -23.47 65.95 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.489 -0.757 . . . . 1.0800000000000001 110.843 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -131.47 157.88 42.34 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.193 -0.942 . . . . 0.68000000000000005 110.525 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.2 tt -75.73 -19.1 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.459 -0.776 . . . . 1.1299999999999999 110.676 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.43 -35.42 79.22 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.243 -0.911 . . . . 0.44 110.403 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -65.21 -48.94 71.61 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.457 -0.777 . . . . 1.1699999999999999 110.351 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.473 HG21 ' HB3' ' A' ' 15' ' ' PHE . 8.0 p -70.23 -25.23 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.448 -0.782 . . . . 1.0 110.485 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -68.7 -50.5 50.35 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.195 -0.94 . . . . 0.39000000000000001 109.584 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 20.6 p -61.47 -40.01 92.97 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 109.028 -0.73 . . . . 1.1200000000000001 109.028 178.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.499 ' CD2' ' HA ' ' A' ' 35' ' ' VAL . 3.1 mp -59.65 -39.07 83.16 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.665 -0.647 . . . . 0.92000000000000004 109.709 178.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.651 ' CD1' ' HB ' ' A' ' 86' ' ' VAL . 0.2 OUTLIER -60.36 -44.98 95.06 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.977 -0.749 . . . . 0.84999999999999998 108.977 178.653 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -69.07 -33.21 73.19 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.59 -0.693 . . . . 1.22 110.322 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.447 ' CB ' HG23 ' A' ' 34' ' ' VAL . 0.3 OUTLIER -64.74 -50.0 68.6 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.464 -0.773 . . . . 0.41999999999999998 109.883 179.48 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.632 ' HA ' ' HG2' ' A' ' 30' ' ' GLN . 0.4 OUTLIER -78.25 -26.57 47.32 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.42 -0.8 . . . . 1.0600000000000001 109.698 178.995 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.489 ' N ' ' HG ' ' A' ' 77' ' ' LEU . . . -105.94 56.25 0.52 Allowed Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.367 -1.493 . . . . 0.29999999999999999 109.367 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.18 4.31 28.83 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.643 -0.916 . . . . 1.8799999999999999 110.573 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.9 mp -60.06 155.27 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.404 -0.81 . . . . 1.1299999999999999 110.094 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.99 -3.93 53.35 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.205 -0.935 . . . . 1.26 111.547 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.484 HG22 ' HG3' ' A' ' 22' ' ' GLN . 39.2 mm -84.71 -104.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.105 -0.997 . . . . 1.02 109.975 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.42 ' O ' ' HA3' ' A' ' 21' ' ' GLY . 84.7 t -124.32 118.73 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 120.943 -1.098 . . . . 1.0800000000000001 110.263 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.33 113.63 19.66 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.517 -0.739 . . . . 1.55 109.488 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.426 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 3.1 mtm -139.95 157.12 46.19 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.361 -0.837 . . . . 1.3100000000000001 110.179 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.651 ' HB ' ' CD1' ' A' ' 74' ' ' TYR . 8.1 p -141.74 152.88 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.362 -0.837 . . . . 0.64000000000000001 110.787 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' A' ' 17' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.5 2.042 0 CA-C-O 117.52 -1.229 . . . . 1.1200000000000001 110.558 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.123 0.487 . . . . 1.5900000000000001 110.216 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.8 mtmp? -110.09 123.36 49.57 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.539 -0.726 . . . . 1.3400000000000001 109.832 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 16.7 p -70.05 -51.26 33.45 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.316 -0.865 . . . . 1.21 109.997 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.05 30.55 2.47 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.615 -0.678 . . . . 1.26 110.175 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.44 142.45 43.68 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.334 -0.854 . . . . 1.9199999999999999 110.399 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -72.21 163.26 28.24 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.461 -0.774 . . . . 1.51 110.509 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.52 ' HG3' HD12 ' A' ' 9' ' ' LEU . 6.3 pt-20 -143.26 171.8 13.61 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.405 -0.81 . . . . 0.68999999999999995 110.703 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.31 56.68 0.71 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.495 -0.753 . . . . 1.71 110.215 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.52 HD12 ' HG3' ' A' ' 7' ' ' GLU . 1.8 mp -115.88 -57.27 2.24 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.347 -0.846 . . . . 1.48 109.887 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 55.9 39.3 30.63 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.808 -0.558 . . . . 0.91000000000000003 110.554 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.429 ' O ' ' HA ' ' A' ' 65' ' ' THR . 73.6 t80 -109.66 119.33 48.14 Favored Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 121.386 -0.821 . . . . 1.0600000000000001 109.767 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.597 ' HB3' HG21 ' A' ' 65' ' ' THR . 43.9 Cg_endo -70.41 111.36 2.92 Favored 'Trans proline' 0 C--N 1.314 -1.277 0 O-C-N 123.951 1.501 . . . . 0.46999999999999997 110.539 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.6 t -136.62 144.55 47.6 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 121.587 -0.695 . . . . 0.84999999999999998 110.41 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.417 ' HA ' ' HA ' ' A' ' 63' ' ' ASN . 45.2 Cg_endo -71.27 126.44 12.32 Favored 'Trans proline' 0 C--N 1.315 -1.188 0 O-C-N 123.997 1.525 . . . . 0.45000000000000001 110.306 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.539 ' HB2' HG23 ' A' ' 62' ' ' ILE . 25.0 m-85 -107.01 99.75 9.29 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.557 -0.714 . . . . 0.48999999999999999 110.451 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.7 m -78.2 92.68 4.48 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.3 -1.0 . . . . 1.1200000000000001 108.3 178.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.473 ' CZ ' HD13 ' A' ' 87' ' ' LEU . 3.4 m-85 -100.53 105.9 17.37 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.535 -0.728 . . . . 0.78000000000000003 110.959 -178.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.589 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 0.0 OUTLIER -80.8 91.77 5.98 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.351 -0.843 . . . . 1.8899999999999999 109.358 179.341 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.625 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . 21.9 t -78.58 95.9 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.462 -0.774 . . . . 1.0800000000000001 109.736 -179.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 7.1 ttt -100.68 151.85 21.16 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.55 -0.719 . . . . 2.04 110.052 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 171.47 -165.08 38.02 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.95 -1.26 . . . . 0.32000000000000001 109.95 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -71.38 154.58 41.46 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.501 -0.999 . . . . 1.97 110.142 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.46 109.65 0.29 Allowed 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.747 -0.595 . . . . 1.1899999999999999 110.707 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.35 114.71 18.4 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.574 -0.704 . . . . 1.28 110.112 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.67 -26.0 20.04 Favored 'Trans proline' 0 N--CA 1.49 1.293 0 O-C-N 123.828 1.436 . . . . 0.54000000000000004 111.108 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -81.92 -6.42 59.09 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.216 -0.927 . . . . 0.68000000000000005 111.193 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.8 -50.29 74.05 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.985 -1.072 . . . . 1.3500000000000001 110.512 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.9 p -65.67 -34.08 67.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.392 -0.818 . . . . 1.0900000000000001 110.349 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -66.68 -46.79 74.52 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.338 -0.851 . . . . 0.62 109.812 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.53 ' HA ' ' CG ' ' A' ' 33' ' ' GLU . 3.3 tp60 -72.14 -30.79 65.37 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.476 -0.765 . . . . 1.8200000000000001 110.252 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.574 HG13 HD11 ' A' ' 60' ' ' ILE . 2.3 t -62.79 -46.26 96.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.412 -0.805 . . . . 1.0800000000000001 110.277 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.8 p -76.12 -35.06 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.36 -0.838 . . . . 1.0 111.583 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.53 ' CG ' ' HA ' ' A' ' 30' ' ' GLN . 0.5 OUTLIER -76.74 -35.17 57.93 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.709 -1.244 . . . . 0.52000000000000002 110.867 -179.733 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.461 ' CG2' ' CB ' ' A' ' 76' ' ' GLU . 6.9 p -78.43 -34.02 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.017 -1.052 . . . . 0.37 110.014 179.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.578 HG22 ' HB2' ' A' ' 43' ' ' TYR . 3.9 p -74.01 -31.52 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.271 -0.893 . . . . 1.03 109.607 178.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -75.59 -35.05 60.67 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.323 -0.861 . . . . 2.1299999999999999 109.649 178.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 28.1 mtm180 -66.42 -24.41 66.45 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.485 -0.759 . . . . 0.94999999999999996 110.788 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -104.96 -45.77 4.46 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.216 -0.927 . . . . 1.04 110.742 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -96.0 153.64 39.13 Favored Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.428 -0.795 . . . . 1.0700000000000001 109.886 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -69.03 -39.5 7.82 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 O-C-N 123.859 1.452 . . . . 1.1100000000000001 111.317 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -95.1 146.83 18.37 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.871 -1.292 . . . . 0.56000000000000005 109.871 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -77.96 159.97 28.5 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.454 -1.027 . . . . 0.62 109.936 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.578 ' HB2' HG22 ' A' ' 35' ' ' VAL . 40.5 m-85 -143.32 167.51 22.0 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.455 -0.778 . . . . 0.96999999999999997 110.717 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.431 HG21 ' HD2' ' A' ' 45' ' ' PRO . 2.0 m -142.33 155.51 64.47 Favored Pre-proline 0 N--CA 1.499 1.989 0 O-C-N 121.47 -0.769 . . . . 0.60999999999999999 110.99 -179.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.556 ' HA ' ' HA ' ' A' ' 60' ' ' ILE . 51.5 Cg_endo -95.95 137.62 0.67 Allowed 'Trans proline' 0 C--N 1.321 -0.881 0 C-N-CA 121.97 1.78 . . . . 0.56000000000000005 110.447 179.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 72.4 m -95.6 100.73 12.43 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.217 -0.927 . . . . 1.02 109.463 179.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.53 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 13.2 p -76.19 141.56 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.413 -0.805 . . . . 0.96999999999999997 111.485 -179.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.512 ' HE2' ' HB3' ' A' ' 57' ' ' SER . 0.1 OUTLIER -142.06 151.96 60.38 Favored Pre-proline 0 N--CA 1.494 1.765 0 N-CA-C 109.479 -0.563 . . . . 1.1200000000000001 109.479 179.039 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -75.09 85.19 1.56 Allowed 'Trans proline' 0 C--N 1.313 -1.324 0 O-C-N 124.01 1.532 . . . . 0.57999999999999996 110.959 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.494 ' HB2' ' HB2' ' A' ' 57' ' ' SER . 1.2 m -91.21 -47.95 7.22 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.496 -0.752 . . . . 1.1100000000000001 109.606 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.0 m -109.57 159.26 17.24 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.628 -0.67 . . . . 1.03 110.028 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.98 160.92 14.0 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.393 -0.817 . . . . 1.6799999999999999 110.466 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.66 -133.81 11.96 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.549 -1.42 . . . . 0.71999999999999997 109.549 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -100.93 64.66 1.07 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.511 -0.994 . . . . 1.8999999999999999 109.883 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -145.06 144.79 31.16 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.346 -0.846 . . . . 1.0 110.536 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -145.13 152.55 40.22 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.492 -0.755 . . . . 0.51000000000000001 110.503 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.512 ' HB3' ' HE2' ' A' ' 48' ' ' LYS . 0.8 OUTLIER -124.47 110.05 14.02 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.397 -0.814 . . . . 1.01 109.758 -179.962 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.53 ' HA ' ' HA ' ' A' ' 47' ' ' VAL . 2.5 m -109.85 147.66 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.122 -0.986 . . . . 0.75 110.711 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.589 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 1.0 OUTLIER -115.24 114.73 25.61 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.965 -0.754 . . . . 1.1100000000000001 108.965 179.209 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.574 HD11 HG13 ' A' ' 31' ' ' VAL . 3.9 tt -92.18 128.4 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.232 -0.917 . . . . 1.01 110.843 -178.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.4 ' O ' ' HB3' ' A' ' 43' ' ' TYR . 26.3 m -93.88 135.09 35.56 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.707 -0.849 . . . . 0.59999999999999998 108.707 179.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.539 HG23 ' HB2' ' A' ' 15' ' ' PHE . 3.9 tt -162.46 118.61 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.171 -0.956 . . . . 1.04 111.165 -179.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.417 ' HA ' ' HA ' ' A' ' 14' ' ' PRO . 4.3 t30 -92.45 100.19 12.79 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.474 -0.766 . . . . 0.57999999999999996 109.005 178.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -115.01 139.55 49.76 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.509 -0.745 . . . . 1.0700000000000001 110.99 -178.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.597 HG21 ' HB3' ' A' ' 12' ' ' PRO . 47.6 p -73.47 -6.63 47.62 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.559 -0.713 . . . . 1.1200000000000001 110.817 179.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 20.8 m80 -129.4 136.31 49.8 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.322 -0.862 . . . . 1.8500000000000001 110.433 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.4 tt -72.11 -24.0 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.483 -0.761 . . . . 1.3899999999999999 109.699 178.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.14 -32.9 61.47 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.411 -0.806 . . . . 0.52000000000000002 110.412 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -60.96 -47.78 84.87 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.477 -0.764 . . . . 0.81999999999999995 110.277 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.496 HG23 ' HB3' ' A' ' 15' ' ' PHE . 11.2 p -71.85 -27.49 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.43 -0.794 . . . . 1.04 110.377 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.443 ' N ' HG13 ' A' ' 70' ' ' VAL . 7.1 mt-10 -71.36 -44.67 64.58 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.16 -0.962 . . . . 0.64000000000000001 109.132 178.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 95.4 m -63.11 -37.61 87.87 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 109.03 -0.73 . . . . 1.0600000000000001 109.03 178.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.509 ' CD2' ' HA ' ' A' ' 35' ' ' VAL . 2.7 mp -62.96 -39.19 93.9 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.716 -0.615 . . . . 1.0600000000000001 109.559 178.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.581 ' CD1' ' HB ' ' A' ' 86' ' ' VAL . 0.5 OUTLIER -60.37 -44.93 95.15 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.519 -0.738 . . . . 0.97999999999999998 109.068 178.497 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.47 -35.46 80.53 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.587 -0.696 . . . . 0.82999999999999996 110.525 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.461 ' CB ' ' CG2' ' A' ' 34' ' ' VAL . 0.2 OUTLIER -69.46 -51.68 33.9 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.48 -0.763 . . . . 0.46999999999999997 110.421 179.886 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.521 ' HA ' ' HG2' ' A' ' 30' ' ' GLN . 0.4 OUTLIER -69.38 -28.4 66.15 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.377 -0.827 . . . . 0.97999999999999998 110.335 179.729 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.468 ' N ' ' HG ' ' A' ' 77' ' ' LEU . . . -107.42 42.9 1.81 Allowed Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.609 -1.397 . . . . 0.33000000000000002 109.609 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.7 4.32 51.91 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.342 -1.093 . . . . 1.0800000000000001 110.694 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.6 mp -69.25 153.21 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.248 -0.907 . . . . 1.04 110.268 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -68.24 -17.47 64.31 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.481 -0.762 . . . . 0.57999999999999996 110.312 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 51.8 mm -70.75 170.12 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.547 -0.72 . . . . 1.23 110.043 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 78.4 t -62.4 114.9 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.37 -0.831 . . . . 1.1799999999999999 110.596 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 5.4 ppt_? -121.42 143.57 49.15 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.86 -0.525 . . . . 1.6100000000000001 110.117 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.416 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 1.6 ttp -156.42 159.04 38.34 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.166 -0.959 . . . . 1.49 110.486 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.625 ' HA ' ' HA ' ' A' ' 19' ' ' VAL . 9.2 p -141.02 156.61 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.44 -0.787 . . . . 0.41999999999999998 110.301 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.473 HD13 ' CZ ' ' A' ' 17' ' ' TYR . 67.3 mt . . . . . 0 N--CA 1.502 2.136 0 CA-C-O 117.655 -1.164 . . . . 1.1200000000000001 110.206 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mtt . . . . . 0 N--CA 1.494 1.754 0 CA-C-O 121.126 0.488 . . . . 2.8399999999999999 110.925 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.46 111.95 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.128 0 CA-C-O 121.353 0.597 . . . . 1.74 110.819 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 91.3 m -103.13 142.87 33.41 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.471 -0.768 . . . . 1.26 109.667 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.488 ' HE3' ' CE1' ' A' ' 66' ' ' HIS . 0.0 OUTLIER -132.46 119.22 20.32 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.425 -0.797 . . . . 1.5900000000000001 110.48 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 53.36 -165.52 0.08 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.763 -0.586 . . . . 1.51 110.896 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -135.51 86.0 2.21 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.347 -0.846 . . . . 2.0099999999999998 110.029 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 51.68 59.6 4.45 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.738 -0.601 . . . . 1.1299999999999999 110.749 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.59 -47.87 2.61 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.35 -0.844 . . . . 1.7 110.48 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.8 mp -77.19 -50.07 13.76 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.418 -0.801 . . . . 1.3700000000000001 110.02 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 58.82 47.47 12.59 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.161 0.505 . . . . 0.95999999999999996 111.113 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.445 ' O ' ' HA ' ' A' ' 65' ' ' THR . 85.8 t80 -95.51 119.97 64.4 Favored Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 121.381 -0.824 . . . . 1.1299999999999999 109.128 179.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.698 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 42.6 Cg_endo -68.55 106.62 1.47 Allowed 'Trans proline' 0 C--N 1.315 -1.23 0 O-C-N 123.703 1.37 . . . . 0.44 110.906 -178.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.1 t -131.88 146.59 62.41 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.851 -0.531 . . . . 1.1000000000000001 110.48 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -72.4 125.93 11.16 Favored 'Trans proline' 0 C--N 1.315 -1.222 0 O-C-N 123.862 1.454 . . . . 0.41999999999999998 110.398 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.406 ' HB2' HG22 ' A' ' 62' ' ' ILE . 23.9 m-85 -106.16 99.6 9.18 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.556 -0.715 . . . . 0.41999999999999998 110.632 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.4 m -76.06 92.88 3.22 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 107.982 -1.118 . . . . 0.84999999999999998 107.982 178.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.443 ' HA ' HD22 ' A' ' 87' ' ' LEU . 2.6 m-85 -100.1 109.47 21.77 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.397 -0.815 . . . . 0.63 111.327 -177.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.551 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 0.1 OUTLIER -81.26 90.45 6.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.592 -0.693 . . . . 1.22 109.402 179.156 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.512 HG13 ' CD1' ' A' ' 77' ' ' LEU . 32.1 t -79.64 98.07 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.623 -0.673 . . . . 1.1000000000000001 109.945 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.457 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 36.7 mtm -106.15 147.55 28.89 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.575 -0.703 . . . . 1.3500000000000001 110.085 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 170.14 -141.5 6.63 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.088 -1.205 . . . . 0.31 110.088 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.425 ' HG3' HG23 ' A' ' 82' ' ' ILE . 0.0 OUTLIER -66.04 154.33 39.81 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.547 -0.973 . . . . 0.62 110.626 -179.817 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.606 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -93.08 97.93 11.0 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.491 -0.756 . . . . 0.71999999999999997 110.305 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.447 HD23 HD12 ' A' ' 80' ' ' ILE . 0.5 OUTLIER -130.44 154.23 81.53 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.523 -0.736 . . . . 1.1399999999999999 110.49 179.901 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.03 -19.94 22.44 Favored 'Trans proline' 0 C--N 1.313 -1.316 0 O-C-N 124.041 1.548 . . . . 0.46000000000000002 111.477 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -75.98 -5.08 44.64 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.084 -1.01 . . . . 0.62 111.358 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.48 HD22 HG23 ' A' ' 58' ' ' VAL . 2.4 mt -60.35 -59.92 4.63 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.067 -1.021 . . . . 1.27 110.219 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.515 HG11 ' HG2' ' A' ' 45' ' ' PRO . 33.6 m -64.99 -29.96 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.436 -0.79 . . . . 1.1200000000000001 110.796 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -67.28 -55.06 15.5 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.395 -0.816 . . . . 0.48999999999999999 110.229 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.49 ' CG ' ' HA ' ' A' ' 77' ' ' LEU . 16.0 tp60 -67.1 -34.85 78.51 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.319 -0.863 . . . . 0.84999999999999998 110.643 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.519 HG11 HD12 ' A' ' 60' ' ' ILE . 3.0 t -59.06 -57.78 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.409 -0.807 . . . . 1.0600000000000001 110.366 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.8 p -64.37 -33.07 60.36 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.323 -0.86 . . . . 1.0900000000000001 111.424 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.6 -55.01 8.59 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.134 -0.979 . . . . 0.63 110.913 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.443 ' CG2' ' CB ' ' A' ' 76' ' ' GLU . 10.0 p -68.58 -27.58 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.407 -0.808 . . . . 0.37 111.481 -179.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.553 ' HA ' HD21 ' A' ' 73' ' ' LEU . 2.4 p -80.64 -28.94 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.028 -1.045 . . . . 0.93999999999999995 110.732 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -79.59 -40.96 28.15 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.264 -0.897 . . . . 1.5900000000000001 110.143 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.3 mtm180 -66.62 -22.85 66.11 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.39 -0.819 . . . . 3.2400000000000002 111.299 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.446 ' CG ' HD12 ' A' ' 73' ' ' LEU . 39.4 m-70 -105.23 -45.79 4.4 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.208 -0.933 . . . . 1.6499999999999999 110.667 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -106.72 143.41 26.98 Favored Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 121.438 -0.789 . . . . 1.22 110.247 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -72.12 144.81 42.96 Favored 'Trans proline' 0 C--N 1.314 -1.27 0 O-C-N 123.827 1.435 . . . . 0.91000000000000003 110.786 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 91.66 148.35 21.9 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.532 -1.427 . . . . 0.56000000000000005 109.532 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -82.01 134.27 35.35 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.531 -0.982 . . . . 1.22 110.113 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.55 ' HB2' ' CG1' ' A' ' 35' ' ' VAL . 38.8 m-85 -123.95 157.49 34.22 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.623 -0.673 . . . . 0.88 110.402 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.407 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 1.4 m -142.36 153.38 62.59 Favored Pre-proline 0 N--CA 1.498 1.937 0 O-C-N 121.515 -0.741 . . . . 1.21 110.955 -179.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.515 ' HG2' HG11 ' A' ' 28' ' ' VAL . 55.3 Cg_endo -95.27 133.15 0.56 Allowed 'Trans proline' 0 C--N 1.32 -0.962 0 C-N-CA 121.898 1.732 . . . . 0.53000000000000003 110.579 179.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.421 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 51.5 m -89.93 93.99 9.63 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.187 -0.945 . . . . 1.04 109.289 179.06 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.498 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 14.4 p -76.46 137.26 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.498 -0.752 . . . . 1.1299999999999999 111.589 -178.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.425 ' HE2' ' HB3' ' A' ' 57' ' ' SER . 0.5 OUTLIER -142.47 149.8 52.28 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.728 -0.608 . . . . 1.3799999999999999 109.833 179.247 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -76.1 84.84 1.74 Allowed 'Trans proline' 0 C--N 1.314 -1.272 0 O-C-N 123.872 1.459 . . . . 0.62 110.578 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.0 -45.65 9.04 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.363 -0.835 . . . . 1.3899999999999999 109.817 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.82 167.93 9.53 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.473 -0.767 . . . . 1.3600000000000001 110.218 179.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.62 158.25 16.07 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.401 -0.812 . . . . 2.1099999999999999 110.44 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.88 -137.38 13.73 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.554 -1.418 . . . . 0.70999999999999996 109.554 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -100.62 63.84 1.09 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.596 -0.944 . . . . 1.95 110.217 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -137.99 130.87 29.93 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.492 -0.755 . . . . 0.76000000000000001 110.178 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.606 ' HB2' ' HA ' ' A' ' 23' ' ' ALA . 0.1 OUTLIER -129.73 137.03 50.35 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.495 -0.753 . . . . 1.03 110.29 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.457 ' HA ' ' HA ' ' A' ' 20' ' ' MET . 6.1 m -110.18 105.46 14.54 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.598 -0.689 . . . . 0.80000000000000004 109.392 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.498 ' HA ' ' HA ' ' A' ' 47' ' ' VAL . 2.8 m -108.36 147.57 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.219 -0.926 . . . . 0.96999999999999997 110.84 -179.267 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.551 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 8.6 t -112.1 112.16 23.58 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.403 -0.81 . . . . 0.94999999999999996 108.843 179.117 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.519 HD12 HG11 ' A' ' 31' ' ' VAL . 9.6 tt -92.33 126.86 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.217 -0.927 . . . . 1.01 111.265 -178.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.411 ' O ' ' HB3' ' A' ' 43' ' ' TYR . 19.1 m -91.72 136.06 33.42 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.944 -0.762 . . . . 0.85999999999999999 108.944 179.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.457 HG21 HG21 ' A' ' 70' ' ' VAL . 5.9 tt -162.5 131.27 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.276 -0.89 . . . . 1.0600000000000001 110.72 -179.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -99.68 98.18 9.05 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.358 -0.838 . . . . 0.52000000000000002 109.698 179.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -113.67 139.69 48.84 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.451 -0.781 . . . . 1.02 110.227 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.698 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 33.9 p -66.54 -22.64 66.16 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.465 -0.772 . . . . 1.1000000000000001 110.864 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.488 ' CE1' ' HE3' ' A' ' 4' ' ' LYS . 1.2 t60 -131.64 157.65 43.15 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.146 -0.971 . . . . 0.78000000000000003 110.8 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.401 ' O ' HG12 ' A' ' 70' ' ' VAL . 3.3 tt -79.9 -16.75 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.529 -0.732 . . . . 1.1599999999999999 110.407 179.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.14 -33.09 71.37 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.125 -0.985 . . . . 0.48999999999999999 110.124 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.12 -48.75 64.59 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.353 -0.842 . . . . 1.6299999999999999 110.053 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.457 HG21 HG21 ' A' ' 62' ' ' ILE . 7.6 p -69.25 -25.02 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.387 -0.821 . . . . 1.1399999999999999 110.262 179.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -69.02 -51.04 43.33 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.252 -0.905 . . . . 0.40999999999999998 109.529 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 20.1 p -62.02 -38.26 87.98 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.526 -0.734 . . . . 1.0700000000000001 109.284 178.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.553 HD21 ' HA ' ' A' ' 35' ' ' VAL . 5.4 mp -61.33 -40.3 93.73 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 109.304 -0.628 . . . . 1.0 109.304 178.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.632 ' CD1' ' HB ' ' A' ' 86' ' ' VAL . 0.1 OUTLIER -59.16 -42.81 91.63 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.858 -0.793 . . . . 0.76000000000000001 108.858 178.387 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -68.5 -34.94 76.78 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.565 -0.709 . . . . 1.3500000000000001 110.336 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.443 ' CB ' ' CG2' ' A' ' 34' ' ' VAL . 0.3 OUTLIER -62.99 -48.59 78.17 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.488 -0.758 . . . . 0.48999999999999999 110.03 179.482 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.512 ' CD1' HG13 ' A' ' 19' ' ' VAL . 0.3 OUTLIER -79.38 -29.42 42.09 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.45 -0.781 . . . . 1.0700000000000001 110.132 179.387 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.495 ' N ' ' HG ' ' A' ' 77' ' ' LEU . . . -102.59 56.36 0.64 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.266 -1.533 . . . . 0.27000000000000002 109.266 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.3 tttt -106.22 4.59 29.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.698 -0.883 . . . . 2.0899999999999999 110.774 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.447 HD12 HD23 ' A' ' 24' ' ' LEU . 2.5 mp -59.78 154.99 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.335 -0.853 . . . . 1.1100000000000001 110.111 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.16 -4.55 55.74 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.285 -0.884 . . . . 1.52 111.505 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.465 HD11 ' HA ' ' A' ' 82' ' ' ILE . 48.9 mm -85.52 -103.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 120.921 -1.112 . . . . 1.23 110.175 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 88.3 t -123.99 118.75 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 120.822 -1.174 . . . . 1.05 110.298 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.47 111.24 16.59 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.614 -0.679 . . . . 1.24 109.543 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.459 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 0.4 OUTLIER -136.73 154.93 50.45 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.36 -0.838 . . . . 1.3500000000000001 110.392 -179.812 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.632 ' HB ' ' CD1' ' A' ' 74' ' ' TYR . 8.0 p -141.81 151.29 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.445 -0.784 . . . . 0.91000000000000003 110.572 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.443 HD22 ' HA ' ' A' ' 17' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.5 2.067 0 CA-C-O 117.545 -1.217 . . . . 1.0800000000000001 110.474 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.758 0 CA-C-O 121.149 0.5 . . . . 1.77 110.118 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.401 ' HG2' HG21 ' A' ' 13' ' ' THR . 0.2 OUTLIER -116.03 -173.13 2.3 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.475 -0.766 . . . . 1.8 110.502 -179.674 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.8 t -136.05 164.02 28.98 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.426 -0.796 . . . . 1.01 110.303 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.07 112.26 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.236 0 CA-C-O 121.34 0.591 . . . . 1.8899999999999999 110.542 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.479 ' HA ' ' HB ' ' A' ' 67' ' ' ILE . 1.5 pp -73.7 137.05 43.82 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.49 -0.756 . . . . 1.6000000000000001 110.69 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -144.75 137.0 26.17 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.433 -0.792 . . . . 1.0900000000000001 110.52 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -104.62 -3.16 24.12 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.385 -0.822 . . . . 1.03 111.051 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.35 -36.42 14.65 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.117 -0.989 . . . . 1.77 110.364 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.7 mp -89.19 -48.32 7.46 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.406 -0.809 . . . . 1.3799999999999999 109.89 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 53.92 67.11 1.06 Allowed 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.595 0.712 . . . . 0.69999999999999996 110.549 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.404 ' O ' ' HA ' ' A' ' 65' ' ' THR . 82.8 t80 -95.58 124.2 53.73 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.479 -0.763 . . . . 0.96999999999999997 109.865 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.599 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 44.2 Cg_endo -70.78 112.35 3.24 Favored 'Trans proline' 0 C--N 1.315 -1.232 0 O-C-N 123.996 1.524 . . . . 0.31 110.434 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.401 HG21 ' HG2' ' A' ' 2' ' ' LYS . 11.2 t -124.87 145.72 50.88 Favored Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 121.608 -0.683 . . . . 1.0 110.438 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.73 120.26 6.57 Favored 'Trans proline' 0 C--N 1.315 -1.227 0 O-C-N 123.897 1.472 . . . . 0.40999999999999998 110.311 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -102.88 99.71 9.64 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.568 -0.707 . . . . 0.42999999999999999 110.606 -179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.7 p -74.45 101.15 4.04 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.545 -0.909 . . . . 0.56999999999999995 108.545 178.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.459 ' HA ' HD23 ' A' ' 87' ' ' LEU . 4.3 m-85 -114.77 160.04 19.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.395 -0.816 . . . . 1.0 111.024 -178.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.649 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 7.6 mttt -135.97 99.18 4.08 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.099 -0.704 . . . . 2.6899999999999999 109.099 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.472 ' O ' HG22 ' A' ' 58' ' ' VAL . 10.2 t -79.76 98.31 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.445 -0.784 . . . . 1.0900000000000001 109.399 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 63.0 mtm -106.66 157.77 17.45 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.32 -0.862 . . . . 1.3700000000000001 110.298 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 164.2 -160.59 33.58 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 110.089 -1.204 . . . . 0.35999999999999999 110.089 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.27 156.48 39.21 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.496 -1.003 . . . . 2.02 110.085 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -48.4 110.13 0.31 Allowed 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.776 -0.578 . . . . 0.59999999999999998 110.814 -179.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.405 ' HB3' ' HB2' ' A' ' 27' ' ' LEU . 0.2 OUTLIER -130.51 110.99 16.34 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.554 -0.716 . . . . 1.1200000000000001 109.966 -179.872 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.6 -30.48 11.95 Favored 'Trans proline' 0 C--N 1.315 -1.209 0 O-C-N 123.914 1.481 . . . . 0.58999999999999997 111.05 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -77.5 -7.12 55.75 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.228 -0.92 . . . . 0.68999999999999995 111.291 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.499 HD21 HG23 ' A' ' 58' ' ' VAL . 0.3 OUTLIER -58.24 -55.14 38.89 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.947 -1.095 . . . . 1.25 110.308 -179.952 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.536 HG21 ' HD2' ' A' ' 45' ' ' PRO . 11.9 p -61.04 -34.9 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 121.461 -0.774 . . . . 1.1200000000000001 110.559 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.422 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 10.1 m-20 -64.23 -49.46 71.84 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.479 -0.763 . . . . 0.53000000000000003 110.125 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.568 ' CG ' ' HA ' ' A' ' 77' ' ' LEU . 13.3 tp60 -71.64 -31.74 67.18 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.477 -0.764 . . . . 0.63 110.517 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.553 HG22 HD13 ' A' ' 60' ' ' ILE . 7.3 t -58.71 -52.48 59.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.324 -0.86 . . . . 1.05 110.043 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.9 p -73.32 -30.54 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.414 -0.804 . . . . 1.0700000000000001 111.198 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.422 ' HB2' ' O ' ' A' ' 29' ' ' ASP . 0.8 OUTLIER -73.64 -50.48 20.83 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.045 -1.034 . . . . 0.55000000000000004 110.484 179.958 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.449 HG23 ' HB2' ' A' ' 76' ' ' GLU . 9.8 p -67.45 -32.41 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.426 -0.796 . . . . 0.47999999999999998 110.706 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.635 ' HA ' HD21 ' A' ' 73' ' ' LEU . 2.5 p -77.17 -27.45 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.046 -1.034 . . . . 0.51000000000000001 110.02 179.112 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -74.18 -36.29 64.04 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.293 -0.88 . . . . 0.78000000000000003 109.602 178.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 52.7 mtm180 -73.1 -25.82 61.01 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.478 -0.764 . . . . 1.0700000000000001 110.758 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 43.0 m-70 -98.39 -45.8 6.01 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.368 -0.833 . . . . 0.81999999999999995 110.715 -179.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -102.8 151.84 38.39 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 121.481 -0.762 . . . . 1.1499999999999999 109.975 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -69.83 -41.1 4.47 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.855 1.45 . . . . 1.3 110.895 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -86.45 144.79 20.01 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.494 -1.442 . . . . 0.56999999999999995 109.494 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.08 149.06 29.36 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.37 -1.076 . . . . 0.59999999999999998 110.047 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.472 ' HB3' ' O ' ' A' ' 61' ' ' THR . 42.3 m-85 -132.43 161.13 34.46 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.572 -0.705 . . . . 0.71999999999999997 110.762 -179.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.44 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 3.7 m -142.6 153.49 61.91 Favored Pre-proline 0 N--CA 1.499 2.01 0 O-C-N 121.484 -0.76 . . . . 0.56000000000000005 111.016 -179.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.627 ' HA ' ' HA ' ' A' ' 60' ' ' ILE . 51.9 Cg_endo -95.1 148.75 1.59 Allowed 'Trans proline' 0 C--N 1.319 -0.997 0 C-N-CA 121.832 1.688 . . . . 0.55000000000000004 110.479 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.489 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 56.9 m -106.81 96.84 6.72 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.174 -0.954 . . . . 0.96999999999999997 109.142 179.04 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.469 HG22 HG11 ' A' ' 58' ' ' VAL . 12.4 p -75.49 139.38 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.364 -0.835 . . . . 0.68999999999999995 111.771 -178.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.59 153.98 62.57 Favored Pre-proline 0 N--CA 1.494 1.758 0 N-CA-C 109.69 -0.485 . . . . 1.3700000000000001 109.69 179.338 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -76.19 85.5 1.66 Allowed 'Trans proline' 0 C--N 1.314 -1.254 0 O-C-N 124.07 1.563 . . . . 0.59999999999999998 110.536 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.6 m -87.51 -49.98 6.83 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.407 -0.808 . . . . 1.3 109.967 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.575 ' HB3' ' HB3' ' A' ' 55' ' ' TYR . 1.0 OUTLIER -106.93 162.75 13.55 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.512 -0.742 . . . . 1.28 110.076 179.738 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.45 154.55 17.21 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.336 -0.853 . . . . 2.0600000000000001 110.604 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.13 -134.37 11.65 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.742 -1.343 . . . . 0.68000000000000005 109.742 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -103.37 60.19 0.76 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.633 -0.922 . . . . 0.87 110.308 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.575 ' HB3' ' HB3' ' A' ' 51' ' ' SER . 22.3 t80 -135.77 147.75 48.5 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.401 -0.812 . . . . 1.01 110.169 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 4.1 p-80 -145.45 147.32 32.08 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.478 -0.764 . . . . 0.46000000000000002 110.54 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.8 m -125.81 117.71 23.98 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.389 -0.819 . . . . 0.79000000000000004 109.524 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.499 HG23 HD21 ' A' ' 27' ' ' LEU . 1.3 m -115.04 139.64 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.188 -0.945 . . . . 0.45000000000000001 111.388 -179.17 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.538 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 7.5 t -95.64 108.0 20.24 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.352 -0.981 . . . . 1.03 108.352 178.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.627 ' HA ' ' HA ' ' A' ' 45' ' ' PRO . 12.1 tt -92.4 125.79 44.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.256 -0.902 . . . . 1.0600000000000001 111.208 -178.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.472 ' O ' ' HB3' ' A' ' 43' ' ' TYR . 98.5 m -93.03 135.51 34.14 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.364 -0.976 . . . . 0.97999999999999998 108.364 178.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.502 HD12 HD22 ' A' ' 73' ' ' LEU . 12.6 tt -160.46 145.18 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.076 -1.015 . . . . 1.1200000000000001 111.059 -179.203 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -121.62 111.13 16.83 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.62 -0.675 . . . . 0.46000000000000002 109.305 179.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -121.46 141.47 50.98 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.47 -0.769 . . . . 1.04 110.762 -179.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.599 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 26.1 p -77.33 -4.5 45.42 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.506 -0.746 . . . . 0.79000000000000004 111.219 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.644 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 62.1 t60 -130.37 150.32 51.65 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.216 -0.927 . . . . 0.66000000000000003 110.191 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.479 ' HB ' ' HA ' ' A' ' 5' ' ' LEU . 7.5 mm -70.67 -48.39 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 121.47 -0.769 . . . . 1.1899999999999999 110.087 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.55 -18.46 65.38 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.454 -0.779 . . . . 0.75 111.236 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.644 ' HB2' ' HB3' ' A' ' 66' ' ' HIS . 0.3 OUTLIER -59.11 -58.87 6.75 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.263 -0.898 . . . . 1.3500000000000001 110.405 179.901 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.0 p -59.57 -26.98 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.416 -0.803 . . . . 1.0800000000000001 110.924 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.23 -45.66 62.8 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.265 -0.897 . . . . 0.81999999999999995 109.668 179.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 67.5 m -62.39 -41.17 98.44 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.573 -0.705 . . . . 1.0900000000000001 109.728 179.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.635 HD21 ' HA ' ' A' ' 35' ' ' VAL . 4.7 mp -65.08 -36.39 84.18 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.636 -0.665 . . . . 1.1899999999999999 110.047 179.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.614 ' CD1' ' HB ' ' A' ' 86' ' ' VAL . 0.3 OUTLIER -61.32 -46.09 91.74 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.46 -0.775 . . . . 0.56000000000000005 109.105 178.837 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.56 -33.82 76.8 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.522 -0.736 . . . . 1.1699999999999999 109.887 179.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.449 ' HB2' HG23 ' A' ' 34' ' ' VAL . 28.1 mt-10 -65.03 -43.47 92.31 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.411 -0.805 . . . . 0.42999999999999999 109.889 179.259 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.568 ' HA ' ' CG ' ' A' ' 30' ' ' GLN . 0.4 OUTLIER -80.73 -29.68 36.33 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.358 -0.839 . . . . 0.98999999999999999 109.964 178.943 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.502 ' N ' ' HG ' ' A' ' 77' ' ' LEU . . . -105.26 54.32 0.61 Allowed Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.475 -1.45 . . . . 0.29999999999999999 109.475 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.97 4.12 29.11 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.567 -0.961 . . . . 1.4299999999999999 110.563 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.7 mp -68.6 154.46 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.34 -0.85 . . . . 1.0900000000000001 110.175 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -66.16 -20.67 66.21 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.361 -0.837 . . . . 0.72999999999999998 110.155 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 43.3 mm -68.91 166.75 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.422 -0.798 . . . . 0.98999999999999999 109.895 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 76.6 t -62.47 114.39 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.287 -0.883 . . . . 1.1299999999999999 110.779 -179.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.25 137.16 54.81 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.774 -0.579 . . . . 1.5800000000000001 109.615 179.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.7 mtm -151.92 160.21 43.58 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.158 -0.964 . . . . 2.0299999999999998 110.523 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.614 ' HB ' ' CD1' ' A' ' 74' ' ' TYR . 5.4 p -142.14 155.23 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.463 -0.773 . . . . 0.45000000000000001 110.378 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.649 ' HB3' ' HB2' ' A' ' 18' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.494 1.764 0 CA-C-O 117.896 -1.05 . . . . 1.0900000000000001 109.824 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.816 0 N-CA-C 110.081 -0.34 . . . . 2.3799999999999999 110.081 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.67 144.1 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.194 0 CA-C-O 121.494 0.664 . . . . 1.3899999999999999 111.15 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 24.0 m -138.96 -62.94 0.54 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.212 -0.93 . . . . 0.77000000000000002 110.361 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.11 148.52 29.76 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.315 -0.866 . . . . 1.1100000000000001 110.733 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.78 -165.76 1.33 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.442 -0.786 . . . . 1.6399999999999999 110.314 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -59.7 117.47 4.99 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.276 -0.89 . . . . 2.1200000000000001 110.504 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.16 153.87 26.47 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.668 -0.645 . . . . 0.67000000000000004 110.607 -179.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.51 38.14 4.08 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.561 -0.712 . . . . 1.51 110.237 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.7 mp -128.27 -62.61 1.04 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.252 -0.905 . . . . 1.3500000000000001 110.011 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 55.56 52.58 10.89 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.673 -0.642 . . . . 0.58999999999999997 110.791 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -95.54 112.47 59.03 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.316 -0.865 . . . . 1.1200000000000001 109.551 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.664 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 44.0 Cg_endo -70.63 108.77 2.32 Favored 'Trans proline' 0 C--N 1.314 -1.243 0 O-C-N 123.994 1.523 . . . . 0.40999999999999998 110.557 -179.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.9 t -128.06 142.4 44.32 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.669 -0.644 . . . . 0.83999999999999997 110.172 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -72.37 129.88 15.48 Favored 'Trans proline' 0 C--N 1.314 -1.277 0 O-C-N 123.939 1.494 . . . . 0.41999999999999998 110.631 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.448 ' HB3' HG21 ' A' ' 70' ' ' VAL . 33.9 m-85 -112.01 100.89 9.24 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.583 -0.698 . . . . 0.46000000000000002 110.022 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 16.5 m -73.52 92.96 1.94 Allowed 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 108.497 -0.927 . . . . 1.1299999999999999 108.497 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.441 ' HA ' ' CD2' ' A' ' 87' ' ' LEU . 3.3 m-85 -103.82 102.16 11.98 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.464 -0.773 . . . . 0.71999999999999997 110.858 -178.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.646 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 0.0 OUTLIER -77.77 89.19 4.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.671 -0.643 . . . . 1.8799999999999999 109.89 179.805 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.634 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . 1.2 m -82.51 108.22 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 C-N-CA 119.358 -0.937 . . . . 0.92000000000000004 109.413 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.1 mtp -108.05 151.72 25.46 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.553 -0.717 . . . . 1.6100000000000001 110.567 -179.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 178.28 -159.81 25.51 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.82 -1.312 . . . . 0.40999999999999998 109.82 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.49 ' HA ' ' HA ' ' A' ' 55' ' ' TYR . 0.9 OUTLIER -70.44 -179.8 2.21 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.426 -1.044 . . . . 1.0700000000000001 110.503 179.973 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.61 100.01 2.2 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.392 -0.817 . . . . 1.1000000000000001 110.126 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.414 ' O ' HD21 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -122.94 108.56 32.53 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.516 -0.74 . . . . 1.47 109.923 -179.773 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -69.91 -15.44 36.54 Favored 'Trans proline' 0 N--CA 1.491 1.354 0 O-C-N 123.805 1.424 . . . . 0.76000000000000001 111.588 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -83.09 -0.41 48.93 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.201 -0.937 . . . . 1.1200000000000001 111.476 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.511 HD13 ' C ' ' A' ' 27' ' ' LEU . 3.1 pp -58.84 -35.11 72.37 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.906 -1.121 . . . . 1.27 110.906 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.463 ' N ' HD13 ' A' ' 27' ' ' LEU . 9.8 p -75.35 -32.9 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.066 -1.021 . . . . 1.1599999999999999 110.557 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -64.77 -48.75 73.39 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.442 -0.786 . . . . 0.63 110.085 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.716 ' HG2' ' HA ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -72.92 -37.3 67.25 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.474 -0.766 . . . . 1.3799999999999999 110.698 179.937 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.574 HG23 HD12 ' A' ' 60' ' ' ILE . 4.2 t -57.11 -47.09 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.31 -0.869 . . . . 0.91000000000000003 110.885 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.4 ' O ' HG11 ' A' ' 35' ' ' VAL . 8.2 p -76.33 -37.19 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.251 -0.905 . . . . 1.03 111.577 -179.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.484 ' CG ' ' HA ' ' A' ' 30' ' ' GLN . 0.2 OUTLIER -75.94 -31.37 59.05 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.828 -1.17 . . . . 0.56000000000000005 110.912 -179.869 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.468 HG23 ' HB2' ' A' ' 76' ' ' GLU . 5.4 p -79.98 -35.02 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.092 -1.005 . . . . 0.33000000000000002 110.14 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.55 ' HA ' HD21 ' A' ' 73' ' ' LEU . 9.7 p -73.99 -29.94 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.181 -0.95 . . . . 0.81999999999999995 109.446 178.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -77.08 -36.39 55.81 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.435 -0.791 . . . . 1.01 109.997 179.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.7 mtp-105 -65.92 -27.09 67.93 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.42 -0.8 . . . . 1.0600000000000001 111.085 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.507 ' CD2' HD12 ' A' ' 73' ' ' LEU . 17.3 m-70 -105.16 -45.86 4.4 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.334 -0.853 . . . . 0.60999999999999999 110.599 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -100.21 150.14 36.65 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.509 -0.745 . . . . 1.01 109.808 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -70.04 -38.46 7.16 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.759 1.4 . . . . 0.69999999999999996 111.15 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -85.78 145.3 20.82 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.918 -1.273 . . . . 0.48999999999999999 109.918 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.83 150.08 22.39 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.523 -0.987 . . . . 0.52000000000000002 109.864 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.471 ' HB2' HG23 ' A' ' 35' ' ' VAL . 51.9 m-85 -135.9 178.86 6.72 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.495 -0.753 . . . . 0.68999999999999995 110.779 -179.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.415 HG21 ' HD2' ' A' ' 45' ' ' PRO . 0.2 OUTLIER -141.0 157.0 68.18 Favored Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 121.476 -0.765 . . . . 0.82999999999999996 110.847 -179.064 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.608 ' HB2' ' CG2' ' A' ' 58' ' ' VAL . 51.7 Cg_endo -93.75 163.27 2.26 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 C-N-CA 121.784 1.656 . . . . 0.40999999999999998 110.366 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.408 ' C ' HG23 ' A' ' 58' ' ' VAL . 44.6 m -127.34 88.79 2.85 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.341 -0.85 . . . . 0.96999999999999997 109.063 178.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.527 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 11.4 p -83.11 142.74 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.401 -0.812 . . . . 1.01 111.651 -178.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.99 152.54 58.84 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.698 -0.626 . . . . 1.48 109.841 179.398 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -75.33 82.9 1.96 Allowed 'Trans proline' 0 C--N 1.314 -1.268 0 O-C-N 123.845 1.445 . . . . 0.63 110.411 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.5 m -88.02 -43.95 11.35 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.477 -0.764 . . . . 1.2 110.089 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -102.74 166.18 10.64 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.595 -0.69 . . . . 1.3200000000000001 110.292 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.16 155.81 17.54 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.412 -0.805 . . . . 2.3199999999999998 110.48 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.33 -136.27 13.03 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.63 -1.388 . . . . 0.73999999999999999 109.63 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -102.17 63.52 0.9 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.574 -0.957 . . . . 0.68000000000000005 110.172 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.49 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 15.0 t80 -140.99 139.44 34.2 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.395 -0.816 . . . . 1.0600000000000001 110.183 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -139.57 136.91 34.92 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.589 -0.694 . . . . 1.1799999999999999 110.469 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.3 m -108.67 120.66 43.13 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.64 -0.663 . . . . 0.84999999999999998 109.318 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.608 ' CG2' ' HB2' ' A' ' 45' ' ' PRO . 3.2 p -127.01 145.27 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.257 -0.902 . . . . 1.03 111.485 -178.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.646 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 66.5 p -111.79 118.07 34.56 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.636 -0.665 . . . . 0.83999999999999997 109.51 179.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.575 ' HA ' ' HA ' ' A' ' 45' ' ' PRO . 7.0 tt -94.55 134.5 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.436 -0.79 . . . . 1.1100000000000001 111.249 -179.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 52.9 m -89.19 114.37 25.67 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.58 -0.896 . . . . 1.0800000000000001 108.58 178.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.414 ' O ' ' HB2' ' A' ' 15' ' ' PHE . 32.3 mm -122.42 99.32 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.171 -0.956 . . . . 1.0600000000000001 111.299 -178.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -88.59 86.25 6.97 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.108 -0.995 . . . . 0.45000000000000001 108.703 178.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.529 ' HB1' ' HB3' ' A' ' 69' ' ' GLN . . . -102.84 140.14 37.51 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.605 -0.685 . . . . 0.95999999999999996 111.042 -178.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.664 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 32.9 p -75.86 -6.84 52.71 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.667 -0.646 . . . . 1.03 110.981 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 4.2 t-160 -129.73 158.59 38.97 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.265 -0.897 . . . . 0.47999999999999998 110.454 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.422 ' O ' HG12 ' A' ' 70' ' ' VAL . 1.8 mt -73.68 -46.92 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.588 -0.695 . . . . 1.46 109.851 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.5 -21.28 66.63 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.495 -0.753 . . . . 0.72999999999999998 110.998 179.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.529 ' HB3' ' HB1' ' A' ' 64' ' ' ALA . 9.9 tt0 -61.04 -52.6 64.28 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.238 -0.914 . . . . 0.46000000000000002 110.44 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.448 HG21 ' HB3' ' A' ' 15' ' ' PHE . 7.4 p -69.73 -27.42 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.335 -0.853 . . . . 1.0900000000000001 110.332 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.56 -52.7 59.92 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.275 -0.89 . . . . 0.92000000000000004 109.533 179.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.8 p -62.65 -37.35 86.04 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.541 -0.724 . . . . 1.1499999999999999 109.298 178.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.55 HD21 ' HA ' ' A' ' 35' ' ' VAL . 2.0 mp -61.85 -39.77 93.01 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.666 -0.646 . . . . 0.97999999999999998 110.021 179.207 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.49 ' CD1' ' C ' ' A' ' 74' ' ' TYR . 0.0 OUTLIER -63.51 -45.97 88.21 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.552 -0.718 . . . . 0.93999999999999995 109.332 179.02 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -70.12 -30.04 67.13 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.542 -0.724 . . . . 0.73999999999999999 110.722 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.468 ' HB2' HG23 ' A' ' 34' ' ' VAL . 23.4 mt-10 -71.65 -51.39 23.34 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.377 -0.827 . . . . 0.42999999999999999 110.362 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.716 ' HA ' ' HG2' ' A' ' 30' ' ' GLN . 0.7 OUTLIER -71.54 -29.69 65.04 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.279 -0.888 . . . . 1.0 109.951 179.236 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.462 ' N ' ' HG ' ' A' ' 77' ' ' LEU . . . -102.61 46.03 1.28 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.362 -1.495 . . . . 0.23999999999999999 109.362 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.76 3.92 29.38 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.533 -0.981 . . . . 1.79 110.998 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.3 mp -60.96 145.88 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.288 -0.883 . . . . 1.0800000000000001 110.159 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -63.57 -21.19 66.21 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.474 -0.766 . . . . 0.81999999999999995 110.525 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.473 HG21 ' HB2' ' A' ' 22' ' ' GLN . 38.2 mm -71.59 172.4 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.405 -0.81 . . . . 1.1499999999999999 109.83 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 68.9 t -62.29 113.7 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.248 -0.908 . . . . 1.21 110.766 -179.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.87 154.26 37.31 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.782 -0.574 . . . . 1.28 110.368 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.478 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 4.4 ttp -156.18 159.86 39.35 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.336 -0.852 . . . . 1.3500000000000001 110.012 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.634 ' HA ' ' HA ' ' A' ' 19' ' ' VAL . 9.8 p -131.87 149.15 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 121.307 -0.871 . . . . 1.0900000000000001 110.891 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.441 ' CD2' ' HA ' ' A' ' 17' ' ' TYR . 37.6 mt . . . . . 0 N--CA 1.501 2.092 0 CA-C-O 117.653 -1.165 . . . . 1.0800000000000001 110.664 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.739 0 CA-C-O 121.021 0.439 . . . . 2.7400000000000002 110.456 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 66.89 105.61 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.075 0 CA-C-O 121.598 0.713 . . . . 2.4900000000000002 110.401 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 26.6 m -75.58 132.66 40.82 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.569 -0.707 . . . . 1.3200000000000001 109.711 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.18 142.37 35.93 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.526 -0.734 . . . . 1.8799999999999999 110.646 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 56.62 -171.65 0.08 Allowed 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.371 0.605 . . . . 2.0600000000000001 110.941 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -135.58 66.48 1.51 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.41 -0.806 . . . . 1.8700000000000001 109.84 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 52.16 58.22 5.65 Favored 'General case' 0 N--CA 1.499 1.975 0 CA-C-O 121.39 0.614 . . . . 0.70999999999999996 110.856 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -99.09 -37.73 9.22 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.343 -0.848 . . . . 1.77 110.369 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.418 HD11 ' HE1' ' A' ' 66' ' ' HIS . 1.5 mp -76.38 -46.07 29.0 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.386 -0.821 . . . . 1.3200000000000001 110.058 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 62.96 34.84 13.74 Favored 'General case' 0 N--CA 1.501 2.098 0 CA-C-O 121.167 0.508 . . . . 0.73999999999999999 110.684 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.478 ' O ' ' HA ' ' A' ' 65' ' ' THR . 91.0 t80 -98.71 118.0 63.69 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.327 -0.858 . . . . 1.02 109.281 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.679 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 43.5 Cg_endo -69.29 107.49 1.78 Allowed 'Trans proline' 0 C--N 1.313 -1.291 0 O-C-N 123.874 1.46 . . . . 0.5 110.776 -179.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.8 t -115.71 143.9 31.55 Favored Pre-proline 0 N--CA 1.497 1.885 0 C-N-CA 120.138 -0.625 . . . . 0.94999999999999996 110.34 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.93 119.75 6.24 Favored 'Trans proline' 0 C--N 1.314 -1.283 0 O-C-N 123.915 1.481 . . . . 0.5 110.634 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.656 ' HB2' ' HB ' ' A' ' 62' ' ' ILE . 15.6 m-85 -103.62 99.8 9.61 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.638 -0.664 . . . . 0.51000000000000001 110.231 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.9 m -75.03 96.05 3.13 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.395 -0.816 . . . . 1.1200000000000001 108.843 179.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.514 ' CZ ' HG22 ' A' ' 70' ' ' VAL . 4.6 m-85 -108.63 115.07 29.41 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.244 -0.91 . . . . 0.46999999999999997 110.848 -178.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.535 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 0.8 OUTLIER -83.64 91.04 7.37 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.478 -0.764 . . . . 1.3500000000000001 109.5 179.452 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.522 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . 11.0 t -79.3 95.4 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.51 -0.744 . . . . 1.3799999999999999 109.645 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.48 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 34.5 mtm -101.58 136.02 42.11 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.461 -0.774 . . . . 1.75 110.15 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -172.25 -156.97 13.04 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.565 -1.414 . . . . 0.45000000000000001 109.565 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.488 ' HB2' HG23 ' A' ' 82' ' ' ILE . 3.3 tp60 -67.68 168.79 10.61 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.458 -1.024 . . . . 0.72999999999999998 110.486 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -90.0 97.85 11.43 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.426 -0.796 . . . . 0.55000000000000004 109.969 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.428 ' CD1' ' HB3' ' A' ' 26' ' ' GLU . 0.8 OUTLIER -130.13 154.45 81.32 Favored Pre-proline 0 N--CA 1.498 1.939 0 O-C-N 121.562 -0.711 . . . . 1.1000000000000001 110.645 -179.837 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -73.06 -26.7 14.76 Favored 'Trans proline' 0 N--CA 1.49 1.316 0 O-C-N 123.877 1.461 . . . . 0.54000000000000004 111.68 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.428 ' HB3' ' CD1' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -68.82 -11.61 60.62 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.135 -0.978 . . . . 0.62 111.258 -179.804 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.14 -64.61 0.88 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.124 -0.985 . . . . 1.4299999999999999 110.441 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.508 HG12 ' HG2' ' A' ' 45' ' ' PRO . 26.9 m -66.77 -29.81 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 O-C-N 121.396 -0.815 . . . . 1.1299999999999999 110.956 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.452 ' N ' HG22 ' A' ' 28' ' ' VAL . 27.9 t70 -65.23 -56.63 11.69 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.314 -0.867 . . . . 0.67000000000000004 110.051 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.543 ' HG2' ' HA ' ' A' ' 77' ' ' LEU . 7.8 tp60 -68.3 -31.55 71.06 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.494 -0.754 . . . . 0.75 110.586 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.526 HG22 HD13 ' A' ' 60' ' ' ILE . 2.4 t -58.2 -52.33 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.37 -0.831 . . . . 0.96999999999999997 110.368 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.7 p -73.49 -32.53 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.303 -0.873 . . . . 1.1100000000000001 111.385 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.69 -49.05 27.66 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.029 -1.044 . . . . 1.1799999999999999 110.777 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.565 HG22 ' HB2' ' A' ' 76' ' ' GLU . 4.6 p -68.79 -34.05 62.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.457 -0.777 . . . . 0.44 111.012 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.538 HG21 HD11 ' A' ' 62' ' ' ILE . 4.7 p -74.16 -31.16 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.007 -1.058 . . . . 0.34999999999999998 110.051 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -73.31 -34.03 65.48 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.269 -0.894 . . . . 1.6699999999999999 109.754 178.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.3 mtt180 -68.96 -33.75 74.22 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.447 -0.783 . . . . 2.48 111.345 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 24.6 m-70 -99.1 -45.81 5.79 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.081 -1.012 . . . . 0.78000000000000003 110.781 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -101.74 150.28 37.2 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 121.449 -0.782 . . . . 1.1599999999999999 110.28 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.55 141.18 34.2 Favored 'Trans proline' 0 C--N 1.314 -1.281 0 O-C-N 123.803 1.423 . . . . 0.80000000000000004 110.762 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.55 165.23 36.41 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.71 -1.356 . . . . 0.54000000000000004 109.71 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -99.01 145.45 27.06 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.411 -1.052 . . . . 0.62 110.21 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.453 ' CD1' HG22 ' A' ' 61' ' ' THR . 78.2 m-85 -129.26 167.11 18.16 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.524 -0.735 . . . . 0.55000000000000004 110.108 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.12 157.61 68.72 Favored Pre-proline 0 N--CA 1.498 1.973 0 O-C-N 121.233 -0.917 . . . . 1.25 111.552 -178.55 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.621 ' HA ' ' HA ' ' A' ' 60' ' ' ILE . 54.8 Cg_endo -96.56 141.74 0.8 Allowed 'Trans proline' 0 C--N 1.319 -0.997 0 C-N-CA 122.131 1.887 . . . . 0.58999999999999997 110.395 179.148 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.452 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 45.2 m -95.64 93.66 7.27 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.21 -0.931 . . . . 1.1200000000000001 109.051 178.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.464 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 11.0 p -76.06 138.24 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.473 -0.767 . . . . 1.0900000000000001 111.598 -178.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.61 150.52 54.41 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.868 -0.52 . . . . 1.3899999999999999 109.705 179.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -74.97 83.79 1.76 Allowed 'Trans proline' 0 C--N 1.314 -1.288 0 O-C-N 123.858 1.451 . . . . 0.62 110.392 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -91.6 -46.9 7.69 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.431 -0.793 . . . . 1.3799999999999999 110.059 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.569 ' HB3' ' HB3' ' A' ' 55' ' ' TYR . 3.5 t -102.82 170.74 7.81 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.487 -0.758 . . . . 1.55 110.266 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.94 163.21 12.4 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.376 -0.828 . . . . 2.48 110.531 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 86.8 -139.84 16.68 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.692 -1.363 . . . . 0.82999999999999996 109.692 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -100.7 58.06 0.92 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.528 -0.984 . . . . 0.68999999999999995 110.215 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.569 ' HB3' ' HB3' ' A' ' 51' ' ' SER . 22.2 t80 -133.2 132.58 41.71 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.356 -0.84 . . . . 1.03 109.905 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -132.72 139.09 47.46 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.431 -0.793 . . . . 0.64000000000000001 110.497 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.48 ' HA ' ' HA ' ' A' ' 20' ' ' MET . 57.7 m -107.89 116.22 31.56 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.605 -0.685 . . . . 0.79000000000000004 109.476 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.464 ' HA ' ' HA ' ' A' ' 47' ' ' VAL . 1.7 m -115.5 143.3 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.27 -0.894 . . . . 0.84999999999999998 111.13 -179.087 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.535 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 13.4 m -104.56 108.28 19.64 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.753 -0.832 . . . . 1.04 108.753 178.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.621 ' HA ' ' HA ' ' A' ' 45' ' ' PRO . 6.4 tt -92.84 132.13 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.326 -0.859 . . . . 1.1100000000000001 111.556 -178.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.453 HG22 ' CD1' ' A' ' 43' ' ' TYR . 13.2 t -87.69 125.12 34.21 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.755 -0.832 . . . . 0.81999999999999995 108.755 178.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.656 ' HB ' ' HB2' ' A' ' 15' ' ' PHE . 45.4 mm -121.37 125.0 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.217 -0.927 . . . . 1.1299999999999999 110.998 -178.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -101.94 64.01 0.94 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.411 -0.806 . . . . 0.62 109.21 178.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -94.68 132.86 38.97 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.353 -0.842 . . . . 0.55000000000000004 110.355 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.679 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 41.3 p -67.7 -22.66 65.26 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.603 -0.685 . . . . 1.03 110.613 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.418 ' HE1' HD11 ' A' ' 9' ' ' LEU . 1.0 OUTLIER -130.42 160.28 34.51 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.411 -0.805 . . . . 1.1299999999999999 110.139 179.647 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -72.06 -16.86 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.412 -0.805 . . . . 1.5600000000000001 110.681 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.1 -33.89 72.44 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.089 -1.007 . . . . 0.84999999999999998 110.399 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -66.35 -48.29 70.7 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.464 -0.772 . . . . 1.1000000000000001 110.381 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.514 HG22 ' CZ ' ' A' ' 17' ' ' TYR . 8.1 p -68.34 -25.89 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.387 -0.821 . . . . 1.03 110.561 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -67.71 -51.28 51.38 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.207 -0.933 . . . . 0.69999999999999996 109.544 179.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.2 p -65.01 -34.95 79.66 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.532 -0.73 . . . . 1.1499999999999999 109.578 178.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.524 HD23 ' HA ' ' A' ' 35' ' ' VAL . 2.9 mp -60.62 -41.74 95.47 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.548 -0.72 . . . . 0.98999999999999999 109.844 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.534 ' CD1' ' HB ' ' A' ' 86' ' ' VAL . 2.0 t80 -65.15 -44.31 89.01 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.476 -0.765 . . . . 1.1599999999999999 109.487 178.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.22 -37.4 83.55 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.521 -0.737 . . . . 0.92000000000000004 110.53 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.565 ' HB2' HG22 ' A' ' 34' ' ' VAL . 26.5 mt-10 -69.01 -49.88 53.78 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.449 -0.782 . . . . 0.5 110.483 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.543 ' HA ' ' HG2' ' A' ' 30' ' ' GLN . 0.3 OUTLIER -74.09 -28.98 61.63 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.352 -0.842 . . . . 1.0900000000000001 110.3 179.633 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.47 ' N ' ' HG ' ' A' ' 77' ' ' LEU . . . -104.09 49.43 0.93 Allowed Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.314 -1.514 . . . . 0.32000000000000001 109.314 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -106.16 3.97 28.51 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.705 -0.88 . . . . 1.1399999999999999 110.791 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.495 HG21 HG12 ' A' ' 82' ' ' ILE . 2.3 mp -61.1 157.27 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.323 -0.86 . . . . 1.2 110.328 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.32 -4.12 40.4 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.131 -0.981 . . . . 1.1499999999999999 111.83 -179.512 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.495 HG12 HG21 ' A' ' 80' ' ' ILE . 17.8 mm -86.68 -125.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 120.962 -1.086 . . . . 1.2 110.402 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 98.9 t -119.51 117.2 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 120.711 -1.243 . . . . 1.02 110.485 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.484 ' HD2' ' HB ' ' A' ' 80' ' ' ILE . 0.0 OUTLIER -122.49 131.65 53.96 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.656 -0.653 . . . . 0.79000000000000004 110.283 179.779 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.485 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 1.8 ttp -143.05 158.56 43.49 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.413 -0.804 . . . . 1.76 109.683 179.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.534 ' HB ' ' CD1' ' A' ' 74' ' ' TYR . 9.8 p -141.62 152.21 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.294 -0.879 . . . . 0.95999999999999996 111.026 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.479 HD23 ' HA ' ' A' ' 17' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.501 2.078 0 CA-C-O 117.54 -1.219 . . . . 1.0700000000000001 110.482 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.422 ' HA ' HD13 ' A' ' 9' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.807 0 CA-C-O 120.856 0.36 . . . . 1.3300000000000001 110.519 . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.75 80.48 8.83 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.216 -0.928 . . . . 2.0 110.451 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 24.7 p -119.92 132.27 55.48 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.563 -0.711 . . . . 1.1000000000000001 109.998 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.1 mttp 59.9 -82.26 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.24 0 O-C-N 122.065 -0.397 . . . . 3.9100000000000001 110.748 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -93.55 -160.6 0.77 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.976 -1.077 . . . . 2.1200000000000001 110.353 179.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -62.56 -55.27 28.82 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.445 -0.784 . . . . 1.6000000000000001 109.779 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -146.78 121.03 9.54 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.591 -0.693 . . . . 0.67000000000000004 110.103 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -102.23 -34.67 9.15 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.661 -0.649 . . . . 1.3400000000000001 110.235 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.422 HD13 ' HA ' ' A' ' 1' ' ' MET . 2.3 mp -83.79 -50.35 8.2 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.517 -0.739 . . . . 1.25 110.241 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 59.48 42.42 17.71 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-O 121.227 0.537 . . . . 0.54000000000000004 110.648 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.468 ' O ' ' HA ' ' A' ' 65' ' ' THR . 90.1 t80 -96.73 131.52 27.9 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.347 -0.846 . . . . 0.82999999999999996 109.673 179.518 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.612 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 43.4 Cg_endo -69.5 107.29 1.77 Allowed 'Trans proline' 0 C--N 1.315 -1.203 0 O-C-N 123.909 1.479 . . . . 0.42999999999999999 110.41 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.2 t -129.18 142.31 44.76 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.643 -0.661 . . . . 1.04 110.633 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.493 ' HA ' ' HA ' ' A' ' 63' ' ' ASN . 46.2 Cg_endo -72.7 125.5 10.6 Favored 'Trans proline' 0 C--N 1.314 -1.248 0 O-C-N 123.94 1.495 . . . . 0.38 110.449 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.42 ' CB ' HG21 ' A' ' 70' ' ' VAL . 32.9 m-85 -103.14 99.45 9.32 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.558 -0.714 . . . . 0.46999999999999997 110.215 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.9 m -78.23 91.94 4.43 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.299 -1.0 . . . . 1.1200000000000001 108.299 178.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.4 ' HA ' ' CD2' ' A' ' 87' ' ' LEU . 3.1 m-85 -97.6 104.37 16.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.573 -0.704 . . . . 0.91000000000000003 110.352 -178.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.562 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 0.0 OUTLIER -78.22 89.12 4.28 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.693 -0.629 . . . . 2.4700000000000002 110.202 179.905 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.559 HG23 HG21 ' A' ' 58' ' ' VAL . 1.0 OUTLIER -83.89 101.67 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.308 -0.87 . . . . 1.04 109.397 179.337 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 36.8 mtm -109.44 151.43 26.69 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.588 -0.695 . . . . 1.6799999999999999 110.254 -179.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -177.67 -154.89 12.85 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.847 -1.301 . . . . 0.40999999999999998 109.847 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.463 ' HB2' HG21 ' A' ' 82' ' ' ILE . 0.1 OUTLIER -66.88 167.27 11.83 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.468 -1.019 . . . . 0.69999999999999996 110.353 179.968 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.29 102.61 1.42 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.37 -0.831 . . . . 0.66000000000000003 110.255 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.55 120.48 19.77 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.499 -0.751 . . . . 1.3400000000000001 110.091 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -71.9 -14.91 29.68 Favored 'Trans proline' 0 N--CA 1.49 1.323 0 O-C-N 123.871 1.458 . . . . 0.57999999999999996 111.465 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -82.28 -0.33 45.0 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.111 -0.993 . . . . 0.73999999999999999 111.456 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.442 HD12 ' N ' ' A' ' 28' ' ' VAL . 3.5 pp -57.87 -36.51 72.47 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 120.969 -1.082 . . . . 1.1799999999999999 111.045 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.442 ' N ' HD12 ' A' ' 27' ' ' LEU . 9.9 p -79.36 -30.91 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.161 -0.962 . . . . 1.1200000000000001 110.497 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -66.72 -50.92 61.25 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.403 -0.81 . . . . 0.40999999999999998 109.891 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.726 ' HG2' ' HA ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -68.81 -45.25 71.73 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.261 -0.9 . . . . 1.3700000000000001 110.525 179.765 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.551 HG22 HD12 ' A' ' 60' ' ' ILE . 2.9 t -53.76 -54.05 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.442 -0.786 . . . . 1.05 111.172 -179.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.9 p -66.77 -35.65 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 121.185 -0.947 . . . . 0.93999999999999995 111.63 -179.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -73.8 -51.06 17.62 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.059 -1.026 . . . . 0.5 110.896 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.407 ' CG2' ' HB3' ' A' ' 76' ' ' GLU . 9.5 p -66.25 -31.7 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.403 -0.81 . . . . 0.47999999999999998 111.162 -179.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.601 ' HA ' HD22 ' A' ' 73' ' ' LEU . 1.6 p -79.59 -28.23 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.145 -0.972 . . . . 0.98999999999999999 110.634 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -75.98 -37.76 58.2 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.226 -0.922 . . . . 1.04 110.524 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 13.3 mtm180 -71.87 -23.11 61.46 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.332 -0.855 . . . . 3.3599999999999999 110.93 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.52 ' CD2' HD11 ' A' ' 73' ' ' LEU . 19.8 m-70 -99.6 -45.78 5.67 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.298 -0.877 . . . . 0.64000000000000001 110.392 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -92.17 153.57 43.13 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.405 -0.809 . . . . 1.1100000000000001 109.695 179.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -68.05 -36.74 16.54 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 O-C-N 123.752 1.396 . . . . 0.82999999999999996 111.082 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -101.74 163.89 17.47 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 109.517 -1.433 . . . . 0.53000000000000003 109.517 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -88.55 154.63 20.19 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.354 -1.086 . . . . 0.66000000000000003 109.885 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.412 ' HD2' HG23 ' A' ' 35' ' ' VAL . 75.3 m-85 -137.65 172.77 12.46 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.471 -0.768 . . . . 0.57999999999999996 110.641 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.444 ' CG2' ' HD2' ' A' ' 45' ' ' PRO . 4.2 m -142.27 154.0 63.65 Favored Pre-proline 0 N--CA 1.498 1.943 0 O-C-N 121.416 -0.803 . . . . 0.67000000000000004 110.919 -179.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.45 ' HA ' ' HA ' ' A' ' 60' ' ' ILE . 55.1 Cg_endo -95.12 132.5 0.56 Allowed 'Trans proline' 0 C--N 1.319 -0.979 0 C-N-CA 121.823 1.682 . . . . 0.56999999999999995 110.421 178.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.436 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 35.8 m -90.24 99.35 12.39 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.067 -1.021 . . . . 0.87 109.202 179.019 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.5 ' HA ' HG12 ' A' ' 58' ' ' VAL . 12.4 p -76.63 135.18 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.544 -0.722 . . . . 1.1200000000000001 111.495 -178.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.401 ' HE2' ' HB3' ' A' ' 57' ' ' SER . 0.2 OUTLIER -142.71 150.78 55.02 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.789 -0.569 . . . . 1.0700000000000001 109.817 179.096 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -80.4 80.04 3.15 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 O-C-N 123.982 1.517 . . . . 0.54000000000000004 110.616 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.54 -47.1 13.53 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.312 -0.867 . . . . 1.23 109.999 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.537 ' HB3' ' HB3' ' A' ' 55' ' ' TYR . 0.6 OUTLIER -105.46 156.42 18.22 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.447 -0.783 . . . . 1.1499999999999999 110.142 179.582 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.52 150.18 20.51 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.49 -0.756 . . . . 1.48 110.439 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.41 -136.78 12.92 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.653 -1.379 . . . . 0.64000000000000001 109.653 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -98.55 72.65 2.04 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.468 -1.019 . . . . 0.70999999999999996 109.974 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.537 ' HB3' ' HB3' ' A' ' 51' ' ' SER . 16.3 t80 -146.36 128.8 15.93 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.416 -0.802 . . . . 0.56999999999999995 110.38 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 4.0 m170 -120.62 126.04 49.27 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.561 -0.712 . . . . 1.1399999999999999 109.974 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.401 ' HB3' ' HE2' ' A' ' 48' ' ' LYS . 38.9 m -109.7 110.88 22.05 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.403 -0.811 . . . . 0.51000000000000001 109.593 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.559 HG21 HG23 ' A' ' 19' ' ' VAL . 3.6 m -119.74 151.34 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.21 -0.931 . . . . 0.93000000000000005 110.931 -179.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.562 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 79.3 p -117.8 118.08 31.06 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.478 -0.764 . . . . 0.79000000000000004 109.422 179.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.551 HD12 HG22 ' A' ' 31' ' ' VAL . 9.1 tt -93.17 130.68 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.33 -0.856 . . . . 1.0 110.922 -179.012 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 97.2 m -86.15 129.91 34.7 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 109.101 -0.703 . . . . 1.03 109.101 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.511 HG12 HG21 ' A' ' 35' ' ' VAL . 91.0 mt -141.65 96.6 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.103 -0.998 . . . . 1.03 110.848 -179.344 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.493 ' HA ' ' HA ' ' A' ' 14' ' ' PRO . 2.0 t30 -82.31 93.94 7.25 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.039 -1.038 . . . . 0.46000000000000002 109.353 178.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -117.45 140.21 49.89 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.598 -0.689 . . . . 1.0700000000000001 110.319 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.612 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 33.8 p -69.74 -15.37 63.13 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.546 -0.722 . . . . 1.0600000000000001 110.653 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -130.53 157.98 41.2 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.399 -0.813 . . . . 0.53000000000000003 109.901 179.466 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.2 tt -89.99 -3.23 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.29 -0.881 . . . . 1.1399999999999999 111.093 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -74.38 -43.68 55.42 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.106 -0.996 . . . . 0.41999999999999998 110.487 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.459 ' CG ' ' HB3' ' A' ' 38' ' ' HIS . 0.6 OUTLIER -67.01 -47.0 72.79 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.531 -0.73 . . . . 0.68000000000000005 110.848 -179.682 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.42 HG21 ' CB ' ' A' ' 15' ' ' PHE . 8.9 p -62.24 -31.13 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 121.446 -0.784 . . . . 0.93999999999999995 110.699 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -66.76 -46.89 73.93 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.326 -0.859 . . . . 0.52000000000000002 109.224 178.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.0 m -61.32 -34.38 75.16 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.679 -0.638 . . . . 1.0700000000000001 109.464 178.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.601 HD22 ' HA ' ' A' ' 35' ' ' VAL . 2.1 mp -65.64 -39.11 91.08 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.515 -0.741 . . . . 1.1499999999999999 109.914 179.202 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.467 ' CD1' ' C ' ' A' ' 74' ' ' TYR . 0.0 OUTLIER -63.12 -48.94 76.37 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.625 -0.672 . . . . 0.95999999999999996 109.779 179.419 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -71.26 -26.24 62.81 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.423 -0.798 . . . . 0.62 110.883 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.407 ' HB3' ' CG2' ' A' ' 34' ' ' VAL . 23.2 mt-10 -73.49 -50.18 22.88 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.216 -0.927 . . . . 0.39000000000000001 110.07 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.726 ' HA ' ' HG2' ' A' ' 30' ' ' GLN . 1.5 pp -76.17 -25.73 55.52 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.282 -0.886 . . . . 1.05 110.023 178.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -101.39 40.74 2.32 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.307 -1.517 . . . . 0.31 109.307 179.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.05 4.12 39.44 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.384 -1.068 . . . . 1.1899999999999999 110.842 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.0 mp -62.04 145.85 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.334 -0.854 . . . . 1.1100000000000001 110.116 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -60.96 -30.29 70.16 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.407 -0.808 . . . . 0.73999999999999999 110.302 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.463 HG21 ' HB2' ' A' ' 22' ' ' GLN . 1.0 OUTLIER -61.35 171.09 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.616 -0.678 . . . . 1.1599999999999999 110.611 179.724 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 78.9 t -63.67 118.16 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.43 -0.794 . . . . 1.1200000000000001 110.288 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.35 158.67 27.74 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.675 -0.641 . . . . 0.81999999999999995 110.369 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.509 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 1.1 ttp -157.76 158.53 35.46 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.511 -0.743 . . . . 1.3500000000000001 109.786 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.458 ' HA ' ' HA ' ' A' ' 19' ' ' VAL . 9.1 p -135.46 147.17 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.378 -0.826 . . . . 1.0 110.628 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.4 ' CD2' ' HA ' ' A' ' 17' ' ' TYR . 35.8 mt . . . . . 0 N--CA 1.5 2.061 0 CA-C-O 118.693 -0.67 . . . . 1.1000000000000001 110.466 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 N--CA 1.495 1.816 0 N-CA-C 109.989 -0.374 . . . . 0.33 109.989 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -69.44 114.64 3.72 Favored 'Trans proline' 0 C--N 1.313 -1.312 0 O-C-N 123.861 1.453 . . . . 0.36 110.979 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.526 ' CE2' ' HB3' ' A' ' 64' ' ' ALA . 15.7 m-85 -102.53 101.13 11.28 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.694 -0.629 . . . . 0.33 110.222 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.4 m -75.5 93.04 2.93 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.631 -0.877 . . . . 0.37 108.631 178.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -110.75 159.25 17.8 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.468 -0.77 . . . . 0.38 110.752 -178.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.546 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -134.82 101.25 4.85 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.348 -0.612 . . . . 0.4 109.348 179.766 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 1.062 HG11 HD11 ' A' ' 77' ' ' LEU . 3.5 t -79.68 95.62 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.477 -0.764 . . . . 0.28 109.59 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.541 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 43.9 mtm -97.73 142.0 30.05 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.538 -0.726 . . . . 0.56 110.178 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 166.42 -147.69 12.46 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.586 -1.406 . . . . 0.31 109.586 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.509 ' HG3' HG21 ' A' ' 82' ' ' ILE . 0.0 OUTLIER -75.8 151.1 37.59 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.326 -1.102 . . . . 0.7 110.106 179.816 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.6 105.04 2.98 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.564 -0.71 . . . . 0.36 110.31 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.522 HD13 ' HD2' ' A' ' 25' ' ' PRO . 2.6 mm? -111.13 129.69 23.74 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.592 -0.693 . . . . 0.56 109.761 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.522 ' HD2' HD13 ' A' ' 24' ' ' LEU . 43.3 Cg_endo -70.49 -30.5 18.81 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 O-C-N 123.701 1.369 . . . . 0.41 110.606 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -83.6 -2.81 56.9 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.463 -0.773 . . . . 0.64 110.791 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.52 HD21 HG21 ' A' ' 58' ' ' VAL . 0.8 OUTLIER -58.48 -52.62 64.85 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.043 -1.035 . . . . 0.82 110.284 179.997 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.499 HG12 ' HG2' ' A' ' 45' ' ' PRO . 35.8 m -62.23 -33.2 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.48 -0.762 . . . . 0.35 110.467 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -67.45 -46.26 73.59 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.511 -0.743 . . . . 0.49 109.937 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.734 ' O ' HG12 ' A' ' 34' ' ' VAL . 3.2 tp60 -72.24 -34.32 68.2 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.446 -0.784 . . . . 0.53 110.328 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.807 HG22 HD12 ' A' ' 60' ' ' ILE . 2.8 t -60.41 -53.21 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.561 -0.712 . . . . 0.26 110.432 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.444 ' HA ' HG12 ' A' ' 35' ' ' VAL . 9.9 p -70.81 -31.47 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 121.329 -0.857 . . . . 0.29 110.846 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.73 -46.27 54.39 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.301 -0.874 . . . . 0.52 110.932 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.849 HG21 ' CB ' ' A' ' 76' ' ' GLU . 7.6 p -75.51 -30.28 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.247 -0.908 . . . . 0.25 111.048 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.67 HG11 ' HB2' ' A' ' 43' ' ' TYR . 4.0 p -75.2 -30.75 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.045 -1.034 . . . . 0.26 110.209 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -79.04 -42.0 27.52 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.383 -0.823 . . . . 0.58 110.32 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.9 mtm180 -62.87 -30.06 71.23 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.269 -0.895 . . . . 2.51 111.053 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.743 ' CG ' HD11 ' A' ' 73' ' ' LEU . 68.6 m-70 -97.5 -41.05 8.36 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.342 -0.849 . . . . 0.51 110.72 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -120.8 145.56 41.58 Favored Pre-proline 0 N--CA 1.497 1.922 0 O-C-N 121.439 -0.788 . . . . 0.3 110.019 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.96 142.53 51.77 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 O-C-N 123.598 1.315 . . . . 0.4 110.985 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 98.09 147.76 22.74 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.724 -1.35 . . . . 0.36 109.724 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -94.48 139.9 30.53 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.573 -0.957 . . . . 0.66 109.949 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.67 ' HB2' HG11 ' A' ' 35' ' ' VAL . 76.5 m-85 -131.81 164.41 26.09 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.444 -0.785 . . . . 0.45 110.67 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.431 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 0.5 OUTLIER -142.79 158.14 60.16 Favored Pre-proline 0 N--CA 1.498 1.935 0 O-C-N 121.424 -0.798 . . . . 0.55 111.713 -179.314 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.688 ' HG3' HG21 ' A' ' 31' ' ' VAL . 55.2 Cg_endo -96.69 120.58 0.19 Allowed 'Trans proline' 0 C--N 1.317 -1.119 0 C-N-CA 122.382 2.055 . . . . 0.51 110.258 179.066 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.522 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 27.6 m -81.41 99.48 8.74 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.021 -1.049 . . . . 0.32 109.397 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.666 HG23 HG12 ' A' ' 58' ' ' VAL . 10.8 p -75.89 144.35 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.419 -0.801 . . . . 0.34 111.469 -178.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 O-C-N 121.834 -0.541 . . . . 0.55 109.665 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 41.3 t80 . . . . . 0 N--CA 1.497 1.894 0 CA-C-O 121.074 0.464 . . . . 0.9 109.797 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -130.35 142.26 50.54 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.281 -0.887 . . . . 0.64 111.311 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.541 ' HA ' ' HA ' ' A' ' 20' ' ' MET . 16.0 m -110.51 117.23 32.99 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.705 -0.85 . . . . 0.36 108.705 179.051 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.666 HG12 HG23 ' A' ' 47' ' ' VAL . 2.8 m -110.09 150.78 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.187 -0.946 . . . . 0.26 111.829 -178.347 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.484 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 0.3 OUTLIER -104.41 104.6 14.5 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.396 -0.965 . . . . 1.0 108.396 178.476 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.807 HD12 HG22 ' A' ' 31' ' ' VAL . 14.5 tt -93.1 130.73 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.305 -0.872 . . . . 0.28 111.849 -178.252 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.523 ' O ' ' HB3' ' A' ' 43' ' ' TYR . 37.7 m -96.44 133.91 40.27 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.633 -0.877 . . . . 0.33 108.633 178.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.511 HG23 HG23 ' A' ' 35' ' ' VAL . 32.3 mt -144.14 139.39 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 120.939 -1.1 . . . . 0.26 111.137 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -112.63 57.21 0.66 Allowed 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.877 0.846 . . . . 0.36 109.161 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.642 ' HB1' ' HB3' ' A' ' 69' ' ' GLN . . . -67.21 130.74 44.06 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.965 -1.085 . . . . 0.25 110.22 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 32.8 p -70.08 -7.57 42.4 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.868 -0.52 . . . . 0.3 111.053 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.743 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 13.1 t-80 -129.75 157.89 40.92 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.198 -0.939 . . . . 0.38 110.104 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.492 ' O ' HG12 ' A' ' 70' ' ' VAL . 16.0 mm -69.7 -51.4 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.413 -0.805 . . . . 0.55 110.504 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.42 ' HB2' ' CE1' ' A' ' 66' ' ' HIS . 1.7 mt-10 -71.58 -14.69 62.16 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.472 -0.768 . . . . 1.15 111.647 -179.346 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.743 ' HB2' ' HB3' ' A' ' 66' ' ' HIS . 14.5 tt0 -62.09 -46.0 91.02 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.013 -1.055 . . . . 0.43 110.306 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.492 HG12 ' O ' ' A' ' 67' ' ' ILE . 5.8 p -60.73 -27.22 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 121.158 -0.964 . . . . 0.33 110.609 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -67.82 -50.24 57.86 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.298 -0.876 . . . . 0.84 109.856 179.328 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.9 p -63.5 -37.33 86.9 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.512 -0.742 . . . . 0.37 109.597 179.243 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.743 HD11 ' CG ' ' A' ' 38' ' ' HIS . 5.5 mp -60.03 -39.96 87.69 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.538 -0.726 . . . . 0.52 109.561 178.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.627 ' CD1' ' HB ' ' A' ' 86' ' ' VAL . 0.6 OUTLIER -63.03 -45.79 90.61 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.531 -0.73 . . . . 0.45 109.084 178.654 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -60.7 -37.67 82.43 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.56 -0.713 . . . . 0.67 109.943 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.849 ' CB ' HG21 ' A' ' 34' ' ' VAL . 0.3 OUTLIER -63.26 -41.38 99.03 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.516 -0.74 . . . . 0.57 110.566 179.801 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 1.062 HD11 HG11 ' A' ' 19' ' ' VAL . 0.3 OUTLIER -84.47 -28.59 26.68 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.382 -0.824 . . . . 0.32 110.557 179.818 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.536 ' N ' ' HG ' ' A' ' 77' ' ' LEU . . . -107.08 58.98 0.4 Allowed Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.806 -1.317 . . . . 0.26 109.806 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.12 4.17 26.56 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.606 -0.938 . . . . 0.46 110.389 178.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.448 HG22 ' H ' ' A' ' 82' ' ' ILE . 2.2 mp -63.4 152.65 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.383 -0.823 . . . . 0.48 110.125 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -69.74 -11.87 61.19 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.333 -0.854 . . . . 0.79 111.063 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.52 HG22 ' H ' ' A' ' 83' ' ' VAL . 22.3 mm -82.94 175.23 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.134 -0.979 . . . . 0.47 109.903 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.52 ' H ' HG22 ' A' ' 82' ' ' ILE . 76.0 t -63.16 112.04 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.373 -0.829 . . . . 0.51 111.395 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.96 136.76 54.94 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 109.109 -0.7 . . . . 1.02 109.109 178.586 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.46 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 2.6 ttt -151.3 161.57 42.46 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.12 -0.987 . . . . 2.36 110.724 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.627 ' HB ' ' CD1' ' A' ' 74' ' ' TYR . 8.1 p -141.71 153.04 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.431 -0.793 . . . . 0.3 110.565 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.546 ' HB3' ' HB2' ' A' ' 18' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.496 1.835 0 CA-C-O 117.944 -1.027 . . . . 0.32 109.705 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.1 t . . . . . 0 N--CA 1.494 1.774 0 N-CA-C 110.306 -0.257 . . . . 0.33 110.306 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.31 125.68 11.57 Favored 'Trans proline' 0 C--N 1.313 -1.301 0 O-C-N 123.925 1.487 . . . . 0.4 110.483 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.577 ' HB2' HG23 ' A' ' 62' ' ' ILE . 29.5 m-85 -105.91 99.31 8.91 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.535 -0.728 . . . . 0.33 110.355 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.1 m -76.93 92.72 3.69 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.072 -1.084 . . . . 0.43 108.072 178.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.478 ' O ' HG22 ' A' ' 60' ' ' ILE . 3.0 m-85 -99.86 107.33 19.32 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.434 -0.792 . . . . 0.3 110.723 -178.212 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 0.1 OUTLIER -82.07 88.79 6.41 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.524 -0.735 . . . . 0.34 109.292 179.547 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 1.034 HG11 HD11 ' A' ' 77' ' ' LEU . 21.3 t -79.95 95.02 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.537 -0.727 . . . . 0.29 109.617 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.8 ttt -107.96 125.91 52.07 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.573 -0.704 . . . . 1.11 110.431 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.486 ' HA3' ' HD3' ' A' ' 84' ' ' ARG . . . -153.82 -160.24 9.64 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.28 -1.528 . . . . 0.26 109.28 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.433 ' HB2' HG23 ' A' ' 82' ' ' ILE . 0.0 OUTLIER -67.02 168.06 10.69 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.38 -1.07 . . . . 1.04 110.253 179.73 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.413 ' O ' HD22 ' A' ' 24' ' ' LEU . . . -63.76 103.62 0.58 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.408 -0.808 . . . . 0.36 110.417 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.761 HD13 ' HD2' ' A' ' 25' ' ' PRO . 0.5 OUTLIER -125.1 123.03 25.39 Favored Pre-proline 0 N--CA 1.496 1.835 0 O-C-N 121.469 -0.769 . . . . 0.42 110.32 -179.706 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.761 ' HD2' HD13 ' A' ' 24' ' ' LEU . 46.3 Cg_endo -73.04 -22.41 19.51 Favored 'Trans proline' 0 N--CA 1.489 1.227 0 O-C-N 123.892 1.47 . . . . 0.49 111.163 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.606 ' HG2' HD12 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -78.49 -0.67 30.36 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.307 -0.87 . . . . 0.56 111.524 -179.985 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.571 HD11 ' NH1' ' A' ' 84' ' ' ARG . 9.3 mt -53.64 -58.44 7.19 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.19 -0.944 . . . . 0.35 110.871 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.441 ' HA ' ' HG3' ' A' ' 45' ' ' PRO . 8.9 p -64.9 -30.35 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.429 -0.794 . . . . 0.35 111.177 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.4 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 13.6 m-20 -67.08 -56.44 10.03 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.317 -0.865 . . . . 0.47 110.649 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.669 ' O ' HG12 ' A' ' 34' ' ' VAL . 0.7 OUTLIER -68.98 -38.02 79.09 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.327 -0.858 . . . . 1.03 110.846 -179.898 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.611 HG22 HD22 ' A' ' 77' ' ' LEU . 3.2 t -57.63 -54.52 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.398 -0.814 . . . . 0.27 110.596 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.3 p -66.09 -34.16 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.329 -0.857 . . . . 0.36 111.284 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' A' ' 29' ' ' ASP . 0.3 OUTLIER -73.88 -52.77 11.9 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.094 -1.004 . . . . 1.26 111.06 -179.681 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.832 HG21 ' CB ' ' A' ' 76' ' ' GLU . 8.0 p -68.26 -27.26 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.3 -0.875 . . . . 0.36 111.34 -179.3 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.805 HG23 HD12 ' A' ' 62' ' ' ILE . 2.9 p -79.92 -34.14 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.01 -1.056 . . . . 0.36 110.703 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -80.92 -23.71 38.7 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.058 -1.027 . . . . 1.17 110.585 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 31.7 mtm180 -76.59 -43.8 37.1 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.318 -0.864 . . . . 1.35 110.793 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.598 ' CB ' HD11 ' A' ' 73' ' ' LEU . 90.1 m-70 -93.19 -45.65 7.77 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.365 -0.834 . . . . 1.49 110.843 -179.398 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.562 ' HB3' ' O ' ' A' ' 35' ' ' VAL . . . -91.92 148.84 37.83 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 121.337 -0.852 . . . . 0.55 110.072 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.02 140.28 34.39 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 O-C-N 123.884 1.465 . . . . 0.75 110.572 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.96 154.45 9.41 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.729 -1.348 . . . . 0.49 109.729 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.94 143.56 26.68 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.399 -1.06 . . . . 0.66 110.002 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.52 ' HB2' HG11 ' A' ' 35' ' ' VAL . 51.0 m-85 -127.65 172.73 10.51 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.516 -0.74 . . . . 0.45 110.517 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.804 HG22 ' HD2' ' A' ' 45' ' ' PRO . 1.0 OUTLIER -142.23 154.38 64.24 Favored Pre-proline 0 N--CA 1.497 1.9 0 O-C-N 121.43 -0.794 . . . . 0.61 110.82 -179.433 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.804 ' HD2' HG22 ' A' ' 44' ' ' THR . 53.4 Cg_endo -93.91 164.39 2.16 Favored 'Trans proline' 0 C--N 1.317 -1.11 0 C-N-CA 121.69 1.593 . . . . 0.47 110.354 179.051 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.476 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 22.7 m -120.28 95.98 4.96 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.688 -0.856 . . . . 0.34 108.688 178.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.401 HG23 HG23 ' A' ' 58' ' ' VAL . 9.9 p -75.78 143.8 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.538 -0.726 . . . . 0.36 111.239 -178.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.438 ' HB2' ' HB3' ' A' ' 57' ' ' SER . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.671 0 O-C-N 121.722 -0.612 . . . . 0.44 110.102 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 121.075 0.464 . . . . 0.52 109.96 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -111.1 129.83 55.8 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.54 -0.725 . . . . 0.63 110.483 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.438 ' HB3' ' HB2' ' A' ' 48' ' ' LYS . 0.4 OUTLIER -97.56 99.31 10.7 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.522 -0.736 . . . . 0.33 109.451 179.341 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.631 HG13 ' HB2' ' A' ' 45' ' ' PRO . 1.0 OUTLIER -103.81 120.93 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.394 -0.816 . . . . 0.28 110.746 -179.216 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.493 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 11.6 t -100.92 114.49 28.41 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.452 -0.78 . . . . 0.41 109.114 178.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.553 ' CD1' HG13 ' A' ' 31' ' ' VAL . 11.2 tt -93.47 132.7 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.268 -0.895 . . . . 0.32 111.344 -178.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.466 ' O ' ' HB3' ' A' ' 43' ' ' TYR . 22.7 m -99.03 135.52 40.31 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.808 -0.812 . . . . 0.41 108.808 178.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.805 HD12 HG23 ' A' ' 35' ' ' VAL . 3.1 tt -162.37 131.75 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.128 -0.983 . . . . 0.44 111.003 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -105.28 101.19 10.75 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.407 -0.808 . . . . 0.58 109.359 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -115.72 146.56 41.78 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.427 -0.795 . . . . 0.3 110.64 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 47.3 p -79.35 -2.87 43.58 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.661 -0.649 . . . . 0.44 111.136 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.541 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 6.7 t60 -129.81 147.4 51.58 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.189 -0.944 . . . . 0.64 110.746 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.509 ' O ' HG12 ' A' ' 70' ' ' VAL . 0.8 OUTLIER -78.95 -41.42 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.638 -0.664 . . . . 0.76 109.843 179.292 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -65.47 -32.5 74.14 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.472 -0.767 . . . . 0.52 110.661 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.541 ' HB2' ' HB3' ' A' ' 66' ' ' HIS . 0.0 OUTLIER -59.91 -55.81 29.53 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.361 -0.837 . . . . 0.58 110.531 -179.936 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.573 HG21 ' HB3' ' A' ' 15' ' ' PHE . 13.3 p -61.16 -29.89 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.351 -0.843 . . . . 0.27 110.452 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -67.69 -43.85 79.13 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.229 -0.919 . . . . 0.47 109.365 178.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 54.7 m -60.52 -38.63 85.02 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.604 -0.685 . . . . 0.35 109.168 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.711 ' HG ' HG22 ' A' ' 34' ' ' VAL . 7.7 mp -63.71 -38.39 90.92 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.68 -0.638 . . . . 0.41 109.777 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.618 ' CD1' ' HB ' ' A' ' 86' ' ' VAL . 0.2 OUTLIER -59.3 -47.92 83.56 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 108.973 -0.751 . . . . 0.64 108.973 178.693 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.14 -31.29 72.41 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.606 -0.684 . . . . 0.55 110.214 179.382 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.832 ' CB ' HG21 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -66.14 -51.38 58.4 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.442 -0.787 . . . . 0.66 110.236 179.501 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 1.034 HD11 HG11 ' A' ' 19' ' ' VAL . 0.4 OUTLIER -76.43 -25.41 54.4 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.431 -0.793 . . . . 0.28 110.536 179.685 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.651 ' HA2' ' HG2' ' A' ' 84' ' ' ARG . . . -101.11 39.23 2.81 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 110.051 -1.22 . . . . 0.27 110.051 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.62 4.23 45.64 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.521 -0.988 . . . . 1.97 110.635 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.7 mp -60.14 153.03 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.303 -0.873 . . . . 0.37 110.064 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.5 -27.79 67.87 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.479 -0.763 . . . . 1.3 109.932 179.063 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.512 HG21 HD23 ' A' ' 24' ' ' LEU . 0.9 OUTLIER -68.26 171.99 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.526 -0.734 . . . . 0.51 110.179 179.36 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.418 ' N ' HG23 ' A' ' 82' ' ' ILE . 97.5 t -81.5 110.8 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.294 -0.879 . . . . 0.61 110.639 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.764 ' HD2' HG12 ' A' ' 19' ' ' VAL . 8.3 tpp180 -121.59 131.85 54.35 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.689 -0.632 . . . . 0.44 109.802 179.192 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.514 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 6.0 mtm -129.82 171.41 12.73 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.382 -0.823 . . . . 1.31 110.516 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.692 HG23 HG22 ' A' ' 19' ' ' VAL . 8.8 p -138.62 156.03 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.548 -0.72 . . . . 0.29 110.619 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.432 ' HA ' HD22 ' A' ' 87' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.5 2.029 0 CA-C-O 118.81 -0.614 . . . . 0.54 110.398 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.2 t . . . . . 0 N--CA 1.495 1.82 0 N-CA-C 110.244 -0.28 . . . . 0.37 110.244 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.43 117.82 5.35 Favored 'Trans proline' 0 C--N 1.315 -1.212 0 O-C-N 123.893 1.47 . . . . 0.39 110.811 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.665 ' HB2' ' HB ' ' A' ' 62' ' ' ILE . 16.7 m-85 -103.29 99.67 9.53 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.589 -0.694 . . . . 0.3 110.429 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.9 m -75.56 92.94 2.95 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.504 -0.925 . . . . 0.34 108.504 178.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.532 ' HD2' HG21 ' A' ' 86' ' ' VAL . 3.4 m-85 -102.72 108.0 19.1 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.343 -0.848 . . . . 0.32 110.9 -178.459 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.551 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 0.0 OUTLIER -78.3 89.72 4.34 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.532 -0.73 . . . . 0.78 109.296 179.404 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 1.054 HG11 HD11 ' A' ' 77' ' ' LEU . 24.8 t -78.57 96.5 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.487 -0.758 . . . . 0.3 109.906 -179.484 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.582 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 1.0 OUTLIER -97.21 149.71 21.72 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.541 -0.724 . . . . 1.18 110.124 -179.772 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 170.21 -151.44 16.61 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.848 -1.301 . . . . 0.34 109.848 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -79.38 151.45 30.95 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.545 -0.973 . . . . 0.74 110.327 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.21 96.99 4.02 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.604 -0.685 . . . . 0.32 110.199 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.408 HD13 HG21 ' A' ' 82' ' ' ILE . 0.1 OUTLIER -127.4 155.53 76.45 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.469 -0.769 . . . . 0.7 110.45 -179.823 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.56 -22.96 20.46 Favored 'Trans proline' 0 C--N 1.314 -1.263 0 O-C-N 123.927 1.488 . . . . 0.53 110.803 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -70.32 -18.09 63.08 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.337 -0.852 . . . . 0.58 111.035 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.472 HD13 ' HA ' ' A' ' 27' ' ' LEU . 1.7 mm? -57.87 -66.28 0.5 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.305 -0.872 . . . . 0.46 110.414 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.5 p -62.99 -29.5 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.449 -0.782 . . . . 0.39 110.965 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -64.59 -57.66 8.5 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.338 -0.851 . . . . 0.46 110.324 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.641 ' O ' HG12 ' A' ' 34' ' ' VAL . 4.9 tp60 -69.33 -30.32 68.33 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.353 -0.842 . . . . 0.91 110.821 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.987 HG22 HD12 ' A' ' 60' ' ' ILE . 2.3 t -59.79 -54.52 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.248 -0.907 . . . . 0.24 110.242 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.418 ' O ' ' HG2' ' A' ' 36' ' ' GLN . 9.5 p -70.77 -32.74 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.339 -0.85 . . . . 0.32 111.15 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.406 ' HA ' ' HG2' ' A' ' 36' ' ' GLN . 0.8 OUTLIER -73.58 -51.42 16.96 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.204 -0.935 . . . . 0.62 110.756 -179.885 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.695 HG21 ' HB2' ' A' ' 76' ' ' GLU . 4.0 p -66.71 -29.22 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.467 -0.771 . . . . 0.27 111.213 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.506 ' CG2' HD13 ' A' ' 62' ' ' ILE . 4.7 p -80.09 -31.93 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.035 -1.041 . . . . 0.28 110.711 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.492 ' HG3' ' N ' ' A' ' 37' ' ' ARG . 1.6 pt20 -82.42 -21.91 35.54 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.055 -1.028 . . . . 1.17 110.685 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.492 ' N ' ' HG3' ' A' ' 36' ' ' GLN . 26.9 mtm180 -79.24 -41.84 27.29 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.278 -0.889 . . . . 0.73 110.704 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.658 ' HB2' HD11 ' A' ' 73' ' ' LEU . 93.7 m-70 -95.9 -43.62 7.75 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.391 -0.818 . . . . 0.45 110.683 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.496 ' HB3' ' O ' ' A' ' 35' ' ' VAL . . . -98.01 150.64 36.96 Favored Pre-proline 0 N--CA 1.497 1.894 0 O-C-N 121.324 -0.86 . . . . 0.27 109.924 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.36 140.09 29.88 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.678 1.357 . . . . 0.3 110.673 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.63 154.02 14.18 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 110.045 -1.222 . . . . 0.4 110.045 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -95.07 148.32 22.48 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.466 -1.02 . . . . 0.45 109.914 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.449 ' HB2' HG11 ' A' ' 35' ' ' VAL . 67.7 m-85 -135.1 175.9 9.16 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.467 -0.771 . . . . 0.5 110.723 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.613 HG22 ' HD2' ' A' ' 45' ' ' PRO . 0.2 OUTLIER -142.7 158.06 60.61 Favored Pre-proline 0 N--CA 1.498 1.95 0 O-C-N 121.398 -0.814 . . . . 0.62 111.239 -178.973 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.613 ' HD2' HG22 ' A' ' 44' ' ' THR . 54.4 Cg_endo -96.24 118.26 0.18 Allowed 'Trans proline' 0 C--N 1.318 -1.029 0 C-N-CA 122.121 1.881 . . . . 0.28 110.431 179.243 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.511 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 31.9 m -76.24 104.71 6.9 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.086 -1.009 . . . . 0.38 109.283 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.548 HG23 HG12 ' A' ' 58' ' ' VAL . 14.3 p -76.2 142.58 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.411 -0.806 . . . . 0.36 111.656 -178.717 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.408 ' HD2' HG22 ' A' ' 46' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.721 0 O-C-N 121.755 -0.591 . . . . 0.8 109.787 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 33.3 t80 . . . . . 0 N--CA 1.497 1.908 0 CA-C-O 121.063 0.459 . . . . 0.7 109.845 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 2.6 m170 -117.27 135.69 53.64 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.428 -0.795 . . . . 0.78 110.904 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.582 ' HA ' ' HA ' ' A' ' 20' ' ' MET . 26.8 m -108.64 102.54 11.59 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 109.139 -0.689 . . . . 0.41 109.139 179.174 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.548 HG12 HG23 ' A' ' 47' ' ' VAL . 3.1 m -103.65 146.79 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.306 -0.871 . . . . 0.31 110.834 -179.022 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.551 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 7.3 t -108.98 114.15 27.66 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.852 -0.796 . . . . 0.47 108.852 179.053 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.987 HD12 HG22 ' A' ' 31' ' ' VAL . 8.8 tt -93.08 132.77 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.269 -0.894 . . . . 0.3 111.763 -178.536 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 56.2 m -86.7 117.4 25.43 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.565 -0.902 . . . . 0.35 108.565 178.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.682 HG21 HG23 ' A' ' 70' ' ' VAL . 38.3 mm -114.29 132.93 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.068 -1.02 . . . . 0.4 111.048 -178.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.418 ' HB2' ' CZ ' ' A' ' 43' ' ' TYR . 3.6 t30 -108.18 62.1 0.61 Allowed 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.521 0.677 . . . . 0.39 109.216 178.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.852 ' HB1' ' HB3' ' A' ' 69' ' ' GLN . . . -91.67 133.83 35.24 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.306 -0.871 . . . . 0.25 110.686 -179.361 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 31.8 p -70.67 -17.83 62.84 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.608 -0.682 . . . . 0.4 110.691 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -129.84 159.88 35.22 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.332 -0.855 . . . . 0.49 110.127 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.2 tt -74.62 -17.01 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.378 -0.826 . . . . 0.8 110.783 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.9 -30.22 40.04 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.188 -0.945 . . . . 0.84 110.25 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.852 ' HB3' ' HB1' ' A' ' 64' ' ' ALA . 0.4 OUTLIER -65.64 -47.97 73.77 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.395 -0.815 . . . . 0.49 110.271 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.682 HG23 HG21 ' A' ' 62' ' ' ILE . 13.7 p -67.44 -28.82 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.367 -0.833 . . . . 0.29 110.294 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.16 -52.94 56.57 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.354 -0.841 . . . . 0.84 109.536 179.425 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.5 p -63.23 -35.66 81.05 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.503 -0.748 . . . . 0.35 109.487 179.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.658 HD11 ' HB2' ' A' ' 38' ' ' HIS . 3.6 mp -60.9 -39.58 89.84 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.634 -0.666 . . . . 0.35 109.557 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.59 ' CD1' ' HB ' ' A' ' 86' ' ' VAL . 0.3 OUTLIER -63.91 -48.69 75.6 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 109.143 -0.688 . . . . 0.6 109.143 178.761 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.76 -36.71 83.95 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.549 -0.719 . . . . 0.68 110.2 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.695 ' HB2' HG21 ' A' ' 34' ' ' VAL . 23.5 mt-10 -65.04 -47.38 77.6 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.586 -0.696 . . . . 0.33 110.459 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 1.054 HD11 HG11 ' A' ' 19' ' ' VAL . 0.3 OUTLIER -76.84 -29.11 55.76 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.246 -0.909 . . . . 0.32 110.433 179.718 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.477 ' N ' ' HG ' ' A' ' 77' ' ' LEU . . . -102.36 48.19 1.08 Allowed Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.503 -1.439 . . . . 0.25 109.503 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.9 ttmt -106.46 4.0 27.85 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.47 -1.017 . . . . 1.66 110.808 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.0 mp -69.57 153.13 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.218 -0.926 . . . . 0.36 110.105 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.12 -26.45 68.31 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.399 -0.813 . . . . 1.38 110.239 179.364 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.453 HG23 ' N ' ' A' ' 83' ' ' VAL . 1.0 OUTLIER -64.13 174.72 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.606 -0.684 . . . . 0.46 110.583 179.671 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.453 ' N ' HG23 ' A' ' 82' ' ' ILE . 75.4 t -63.71 117.49 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.392 -0.818 . . . . 0.38 110.546 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.94 132.81 54.74 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.728 -0.607 . . . . 0.77 110.049 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.526 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -154.22 160.54 41.89 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.215 -0.928 . . . . 1.7 110.318 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.641 HG23 HG22 ' A' ' 19' ' ' VAL . 8.2 p -141.48 157.23 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.406 -0.809 . . . . 0.26 110.763 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.49 HD11 ' CZ ' ' A' ' 17' ' ' TYR . 77.4 mt . . . . . 0 N--CA 1.501 2.08 0 CA-C-O 117.674 -1.155 . . . . 0.48 110.554 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.7 t . . . . . 0 N--CA 1.495 1.784 0 N-CA-C 110.227 -0.286 . . . . 0.4 110.227 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.94 122.56 8.92 Favored 'Trans proline' 0 C--N 1.315 -1.197 0 O-C-N 123.83 1.437 . . . . 0.4 110.883 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.491 ' HB2' HG23 ' A' ' 62' ' ' ILE . 20.3 m-85 -106.38 99.78 9.34 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.652 -0.655 . . . . 0.34 110.281 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.1 p -73.64 99.22 3.03 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.248 -1.019 . . . . 0.33 108.248 178.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -113.91 159.54 19.77 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.384 -0.822 . . . . 0.33 111.031 -178.293 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.703 ' HD2' HD22 ' A' ' 87' ' ' LEU . 0.7 OUTLIER -137.35 102.46 4.8 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.822 -0.807 . . . . 0.66 108.822 179.204 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 1.005 HG11 HD11 ' A' ' 77' ' ' LEU . 15.6 t -81.14 99.74 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 CA-C-O 121.463 0.649 . . . . 0.26 110.193 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.413 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 35.7 mtt -94.77 155.01 17.01 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.479 -0.763 . . . . 1.2 109.961 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 157.5 -150.12 20.98 Favored Glycine 0 N--CA 1.497 2.722 0 N-CA-C 110.194 -1.163 . . . . 0.34 110.194 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.422 ' O ' HD23 ' A' ' 24' ' ' LEU . 1.1 tm0? -76.93 160.81 28.89 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.51 -0.994 . . . . 0.74 110.642 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -86.43 92.28 8.79 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.628 -0.67 . . . . 0.47 110.053 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.422 HD23 ' O ' ' A' ' 22' ' ' GLN . 0.7 OUTLIER -127.59 150.31 72.62 Favored Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 121.504 -0.748 . . . . 0.42 110.386 179.924 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -71.86 -24.06 21.56 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 O-C-N 123.861 1.453 . . . . 0.43 111.461 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.82 -18.31 64.8 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.216 -0.927 . . . . 0.6 111.044 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.459 HD22 HG21 ' A' ' 58' ' ' VAL . 0.7 OUTLIER -60.8 -63.18 1.39 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.225 -0.922 . . . . 0.69 110.365 -179.956 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.726 HG23 ' HD2' ' A' ' 45' ' ' PRO . 8.6 p -65.38 -31.58 54.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.421 -0.799 . . . . 0.35 110.63 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -63.4 -53.71 48.16 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.339 -0.851 . . . . 0.51 110.188 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.725 ' O ' HG12 ' A' ' 34' ' ' VAL . 1.1 tp-100 -68.55 -34.87 76.6 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.426 -0.796 . . . . 0.8 110.658 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.768 HG22 HD22 ' A' ' 77' ' ' LEU . 2.7 t -57.28 -46.94 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.342 -0.849 . . . . 0.3 109.997 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 77.4 t -71.17 -37.25 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.493 -0.754 . . . . 0.39 110.681 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.43 -54.32 11.05 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.181 -0.95 . . . . 1.03 110.839 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.779 HG21 ' CB ' ' A' ' 76' ' ' GLU . 9.9 p -62.79 -33.02 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.43 -0.794 . . . . 0.35 111.395 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.654 HG21 ' HB2' ' A' ' 43' ' ' TYR . 3.2 p -77.21 -29.61 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.032 -1.043 . . . . 0.4 110.343 179.381 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -74.26 -35.19 63.77 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.235 -0.916 . . . . 1.08 109.977 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.48 -23.87 61.1 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.493 -0.755 . . . . 1.41 110.811 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.419 ' CD2' HD11 ' A' ' 73' ' ' LEU . 0.3 OUTLIER -101.51 -46.0 5.12 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.206 -0.934 . . . . 0.6 110.546 -179.905 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -103.15 151.09 38.44 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.484 -0.76 . . . . 0.54 109.841 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -69.94 -41.26 4.2 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 O-C-N 123.857 1.451 . . . . 0.75 111.115 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -85.81 145.24 20.77 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.634 -1.386 . . . . 0.51 109.634 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.9 152.03 27.0 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.446 -1.032 . . . . 0.8 109.962 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.654 ' HB2' HG21 ' A' ' 35' ' ' VAL . 45.2 m-85 -136.9 159.79 40.82 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.529 -0.732 . . . . 0.41 110.573 -179.483 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.495 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 22.8 m -142.32 151.51 58.35 Favored Pre-proline 0 N--CA 1.499 1.984 0 O-C-N 121.445 -0.784 . . . . 0.36 111.301 -179.054 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.726 ' HD2' HG23 ' A' ' 28' ' ' VAL . 54.1 Cg_endo -96.51 135.84 0.5 Allowed 'Trans proline' 0 C--N 1.32 -0.958 0 C-N-CA 122.03 1.82 . . . . 0.48 110.508 178.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.511 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 32.1 m -95.03 108.43 20.5 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.16 -0.963 . . . . 0.4 109.17 179.01 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.739 HG23 HG12 ' A' ' 58' ' ' VAL . 7.7 p -75.9 141.58 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.444 -0.785 . . . . 0.43 111.54 -178.601 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.7 mtmp? . . . . . 0 N--CA 1.495 1.782 0 O-C-N 121.885 -0.509 . . . . 0.99 109.905 179.611 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 30.2 t80 . . . . . 0 N--CA 1.497 1.904 0 CA-C-O 121.137 0.494 . . . . 0.61 110.111 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 1.2 m170 -125.06 145.26 50.0 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.281 -0.887 . . . . 1.01 111.333 -179.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.413 ' HA ' ' HA ' ' A' ' 20' ' ' MET . 14.0 t -119.22 106.09 12.0 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.54 -0.911 . . . . 0.36 108.54 178.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.739 HG12 HG23 ' A' ' 47' ' ' VAL . 2.1 m -103.29 146.4 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.272 -0.892 . . . . 0.32 111.176 -178.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.609 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 16.9 p -103.89 110.67 22.89 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.64 -0.874 . . . . 0.34 108.64 178.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.621 ' HA ' ' HA ' ' A' ' 45' ' ' PRO . 13.8 tt -93.12 128.34 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 CA-C-O 121.902 0.858 . . . . 0.36 111.459 -178.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.491 ' O ' ' HB3' ' A' ' 43' ' ' TYR . 22.5 m -97.18 126.83 42.62 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.193 -1.04 . . . . 0.39 108.193 178.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.491 HG23 ' HB2' ' A' ' 15' ' ' PHE . 11.0 tt -153.9 141.03 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.124 -0.985 . . . . 0.63 111.466 -178.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -117.22 102.99 9.74 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.723 -0.843 . . . . 0.67 108.723 178.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.727 ' HB1' ' HB3' ' A' ' 69' ' ' GLN . . . -109.86 141.01 43.17 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.485 -0.759 . . . . 0.34 111.312 -178.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.2 p -74.29 -5.23 40.95 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.788 -0.57 . . . . 0.53 111.269 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.735 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 49.5 t60 -129.73 146.54 51.49 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.969 -1.082 . . . . 0.54 110.188 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -67.64 -30.01 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.52 -0.738 . . . . 1.04 110.749 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.05 -11.66 43.49 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.274 -0.891 . . . . 0.93 111.068 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.735 ' HB2' ' HB3' ' A' ' 66' ' ' HIS . 7.4 tt0 -61.52 -46.54 89.54 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.22 -0.925 . . . . 0.86 109.874 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.1 p -70.48 -28.92 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.638 -0.664 . . . . 0.37 110.01 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.99 -50.06 45.35 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.485 -0.759 . . . . 0.56 109.604 179.136 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.6 p -61.81 -40.78 96.43 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.527 -0.733 . . . . 0.32 109.51 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.452 ' HG ' HG22 ' A' ' 34' ' ' VAL . 2.8 mp -60.45 -37.59 81.44 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.682 -0.636 . . . . 0.4 109.694 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.541 ' CD1' ' HB ' ' A' ' 86' ' ' VAL . 0.4 OUTLIER -62.97 -45.03 94.36 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.564 -0.71 . . . . 0.57 109.179 178.662 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.46 -36.15 79.61 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.498 -0.751 . . . . 0.4 109.988 179.21 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.779 ' CB ' HG21 ' A' ' 34' ' ' VAL . 0.5 OUTLIER -67.55 -49.07 65.01 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.544 -0.722 . . . . 0.48 110.279 179.497 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 1.005 HD11 HG11 ' A' ' 19' ' ' VAL . 0.3 OUTLIER -72.62 -27.23 62.02 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.423 -0.798 . . . . 0.29 110.533 179.622 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.466 ' N ' ' HG ' ' A' ' 77' ' ' LEU . . . -107.44 38.96 3.07 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.678 -1.369 . . . . 0.31 109.678 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.91 4.09 54.54 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.31 -1.112 . . . . 1.04 110.732 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.4 mp -72.17 155.07 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.321 -0.862 . . . . 0.52 109.982 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -68.71 -15.78 63.62 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.41 -0.806 . . . . 0.91 110.235 178.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.472 HG22 ' N ' ' A' ' 83' ' ' VAL . 49.7 mm -71.33 170.14 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.544 -0.723 . . . . 0.72 109.985 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.472 ' N ' HG22 ' A' ' 82' ' ' ILE . 76.1 t -62.42 115.06 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.342 -0.849 . . . . 0.51 110.818 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -121.19 140.74 51.61 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.857 -0.527 . . . . 0.84 109.595 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.1 mtp -158.54 154.05 26.05 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.062 -1.024 . . . . 1.44 110.29 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.573 HG23 HG22 ' A' ' 19' ' ' VAL . 5.9 p -142.5 157.44 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.32 -0.863 . . . . 0.32 110.801 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.703 HD22 ' HD2' ' A' ' 18' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.497 1.899 0 CA-C-O 117.955 -1.022 . . . . 0.4 109.878 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.0 t . . . . . 0 N--CA 1.495 1.802 0 CA-C-O 120.559 0.219 . . . . 0.31 110.455 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -71.65 127.23 12.89 Favored 'Trans proline' 0 C--N 1.315 -1.213 0 O-C-N 123.911 1.48 . . . . 0.3 110.389 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.629 ' HB3' HG21 ' A' ' 70' ' ' VAL . 23.1 m-85 -108.5 99.69 9.05 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.482 -0.761 . . . . 0.37 110.467 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.5 m -74.18 92.9 2.25 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.169 -1.049 . . . . 0.38 108.169 178.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.563 ' O ' HG22 ' A' ' 60' ' ' ILE . 3.0 m-85 -105.09 106.69 17.3 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.379 -0.826 . . . . 0.35 110.897 -178.217 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.571 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 0.0 OUTLIER -79.27 92.49 5.14 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.533 -0.729 . . . . 1.18 109.532 179.525 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.952 HG11 HD11 ' A' ' 77' ' ' LEU . 15.7 t -79.02 96.09 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.462 -0.774 . . . . 0.29 109.516 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.662 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 44.4 ttp -98.05 148.71 23.24 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.601 -0.687 . . . . 0.93 110.295 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 166.83 -152.35 21.17 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.664 -1.374 . . . . 0.26 109.664 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.431 ' HG2' HG21 ' A' ' 82' ' ' ILE . 20.7 tp60 -74.01 138.9 44.39 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.423 -1.045 . . . . 1.34 110.394 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.35 115.24 7.56 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.665 -0.647 . . . . 0.38 110.378 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.612 ' HB2' HD12 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -131.86 150.91 77.5 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.623 -0.673 . . . . 0.77 110.2 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -73.0 -24.87 16.89 Favored 'Trans proline' 0 C--N 1.313 -1.335 0 O-C-N 123.839 1.442 . . . . 0.55 111.079 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.15 -7.32 58.1 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.244 -0.91 . . . . 0.81 111.643 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.612 HD12 ' HB2' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -59.85 -60.03 4.48 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.033 -1.042 . . . . 1.21 110.374 -179.665 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.2 p -62.97 -31.36 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 121.439 -0.788 . . . . 0.57 110.567 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -68.32 -56.42 8.65 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.372 -0.83 . . . . 0.47 109.913 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.702 ' O ' HG12 ' A' ' 34' ' ' VAL . 0.1 OUTLIER -63.19 -38.62 91.9 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.338 -0.851 . . . . 1.06 110.269 179.524 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.881 HG22 HD12 ' A' ' 60' ' ' ILE . 2.4 t -56.57 -52.0 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.542 -0.723 . . . . 0.31 110.216 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 40.1 t -63.68 -40.88 90.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.47 -0.769 . . . . 0.34 111.244 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.13 -50.77 29.93 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.309 -0.869 . . . . 0.62 111.134 -179.313 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.844 HG21 ' CB ' ' A' ' 76' ' ' GLU . 8.9 p -69.1 -28.05 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.485 -0.759 . . . . 0.26 111.521 -179.248 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.593 HG11 ' HB2' ' A' ' 43' ' ' TYR . 1.9 p -83.21 -27.05 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.034 -1.041 . . . . 0.3 110.784 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -78.89 -39.7 34.27 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.235 -0.915 . . . . 0.55 110.429 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 14.4 ptt180 -69.56 -20.1 63.67 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.344 -0.847 . . . . 1.0 111.33 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.567 ' HB2' HD11 ' A' ' 73' ' ' LEU . 1.8 m-70 -106.16 -45.77 4.23 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.15 -0.969 . . . . 0.87 110.768 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -103.68 149.84 37.52 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.401 -0.812 . . . . 0.42 109.997 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.33 140.4 36.88 Favored 'Trans proline' 0 C--N 1.314 -1.241 0 O-C-N 123.802 1.422 . . . . 0.57 110.636 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.06 172.92 49.25 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.706 -1.357 . . . . 0.56 109.706 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -100.99 144.69 29.62 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.439 -1.036 . . . . 0.57 110.338 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.593 ' HB2' HG11 ' A' ' 35' ' ' VAL . 83.5 m-85 -129.08 165.46 21.18 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.509 -0.745 . . . . 0.41 110.325 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.542 HG22 ' HD2' ' A' ' 45' ' ' PRO . 0.2 OUTLIER -142.57 156.79 63.21 Favored Pre-proline 0 N--CA 1.499 1.992 0 O-C-N 121.371 -0.831 . . . . 0.71 111.165 -179.417 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.542 ' HD2' HG22 ' A' ' 44' ' ' THR . 53.2 Cg_endo -96.54 132.78 0.41 Allowed 'Trans proline' 0 C--N 1.32 -0.952 0 C-N-CA 122.233 1.955 . . . . 0.53 110.292 178.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.473 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 36.2 m -93.89 92.11 7.24 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.955 -1.09 . . . . 0.4 109.502 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.688 HG23 HG12 ' A' ' 58' ' ' VAL . 11.3 p -76.55 140.69 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.474 -0.766 . . . . 0.29 111.638 -178.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.1 ptpt . . . . . 0 N--CA 1.493 1.715 0 O-C-N 121.785 -0.572 . . . . 1.57 109.498 179.089 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 23.0 t80 . . . . . 0 N--CA 1.498 1.926 0 CA-C-O 121.181 0.515 . . . . 0.48 110.021 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.474 ' HB3' ' CG2' ' A' ' 47' ' ' VAL . 1.4 m-70 -130.16 148.14 51.97 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.373 -0.829 . . . . 0.45 111.174 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.662 ' HA ' ' HA ' ' A' ' 20' ' ' MET . 89.3 p -113.34 126.12 55.03 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 109.155 -0.683 . . . . 0.37 109.155 179.119 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.688 HG12 HG23 ' A' ' 47' ' ' VAL . 1.5 m -116.59 141.37 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.241 -0.912 . . . . 0.35 111.116 -178.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.571 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 1.3 t -103.08 106.41 16.92 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.387 -0.821 . . . . 0.73 108.87 178.71 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.881 HD12 HG22 ' A' ' 31' ' ' VAL . 6.2 tt -93.7 132.1 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.273 -0.892 . . . . 0.34 111.264 -178.62 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.465 ' O ' ' HB3' ' A' ' 43' ' ' TYR . 85.9 m -87.12 127.79 35.12 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 108.635 -0.876 . . . . 0.43 108.635 178.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.606 HD11 HD13 ' A' ' 60' ' ' ILE . 44.5 mt -137.85 103.36 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 120.995 -1.065 . . . . 0.29 111.176 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -85.08 80.51 9.23 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.298 -0.876 . . . . 0.44 109.17 178.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -101.74 136.74 41.07 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.515 -0.741 . . . . 0.23 110.311 -179.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 39.9 p -68.8 -14.8 63.26 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.45 -0.781 . . . . 0.36 111.063 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -130.85 159.74 36.47 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.246 -0.909 . . . . 0.48 110.764 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 8.4 tp -76.5 -27.15 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.532 -0.73 . . . . 0.4 110.367 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.32 -26.9 63.04 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.203 -0.936 . . . . 0.64 110.558 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.461 ' O ' HD13 ' A' ' 73' ' ' LEU . 28.3 mt-30 -63.84 -53.46 50.41 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.393 -0.817 . . . . 1.73 110.231 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.629 HG21 ' HB3' ' A' ' 15' ' ' PHE . 7.4 p -65.73 -27.59 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.662 -0.649 . . . . 0.27 110.441 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.18 -48.31 73.89 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.316 -0.865 . . . . 0.46 109.286 178.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 82.7 m -64.36 -34.59 78.52 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.741 -0.599 . . . . 0.38 109.436 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.567 HD11 ' HB2' ' A' ' 38' ' ' HIS . 5.2 mp -63.14 -40.29 97.14 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.67 -0.644 . . . . 0.28 109.714 179.373 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.642 ' CD1' ' HB ' ' A' ' 86' ' ' VAL . 0.7 OUTLIER -64.77 -43.86 91.9 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.604 -0.685 . . . . 0.41 109.457 178.886 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -65.98 -32.87 74.6 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.474 -0.766 . . . . 0.75 110.735 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.844 ' CB ' HG21 ' A' ' 34' ' ' VAL . 0.3 OUTLIER -70.49 -55.52 8.76 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.333 -0.854 . . . . 0.51 110.378 179.972 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.952 HD11 HG11 ' A' ' 19' ' ' VAL . 0.3 OUTLIER -70.27 -28.19 65.02 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.361 -0.837 . . . . 0.29 110.199 179.677 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.514 ' N ' ' HG ' ' A' ' 77' ' ' LEU . . . -107.59 55.78 0.51 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.428 -1.469 . . . . 0.22 109.428 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -106.07 4.18 28.95 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.702 -0.881 . . . . 1.53 110.6 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.695 HG22 ' H ' ' A' ' 82' ' ' ILE . 2.7 mp -63.44 145.05 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.35 -0.844 . . . . 0.45 110.195 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.73 -5.93 41.08 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.509 -0.744 . . . . 1.62 111.603 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.695 ' H ' HG22 ' A' ' 80' ' ' ILE . 47.3 mm -80.77 -106.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.031 -1.043 . . . . 0.55 109.887 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 63.5 t -123.93 112.16 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 120.915 -1.116 . . . . 0.47 110.389 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.06 122.02 38.31 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.37 0.605 . . . . 0.67 109.727 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.545 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 1.3 ttm -146.88 158.6 43.96 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.25 -0.906 . . . . 2.53 110.174 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.642 ' HB ' ' CD1' ' A' ' 74' ' ' TYR . 9.8 p -141.45 154.13 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.429 -0.795 . . . . 0.32 110.837 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.499 1.989 0 CA-C-O 118.823 -0.608 . . . . 0.65 110.407 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.5 t . . . . . 0 N--CA 1.496 1.836 0 CA-C-O 120.612 0.244 . . . . 0.39 110.459 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.66 129.6 14.79 Favored 'Trans proline' 0 C--N 1.314 -1.261 0 O-C-N 123.879 1.462 . . . . 0.36 110.637 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.675 ' HB3' HG21 ' A' ' 70' ' ' VAL . 31.1 m-85 -109.6 99.7 8.86 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.596 -0.69 . . . . 0.39 110.217 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.2 m -73.95 92.58 2.12 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.257 -1.016 . . . . 0.38 108.257 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.581 ' O ' HG22 ' A' ' 60' ' ' ILE . 2.9 m-85 -103.55 103.74 13.72 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.461 -0.774 . . . . 0.38 110.949 -178.372 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.616 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 0.1 OUTLIER -82.3 97.45 8.31 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.344 -0.847 . . . . 3.13 109.741 179.404 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.982 HG11 HD11 ' A' ' 77' ' ' LEU . 15.9 t -79.95 96.89 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.427 -0.795 . . . . 0.28 109.37 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 60.2 mtm -101.36 127.3 48.05 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.571 -0.705 . . . . 0.62 110.254 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -157.15 -158.81 9.12 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.875 -1.29 . . . . 0.33 109.875 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.451 ' HB2' ' CG2' ' A' ' 82' ' ' ILE . 0.0 OUTLIER -68.78 177.49 2.53 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.364 -1.08 . . . . 1.18 110.559 -179.979 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.43 ' HA ' ' CG ' ' A' ' 56' ' ' HIS . . . -79.4 91.03 5.04 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.427 -0.796 . . . . 0.36 110.459 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.585 ' O ' HD23 ' A' ' 27' ' ' LEU . 1.0 OUTLIER -133.81 132.29 21.48 Favored Pre-proline 0 N--CA 1.496 1.847 0 O-C-N 121.397 -0.814 . . . . 0.37 110.249 179.664 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -76.43 -4.19 14.73 Favored 'Trans proline' 0 N--CA 1.489 1.216 0 O-C-N 123.702 1.369 . . . . 0.53 112.057 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -80.14 -5.84 56.7 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 120.968 -1.082 . . . . 0.62 111.466 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.639 HD13 HG11 ' A' ' 58' ' ' VAL . 4.1 pp -66.13 -38.23 87.63 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.932 -1.105 . . . . 0.38 111.083 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.629 ' N ' HD12 ' A' ' 27' ' ' LEU . 9.8 p -76.53 -29.83 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.256 -0.902 . . . . 0.32 110.855 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -69.27 -53.84 17.73 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.365 -0.834 . . . . 0.39 110.116 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.686 ' O ' HG12 ' A' ' 34' ' ' VAL . 0.6 OUTLIER -67.66 -38.78 84.25 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.34 -0.85 . . . . 0.63 110.75 179.911 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.737 ' CG1' HD13 ' A' ' 60' ' ' ILE . 2.8 t -59.39 -56.87 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.362 -0.836 . . . . 0.27 110.615 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.7 p -62.79 -33.71 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 121.292 -0.88 . . . . 0.31 111.549 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.85 -55.91 5.32 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.043 -1.036 . . . . 0.43 110.823 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.884 HG21 ' HB2' ' A' ' 76' ' ' GLU . 6.2 p -65.53 -23.97 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.34 -0.85 . . . . 0.28 111.512 -179.324 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.581 HG11 ' HB2' ' A' ' 43' ' ' TYR . 1.8 p -86.0 -32.52 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 120.922 -1.111 . . . . 0.29 111.078 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -78.73 -26.92 44.78 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.966 -1.084 . . . . 0.45 110.558 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.86 -39.51 35.03 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.276 -0.89 . . . . 0.65 110.609 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.675 ' HB2' HD11 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -86.69 -45.54 10.88 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.35 -0.844 . . . . 0.39 110.571 -179.878 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -100.69 152.15 37.77 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.434 -0.791 . . . . 0.3 109.993 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.42 140.58 36.92 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 O-C-N 123.844 1.444 . . . . 0.41 110.584 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.22 162.41 26.2 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.749 -1.341 . . . . 0.52 109.749 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.05 143.62 27.71 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.426 -1.043 . . . . 0.42 110.088 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.581 ' HB2' HG11 ' A' ' 35' ' ' VAL . 82.8 m-85 -125.79 166.37 16.96 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.493 -0.754 . . . . 0.42 110.448 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.61 HG22 ' HD2' ' A' ' 45' ' ' PRO . 3.9 m -140.76 152.36 65.58 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.408 -0.808 . . . . 0.36 111.083 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.61 ' HD2' HG22 ' A' ' 44' ' ' THR . 54.6 Cg_endo -96.06 123.42 0.27 Allowed 'Trans proline' 0 C--N 1.319 -0.999 0 C-N-CA 122.125 1.884 . . . . 0.22 110.545 179.064 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.53 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 58.6 m -75.3 92.72 2.79 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.213 -0.929 . . . . 0.31 108.779 178.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.76 HG23 HG12 ' A' ' 58' ' ' VAL . 8.3 p -80.75 139.38 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 CA-C-O 121.863 0.84 . . . . 0.33 112.406 -178.108 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.464 ' HG2' ' O ' ' A' ' 57' ' ' SER . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.695 0 N-CA-C 108.709 -0.848 . . . . 0.64 108.709 178.198 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 16.0 t80 . . . . . 0 N--CA 1.497 1.879 0 CA-C-O 121.144 0.497 . . . . 0.83 110.351 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.43 ' CG ' ' HA ' ' A' ' 23' ' ' ALA . 5.4 m170 -116.27 123.76 48.49 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.558 -0.713 . . . . 0.74 110.317 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.464 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 26.0 m -108.7 119.88 40.82 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.435 -0.791 . . . . 0.38 108.913 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.76 HG12 HG23 ' A' ' 47' ' ' VAL . 1.7 m -124.81 151.62 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 120.957 -1.089 . . . . 0.3 111.221 -178.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.616 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 6.4 t -118.82 105.86 11.95 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.586 -0.696 . . . . 0.63 109.155 179.207 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.737 HD13 ' CG1' ' A' ' 31' ' ' VAL . 2.5 tp -93.29 129.93 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.238 -0.914 . . . . 0.25 111.07 -179.027 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.436 ' O ' ' HB3' ' A' ' 43' ' ' TYR . 49.5 m -85.44 121.92 28.84 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.855 -0.794 . . . . 0.32 108.855 178.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.504 HG21 HG23 ' A' ' 70' ' ' VAL . 68.2 mt -127.82 109.25 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 120.939 -1.101 . . . . 0.43 110.986 -178.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -90.7 92.96 9.04 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.418 -0.801 . . . . 0.62 109.576 179.126 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.426 ' HB1' ' HB3' ' A' ' 69' ' ' GLN . . . -117.79 139.38 51.15 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.53 -0.731 . . . . 0.25 110.39 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 34.5 p -74.86 -13.0 60.51 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.502 -0.749 . . . . 0.32 110.729 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -129.14 148.15 51.06 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.338 -0.851 . . . . 0.42 110.311 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -72.87 -21.7 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.511 -0.743 . . . . 0.78 110.763 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.18 -23.86 57.76 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.144 -0.973 . . . . 0.5 110.844 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.426 ' HB3' ' HB1' ' A' ' 64' ' ' ALA . 0.2 OUTLIER -71.21 -50.45 32.94 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.296 -0.877 . . . . 0.52 110.268 -179.99 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.675 HG21 ' HB3' ' A' ' 15' ' ' PHE . 8.1 p -65.81 -31.52 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.56 -0.712 . . . . 0.26 110.339 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.4 -47.22 77.04 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.361 -0.837 . . . . 0.47 109.343 178.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.402 HG22 ' OE1' ' A' ' 76' ' ' GLU . 93.4 m -62.47 -34.7 77.35 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.705 -0.622 . . . . 0.38 109.498 178.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.675 HD11 ' HB2' ' A' ' 38' ' ' HIS . 2.0 mp -61.96 -41.02 97.51 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.583 -0.698 . . . . 0.35 109.593 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.539 ' CD1' ' HB ' ' A' ' 86' ' ' VAL . 2.7 t80 -64.64 -40.47 95.51 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.597 -0.689 . . . . 0.38 109.323 178.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.57 -38.49 87.7 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.379 -0.826 . . . . 0.41 110.254 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.884 ' HB2' HG21 ' A' ' 34' ' ' VAL . 0.4 OUTLIER -71.12 -50.73 30.46 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.483 -0.76 . . . . 0.47 110.721 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.982 HD11 HG11 ' A' ' 19' ' ' VAL . 0.2 OUTLIER -72.01 -27.71 62.91 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.316 -0.865 . . . . 0.28 110.574 179.944 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.494 ' N ' ' HG ' ' A' ' 77' ' ' LEU . . . -100.84 38.13 3.28 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.646 -1.382 . . . . 0.28 109.646 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.54 3.72 27.36 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.545 -0.974 . . . . 0.55 110.815 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.0 mt -67.36 155.91 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.15 -0.969 . . . . 0.34 109.911 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -62.25 -25.0 67.58 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.349 -0.844 . . . . 0.5 110.005 179.074 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.451 ' CG2' ' HB2' ' A' ' 22' ' ' GLN . 49.7 mm -73.54 163.89 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.555 -0.716 . . . . 0.39 109.92 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 92.2 t -71.6 106.28 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.409 -0.807 . . . . 0.46 110.843 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.415 ' HG2' ' HA2' ' A' ' 78' ' ' GLY . 1.4 tpm_? -121.99 114.03 20.4 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.598 -0.689 . . . . 0.4 109.585 179.164 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.51 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -120.65 170.54 9.33 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.296 -0.877 . . . . 1.63 110.38 -179.713 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.56 HG23 HG22 ' A' ' 19' ' ' VAL . 4.7 p -138.16 155.21 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.472 -0.768 . . . . 0.32 110.629 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.498 1.937 0 CA-C-O 117.738 -1.125 . . . . 0.64 110.43 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.5 t . . . . . 0 N--CA 1.496 1.835 0 N-CA-C 110.037 -0.357 . . . . 0.43 110.037 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -71.98 125.22 10.75 Favored 'Trans proline' 0 C--N 1.314 -1.282 0 O-C-N 123.869 1.458 . . . . 0.37 111.19 -179.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.661 ' HB3' HG21 ' A' ' 70' ' ' VAL . 23.4 m-85 -110.35 99.31 8.36 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.591 -0.693 . . . . 0.31 110.249 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.482 HG22 ' HD2' ' A' ' 18' ' ' LYS . 24.4 m -78.99 92.32 4.94 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.21 -1.033 . . . . 0.36 108.21 178.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -99.66 107.91 20.14 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.496 -0.752 . . . . 0.35 110.768 -178.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.644 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 0.0 OUTLIER -87.56 89.7 8.09 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.592 -0.693 . . . . 1.77 109.944 179.825 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.847 HG11 HD11 ' A' ' 77' ' ' LEU . 2.4 m -82.34 110.35 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.36 -0.837 . . . . 0.28 109.828 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 53.9 mtt -109.36 157.34 18.99 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.611 -0.681 . . . . 0.74 110.282 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 169.36 -164.04 37.62 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 109.986 -1.246 . . . . 0.42 109.986 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -69.59 150.85 46.64 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.53 -0.982 . . . . 1.69 110.017 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -53.74 111.7 0.78 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.583 -0.698 . . . . 0.45 110.548 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.7 mt -132.21 129.72 21.75 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.585 -0.697 . . . . 1.08 110.395 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.65 -21.65 18.91 Favored 'Trans proline' 0 C--N 1.315 -1.231 0 O-C-N 123.849 1.447 . . . . 0.72 111.171 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -81.33 -4.25 55.08 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.271 -0.893 . . . . 1.46 111.298 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.98 -58.34 8.27 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.991 -1.068 . . . . 0.6 110.332 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.505 HG12 ' HG2' ' A' ' 45' ' ' PRO . 36.0 m -62.22 -29.67 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 O-C-N 121.497 -0.752 . . . . 0.38 111.042 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.417 ' O ' HG12 ' A' ' 32' ' ' VAL . 31.9 t70 -70.22 -53.26 17.77 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.286 -0.884 . . . . 0.52 110.427 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.704 ' O ' HG12 ' A' ' 34' ' ' VAL . 0.2 OUTLIER -69.17 -35.8 76.68 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.326 -0.859 . . . . 1.41 110.352 179.6 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.743 ' CG1' HD13 ' A' ' 60' ' ' ILE . 3.8 t -61.81 -51.47 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.574 -0.704 . . . . 0.35 110.562 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.417 HG12 ' O ' ' A' ' 29' ' ' ASP . 6.1 p -67.03 -32.63 58.77 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.232 -0.917 . . . . 0.29 111.223 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.417 ' O ' ' HG2' ' A' ' 36' ' ' GLN . 0.1 OUTLIER -75.63 -50.93 14.02 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.079 -1.013 . . . . 1.08 110.509 179.806 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.815 HG21 ' CB ' ' A' ' 76' ' ' GLU . 9.9 p -67.69 -30.37 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.366 -0.834 . . . . 0.28 110.898 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.607 HG23 ' CG1' ' A' ' 62' ' ' ILE . 2.3 p -76.64 -38.2 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.073 -1.017 . . . . 0.28 110.352 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.417 ' HG2' ' O ' ' A' ' 33' ' ' GLU . 7.4 pt20 -74.05 -22.45 59.53 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.054 -1.029 . . . . 0.51 109.946 179.119 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.0 mtp-105 -68.48 -49.24 61.24 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.415 -0.803 . . . . 0.77 110.154 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.626 ' HB2' HD11 ' A' ' 73' ' ' LEU . 2.0 m-70 -84.54 -45.78 12.25 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.39 -0.819 . . . . 0.34 110.498 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.509 ' HB3' ' O ' ' A' ' 35' ' ' VAL . . . -76.83 153.79 83.11 Favored Pre-proline 0 N--CA 1.497 1.897 0 O-C-N 121.351 -0.843 . . . . 0.27 110.068 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -69.06 -34.54 16.68 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.922 1.485 . . . . 0.49 111.395 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -108.86 -178.61 21.57 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 110.063 -1.215 . . . . 0.38 110.063 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.14 148.68 22.8 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.553 -0.969 . . . . 0.52 109.648 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.473 ' HB2' HG11 ' A' ' 35' ' ' VAL . 98.0 m-85 -135.4 172.84 12.43 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.409 -0.807 . . . . 0.39 111.188 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.685 HG22 ' HD2' ' A' ' 45' ' ' PRO . 0.3 OUTLIER -142.39 156.53 63.89 Favored Pre-proline 0 N--CA 1.496 1.851 0 O-C-N 121.613 -0.68 . . . . 0.48 110.513 -179.64 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.685 ' HD2' HG22 ' A' ' 44' ' ' THR . 52.6 Cg_endo -94.64 121.94 0.34 Allowed 'Trans proline' 0 C--N 1.317 -1.125 0 C-N-CA 121.986 1.79 . . . . 0.33 110.229 179.193 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 74.2 m -80.44 101.4 9.02 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.079 -1.013 . . . . 0.41 109.572 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.665 ' CB ' HG12 ' A' ' 58' ' ' VAL . 12.1 p -76.52 141.2 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.408 -0.807 . . . . 0.37 111.525 -179.053 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.487 ' HE2' ' HB3' ' A' ' 57' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.729 0 O-C-N 121.752 -0.593 . . . . 0.88 109.691 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 14.9 t80 . . . . . 0 N--CA 1.495 1.793 0 CA-C-O 121.17 0.51 . . . . 1.2 110.231 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 5.0 p-80 -142.25 146.71 35.44 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.506 -0.746 . . . . 0.44 110.31 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.487 ' HB3' ' HE2' ' A' ' 48' ' ' LYS . 37.5 m -119.69 114.22 21.85 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.282 -0.886 . . . . 0.36 109.719 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.665 HG12 ' CB ' ' A' ' 47' ' ' VAL . 3.1 m -114.07 146.76 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.136 -0.977 . . . . 0.31 110.952 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.644 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 45.5 t -112.97 111.1 21.6 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.687 -0.633 . . . . 0.43 109.43 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.743 HD13 ' CG1' ' A' ' 31' ' ' VAL . 2.2 tp -92.74 129.79 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 C-N-CA 119.773 -0.771 . . . . 0.26 111.042 -179.15 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 82.7 m -82.34 137.83 34.67 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.934 -0.765 . . . . 0.32 108.934 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.607 ' CG1' HG23 ' A' ' 35' ' ' VAL . 2.3 mt -136.95 139.54 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.105 -0.997 . . . . 0.39 111.017 -179.239 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -117.99 69.55 0.78 Allowed 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 121.457 0.646 . . . . 0.45 109.299 179.056 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.606 ' HB1' ' HB2' ' A' ' 69' ' ' GLN . . . -99.59 135.78 40.5 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.489 -0.757 . . . . 0.28 110.269 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 58.0 p -73.73 -13.05 60.9 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.492 -0.755 . . . . 0.35 110.847 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 8.7 t60 -129.47 157.16 42.78 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.249 -0.907 . . . . 0.57 110.76 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.14 -24.88 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.534 -0.729 . . . . 1.06 110.43 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -70.96 -31.26 67.77 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.319 -0.863 . . . . 0.95 110.278 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.606 ' HB2' ' HB1' ' A' ' 64' ' ' ALA . 29.2 mt-30 -63.06 -52.74 61.59 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.472 -0.768 . . . . 0.43 110.025 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.661 HG21 ' HB3' ' A' ' 15' ' ' PHE . 7.7 p -69.31 -26.98 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.371 -0.831 . . . . 0.33 110.222 179.322 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.95 -52.27 64.72 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.345 -0.847 . . . . 0.71 109.229 178.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.5 p -63.83 -35.75 81.65 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.474 -0.767 . . . . 0.34 109.239 178.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.626 HD11 ' HB2' ' A' ' 38' ' ' HIS . 3.7 mp -57.3 -42.2 81.3 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.541 -0.724 . . . . 0.29 109.693 178.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.461 ' CD1' ' HB ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -65.03 -44.22 89.82 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 109.102 -0.703 . . . . 0.48 109.102 178.766 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -65.71 -33.84 76.81 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.548 -0.72 . . . . 0.63 110.616 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.815 ' CB ' HG21 ' A' ' 34' ' ' VAL . 0.2 OUTLIER -70.31 -54.3 13.19 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.452 -0.78 . . . . 0.44 110.629 -179.897 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.847 HD11 HG11 ' A' ' 19' ' ' VAL . 0.9 OUTLIER -73.13 -24.67 60.63 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.309 -0.87 . . . . 0.32 110.177 179.588 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -103.68 43.67 1.63 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.492 -1.443 . . . . 0.34 109.492 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.13 3.89 28.5 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.435 -1.038 . . . . 0.81 110.842 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.612 HG22 ' H ' ' A' ' 82' ' ' ILE . 2.2 mp -65.3 144.89 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.26 -0.9 . . . . 0.45 110.292 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.8 -20.87 66.03 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.332 -0.855 . . . . 1.48 110.322 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.612 ' H ' HG22 ' A' ' 80' ' ' ILE . 40.4 mm -70.46 170.13 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.431 -0.793 . . . . 0.51 109.87 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.473 ' N ' HG22 ' A' ' 82' ' ' ILE . 75.3 t -62.32 112.75 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.335 -0.853 . . . . 0.47 110.544 -179.603 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.31 161.64 21.67 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.733 -0.605 . . . . 1.18 110.113 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.488 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 1.7 ttp -157.72 160.19 37.65 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.401 -0.812 . . . . 1.13 109.882 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.538 ' HA ' ' HA ' ' A' ' 19' ' ' VAL . 11.3 p -134.1 146.46 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.32 -0.863 . . . . 0.33 110.524 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 34.8 mt . . . . . 0 N--CA 1.5 2.063 0 CA-C-O 117.646 -1.169 . . . . 0.51 110.488 -179.807 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.5 t . . . . . 0 N--CA 1.495 1.81 0 CA-C-O 120.611 0.243 . . . . 0.36 110.54 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.17 129.54 15.23 Favored 'Trans proline' 0 C--N 1.315 -1.199 0 O-C-N 123.917 1.483 . . . . 0.44 110.334 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.571 ' HB3' HG21 ' A' ' 70' ' ' VAL . 32.8 m-85 -108.29 100.76 10.03 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.595 -0.69 . . . . 0.33 110.32 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.9 m -74.19 92.26 2.2 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.407 -0.96 . . . . 0.39 108.407 178.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.599 ' O ' HG22 ' A' ' 60' ' ' ILE . 3.3 m-85 -102.8 104.41 14.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.441 -0.787 . . . . 0.35 110.611 -178.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.605 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 0.0 OUTLIER -78.99 93.47 5.1 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.573 -0.704 . . . . 2.0 109.484 179.605 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 1.004 HG11 HD11 ' A' ' 77' ' ' LEU . 24.8 t -78.36 95.3 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.463 -0.773 . . . . 0.26 109.15 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.454 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 53.7 mtt -97.71 153.57 18.16 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.577 -0.702 . . . . 1.02 110.535 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 168.4 -151.94 19.37 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.877 -1.289 . . . . 0.31 109.877 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.565 ' HA ' ' HA ' ' A' ' 55' ' ' TYR . 5.9 mt-30 -78.19 170.26 16.91 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.458 -1.025 . . . . 1.13 110.414 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.434 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -78.0 101.33 6.85 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.29 -0.881 . . . . 0.43 109.816 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.526 ' HG ' ' HD2' ' A' ' 25' ' ' PRO . 1.0 OUTLIER -130.33 136.37 28.89 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.49 -0.756 . . . . 1.14 110.548 -179.404 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.526 ' HD2' ' HG ' ' A' ' 24' ' ' LEU . 47.3 Cg_endo -72.92 -20.48 22.18 Favored 'Trans proline' 0 C--N 1.316 -1.181 0 O-C-N 123.822 1.433 . . . . 0.49 110.997 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -72.07 -13.74 61.67 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.351 -0.843 . . . . 0.69 111.213 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.8 mt -56.83 -64.01 1.01 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.213 -0.929 . . . . 0.53 110.577 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.6 p -60.94 -30.84 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 O-C-N 121.388 -0.82 . . . . 0.3 111.021 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -64.35 -62.39 1.63 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.395 -0.816 . . . . 0.51 110.389 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.681 ' O ' HG12 ' A' ' 34' ' ' VAL . 5.5 tp60 -64.35 -32.53 74.18 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.354 -0.841 . . . . 0.6 110.724 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.706 HG22 HD12 ' A' ' 60' ' ' ILE . 2.3 t -59.03 -56.67 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.269 -0.894 . . . . 0.26 110.346 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.402 ' HA ' HG12 ' A' ' 35' ' ' VAL . 8.6 p -68.49 -28.36 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.381 -0.824 . . . . 0.31 111.548 -179.151 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.417 ' O ' ' HG2' ' A' ' 36' ' ' GLN . 1.0 OUTLIER -76.02 -55.97 5.1 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.031 -1.043 . . . . 0.52 110.773 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.834 HG21 ' CB ' ' A' ' 76' ' ' GLU . 5.7 p -66.93 -25.8 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.428 -0.795 . . . . 0.27 111.339 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.64 HG11 ' HB2' ' A' ' 43' ' ' TYR . 2.4 p -82.64 -35.02 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.013 -1.055 . . . . 0.25 110.828 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.417 ' HG2' ' O ' ' A' ' 33' ' ' GLU . 13.8 pt20 -76.73 -25.98 54.13 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.066 -1.021 . . . . 0.52 110.2 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 25.7 mtm-85 -75.96 -39.7 55.45 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.267 -0.896 . . . . 1.29 110.533 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.754 ' HB2' HD11 ' A' ' 73' ' ' LEU . 0.5 OUTLIER -90.26 -45.71 8.89 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.285 -0.884 . . . . 0.65 110.691 -179.818 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -98.52 150.95 37.22 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.56 -0.713 . . . . 0.29 110.149 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -71.3 140.72 37.6 Favored 'Trans proline' 0 C--N 1.313 -1.302 0 O-C-N 123.823 1.433 . . . . 0.41 110.385 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.83 164.77 32.29 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.597 -1.401 . . . . 0.54 109.597 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -99.98 139.56 35.47 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.376 -1.073 . . . . 0.51 110.117 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.64 ' HB2' HG11 ' A' ' 35' ' ' VAL . 93.0 m-85 -119.21 170.59 8.95 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.527 -0.733 . . . . 0.37 110.541 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.666 HG22 ' HD2' ' A' ' 45' ' ' PRO . 0.2 OUTLIER -142.44 153.91 62.97 Favored Pre-proline 0 N--CA 1.498 1.974 0 O-C-N 121.423 -0.798 . . . . 0.45 110.836 -179.136 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.666 ' HD2' HG22 ' A' ' 44' ' ' THR . 52.6 Cg_endo -96.36 121.16 0.22 Allowed 'Trans proline' 0 C--N 1.321 -0.9 0 C-N-CA 122.015 1.81 . . . . 0.29 110.104 178.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 53.2 m -78.81 97.6 6.0 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.129 -0.982 . . . . 0.36 109.686 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.648 HG23 HG12 ' A' ' 58' ' ' VAL . 11.5 p -76.53 139.22 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.515 -0.74 . . . . 0.43 111.479 -179.065 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.3 pttt . . . . . 0 N--CA 1.494 1.772 0 O-C-N 121.684 -0.635 . . . . 1.97 109.884 179.199 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.565 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 17.6 m-85 . . . . . 0 N--CA 1.496 1.83 0 CA-C-O 121.129 0.49 . . . . 1.08 110.394 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.434 ' HB2' ' HA ' ' A' ' 23' ' ' ALA . 0.2 OUTLIER -137.5 142.44 41.49 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.561 -0.712 . . . . 0.91 110.417 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.454 ' HA ' ' HA ' ' A' ' 20' ' ' MET . 17.1 m -116.87 107.84 15.1 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.601 -0.687 . . . . 0.33 109.445 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.648 HG12 HG23 ' A' ' 47' ' ' VAL . 3.1 m -108.23 149.8 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.336 -0.853 . . . . 0.33 110.85 -179.155 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.605 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 9.1 t -114.76 110.08 19.18 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.938 -0.764 . . . . 0.5 108.938 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.706 HD12 HG22 ' A' ' 31' ' ' VAL . 6.6 tt -92.43 131.06 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.228 -0.92 . . . . 0.31 111.423 -178.479 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.406 ' O ' ' HB3' ' A' ' 43' ' ' TYR . 91.9 m -86.13 130.21 34.6 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.684 -0.858 . . . . 0.36 108.684 178.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.577 HD11 HD13 ' A' ' 60' ' ' ILE . 59.3 mt -139.75 99.16 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.004 -1.06 . . . . 0.32 111.086 -179.069 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -84.02 97.97 9.58 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.277 -0.889 . . . . 0.37 108.925 178.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -119.05 138.79 52.61 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.533 -0.729 . . . . 0.24 111.19 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 37.8 p -74.23 -9.93 59.1 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.619 -0.676 . . . . 0.37 110.475 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -129.51 156.97 43.29 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.398 -0.814 . . . . 0.6 110.201 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.421 ' O ' HG12 ' A' ' 70' ' ' VAL . 0.8 OUTLIER -82.37 -22.66 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.476 -0.765 . . . . 0.82 111.075 179.895 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -77.33 -30.27 53.92 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.057 -1.027 . . . . 0.97 110.928 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.509 ' O ' HD13 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -61.74 -44.58 96.63 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.3 -0.875 . . . . 0.54 110.214 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.571 HG21 ' HB3' ' A' ' 15' ' ' PHE . 9.2 p -71.77 -29.31 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.234 -0.917 . . . . 0.3 110.238 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.83 -47.5 74.81 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.31 -0.869 . . . . 0.68 109.32 179.036 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.532 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . 17.9 p -65.36 -35.17 80.16 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.654 -0.654 . . . . 0.33 109.466 178.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.754 HD11 ' HB2' ' A' ' 38' ' ' HIS . 3.8 mp -61.86 -37.23 83.72 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.367 -0.833 . . . . 0.28 109.942 179.018 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.549 ' CD1' ' HB ' ' A' ' 86' ' ' VAL . 0.8 OUTLIER -67.74 -52.78 33.46 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.386 -0.821 . . . . 0.59 109.715 179.28 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.532 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 10.6 pt-20 -63.04 -28.03 69.81 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.375 -0.828 . . . . 0.64 110.705 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.834 ' CB ' HG21 ' A' ' 34' ' ' VAL . 0.1 OUTLIER -71.29 -48.05 53.15 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.277 -0.889 . . . . 0.44 110.003 179.454 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 1.004 HD11 HG11 ' A' ' 19' ' ' VAL . 0.3 OUTLIER -76.94 -28.09 55.1 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.468 -0.77 . . . . 0.33 110.198 179.519 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.638 ' HA2' ' HG2' ' A' ' 84' ' ' ARG . . . -103.49 44.96 1.39 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.701 -1.36 . . . . 0.32 109.701 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.1 3.83 36.39 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.626 -0.926 . . . . 0.87 110.778 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.614 HD12 ' HG2' ' A' ' 84' ' ' ARG . 1.7 mp -73.87 154.87 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.276 -0.89 . . . . 0.39 110.03 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.0 -19.91 66.01 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.442 -0.786 . . . . 1.45 110.638 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.465 HG22 ' HB2' ' A' ' 22' ' ' GLN . 51.9 mm -70.19 169.27 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.395 -0.815 . . . . 0.5 109.985 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.457 ' N ' HG22 ' A' ' 82' ' ' ILE . 90.3 t -62.47 104.6 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.439 -0.788 . . . . 0.42 110.445 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.638 ' HG2' ' HA2' ' A' ' 78' ' ' GLY . 0.1 OUTLIER -121.82 112.61 18.57 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.692 -0.484 . . . . 0.54 109.692 179.911 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.518 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 0.2 OUTLIER -135.5 166.37 23.36 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.287 -0.883 . . . . 1.31 110.419 -179.611 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.557 HG23 HG22 ' A' ' 19' ' ' VAL . 5.1 p -139.2 157.06 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.393 -0.817 . . . . 0.27 110.583 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.499 2.003 0 CA-C-O 118.843 -0.599 . . . . 0.48 110.459 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.4 t . . . . . 0 N--CA 1.496 1.833 0 CA-C-O 120.551 0.215 . . . . 0.37 110.441 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.69 123.47 9.04 Favored 'Trans proline' 0 C--N 1.314 -1.238 0 O-C-N 123.864 1.455 . . . . 0.34 110.49 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.646 ' HB2' HG23 ' A' ' 62' ' ' ILE . 21.8 m-85 -104.42 99.47 9.17 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.508 -0.745 . . . . 0.34 110.587 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.8 m -75.7 93.35 3.09 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.085 -1.079 . . . . 0.43 108.085 178.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.57 ' O ' HG22 ' A' ' 60' ' ' ILE . 2.7 m-85 -101.91 109.74 21.56 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.306 -0.871 . . . . 0.33 111.306 -178.041 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.597 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 0.0 OUTLIER -81.66 91.15 6.38 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.533 -0.729 . . . . 1.17 109.331 179.06 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 1.083 HG11 HD11 ' A' ' 77' ' ' LEU . 38.4 t -79.25 96.96 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.666 -0.646 . . . . 0.3 109.955 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.429 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 58.6 mtm -102.17 148.4 25.46 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.405 -0.81 . . . . 0.65 110.028 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.443 ' HA3' ' O ' ' A' ' 83' ' ' VAL . . . 166.77 -142.35 7.55 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 110.035 -1.226 . . . . 0.22 110.035 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.622 ' HG3' HG21 ' A' ' 82' ' ' ILE . 0.0 OUTLIER -66.25 153.93 41.23 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.523 -0.987 . . . . 0.44 110.57 -179.934 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -96.58 99.1 10.76 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.568 -0.708 . . . . 0.33 110.232 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -128.71 155.82 78.55 Favored Pre-proline 0 N--CA 1.498 1.946 0 O-C-N 121.479 -0.763 . . . . 0.38 110.546 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -72.56 -24.58 18.66 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 O-C-N 123.879 1.463 . . . . 0.43 111.367 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.27 -5.62 45.57 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.182 -0.948 . . . . 0.57 111.291 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.509 ' CD2' HG21 ' A' ' 58' ' ' VAL . 0.3 OUTLIER -61.14 -55.66 29.83 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.107 -0.995 . . . . 1.0 110.266 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.614 HG12 ' HG2' ' A' ' 45' ' ' PRO . 26.8 m -66.99 -29.48 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.426 -0.796 . . . . 0.37 110.69 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -66.83 -53.42 32.88 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.364 -0.835 . . . . 0.42 110.33 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.726 ' O ' HG12 ' A' ' 34' ' ' VAL . 0.3 OUTLIER -68.29 -34.29 75.89 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.25 -0.906 . . . . 1.42 110.376 179.594 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.622 HG22 HD22 ' A' ' 77' ' ' LEU . 2.7 t -57.58 -56.09 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.405 -0.81 . . . . 0.25 110.268 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.8 p -66.81 -32.98 60.45 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.352 -0.842 . . . . 0.34 111.266 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.19 -54.93 7.21 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.14 -0.975 . . . . 0.85 110.772 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.893 HG21 ' CB ' ' A' ' 76' ' ' GLU . 8.2 p -66.66 -29.68 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 121.412 -0.805 . . . . 0.27 111.153 -179.445 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.726 HG11 ' HB2' ' A' ' 43' ' ' TYR . 2.4 p -78.08 -30.66 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.058 -1.026 . . . . 0.33 110.304 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -73.67 -38.32 64.97 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.201 -0.937 . . . . 0.67 110.063 179.366 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.27 -25.14 65.91 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.526 -0.734 . . . . 1.45 111.199 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.446 ' CD2' HD11 ' A' ' 73' ' ' LEU . 1.1 m-70 -103.39 -45.62 4.82 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.291 -0.881 . . . . 1.0 110.792 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -106.65 149.51 38.49 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.424 -0.798 . . . . 0.48 110.173 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -71.53 142.4 40.31 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 O-C-N 123.858 1.452 . . . . 0.7 110.652 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.21 156.26 21.25 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.751 -1.34 . . . . 0.46 109.751 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -89.97 140.49 29.58 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.463 -1.021 . . . . 0.55 110.127 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.726 ' HB2' HG11 ' A' ' 35' ' ' VAL . 67.8 m-85 -121.76 169.07 11.11 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.556 -0.715 . . . . 0.34 110.39 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.695 HG22 ' HD2' ' A' ' 45' ' ' PRO . 2.0 m -142.4 153.19 62.24 Favored Pre-proline 0 N--CA 1.497 1.92 0 O-C-N 121.374 -0.829 . . . . 0.54 110.912 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.695 ' HD2' HG22 ' A' ' 44' ' ' THR . 54.3 Cg_endo -95.94 125.06 0.31 Allowed 'Trans proline' 0 C--N 1.32 -0.957 0 C-N-CA 122.022 1.814 . . . . 0.45 110.389 178.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 55.5 m -83.04 94.39 7.78 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.09 -1.006 . . . . 0.49 109.468 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.674 HG23 HG12 ' A' ' 58' ' ' VAL . 14.1 p -76.76 141.66 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.453 -0.779 . . . . 0.45 111.543 -178.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.43 ' HG2' ' O ' ' A' ' 57' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.777 0 O-C-N 121.724 -0.61 . . . . 0.57 109.732 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 13.3 t80 . . . . . 0 N--CA 1.495 1.81 0 CA-C-O 121.168 0.509 . . . . 0.5 110.131 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -132.59 140.53 48.28 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.504 -0.747 . . . . 0.69 110.383 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.43 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 28.9 m -108.0 108.93 20.27 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.649 -0.657 . . . . 0.34 109.387 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.674 HG12 HG23 ' A' ' 47' ' ' VAL . 2.9 m -109.86 152.75 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.143 -0.973 . . . . 0.39 110.858 -179.315 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.597 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 1.7 t -116.59 111.27 19.65 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.613 -0.884 . . . . 0.74 108.613 178.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.599 ' CD1' HG13 ' A' ' 31' ' ' VAL . 10.5 tt -92.21 127.9 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.218 -0.926 . . . . 0.4 111.296 -178.43 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.481 ' O ' ' HB3' ' A' ' 43' ' ' TYR . 65.9 m -90.91 141.16 29.12 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 109.047 -0.723 . . . . 0.43 109.047 179.136 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.646 HD12 HG23 ' A' ' 35' ' ' VAL . 7.8 tt -162.54 141.76 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.012 -1.055 . . . . 0.43 110.998 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -108.0 87.56 2.53 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.509 -0.744 . . . . 0.69 109.317 178.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.442 ' HB3' ' CD2' ' A' ' 15' ' ' PHE . . . -106.63 136.73 45.91 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.46 -0.775 . . . . 0.33 110.524 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.2 p -66.98 -23.47 65.95 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.489 -0.757 . . . . 0.45 110.843 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -131.47 157.88 42.34 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.193 -0.942 . . . . 0.57 110.525 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.2 tt -75.73 -19.1 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.459 -0.776 . . . . 0.43 110.676 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.43 -35.42 79.22 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.243 -0.911 . . . . 0.44 110.403 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -65.21 -48.94 71.61 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.457 -0.777 . . . . 0.88 110.351 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.557 HG23 HG21 ' A' ' 62' ' ' ILE . 8.0 p -70.23 -25.23 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.448 -0.782 . . . . 0.27 110.485 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -68.7 -50.5 50.35 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.195 -0.94 . . . . 0.39 109.584 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 20.6 p -61.47 -40.01 92.97 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 109.028 -0.73 . . . . 0.38 109.028 178.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.536 HD23 HD12 ' A' ' 62' ' ' ILE . 3.1 mp -59.65 -39.07 83.16 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.665 -0.647 . . . . 0.31 109.709 178.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.66 ' CD1' ' HB ' ' A' ' 86' ' ' VAL . 0.2 OUTLIER -60.36 -44.98 95.06 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.977 -0.749 . . . . 0.44 108.977 178.653 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -69.07 -33.21 73.19 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.59 -0.693 . . . . 1.22 110.322 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.893 ' CB ' HG21 ' A' ' 34' ' ' VAL . 0.3 OUTLIER -64.74 -50.0 68.6 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.464 -0.773 . . . . 0.42 109.883 179.48 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 1.083 HD11 HG11 ' A' ' 19' ' ' VAL . 0.4 OUTLIER -78.25 -26.57 47.32 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.42 -0.8 . . . . 0.31 109.698 178.995 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.501 ' N ' ' HG ' ' A' ' 77' ' ' LEU . . . -105.94 56.25 0.52 Allowed Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.367 -1.493 . . . . 0.26 109.367 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.18 4.31 28.83 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.643 -0.916 . . . . 1.44 110.573 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.9 mp -60.06 155.27 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.404 -0.81 . . . . 0.43 110.094 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.99 -3.93 53.35 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.205 -0.935 . . . . 1.26 111.547 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.622 HG21 ' HG3' ' A' ' 22' ' ' GLN . 39.2 mm -84.71 -104.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.105 -0.997 . . . . 0.37 109.975 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.443 ' O ' ' HA3' ' A' ' 21' ' ' GLY . 84.7 t -124.32 118.73 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 120.943 -1.098 . . . . 0.33 110.263 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.33 113.63 19.66 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.517 -0.739 . . . . 1.13 109.488 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.476 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 3.1 mtm -139.95 157.12 46.19 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.361 -0.837 . . . . 0.71 110.179 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.66 ' HB ' ' CD1' ' A' ' 74' ' ' TYR . 8.1 p -141.74 152.88 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.362 -0.837 . . . . 0.27 110.787 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.413 ' HA ' HD22 ' A' ' 87' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.5 2.042 0 CA-C-O 117.52 -1.229 . . . . 0.64 110.558 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.6 t . . . . . 0 N--CA 1.496 1.826 0 N-CA-C 110.41 -0.218 . . . . 0.34 110.41 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -71.27 126.44 12.32 Favored 'Trans proline' 0 C--N 1.315 -1.188 0 O-C-N 123.997 1.525 . . . . 0.37 110.306 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.623 ' HB2' HG23 ' A' ' 62' ' ' ILE . 25.0 m-85 -107.01 99.75 9.29 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.557 -0.714 . . . . 0.36 110.451 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.7 m -78.2 92.68 4.48 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.3 -1.0 . . . . 0.38 108.3 178.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.473 ' O ' HG22 ' A' ' 60' ' ' ILE . 3.4 m-85 -100.53 105.9 17.37 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.535 -0.728 . . . . 0.37 110.959 -178.308 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.586 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 0.0 OUTLIER -80.8 91.77 5.98 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.351 -0.843 . . . . 1.34 109.358 179.341 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 1.081 HG11 HD11 ' A' ' 77' ' ' LEU . 21.9 t -78.58 95.9 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.462 -0.774 . . . . 0.28 109.736 -179.528 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 7.1 ttt -100.68 151.85 21.16 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.55 -0.719 . . . . 1.45 110.052 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 171.47 -165.08 38.02 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.95 -1.26 . . . . 0.3 109.95 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.462 ' HB3' HG21 ' A' ' 82' ' ' ILE . 4.5 tt0 -71.38 154.58 41.46 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.501 -0.999 . . . . 1.51 110.142 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.46 109.65 0.29 Allowed 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.747 -0.595 . . . . 0.53 110.707 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.589 HD13 ' HD2' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -129.35 114.71 18.4 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.574 -0.704 . . . . 0.71 110.112 -179.602 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.589 ' HD2' HD13 ' A' ' 24' ' ' LEU . 44.0 Cg_endo -71.67 -26.0 20.04 Favored 'Trans proline' 0 N--CA 1.49 1.293 0 O-C-N 123.828 1.436 . . . . 0.47 111.108 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -81.92 -6.42 59.09 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.216 -0.927 . . . . 0.68 111.193 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.626 HD23 HG21 ' A' ' 58' ' ' VAL . 0.3 OUTLIER -60.8 -50.29 74.05 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.985 -1.072 . . . . 0.68 110.512 -179.88 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.441 HG23 ' HD2' ' A' ' 45' ' ' PRO . 8.9 p -65.67 -34.08 67.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.392 -0.818 . . . . 0.33 110.349 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -66.68 -46.79 74.52 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.338 -0.851 . . . . 0.62 109.812 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.682 ' O ' HG12 ' A' ' 34' ' ' VAL . 3.3 tp60 -72.14 -30.79 65.37 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.476 -0.765 . . . . 1.18 110.252 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.627 HG22 HD22 ' A' ' 77' ' ' LEU . 2.3 t -62.79 -46.26 96.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.412 -0.805 . . . . 0.26 110.277 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.8 p -76.12 -35.06 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.36 -0.838 . . . . 0.29 111.583 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.575 ' CG ' ' HA ' ' A' ' 30' ' ' GLN . 0.5 OUTLIER -76.74 -35.17 57.93 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.709 -1.244 . . . . 0.52 110.867 -179.733 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.843 HG21 ' CB ' ' A' ' 76' ' ' GLU . 6.9 p -78.43 -34.02 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.017 -1.052 . . . . 0.27 110.014 179.415 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.95 HG23 HD12 ' A' ' 62' ' ' ILE . 3.9 p -74.01 -31.52 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.271 -0.893 . . . . 0.38 109.607 178.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -75.59 -35.05 60.67 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.323 -0.861 . . . . 1.62 109.649 178.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 28.1 mtm180 -66.42 -24.41 66.45 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.485 -0.759 . . . . 0.84 110.788 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 2.1 m80 -104.96 -45.77 4.46 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.216 -0.927 . . . . 0.89 110.742 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -96.0 153.64 39.13 Favored Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.428 -0.795 . . . . 0.55 109.886 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -69.03 -39.5 7.82 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 O-C-N 123.859 1.452 . . . . 0.93 111.317 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -95.1 146.83 18.37 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.871 -1.292 . . . . 0.46 109.871 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -77.96 159.97 28.5 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.454 -1.027 . . . . 0.62 109.936 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.57 ' HB2' HG21 ' A' ' 35' ' ' VAL . 40.5 m-85 -143.32 167.51 22.0 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.455 -0.778 . . . . 0.42 110.717 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.772 HG22 ' HD2' ' A' ' 45' ' ' PRO . 2.0 m -142.33 155.51 64.47 Favored Pre-proline 0 N--CA 1.499 1.989 0 O-C-N 121.47 -0.769 . . . . 0.42 110.99 -179.245 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.772 ' HD2' HG22 ' A' ' 44' ' ' THR . 51.5 Cg_endo -95.95 137.62 0.67 Allowed 'Trans proline' 0 C--N 1.321 -0.881 0 C-N-CA 121.97 1.78 . . . . 0.56 110.447 179.017 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.462 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 72.4 m -95.6 100.73 12.43 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.217 -0.927 . . . . 0.44 109.463 179.246 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.635 ' CB ' HG12 ' A' ' 58' ' ' VAL . 13.2 p -76.19 141.56 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.413 -0.805 . . . . 0.38 111.485 -179.023 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.517 ' HE2' ' HB3' ' A' ' 57' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.765 0 N-CA-C 109.479 -0.563 . . . . 0.71 109.479 179.039 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 1.6 t80 . . . . . 0 N--CA 1.495 1.79 0 CA-C-O 121.191 0.519 . . . . 0.89 110.536 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -145.13 152.55 40.22 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.492 -0.755 . . . . 0.42 110.503 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.517 ' HB3' ' HE2' ' A' ' 48' ' ' LYS . 0.8 OUTLIER -124.47 110.05 14.02 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.397 -0.814 . . . . 1.01 109.758 -179.962 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.635 HG12 ' CB ' ' A' ' 47' ' ' VAL . 2.5 m -109.85 147.66 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.122 -0.986 . . . . 0.33 110.711 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.586 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 1.0 OUTLIER -115.24 114.73 25.61 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.965 -0.754 . . . . 0.83 108.965 179.209 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.607 ' CD1' HG13 ' A' ' 31' ' ' VAL . 3.9 tt -92.18 128.4 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.232 -0.917 . . . . 0.4 110.843 -178.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.404 ' O ' ' HB3' ' A' ' 43' ' ' TYR . 26.3 m -93.88 135.09 35.56 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.707 -0.849 . . . . 0.42 108.707 179.151 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.95 HD12 HG23 ' A' ' 35' ' ' VAL . 3.9 tt -162.46 118.61 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.171 -0.956 . . . . 0.36 111.165 -179.338 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -92.45 100.19 12.79 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.474 -0.766 . . . . 0.53 109.005 178.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -115.01 139.55 49.76 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.509 -0.745 . . . . 0.31 110.99 -178.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 47.6 p -73.47 -6.63 47.62 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.559 -0.713 . . . . 0.44 110.817 179.194 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 20.8 m80 -129.4 136.31 49.8 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.322 -0.862 . . . . 1.18 110.433 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.4 tt -72.11 -24.0 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.483 -0.761 . . . . 0.74 109.699 178.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.14 -32.9 61.47 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.411 -0.806 . . . . 0.52 110.412 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -60.96 -47.78 84.87 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.477 -0.764 . . . . 0.65 110.277 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.576 HG21 ' HB3' ' A' ' 15' ' ' PHE . 11.2 p -71.85 -27.49 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.43 -0.794 . . . . 0.32 110.377 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -71.36 -44.67 64.58 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.16 -0.962 . . . . 0.45 109.132 178.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 95.4 m -63.11 -37.61 87.87 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 109.03 -0.73 . . . . 0.41 109.03 178.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.544 HD21 ' HA ' ' A' ' 35' ' ' VAL . 2.7 mp -62.96 -39.19 93.9 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.716 -0.615 . . . . 0.34 109.559 178.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.587 ' CD1' ' HB ' ' A' ' 86' ' ' VAL . 0.5 OUTLIER -60.37 -44.93 95.15 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.519 -0.738 . . . . 0.62 109.068 178.497 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.47 -35.46 80.53 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.587 -0.696 . . . . 0.83 110.525 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.843 ' CB ' HG21 ' A' ' 34' ' ' VAL . 0.2 OUTLIER -69.46 -51.68 33.9 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.48 -0.763 . . . . 0.47 110.421 179.886 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 1.081 HD11 HG11 ' A' ' 19' ' ' VAL . 0.4 OUTLIER -69.38 -28.4 66.15 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.377 -0.827 . . . . 0.3 110.335 179.729 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.476 ' N ' ' HG ' ' A' ' 77' ' ' LEU . . . -107.42 42.9 1.81 Allowed Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.609 -1.397 . . . . 0.33 109.609 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.7 4.32 51.91 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.342 -1.093 . . . . 0.73 110.694 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.402 ' H ' HD12 ' A' ' 80' ' ' ILE . 1.6 mp -69.25 153.21 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.248 -0.907 . . . . 0.43 110.268 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -68.24 -17.47 64.31 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.481 -0.762 . . . . 0.58 110.312 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.483 HG22 ' N ' ' A' ' 83' ' ' VAL . 51.8 mm -70.75 170.12 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.547 -0.72 . . . . 0.53 110.043 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.483 ' N ' HG22 ' A' ' 82' ' ' ILE . 78.4 t -62.4 114.9 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.37 -0.831 . . . . 0.58 110.596 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 5.4 ppt_? -121.42 143.57 49.15 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.86 -0.525 . . . . 1.21 110.117 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.47 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 1.6 ttp -156.42 159.04 38.34 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.166 -0.959 . . . . 0.88 110.486 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.695 HG23 HG22 ' A' ' 19' ' ' VAL . 9.2 p -141.02 156.61 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.44 -0.787 . . . . 0.27 110.301 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.46 HD11 ' CZ ' ' A' ' 17' ' ' TYR . 67.3 mt . . . . . 0 N--CA 1.502 2.136 0 CA-C-O 117.655 -1.164 . . . . 0.52 110.206 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.1 t . . . . . 0 N--CA 1.495 1.788 0 CA-C-O 120.614 0.245 . . . . 0.34 110.48 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -72.4 125.93 11.16 Favored 'Trans proline' 0 C--N 1.315 -1.222 0 O-C-N 123.862 1.454 . . . . 0.35 110.398 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.5 ' HB2' HG23 ' A' ' 62' ' ' ILE . 23.9 m-85 -106.16 99.6 9.18 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.556 -0.715 . . . . 0.32 110.632 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.4 m -76.06 92.88 3.22 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 107.982 -1.118 . . . . 0.43 107.982 178.471 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.532 ' O ' HG22 ' A' ' 60' ' ' ILE . 2.6 m-85 -100.1 109.47 21.77 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.397 -0.815 . . . . 0.43 111.327 -177.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.543 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 0.1 OUTLIER -81.26 90.45 6.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.592 -0.693 . . . . 0.93 109.402 179.156 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.996 HG11 HD11 ' A' ' 77' ' ' LEU . 32.1 t -79.64 98.07 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.623 -0.673 . . . . 0.34 109.945 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.435 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 36.7 mtm -106.15 147.55 28.89 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.575 -0.703 . . . . 0.67 110.085 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.418 ' HA3' ' O ' ' A' ' 83' ' ' VAL . . . 170.14 -141.5 6.63 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.088 -1.205 . . . . 0.26 110.088 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.747 ' HG3' HG21 ' A' ' 82' ' ' ILE . 0.0 OUTLIER -66.04 154.33 39.81 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.547 -0.973 . . . . 0.61 110.626 -179.817 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.576 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -93.08 97.93 11.0 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.491 -0.756 . . . . 0.34 110.305 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -130.44 154.23 81.53 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.523 -0.736 . . . . 0.41 110.49 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.03 -19.94 22.44 Favored 'Trans proline' 0 C--N 1.313 -1.316 0 O-C-N 124.041 1.548 . . . . 0.43 111.477 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -75.98 -5.08 44.64 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.084 -1.01 . . . . 0.57 111.358 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.4 mt -60.35 -59.92 4.63 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.067 -1.021 . . . . 0.62 110.219 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.604 HG12 ' HG2' ' A' ' 45' ' ' PRO . 33.6 m -64.99 -29.96 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.436 -0.79 . . . . 0.35 110.796 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -67.28 -55.06 15.5 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.395 -0.816 . . . . 0.49 110.229 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.72 ' O ' HG12 ' A' ' 34' ' ' VAL . 3.8 tp-100 -67.1 -34.85 78.51 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.319 -0.863 . . . . 0.69 110.643 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.842 HG22 HD22 ' A' ' 77' ' ' LEU . 3.0 t -59.06 -57.78 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.409 -0.807 . . . . 0.25 110.366 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.428 ' HA ' HG12 ' A' ' 35' ' ' VAL . 9.8 p -64.37 -33.07 60.36 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.323 -0.86 . . . . 0.31 111.424 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.6 -55.01 8.59 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.134 -0.979 . . . . 0.63 110.913 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.897 HG21 ' CB ' ' A' ' 76' ' ' GLU . 10.0 p -68.58 -27.58 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.407 -0.808 . . . . 0.29 111.481 -179.457 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.887 HG23 HD12 ' A' ' 62' ' ' ILE . 2.4 p -80.64 -28.94 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.028 -1.045 . . . . 0.38 110.732 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -79.59 -40.96 28.15 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.264 -0.897 . . . . 1.27 110.143 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.3 mtm180 -66.62 -22.85 66.11 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.39 -0.819 . . . . 2.5 111.299 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.672 ' CG ' HD11 ' A' ' 73' ' ' LEU . 15.9 m80 -105.23 -45.79 4.4 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.208 -0.933 . . . . 1.32 110.667 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -106.72 143.41 26.98 Favored Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 121.438 -0.789 . . . . 0.59 110.247 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -72.12 144.81 42.96 Favored 'Trans proline' 0 C--N 1.314 -1.27 0 O-C-N 123.827 1.435 . . . . 0.79 110.786 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 91.66 148.35 21.9 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.532 -1.427 . . . . 0.5 109.532 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -82.01 134.27 35.35 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.531 -0.982 . . . . 1.22 110.113 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.652 ' HB2' HG11 ' A' ' 35' ' ' VAL . 38.8 m-85 -123.95 157.49 34.22 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.623 -0.673 . . . . 0.41 110.402 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.732 HG22 ' HD2' ' A' ' 45' ' ' PRO . 1.4 m -142.36 153.38 62.59 Favored Pre-proline 0 N--CA 1.498 1.937 0 O-C-N 121.515 -0.741 . . . . 0.6 110.955 -179.265 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.732 ' HD2' HG22 ' A' ' 44' ' ' THR . 55.3 Cg_endo -95.27 133.15 0.56 Allowed 'Trans proline' 0 C--N 1.32 -0.962 0 C-N-CA 121.898 1.732 . . . . 0.53 110.579 179.025 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.452 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 51.5 m -89.93 93.99 9.63 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.187 -0.945 . . . . 0.39 109.289 179.06 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.645 ' CB ' HG12 ' A' ' 58' ' ' VAL . 14.4 p -76.46 137.26 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.498 -0.752 . . . . 0.39 111.589 -178.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.448 ' HE2' ' HB3' ' A' ' 57' ' ' SER . 0.5 OUTLIER . . . . . 0 N--CA 1.494 1.733 0 O-C-N 121.728 -0.608 . . . . 0.87 109.833 179.247 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 14.6 t80 . . . . . 0 N--CA 1.493 1.724 0 CA-C-O 121.156 0.503 . . . . 0.53 110.178 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.576 ' HB2' ' HA ' ' A' ' 23' ' ' ALA . 0.1 OUTLIER -129.73 137.03 50.35 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.495 -0.753 . . . . 0.89 110.29 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.448 ' HB3' ' HE2' ' A' ' 48' ' ' LYS . 6.1 m -110.18 105.46 14.54 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.598 -0.689 . . . . 0.36 109.392 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.645 HG12 ' CB ' ' A' ' 47' ' ' VAL . 2.8 m -108.36 147.57 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.219 -0.926 . . . . 0.37 110.84 -179.267 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.543 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 8.6 t -112.1 112.16 23.58 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.403 -0.81 . . . . 0.45 108.843 179.117 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.636 ' CD1' HG13 ' A' ' 31' ' ' VAL . 9.6 tt -92.33 126.86 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.217 -0.927 . . . . 0.33 111.265 -178.518 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.412 ' O ' ' HB3' ' A' ' 43' ' ' TYR . 19.1 m -91.72 136.06 33.42 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.944 -0.762 . . . . 0.43 108.944 179.228 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.887 HD12 HG23 ' A' ' 35' ' ' VAL . 5.9 tt -162.5 131.27 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.276 -0.89 . . . . 0.43 110.72 -179.565 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -99.68 98.18 9.05 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.358 -0.838 . . . . 0.52 109.698 179.374 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -113.67 139.69 48.84 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.451 -0.781 . . . . 0.26 110.227 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 33.9 p -66.54 -22.64 66.16 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.465 -0.772 . . . . 0.35 110.864 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -131.64 157.65 43.15 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.146 -0.971 . . . . 0.57 110.8 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.3 tt -79.9 -16.75 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.529 -0.732 . . . . 0.41 110.407 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.14 -33.09 71.37 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.125 -0.985 . . . . 0.46 110.124 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.449 ' O ' HD13 ' A' ' 73' ' ' LEU . 0.0 OUTLIER -68.12 -48.75 64.59 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.353 -0.842 . . . . 1.24 110.053 179.549 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.464 HG23 HG21 ' A' ' 62' ' ' ILE . 7.6 p -69.25 -25.02 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.387 -0.821 . . . . 0.33 110.262 179.503 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -69.02 -51.04 43.33 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.252 -0.905 . . . . 0.41 109.529 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 20.1 p -62.02 -38.26 87.98 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.526 -0.734 . . . . 0.37 109.284 178.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.672 HD11 ' CG ' ' A' ' 38' ' ' HIS . 5.4 mp -61.33 -40.3 93.73 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 109.304 -0.628 . . . . 0.37 109.304 178.807 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.642 ' CD1' ' HB ' ' A' ' 86' ' ' VAL . 0.1 OUTLIER -59.16 -42.81 91.63 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.858 -0.793 . . . . 0.55 108.858 178.387 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -68.5 -34.94 76.78 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.565 -0.709 . . . . 1.35 110.336 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.897 ' CB ' HG21 ' A' ' 34' ' ' VAL . 0.3 OUTLIER -62.99 -48.59 78.17 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.488 -0.758 . . . . 0.49 110.03 179.482 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.996 HD11 HG11 ' A' ' 19' ' ' VAL . 0.3 OUTLIER -79.38 -29.42 42.09 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.45 -0.781 . . . . 0.3 110.132 179.387 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.502 ' N ' ' HG ' ' A' ' 77' ' ' LEU . . . -102.59 56.36 0.64 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.266 -1.533 . . . . 0.26 109.266 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.3 tttt -106.22 4.59 29.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.698 -0.883 . . . . 1.61 110.774 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.468 HG22 ' H ' ' A' ' 82' ' ' ILE . 2.5 mp -59.78 154.99 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.335 -0.853 . . . . 0.45 110.111 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.16 -4.55 55.74 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.285 -0.884 . . . . 1.52 111.505 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.747 HG21 ' HG3' ' A' ' 22' ' ' GLN . 48.9 mm -85.52 -103.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 120.921 -1.112 . . . . 0.48 110.175 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.432 HG23 HG22 ' A' ' 82' ' ' ILE . 88.3 t -123.99 118.75 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 120.822 -1.174 . . . . 0.4 110.298 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.47 111.24 16.59 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.614 -0.679 . . . . 0.97 109.543 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.509 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 0.4 OUTLIER -136.73 154.93 50.45 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.36 -0.838 . . . . 0.78 110.392 -179.812 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.642 ' HB ' ' CD1' ' A' ' 74' ' ' TYR . 8.0 p -141.81 151.29 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.445 -0.784 . . . . 0.35 110.572 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.427 HD22 ' HA ' ' A' ' 87' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.5 2.067 0 CA-C-O 117.545 -1.217 . . . . 0.52 110.474 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.2 t . . . . . 0 N--CA 1.495 1.804 0 N-CA-C 110.438 -0.208 . . . . 0.31 110.438 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.73 120.26 6.57 Favored 'Trans proline' 0 C--N 1.315 -1.227 0 O-C-N 123.897 1.472 . . . . 0.34 110.311 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.521 ' HB2' HG23 ' A' ' 62' ' ' ILE . 18.3 m-85 -102.88 99.71 9.64 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.568 -0.707 . . . . 0.33 110.606 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.7 p -74.45 101.15 4.04 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.545 -0.909 . . . . 0.28 108.545 178.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -114.77 160.04 19.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.395 -0.816 . . . . 0.37 111.024 -178.467 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.684 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 7.6 mttt -135.97 99.18 4.08 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.099 -0.704 . . . . 2.06 109.099 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.988 HG11 HD11 ' A' ' 77' ' ' LEU . 10.2 t -79.76 98.31 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.445 -0.784 . . . . 0.26 109.399 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 63.0 mtm -106.66 157.77 17.45 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.32 -0.862 . . . . 0.7 110.298 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 164.2 -160.59 33.58 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 110.089 -1.204 . . . . 0.29 110.089 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.418 ' HB3' ' CG2' ' A' ' 82' ' ' ILE . 0.0 OUTLIER -70.27 156.48 39.21 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.496 -1.003 . . . . 1.51 110.085 179.868 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -48.4 110.13 0.31 Allowed 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.776 -0.578 . . . . 0.51 110.814 -179.579 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.472 HD13 ' HD2' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -130.51 110.99 16.34 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.554 -0.716 . . . . 0.52 109.966 -179.872 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.472 ' HD2' HD13 ' A' ' 24' ' ' LEU . 44.9 Cg_endo -72.6 -30.48 11.95 Favored 'Trans proline' 0 C--N 1.315 -1.209 0 O-C-N 123.914 1.481 . . . . 0.54 111.05 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -77.5 -7.12 55.75 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.228 -0.92 . . . . 0.69 111.291 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.469 ' O ' HG23 ' A' ' 31' ' ' VAL . 0.3 OUTLIER -58.24 -55.14 38.89 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.947 -1.095 . . . . 0.64 110.308 -179.952 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.552 HG23 ' HD2' ' A' ' 45' ' ' PRO . 11.9 p -61.04 -34.9 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 121.461 -0.774 . . . . 0.32 110.559 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.441 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 10.1 m-20 -64.23 -49.46 71.84 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.479 -0.763 . . . . 0.53 110.125 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.73 ' O ' HG12 ' A' ' 34' ' ' VAL . 13.3 tp60 -71.64 -31.74 67.18 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.477 -0.764 . . . . 0.55 110.517 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.702 HG22 HD22 ' A' ' 77' ' ' LEU . 7.3 t -58.71 -52.48 59.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.324 -0.86 . . . . 0.24 110.043 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.431 ' HA ' HG12 ' A' ' 35' ' ' VAL . 8.9 p -73.32 -30.54 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.414 -0.804 . . . . 0.33 111.198 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.441 ' HB2' ' O ' ' A' ' 29' ' ' ASP . 0.8 OUTLIER -73.64 -50.48 20.83 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.045 -1.034 . . . . 0.55 110.484 179.958 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.757 HG21 ' CB ' ' A' ' 76' ' ' GLU . 9.8 p -67.45 -32.41 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.426 -0.796 . . . . 0.34 110.706 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.555 HG21 ' HB2' ' A' ' 43' ' ' TYR . 2.5 p -77.17 -27.45 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.046 -1.034 . . . . 0.34 110.02 179.112 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -74.18 -36.29 64.04 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.293 -0.88 . . . . 0.75 109.602 178.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 52.7 mtm180 -73.1 -25.82 61.01 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.478 -0.764 . . . . 0.89 110.758 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.767 ' CG ' HD11 ' A' ' 73' ' ' LEU . 43.0 m-70 -98.39 -45.8 6.01 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.368 -0.833 . . . . 0.67 110.715 -179.388 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -102.8 151.84 38.39 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 121.481 -0.762 . . . . 0.63 109.975 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -69.83 -41.1 4.47 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.855 1.45 . . . . 1.07 110.895 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -86.45 144.79 20.01 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.494 -1.442 . . . . 0.46 109.494 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.08 149.06 29.36 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.37 -1.076 . . . . 0.6 110.047 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.555 ' HB2' HG21 ' A' ' 35' ' ' VAL . 42.3 m-85 -132.43 161.13 34.46 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.572 -0.705 . . . . 0.48 110.762 -179.495 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.67 HG22 ' HD2' ' A' ' 45' ' ' PRO . 3.7 m -142.6 153.49 61.91 Favored Pre-proline 0 N--CA 1.499 2.01 0 O-C-N 121.484 -0.76 . . . . 0.39 111.016 -179.299 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.67 ' HD2' HG22 ' A' ' 44' ' ' THR . 51.9 Cg_endo -95.1 148.75 1.59 Allowed 'Trans proline' 0 C--N 1.319 -0.997 0 C-N-CA 121.832 1.688 . . . . 0.55 110.479 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.522 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 56.9 m -106.81 96.84 6.72 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.174 -0.954 . . . . 0.39 109.142 179.04 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.586 HG23 HG12 ' A' ' 58' ' ' VAL . 12.4 p -75.49 139.38 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.364 -0.835 . . . . 0.32 111.771 -178.653 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.758 0 N-CA-C 109.69 -0.485 . . . . 0.93 109.69 179.338 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 22.3 t80 . . . . . 0 N--CA 1.497 1.885 0 CA-C-O 121.097 0.475 . . . . 0.82 110.169 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 4.1 p-80 -145.45 147.32 32.08 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.478 -0.764 . . . . 0.38 110.54 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.8 m -125.81 117.71 23.98 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.389 -0.819 . . . . 0.35 109.524 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.586 HG12 HG23 ' A' ' 47' ' ' VAL . 1.3 m -115.04 139.64 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.188 -0.945 . . . . 0.27 111.388 -179.17 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.54 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 7.5 t -95.64 108.0 20.24 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.352 -0.981 . . . . 0.61 108.352 178.394 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.573 ' HA ' ' HA ' ' A' ' 45' ' ' PRO . 12.1 tt -92.4 125.79 44.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.256 -0.902 . . . . 0.35 111.208 -178.543 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.48 ' O ' ' HB3' ' A' ' 43' ' ' TYR . 98.5 m -93.03 135.51 34.14 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.364 -0.976 . . . . 0.41 108.364 178.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.521 HG23 ' HB2' ' A' ' 15' ' ' PHE . 12.6 tt -160.46 145.18 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.076 -1.015 . . . . 0.38 111.059 -179.203 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -121.62 111.13 16.83 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.62 -0.675 . . . . 0.42 109.305 179.198 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.453 ' HB1' ' HB3' ' A' ' 69' ' ' GLN . . . -121.46 141.47 50.98 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.47 -0.769 . . . . 0.26 110.762 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 26.1 p -77.33 -4.5 45.42 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.506 -0.746 . . . . 0.32 111.219 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.651 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 62.1 t60 -130.37 150.32 51.65 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.216 -0.927 . . . . 0.49 110.191 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.439 ' O ' HG12 ' A' ' 70' ' ' VAL . 7.5 mm -70.67 -48.39 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 121.47 -0.769 . . . . 0.49 110.087 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.55 -18.46 65.38 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.454 -0.779 . . . . 0.75 111.236 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.651 ' HB2' ' HB3' ' A' ' 66' ' ' HIS . 0.3 OUTLIER -59.11 -58.87 6.75 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.263 -0.898 . . . . 1.12 110.405 179.901 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.439 HG12 ' O ' ' A' ' 67' ' ' ILE . 8.0 p -59.57 -26.98 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.416 -0.803 . . . . 0.31 110.924 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.23 -45.66 62.8 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.265 -0.897 . . . . 0.82 109.668 179.08 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 67.5 m -62.39 -41.17 98.44 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.573 -0.705 . . . . 0.34 109.728 179.236 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.767 HD11 ' CG ' ' A' ' 38' ' ' HIS . 4.7 mp -65.08 -36.39 84.18 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.636 -0.665 . . . . 0.55 110.047 179.431 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.627 ' CD1' ' HB ' ' A' ' 86' ' ' VAL . 0.3 OUTLIER -61.32 -46.09 91.74 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.46 -0.775 . . . . 0.52 109.105 178.837 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.56 -33.82 76.8 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.522 -0.736 . . . . 1.17 109.887 179.278 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.757 ' CB ' HG21 ' A' ' 34' ' ' VAL . 28.1 mt-10 -65.03 -43.47 92.31 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.411 -0.805 . . . . 0.37 109.889 179.259 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.988 HD11 HG11 ' A' ' 19' ' ' VAL . 0.4 OUTLIER -80.73 -29.68 36.33 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.358 -0.839 . . . . 0.27 109.964 178.943 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.509 ' N ' ' HG ' ' A' ' 77' ' ' LEU . . . -105.26 54.32 0.61 Allowed Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.475 -1.45 . . . . 0.3 109.475 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.97 4.12 29.11 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.567 -0.961 . . . . 0.95 110.563 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.411 ' H ' HD12 ' A' ' 80' ' ' ILE . 1.7 mp -68.6 154.46 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.34 -0.85 . . . . 0.33 110.175 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -66.16 -20.67 66.21 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.361 -0.837 . . . . 0.73 110.155 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.44 HG22 ' N ' ' A' ' 83' ' ' VAL . 43.3 mm -68.91 166.75 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.422 -0.798 . . . . 0.38 109.895 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.44 ' N ' HG22 ' A' ' 82' ' ' ILE . 76.6 t -62.47 114.39 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.287 -0.883 . . . . 0.47 110.779 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.25 137.16 54.81 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.774 -0.579 . . . . 1.22 109.615 179.305 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.424 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 2.7 mtm -151.92 160.21 43.58 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.158 -0.964 . . . . 1.49 110.523 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.627 ' HB ' ' CD1' ' A' ' 74' ' ' TYR . 5.4 p -142.14 155.23 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.463 -0.773 . . . . 0.31 110.378 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.684 ' HB3' ' HB2' ' A' ' 18' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.494 1.764 0 CA-C-O 117.896 -1.05 . . . . 0.34 109.824 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.9 t . . . . . 0 N--CA 1.495 1.782 0 N-CA-C 110.172 -0.307 . . . . 0.34 110.172 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -72.37 129.88 15.48 Favored 'Trans proline' 0 C--N 1.314 -1.277 0 O-C-N 123.939 1.494 . . . . 0.37 110.631 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.692 ' HB3' HG21 ' A' ' 70' ' ' VAL . 33.9 m-85 -112.01 100.89 9.24 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.583 -0.698 . . . . 0.36 110.022 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 16.5 m -73.52 92.96 1.94 Allowed 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 108.497 -0.927 . . . . 0.43 108.497 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.598 ' O ' HG22 ' A' ' 60' ' ' ILE . 3.3 m-85 -103.82 102.16 11.98 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.464 -0.773 . . . . 0.35 110.858 -178.356 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.649 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 0.0 OUTLIER -77.77 89.19 4.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.671 -0.643 . . . . 1.34 109.89 179.805 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.779 HG23 HG13 ' A' ' 58' ' ' VAL . 1.2 m -82.51 108.22 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 C-N-CA 119.358 -0.937 . . . . 0.27 109.413 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.1 mtp -108.05 151.72 25.46 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.553 -0.717 . . . . 0.96 110.567 -179.088 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 178.28 -159.81 25.51 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.82 -1.312 . . . . 0.34 109.82 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.537 ' HA ' ' HA ' ' A' ' 55' ' ' TYR . 0.9 OUTLIER -70.44 -179.8 2.21 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.426 -1.044 . . . . 0.86 110.503 179.973 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.61 100.01 2.2 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.392 -0.817 . . . . 0.48 110.126 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.421 ' O ' HD23 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -122.94 108.56 32.53 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.516 -0.74 . . . . 0.9 109.923 -179.773 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.402 ' HD2' HD13 ' A' ' 24' ' ' LEU . 44.0 Cg_endo -69.91 -15.44 36.54 Favored 'Trans proline' 0 N--CA 1.491 1.354 0 O-C-N 123.805 1.424 . . . . 0.63 111.588 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -83.09 -0.41 48.93 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.201 -0.937 . . . . 1.12 111.476 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.687 HD13 HG21 ' A' ' 58' ' ' VAL . 3.1 pp -58.84 -35.11 72.37 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.906 -1.121 . . . . 0.61 110.906 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.451 ' N ' HD12 ' A' ' 27' ' ' LEU . 9.8 p -75.35 -32.9 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.066 -1.021 . . . . 0.4 110.557 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -64.77 -48.75 73.39 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.442 -0.786 . . . . 0.63 110.085 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.7 ' HG2' ' HA ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -72.92 -37.3 67.25 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.474 -0.766 . . . . 1.04 110.698 179.937 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.995 HG22 HD12 ' A' ' 60' ' ' ILE . 4.2 t -57.11 -47.09 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.31 -0.869 . . . . 0.26 110.885 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.2 p -76.33 -37.19 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.251 -0.905 . . . . 0.34 111.577 -179.389 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.529 ' CG ' ' HA ' ' A' ' 30' ' ' GLN . 0.2 OUTLIER -75.94 -31.37 59.05 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.828 -1.17 . . . . 0.56 110.912 -179.869 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.681 HG21 ' HB2' ' A' ' 76' ' ' GLU . 5.4 p -79.98 -35.02 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.092 -1.005 . . . . 0.24 110.14 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.565 HG21 ' HB2' ' A' ' 43' ' ' TYR . 9.7 p -73.99 -29.94 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.181 -0.95 . . . . 0.31 109.446 178.457 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -77.08 -36.39 55.81 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.435 -0.791 . . . . 0.76 109.997 179.212 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.7 mtp-105 -65.92 -27.09 67.93 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.42 -0.8 . . . . 0.91 111.085 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 19.7 m80 -105.16 -45.86 4.4 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.334 -0.853 . . . . 0.49 110.599 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -100.21 150.14 36.65 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.509 -0.745 . . . . 0.38 109.808 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -70.04 -38.46 7.16 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.759 1.4 . . . . 0.6 111.15 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -85.78 145.3 20.82 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.918 -1.273 . . . . 0.43 109.918 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.83 150.08 22.39 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.523 -0.987 . . . . 0.52 109.864 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.565 ' HB2' HG21 ' A' ' 35' ' ' VAL . 51.9 m-85 -135.9 178.86 6.72 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.495 -0.753 . . . . 0.39 110.779 -179.445 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.839 HG22 ' HD2' ' A' ' 45' ' ' PRO . 0.2 OUTLIER -141.0 157.0 68.18 Favored Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 121.476 -0.765 . . . . 0.48 110.847 -179.064 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.839 ' HD2' HG22 ' A' ' 44' ' ' THR . 51.7 Cg_endo -93.75 163.27 2.26 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 C-N-CA 121.784 1.656 . . . . 0.41 110.366 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.494 ' C ' HG23 ' A' ' 58' ' ' VAL . 44.6 m -127.34 88.79 2.85 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.341 -0.85 . . . . 0.39 109.063 178.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.475 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 11.4 p -83.11 142.74 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.401 -0.812 . . . . 0.34 111.651 -178.597 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.671 0 O-C-N 121.698 -0.626 . . . . 0.73 109.841 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.537 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 15.0 t80 . . . . . 0 N--CA 1.494 1.761 0 CA-C-O 121.164 0.507 . . . . 0.91 110.183 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -139.57 136.91 34.92 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.589 -0.694 . . . . 0.88 110.469 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.3 m -108.67 120.66 43.13 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.64 -0.663 . . . . 0.38 109.318 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.779 HG13 HG23 ' A' ' 19' ' ' VAL . 3.2 p -127.01 145.27 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.257 -0.902 . . . . 0.24 111.485 -178.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.649 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 66.5 p -111.79 118.07 34.56 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.636 -0.665 . . . . 0.35 109.51 179.302 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.995 HD12 HG22 ' A' ' 31' ' ' VAL . 7.0 tt -94.55 134.5 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.436 -0.79 . . . . 0.32 111.249 -179.194 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 52.9 m -89.19 114.37 25.67 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.58 -0.896 . . . . 0.37 108.58 178.52 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.608 HD11 HD11 ' A' ' 60' ' ' ILE . 32.3 mm -122.42 99.32 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.171 -0.956 . . . . 0.34 111.299 -178.58 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -88.59 86.25 6.97 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.108 -0.995 . . . . 0.45 108.703 178.367 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.719 ' HB1' ' HB3' ' A' ' 69' ' ' GLN . . . -102.84 140.14 37.51 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.605 -0.685 . . . . 0.24 111.042 -178.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 32.9 p -75.86 -6.84 52.71 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.667 -0.646 . . . . 0.38 110.981 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.421 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 4.2 t-160 -129.73 158.59 38.97 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.265 -0.897 . . . . 0.45 110.454 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.461 ' O ' HG12 ' A' ' 70' ' ' VAL . 1.8 mt -73.68 -46.92 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.588 -0.695 . . . . 0.8 109.851 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.5 -21.28 66.63 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.495 -0.753 . . . . 0.73 110.998 179.692 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.719 ' HB3' ' HB1' ' A' ' 64' ' ' ALA . 9.9 tt0 -61.04 -52.6 64.28 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.238 -0.914 . . . . 0.38 110.44 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.692 HG21 ' HB3' ' A' ' 15' ' ' PHE . 7.4 p -69.73 -27.42 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.335 -0.853 . . . . 0.3 110.332 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.56 -52.7 59.92 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.275 -0.89 . . . . 0.92 109.533 179.218 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.8 p -62.65 -37.35 86.04 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.541 -0.724 . . . . 0.37 109.298 178.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.497 HD23 HD12 ' A' ' 62' ' ' ILE . 2.0 mp -61.85 -39.77 93.01 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.666 -0.646 . . . . 0.3 110.021 179.207 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.49 ' CD1' ' C ' ' A' ' 74' ' ' TYR . 0.0 OUTLIER -63.51 -45.97 88.21 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.552 -0.718 . . . . 0.46 109.332 179.02 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -70.12 -30.04 67.13 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.542 -0.724 . . . . 0.74 110.722 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.681 ' HB2' HG21 ' A' ' 34' ' ' VAL . 23.4 mt-10 -71.65 -51.39 23.34 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.377 -0.827 . . . . 0.43 110.362 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.7 ' HA ' ' HG2' ' A' ' 30' ' ' GLN . 0.7 OUTLIER -71.54 -29.69 65.04 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.279 -0.888 . . . . 0.29 109.951 179.236 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.473 ' N ' ' HG ' ' A' ' 77' ' ' LEU . . . -102.61 46.03 1.28 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.362 -1.495 . . . . 0.24 109.362 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.76 3.92 29.38 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.533 -0.981 . . . . 1.48 110.998 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.592 HG22 ' H ' ' A' ' 82' ' ' ILE . 2.3 mp -60.96 145.88 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.288 -0.883 . . . . 0.44 110.159 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -63.57 -21.19 66.21 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.474 -0.766 . . . . 0.82 110.525 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.592 ' H ' HG22 ' A' ' 80' ' ' ILE . 38.2 mm -71.59 172.4 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.405 -0.81 . . . . 0.5 109.83 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.469 ' N ' HG22 ' A' ' 82' ' ' ILE . 68.9 t -62.29 113.7 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.248 -0.908 . . . . 0.5 110.766 -179.445 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.87 154.26 37.31 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.782 -0.574 . . . . 1.01 110.368 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.516 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 4.4 ttp -156.18 159.86 39.35 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.336 -0.852 . . . . 0.65 110.012 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.623 ' HA ' ' HA ' ' A' ' 19' ' ' VAL . 9.8 p -131.87 149.15 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 121.307 -0.871 . . . . 0.34 110.891 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.463 ' CD2' ' HA ' ' A' ' 17' ' ' TYR . 37.6 mt . . . . . 0 N--CA 1.501 2.092 0 CA-C-O 117.653 -1.165 . . . . 0.45 110.664 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 N--CA 1.497 1.885 0 N-CA-C 110.34 -0.244 . . . . 0.44 110.34 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.93 119.75 6.24 Favored 'Trans proline' 0 C--N 1.314 -1.283 0 O-C-N 123.915 1.481 . . . . 0.44 110.634 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.683 ' HB2' ' HB ' ' A' ' 62' ' ' ILE . 15.6 m-85 -103.62 99.8 9.61 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.638 -0.664 . . . . 0.39 110.231 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.9 m -75.03 96.05 3.13 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.395 -0.816 . . . . 0.38 108.843 179.1 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.459 ' HD2' HG21 ' A' ' 86' ' ' VAL . 4.6 m-85 -108.63 115.07 29.41 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.244 -0.91 . . . . 0.4 110.848 -178.583 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.528 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 0.8 OUTLIER -83.64 91.04 7.37 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.478 -0.764 . . . . 0.9 109.5 179.452 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.946 HG11 HD11 ' A' ' 77' ' ' LEU . 11.0 t -79.3 95.4 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.51 -0.744 . . . . 0.66 109.645 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.486 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 34.5 mtm -101.58 136.02 42.11 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.461 -0.774 . . . . 0.97 110.15 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -172.25 -156.97 13.04 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.565 -1.414 . . . . 0.37 109.565 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.594 ' HG2' HG21 ' A' ' 82' ' ' ILE . 3.3 tp60 -67.68 168.79 10.61 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.458 -1.024 . . . . 0.59 110.486 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -90.0 97.85 11.43 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.426 -0.796 . . . . 0.42 109.969 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.441 ' CD1' ' HB3' ' A' ' 26' ' ' GLU . 0.8 OUTLIER -130.13 154.45 81.32 Favored Pre-proline 0 N--CA 1.498 1.939 0 O-C-N 121.562 -0.711 . . . . 0.4 110.645 -179.837 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -73.06 -26.7 14.76 Favored 'Trans proline' 0 N--CA 1.49 1.316 0 O-C-N 123.877 1.461 . . . . 0.47 111.68 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.441 ' HB3' ' CD1' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -68.82 -11.61 60.62 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.135 -0.978 . . . . 0.62 111.258 -179.804 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.417 HD22 HG21 ' A' ' 58' ' ' VAL . 0.7 OUTLIER -59.14 -64.61 0.88 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.124 -0.985 . . . . 0.81 110.441 -179.867 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.585 HG12 ' HG2' ' A' ' 45' ' ' PRO . 26.9 m -66.77 -29.81 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 O-C-N 121.396 -0.815 . . . . 0.57 110.956 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -65.23 -56.63 11.69 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.314 -0.867 . . . . 0.67 110.051 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.655 ' O ' HG12 ' A' ' 34' ' ' VAL . 7.8 tp60 -68.3 -31.55 71.06 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.494 -0.754 . . . . 0.61 110.586 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.882 HG22 HD12 ' A' ' 60' ' ' ILE . 2.4 t -58.2 -52.33 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.37 -0.831 . . . . 0.31 110.368 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.7 p -73.49 -32.53 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.303 -0.873 . . . . 0.35 111.385 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.69 -49.05 27.66 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.029 -1.044 . . . . 1.18 110.777 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.79 HG21 ' HB2' ' A' ' 76' ' ' GLU . 4.6 p -68.79 -34.05 62.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.457 -0.777 . . . . 0.29 111.012 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.564 HG11 ' HB2' ' A' ' 43' ' ' TYR . 4.7 p -74.16 -31.16 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.007 -1.058 . . . . 0.31 110.051 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -73.31 -34.03 65.48 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.269 -0.894 . . . . 1.36 109.754 178.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.3 mtt180 -68.96 -33.75 74.22 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.447 -0.783 . . . . 2.0 111.345 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.586 ' HB2' HD11 ' A' ' 73' ' ' LEU . 15.6 m80 -99.1 -45.81 5.79 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.081 -1.012 . . . . 0.62 110.781 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -101.74 150.28 37.2 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 121.449 -0.782 . . . . 0.42 110.28 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.55 141.18 34.2 Favored 'Trans proline' 0 C--N 1.314 -1.281 0 O-C-N 123.803 1.423 . . . . 0.67 110.762 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.55 165.23 36.41 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.71 -1.356 . . . . 0.54 109.71 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -99.01 145.45 27.06 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.411 -1.052 . . . . 0.62 110.21 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.564 ' HB2' HG11 ' A' ' 35' ' ' VAL . 78.2 m-85 -129.26 167.11 18.16 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.524 -0.735 . . . . 0.43 110.108 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.778 HG22 ' HD2' ' A' ' 45' ' ' PRO . 0.2 OUTLIER -140.12 157.61 68.72 Favored Pre-proline 0 N--CA 1.498 1.973 0 O-C-N 121.233 -0.917 . . . . 0.71 111.552 -178.55 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.778 ' HD2' HG22 ' A' ' 44' ' ' THR . 54.8 Cg_endo -96.56 141.74 0.8 Allowed 'Trans proline' 0 C--N 1.319 -0.997 0 C-N-CA 122.131 1.887 . . . . 0.59 110.395 179.148 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.479 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 45.2 m -95.64 93.66 7.27 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.21 -0.931 . . . . 0.41 109.051 178.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.762 HG23 HG12 ' A' ' 58' ' ' VAL . 11.0 p -76.06 138.24 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.473 -0.767 . . . . 0.37 111.598 -178.693 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.722 0 O-C-N 121.868 -0.52 . . . . 1.09 109.705 179.364 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 22.2 t80 . . . . . 0 N--CA 1.494 1.764 0 CA-C-O 121.195 0.522 . . . . 0.85 109.905 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -132.72 139.09 47.46 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.431 -0.793 . . . . 0.59 110.497 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.486 ' HA ' ' HA ' ' A' ' 20' ' ' MET . 57.7 m -107.89 116.22 31.56 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.605 -0.685 . . . . 0.34 109.476 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.762 HG12 HG23 ' A' ' 47' ' ' VAL . 1.7 m -115.5 143.3 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.27 -0.894 . . . . 0.36 111.13 -179.087 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.528 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 13.4 m -104.56 108.28 19.64 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.753 -0.832 . . . . 0.72 108.753 178.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.882 HD12 HG22 ' A' ' 31' ' ' VAL . 6.4 tt -92.84 132.13 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.326 -0.859 . . . . 0.34 111.556 -178.439 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.428 HG23 ' O ' ' A' ' 61' ' ' THR . 13.2 t -87.69 125.12 34.21 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.755 -0.832 . . . . 0.32 108.755 178.636 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.683 ' HB ' ' HB2' ' A' ' 15' ' ' PHE . 45.4 mm -121.37 125.0 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.217 -0.927 . . . . 0.47 110.998 -178.515 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -101.94 64.01 0.94 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.411 -0.806 . . . . 0.62 109.21 178.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.707 ' HB1' ' HB2' ' A' ' 69' ' ' GLN . . . -94.68 132.86 38.97 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.353 -0.842 . . . . 0.29 110.355 -179.547 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 41.3 p -67.7 -22.66 65.26 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.603 -0.685 . . . . 0.44 110.613 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -130.42 160.28 34.51 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.411 -0.805 . . . . 1.03 110.139 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.432 ' O ' HG12 ' A' ' 70' ' ' VAL . 0.9 OUTLIER -72.06 -16.86 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.412 -0.805 . . . . 0.89 110.681 179.604 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.1 -33.89 72.44 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.089 -1.007 . . . . 0.85 110.399 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.707 ' HB2' ' HB1' ' A' ' 64' ' ' ALA . 8.5 mt-30 -66.35 -48.29 70.7 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.464 -0.772 . . . . 0.88 110.381 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.584 HG23 HG21 ' A' ' 62' ' ' ILE . 8.1 p -68.34 -25.89 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.387 -0.821 . . . . 0.34 110.561 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -67.71 -51.28 51.38 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.207 -0.933 . . . . 0.52 109.544 179.142 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.2 p -65.01 -34.95 79.66 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.532 -0.73 . . . . 0.42 109.578 178.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.586 HD11 ' HB2' ' A' ' 38' ' ' HIS . 2.9 mp -60.62 -41.74 95.47 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.548 -0.72 . . . . 0.31 109.844 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.54 ' CD1' ' HB ' ' A' ' 86' ' ' VAL . 2.0 t80 -65.15 -44.31 89.01 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.476 -0.765 . . . . 1.04 109.487 178.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.22 -37.4 83.55 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.521 -0.737 . . . . 0.92 110.53 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.79 ' HB2' HG21 ' A' ' 34' ' ' VAL . 26.5 mt-10 -69.01 -49.88 53.78 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.449 -0.782 . . . . 0.45 110.483 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.946 HD11 HG11 ' A' ' 19' ' ' VAL . 0.3 OUTLIER -74.09 -28.98 61.63 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.352 -0.842 . . . . 0.42 110.3 179.633 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.481 ' N ' ' HG ' ' A' ' 77' ' ' LEU . . . -104.09 49.43 0.93 Allowed Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.314 -1.514 . . . . 0.31 109.314 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -106.16 3.97 28.51 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.705 -0.88 . . . . 0.83 110.791 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.507 HG22 HG12 ' A' ' 82' ' ' ILE . 2.3 mp -61.1 157.27 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.323 -0.86 . . . . 0.39 110.328 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.32 -4.12 40.4 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.131 -0.981 . . . . 1.15 111.83 -179.512 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.594 HG21 ' HG2' ' A' ' 22' ' ' GLN . 17.8 mm -86.68 -125.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 120.962 -1.086 . . . . 0.46 110.402 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 98.9 t -119.51 117.2 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 120.711 -1.243 . . . . 0.37 110.485 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.493 ' HD2' ' HB ' ' A' ' 80' ' ' ILE . 0.0 OUTLIER -122.49 131.65 53.96 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.656 -0.653 . . . . 0.63 110.283 179.779 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.541 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 1.8 ttp -143.05 158.56 43.49 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.413 -0.804 . . . . 1.17 109.683 179.456 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.633 HG23 HG22 ' A' ' 19' ' ' VAL . 9.8 p -141.62 152.21 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.294 -0.879 . . . . 0.46 111.026 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.501 2.078 0 CA-C-O 117.54 -1.219 . . . . 0.51 110.482 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.2 t . . . . . 0 N--CA 1.495 1.785 0 CA-C-O 120.604 0.24 . . . . 0.33 110.633 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.467 ' HA ' ' HA ' ' A' ' 63' ' ' ASN . 46.2 Cg_endo -72.7 125.5 10.6 Favored 'Trans proline' 0 C--N 1.314 -1.248 0 O-C-N 123.94 1.495 . . . . 0.34 110.449 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.704 ' CB ' HG21 ' A' ' 70' ' ' VAL . 32.9 m-85 -103.14 99.45 9.32 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.558 -0.714 . . . . 0.36 110.215 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.9 m -78.23 91.94 4.43 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.299 -1.0 . . . . 0.37 108.299 178.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.408 ' HA ' ' CD2' ' A' ' 87' ' ' LEU . 3.1 m-85 -97.6 104.37 16.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.573 -0.704 . . . . 0.41 110.352 -178.724 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.566 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 0.0 OUTLIER -78.22 89.12 4.28 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.693 -0.629 . . . . 1.87 110.202 179.905 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.673 HG23 HG23 ' A' ' 58' ' ' VAL . 1.0 OUTLIER -83.89 101.67 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.308 -0.87 . . . . 0.23 109.397 179.337 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.407 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 36.8 mtm -109.44 151.43 26.69 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.588 -0.695 . . . . 1.01 110.254 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -177.67 -154.89 12.85 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.847 -1.301 . . . . 0.31 109.847 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.88 167.27 11.83 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.468 -1.019 . . . . 0.68 110.353 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.29 102.61 1.42 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.37 -0.831 . . . . 0.33 110.255 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.727 ' O ' HD23 ' A' ' 27' ' ' LEU . 0.5 OUTLIER -129.55 120.48 19.77 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.499 -0.751 . . . . 0.9 110.091 -179.785 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -71.9 -14.91 29.68 Favored 'Trans proline' 0 N--CA 1.49 1.323 0 O-C-N 123.871 1.458 . . . . 0.53 111.465 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -82.28 -0.33 45.0 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.111 -0.993 . . . . 0.74 111.456 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.727 HD23 ' O ' ' A' ' 24' ' ' LEU . 3.5 pp -57.87 -36.51 72.47 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 120.969 -1.082 . . . . 0.46 111.045 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.9 p -79.36 -30.91 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.161 -0.962 . . . . 0.39 110.497 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -66.72 -50.92 61.25 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.403 -0.81 . . . . 0.41 109.891 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.695 ' HG2' ' HA ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -68.81 -45.25 71.73 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.261 -0.9 . . . . 1.05 110.525 179.765 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.693 HG13 ' CD1' ' A' ' 60' ' ' ILE . 2.9 t -53.76 -54.05 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.442 -0.786 . . . . 0.24 111.172 -179.641 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.9 p -66.77 -35.65 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 121.185 -0.947 . . . . 0.32 111.63 -179.053 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -73.8 -51.06 17.62 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.059 -1.026 . . . . 0.5 110.896 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.733 HG21 ' CB ' ' A' ' 76' ' ' GLU . 9.5 p -66.25 -31.7 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.403 -0.81 . . . . 0.33 111.162 -179.68 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.468 HG11 ' HB2' ' A' ' 43' ' ' TYR . 1.6 p -79.59 -28.23 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.145 -0.972 . . . . 0.31 110.634 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -75.98 -37.76 58.2 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.226 -0.922 . . . . 0.78 110.524 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 13.3 mtm180 -71.87 -23.11 61.46 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.332 -0.855 . . . . 2.55 110.93 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.461 ' HB3' ' CG ' ' A' ' 69' ' ' GLN . 7.5 m80 -99.6 -45.78 5.67 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.298 -0.877 . . . . 0.51 110.392 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -92.17 153.57 43.13 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.405 -0.809 . . . . 0.44 109.695 179.243 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -68.05 -36.74 16.54 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 O-C-N 123.752 1.396 . . . . 0.72 111.082 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -101.74 163.89 17.47 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 109.517 -1.433 . . . . 0.47 109.517 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -88.55 154.63 20.19 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.354 -1.086 . . . . 0.66 109.885 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.468 ' HB2' HG11 ' A' ' 35' ' ' VAL . 75.3 m-85 -137.65 172.77 12.46 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.471 -0.768 . . . . 0.47 110.641 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.675 HG22 ' HD2' ' A' ' 45' ' ' PRO . 4.2 m -142.27 154.0 63.65 Favored Pre-proline 0 N--CA 1.498 1.943 0 O-C-N 121.416 -0.803 . . . . 0.45 110.919 -179.149 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.675 ' HD2' HG22 ' A' ' 44' ' ' THR . 55.1 Cg_endo -95.12 132.5 0.56 Allowed 'Trans proline' 0 C--N 1.319 -0.979 0 C-N-CA 121.823 1.682 . . . . 0.57 110.421 178.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 35.8 m -90.24 99.35 12.39 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.067 -1.021 . . . . 0.34 109.202 179.019 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.73 ' HA ' HG12 ' A' ' 58' ' ' VAL . 12.4 p -76.63 135.18 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.544 -0.722 . . . . 0.33 111.495 -178.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.426 ' HE2' ' HB3' ' A' ' 57' ' ' SER . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.802 0 O-C-N 121.789 -0.569 . . . . 0.74 109.817 179.096 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 16.3 t80 . . . . . 0 N--CA 1.494 1.761 0 CA-C-O 121.139 0.495 . . . . 0.57 110.38 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 4.0 m170 -120.62 126.04 49.27 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.561 -0.712 . . . . 0.7 109.974 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.426 ' HB3' ' HE2' ' A' ' 48' ' ' LYS . 38.9 m -109.7 110.88 22.05 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.403 -0.811 . . . . 0.4 109.593 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.73 HG12 ' HA ' ' A' ' 47' ' ' VAL . 3.6 m -119.74 151.34 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.21 -0.931 . . . . 0.25 110.931 -179.313 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.566 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 79.3 p -117.8 118.08 31.06 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.478 -0.764 . . . . 0.32 109.422 179.347 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.693 ' CD1' HG13 ' A' ' 31' ' ' VAL . 9.1 tt -93.17 130.68 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.33 -0.856 . . . . 0.28 110.922 -179.012 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 97.2 m -86.15 129.91 34.7 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 109.101 -0.703 . . . . 0.35 109.101 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.434 HD11 HD13 ' A' ' 60' ' ' ILE . 91.0 mt -141.65 96.6 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.103 -0.998 . . . . 0.3 110.848 -179.344 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.467 ' HA ' ' HA ' ' A' ' 14' ' ' PRO . 2.0 t30 -82.31 93.94 7.25 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.039 -1.038 . . . . 0.46 109.353 178.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -117.45 140.21 49.89 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.598 -0.689 . . . . 0.26 110.319 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 33.8 p -69.74 -15.37 63.13 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.546 -0.722 . . . . 0.35 110.653 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -130.53 157.98 41.2 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.399 -0.813 . . . . 0.43 109.901 179.466 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.2 tt -89.99 -3.23 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.29 -0.881 . . . . 0.55 111.093 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -74.38 -43.68 55.42 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.106 -0.996 . . . . 0.42 110.487 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.461 ' CG ' ' HB3' ' A' ' 38' ' ' HIS . 0.6 OUTLIER -67.01 -47.0 72.79 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.531 -0.73 . . . . 0.58 110.848 -179.682 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.704 HG21 ' CB ' ' A' ' 15' ' ' PHE . 8.9 p -62.24 -31.13 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 121.446 -0.784 . . . . 0.3 110.699 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -66.76 -46.89 73.93 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.326 -0.859 . . . . 0.52 109.224 178.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.447 HG22 ' OE1' ' A' ' 76' ' ' GLU . 7.0 m -61.32 -34.38 75.16 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.679 -0.638 . . . . 0.41 109.464 178.829 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.453 HD11 ' CG ' ' A' ' 38' ' ' HIS . 2.1 mp -65.64 -39.11 91.08 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.515 -0.741 . . . . 0.37 109.914 179.202 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.48 ' HB2' HG21 ' A' ' 86' ' ' VAL . 0.0 OUTLIER -63.12 -48.94 76.37 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.625 -0.672 . . . . 0.43 109.779 179.419 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -71.26 -26.24 62.81 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.423 -0.798 . . . . 0.62 110.883 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.733 ' CB ' HG21 ' A' ' 34' ' ' VAL . 23.2 mt-10 -73.49 -50.18 22.88 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.216 -0.927 . . . . 0.39 110.07 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.695 ' HA ' ' HG2' ' A' ' 30' ' ' GLN . 1.5 pp -76.17 -25.73 55.52 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.282 -0.886 . . . . 0.34 110.023 178.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -101.39 40.74 2.32 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.307 -1.517 . . . . 0.31 109.307 179.261 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.05 4.12 39.44 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.384 -1.068 . . . . 0.81 110.842 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.0 mp -62.04 145.85 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.334 -0.854 . . . . 0.35 110.116 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -60.96 -30.29 70.16 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.407 -0.808 . . . . 0.74 110.302 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -61.35 171.09 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.616 -0.678 . . . . 0.41 110.611 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 78.9 t -63.67 118.16 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.43 -0.794 . . . . 0.41 110.288 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.35 158.67 27.74 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.675 -0.641 . . . . 0.7 110.369 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.549 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 1.1 ttp -157.76 158.53 35.46 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.511 -0.743 . . . . 0.88 109.786 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.48 HG21 ' HB2' ' A' ' 74' ' ' TYR . 9.1 p -135.46 147.17 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.378 -0.826 . . . . 0.32 110.628 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.408 ' CD2' ' HA ' ' A' ' 17' ' ' TYR . 35.8 mt . . . . . 0 N--CA 1.5 2.061 0 CA-C-O 118.693 -0.67 . . . . 0.47 110.466 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.653 ' HB3' ' HB3' ' A' ' 7' ' ' GLU . 2.4 mtm . . . . . 0 N--CA 1.496 1.831 0 CA-C-O 121.225 0.535 . . . . 2.02 110.556 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.89 89.48 1.97 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.486 -0.759 . . . . 2.75 110.033 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 27.0 p -120.62 -5.71 9.73 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.465 -0.772 . . . . 0.7 111.326 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.35 41.92 28.4 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.172 -0.955 . . . . 2.22 110.769 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -163.8 -55.22 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.546 -0.721 . . . . 1.23 110.086 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -113.35 -21.17 11.05 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.38 -0.825 . . . . 0.96 110.931 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.653 ' HB3' ' HB3' ' A' ' 1' ' ' MET . 0.6 OUTLIER -157.11 141.68 16.67 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.158 -0.964 . . . . 0.55 110.822 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.3 tt -158.2 -55.92 0.07 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.583 -0.698 . . . . 0.95 110.269 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.669 HD12 ' CB ' ' A' ' 11' ' ' PHE . 0.6 OUTLIER -89.04 -13.96 37.51 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.693 -0.629 . . . . 0.37 111.178 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 55.03 52.17 12.27 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.354 -0.841 . . . . 0.55 111.183 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.669 ' CB ' HD12 ' A' ' 9' ' ' LEU . 13.4 t80 -139.87 111.39 7.4 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.441 -0.787 . . . . 1.24 109.425 179.178 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.463 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 43.4 Cg_endo -69.89 107.54 1.91 Allowed 'Trans proline' 0 C--N 1.314 -1.264 0 O-C-N 123.884 1.465 . . . . 0.31 110.911 -179.141 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.9 t -110.44 146.02 33.43 Favored Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 121.66 -0.65 . . . . 0.33 109.989 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -69.44 114.64 3.72 Favored 'Trans proline' 0 C--N 1.313 -1.312 0 O-C-N 123.861 1.453 . . . . 0.36 110.979 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.526 ' CE2' ' HB3' ' A' ' 64' ' ' ALA . 15.7 m-85 -102.53 101.13 11.28 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.694 -0.629 . . . . 0.33 110.222 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.4 m -75.5 93.04 2.93 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.631 -0.877 . . . . 0.37 108.631 178.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -110.75 159.25 17.8 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.468 -0.77 . . . . 0.38 110.752 -178.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.546 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -134.82 101.25 4.85 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.348 -0.612 . . . . 0.4 109.348 179.766 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 1.062 HG11 HD11 ' A' ' 77' ' ' LEU . 3.5 t -79.68 95.62 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.477 -0.764 . . . . 0.28 109.59 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.541 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 43.9 mtm -97.73 142.0 30.05 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.538 -0.726 . . . . 0.56 110.178 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 166.42 -147.69 12.46 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.586 -1.406 . . . . 0.31 109.586 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.509 ' HG3' HG21 ' A' ' 82' ' ' ILE . 0.0 OUTLIER -75.8 151.1 37.59 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.326 -1.102 . . . . 0.7 110.106 179.816 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.6 105.04 2.98 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.564 -0.71 . . . . 0.36 110.31 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.522 HD13 ' HD2' ' A' ' 25' ' ' PRO . 2.6 mm? -111.13 129.69 23.74 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.592 -0.693 . . . . 0.56 109.761 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.522 ' HD2' HD13 ' A' ' 24' ' ' LEU . 43.3 Cg_endo -70.49 -30.5 18.81 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 O-C-N 123.701 1.369 . . . . 0.41 110.606 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -83.6 -2.81 56.9 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.463 -0.773 . . . . 0.64 110.791 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.52 HD21 HG21 ' A' ' 58' ' ' VAL . 0.8 OUTLIER -58.48 -52.62 64.85 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.043 -1.035 . . . . 0.82 110.284 179.997 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.499 HG12 ' HG2' ' A' ' 45' ' ' PRO . 35.8 m -62.23 -33.2 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.48 -0.762 . . . . 0.35 110.467 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -67.45 -46.26 73.59 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.511 -0.743 . . . . 0.49 109.937 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.734 ' O ' HG12 ' A' ' 34' ' ' VAL . 3.2 tp60 -72.24 -34.32 68.2 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.446 -0.784 . . . . 0.53 110.328 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.807 HG22 HD12 ' A' ' 60' ' ' ILE . 2.8 t -60.41 -53.21 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.561 -0.712 . . . . 0.26 110.432 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.444 ' HA ' HG12 ' A' ' 35' ' ' VAL . 9.9 p -70.81 -31.47 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 121.329 -0.857 . . . . 0.29 110.846 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.73 -46.27 54.39 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.301 -0.874 . . . . 0.52 110.932 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.849 HG21 ' CB ' ' A' ' 76' ' ' GLU . 7.6 p -75.51 -30.28 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.247 -0.908 . . . . 0.25 111.048 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.67 HG11 ' HB2' ' A' ' 43' ' ' TYR . 4.0 p -75.2 -30.75 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.045 -1.034 . . . . 0.26 110.209 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -79.04 -42.0 27.52 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.383 -0.823 . . . . 0.58 110.32 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.9 mtm180 -62.87 -30.06 71.23 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.269 -0.895 . . . . 2.51 111.053 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.743 ' CG ' HD11 ' A' ' 73' ' ' LEU . 68.6 m-70 -97.5 -41.05 8.36 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.342 -0.849 . . . . 0.51 110.72 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -120.8 145.56 41.58 Favored Pre-proline 0 N--CA 1.497 1.922 0 O-C-N 121.439 -0.788 . . . . 0.3 110.019 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.96 142.53 51.77 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 O-C-N 123.598 1.315 . . . . 0.4 110.985 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 98.09 147.76 22.74 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.724 -1.35 . . . . 0.36 109.724 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -94.48 139.9 30.53 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.573 -0.957 . . . . 0.66 109.949 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.67 ' HB2' HG11 ' A' ' 35' ' ' VAL . 76.5 m-85 -131.81 164.41 26.09 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.444 -0.785 . . . . 0.45 110.67 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.431 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 0.5 OUTLIER -142.79 158.14 60.16 Favored Pre-proline 0 N--CA 1.498 1.935 0 O-C-N 121.424 -0.798 . . . . 0.55 111.713 -179.314 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.688 ' HG3' HG21 ' A' ' 31' ' ' VAL . 55.2 Cg_endo -96.69 120.58 0.19 Allowed 'Trans proline' 0 C--N 1.317 -1.119 0 C-N-CA 122.382 2.055 . . . . 0.51 110.258 179.066 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.522 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 27.6 m -81.41 99.48 8.74 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.021 -1.049 . . . . 0.32 109.397 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.666 HG23 HG12 ' A' ' 58' ' ' VAL . 10.8 p -75.89 144.35 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.419 -0.801 . . . . 0.34 111.469 -178.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.41 147.28 42.56 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.834 -0.541 . . . . 0.55 109.665 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.66 97.73 0.73 Allowed 'Trans proline' 0 C--N 1.314 -1.265 0 O-C-N 123.767 1.404 . . . . 0.54 110.307 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.1 t -86.33 -50.04 7.22 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.561 -0.712 . . . . 0.96 110.998 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.41 -52.15 1.62 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.134 -0.979 . . . . 1.23 111.204 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 10.2 tttt -150.35 179.56 8.03 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.304 -0.872 . . . . 2.8 110.306 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.78 -27.94 73.48 Favored Glycine 0 N--CA 1.497 2.716 0 N-CA-C 109.355 -1.498 . . . . 0.49 109.355 179.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -74.43 -31.74 62.4 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.505 -0.997 . . . . 0.78 110.547 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -111.27 123.83 51.01 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.35 -0.844 . . . . 0.9 109.797 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -130.35 142.26 50.54 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.281 -0.887 . . . . 0.64 111.311 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.541 ' HA ' ' HA ' ' A' ' 20' ' ' MET . 16.0 m -110.51 117.23 32.99 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.705 -0.85 . . . . 0.36 108.705 179.051 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.666 HG12 HG23 ' A' ' 47' ' ' VAL . 2.8 m -110.09 150.78 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.187 -0.946 . . . . 0.26 111.829 -178.347 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.484 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 0.3 OUTLIER -104.41 104.6 14.5 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.396 -0.965 . . . . 1.0 108.396 178.476 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.807 HD12 HG22 ' A' ' 31' ' ' VAL . 14.5 tt -93.1 130.73 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.305 -0.872 . . . . 0.28 111.849 -178.252 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.523 ' O ' ' HB3' ' A' ' 43' ' ' TYR . 37.7 m -96.44 133.91 40.27 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.633 -0.877 . . . . 0.33 108.633 178.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.511 HG23 HG23 ' A' ' 35' ' ' VAL . 32.3 mt -144.14 139.39 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 120.939 -1.1 . . . . 0.26 111.137 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -112.63 57.21 0.66 Allowed 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.877 0.846 . . . . 0.36 109.161 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.642 ' HB1' ' HB3' ' A' ' 69' ' ' GLN . . . -67.21 130.74 44.06 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.965 -1.085 . . . . 0.25 110.22 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 32.8 p -70.08 -7.57 42.4 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.868 -0.52 . . . . 0.3 111.053 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.743 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 13.1 t-80 -129.75 157.89 40.92 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.198 -0.939 . . . . 0.38 110.104 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.492 ' O ' HG12 ' A' ' 70' ' ' VAL . 16.0 mm -69.7 -51.4 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.413 -0.805 . . . . 0.55 110.504 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.42 ' HB2' ' CE1' ' A' ' 66' ' ' HIS . 1.7 mt-10 -71.58 -14.69 62.16 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.472 -0.768 . . . . 1.15 111.647 -179.346 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.743 ' HB2' ' HB3' ' A' ' 66' ' ' HIS . 14.5 tt0 -62.09 -46.0 91.02 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.013 -1.055 . . . . 0.43 110.306 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.492 HG12 ' O ' ' A' ' 67' ' ' ILE . 5.8 p -60.73 -27.22 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 121.158 -0.964 . . . . 0.33 110.609 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -67.82 -50.24 57.86 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.298 -0.876 . . . . 0.84 109.856 179.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.9 p -63.5 -37.33 86.9 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.512 -0.742 . . . . 0.37 109.597 179.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.743 HD11 ' CG ' ' A' ' 38' ' ' HIS . 5.5 mp -60.03 -39.96 87.69 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.538 -0.726 . . . . 0.52 109.561 178.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.627 ' CD1' ' HB ' ' A' ' 86' ' ' VAL . 0.6 OUTLIER -63.03 -45.79 90.61 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.531 -0.73 . . . . 0.45 109.084 178.654 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -60.7 -37.67 82.43 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.56 -0.713 . . . . 0.67 109.943 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.849 ' CB ' HG21 ' A' ' 34' ' ' VAL . 0.3 OUTLIER -63.26 -41.38 99.03 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.516 -0.74 . . . . 0.57 110.566 179.801 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 1.062 HD11 HG11 ' A' ' 19' ' ' VAL . 0.3 OUTLIER -84.47 -28.59 26.68 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.382 -0.824 . . . . 0.32 110.557 179.818 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.536 ' N ' ' HG ' ' A' ' 77' ' ' LEU . . . -107.08 58.98 0.4 Allowed Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.806 -1.317 . . . . 0.26 109.806 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.12 4.17 26.56 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.606 -0.938 . . . . 0.46 110.389 178.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.448 HG22 ' H ' ' A' ' 82' ' ' ILE . 2.2 mp -63.4 152.65 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.383 -0.823 . . . . 0.48 110.125 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -69.74 -11.87 61.19 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.333 -0.854 . . . . 0.79 111.063 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.52 HG22 ' H ' ' A' ' 83' ' ' VAL . 22.3 mm -82.94 175.23 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.134 -0.979 . . . . 0.47 109.903 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.52 ' H ' HG22 ' A' ' 82' ' ' ILE . 76.0 t -63.16 112.04 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.373 -0.829 . . . . 0.51 111.395 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.96 136.76 54.94 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 109.109 -0.7 . . . . 1.02 109.109 178.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.46 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 2.6 ttt -151.3 161.57 42.46 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.12 -0.987 . . . . 2.36 110.724 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.627 ' HB ' ' CD1' ' A' ' 74' ' ' TYR . 8.1 p -141.71 153.04 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.431 -0.793 . . . . 0.3 110.565 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.546 ' HB3' ' HB2' ' A' ' 18' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.496 1.835 0 CA-C-O 117.944 -1.027 . . . . 0.32 109.705 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.805 0 CA-C-O 121.022 0.439 . . . . 1.8 110.28 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.419 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -137.04 -57.38 0.72 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.422 -0.799 . . . . 1.35 110.125 179.729 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 28.5 p -84.87 -175.11 5.63 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.533 -0.729 . . . . 1.07 110.276 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.16 71.48 0.56 Allowed 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.526 0.679 . . . . 2.42 110.21 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.07 82.68 1.85 Allowed 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.5 0.667 . . . . 1.4 109.408 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -97.45 -24.52 15.56 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.492 -0.755 . . . . 2.15 110.461 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.487 ' HG2' ' CG ' ' A' ' 66' ' ' HIS . 0.0 OUTLIER 64.59 99.63 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.68 -0.637 . . . . 0.76 110.413 -179.906 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -124.37 22.43 8.49 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.456 -0.778 . . . . 1.46 110.463 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.462 ' O ' ' HB2' ' A' ' 10' ' ' GLU . 3.7 mp -123.52 -48.49 1.93 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.445 -0.784 . . . . 0.7 109.939 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 9' ' ' LEU . 3.7 mp0 61.14 31.82 19.63 Favored 'General case' 0 N--CA 1.5 2.037 0 CA-C-O 121.112 0.482 . . . . 0.66 110.698 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.481 ' O ' ' HA ' ' A' ' 65' ' ' THR . 29.8 m-85 -111.63 109.07 55.93 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.42 -0.8 . . . . 1.15 109.395 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.506 ' HB3' HG22 ' A' ' 65' ' ' THR . 44.0 Cg_endo -70.37 110.26 2.63 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 O-C-N 124.019 1.536 . . . . 0.45 110.684 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.1 t -132.29 146.29 60.95 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.663 -0.648 . . . . 0.33 110.306 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.31 125.68 11.57 Favored 'Trans proline' 0 C--N 1.313 -1.301 0 O-C-N 123.925 1.487 . . . . 0.4 110.483 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.577 ' HB2' HG23 ' A' ' 62' ' ' ILE . 29.5 m-85 -105.91 99.31 8.91 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.535 -0.728 . . . . 0.33 110.355 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.1 m -76.93 92.72 3.69 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.072 -1.084 . . . . 0.43 108.072 178.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.478 ' O ' HG22 ' A' ' 60' ' ' ILE . 3.0 m-85 -99.86 107.33 19.32 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.434 -0.792 . . . . 0.3 110.723 -178.212 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 0.1 OUTLIER -82.07 88.79 6.41 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.524 -0.735 . . . . 0.34 109.292 179.547 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 1.034 HG11 HD11 ' A' ' 77' ' ' LEU . 21.3 t -79.95 95.02 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.537 -0.727 . . . . 0.29 109.617 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.8 ttt -107.96 125.91 52.07 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.573 -0.704 . . . . 1.11 110.431 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.486 ' HA3' ' HD3' ' A' ' 84' ' ' ARG . . . -153.82 -160.24 9.64 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.28 -1.528 . . . . 0.26 109.28 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.433 ' HB2' HG23 ' A' ' 82' ' ' ILE . 0.0 OUTLIER -67.02 168.06 10.69 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.38 -1.07 . . . . 1.04 110.253 179.73 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.413 ' O ' HD22 ' A' ' 24' ' ' LEU . . . -63.76 103.62 0.58 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.408 -0.808 . . . . 0.36 110.417 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.761 HD13 ' HD2' ' A' ' 25' ' ' PRO . 0.5 OUTLIER -125.1 123.03 25.39 Favored Pre-proline 0 N--CA 1.496 1.835 0 O-C-N 121.469 -0.769 . . . . 0.42 110.32 -179.706 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.761 ' HD2' HD13 ' A' ' 24' ' ' LEU . 46.3 Cg_endo -73.04 -22.41 19.51 Favored 'Trans proline' 0 N--CA 1.489 1.227 0 O-C-N 123.892 1.47 . . . . 0.49 111.163 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.606 ' HG2' HD12 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -78.49 -0.67 30.36 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.307 -0.87 . . . . 0.56 111.524 -179.985 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.571 HD11 ' NH1' ' A' ' 84' ' ' ARG . 9.3 mt -53.64 -58.44 7.19 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.19 -0.944 . . . . 0.35 110.871 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.441 ' HA ' ' HG3' ' A' ' 45' ' ' PRO . 8.9 p -64.9 -30.35 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.429 -0.794 . . . . 0.35 111.177 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.4 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 13.6 m-20 -67.08 -56.44 10.03 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.317 -0.865 . . . . 0.47 110.649 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.669 ' O ' HG12 ' A' ' 34' ' ' VAL . 0.7 OUTLIER -68.98 -38.02 79.09 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.327 -0.858 . . . . 1.03 110.846 -179.898 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.611 HG22 HD22 ' A' ' 77' ' ' LEU . 3.2 t -57.63 -54.52 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.398 -0.814 . . . . 0.27 110.596 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.3 p -66.09 -34.16 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.329 -0.857 . . . . 0.36 111.284 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' A' ' 29' ' ' ASP . 0.3 OUTLIER -73.88 -52.77 11.9 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.094 -1.004 . . . . 1.26 111.06 -179.681 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.832 HG21 ' CB ' ' A' ' 76' ' ' GLU . 8.0 p -68.26 -27.26 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.3 -0.875 . . . . 0.36 111.34 -179.3 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.805 HG23 HD12 ' A' ' 62' ' ' ILE . 2.9 p -79.92 -34.14 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.01 -1.056 . . . . 0.36 110.703 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -80.92 -23.71 38.7 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.058 -1.027 . . . . 1.17 110.585 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 31.7 mtm180 -76.59 -43.8 37.1 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.318 -0.864 . . . . 1.35 110.793 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.598 ' CB ' HD11 ' A' ' 73' ' ' LEU . 90.1 m-70 -93.19 -45.65 7.77 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.365 -0.834 . . . . 1.49 110.843 -179.398 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.562 ' HB3' ' O ' ' A' ' 35' ' ' VAL . . . -91.92 148.84 37.83 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 121.337 -0.852 . . . . 0.55 110.072 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.02 140.28 34.39 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 O-C-N 123.884 1.465 . . . . 0.75 110.572 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.96 154.45 9.41 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.729 -1.348 . . . . 0.49 109.729 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.94 143.56 26.68 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.399 -1.06 . . . . 0.66 110.002 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.52 ' HB2' HG11 ' A' ' 35' ' ' VAL . 51.0 m-85 -127.65 172.73 10.51 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.516 -0.74 . . . . 0.45 110.517 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.804 HG22 ' HD2' ' A' ' 45' ' ' PRO . 1.0 OUTLIER -142.23 154.38 64.24 Favored Pre-proline 0 N--CA 1.497 1.9 0 O-C-N 121.43 -0.794 . . . . 0.61 110.82 -179.433 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.804 ' HD2' HG22 ' A' ' 44' ' ' THR . 53.4 Cg_endo -93.91 164.39 2.16 Favored 'Trans proline' 0 C--N 1.317 -1.11 0 C-N-CA 121.69 1.593 . . . . 0.47 110.354 179.051 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.476 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 22.7 m -120.28 95.98 4.96 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.688 -0.856 . . . . 0.34 108.688 178.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.401 HG23 HG23 ' A' ' 58' ' ' VAL . 9.9 p -75.78 143.8 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.538 -0.726 . . . . 0.36 111.239 -178.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.438 ' HB2' ' HB3' ' A' ' 57' ' ' SER . 0.8 OUTLIER -135.76 106.19 9.82 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.722 -0.612 . . . . 0.44 110.102 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -76.7 -18.81 14.93 Favored 'Trans proline' 0 C--N 1.315 -1.235 0 O-C-N 124.115 1.587 . . . . 0.56 110.916 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 88.1 p -60.66 -24.39 65.55 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.403 -0.81 . . . . 0.68 111.129 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 28.9 m -63.25 -56.11 19.28 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.292 -0.88 . . . . 0.77 110.322 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.403 ' HB3' ' HB2' ' A' ' 55' ' ' TYR . 0.0 OUTLIER -152.49 166.26 32.53 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.475 -0.765 . . . . 1.94 110.578 -179.929 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.52 -51.66 5.91 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.737 -1.345 . . . . 0.68 109.737 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -93.57 14.32 19.24 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.445 -1.032 . . . . 0.78 111.068 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.403 ' HB2' ' HB3' ' A' ' 52' ' ' LYS . 0.2 OUTLIER -132.26 129.75 40.01 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.209 -0.932 . . . . 0.52 109.96 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -111.1 129.83 55.8 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.54 -0.725 . . . . 0.63 110.483 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.438 ' HB3' ' HB2' ' A' ' 48' ' ' LYS . 0.4 OUTLIER -97.56 99.31 10.7 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.522 -0.736 . . . . 0.33 109.451 179.341 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.631 HG13 ' HB2' ' A' ' 45' ' ' PRO . 1.0 OUTLIER -103.81 120.93 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.394 -0.816 . . . . 0.28 110.746 -179.216 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.493 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 11.6 t -100.92 114.49 28.41 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.452 -0.78 . . . . 0.41 109.114 178.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.553 ' CD1' HG13 ' A' ' 31' ' ' VAL . 11.2 tt -93.47 132.7 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.268 -0.895 . . . . 0.32 111.344 -178.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.466 ' O ' ' HB3' ' A' ' 43' ' ' TYR . 22.7 m -99.03 135.52 40.31 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.808 -0.812 . . . . 0.41 108.808 178.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.805 HD12 HG23 ' A' ' 35' ' ' VAL . 3.1 tt -162.37 131.75 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.128 -0.983 . . . . 0.44 111.003 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -105.28 101.19 10.75 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.407 -0.808 . . . . 0.58 109.359 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -115.72 146.56 41.78 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.427 -0.795 . . . . 0.3 110.64 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.506 HG22 ' HB3' ' A' ' 12' ' ' PRO . 47.3 p -79.35 -2.87 43.58 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.661 -0.649 . . . . 0.44 111.136 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.541 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 6.7 t60 -129.81 147.4 51.58 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.189 -0.944 . . . . 0.64 110.746 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.509 ' O ' HG12 ' A' ' 70' ' ' VAL . 0.8 OUTLIER -78.95 -41.42 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.638 -0.664 . . . . 0.76 109.843 179.292 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -65.47 -32.5 74.14 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.472 -0.767 . . . . 0.52 110.661 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.541 ' HB2' ' HB3' ' A' ' 66' ' ' HIS . 0.0 OUTLIER -59.91 -55.81 29.53 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.361 -0.837 . . . . 0.58 110.531 -179.936 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.573 HG21 ' HB3' ' A' ' 15' ' ' PHE . 13.3 p -61.16 -29.89 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.351 -0.843 . . . . 0.27 110.452 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -67.69 -43.85 79.13 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.229 -0.919 . . . . 0.47 109.365 178.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.419 ' HA ' ' HG2' ' A' ' 2' ' ' LYS . 54.7 m -60.52 -38.63 85.02 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.604 -0.685 . . . . 0.35 109.168 178.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.711 ' HG ' HG22 ' A' ' 34' ' ' VAL . 7.7 mp -63.71 -38.39 90.92 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.68 -0.638 . . . . 0.41 109.777 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.618 ' CD1' ' HB ' ' A' ' 86' ' ' VAL . 0.2 OUTLIER -59.3 -47.92 83.56 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 108.973 -0.751 . . . . 0.64 108.973 178.693 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.14 -31.29 72.41 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.606 -0.684 . . . . 0.55 110.214 179.382 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.832 ' CB ' HG21 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -66.14 -51.38 58.4 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.442 -0.787 . . . . 0.66 110.236 179.501 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 1.034 HD11 HG11 ' A' ' 19' ' ' VAL . 0.4 OUTLIER -76.43 -25.41 54.4 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.431 -0.793 . . . . 0.28 110.536 179.685 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.651 ' HA2' ' HG2' ' A' ' 84' ' ' ARG . . . -101.11 39.23 2.81 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 110.051 -1.22 . . . . 0.27 110.051 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.62 4.23 45.64 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.521 -0.988 . . . . 1.97 110.635 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.7 mp -60.14 153.03 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.303 -0.873 . . . . 0.37 110.064 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.5 -27.79 67.87 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.479 -0.763 . . . . 1.3 109.932 179.063 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.512 HG21 HD23 ' A' ' 24' ' ' LEU . 0.9 OUTLIER -68.26 171.99 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.526 -0.734 . . . . 0.51 110.179 179.36 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.418 ' N ' HG23 ' A' ' 82' ' ' ILE . 97.5 t -81.5 110.8 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.294 -0.879 . . . . 0.61 110.639 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.764 ' HD2' HG12 ' A' ' 19' ' ' VAL . 8.3 tpp180 -121.59 131.85 54.35 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.689 -0.632 . . . . 0.44 109.802 179.192 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.514 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 6.0 mtm -129.82 171.41 12.73 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.382 -0.823 . . . . 1.31 110.516 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.692 HG23 HG22 ' A' ' 19' ' ' VAL . 8.8 p -138.62 156.03 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.548 -0.72 . . . . 0.29 110.619 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.432 ' HA ' HD22 ' A' ' 87' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.5 2.029 0 CA-C-O 118.81 -0.614 . . . . 0.54 110.398 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.496 1.851 0 CA-C-O 121.014 0.435 . . . . 2.43 110.299 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.427 ' HE2' ' HA ' ' A' ' 7' ' ' GLU . 0.1 OUTLIER -67.49 144.09 55.86 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.544 -0.723 . . . . 0.92 110.546 -179.836 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.7 m 53.11 42.48 32.19 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-O 121.072 0.463 . . . . 0.55 111.13 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 14.2 tttt -168.24 -67.34 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.114 -0.991 . . . . 0.98 110.065 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.419 HD11 ' HA ' ' A' ' 38' ' ' HIS . 0.2 OUTLIER -106.57 -46.68 3.94 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.232 -0.918 . . . . 0.96 109.949 179.338 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -120.62 112.56 19.05 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.516 -0.74 . . . . 1.78 109.816 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.427 ' HA ' ' HE2' ' A' ' 2' ' ' LYS . 0.8 OUTLIER -144.18 -164.48 1.91 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.38 -0.825 . . . . 0.89 110.76 -179.617 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.411 ' HA ' HD13 ' A' ' 8' ' ' LEU . 0.8 OUTLIER -77.73 -32.3 52.73 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.294 -0.879 . . . . 1.05 110.864 -179.531 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.5 mp -74.12 -58.45 3.29 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.356 -0.84 . . . . 0.93 109.987 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 56.87 37.47 28.82 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.77 -0.581 . . . . 0.91 111.153 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.444 ' O ' ' HA ' ' A' ' 65' ' ' THR . 87.4 t80 -105.44 109.25 62.99 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.298 -0.876 . . . . 0.74 109.687 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.615 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 45.6 Cg_endo -70.64 108.63 2.29 Favored 'Trans proline' 0 C--N 1.314 -1.265 0 O-C-N 123.861 1.453 . . . . 0.37 110.798 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.2 t -110.35 144.06 29.36 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.494 -0.754 . . . . 0.37 110.244 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.43 117.82 5.35 Favored 'Trans proline' 0 C--N 1.315 -1.212 0 O-C-N 123.893 1.47 . . . . 0.39 110.811 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.665 ' HB2' ' HB ' ' A' ' 62' ' ' ILE . 16.7 m-85 -103.29 99.67 9.53 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.589 -0.694 . . . . 0.3 110.429 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.9 m -75.56 92.94 2.95 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.504 -0.925 . . . . 0.34 108.504 178.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.532 ' HD2' HG21 ' A' ' 86' ' ' VAL . 3.4 m-85 -102.72 108.0 19.1 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.343 -0.848 . . . . 0.32 110.9 -178.459 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.551 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 0.0 OUTLIER -78.3 89.72 4.34 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.532 -0.73 . . . . 0.78 109.296 179.404 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 1.054 HG11 HD11 ' A' ' 77' ' ' LEU . 24.8 t -78.57 96.5 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.487 -0.758 . . . . 0.3 109.906 -179.484 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.582 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 1.0 OUTLIER -97.21 149.71 21.72 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.541 -0.724 . . . . 1.18 110.124 -179.772 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 170.21 -151.44 16.61 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.848 -1.301 . . . . 0.34 109.848 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -79.38 151.45 30.95 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.545 -0.973 . . . . 0.74 110.327 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.21 96.99 4.02 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.604 -0.685 . . . . 0.32 110.199 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.408 HD13 HG21 ' A' ' 82' ' ' ILE . 0.1 OUTLIER -127.4 155.53 76.45 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.469 -0.769 . . . . 0.7 110.45 -179.823 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.56 -22.96 20.46 Favored 'Trans proline' 0 C--N 1.314 -1.263 0 O-C-N 123.927 1.488 . . . . 0.53 110.803 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -70.32 -18.09 63.08 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.337 -0.852 . . . . 0.58 111.035 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.472 HD13 ' HA ' ' A' ' 27' ' ' LEU . 1.7 mm? -57.87 -66.28 0.5 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.305 -0.872 . . . . 0.46 110.414 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.5 p -62.99 -29.5 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.449 -0.782 . . . . 0.39 110.965 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -64.59 -57.66 8.5 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.338 -0.851 . . . . 0.46 110.324 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.641 ' O ' HG12 ' A' ' 34' ' ' VAL . 4.9 tp60 -69.33 -30.32 68.33 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.353 -0.842 . . . . 0.91 110.821 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.987 HG22 HD12 ' A' ' 60' ' ' ILE . 2.3 t -59.79 -54.52 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.248 -0.907 . . . . 0.24 110.242 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.418 ' O ' ' HG2' ' A' ' 36' ' ' GLN . 9.5 p -70.77 -32.74 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.339 -0.85 . . . . 0.32 111.15 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.406 ' HA ' ' HG2' ' A' ' 36' ' ' GLN . 0.8 OUTLIER -73.58 -51.42 16.96 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.204 -0.935 . . . . 0.62 110.756 -179.885 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.695 HG21 ' HB2' ' A' ' 76' ' ' GLU . 4.0 p -66.71 -29.22 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.467 -0.771 . . . . 0.27 111.213 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.506 ' CG2' HD13 ' A' ' 62' ' ' ILE . 4.7 p -80.09 -31.93 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.035 -1.041 . . . . 0.28 110.711 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.492 ' HG3' ' N ' ' A' ' 37' ' ' ARG . 1.6 pt20 -82.42 -21.91 35.54 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.055 -1.028 . . . . 1.17 110.685 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.492 ' N ' ' HG3' ' A' ' 36' ' ' GLN . 26.9 mtm180 -79.24 -41.84 27.29 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.278 -0.889 . . . . 0.73 110.704 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.658 ' HB2' HD11 ' A' ' 73' ' ' LEU . 93.7 m-70 -95.9 -43.62 7.75 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.391 -0.818 . . . . 0.45 110.683 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.496 ' HB3' ' O ' ' A' ' 35' ' ' VAL . . . -98.01 150.64 36.96 Favored Pre-proline 0 N--CA 1.497 1.894 0 O-C-N 121.324 -0.86 . . . . 0.27 109.924 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.36 140.09 29.88 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.678 1.357 . . . . 0.3 110.673 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.63 154.02 14.18 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 110.045 -1.222 . . . . 0.4 110.045 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -95.07 148.32 22.48 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.466 -1.02 . . . . 0.45 109.914 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.449 ' HB2' HG11 ' A' ' 35' ' ' VAL . 67.7 m-85 -135.1 175.9 9.16 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.467 -0.771 . . . . 0.5 110.723 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.613 HG22 ' HD2' ' A' ' 45' ' ' PRO . 0.2 OUTLIER -142.7 158.06 60.61 Favored Pre-proline 0 N--CA 1.498 1.95 0 O-C-N 121.398 -0.814 . . . . 0.62 111.239 -178.973 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.613 ' HD2' HG22 ' A' ' 44' ' ' THR . 54.4 Cg_endo -96.24 118.26 0.18 Allowed 'Trans proline' 0 C--N 1.318 -1.029 0 C-N-CA 122.121 1.881 . . . . 0.28 110.431 179.243 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.511 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 31.9 m -76.24 104.71 6.9 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.086 -1.009 . . . . 0.38 109.283 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.548 HG23 HG12 ' A' ' 58' ' ' VAL . 14.3 p -76.2 142.58 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.411 -0.806 . . . . 0.36 111.656 -178.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.408 ' HD2' HG22 ' A' ' 46' ' ' THR . 0.0 OUTLIER -142.91 135.96 13.88 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.755 -0.591 . . . . 0.8 109.787 179.784 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.78 101.48 1.31 Allowed 'Trans proline' 0 C--N 1.316 -1.177 0 O-C-N 123.763 1.402 . . . . 0.54 110.071 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -87.58 -51.03 6.13 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.405 -0.81 . . . . 0.99 110.931 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.8 m -119.73 -57.44 1.97 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.339 -0.851 . . . . 0.93 110.801 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.79 -179.43 6.79 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.355 -0.841 . . . . 1.68 110.388 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.53 -32.45 71.35 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.542 -1.423 . . . . 0.39 109.542 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -63.81 -34.99 79.16 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.631 -0.923 . . . . 1.28 110.781 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -109.01 119.3 39.14 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.222 -0.924 . . . . 0.7 109.845 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 2.6 m170 -117.27 135.69 53.64 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.428 -0.795 . . . . 0.78 110.904 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.582 ' HA ' ' HA ' ' A' ' 20' ' ' MET . 26.8 m -108.64 102.54 11.59 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 109.139 -0.689 . . . . 0.41 109.139 179.174 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.548 HG12 HG23 ' A' ' 47' ' ' VAL . 3.1 m -103.65 146.79 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.306 -0.871 . . . . 0.31 110.834 -179.022 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.551 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 7.3 t -108.98 114.15 27.66 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.852 -0.796 . . . . 0.47 108.852 179.053 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.987 HD12 HG22 ' A' ' 31' ' ' VAL . 8.8 tt -93.08 132.77 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.269 -0.894 . . . . 0.3 111.763 -178.536 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 56.2 m -86.7 117.4 25.43 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.565 -0.902 . . . . 0.35 108.565 178.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.682 HG21 HG23 ' A' ' 70' ' ' VAL . 38.3 mm -114.29 132.93 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.068 -1.02 . . . . 0.4 111.048 -178.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.418 ' HB2' ' CZ ' ' A' ' 43' ' ' TYR . 3.6 t30 -108.18 62.1 0.61 Allowed 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.521 0.677 . . . . 0.39 109.216 178.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.852 ' HB1' ' HB3' ' A' ' 69' ' ' GLN . . . -91.67 133.83 35.24 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.306 -0.871 . . . . 0.25 110.686 -179.361 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.615 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 31.8 p -70.67 -17.83 62.84 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.608 -0.682 . . . . 0.4 110.691 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -129.84 159.88 35.22 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.332 -0.855 . . . . 0.49 110.127 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.2 tt -74.62 -17.01 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.378 -0.826 . . . . 0.8 110.783 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.9 -30.22 40.04 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.188 -0.945 . . . . 0.84 110.25 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.852 ' HB3' ' HB1' ' A' ' 64' ' ' ALA . 0.4 OUTLIER -65.64 -47.97 73.77 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.395 -0.815 . . . . 0.49 110.271 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.682 HG23 HG21 ' A' ' 62' ' ' ILE . 13.7 p -67.44 -28.82 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.367 -0.833 . . . . 0.29 110.294 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.16 -52.94 56.57 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.354 -0.841 . . . . 0.84 109.536 179.425 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.5 p -63.23 -35.66 81.05 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.503 -0.748 . . . . 0.35 109.487 179.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.658 HD11 ' HB2' ' A' ' 38' ' ' HIS . 3.6 mp -60.9 -39.58 89.84 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.634 -0.666 . . . . 0.35 109.557 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.59 ' CD1' ' HB ' ' A' ' 86' ' ' VAL . 0.3 OUTLIER -63.91 -48.69 75.6 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 109.143 -0.688 . . . . 0.6 109.143 178.761 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.76 -36.71 83.95 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.549 -0.719 . . . . 0.68 110.2 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.695 ' HB2' HG21 ' A' ' 34' ' ' VAL . 23.5 mt-10 -65.04 -47.38 77.6 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.586 -0.696 . . . . 0.33 110.459 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 1.054 HD11 HG11 ' A' ' 19' ' ' VAL . 0.3 OUTLIER -76.84 -29.11 55.76 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.246 -0.909 . . . . 0.32 110.433 179.718 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.477 ' N ' ' HG ' ' A' ' 77' ' ' LEU . . . -102.36 48.19 1.08 Allowed Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.503 -1.439 . . . . 0.25 109.503 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.9 ttmt -106.46 4.0 27.85 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.47 -1.017 . . . . 1.66 110.808 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.0 mp -69.57 153.13 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.218 -0.926 . . . . 0.36 110.105 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.12 -26.45 68.31 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.399 -0.813 . . . . 1.38 110.239 179.364 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.453 HG23 ' N ' ' A' ' 83' ' ' VAL . 1.0 OUTLIER -64.13 174.72 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.606 -0.684 . . . . 0.46 110.583 179.671 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.453 ' N ' HG23 ' A' ' 82' ' ' ILE . 75.4 t -63.71 117.49 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.392 -0.818 . . . . 0.38 110.546 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.94 132.81 54.74 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.728 -0.607 . . . . 0.77 110.049 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.526 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -154.22 160.54 41.89 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.215 -0.928 . . . . 1.7 110.318 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.641 HG23 HG22 ' A' ' 19' ' ' VAL . 8.2 p -141.48 157.23 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.406 -0.809 . . . . 0.26 110.763 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.49 HD11 ' CZ ' ' A' ' 17' ' ' TYR . 77.4 mt . . . . . 0 N--CA 1.501 2.08 0 CA-C-O 117.674 -1.155 . . . . 0.48 110.554 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.0 ttt . . . . . 0 N--CA 1.493 1.718 0 CA-C-O 121.249 0.547 . . . . 1.75 110.525 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.7 ptmt -134.64 169.79 16.79 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.517 -0.739 . . . . 1.46 110.35 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.8 t -65.85 150.98 47.72 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.427 -0.796 . . . . 0.7 110.422 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.22 -48.28 0.92 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.387 -0.821 . . . . 0.84 110.689 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.82 171.17 16.71 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.373 -0.829 . . . . 1.19 110.463 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -118.47 -48.54 2.5 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.533 -0.729 . . . . 1.54 110.408 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -158.06 144.22 17.34 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.376 -0.827 . . . . 0.72 110.712 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -159.22 -60.23 0.07 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.557 -0.714 . . . . 1.06 110.475 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.602 HD12 ' HB3' ' A' ' 11' ' ' PHE . 0.6 OUTLIER -77.77 -24.89 48.83 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.435 -0.791 . . . . 0.69 110.856 179.867 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 56.07 45.67 23.13 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.536 -0.728 . . . . 0.8 111.638 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.602 ' HB3' HD12 ' A' ' 9' ' ' LEU . 53.9 t80 -117.53 109.5 41.81 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.38 -0.825 . . . . 0.66 109.095 178.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.578 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 44.5 Cg_endo -70.14 112.29 3.11 Favored 'Trans proline' 0 C--N 1.313 -1.303 0 O-C-N 123.897 1.472 . . . . 0.49 110.741 -179.18 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.7 t -132.89 145.28 56.41 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 121.731 -0.606 . . . . 0.4 110.227 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.94 122.56 8.92 Favored 'Trans proline' 0 C--N 1.315 -1.197 0 O-C-N 123.83 1.437 . . . . 0.4 110.883 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.491 ' HB2' HG23 ' A' ' 62' ' ' ILE . 20.3 m-85 -106.38 99.78 9.34 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.652 -0.655 . . . . 0.34 110.281 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.1 p -73.64 99.22 3.03 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.248 -1.019 . . . . 0.33 108.248 178.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -113.91 159.54 19.77 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.384 -0.822 . . . . 0.33 111.031 -178.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.703 ' HD2' HD22 ' A' ' 87' ' ' LEU . 0.7 OUTLIER -137.35 102.46 4.8 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.822 -0.807 . . . . 0.66 108.822 179.204 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 1.005 HG11 HD11 ' A' ' 77' ' ' LEU . 15.6 t -81.14 99.74 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 CA-C-O 121.463 0.649 . . . . 0.26 110.193 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.413 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 35.7 mtt -94.77 155.01 17.01 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.479 -0.763 . . . . 1.2 109.961 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 157.5 -150.12 20.98 Favored Glycine 0 N--CA 1.497 2.722 0 N-CA-C 110.194 -1.163 . . . . 0.34 110.194 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.422 ' O ' HD23 ' A' ' 24' ' ' LEU . 1.1 tm0? -76.93 160.81 28.89 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.51 -0.994 . . . . 0.74 110.642 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -86.43 92.28 8.79 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.628 -0.67 . . . . 0.47 110.053 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.422 HD23 ' O ' ' A' ' 22' ' ' GLN . 0.7 OUTLIER -127.59 150.31 72.62 Favored Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 121.504 -0.748 . . . . 0.42 110.386 179.924 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -71.86 -24.06 21.56 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 O-C-N 123.861 1.453 . . . . 0.43 111.461 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.82 -18.31 64.8 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.216 -0.927 . . . . 0.6 111.044 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.459 HD22 HG21 ' A' ' 58' ' ' VAL . 0.7 OUTLIER -60.8 -63.18 1.39 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.225 -0.922 . . . . 0.69 110.365 -179.956 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.726 HG23 ' HD2' ' A' ' 45' ' ' PRO . 8.6 p -65.38 -31.58 54.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.421 -0.799 . . . . 0.35 110.63 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -63.4 -53.71 48.16 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.339 -0.851 . . . . 0.51 110.188 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.725 ' O ' HG12 ' A' ' 34' ' ' VAL . 1.1 tp-100 -68.55 -34.87 76.6 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.426 -0.796 . . . . 0.8 110.658 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.768 HG22 HD22 ' A' ' 77' ' ' LEU . 2.7 t -57.28 -46.94 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.342 -0.849 . . . . 0.3 109.997 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 77.4 t -71.17 -37.25 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.493 -0.754 . . . . 0.39 110.681 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.43 -54.32 11.05 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.181 -0.95 . . . . 1.03 110.839 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.779 HG21 ' CB ' ' A' ' 76' ' ' GLU . 9.9 p -62.79 -33.02 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.43 -0.794 . . . . 0.35 111.395 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.654 HG21 ' HB2' ' A' ' 43' ' ' TYR . 3.2 p -77.21 -29.61 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.032 -1.043 . . . . 0.4 110.343 179.381 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -74.26 -35.19 63.77 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.235 -0.916 . . . . 1.08 109.977 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.48 -23.87 61.1 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.493 -0.755 . . . . 1.41 110.811 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.419 ' CD2' HD11 ' A' ' 73' ' ' LEU . 0.3 OUTLIER -101.51 -46.0 5.12 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.206 -0.934 . . . . 0.6 110.546 -179.905 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -103.15 151.09 38.44 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.484 -0.76 . . . . 0.54 109.841 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -69.94 -41.26 4.2 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 O-C-N 123.857 1.451 . . . . 0.75 111.115 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -85.81 145.24 20.77 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.634 -1.386 . . . . 0.51 109.634 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.9 152.03 27.0 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.446 -1.032 . . . . 0.8 109.962 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.654 ' HB2' HG21 ' A' ' 35' ' ' VAL . 45.2 m-85 -136.9 159.79 40.82 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.529 -0.732 . . . . 0.41 110.573 -179.483 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.495 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 22.8 m -142.32 151.51 58.35 Favored Pre-proline 0 N--CA 1.499 1.984 0 O-C-N 121.445 -0.784 . . . . 0.36 111.301 -179.054 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.726 ' HD2' HG23 ' A' ' 28' ' ' VAL . 54.1 Cg_endo -96.51 135.84 0.5 Allowed 'Trans proline' 0 C--N 1.32 -0.958 0 C-N-CA 122.03 1.82 . . . . 0.48 110.508 178.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.511 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 32.1 m -95.03 108.43 20.5 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.16 -0.963 . . . . 0.4 109.17 179.01 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.739 HG23 HG12 ' A' ' 58' ' ' VAL . 7.7 p -75.9 141.58 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.444 -0.785 . . . . 0.43 111.54 -178.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.7 mtmp? -140.09 149.19 57.58 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.885 -0.509 . . . . 0.99 109.905 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.99 100.14 1.17 Allowed 'Trans proline' 0 C--N 1.315 -1.212 0 O-C-N 123.747 1.393 . . . . 0.51 109.825 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.4 ' HB3' ' HB3' ' A' ' 57' ' ' SER . 20.9 p -89.83 -49.12 6.81 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.552 -0.717 . . . . 0.57 111.165 -179.331 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.5 m -123.94 -60.32 1.45 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.309 -0.87 . . . . 1.13 110.563 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -144.87 179.82 7.08 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.394 -0.816 . . . . 1.73 110.563 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.16 -31.57 79.65 Favored Glycine 0 N--CA 1.496 2.653 0 N-CA-C 109.862 -1.295 . . . . 0.58 109.862 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -71.45 -35.19 70.8 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.483 -1.01 . . . . 0.87 110.952 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -105.36 127.4 52.95 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.142 -0.974 . . . . 0.61 110.111 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 1.2 m170 -125.06 145.26 50.0 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.281 -0.887 . . . . 1.01 111.333 -179.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.413 ' HA ' ' HA ' ' A' ' 20' ' ' MET . 14.0 t -119.22 106.09 12.0 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.54 -0.911 . . . . 0.36 108.54 178.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.739 HG12 HG23 ' A' ' 47' ' ' VAL . 2.1 m -103.29 146.4 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.272 -0.892 . . . . 0.32 111.176 -178.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.609 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 16.9 p -103.89 110.67 22.89 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.64 -0.874 . . . . 0.34 108.64 178.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.621 ' HA ' ' HA ' ' A' ' 45' ' ' PRO . 13.8 tt -93.12 128.34 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 CA-C-O 121.902 0.858 . . . . 0.36 111.459 -178.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.491 ' O ' ' HB3' ' A' ' 43' ' ' TYR . 22.5 m -97.18 126.83 42.62 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.193 -1.04 . . . . 0.39 108.193 178.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.491 HG23 ' HB2' ' A' ' 15' ' ' PHE . 11.0 tt -153.9 141.03 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.124 -0.985 . . . . 0.63 111.466 -178.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -117.22 102.99 9.74 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.723 -0.843 . . . . 0.67 108.723 178.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.727 ' HB1' ' HB3' ' A' ' 69' ' ' GLN . . . -109.86 141.01 43.17 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.485 -0.759 . . . . 0.34 111.312 -178.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.578 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 13.2 p -74.29 -5.23 40.95 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.788 -0.57 . . . . 0.53 111.269 179.383 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.735 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 49.5 t60 -129.73 146.54 51.49 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.969 -1.082 . . . . 0.54 110.188 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -67.64 -30.01 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.52 -0.738 . . . . 1.04 110.749 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.05 -11.66 43.49 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.274 -0.891 . . . . 0.93 111.068 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.735 ' HB2' ' HB3' ' A' ' 66' ' ' HIS . 7.4 tt0 -61.52 -46.54 89.54 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.22 -0.925 . . . . 0.86 109.874 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.1 p -70.48 -28.92 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.638 -0.664 . . . . 0.37 110.01 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.99 -50.06 45.35 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.485 -0.759 . . . . 0.56 109.604 179.136 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.6 p -61.81 -40.78 96.43 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.527 -0.733 . . . . 0.32 109.51 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.452 ' HG ' HG22 ' A' ' 34' ' ' VAL . 2.8 mp -60.45 -37.59 81.44 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.682 -0.636 . . . . 0.4 109.694 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.541 ' CD1' ' HB ' ' A' ' 86' ' ' VAL . 0.4 OUTLIER -62.97 -45.03 94.36 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.564 -0.71 . . . . 0.57 109.179 178.662 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.46 -36.15 79.61 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.498 -0.751 . . . . 0.4 109.988 179.21 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.779 ' CB ' HG21 ' A' ' 34' ' ' VAL . 0.5 OUTLIER -67.55 -49.07 65.01 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.544 -0.722 . . . . 0.48 110.279 179.497 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 1.005 HD11 HG11 ' A' ' 19' ' ' VAL . 0.3 OUTLIER -72.62 -27.23 62.02 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.423 -0.798 . . . . 0.29 110.533 179.622 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.466 ' N ' ' HG ' ' A' ' 77' ' ' LEU . . . -107.44 38.96 3.07 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.678 -1.369 . . . . 0.31 109.678 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.91 4.09 54.54 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.31 -1.112 . . . . 1.04 110.732 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.4 mp -72.17 155.07 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.321 -0.862 . . . . 0.52 109.982 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -68.71 -15.78 63.62 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.41 -0.806 . . . . 0.91 110.235 178.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.472 HG22 ' N ' ' A' ' 83' ' ' VAL . 49.7 mm -71.33 170.14 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.544 -0.723 . . . . 0.72 109.985 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.472 ' N ' HG22 ' A' ' 82' ' ' ILE . 76.1 t -62.42 115.06 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.342 -0.849 . . . . 0.51 110.818 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -121.19 140.74 51.61 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.857 -0.527 . . . . 0.84 109.595 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.1 mtp -158.54 154.05 26.05 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.062 -1.024 . . . . 1.44 110.29 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.573 HG23 HG22 ' A' ' 19' ' ' VAL . 5.9 p -142.5 157.44 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.32 -0.863 . . . . 0.32 110.801 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.703 HD22 ' HD2' ' A' ' 18' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.497 1.899 0 CA-C-O 117.955 -1.022 . . . . 0.4 109.878 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 ttt . . . . . 0 N--CA 1.496 1.845 0 CA-C-O 121.074 0.464 . . . . 1.72 110.368 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.558 ' HG3' ' HB ' ' A' ' 67' ' ' ILE . 0.0 OUTLIER -89.09 63.21 6.56 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.429 -0.795 . . . . 0.53 110.271 179.962 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 10.7 p -136.58 -56.54 0.74 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.405 -0.809 . . . . 0.53 109.89 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.33 49.0 0.83 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.594 -0.691 . . . . 1.41 109.979 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.454 HD13 ' HA ' ' A' ' 5' ' ' LEU . 1.4 mm? -108.85 161.91 14.69 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.351 -0.843 . . . . 0.75 110.669 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -133.9 129.49 36.43 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.541 -0.725 . . . . 1.74 109.923 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 51.91 61.83 3.01 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-O 121.421 0.629 . . . . 1.99 110.679 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -146.04 -42.97 0.2 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.264 -0.898 . . . . 0.88 110.901 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.5 mp -88.58 -53.26 4.73 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.352 -0.842 . . . . 0.45 110.589 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 56.88 32.64 21.81 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.708 -0.62 . . . . 0.73 110.662 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.506 ' O ' ' HA ' ' A' ' 65' ' ' THR . 92.2 t80 -111.74 118.8 46.09 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.35 -0.844 . . . . 0.65 109.762 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.617 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 43.4 Cg_endo -69.67 108.43 2.06 Favored 'Trans proline' 0 C--N 1.315 -1.208 0 O-C-N 123.854 1.449 . . . . 0.38 110.686 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.0 t -129.58 143.79 50.36 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.608 -0.682 . . . . 0.31 110.455 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -71.65 127.23 12.89 Favored 'Trans proline' 0 C--N 1.315 -1.213 0 O-C-N 123.911 1.48 . . . . 0.3 110.389 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.629 ' HB3' HG21 ' A' ' 70' ' ' VAL . 23.1 m-85 -108.5 99.69 9.05 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.482 -0.761 . . . . 0.37 110.467 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.5 m -74.18 92.9 2.25 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.169 -1.049 . . . . 0.38 108.169 178.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.563 ' O ' HG22 ' A' ' 60' ' ' ILE . 3.0 m-85 -105.09 106.69 17.3 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.379 -0.826 . . . . 0.35 110.897 -178.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.571 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 0.0 OUTLIER -79.27 92.49 5.14 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.533 -0.729 . . . . 1.18 109.532 179.525 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.952 HG11 HD11 ' A' ' 77' ' ' LEU . 15.7 t -79.02 96.09 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.462 -0.774 . . . . 0.29 109.516 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.662 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 44.4 ttp -98.05 148.71 23.24 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.601 -0.687 . . . . 0.93 110.295 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 166.83 -152.35 21.17 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.664 -1.374 . . . . 0.26 109.664 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.431 ' HG2' HG21 ' A' ' 82' ' ' ILE . 20.7 tp60 -74.01 138.9 44.39 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.423 -1.045 . . . . 1.34 110.394 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.35 115.24 7.56 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.665 -0.647 . . . . 0.38 110.378 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.612 ' HB2' HD12 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -131.86 150.91 77.5 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.623 -0.673 . . . . 0.77 110.2 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -73.0 -24.87 16.89 Favored 'Trans proline' 0 C--N 1.313 -1.335 0 O-C-N 123.839 1.442 . . . . 0.55 111.079 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.15 -7.32 58.1 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.244 -0.91 . . . . 0.81 111.643 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.612 HD12 ' HB2' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -59.85 -60.03 4.48 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.033 -1.042 . . . . 1.21 110.374 -179.665 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.2 p -62.97 -31.36 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 121.439 -0.788 . . . . 0.57 110.567 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -68.32 -56.42 8.65 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.372 -0.83 . . . . 0.47 109.913 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.702 ' O ' HG12 ' A' ' 34' ' ' VAL . 0.1 OUTLIER -63.19 -38.62 91.9 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.338 -0.851 . . . . 1.06 110.269 179.524 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.881 HG22 HD12 ' A' ' 60' ' ' ILE . 2.4 t -56.57 -52.0 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.542 -0.723 . . . . 0.31 110.216 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 40.1 t -63.68 -40.88 90.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.47 -0.769 . . . . 0.34 111.244 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.13 -50.77 29.93 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.309 -0.869 . . . . 0.62 111.134 -179.313 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.844 HG21 ' CB ' ' A' ' 76' ' ' GLU . 8.9 p -69.1 -28.05 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.485 -0.759 . . . . 0.26 111.521 -179.248 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.593 HG11 ' HB2' ' A' ' 43' ' ' TYR . 1.9 p -83.21 -27.05 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.034 -1.041 . . . . 0.3 110.784 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -78.89 -39.7 34.27 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.235 -0.915 . . . . 0.55 110.429 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 14.4 ptt180 -69.56 -20.1 63.67 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.344 -0.847 . . . . 1.0 111.33 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.567 ' HB2' HD11 ' A' ' 73' ' ' LEU . 1.8 m-70 -106.16 -45.77 4.23 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.15 -0.969 . . . . 0.87 110.768 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -103.68 149.84 37.52 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.401 -0.812 . . . . 0.42 109.997 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.33 140.4 36.88 Favored 'Trans proline' 0 C--N 1.314 -1.241 0 O-C-N 123.802 1.422 . . . . 0.57 110.636 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.06 172.92 49.25 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.706 -1.357 . . . . 0.56 109.706 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -100.99 144.69 29.62 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.439 -1.036 . . . . 0.57 110.338 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.593 ' HB2' HG11 ' A' ' 35' ' ' VAL . 83.5 m-85 -129.08 165.46 21.18 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.509 -0.745 . . . . 0.41 110.325 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.542 HG22 ' HD2' ' A' ' 45' ' ' PRO . 0.2 OUTLIER -142.57 156.79 63.21 Favored Pre-proline 0 N--CA 1.499 1.992 0 O-C-N 121.371 -0.831 . . . . 0.71 111.165 -179.417 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.542 ' HD2' HG22 ' A' ' 44' ' ' THR . 53.2 Cg_endo -96.54 132.78 0.41 Allowed 'Trans proline' 0 C--N 1.32 -0.952 0 C-N-CA 122.233 1.955 . . . . 0.53 110.292 178.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.473 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 36.2 m -93.89 92.11 7.24 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.955 -1.09 . . . . 0.4 109.502 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.688 HG23 HG12 ' A' ' 58' ' ' VAL . 11.3 p -76.55 140.69 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.474 -0.766 . . . . 0.29 111.638 -178.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.1 ptpt -142.32 154.9 64.58 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.785 -0.572 . . . . 1.57 109.498 179.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -71.36 99.61 0.93 Allowed 'Trans proline' 0 C--N 1.313 -1.331 0 O-C-N 123.845 1.445 . . . . 0.49 110.209 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.5 p -89.94 -47.17 8.04 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.547 -0.72 . . . . 0.61 110.955 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.24 -52.44 1.74 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.252 -0.905 . . . . 1.18 110.872 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.3 mttt -151.2 176.79 10.86 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.399 -0.813 . . . . 2.3 110.34 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -64.42 -28.42 73.08 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.309 -1.516 . . . . 0.48 109.309 178.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -78.89 -28.57 44.08 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.475 -1.014 . . . . 1.35 110.552 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -111.35 118.1 34.93 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.359 -0.838 . . . . 0.48 110.021 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.474 ' HB3' ' CG2' ' A' ' 47' ' ' VAL . 1.4 m-70 -130.16 148.14 51.97 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.373 -0.829 . . . . 0.45 111.174 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.662 ' HA ' ' HA ' ' A' ' 20' ' ' MET . 89.3 p -113.34 126.12 55.03 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 109.155 -0.683 . . . . 0.37 109.155 179.119 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.688 HG12 HG23 ' A' ' 47' ' ' VAL . 1.5 m -116.59 141.37 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.241 -0.912 . . . . 0.35 111.116 -178.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.571 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 1.3 t -103.08 106.41 16.92 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.387 -0.821 . . . . 0.73 108.87 178.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.881 HD12 HG22 ' A' ' 31' ' ' VAL . 6.2 tt -93.7 132.1 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.273 -0.892 . . . . 0.34 111.264 -178.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.465 ' O ' ' HB3' ' A' ' 43' ' ' TYR . 85.9 m -87.12 127.79 35.12 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 108.635 -0.876 . . . . 0.43 108.635 178.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.606 HD11 HD13 ' A' ' 60' ' ' ILE . 44.5 mt -137.85 103.36 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 120.995 -1.065 . . . . 0.29 111.176 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -85.08 80.51 9.23 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.298 -0.876 . . . . 0.44 109.17 178.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -101.74 136.74 41.07 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.515 -0.741 . . . . 0.23 110.311 -179.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.617 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 39.9 p -68.8 -14.8 63.26 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.45 -0.781 . . . . 0.36 111.063 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -130.85 159.74 36.47 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.246 -0.909 . . . . 0.48 110.764 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.558 ' HB ' ' HG3' ' A' ' 2' ' ' LYS . 8.4 tp -76.5 -27.15 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.532 -0.73 . . . . 0.4 110.367 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.32 -26.9 63.04 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.203 -0.936 . . . . 0.64 110.558 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.461 ' O ' HD13 ' A' ' 73' ' ' LEU . 28.3 mt-30 -63.84 -53.46 50.41 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.393 -0.817 . . . . 1.73 110.231 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.629 HG21 ' HB3' ' A' ' 15' ' ' PHE . 7.4 p -65.73 -27.59 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.662 -0.649 . . . . 0.27 110.441 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.18 -48.31 73.89 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.316 -0.865 . . . . 0.46 109.286 178.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 82.7 m -64.36 -34.59 78.52 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.741 -0.599 . . . . 0.38 109.436 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.567 HD11 ' HB2' ' A' ' 38' ' ' HIS . 5.2 mp -63.14 -40.29 97.14 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.67 -0.644 . . . . 0.28 109.714 179.373 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.642 ' CD1' ' HB ' ' A' ' 86' ' ' VAL . 0.7 OUTLIER -64.77 -43.86 91.9 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.604 -0.685 . . . . 0.41 109.457 178.886 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -65.98 -32.87 74.6 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.474 -0.766 . . . . 0.75 110.735 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.844 ' CB ' HG21 ' A' ' 34' ' ' VAL . 0.3 OUTLIER -70.49 -55.52 8.76 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.333 -0.854 . . . . 0.51 110.378 179.972 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.952 HD11 HG11 ' A' ' 19' ' ' VAL . 0.3 OUTLIER -70.27 -28.19 65.02 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.361 -0.837 . . . . 0.29 110.199 179.677 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.514 ' N ' ' HG ' ' A' ' 77' ' ' LEU . . . -107.59 55.78 0.51 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.428 -1.469 . . . . 0.22 109.428 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -106.07 4.18 28.95 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.702 -0.881 . . . . 1.53 110.6 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.695 HG22 ' H ' ' A' ' 82' ' ' ILE . 2.7 mp -63.44 145.05 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.35 -0.844 . . . . 0.45 110.195 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.73 -5.93 41.08 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.509 -0.744 . . . . 1.62 111.603 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.695 ' H ' HG22 ' A' ' 80' ' ' ILE . 47.3 mm -80.77 -106.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.031 -1.043 . . . . 0.55 109.887 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 63.5 t -123.93 112.16 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 120.915 -1.116 . . . . 0.47 110.389 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.06 122.02 38.31 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.37 0.605 . . . . 0.67 109.727 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.545 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 1.3 ttm -146.88 158.6 43.96 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.25 -0.906 . . . . 2.53 110.174 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.642 ' HB ' ' CD1' ' A' ' 74' ' ' TYR . 9.8 p -141.45 154.13 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.429 -0.795 . . . . 0.32 110.837 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.499 1.989 0 CA-C-O 118.823 -0.608 . . . . 0.65 110.407 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.769 0 CA-C-O 120.874 0.369 . . . . 2.77 110.586 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.05 -62.87 1.44 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.301 -0.874 . . . . 1.1 109.83 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 57.6 m -138.83 84.95 2.04 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.493 -0.754 . . . . 1.14 109.602 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.71 -54.91 0.61 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.445 -0.784 . . . . 1.08 110.498 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.637 HD11 ' HG3' ' A' ' 69' ' ' GLN . 0.2 OUTLIER 52.54 55.19 9.44 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.701 -0.624 . . . . 1.12 110.303 -179.666 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -102.14 73.14 1.35 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.399 -0.813 . . . . 1.15 109.937 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -105.39 155.69 18.89 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.553 -0.717 . . . . 0.54 110.224 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.419 ' HA ' HD13 ' A' ' 8' ' ' LEU . 0.6 OUTLIER -81.91 -41.84 20.35 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.388 -0.82 . . . . 0.85 109.487 179.367 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -94.37 -30.38 14.53 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.75 -0.594 . . . . 0.52 110.345 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 46.27 67.43 0.76 Allowed 'General case' 0 N--CA 1.499 2.01 0 CA-C-O 121.509 0.671 . . . . 0.6 110.877 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.409 ' O ' ' HA ' ' A' ' 65' ' ' THR . 87.4 t80 -94.93 125.26 51.56 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.482 -0.761 . . . . 0.56 110.039 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.568 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 43.4 Cg_endo -70.79 112.05 3.17 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 O-C-N 124.051 1.553 . . . . 0.31 110.424 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.5 t -121.5 141.56 33.71 Favored Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 121.556 -0.715 . . . . 0.39 110.459 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.66 129.6 14.79 Favored 'Trans proline' 0 C--N 1.314 -1.261 0 O-C-N 123.879 1.462 . . . . 0.36 110.637 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.675 ' HB3' HG21 ' A' ' 70' ' ' VAL . 31.1 m-85 -109.6 99.7 8.86 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.596 -0.69 . . . . 0.39 110.217 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.2 m -73.95 92.58 2.12 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.257 -1.016 . . . . 0.38 108.257 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.581 ' O ' HG22 ' A' ' 60' ' ' ILE . 2.9 m-85 -103.55 103.74 13.72 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.461 -0.774 . . . . 0.38 110.949 -178.372 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.616 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 0.1 OUTLIER -82.3 97.45 8.31 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.344 -0.847 . . . . 3.13 109.741 179.404 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.982 HG11 HD11 ' A' ' 77' ' ' LEU . 15.9 t -79.95 96.89 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.427 -0.795 . . . . 0.28 109.37 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 60.2 mtm -101.36 127.3 48.05 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.571 -0.705 . . . . 0.62 110.254 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -157.15 -158.81 9.12 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.875 -1.29 . . . . 0.33 109.875 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.451 ' HB2' ' CG2' ' A' ' 82' ' ' ILE . 0.0 OUTLIER -68.78 177.49 2.53 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.364 -1.08 . . . . 1.18 110.559 -179.979 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.43 ' HA ' ' CG ' ' A' ' 56' ' ' HIS . . . -79.4 91.03 5.04 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.427 -0.796 . . . . 0.36 110.459 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.585 ' O ' HD23 ' A' ' 27' ' ' LEU . 1.0 OUTLIER -133.81 132.29 21.48 Favored Pre-proline 0 N--CA 1.496 1.847 0 O-C-N 121.397 -0.814 . . . . 0.37 110.249 179.664 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -76.43 -4.19 14.73 Favored 'Trans proline' 0 N--CA 1.489 1.216 0 O-C-N 123.702 1.369 . . . . 0.53 112.057 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -80.14 -5.84 56.7 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 120.968 -1.082 . . . . 0.62 111.466 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.639 HD13 HG11 ' A' ' 58' ' ' VAL . 4.1 pp -66.13 -38.23 87.63 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.932 -1.105 . . . . 0.38 111.083 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.629 ' N ' HD12 ' A' ' 27' ' ' LEU . 9.8 p -76.53 -29.83 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.256 -0.902 . . . . 0.32 110.855 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -69.27 -53.84 17.73 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.365 -0.834 . . . . 0.39 110.116 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.686 ' O ' HG12 ' A' ' 34' ' ' VAL . 0.6 OUTLIER -67.66 -38.78 84.25 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.34 -0.85 . . . . 0.63 110.75 179.911 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.737 ' CG1' HD13 ' A' ' 60' ' ' ILE . 2.8 t -59.39 -56.87 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.362 -0.836 . . . . 0.27 110.615 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.7 p -62.79 -33.71 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 121.292 -0.88 . . . . 0.31 111.549 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.85 -55.91 5.32 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.043 -1.036 . . . . 0.43 110.823 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.884 HG21 ' HB2' ' A' ' 76' ' ' GLU . 6.2 p -65.53 -23.97 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.34 -0.85 . . . . 0.28 111.512 -179.324 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.581 HG11 ' HB2' ' A' ' 43' ' ' TYR . 1.8 p -86.0 -32.52 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 120.922 -1.111 . . . . 0.29 111.078 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -78.73 -26.92 44.78 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.966 -1.084 . . . . 0.45 110.558 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.86 -39.51 35.03 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.276 -0.89 . . . . 0.65 110.609 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.675 ' HB2' HD11 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -86.69 -45.54 10.88 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.35 -0.844 . . . . 0.39 110.571 -179.878 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -100.69 152.15 37.77 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.434 -0.791 . . . . 0.3 109.993 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.42 140.58 36.92 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 O-C-N 123.844 1.444 . . . . 0.41 110.584 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.22 162.41 26.2 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.749 -1.341 . . . . 0.52 109.749 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.05 143.62 27.71 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.426 -1.043 . . . . 0.42 110.088 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.581 ' HB2' HG11 ' A' ' 35' ' ' VAL . 82.8 m-85 -125.79 166.37 16.96 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.493 -0.754 . . . . 0.42 110.448 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.61 HG22 ' HD2' ' A' ' 45' ' ' PRO . 3.9 m -140.76 152.36 65.58 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.408 -0.808 . . . . 0.36 111.083 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.61 ' HD2' HG22 ' A' ' 44' ' ' THR . 54.6 Cg_endo -96.06 123.42 0.27 Allowed 'Trans proline' 0 C--N 1.319 -0.999 0 C-N-CA 122.125 1.884 . . . . 0.22 110.545 179.064 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.53 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 58.6 m -75.3 92.72 2.79 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.213 -0.929 . . . . 0.31 108.779 178.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.76 HG23 HG12 ' A' ' 58' ' ' VAL . 8.3 p -80.75 139.38 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 CA-C-O 121.863 0.84 . . . . 0.33 112.406 -178.108 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.464 ' HG2' ' O ' ' A' ' 57' ' ' SER . 0.2 OUTLIER -142.57 109.39 5.67 Favored Pre-proline 0 N--CA 1.493 1.695 0 N-CA-C 108.709 -0.848 . . . . 0.64 108.709 178.198 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -77.09 126.44 8.62 Favored 'Trans proline' 0 C--N 1.315 -1.191 0 O-C-N 123.766 1.403 . . . . 0.47 111.021 -178.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 31.1 p -77.25 -44.95 28.04 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.444 -0.785 . . . . 0.61 109.802 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -122.86 -165.66 1.34 Allowed 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 109.347 -0.612 . . . . 1.16 109.347 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.63 118.31 31.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.265 -0.897 . . . . 2.91 109.589 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 50.18 33.21 22.37 Favored Glycine 0 N--CA 1.497 2.762 0 N-CA-C 110.596 -1.002 . . . . 0.51 110.596 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -108.22 -65.93 1.08 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.277 -1.131 . . . . 1.61 110.817 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -142.5 136.97 29.9 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.51 -0.744 . . . . 0.83 110.351 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.43 ' CG ' ' HA ' ' A' ' 23' ' ' ALA . 5.4 m170 -116.27 123.76 48.49 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.558 -0.713 . . . . 0.74 110.317 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.464 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 26.0 m -108.7 119.88 40.82 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.435 -0.791 . . . . 0.38 108.913 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.76 HG12 HG23 ' A' ' 47' ' ' VAL . 1.7 m -124.81 151.62 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 120.957 -1.089 . . . . 0.3 111.221 -178.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.616 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 6.4 t -118.82 105.86 11.95 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.586 -0.696 . . . . 0.63 109.155 179.207 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.737 HD13 ' CG1' ' A' ' 31' ' ' VAL . 2.5 tp -93.29 129.93 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.238 -0.914 . . . . 0.25 111.07 -179.027 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.436 ' O ' ' HB3' ' A' ' 43' ' ' TYR . 49.5 m -85.44 121.92 28.84 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.855 -0.794 . . . . 0.32 108.855 178.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.504 HG21 HG23 ' A' ' 70' ' ' VAL . 68.2 mt -127.82 109.25 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 120.939 -1.101 . . . . 0.43 110.986 -178.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -90.7 92.96 9.04 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.418 -0.801 . . . . 0.62 109.576 179.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.426 ' HB1' ' HB3' ' A' ' 69' ' ' GLN . . . -117.79 139.38 51.15 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.53 -0.731 . . . . 0.25 110.39 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.568 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 34.5 p -74.86 -13.0 60.51 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.502 -0.749 . . . . 0.32 110.729 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -129.14 148.15 51.06 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.338 -0.851 . . . . 0.42 110.311 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -72.87 -21.7 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.511 -0.743 . . . . 0.78 110.763 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.18 -23.86 57.76 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.144 -0.973 . . . . 0.5 110.844 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.637 ' HG3' HD11 ' A' ' 5' ' ' LEU . 0.2 OUTLIER -71.21 -50.45 32.94 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.296 -0.877 . . . . 0.52 110.268 -179.99 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.675 HG21 ' HB3' ' A' ' 15' ' ' PHE . 8.1 p -65.81 -31.52 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.56 -0.712 . . . . 0.26 110.339 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.4 -47.22 77.04 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.361 -0.837 . . . . 0.47 109.343 178.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.402 HG22 ' OE1' ' A' ' 76' ' ' GLU . 93.4 m -62.47 -34.7 77.35 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.705 -0.622 . . . . 0.38 109.498 178.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.675 HD11 ' HB2' ' A' ' 38' ' ' HIS . 2.0 mp -61.96 -41.02 97.51 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.583 -0.698 . . . . 0.35 109.593 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.539 ' CD1' ' HB ' ' A' ' 86' ' ' VAL . 2.7 t80 -64.64 -40.47 95.51 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.597 -0.689 . . . . 0.38 109.323 178.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.57 -38.49 87.7 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.379 -0.826 . . . . 0.41 110.254 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.884 ' HB2' HG21 ' A' ' 34' ' ' VAL . 0.4 OUTLIER -71.12 -50.73 30.46 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.483 -0.76 . . . . 0.47 110.721 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.982 HD11 HG11 ' A' ' 19' ' ' VAL . 0.2 OUTLIER -72.01 -27.71 62.91 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.316 -0.865 . . . . 0.28 110.574 179.944 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.494 ' N ' ' HG ' ' A' ' 77' ' ' LEU . . . -100.84 38.13 3.28 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.646 -1.382 . . . . 0.28 109.646 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.54 3.72 27.36 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.545 -0.974 . . . . 0.55 110.815 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.0 mt -67.36 155.91 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.15 -0.969 . . . . 0.34 109.911 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -62.25 -25.0 67.58 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.349 -0.844 . . . . 0.5 110.005 179.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.451 ' CG2' ' HB2' ' A' ' 22' ' ' GLN . 49.7 mm -73.54 163.89 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.555 -0.716 . . . . 0.39 109.92 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 92.2 t -71.6 106.28 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.409 -0.807 . . . . 0.46 110.843 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.415 ' HG2' ' HA2' ' A' ' 78' ' ' GLY . 1.4 tpm_? -121.99 114.03 20.4 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.598 -0.689 . . . . 0.4 109.585 179.164 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.51 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -120.65 170.54 9.33 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.296 -0.877 . . . . 1.63 110.38 -179.713 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.56 HG23 HG22 ' A' ' 19' ' ' VAL . 4.7 p -138.16 155.21 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.472 -0.768 . . . . 0.32 110.629 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.498 1.937 0 CA-C-O 117.738 -1.125 . . . . 0.64 110.43 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.5 mtt . . . . . 0 N--CA 1.495 1.812 0 CA-C-O 121.223 0.535 . . . . 1.35 110.372 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -162.61 -170.38 2.39 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.47 -0.769 . . . . 1.75 110.007 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 85.1 m -111.51 -53.1 2.74 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.359 -0.838 . . . . 0.54 110.045 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.6 tptt -145.68 158.35 43.86 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.381 -0.825 . . . . 0.59 110.069 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.45 ' O ' ' HB2' ' A' ' 6' ' ' ASN . 0.9 OUTLIER -102.01 12.94 36.07 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.418 -0.801 . . . . 0.75 110.734 179.8 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' ' 5' ' ' LEU . 22.5 m-80 62.25 -79.2 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.808 -0.557 . . . . 1.52 111.41 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.415 ' HB2' ' O ' ' A' ' 6' ' ' ASN . 1.2 mt-10 62.96 176.37 0.15 Allowed 'General case' 0 N--CA 1.506 2.359 0 O-C-N 121.468 -0.77 . . . . 0.61 110.965 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -98.07 -33.2 11.26 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.436 -0.79 . . . . 1.28 110.039 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.2 mp -98.39 -41.88 7.61 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.424 -0.798 . . . . 0.74 110.008 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 58.65 60.09 2.66 Favored 'General case' 0 N--CA 1.5 2.025 0 CA-C-O 121.505 0.669 . . . . 0.53 110.208 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.448 ' O ' ' HA ' ' A' ' 65' ' ' THR . 84.9 t80 -95.63 113.51 62.02 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.488 -0.757 . . . . 0.94 109.705 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.616 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 44.7 Cg_endo -70.62 116.66 4.75 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 O-C-N 124.021 1.537 . . . . 0.38 110.949 -179.431 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.5 t -119.51 142.94 33.6 Favored Pre-proline 0 N--CA 1.496 1.835 0 O-C-N 121.687 -0.633 . . . . 0.43 110.037 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -71.98 125.22 10.75 Favored 'Trans proline' 0 C--N 1.314 -1.282 0 O-C-N 123.869 1.458 . . . . 0.37 111.19 -179.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.661 ' HB3' HG21 ' A' ' 70' ' ' VAL . 23.4 m-85 -110.35 99.31 8.36 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.591 -0.693 . . . . 0.31 110.249 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.482 HG22 ' HD2' ' A' ' 18' ' ' LYS . 24.4 m -78.99 92.32 4.94 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.21 -1.033 . . . . 0.36 108.21 178.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -99.66 107.91 20.14 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.496 -0.752 . . . . 0.35 110.768 -178.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.644 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 0.0 OUTLIER -87.56 89.7 8.09 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.592 -0.693 . . . . 1.77 109.944 179.825 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.847 HG11 HD11 ' A' ' 77' ' ' LEU . 2.4 m -82.34 110.35 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.36 -0.837 . . . . 0.28 109.828 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 53.9 mtt -109.36 157.34 18.99 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.611 -0.681 . . . . 0.74 110.282 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 169.36 -164.04 37.62 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 109.986 -1.246 . . . . 0.42 109.986 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -69.59 150.85 46.64 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.53 -0.982 . . . . 1.69 110.017 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -53.74 111.7 0.78 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.583 -0.698 . . . . 0.45 110.548 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.7 mt -132.21 129.72 21.75 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.585 -0.697 . . . . 1.08 110.395 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.65 -21.65 18.91 Favored 'Trans proline' 0 C--N 1.315 -1.231 0 O-C-N 123.849 1.447 . . . . 0.72 111.171 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -81.33 -4.25 55.08 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.271 -0.893 . . . . 1.46 111.298 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.98 -58.34 8.27 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.991 -1.068 . . . . 0.6 110.332 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.505 HG12 ' HG2' ' A' ' 45' ' ' PRO . 36.0 m -62.22 -29.67 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 O-C-N 121.497 -0.752 . . . . 0.38 111.042 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.417 ' O ' HG12 ' A' ' 32' ' ' VAL . 31.9 t70 -70.22 -53.26 17.77 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.286 -0.884 . . . . 0.52 110.427 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.704 ' O ' HG12 ' A' ' 34' ' ' VAL . 0.2 OUTLIER -69.17 -35.8 76.68 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.326 -0.859 . . . . 1.41 110.352 179.6 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.743 ' CG1' HD13 ' A' ' 60' ' ' ILE . 3.8 t -61.81 -51.47 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.574 -0.704 . . . . 0.35 110.562 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.417 HG12 ' O ' ' A' ' 29' ' ' ASP . 6.1 p -67.03 -32.63 58.77 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.232 -0.917 . . . . 0.29 111.223 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.417 ' O ' ' HG2' ' A' ' 36' ' ' GLN . 0.1 OUTLIER -75.63 -50.93 14.02 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.079 -1.013 . . . . 1.08 110.509 179.806 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.815 HG21 ' CB ' ' A' ' 76' ' ' GLU . 9.9 p -67.69 -30.37 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.366 -0.834 . . . . 0.28 110.898 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.607 HG23 ' CG1' ' A' ' 62' ' ' ILE . 2.3 p -76.64 -38.2 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.073 -1.017 . . . . 0.28 110.352 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.417 ' HG2' ' O ' ' A' ' 33' ' ' GLU . 7.4 pt20 -74.05 -22.45 59.53 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.054 -1.029 . . . . 0.51 109.946 179.119 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.0 mtp-105 -68.48 -49.24 61.24 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.415 -0.803 . . . . 0.77 110.154 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.626 ' HB2' HD11 ' A' ' 73' ' ' LEU . 2.0 m-70 -84.54 -45.78 12.25 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.39 -0.819 . . . . 0.34 110.498 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.509 ' HB3' ' O ' ' A' ' 35' ' ' VAL . . . -76.83 153.79 83.11 Favored Pre-proline 0 N--CA 1.497 1.897 0 O-C-N 121.351 -0.843 . . . . 0.27 110.068 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -69.06 -34.54 16.68 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.922 1.485 . . . . 0.49 111.395 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -108.86 -178.61 21.57 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 110.063 -1.215 . . . . 0.38 110.063 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.14 148.68 22.8 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.553 -0.969 . . . . 0.52 109.648 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.473 ' HB2' HG11 ' A' ' 35' ' ' VAL . 98.0 m-85 -135.4 172.84 12.43 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.409 -0.807 . . . . 0.39 111.188 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.685 HG22 ' HD2' ' A' ' 45' ' ' PRO . 0.3 OUTLIER -142.39 156.53 63.89 Favored Pre-proline 0 N--CA 1.496 1.851 0 O-C-N 121.613 -0.68 . . . . 0.48 110.513 -179.64 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.685 ' HD2' HG22 ' A' ' 44' ' ' THR . 52.6 Cg_endo -94.64 121.94 0.34 Allowed 'Trans proline' 0 C--N 1.317 -1.125 0 C-N-CA 121.986 1.79 . . . . 0.33 110.229 179.193 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 74.2 m -80.44 101.4 9.02 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.079 -1.013 . . . . 0.41 109.572 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.665 ' CB ' HG12 ' A' ' 58' ' ' VAL . 12.1 p -76.52 141.2 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.408 -0.807 . . . . 0.37 111.525 -179.053 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.487 ' HE2' ' HB3' ' A' ' 57' ' ' SER . 0.1 OUTLIER -142.27 149.55 52.05 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.752 -0.593 . . . . 0.88 109.691 179.215 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -75.85 88.46 1.31 Allowed 'Trans proline' 0 C--N 1.314 -1.267 0 O-C-N 124.03 1.542 . . . . 0.69 110.649 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.3 m -93.23 -44.83 8.14 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.49 -0.757 . . . . 0.83 109.968 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.504 ' HB3' ' HB3' ' A' ' 55' ' ' TYR . 0.1 OUTLIER -112.85 161.12 17.31 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.531 -0.731 . . . . 1.21 110.092 179.651 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.42 158.25 15.52 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.363 -0.835 . . . . 2.08 110.54 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.93 -138.28 13.98 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.68 -1.368 . . . . 0.75 109.68 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -98.07 67.43 1.91 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.452 -1.028 . . . . 0.96 109.945 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.504 ' HB3' ' HB3' ' A' ' 51' ' ' SER . 14.9 t80 -145.47 139.4 26.82 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.445 -0.784 . . . . 1.2 110.231 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 5.0 p-80 -142.25 146.71 35.44 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.506 -0.746 . . . . 0.44 110.31 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.487 ' HB3' ' HE2' ' A' ' 48' ' ' LYS . 37.5 m -119.69 114.22 21.85 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.282 -0.886 . . . . 0.36 109.719 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.665 HG12 ' CB ' ' A' ' 47' ' ' VAL . 3.1 m -114.07 146.76 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.136 -0.977 . . . . 0.31 110.952 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.644 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 45.5 t -112.97 111.1 21.6 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.687 -0.633 . . . . 0.43 109.43 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.743 HD13 ' CG1' ' A' ' 31' ' ' VAL . 2.2 tp -92.74 129.79 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 C-N-CA 119.773 -0.771 . . . . 0.26 111.042 -179.15 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 82.7 m -82.34 137.83 34.67 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.934 -0.765 . . . . 0.32 108.934 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.607 ' CG1' HG23 ' A' ' 35' ' ' VAL . 2.3 mt -136.95 139.54 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.105 -0.997 . . . . 0.39 111.017 -179.239 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -117.99 69.55 0.78 Allowed 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 121.457 0.646 . . . . 0.45 109.299 179.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.606 ' HB1' ' HB2' ' A' ' 69' ' ' GLN . . . -99.59 135.78 40.5 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.489 -0.757 . . . . 0.28 110.269 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.616 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 58.0 p -73.73 -13.05 60.9 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.492 -0.755 . . . . 0.35 110.847 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 8.7 t60 -129.47 157.16 42.78 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.249 -0.907 . . . . 0.57 110.76 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.14 -24.88 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.534 -0.729 . . . . 1.06 110.43 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -70.96 -31.26 67.77 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.319 -0.863 . . . . 0.95 110.278 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.606 ' HB2' ' HB1' ' A' ' 64' ' ' ALA . 57.1 mt-30 -63.06 -52.74 61.59 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.472 -0.768 . . . . 0.43 110.025 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.661 HG21 ' HB3' ' A' ' 15' ' ' PHE . 7.7 p -69.31 -26.98 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.371 -0.831 . . . . 0.33 110.222 179.322 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.95 -52.27 64.72 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.345 -0.847 . . . . 0.71 109.229 178.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.5 p -63.83 -35.75 81.65 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.474 -0.767 . . . . 0.34 109.239 178.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.626 HD11 ' HB2' ' A' ' 38' ' ' HIS . 3.7 mp -57.3 -42.2 81.3 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.541 -0.724 . . . . 0.29 109.693 178.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.461 ' CD1' ' HB ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -65.03 -44.22 89.82 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 109.102 -0.703 . . . . 0.48 109.102 178.766 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -65.71 -33.84 76.81 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.548 -0.72 . . . . 0.63 110.616 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.815 ' CB ' HG21 ' A' ' 34' ' ' VAL . 0.2 OUTLIER -70.31 -54.3 13.19 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.452 -0.78 . . . . 0.44 110.629 -179.897 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.847 HD11 HG11 ' A' ' 19' ' ' VAL . 0.9 OUTLIER -73.13 -24.67 60.63 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.309 -0.87 . . . . 0.32 110.177 179.588 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -103.68 43.67 1.63 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.492 -1.443 . . . . 0.34 109.492 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.13 3.89 28.5 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.435 -1.038 . . . . 0.81 110.842 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.612 HG22 ' H ' ' A' ' 82' ' ' ILE . 2.2 mp -65.3 144.89 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.26 -0.9 . . . . 0.45 110.292 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.8 -20.87 66.03 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.332 -0.855 . . . . 1.48 110.322 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.612 ' H ' HG22 ' A' ' 80' ' ' ILE . 40.4 mm -70.46 170.13 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.431 -0.793 . . . . 0.51 109.87 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.473 ' N ' HG22 ' A' ' 82' ' ' ILE . 75.3 t -62.32 112.75 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.335 -0.853 . . . . 0.47 110.544 -179.603 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.31 161.64 21.67 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.733 -0.605 . . . . 1.18 110.113 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.488 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 1.7 ttp -157.72 160.19 37.65 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.401 -0.812 . . . . 1.13 109.882 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.538 ' HA ' ' HA ' ' A' ' 19' ' ' VAL . 11.3 p -134.1 146.46 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.32 -0.863 . . . . 0.33 110.524 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 34.8 mt . . . . . 0 N--CA 1.5 2.063 0 CA-C-O 117.646 -1.169 . . . . 0.51 110.488 -179.807 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.406 ' SD ' ' HB3' ' A' ' 71' ' ' GLU . 9.8 ptm . . . . . 0 N--CA 1.497 1.891 0 CA-C-O 121.312 0.577 . . . . 1.02 111.173 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.82 170.6 9.76 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.648 -0.657 . . . . 3.46 110.866 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.419 ' O ' ' C ' ' A' ' 4' ' ' LYS . 26.4 p -129.3 -52.17 1.19 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.457 -0.777 . . . . 0.64 110.79 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.459 ' HE2' ' CE1' ' A' ' 66' ' ' HIS . 5.6 ptmt 33.54 68.62 0.16 Allowed 'General case' 0 N--CA 1.509 2.496 0 CA-C-O 121.587 0.708 . . . . 1.07 111.236 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.498 HD21 ' HG3' ' A' ' 69' ' ' GLN . 0.4 OUTLIER -69.0 151.83 46.01 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.444 -0.785 . . . . 0.92 111.062 -179.461 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.414 ' HA ' ' HG3' ' A' ' 10' ' ' GLU . 0.5 OUTLIER 51.61 61.43 3.23 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.333 0.587 . . . . 1.08 111.178 179.487 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -129.02 -57.19 1.17 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.306 -0.871 . . . . 0.63 110.021 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -110.11 -35.92 5.98 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.648 -0.658 . . . . 1.08 110.413 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.4 mp -96.05 -56.15 2.74 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.401 -0.812 . . . . 0.98 110.331 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.414 ' HG3' ' HA ' ' A' ' 6' ' ' ASN . 3.2 mt-10 54.77 33.71 20.21 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.801 -0.562 . . . . 0.74 110.803 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.479 ' O ' ' HA ' ' A' ' 65' ' ' THR . 69.7 t80 -121.66 114.41 31.39 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.329 -0.857 . . . . 0.82 109.8 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.507 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 44.3 Cg_endo -70.3 108.94 2.29 Favored 'Trans proline' 0 C--N 1.314 -1.272 0 O-C-N 123.911 1.479 . . . . 0.33 110.51 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.5 t -129.65 142.43 45.27 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.658 -0.651 . . . . 0.36 110.54 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.17 129.54 15.23 Favored 'Trans proline' 0 C--N 1.315 -1.199 0 O-C-N 123.917 1.483 . . . . 0.44 110.334 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.571 ' HB3' HG21 ' A' ' 70' ' ' VAL . 32.8 m-85 -108.29 100.76 10.03 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.595 -0.69 . . . . 0.33 110.32 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.9 m -74.19 92.26 2.2 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.407 -0.96 . . . . 0.39 108.407 178.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.599 ' O ' HG22 ' A' ' 60' ' ' ILE . 3.3 m-85 -102.8 104.41 14.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.441 -0.787 . . . . 0.35 110.611 -178.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.605 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 0.0 OUTLIER -78.99 93.47 5.1 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.573 -0.704 . . . . 2.0 109.484 179.605 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 1.004 HG11 HD11 ' A' ' 77' ' ' LEU . 24.8 t -78.36 95.3 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.463 -0.773 . . . . 0.26 109.15 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.454 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 53.7 mtt -97.71 153.57 18.16 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.577 -0.702 . . . . 1.02 110.535 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 168.4 -151.94 19.37 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.877 -1.289 . . . . 0.31 109.877 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.565 ' HA ' ' HA ' ' A' ' 55' ' ' TYR . 5.9 mt-30 -78.19 170.26 16.91 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.458 -1.025 . . . . 1.13 110.414 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.434 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -78.0 101.33 6.85 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.29 -0.881 . . . . 0.43 109.816 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.526 ' HG ' ' HD2' ' A' ' 25' ' ' PRO . 1.0 OUTLIER -130.33 136.37 28.89 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.49 -0.756 . . . . 1.14 110.548 -179.404 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.526 ' HD2' ' HG ' ' A' ' 24' ' ' LEU . 47.3 Cg_endo -72.92 -20.48 22.18 Favored 'Trans proline' 0 C--N 1.316 -1.181 0 O-C-N 123.822 1.433 . . . . 0.49 110.997 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -72.07 -13.74 61.67 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.351 -0.843 . . . . 0.69 111.213 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.8 mt -56.83 -64.01 1.01 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.213 -0.929 . . . . 0.53 110.577 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.6 p -60.94 -30.84 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 O-C-N 121.388 -0.82 . . . . 0.3 111.021 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -64.35 -62.39 1.63 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.395 -0.816 . . . . 0.51 110.389 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.681 ' O ' HG12 ' A' ' 34' ' ' VAL . 5.5 tp60 -64.35 -32.53 74.18 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.354 -0.841 . . . . 0.6 110.724 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.706 HG22 HD12 ' A' ' 60' ' ' ILE . 2.3 t -59.03 -56.67 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.269 -0.894 . . . . 0.26 110.346 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.402 ' HA ' HG12 ' A' ' 35' ' ' VAL . 8.6 p -68.49 -28.36 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.381 -0.824 . . . . 0.31 111.548 -179.151 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.417 ' O ' ' HG2' ' A' ' 36' ' ' GLN . 1.0 OUTLIER -76.02 -55.97 5.1 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.031 -1.043 . . . . 0.52 110.773 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.834 HG21 ' CB ' ' A' ' 76' ' ' GLU . 5.7 p -66.93 -25.8 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.428 -0.795 . . . . 0.27 111.339 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.64 HG11 ' HB2' ' A' ' 43' ' ' TYR . 2.4 p -82.64 -35.02 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.013 -1.055 . . . . 0.25 110.828 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.417 ' HG2' ' O ' ' A' ' 33' ' ' GLU . 13.8 pt20 -76.73 -25.98 54.13 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.066 -1.021 . . . . 0.52 110.2 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 25.7 mtm-85 -75.96 -39.7 55.45 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.267 -0.896 . . . . 1.29 110.533 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.754 ' HB2' HD11 ' A' ' 73' ' ' LEU . 0.5 OUTLIER -90.26 -45.71 8.89 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.285 -0.884 . . . . 0.65 110.691 -179.818 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -98.52 150.95 37.22 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.56 -0.713 . . . . 0.29 110.149 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -71.3 140.72 37.6 Favored 'Trans proline' 0 C--N 1.313 -1.302 0 O-C-N 123.823 1.433 . . . . 0.41 110.385 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.83 164.77 32.29 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.597 -1.401 . . . . 0.54 109.597 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -99.98 139.56 35.47 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.376 -1.073 . . . . 0.51 110.117 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.64 ' HB2' HG11 ' A' ' 35' ' ' VAL . 93.0 m-85 -119.21 170.59 8.95 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.527 -0.733 . . . . 0.37 110.541 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.666 HG22 ' HD2' ' A' ' 45' ' ' PRO . 0.2 OUTLIER -142.44 153.91 62.97 Favored Pre-proline 0 N--CA 1.498 1.974 0 O-C-N 121.423 -0.798 . . . . 0.45 110.836 -179.136 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.666 ' HD2' HG22 ' A' ' 44' ' ' THR . 52.6 Cg_endo -96.36 121.16 0.22 Allowed 'Trans proline' 0 C--N 1.321 -0.9 0 C-N-CA 122.015 1.81 . . . . 0.29 110.104 178.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 53.2 m -78.81 97.6 6.0 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.129 -0.982 . . . . 0.36 109.686 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.648 HG23 HG12 ' A' ' 58' ' ' VAL . 11.5 p -76.53 139.22 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.515 -0.74 . . . . 0.43 111.479 -179.065 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.3 pttt -142.53 152.53 60.33 Favored Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.684 -0.635 . . . . 1.97 109.884 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -77.16 81.49 2.6 Favored 'Trans proline' 0 C--N 1.313 -1.308 0 O-C-N 123.934 1.492 . . . . 0.67 110.49 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.478 ' HB2' ' HB2' ' A' ' 57' ' ' SER . 0.4 OUTLIER -90.15 -46.55 8.38 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.424 -0.797 . . . . 1.0 110.07 179.829 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.442 ' HB3' ' CB ' ' A' ' 55' ' ' TYR . 0.1 OUTLIER -102.73 166.23 10.61 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.45 -0.781 . . . . 1.36 110.202 179.767 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.39 160.07 14.74 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.422 -0.799 . . . . 1.66 110.586 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.44 -136.24 13.75 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.563 -1.415 . . . . 0.79 109.563 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -99.23 64.88 1.39 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.578 -0.954 . . . . 0.93 110.01 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.565 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 17.6 m-85 -139.0 139.27 37.82 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.494 -0.754 . . . . 1.08 110.394 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.434 ' HB2' ' HA ' ' A' ' 23' ' ' ALA . 0.2 OUTLIER -137.5 142.44 41.49 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.561 -0.712 . . . . 0.91 110.417 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.478 ' HB2' ' HB2' ' A' ' 50' ' ' SER . 17.1 m -116.87 107.84 15.1 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.601 -0.687 . . . . 0.33 109.445 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.648 HG12 HG23 ' A' ' 47' ' ' VAL . 3.1 m -108.23 149.8 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.336 -0.853 . . . . 0.33 110.85 -179.155 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.605 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 9.1 t -114.76 110.08 19.18 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.938 -0.764 . . . . 0.5 108.938 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.706 HD12 HG22 ' A' ' 31' ' ' VAL . 6.6 tt -92.43 131.06 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.228 -0.92 . . . . 0.31 111.423 -178.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.406 ' O ' ' HB3' ' A' ' 43' ' ' TYR . 91.9 m -86.13 130.21 34.6 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.684 -0.858 . . . . 0.36 108.684 178.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.577 HD11 HD13 ' A' ' 60' ' ' ILE . 59.3 mt -139.75 99.16 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.004 -1.06 . . . . 0.32 111.086 -179.069 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -84.02 97.97 9.58 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.277 -0.889 . . . . 0.37 108.925 178.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -119.05 138.79 52.61 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.533 -0.729 . . . . 0.24 111.19 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.507 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 37.8 p -74.23 -9.93 59.1 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.619 -0.676 . . . . 0.37 110.475 179.008 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.459 ' CE1' ' HE2' ' A' ' 4' ' ' LYS . 2.5 t-80 -129.51 156.97 43.29 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.398 -0.814 . . . . 0.6 110.201 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.421 ' O ' HG12 ' A' ' 70' ' ' VAL . 0.8 OUTLIER -82.37 -22.66 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.476 -0.765 . . . . 0.82 111.075 179.895 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.41 ' HB3' ' HA ' ' A' ' 3' ' ' THR . 39.5 mt-10 -77.33 -30.27 53.92 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.057 -1.027 . . . . 0.97 110.928 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.509 ' O ' HD13 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -61.74 -44.58 96.63 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.3 -0.875 . . . . 0.54 110.214 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.571 HG21 ' HB3' ' A' ' 15' ' ' PHE . 9.2 p -71.77 -29.31 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.234 -0.917 . . . . 0.3 110.238 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.406 ' HB3' ' SD ' ' A' ' 1' ' ' MET . 0.1 OUTLIER -65.83 -47.5 74.81 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.31 -0.869 . . . . 0.68 109.32 179.036 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.532 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . 17.9 p -65.36 -35.17 80.16 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.654 -0.654 . . . . 0.33 109.466 178.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.754 HD11 ' HB2' ' A' ' 38' ' ' HIS . 3.8 mp -61.86 -37.23 83.72 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.367 -0.833 . . . . 0.28 109.942 179.018 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.549 ' CD1' ' HB ' ' A' ' 86' ' ' VAL . 0.8 OUTLIER -67.74 -52.78 33.46 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.386 -0.821 . . . . 0.59 109.715 179.28 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.532 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 10.6 pt-20 -63.04 -28.03 69.81 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.375 -0.828 . . . . 0.64 110.705 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.834 ' CB ' HG21 ' A' ' 34' ' ' VAL . 0.1 OUTLIER -71.29 -48.05 53.15 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.277 -0.889 . . . . 0.44 110.003 179.454 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 1.004 HD11 HG11 ' A' ' 19' ' ' VAL . 0.3 OUTLIER -76.94 -28.09 55.1 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.468 -0.77 . . . . 0.33 110.198 179.519 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.638 ' HA2' ' HG2' ' A' ' 84' ' ' ARG . . . -103.49 44.96 1.39 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.701 -1.36 . . . . 0.32 109.701 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.1 3.83 36.39 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.626 -0.926 . . . . 0.87 110.778 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.614 HD12 ' HG2' ' A' ' 84' ' ' ARG . 1.7 mp -73.87 154.87 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.276 -0.89 . . . . 0.39 110.03 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.0 -19.91 66.01 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.442 -0.786 . . . . 1.45 110.638 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.465 HG22 ' HB2' ' A' ' 22' ' ' GLN . 51.9 mm -70.19 169.27 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.395 -0.815 . . . . 0.5 109.985 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.457 ' N ' HG22 ' A' ' 82' ' ' ILE . 90.3 t -62.47 104.6 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.439 -0.788 . . . . 0.42 110.445 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.638 ' HG2' ' HA2' ' A' ' 78' ' ' GLY . 0.1 OUTLIER -121.82 112.61 18.57 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.692 -0.484 . . . . 0.54 109.692 179.911 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.518 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 0.2 OUTLIER -135.5 166.37 23.36 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.287 -0.883 . . . . 1.31 110.419 -179.611 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.557 HG23 HG22 ' A' ' 19' ' ' VAL . 5.1 p -139.2 157.06 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.393 -0.817 . . . . 0.27 110.583 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.499 2.003 0 CA-C-O 118.843 -0.599 . . . . 0.48 110.459 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.795 0 CA-C-O 120.981 0.419 . . . . 1.58 110.767 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? 65.36 106.58 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.161 0 CA-C-O 121.431 0.634 . . . . 1.83 110.718 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 87.4 m -97.74 140.04 32.72 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.54 -0.725 . . . . 0.75 109.883 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -138.26 128.13 25.35 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.572 -0.705 . . . . 0.77 110.408 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.647 HD13 HD11 ' A' ' 9' ' ' LEU . 0.5 OUTLIER 56.4 -172.06 0.08 Allowed 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 121.296 0.57 . . . . 1.46 111.148 -179.886 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -136.42 78.23 1.7 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.435 -0.791 . . . . 1.87 110.271 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 52.05 58.18 5.71 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.701 -0.625 . . . . 0.65 110.798 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.9 mt -113.3 -44.18 3.27 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.378 -0.826 . . . . 0.89 110.275 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.647 HD11 HD13 ' A' ' 5' ' ' LEU . 1.4 mp -81.18 -48.13 12.51 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.347 -0.846 . . . . 1.09 109.936 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 60.38 50.26 6.22 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.341 0.591 . . . . 0.96 111.082 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.514 ' O ' ' HA ' ' A' ' 65' ' ' THR . 7.3 m-85 -96.55 117.32 66.13 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 121.371 -0.831 . . . . 1.04 109.001 178.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.651 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 42.6 Cg_endo -68.13 106.17 1.32 Allowed 'Trans proline' 0 C--N 1.313 -1.312 0 O-C-N 123.779 1.41 . . . . 0.5 111.107 -178.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.4 t -129.15 146.75 62.07 Favored Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 121.84 -0.537 . . . . 0.37 110.441 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.69 123.47 9.04 Favored 'Trans proline' 0 C--N 1.314 -1.238 0 O-C-N 123.864 1.455 . . . . 0.34 110.49 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.646 ' HB2' HG23 ' A' ' 62' ' ' ILE . 21.8 m-85 -104.42 99.47 9.17 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.508 -0.745 . . . . 0.34 110.587 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.8 m -75.7 93.35 3.09 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.085 -1.079 . . . . 0.43 108.085 178.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.57 ' O ' HG22 ' A' ' 60' ' ' ILE . 2.7 m-85 -101.91 109.74 21.56 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.306 -0.871 . . . . 0.33 111.306 -178.041 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.597 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 0.0 OUTLIER -81.66 91.15 6.38 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.533 -0.729 . . . . 1.17 109.331 179.06 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 1.083 HG11 HD11 ' A' ' 77' ' ' LEU . 38.4 t -79.25 96.96 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.666 -0.646 . . . . 0.3 109.955 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.429 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 58.6 mtm -102.17 148.4 25.46 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.405 -0.81 . . . . 0.65 110.028 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.443 ' HA3' ' O ' ' A' ' 83' ' ' VAL . . . 166.77 -142.35 7.55 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 110.035 -1.226 . . . . 0.22 110.035 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.622 ' HG3' HG21 ' A' ' 82' ' ' ILE . 0.0 OUTLIER -66.25 153.93 41.23 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.523 -0.987 . . . . 0.44 110.57 -179.934 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -96.58 99.1 10.76 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.568 -0.708 . . . . 0.33 110.232 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -128.71 155.82 78.55 Favored Pre-proline 0 N--CA 1.498 1.946 0 O-C-N 121.479 -0.763 . . . . 0.38 110.546 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -72.56 -24.58 18.66 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 O-C-N 123.879 1.463 . . . . 0.43 111.367 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.27 -5.62 45.57 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.182 -0.948 . . . . 0.57 111.291 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.509 ' CD2' HG21 ' A' ' 58' ' ' VAL . 0.3 OUTLIER -61.14 -55.66 29.83 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.107 -0.995 . . . . 1.0 110.266 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.614 HG12 ' HG2' ' A' ' 45' ' ' PRO . 26.8 m -66.99 -29.48 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.426 -0.796 . . . . 0.37 110.69 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -66.83 -53.42 32.88 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.364 -0.835 . . . . 0.42 110.33 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.726 ' O ' HG12 ' A' ' 34' ' ' VAL . 0.3 OUTLIER -68.29 -34.29 75.89 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.25 -0.906 . . . . 1.42 110.376 179.594 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.622 HG22 HD22 ' A' ' 77' ' ' LEU . 2.7 t -57.58 -56.09 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.405 -0.81 . . . . 0.25 110.268 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.8 p -66.81 -32.98 60.45 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.352 -0.842 . . . . 0.34 111.266 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.19 -54.93 7.21 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.14 -0.975 . . . . 0.85 110.772 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.893 HG21 ' CB ' ' A' ' 76' ' ' GLU . 8.2 p -66.66 -29.68 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 121.412 -0.805 . . . . 0.27 111.153 -179.445 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.726 HG11 ' HB2' ' A' ' 43' ' ' TYR . 2.4 p -78.08 -30.66 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.058 -1.026 . . . . 0.33 110.304 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -73.67 -38.32 64.97 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.201 -0.937 . . . . 0.67 110.063 179.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.27 -25.14 65.91 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.526 -0.734 . . . . 1.45 111.199 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.446 ' CD2' HD11 ' A' ' 73' ' ' LEU . 1.1 m-70 -103.39 -45.62 4.82 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.291 -0.881 . . . . 1.0 110.792 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -106.65 149.51 38.49 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.424 -0.798 . . . . 0.48 110.173 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -71.53 142.4 40.31 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 O-C-N 123.858 1.452 . . . . 0.7 110.652 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.21 156.26 21.25 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.751 -1.34 . . . . 0.46 109.751 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -89.97 140.49 29.58 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.463 -1.021 . . . . 0.55 110.127 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.726 ' HB2' HG11 ' A' ' 35' ' ' VAL . 67.8 m-85 -121.76 169.07 11.11 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.556 -0.715 . . . . 0.34 110.39 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.695 HG22 ' HD2' ' A' ' 45' ' ' PRO . 2.0 m -142.4 153.19 62.24 Favored Pre-proline 0 N--CA 1.497 1.92 0 O-C-N 121.374 -0.829 . . . . 0.54 110.912 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.695 ' HD2' HG22 ' A' ' 44' ' ' THR . 54.3 Cg_endo -95.94 125.06 0.31 Allowed 'Trans proline' 0 C--N 1.32 -0.957 0 C-N-CA 122.022 1.814 . . . . 0.45 110.389 178.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 55.5 m -83.04 94.39 7.78 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.09 -1.006 . . . . 0.49 109.468 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.674 HG23 HG12 ' A' ' 58' ' ' VAL . 14.1 p -76.76 141.66 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.453 -0.779 . . . . 0.45 111.543 -178.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.43 ' HG2' ' O ' ' A' ' 57' ' ' SER . 0.1 OUTLIER -142.46 149.62 51.65 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.724 -0.61 . . . . 0.57 109.732 179.293 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -75.04 84.63 1.64 Allowed 'Trans proline' 0 C--N 1.315 -1.197 0 O-C-N 123.9 1.474 . . . . 0.66 110.472 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -91.18 -46.47 8.07 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.484 -0.76 . . . . 1.05 109.964 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 13.9 m -110.21 163.27 13.79 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.542 -0.724 . . . . 0.66 110.188 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.56 158.99 15.18 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.462 -0.774 . . . . 1.58 110.265 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.52 -135.78 12.76 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.579 -1.408 . . . . 0.58 109.579 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -103.37 57.76 0.75 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.414 -1.051 . . . . 1.23 110.199 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -135.4 130.21 34.51 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.376 -0.827 . . . . 0.5 110.131 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -132.59 140.53 48.28 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.504 -0.747 . . . . 0.69 110.383 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.43 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 28.9 m -108.0 108.93 20.27 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.649 -0.657 . . . . 0.34 109.387 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.674 HG12 HG23 ' A' ' 47' ' ' VAL . 2.9 m -109.86 152.75 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.143 -0.973 . . . . 0.39 110.858 -179.315 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.597 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 1.7 t -116.59 111.27 19.65 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.613 -0.884 . . . . 0.74 108.613 178.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.599 ' CD1' HG13 ' A' ' 31' ' ' VAL . 10.5 tt -92.21 127.9 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.218 -0.926 . . . . 0.4 111.296 -178.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.481 ' O ' ' HB3' ' A' ' 43' ' ' TYR . 65.9 m -90.91 141.16 29.12 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 109.047 -0.723 . . . . 0.43 109.047 179.136 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.646 HD12 HG23 ' A' ' 35' ' ' VAL . 7.8 tt -162.54 141.76 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.012 -1.055 . . . . 0.43 110.998 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -108.0 87.56 2.53 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.509 -0.744 . . . . 0.69 109.317 178.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.442 ' HB3' ' CD2' ' A' ' 15' ' ' PHE . . . -106.63 136.73 45.91 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.46 -0.775 . . . . 0.33 110.524 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.651 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 40.2 p -66.98 -23.47 65.95 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.489 -0.757 . . . . 0.45 110.843 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -131.47 157.88 42.34 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.193 -0.942 . . . . 0.57 110.525 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.2 tt -75.73 -19.1 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.459 -0.776 . . . . 0.43 110.676 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.43 -35.42 79.22 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.243 -0.911 . . . . 0.44 110.403 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -65.21 -48.94 71.61 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.457 -0.777 . . . . 0.88 110.351 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.557 HG23 HG21 ' A' ' 62' ' ' ILE . 8.0 p -70.23 -25.23 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.448 -0.782 . . . . 0.27 110.485 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -68.7 -50.5 50.35 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.195 -0.94 . . . . 0.39 109.584 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 20.6 p -61.47 -40.01 92.97 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 109.028 -0.73 . . . . 0.38 109.028 178.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.536 HD23 HD12 ' A' ' 62' ' ' ILE . 3.1 mp -59.65 -39.07 83.16 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.665 -0.647 . . . . 0.31 109.709 178.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.66 ' CD1' ' HB ' ' A' ' 86' ' ' VAL . 0.2 OUTLIER -60.36 -44.98 95.06 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.977 -0.749 . . . . 0.44 108.977 178.653 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -69.07 -33.21 73.19 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.59 -0.693 . . . . 1.22 110.322 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.893 ' CB ' HG21 ' A' ' 34' ' ' VAL . 0.3 OUTLIER -64.74 -50.0 68.6 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.464 -0.773 . . . . 0.42 109.883 179.48 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 1.083 HD11 HG11 ' A' ' 19' ' ' VAL . 0.4 OUTLIER -78.25 -26.57 47.32 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.42 -0.8 . . . . 0.31 109.698 178.995 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.501 ' N ' ' HG ' ' A' ' 77' ' ' LEU . . . -105.94 56.25 0.52 Allowed Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.367 -1.493 . . . . 0.26 109.367 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.18 4.31 28.83 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.643 -0.916 . . . . 1.44 110.573 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.9 mp -60.06 155.27 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.404 -0.81 . . . . 0.43 110.094 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.99 -3.93 53.35 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.205 -0.935 . . . . 1.26 111.547 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.622 HG21 ' HG3' ' A' ' 22' ' ' GLN . 39.2 mm -84.71 -104.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.105 -0.997 . . . . 0.37 109.975 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.443 ' O ' ' HA3' ' A' ' 21' ' ' GLY . 84.7 t -124.32 118.73 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 120.943 -1.098 . . . . 0.33 110.263 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.33 113.63 19.66 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.517 -0.739 . . . . 1.13 109.488 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.476 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 3.1 mtm -139.95 157.12 46.19 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.361 -0.837 . . . . 0.71 110.179 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.66 ' HB ' ' CD1' ' A' ' 74' ' ' TYR . 8.1 p -141.74 152.88 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.362 -0.837 . . . . 0.27 110.787 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.413 ' HA ' HD22 ' A' ' 87' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.5 2.042 0 CA-C-O 117.52 -1.229 . . . . 0.64 110.558 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.123 0.487 . . . . 1.37 110.216 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.8 mtmp? -110.09 123.36 49.57 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.539 -0.726 . . . . 0.9 109.832 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 16.7 p -70.05 -51.26 33.45 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.316 -0.865 . . . . 0.78 109.997 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.05 30.55 2.47 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.615 -0.678 . . . . 0.98 110.175 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.44 142.45 43.68 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.334 -0.854 . . . . 1.43 110.399 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -72.21 163.26 28.24 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.461 -0.774 . . . . 1.35 110.509 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -143.26 171.8 13.61 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.405 -0.81 . . . . 0.69 110.703 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.421 HD13 ' HA ' ' A' ' 8' ' ' LEU . 0.4 OUTLIER -114.31 56.68 0.71 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.495 -0.753 . . . . 1.31 110.215 179.875 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.8 mp -115.88 -57.27 2.24 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.347 -0.846 . . . . 1.01 109.887 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 55.9 39.3 30.63 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.808 -0.558 . . . . 0.91 110.554 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.479 ' O ' ' HA ' ' A' ' 65' ' ' THR . 73.6 t80 -109.66 119.33 48.14 Favored Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 121.386 -0.821 . . . . 0.82 109.767 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.508 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 43.9 Cg_endo -70.41 111.36 2.92 Favored 'Trans proline' 0 C--N 1.314 -1.277 0 O-C-N 123.951 1.501 . . . . 0.43 110.539 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.6 t -136.62 144.55 47.6 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 121.587 -0.695 . . . . 0.34 110.41 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -71.27 126.44 12.32 Favored 'Trans proline' 0 C--N 1.315 -1.188 0 O-C-N 123.997 1.525 . . . . 0.37 110.306 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.623 ' HB2' HG23 ' A' ' 62' ' ' ILE . 25.0 m-85 -107.01 99.75 9.29 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.557 -0.714 . . . . 0.36 110.451 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.7 m -78.2 92.68 4.48 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.3 -1.0 . . . . 0.38 108.3 178.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.473 ' O ' HG22 ' A' ' 60' ' ' ILE . 3.4 m-85 -100.53 105.9 17.37 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.535 -0.728 . . . . 0.37 110.959 -178.308 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.586 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 0.0 OUTLIER -80.8 91.77 5.98 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.351 -0.843 . . . . 1.34 109.358 179.341 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 1.081 HG11 HD11 ' A' ' 77' ' ' LEU . 21.9 t -78.58 95.9 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.462 -0.774 . . . . 0.28 109.736 -179.528 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 7.1 ttt -100.68 151.85 21.16 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.55 -0.719 . . . . 1.45 110.052 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 171.47 -165.08 38.02 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.95 -1.26 . . . . 0.3 109.95 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.462 ' HB3' HG21 ' A' ' 82' ' ' ILE . 4.5 tt0 -71.38 154.58 41.46 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.501 -0.999 . . . . 1.51 110.142 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.46 109.65 0.29 Allowed 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.747 -0.595 . . . . 0.53 110.707 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.589 HD13 ' HD2' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -129.35 114.71 18.4 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.574 -0.704 . . . . 0.71 110.112 -179.602 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.589 ' HD2' HD13 ' A' ' 24' ' ' LEU . 44.0 Cg_endo -71.67 -26.0 20.04 Favored 'Trans proline' 0 N--CA 1.49 1.293 0 O-C-N 123.828 1.436 . . . . 0.47 111.108 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -81.92 -6.42 59.09 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.216 -0.927 . . . . 0.68 111.193 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.626 HD23 HG21 ' A' ' 58' ' ' VAL . 0.3 OUTLIER -60.8 -50.29 74.05 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.985 -1.072 . . . . 0.68 110.512 -179.88 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.441 HG23 ' HD2' ' A' ' 45' ' ' PRO . 8.9 p -65.67 -34.08 67.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.392 -0.818 . . . . 0.33 110.349 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -66.68 -46.79 74.52 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.338 -0.851 . . . . 0.62 109.812 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.682 ' O ' HG12 ' A' ' 34' ' ' VAL . 3.3 tp60 -72.14 -30.79 65.37 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.476 -0.765 . . . . 1.18 110.252 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.627 HG22 HD22 ' A' ' 77' ' ' LEU . 2.3 t -62.79 -46.26 96.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.412 -0.805 . . . . 0.26 110.277 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.8 p -76.12 -35.06 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.36 -0.838 . . . . 0.29 111.583 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.575 ' CG ' ' HA ' ' A' ' 30' ' ' GLN . 0.5 OUTLIER -76.74 -35.17 57.93 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.709 -1.244 . . . . 0.52 110.867 -179.733 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.843 HG21 ' CB ' ' A' ' 76' ' ' GLU . 6.9 p -78.43 -34.02 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.017 -1.052 . . . . 0.27 110.014 179.415 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.95 HG23 HD12 ' A' ' 62' ' ' ILE . 3.9 p -74.01 -31.52 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.271 -0.893 . . . . 0.38 109.607 178.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -75.59 -35.05 60.67 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.323 -0.861 . . . . 1.62 109.649 178.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 28.1 mtm180 -66.42 -24.41 66.45 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.485 -0.759 . . . . 0.84 110.788 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 2.1 m80 -104.96 -45.77 4.46 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.216 -0.927 . . . . 0.89 110.742 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -96.0 153.64 39.13 Favored Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.428 -0.795 . . . . 0.55 109.886 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -69.03 -39.5 7.82 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 O-C-N 123.859 1.452 . . . . 0.93 111.317 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -95.1 146.83 18.37 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.871 -1.292 . . . . 0.46 109.871 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -77.96 159.97 28.5 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.454 -1.027 . . . . 0.62 109.936 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.57 ' HB2' HG21 ' A' ' 35' ' ' VAL . 40.5 m-85 -143.32 167.51 22.0 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.455 -0.778 . . . . 0.42 110.717 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.772 HG22 ' HD2' ' A' ' 45' ' ' PRO . 2.0 m -142.33 155.51 64.47 Favored Pre-proline 0 N--CA 1.499 1.989 0 O-C-N 121.47 -0.769 . . . . 0.42 110.99 -179.245 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.772 ' HD2' HG22 ' A' ' 44' ' ' THR . 51.5 Cg_endo -95.95 137.62 0.67 Allowed 'Trans proline' 0 C--N 1.321 -0.881 0 C-N-CA 121.97 1.78 . . . . 0.56 110.447 179.017 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.462 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 72.4 m -95.6 100.73 12.43 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.217 -0.927 . . . . 0.44 109.463 179.246 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.635 ' CB ' HG12 ' A' ' 58' ' ' VAL . 13.2 p -76.19 141.56 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.413 -0.805 . . . . 0.38 111.485 -179.023 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.517 ' HE2' ' HB3' ' A' ' 57' ' ' SER . 0.1 OUTLIER -142.06 151.96 60.38 Favored Pre-proline 0 N--CA 1.494 1.765 0 N-CA-C 109.479 -0.563 . . . . 0.71 109.479 179.039 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -75.09 85.19 1.56 Allowed 'Trans proline' 0 C--N 1.313 -1.324 0 O-C-N 124.01 1.532 . . . . 0.5 110.959 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.529 ' HB2' ' HB2' ' A' ' 57' ' ' SER . 1.2 m -91.21 -47.95 7.22 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.496 -0.752 . . . . 0.93 109.606 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.413 ' HB2' ' HB3' ' A' ' 55' ' ' TYR . 4.0 m -109.57 159.26 17.24 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.628 -0.67 . . . . 0.58 110.028 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.98 160.92 14.0 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.393 -0.817 . . . . 1.29 110.466 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.66 -133.81 11.96 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.549 -1.42 . . . . 0.57 109.549 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -100.93 64.66 1.07 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.511 -0.994 . . . . 1.52 109.883 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.413 ' HB3' ' HB2' ' A' ' 51' ' ' SER . 1.6 t80 -145.06 144.79 31.16 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.346 -0.846 . . . . 0.89 110.536 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -145.13 152.55 40.22 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.492 -0.755 . . . . 0.42 110.503 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.529 ' HB2' ' HB2' ' A' ' 50' ' ' SER . 0.8 OUTLIER -124.47 110.05 14.02 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.397 -0.814 . . . . 1.01 109.758 -179.962 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.635 HG12 ' CB ' ' A' ' 47' ' ' VAL . 2.5 m -109.85 147.66 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.122 -0.986 . . . . 0.33 110.711 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.586 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 1.0 OUTLIER -115.24 114.73 25.61 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.965 -0.754 . . . . 0.83 108.965 179.209 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.607 ' CD1' HG13 ' A' ' 31' ' ' VAL . 3.9 tt -92.18 128.4 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.232 -0.917 . . . . 0.4 110.843 -178.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.404 ' O ' ' HB3' ' A' ' 43' ' ' TYR . 26.3 m -93.88 135.09 35.56 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.707 -0.849 . . . . 0.42 108.707 179.151 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.95 HD12 HG23 ' A' ' 35' ' ' VAL . 3.9 tt -162.46 118.61 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.171 -0.956 . . . . 0.36 111.165 -179.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -92.45 100.19 12.79 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.474 -0.766 . . . . 0.53 109.005 178.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -115.01 139.55 49.76 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.509 -0.745 . . . . 0.31 110.99 -178.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.508 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 47.6 p -73.47 -6.63 47.62 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.559 -0.713 . . . . 0.44 110.817 179.194 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 20.8 m80 -129.4 136.31 49.8 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.322 -0.862 . . . . 1.18 110.433 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.4 tt -72.11 -24.0 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.483 -0.761 . . . . 0.74 109.699 178.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.14 -32.9 61.47 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.411 -0.806 . . . . 0.52 110.412 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -60.96 -47.78 84.87 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.477 -0.764 . . . . 0.65 110.277 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.576 HG21 ' HB3' ' A' ' 15' ' ' PHE . 11.2 p -71.85 -27.49 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.43 -0.794 . . . . 0.32 110.377 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -71.36 -44.67 64.58 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.16 -0.962 . . . . 0.45 109.132 178.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 95.4 m -63.11 -37.61 87.87 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 109.03 -0.73 . . . . 0.41 109.03 178.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.544 HD21 ' HA ' ' A' ' 35' ' ' VAL . 2.7 mp -62.96 -39.19 93.9 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.716 -0.615 . . . . 0.34 109.559 178.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.587 ' CD1' ' HB ' ' A' ' 86' ' ' VAL . 0.5 OUTLIER -60.37 -44.93 95.15 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.519 -0.738 . . . . 0.62 109.068 178.497 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.47 -35.46 80.53 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.587 -0.696 . . . . 0.83 110.525 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.843 ' CB ' HG21 ' A' ' 34' ' ' VAL . 0.2 OUTLIER -69.46 -51.68 33.9 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.48 -0.763 . . . . 0.47 110.421 179.886 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 1.081 HD11 HG11 ' A' ' 19' ' ' VAL . 0.4 OUTLIER -69.38 -28.4 66.15 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.377 -0.827 . . . . 0.3 110.335 179.729 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.476 ' N ' ' HG ' ' A' ' 77' ' ' LEU . . . -107.42 42.9 1.81 Allowed Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.609 -1.397 . . . . 0.33 109.609 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.7 4.32 51.91 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.342 -1.093 . . . . 0.73 110.694 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.402 ' H ' HD12 ' A' ' 80' ' ' ILE . 1.6 mp -69.25 153.21 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.248 -0.907 . . . . 0.43 110.268 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -68.24 -17.47 64.31 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.481 -0.762 . . . . 0.58 110.312 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.483 HG22 ' N ' ' A' ' 83' ' ' VAL . 51.8 mm -70.75 170.12 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.547 -0.72 . . . . 0.53 110.043 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.483 ' N ' HG22 ' A' ' 82' ' ' ILE . 78.4 t -62.4 114.9 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.37 -0.831 . . . . 0.58 110.596 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 5.4 ppt_? -121.42 143.57 49.15 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.86 -0.525 . . . . 1.21 110.117 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.47 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 1.6 ttp -156.42 159.04 38.34 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.166 -0.959 . . . . 0.88 110.486 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.695 HG23 HG22 ' A' ' 19' ' ' VAL . 9.2 p -141.02 156.61 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.44 -0.787 . . . . 0.27 110.301 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.46 HD11 ' CZ ' ' A' ' 17' ' ' TYR . 67.3 mt . . . . . 0 N--CA 1.502 2.136 0 CA-C-O 117.655 -1.164 . . . . 0.52 110.206 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mtt . . . . . 0 N--CA 1.494 1.754 0 CA-C-O 121.126 0.488 . . . . 2.33 110.925 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.46 111.95 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.128 0 CA-C-O 121.353 0.597 . . . . 1.26 110.819 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 91.3 m -103.13 142.87 33.41 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.471 -0.768 . . . . 0.68 109.667 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.511 ' HE3' ' CE1' ' A' ' 66' ' ' HIS . 0.0 OUTLIER -132.46 119.22 20.32 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.425 -0.797 . . . . 1.05 110.48 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.44 HD13 HD11 ' A' ' 9' ' ' LEU . 0.8 OUTLIER 53.36 -165.52 0.08 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.763 -0.586 . . . . 1.01 110.896 -179.855 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -135.51 86.0 2.21 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.347 -0.846 . . . . 1.61 110.029 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 51.68 59.6 4.45 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.738 -0.601 . . . . 1.13 110.749 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.59 -47.87 2.61 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.35 -0.844 . . . . 1.19 110.48 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.44 HD11 HD13 ' A' ' 5' ' ' LEU . 1.8 mp -77.19 -50.07 13.76 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.418 -0.801 . . . . 0.83 110.02 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 58.82 47.47 12.59 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.161 0.505 . . . . 0.96 111.113 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.502 ' O ' ' HA ' ' A' ' 65' ' ' THR . 85.8 t80 -95.51 119.97 64.4 Favored Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 121.381 -0.824 . . . . 0.95 109.128 179.092 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.654 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 42.6 Cg_endo -68.55 106.62 1.47 Allowed 'Trans proline' 0 C--N 1.315 -1.23 0 O-C-N 123.703 1.37 . . . . 0.39 110.906 -178.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.1 t -131.88 146.59 62.41 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.851 -0.531 . . . . 0.34 110.48 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -72.4 125.93 11.16 Favored 'Trans proline' 0 C--N 1.315 -1.222 0 O-C-N 123.862 1.454 . . . . 0.35 110.398 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.5 ' HB2' HG23 ' A' ' 62' ' ' ILE . 23.9 m-85 -106.16 99.6 9.18 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.556 -0.715 . . . . 0.32 110.632 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.4 m -76.06 92.88 3.22 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 107.982 -1.118 . . . . 0.43 107.982 178.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.532 ' O ' HG22 ' A' ' 60' ' ' ILE . 2.6 m-85 -100.1 109.47 21.77 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.397 -0.815 . . . . 0.43 111.327 -177.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.543 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 0.1 OUTLIER -81.26 90.45 6.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.592 -0.693 . . . . 0.93 109.402 179.156 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.996 HG11 HD11 ' A' ' 77' ' ' LEU . 32.1 t -79.64 98.07 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.623 -0.673 . . . . 0.34 109.945 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.435 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 36.7 mtm -106.15 147.55 28.89 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.575 -0.703 . . . . 0.67 110.085 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.418 ' HA3' ' O ' ' A' ' 83' ' ' VAL . . . 170.14 -141.5 6.63 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.088 -1.205 . . . . 0.26 110.088 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.747 ' HG3' HG21 ' A' ' 82' ' ' ILE . 0.0 OUTLIER -66.04 154.33 39.81 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.547 -0.973 . . . . 0.61 110.626 -179.817 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.576 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -93.08 97.93 11.0 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.491 -0.756 . . . . 0.34 110.305 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -130.44 154.23 81.53 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.523 -0.736 . . . . 0.41 110.49 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.03 -19.94 22.44 Favored 'Trans proline' 0 C--N 1.313 -1.316 0 O-C-N 124.041 1.548 . . . . 0.43 111.477 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -75.98 -5.08 44.64 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.084 -1.01 . . . . 0.57 111.358 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.4 mt -60.35 -59.92 4.63 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.067 -1.021 . . . . 0.62 110.219 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.604 HG12 ' HG2' ' A' ' 45' ' ' PRO . 33.6 m -64.99 -29.96 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.436 -0.79 . . . . 0.35 110.796 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -67.28 -55.06 15.5 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.395 -0.816 . . . . 0.49 110.229 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.72 ' O ' HG12 ' A' ' 34' ' ' VAL . 3.8 tp-100 -67.1 -34.85 78.51 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.319 -0.863 . . . . 0.69 110.643 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.842 HG22 HD22 ' A' ' 77' ' ' LEU . 3.0 t -59.06 -57.78 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.409 -0.807 . . . . 0.25 110.366 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.428 ' HA ' HG12 ' A' ' 35' ' ' VAL . 9.8 p -64.37 -33.07 60.36 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.323 -0.86 . . . . 0.31 111.424 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.6 -55.01 8.59 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.134 -0.979 . . . . 0.63 110.913 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.897 HG21 ' CB ' ' A' ' 76' ' ' GLU . 10.0 p -68.58 -27.58 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.407 -0.808 . . . . 0.29 111.481 -179.457 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.887 HG23 HD12 ' A' ' 62' ' ' ILE . 2.4 p -80.64 -28.94 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.028 -1.045 . . . . 0.38 110.732 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -79.59 -40.96 28.15 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.264 -0.897 . . . . 1.27 110.143 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.3 mtm180 -66.62 -22.85 66.11 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.39 -0.819 . . . . 2.5 111.299 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.672 ' CG ' HD11 ' A' ' 73' ' ' LEU . 15.9 m80 -105.23 -45.79 4.4 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.208 -0.933 . . . . 1.32 110.667 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -106.72 143.41 26.98 Favored Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 121.438 -0.789 . . . . 0.59 110.247 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -72.12 144.81 42.96 Favored 'Trans proline' 0 C--N 1.314 -1.27 0 O-C-N 123.827 1.435 . . . . 0.79 110.786 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 91.66 148.35 21.9 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.532 -1.427 . . . . 0.5 109.532 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -82.01 134.27 35.35 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.531 -0.982 . . . . 1.22 110.113 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.652 ' HB2' HG11 ' A' ' 35' ' ' VAL . 38.8 m-85 -123.95 157.49 34.22 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.623 -0.673 . . . . 0.41 110.402 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.732 HG22 ' HD2' ' A' ' 45' ' ' PRO . 1.4 m -142.36 153.38 62.59 Favored Pre-proline 0 N--CA 1.498 1.937 0 O-C-N 121.515 -0.741 . . . . 0.6 110.955 -179.265 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.732 ' HD2' HG22 ' A' ' 44' ' ' THR . 55.3 Cg_endo -95.27 133.15 0.56 Allowed 'Trans proline' 0 C--N 1.32 -0.962 0 C-N-CA 121.898 1.732 . . . . 0.53 110.579 179.025 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.452 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 51.5 m -89.93 93.99 9.63 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.187 -0.945 . . . . 0.39 109.289 179.06 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.645 ' CB ' HG12 ' A' ' 58' ' ' VAL . 14.4 p -76.46 137.26 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.498 -0.752 . . . . 0.39 111.589 -178.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.448 ' HE2' ' HB3' ' A' ' 57' ' ' SER . 0.5 OUTLIER -142.47 149.8 52.28 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.728 -0.608 . . . . 0.87 109.833 179.247 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -76.1 84.84 1.74 Allowed 'Trans proline' 0 C--N 1.314 -1.272 0 O-C-N 123.872 1.459 . . . . 0.55 110.578 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.0 -45.65 9.04 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.363 -0.835 . . . . 1.0 109.817 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.403 ' HB2' ' CD1' ' A' ' 55' ' ' TYR . 0.4 OUTLIER -106.82 167.93 9.53 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.473 -0.767 . . . . 0.94 110.218 179.573 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.62 158.25 16.07 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.401 -0.812 . . . . 1.55 110.44 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.88 -137.38 13.73 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.554 -1.418 . . . . 0.6 109.554 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -100.62 63.84 1.09 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.596 -0.944 . . . . 1.38 110.217 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.403 ' CD1' ' HB2' ' A' ' 51' ' ' SER . 14.6 t80 -137.99 130.87 29.93 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.492 -0.755 . . . . 0.53 110.178 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.576 ' HB2' ' HA ' ' A' ' 23' ' ' ALA . 0.1 OUTLIER -129.73 137.03 50.35 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.495 -0.753 . . . . 0.89 110.29 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.448 ' HB3' ' HE2' ' A' ' 48' ' ' LYS . 6.1 m -110.18 105.46 14.54 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.598 -0.689 . . . . 0.36 109.392 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.645 HG12 ' CB ' ' A' ' 47' ' ' VAL . 2.8 m -108.36 147.57 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.219 -0.926 . . . . 0.37 110.84 -179.267 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.543 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 8.6 t -112.1 112.16 23.58 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.403 -0.81 . . . . 0.45 108.843 179.117 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.636 ' CD1' HG13 ' A' ' 31' ' ' VAL . 9.6 tt -92.33 126.86 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.217 -0.927 . . . . 0.33 111.265 -178.518 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.412 ' O ' ' HB3' ' A' ' 43' ' ' TYR . 19.1 m -91.72 136.06 33.42 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.944 -0.762 . . . . 0.43 108.944 179.228 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.887 HD12 HG23 ' A' ' 35' ' ' VAL . 5.9 tt -162.5 131.27 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.276 -0.89 . . . . 0.43 110.72 -179.565 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -99.68 98.18 9.05 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.358 -0.838 . . . . 0.52 109.698 179.374 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -113.67 139.69 48.84 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.451 -0.781 . . . . 0.26 110.227 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.654 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 33.9 p -66.54 -22.64 66.16 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.465 -0.772 . . . . 0.35 110.864 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.511 ' CE1' ' HE3' ' A' ' 4' ' ' LYS . 1.2 t60 -131.64 157.65 43.15 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.146 -0.971 . . . . 0.57 110.8 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.3 tt -79.9 -16.75 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.529 -0.732 . . . . 0.41 110.407 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.14 -33.09 71.37 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.125 -0.985 . . . . 0.46 110.124 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.449 ' O ' HD13 ' A' ' 73' ' ' LEU . 0.0 OUTLIER -68.12 -48.75 64.59 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.353 -0.842 . . . . 1.24 110.053 179.549 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.464 HG23 HG21 ' A' ' 62' ' ' ILE . 7.6 p -69.25 -25.02 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.387 -0.821 . . . . 0.33 110.262 179.503 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -69.02 -51.04 43.33 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.252 -0.905 . . . . 0.41 109.529 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 20.1 p -62.02 -38.26 87.98 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.526 -0.734 . . . . 0.37 109.284 178.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.672 HD11 ' CG ' ' A' ' 38' ' ' HIS . 5.4 mp -61.33 -40.3 93.73 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 109.304 -0.628 . . . . 0.37 109.304 178.807 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.642 ' CD1' ' HB ' ' A' ' 86' ' ' VAL . 0.1 OUTLIER -59.16 -42.81 91.63 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.858 -0.793 . . . . 0.55 108.858 178.387 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -68.5 -34.94 76.78 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.565 -0.709 . . . . 1.35 110.336 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.897 ' CB ' HG21 ' A' ' 34' ' ' VAL . 0.3 OUTLIER -62.99 -48.59 78.17 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.488 -0.758 . . . . 0.49 110.03 179.482 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.996 HD11 HG11 ' A' ' 19' ' ' VAL . 0.3 OUTLIER -79.38 -29.42 42.09 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.45 -0.781 . . . . 0.3 110.132 179.387 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.502 ' N ' ' HG ' ' A' ' 77' ' ' LEU . . . -102.59 56.36 0.64 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.266 -1.533 . . . . 0.26 109.266 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.3 tttt -106.22 4.59 29.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.698 -0.883 . . . . 1.61 110.774 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.468 HG22 ' H ' ' A' ' 82' ' ' ILE . 2.5 mp -59.78 154.99 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.335 -0.853 . . . . 0.45 110.111 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.16 -4.55 55.74 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.285 -0.884 . . . . 1.52 111.505 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.747 HG21 ' HG3' ' A' ' 22' ' ' GLN . 48.9 mm -85.52 -103.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 120.921 -1.112 . . . . 0.48 110.175 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.432 HG23 HG22 ' A' ' 82' ' ' ILE . 88.3 t -123.99 118.75 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 120.822 -1.174 . . . . 0.4 110.298 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.47 111.24 16.59 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.614 -0.679 . . . . 0.97 109.543 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.509 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 0.4 OUTLIER -136.73 154.93 50.45 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.36 -0.838 . . . . 0.78 110.392 -179.812 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.642 ' HB ' ' CD1' ' A' ' 74' ' ' TYR . 8.0 p -141.81 151.29 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.445 -0.784 . . . . 0.35 110.572 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.427 HD22 ' HA ' ' A' ' 87' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.5 2.067 0 CA-C-O 117.545 -1.217 . . . . 0.52 110.474 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.758 0 CA-C-O 121.149 0.5 . . . . 1.28 110.118 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.401 ' HG2' HG21 ' A' ' 13' ' ' THR . 0.2 OUTLIER -116.03 -173.13 2.3 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.475 -0.766 . . . . 1.04 110.502 -179.674 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.8 t -136.05 164.02 28.98 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.426 -0.796 . . . . 0.78 110.303 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.07 112.26 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.236 0 CA-C-O 121.34 0.591 . . . . 1.42 110.542 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.426 ' HA ' ' HB ' ' A' ' 67' ' ' ILE . 1.5 pp -73.7 137.05 43.82 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.49 -0.756 . . . . 0.98 110.69 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -144.75 137.0 26.17 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.433 -0.792 . . . . 0.93 110.52 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -104.62 -3.16 24.12 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.385 -0.822 . . . . 1.03 111.051 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.4 HD13 ' HA ' ' A' ' 8' ' ' LEU . 0.5 OUTLIER -90.35 -36.42 14.65 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.117 -0.989 . . . . 1.26 110.364 -179.974 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.7 mp -89.19 -48.32 7.46 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.406 -0.809 . . . . 0.82 109.89 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 53.92 67.11 1.06 Allowed 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.595 0.712 . . . . 0.7 110.549 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.453 ' O ' ' HA ' ' A' ' 65' ' ' THR . 82.8 t80 -95.58 124.2 53.73 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.479 -0.763 . . . . 0.78 109.865 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.541 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 44.2 Cg_endo -70.78 112.35 3.24 Favored 'Trans proline' 0 C--N 1.315 -1.232 0 O-C-N 123.996 1.524 . . . . 0.31 110.434 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.401 HG21 ' HG2' ' A' ' 2' ' ' LYS . 11.2 t -124.87 145.72 50.88 Favored Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 121.608 -0.683 . . . . 0.31 110.438 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.73 120.26 6.57 Favored 'Trans proline' 0 C--N 1.315 -1.227 0 O-C-N 123.897 1.472 . . . . 0.34 110.311 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.521 ' HB2' HG23 ' A' ' 62' ' ' ILE . 18.3 m-85 -102.88 99.71 9.64 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.568 -0.707 . . . . 0.33 110.606 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.7 p -74.45 101.15 4.04 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.545 -0.909 . . . . 0.28 108.545 178.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -114.77 160.04 19.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.395 -0.816 . . . . 0.37 111.024 -178.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.684 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 7.6 mttt -135.97 99.18 4.08 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.099 -0.704 . . . . 2.06 109.099 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.988 HG11 HD11 ' A' ' 77' ' ' LEU . 10.2 t -79.76 98.31 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.445 -0.784 . . . . 0.26 109.399 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 63.0 mtm -106.66 157.77 17.45 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.32 -0.862 . . . . 0.7 110.298 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 164.2 -160.59 33.58 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 110.089 -1.204 . . . . 0.29 110.089 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.418 ' HB3' ' CG2' ' A' ' 82' ' ' ILE . 0.0 OUTLIER -70.27 156.48 39.21 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.496 -1.003 . . . . 1.51 110.085 179.868 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -48.4 110.13 0.31 Allowed 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.776 -0.578 . . . . 0.51 110.814 -179.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.472 HD13 ' HD2' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -130.51 110.99 16.34 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.554 -0.716 . . . . 0.52 109.966 -179.872 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.472 ' HD2' HD13 ' A' ' 24' ' ' LEU . 44.9 Cg_endo -72.6 -30.48 11.95 Favored 'Trans proline' 0 C--N 1.315 -1.209 0 O-C-N 123.914 1.481 . . . . 0.54 111.05 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -77.5 -7.12 55.75 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.228 -0.92 . . . . 0.69 111.291 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.469 ' O ' HG23 ' A' ' 31' ' ' VAL . 0.3 OUTLIER -58.24 -55.14 38.89 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.947 -1.095 . . . . 0.64 110.308 -179.952 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.552 HG23 ' HD2' ' A' ' 45' ' ' PRO . 11.9 p -61.04 -34.9 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 121.461 -0.774 . . . . 0.32 110.559 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.441 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 10.1 m-20 -64.23 -49.46 71.84 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.479 -0.763 . . . . 0.53 110.125 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.73 ' O ' HG12 ' A' ' 34' ' ' VAL . 13.3 tp60 -71.64 -31.74 67.18 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.477 -0.764 . . . . 0.55 110.517 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.702 HG22 HD22 ' A' ' 77' ' ' LEU . 7.3 t -58.71 -52.48 59.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.324 -0.86 . . . . 0.24 110.043 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.431 ' HA ' HG12 ' A' ' 35' ' ' VAL . 8.9 p -73.32 -30.54 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.414 -0.804 . . . . 0.33 111.198 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.441 ' HB2' ' O ' ' A' ' 29' ' ' ASP . 0.8 OUTLIER -73.64 -50.48 20.83 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.045 -1.034 . . . . 0.55 110.484 179.958 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.757 HG21 ' CB ' ' A' ' 76' ' ' GLU . 9.8 p -67.45 -32.41 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.426 -0.796 . . . . 0.34 110.706 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.555 HG21 ' HB2' ' A' ' 43' ' ' TYR . 2.5 p -77.17 -27.45 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.046 -1.034 . . . . 0.34 110.02 179.112 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -74.18 -36.29 64.04 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.293 -0.88 . . . . 0.75 109.602 178.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 52.7 mtm180 -73.1 -25.82 61.01 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.478 -0.764 . . . . 0.89 110.758 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.767 ' CG ' HD11 ' A' ' 73' ' ' LEU . 43.0 m-70 -98.39 -45.8 6.01 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.368 -0.833 . . . . 0.67 110.715 -179.388 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -102.8 151.84 38.39 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 121.481 -0.762 . . . . 0.63 109.975 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -69.83 -41.1 4.47 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.855 1.45 . . . . 1.07 110.895 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -86.45 144.79 20.01 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.494 -1.442 . . . . 0.46 109.494 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.08 149.06 29.36 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.37 -1.076 . . . . 0.6 110.047 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.555 ' HB2' HG21 ' A' ' 35' ' ' VAL . 42.3 m-85 -132.43 161.13 34.46 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.572 -0.705 . . . . 0.48 110.762 -179.495 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.67 HG22 ' HD2' ' A' ' 45' ' ' PRO . 3.7 m -142.6 153.49 61.91 Favored Pre-proline 0 N--CA 1.499 2.01 0 O-C-N 121.484 -0.76 . . . . 0.39 111.016 -179.299 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.67 ' HD2' HG22 ' A' ' 44' ' ' THR . 51.9 Cg_endo -95.1 148.75 1.59 Allowed 'Trans proline' 0 C--N 1.319 -0.997 0 C-N-CA 121.832 1.688 . . . . 0.55 110.479 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.522 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 56.9 m -106.81 96.84 6.72 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.174 -0.954 . . . . 0.39 109.142 179.04 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.586 HG23 HG12 ' A' ' 58' ' ' VAL . 12.4 p -75.49 139.38 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.364 -0.835 . . . . 0.32 111.771 -178.653 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.59 153.98 62.57 Favored Pre-proline 0 N--CA 1.494 1.758 0 N-CA-C 109.69 -0.485 . . . . 0.93 109.69 179.338 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -76.19 85.5 1.66 Allowed 'Trans proline' 0 C--N 1.314 -1.254 0 O-C-N 124.07 1.563 . . . . 0.52 110.536 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.6 m -87.51 -49.98 6.83 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.407 -0.808 . . . . 1.0 109.967 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.604 ' HB3' ' HB3' ' A' ' 55' ' ' TYR . 1.0 OUTLIER -106.93 162.75 13.55 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.512 -0.742 . . . . 0.95 110.076 179.738 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.45 154.55 17.21 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.336 -0.853 . . . . 1.71 110.604 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.13 -134.37 11.65 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.742 -1.343 . . . . 0.6 109.742 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -103.37 60.19 0.76 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.633 -0.922 . . . . 0.8 110.308 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.604 ' HB3' ' HB3' ' A' ' 51' ' ' SER . 22.3 t80 -135.77 147.75 48.5 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.401 -0.812 . . . . 0.82 110.169 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 4.1 p-80 -145.45 147.32 32.08 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.478 -0.764 . . . . 0.38 110.54 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.8 m -125.81 117.71 23.98 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.389 -0.819 . . . . 0.35 109.524 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.586 HG12 HG23 ' A' ' 47' ' ' VAL . 1.3 m -115.04 139.64 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.188 -0.945 . . . . 0.27 111.388 -179.17 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.54 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 7.5 t -95.64 108.0 20.24 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.352 -0.981 . . . . 0.61 108.352 178.394 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.573 ' HA ' ' HA ' ' A' ' 45' ' ' PRO . 12.1 tt -92.4 125.79 44.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.256 -0.902 . . . . 0.35 111.208 -178.543 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.48 ' O ' ' HB3' ' A' ' 43' ' ' TYR . 98.5 m -93.03 135.51 34.14 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.364 -0.976 . . . . 0.41 108.364 178.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.521 HG23 ' HB2' ' A' ' 15' ' ' PHE . 12.6 tt -160.46 145.18 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.076 -1.015 . . . . 0.38 111.059 -179.203 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -121.62 111.13 16.83 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.62 -0.675 . . . . 0.42 109.305 179.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.453 ' HB1' ' HB3' ' A' ' 69' ' ' GLN . . . -121.46 141.47 50.98 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.47 -0.769 . . . . 0.26 110.762 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 26.1 p -77.33 -4.5 45.42 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.506 -0.746 . . . . 0.32 111.219 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.651 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 62.1 t60 -130.37 150.32 51.65 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.216 -0.927 . . . . 0.49 110.191 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.439 ' O ' HG12 ' A' ' 70' ' ' VAL . 7.5 mm -70.67 -48.39 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 121.47 -0.769 . . . . 0.49 110.087 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.55 -18.46 65.38 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.454 -0.779 . . . . 0.75 111.236 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.651 ' HB2' ' HB3' ' A' ' 66' ' ' HIS . 0.3 OUTLIER -59.11 -58.87 6.75 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.263 -0.898 . . . . 1.12 110.405 179.901 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.439 HG12 ' O ' ' A' ' 67' ' ' ILE . 8.0 p -59.57 -26.98 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.416 -0.803 . . . . 0.31 110.924 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.23 -45.66 62.8 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.265 -0.897 . . . . 0.82 109.668 179.08 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 67.5 m -62.39 -41.17 98.44 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.573 -0.705 . . . . 0.34 109.728 179.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.767 HD11 ' CG ' ' A' ' 38' ' ' HIS . 4.7 mp -65.08 -36.39 84.18 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.636 -0.665 . . . . 0.55 110.047 179.431 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.627 ' CD1' ' HB ' ' A' ' 86' ' ' VAL . 0.3 OUTLIER -61.32 -46.09 91.74 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.46 -0.775 . . . . 0.52 109.105 178.837 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.56 -33.82 76.8 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.522 -0.736 . . . . 1.17 109.887 179.278 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.757 ' CB ' HG21 ' A' ' 34' ' ' VAL . 28.1 mt-10 -65.03 -43.47 92.31 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.411 -0.805 . . . . 0.37 109.889 179.259 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.988 HD11 HG11 ' A' ' 19' ' ' VAL . 0.4 OUTLIER -80.73 -29.68 36.33 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.358 -0.839 . . . . 0.27 109.964 178.943 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.509 ' N ' ' HG ' ' A' ' 77' ' ' LEU . . . -105.26 54.32 0.61 Allowed Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.475 -1.45 . . . . 0.3 109.475 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.97 4.12 29.11 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.567 -0.961 . . . . 0.95 110.563 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.411 ' H ' HD12 ' A' ' 80' ' ' ILE . 1.7 mp -68.6 154.46 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.34 -0.85 . . . . 0.33 110.175 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -66.16 -20.67 66.21 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.361 -0.837 . . . . 0.73 110.155 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.44 HG22 ' N ' ' A' ' 83' ' ' VAL . 43.3 mm -68.91 166.75 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.422 -0.798 . . . . 0.38 109.895 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.44 ' N ' HG22 ' A' ' 82' ' ' ILE . 76.6 t -62.47 114.39 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.287 -0.883 . . . . 0.47 110.779 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.25 137.16 54.81 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.774 -0.579 . . . . 1.22 109.615 179.305 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.424 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 2.7 mtm -151.92 160.21 43.58 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.158 -0.964 . . . . 1.49 110.523 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.627 ' HB ' ' CD1' ' A' ' 74' ' ' TYR . 5.4 p -142.14 155.23 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.463 -0.773 . . . . 0.31 110.378 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.684 ' HB3' ' HB2' ' A' ' 18' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.494 1.764 0 CA-C-O 117.896 -1.05 . . . . 0.34 109.824 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.816 0 N-CA-C 110.081 -0.34 . . . . 1.77 110.081 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.67 144.1 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.194 0 CA-C-O 121.494 0.664 . . . . 0.78 111.15 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.462 HG23 ' O ' ' A' ' 38' ' ' HIS . 24.0 m -138.96 -62.94 0.54 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.212 -0.93 . . . . 0.51 110.361 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.11 148.52 29.76 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.315 -0.866 . . . . 0.88 110.733 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.78 -165.76 1.33 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.442 -0.786 . . . . 1.16 110.314 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -59.7 117.47 4.99 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.276 -0.89 . . . . 1.67 110.504 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.16 153.87 26.47 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.668 -0.645 . . . . 0.67 110.607 -179.653 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.51 38.14 4.08 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.561 -0.712 . . . . 0.95 110.237 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.7 mp -128.27 -62.61 1.04 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.252 -0.905 . . . . 0.73 110.011 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 55.56 52.58 10.89 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.673 -0.642 . . . . 0.59 110.791 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.424 ' O ' ' HA ' ' A' ' 65' ' ' THR . 72.9 t80 -95.54 112.47 59.03 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.316 -0.865 . . . . 0.85 109.551 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.6 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 44.0 Cg_endo -70.63 108.77 2.32 Favored 'Trans proline' 0 C--N 1.314 -1.243 0 O-C-N 123.994 1.523 . . . . 0.36 110.557 -179.339 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.9 t -128.06 142.4 44.32 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.669 -0.644 . . . . 0.34 110.172 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -72.37 129.88 15.48 Favored 'Trans proline' 0 C--N 1.314 -1.277 0 O-C-N 123.939 1.494 . . . . 0.37 110.631 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.692 ' HB3' HG21 ' A' ' 70' ' ' VAL . 33.9 m-85 -112.01 100.89 9.24 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.583 -0.698 . . . . 0.36 110.022 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 16.5 m -73.52 92.96 1.94 Allowed 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 108.497 -0.927 . . . . 0.43 108.497 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.598 ' O ' HG22 ' A' ' 60' ' ' ILE . 3.3 m-85 -103.82 102.16 11.98 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.464 -0.773 . . . . 0.35 110.858 -178.356 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.649 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 0.0 OUTLIER -77.77 89.19 4.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.671 -0.643 . . . . 1.34 109.89 179.805 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.779 HG23 HG13 ' A' ' 58' ' ' VAL . 1.2 m -82.51 108.22 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 C-N-CA 119.358 -0.937 . . . . 0.27 109.413 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.1 mtp -108.05 151.72 25.46 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.553 -0.717 . . . . 0.96 110.567 -179.088 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 178.28 -159.81 25.51 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.82 -1.312 . . . . 0.34 109.82 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.537 ' HA ' ' HA ' ' A' ' 55' ' ' TYR . 0.9 OUTLIER -70.44 -179.8 2.21 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.426 -1.044 . . . . 0.86 110.503 179.973 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.61 100.01 2.2 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.392 -0.817 . . . . 0.48 110.126 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.421 ' O ' HD23 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -122.94 108.56 32.53 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.516 -0.74 . . . . 0.9 109.923 -179.773 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.402 ' HD2' HD13 ' A' ' 24' ' ' LEU . 44.0 Cg_endo -69.91 -15.44 36.54 Favored 'Trans proline' 0 N--CA 1.491 1.354 0 O-C-N 123.805 1.424 . . . . 0.63 111.588 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -83.09 -0.41 48.93 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.201 -0.937 . . . . 1.12 111.476 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.687 HD13 HG21 ' A' ' 58' ' ' VAL . 3.1 pp -58.84 -35.11 72.37 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.906 -1.121 . . . . 0.61 110.906 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.451 ' N ' HD12 ' A' ' 27' ' ' LEU . 9.8 p -75.35 -32.9 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.066 -1.021 . . . . 0.4 110.557 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -64.77 -48.75 73.39 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.442 -0.786 . . . . 0.63 110.085 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.7 ' HG2' ' HA ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -72.92 -37.3 67.25 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.474 -0.766 . . . . 1.04 110.698 179.937 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.995 HG22 HD12 ' A' ' 60' ' ' ILE . 4.2 t -57.11 -47.09 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.31 -0.869 . . . . 0.26 110.885 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.2 p -76.33 -37.19 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.251 -0.905 . . . . 0.34 111.577 -179.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.529 ' CG ' ' HA ' ' A' ' 30' ' ' GLN . 0.2 OUTLIER -75.94 -31.37 59.05 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.828 -1.17 . . . . 0.56 110.912 -179.869 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.681 HG21 ' HB2' ' A' ' 76' ' ' GLU . 5.4 p -79.98 -35.02 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.092 -1.005 . . . . 0.24 110.14 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.565 HG21 ' HB2' ' A' ' 43' ' ' TYR . 9.7 p -73.99 -29.94 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.181 -0.95 . . . . 0.31 109.446 178.457 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -77.08 -36.39 55.81 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.435 -0.791 . . . . 0.76 109.997 179.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.7 mtp-105 -65.92 -27.09 67.93 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.42 -0.8 . . . . 0.91 111.085 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.462 ' O ' HG23 ' A' ' 3' ' ' THR . 19.7 m80 -105.16 -45.86 4.4 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.334 -0.853 . . . . 0.49 110.599 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -100.21 150.14 36.65 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.509 -0.745 . . . . 0.38 109.808 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -70.04 -38.46 7.16 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.759 1.4 . . . . 0.6 111.15 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -85.78 145.3 20.82 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.918 -1.273 . . . . 0.43 109.918 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.83 150.08 22.39 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.523 -0.987 . . . . 0.52 109.864 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.565 ' HB2' HG21 ' A' ' 35' ' ' VAL . 51.9 m-85 -135.9 178.86 6.72 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.495 -0.753 . . . . 0.39 110.779 -179.445 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.839 HG22 ' HD2' ' A' ' 45' ' ' PRO . 0.2 OUTLIER -141.0 157.0 68.18 Favored Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 121.476 -0.765 . . . . 0.48 110.847 -179.064 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.839 ' HD2' HG22 ' A' ' 44' ' ' THR . 51.7 Cg_endo -93.75 163.27 2.26 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 C-N-CA 121.784 1.656 . . . . 0.41 110.366 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.494 ' C ' HG23 ' A' ' 58' ' ' VAL . 44.6 m -127.34 88.79 2.85 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.341 -0.85 . . . . 0.39 109.063 178.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.475 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 11.4 p -83.11 142.74 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.401 -0.812 . . . . 0.34 111.651 -178.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.99 152.54 58.84 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.698 -0.626 . . . . 0.73 109.841 179.398 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -75.33 82.9 1.96 Allowed 'Trans proline' 0 C--N 1.314 -1.268 0 O-C-N 123.845 1.445 . . . . 0.55 110.411 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.5 m -88.02 -43.95 11.35 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.477 -0.764 . . . . 0.85 110.089 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -102.74 166.18 10.64 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.595 -0.69 . . . . 0.97 110.292 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.16 155.81 17.54 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.412 -0.805 . . . . 1.9 110.48 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.33 -136.27 13.03 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.63 -1.388 . . . . 0.61 109.63 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -102.17 63.52 0.9 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.574 -0.957 . . . . 0.62 110.172 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.537 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 15.0 t80 -140.99 139.44 34.2 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.395 -0.816 . . . . 0.91 110.183 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -139.57 136.91 34.92 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.589 -0.694 . . . . 0.88 110.469 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.3 m -108.67 120.66 43.13 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.64 -0.663 . . . . 0.38 109.318 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.779 HG13 HG23 ' A' ' 19' ' ' VAL . 3.2 p -127.01 145.27 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.257 -0.902 . . . . 0.24 111.485 -178.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.649 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 66.5 p -111.79 118.07 34.56 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.636 -0.665 . . . . 0.35 109.51 179.302 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.995 HD12 HG22 ' A' ' 31' ' ' VAL . 7.0 tt -94.55 134.5 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.436 -0.79 . . . . 0.32 111.249 -179.194 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 52.9 m -89.19 114.37 25.67 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.58 -0.896 . . . . 0.37 108.58 178.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.608 HD11 HD11 ' A' ' 60' ' ' ILE . 32.3 mm -122.42 99.32 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.171 -0.956 . . . . 0.34 111.299 -178.58 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -88.59 86.25 6.97 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.108 -0.995 . . . . 0.45 108.703 178.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.719 ' HB1' ' HB3' ' A' ' 69' ' ' GLN . . . -102.84 140.14 37.51 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.605 -0.685 . . . . 0.24 111.042 -178.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.6 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 32.9 p -75.86 -6.84 52.71 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.667 -0.646 . . . . 0.38 110.981 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.421 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 4.2 t-160 -129.73 158.59 38.97 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.265 -0.897 . . . . 0.45 110.454 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.461 ' O ' HG12 ' A' ' 70' ' ' VAL . 1.8 mt -73.68 -46.92 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.588 -0.695 . . . . 0.8 109.851 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.5 -21.28 66.63 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.495 -0.753 . . . . 0.73 110.998 179.692 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.719 ' HB3' ' HB1' ' A' ' 64' ' ' ALA . 9.9 tt0 -61.04 -52.6 64.28 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.238 -0.914 . . . . 0.38 110.44 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.692 HG21 ' HB3' ' A' ' 15' ' ' PHE . 7.4 p -69.73 -27.42 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.335 -0.853 . . . . 0.3 110.332 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.56 -52.7 59.92 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.275 -0.89 . . . . 0.92 109.533 179.218 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.8 p -62.65 -37.35 86.04 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.541 -0.724 . . . . 0.37 109.298 178.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.497 HD23 HD12 ' A' ' 62' ' ' ILE . 2.0 mp -61.85 -39.77 93.01 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.666 -0.646 . . . . 0.3 110.021 179.207 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.49 ' CD1' ' C ' ' A' ' 74' ' ' TYR . 0.0 OUTLIER -63.51 -45.97 88.21 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.552 -0.718 . . . . 0.46 109.332 179.02 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -70.12 -30.04 67.13 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.542 -0.724 . . . . 0.74 110.722 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.681 ' HB2' HG21 ' A' ' 34' ' ' VAL . 23.4 mt-10 -71.65 -51.39 23.34 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.377 -0.827 . . . . 0.43 110.362 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.7 ' HA ' ' HG2' ' A' ' 30' ' ' GLN . 0.7 OUTLIER -71.54 -29.69 65.04 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.279 -0.888 . . . . 0.29 109.951 179.236 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.473 ' N ' ' HG ' ' A' ' 77' ' ' LEU . . . -102.61 46.03 1.28 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.362 -1.495 . . . . 0.24 109.362 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.76 3.92 29.38 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.533 -0.981 . . . . 1.48 110.998 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.592 HG22 ' H ' ' A' ' 82' ' ' ILE . 2.3 mp -60.96 145.88 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.288 -0.883 . . . . 0.44 110.159 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -63.57 -21.19 66.21 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.474 -0.766 . . . . 0.82 110.525 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.592 ' H ' HG22 ' A' ' 80' ' ' ILE . 38.2 mm -71.59 172.4 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.405 -0.81 . . . . 0.5 109.83 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.469 ' N ' HG22 ' A' ' 82' ' ' ILE . 68.9 t -62.29 113.7 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.248 -0.908 . . . . 0.5 110.766 -179.445 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.87 154.26 37.31 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.782 -0.574 . . . . 1.01 110.368 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.516 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 4.4 ttp -156.18 159.86 39.35 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.336 -0.852 . . . . 0.65 110.012 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.623 ' HA ' ' HA ' ' A' ' 19' ' ' VAL . 9.8 p -131.87 149.15 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 121.307 -0.871 . . . . 0.34 110.891 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.463 ' CD2' ' HA ' ' A' ' 17' ' ' TYR . 37.6 mt . . . . . 0 N--CA 1.501 2.092 0 CA-C-O 117.653 -1.165 . . . . 0.45 110.664 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.739 0 CA-C-O 121.021 0.439 . . . . 2.29 110.456 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 66.89 105.61 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.075 0 CA-C-O 121.598 0.713 . . . . 1.95 110.401 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.508 HG23 ' CG ' ' A' ' 68' ' ' GLU . 26.6 m -75.58 132.66 40.82 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.569 -0.707 . . . . 0.74 109.711 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.18 142.37 35.93 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.526 -0.734 . . . . 1.17 110.646 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.597 HD23 HD13 ' A' ' 8' ' ' LEU . 0.4 OUTLIER 56.62 -171.65 0.08 Allowed 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.371 0.605 . . . . 1.6 110.941 -179.785 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -135.58 66.48 1.51 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.41 -0.806 . . . . 1.55 109.84 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 52.16 58.22 5.65 Favored 'General case' 0 N--CA 1.499 1.975 0 CA-C-O 121.39 0.614 . . . . 0.71 110.856 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.597 HD13 HD23 ' A' ' 5' ' ' LEU . 0.1 OUTLIER -99.09 -37.73 9.22 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.343 -0.848 . . . . 1.16 110.369 179.847 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.5 mp -76.38 -46.07 29.0 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.386 -0.821 . . . . 0.94 110.058 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 62.96 34.84 13.74 Favored 'General case' 0 N--CA 1.501 2.098 0 CA-C-O 121.167 0.508 . . . . 0.74 110.684 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.525 ' O ' ' HA ' ' A' ' 65' ' ' THR . 91.0 t80 -98.71 118.0 63.69 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.327 -0.858 . . . . 0.82 109.281 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.637 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 43.5 Cg_endo -69.29 107.49 1.78 Allowed 'Trans proline' 0 C--N 1.313 -1.291 0 O-C-N 123.874 1.46 . . . . 0.43 110.776 -179.202 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.8 t -115.71 143.9 31.55 Favored Pre-proline 0 N--CA 1.497 1.885 0 C-N-CA 120.138 -0.625 . . . . 0.44 110.34 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.93 119.75 6.24 Favored 'Trans proline' 0 C--N 1.314 -1.283 0 O-C-N 123.915 1.481 . . . . 0.44 110.634 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.683 ' HB2' ' HB ' ' A' ' 62' ' ' ILE . 15.6 m-85 -103.62 99.8 9.61 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.638 -0.664 . . . . 0.39 110.231 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.9 m -75.03 96.05 3.13 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.395 -0.816 . . . . 0.38 108.843 179.1 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.459 ' HD2' HG21 ' A' ' 86' ' ' VAL . 4.6 m-85 -108.63 115.07 29.41 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.244 -0.91 . . . . 0.4 110.848 -178.583 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.528 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 0.8 OUTLIER -83.64 91.04 7.37 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.478 -0.764 . . . . 0.9 109.5 179.452 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.946 HG11 HD11 ' A' ' 77' ' ' LEU . 11.0 t -79.3 95.4 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.51 -0.744 . . . . 0.66 109.645 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.486 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 34.5 mtm -101.58 136.02 42.11 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.461 -0.774 . . . . 0.97 110.15 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -172.25 -156.97 13.04 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.565 -1.414 . . . . 0.37 109.565 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.594 ' HG2' HG21 ' A' ' 82' ' ' ILE . 3.3 tp60 -67.68 168.79 10.61 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.458 -1.024 . . . . 0.59 110.486 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -90.0 97.85 11.43 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.426 -0.796 . . . . 0.42 109.969 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.441 ' CD1' ' HB3' ' A' ' 26' ' ' GLU . 0.8 OUTLIER -130.13 154.45 81.32 Favored Pre-proline 0 N--CA 1.498 1.939 0 O-C-N 121.562 -0.711 . . . . 0.4 110.645 -179.837 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -73.06 -26.7 14.76 Favored 'Trans proline' 0 N--CA 1.49 1.316 0 O-C-N 123.877 1.461 . . . . 0.47 111.68 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.441 ' HB3' ' CD1' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -68.82 -11.61 60.62 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.135 -0.978 . . . . 0.62 111.258 -179.804 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.417 HD22 HG21 ' A' ' 58' ' ' VAL . 0.7 OUTLIER -59.14 -64.61 0.88 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.124 -0.985 . . . . 0.81 110.441 -179.867 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.585 HG12 ' HG2' ' A' ' 45' ' ' PRO . 26.9 m -66.77 -29.81 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 O-C-N 121.396 -0.815 . . . . 0.57 110.956 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -65.23 -56.63 11.69 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.314 -0.867 . . . . 0.67 110.051 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.655 ' O ' HG12 ' A' ' 34' ' ' VAL . 7.8 tp60 -68.3 -31.55 71.06 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.494 -0.754 . . . . 0.61 110.586 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.882 HG22 HD12 ' A' ' 60' ' ' ILE . 2.4 t -58.2 -52.33 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.37 -0.831 . . . . 0.31 110.368 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.7 p -73.49 -32.53 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.303 -0.873 . . . . 0.35 111.385 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.69 -49.05 27.66 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.029 -1.044 . . . . 1.18 110.777 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.79 HG21 ' HB2' ' A' ' 76' ' ' GLU . 4.6 p -68.79 -34.05 62.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.457 -0.777 . . . . 0.29 111.012 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.564 HG11 ' HB2' ' A' ' 43' ' ' TYR . 4.7 p -74.16 -31.16 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.007 -1.058 . . . . 0.31 110.051 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -73.31 -34.03 65.48 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.269 -0.894 . . . . 1.36 109.754 178.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.3 mtt180 -68.96 -33.75 74.22 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.447 -0.783 . . . . 2.0 111.345 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.586 ' HB2' HD11 ' A' ' 73' ' ' LEU . 15.6 m80 -99.1 -45.81 5.79 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.081 -1.012 . . . . 0.62 110.781 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -101.74 150.28 37.2 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 121.449 -0.782 . . . . 0.42 110.28 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.55 141.18 34.2 Favored 'Trans proline' 0 C--N 1.314 -1.281 0 O-C-N 123.803 1.423 . . . . 0.67 110.762 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.55 165.23 36.41 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.71 -1.356 . . . . 0.54 109.71 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -99.01 145.45 27.06 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.411 -1.052 . . . . 0.62 110.21 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.564 ' HB2' HG11 ' A' ' 35' ' ' VAL . 78.2 m-85 -129.26 167.11 18.16 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.524 -0.735 . . . . 0.43 110.108 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.778 HG22 ' HD2' ' A' ' 45' ' ' PRO . 0.2 OUTLIER -140.12 157.61 68.72 Favored Pre-proline 0 N--CA 1.498 1.973 0 O-C-N 121.233 -0.917 . . . . 0.71 111.552 -178.55 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.778 ' HD2' HG22 ' A' ' 44' ' ' THR . 54.8 Cg_endo -96.56 141.74 0.8 Allowed 'Trans proline' 0 C--N 1.319 -0.997 0 C-N-CA 122.131 1.887 . . . . 0.59 110.395 179.148 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.479 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 45.2 m -95.64 93.66 7.27 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.21 -0.931 . . . . 0.41 109.051 178.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.762 HG23 HG12 ' A' ' 58' ' ' VAL . 11.0 p -76.06 138.24 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.473 -0.767 . . . . 0.37 111.598 -178.693 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.61 150.52 54.41 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.868 -0.52 . . . . 1.09 109.705 179.364 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -74.97 83.79 1.76 Allowed 'Trans proline' 0 C--N 1.314 -1.288 0 O-C-N 123.858 1.451 . . . . 0.54 110.392 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -91.6 -46.9 7.69 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.431 -0.793 . . . . 1.06 110.059 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.589 ' HB3' ' HB3' ' A' ' 55' ' ' TYR . 3.5 t -102.82 170.74 7.81 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.487 -0.758 . . . . 1.17 110.266 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.94 163.21 12.4 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.376 -0.828 . . . . 1.96 110.531 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 86.8 -139.84 16.68 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.692 -1.363 . . . . 0.71 109.692 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -100.7 58.06 0.92 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.528 -0.984 . . . . 0.69 110.215 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.589 ' HB3' ' HB3' ' A' ' 51' ' ' SER . 22.2 t80 -133.2 132.58 41.71 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.356 -0.84 . . . . 0.85 109.905 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -132.72 139.09 47.46 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.431 -0.793 . . . . 0.59 110.497 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.486 ' HA ' ' HA ' ' A' ' 20' ' ' MET . 57.7 m -107.89 116.22 31.56 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.605 -0.685 . . . . 0.34 109.476 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.762 HG12 HG23 ' A' ' 47' ' ' VAL . 1.7 m -115.5 143.3 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.27 -0.894 . . . . 0.36 111.13 -179.087 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.528 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 13.4 m -104.56 108.28 19.64 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.753 -0.832 . . . . 0.72 108.753 178.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.882 HD12 HG22 ' A' ' 31' ' ' VAL . 6.4 tt -92.84 132.13 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.326 -0.859 . . . . 0.34 111.556 -178.439 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.428 HG23 ' O ' ' A' ' 61' ' ' THR . 13.2 t -87.69 125.12 34.21 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.755 -0.832 . . . . 0.32 108.755 178.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.683 ' HB ' ' HB2' ' A' ' 15' ' ' PHE . 45.4 mm -121.37 125.0 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.217 -0.927 . . . . 0.47 110.998 -178.515 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -101.94 64.01 0.94 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.411 -0.806 . . . . 0.62 109.21 178.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.707 ' HB1' ' HB2' ' A' ' 69' ' ' GLN . . . -94.68 132.86 38.97 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.353 -0.842 . . . . 0.29 110.355 -179.547 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.637 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 41.3 p -67.7 -22.66 65.26 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.603 -0.685 . . . . 0.44 110.613 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -130.42 160.28 34.51 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.411 -0.805 . . . . 1.03 110.139 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.432 ' O ' HG12 ' A' ' 70' ' ' VAL . 0.9 OUTLIER -72.06 -16.86 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.412 -0.805 . . . . 0.89 110.681 179.604 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.508 ' CG ' HG23 ' A' ' 3' ' ' THR . 0.3 OUTLIER -70.1 -33.89 72.44 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.089 -1.007 . . . . 0.85 110.399 179.499 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.707 ' HB2' ' HB1' ' A' ' 64' ' ' ALA . 8.5 mt-30 -66.35 -48.29 70.7 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.464 -0.772 . . . . 0.88 110.381 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.584 HG23 HG21 ' A' ' 62' ' ' ILE . 8.1 p -68.34 -25.89 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.387 -0.821 . . . . 0.34 110.561 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -67.71 -51.28 51.38 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.207 -0.933 . . . . 0.52 109.544 179.142 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.2 p -65.01 -34.95 79.66 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.532 -0.73 . . . . 0.42 109.578 178.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.586 HD11 ' HB2' ' A' ' 38' ' ' HIS . 2.9 mp -60.62 -41.74 95.47 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.548 -0.72 . . . . 0.31 109.844 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.54 ' CD1' ' HB ' ' A' ' 86' ' ' VAL . 2.0 t80 -65.15 -44.31 89.01 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.476 -0.765 . . . . 1.04 109.487 178.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.22 -37.4 83.55 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.521 -0.737 . . . . 0.92 110.53 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.79 ' HB2' HG21 ' A' ' 34' ' ' VAL . 26.5 mt-10 -69.01 -49.88 53.78 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.449 -0.782 . . . . 0.45 110.483 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.946 HD11 HG11 ' A' ' 19' ' ' VAL . 0.3 OUTLIER -74.09 -28.98 61.63 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.352 -0.842 . . . . 0.42 110.3 179.633 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.481 ' N ' ' HG ' ' A' ' 77' ' ' LEU . . . -104.09 49.43 0.93 Allowed Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.314 -1.514 . . . . 0.31 109.314 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -106.16 3.97 28.51 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.705 -0.88 . . . . 0.83 110.791 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.507 HG22 HG12 ' A' ' 82' ' ' ILE . 2.3 mp -61.1 157.27 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.323 -0.86 . . . . 0.39 110.328 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.32 -4.12 40.4 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.131 -0.981 . . . . 1.15 111.83 -179.512 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.594 HG21 ' HG2' ' A' ' 22' ' ' GLN . 17.8 mm -86.68 -125.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 120.962 -1.086 . . . . 0.46 110.402 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 98.9 t -119.51 117.2 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 120.711 -1.243 . . . . 0.37 110.485 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.493 ' HD2' ' HB ' ' A' ' 80' ' ' ILE . 0.0 OUTLIER -122.49 131.65 53.96 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.656 -0.653 . . . . 0.63 110.283 179.779 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.541 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 1.8 ttp -143.05 158.56 43.49 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.413 -0.804 . . . . 1.17 109.683 179.456 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.633 HG23 HG22 ' A' ' 19' ' ' VAL . 9.8 p -141.62 152.21 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.294 -0.879 . . . . 0.46 111.026 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.501 2.078 0 CA-C-O 117.54 -1.219 . . . . 0.51 110.482 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.807 0 CA-C-O 120.856 0.36 . . . . 0.75 110.519 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.75 80.48 8.83 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.216 -0.928 . . . . 1.56 110.451 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 24.7 p -119.92 132.27 55.48 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.563 -0.711 . . . . 0.91 109.998 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.1 mttp 59.9 -82.26 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.24 0 O-C-N 122.065 -0.397 . . . . 3.28 110.748 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -93.55 -160.6 0.77 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.976 -1.077 . . . . 1.59 110.353 179.544 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -62.56 -55.27 28.82 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.445 -0.784 . . . . 1.38 109.779 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -146.78 121.03 9.54 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.591 -0.693 . . . . 0.6 110.103 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -102.23 -34.67 9.15 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.661 -0.649 . . . . 0.81 110.235 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.3 mp -83.79 -50.35 8.2 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.517 -0.739 . . . . 0.58 110.241 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 59.48 42.42 17.71 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-O 121.227 0.537 . . . . 0.54 110.648 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.52 ' O ' ' HA ' ' A' ' 65' ' ' THR . 90.1 t80 -96.73 131.52 27.9 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.347 -0.846 . . . . 0.7 109.673 179.518 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.558 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 43.4 Cg_endo -69.5 107.29 1.77 Allowed 'Trans proline' 0 C--N 1.315 -1.203 0 O-C-N 123.909 1.479 . . . . 0.39 110.41 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.2 t -129.18 142.31 44.76 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.643 -0.661 . . . . 0.33 110.633 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.467 ' HA ' ' HA ' ' A' ' 63' ' ' ASN . 46.2 Cg_endo -72.7 125.5 10.6 Favored 'Trans proline' 0 C--N 1.314 -1.248 0 O-C-N 123.94 1.495 . . . . 0.34 110.449 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.704 ' CB ' HG21 ' A' ' 70' ' ' VAL . 32.9 m-85 -103.14 99.45 9.32 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.558 -0.714 . . . . 0.36 110.215 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.9 m -78.23 91.94 4.43 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.299 -1.0 . . . . 0.37 108.299 178.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.408 ' HA ' ' CD2' ' A' ' 87' ' ' LEU . 3.1 m-85 -97.6 104.37 16.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.573 -0.704 . . . . 0.41 110.352 -178.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.566 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 0.0 OUTLIER -78.22 89.12 4.28 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.693 -0.629 . . . . 1.87 110.202 179.905 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.673 HG23 HG23 ' A' ' 58' ' ' VAL . 1.0 OUTLIER -83.89 101.67 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.308 -0.87 . . . . 0.23 109.397 179.337 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.407 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 36.8 mtm -109.44 151.43 26.69 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.588 -0.695 . . . . 1.01 110.254 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -177.67 -154.89 12.85 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.847 -1.301 . . . . 0.31 109.847 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.88 167.27 11.83 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.468 -1.019 . . . . 0.68 110.353 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.29 102.61 1.42 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.37 -0.831 . . . . 0.33 110.255 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.727 ' O ' HD23 ' A' ' 27' ' ' LEU . 0.5 OUTLIER -129.55 120.48 19.77 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.499 -0.751 . . . . 0.9 110.091 -179.785 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -71.9 -14.91 29.68 Favored 'Trans proline' 0 N--CA 1.49 1.323 0 O-C-N 123.871 1.458 . . . . 0.53 111.465 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -82.28 -0.33 45.0 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.111 -0.993 . . . . 0.74 111.456 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.727 HD23 ' O ' ' A' ' 24' ' ' LEU . 3.5 pp -57.87 -36.51 72.47 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 120.969 -1.082 . . . . 0.46 111.045 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.9 p -79.36 -30.91 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.161 -0.962 . . . . 0.39 110.497 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -66.72 -50.92 61.25 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.403 -0.81 . . . . 0.41 109.891 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.695 ' HG2' ' HA ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -68.81 -45.25 71.73 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.261 -0.9 . . . . 1.05 110.525 179.765 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.693 HG13 ' CD1' ' A' ' 60' ' ' ILE . 2.9 t -53.76 -54.05 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.442 -0.786 . . . . 0.24 111.172 -179.641 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.9 p -66.77 -35.65 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 121.185 -0.947 . . . . 0.32 111.63 -179.053 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -73.8 -51.06 17.62 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.059 -1.026 . . . . 0.5 110.896 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.733 HG21 ' CB ' ' A' ' 76' ' ' GLU . 9.5 p -66.25 -31.7 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.403 -0.81 . . . . 0.33 111.162 -179.68 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.468 HG11 ' HB2' ' A' ' 43' ' ' TYR . 1.6 p -79.59 -28.23 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.145 -0.972 . . . . 0.31 110.634 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -75.98 -37.76 58.2 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.226 -0.922 . . . . 0.78 110.524 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 13.3 mtm180 -71.87 -23.11 61.46 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.332 -0.855 . . . . 2.55 110.93 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.461 ' HB3' ' CG ' ' A' ' 69' ' ' GLN . 7.5 m80 -99.6 -45.78 5.67 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.298 -0.877 . . . . 0.51 110.392 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -92.17 153.57 43.13 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.405 -0.809 . . . . 0.44 109.695 179.243 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -68.05 -36.74 16.54 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 O-C-N 123.752 1.396 . . . . 0.72 111.082 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -101.74 163.89 17.47 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 109.517 -1.433 . . . . 0.47 109.517 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -88.55 154.63 20.19 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.354 -1.086 . . . . 0.66 109.885 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.468 ' HB2' HG11 ' A' ' 35' ' ' VAL . 75.3 m-85 -137.65 172.77 12.46 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.471 -0.768 . . . . 0.47 110.641 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.675 HG22 ' HD2' ' A' ' 45' ' ' PRO . 4.2 m -142.27 154.0 63.65 Favored Pre-proline 0 N--CA 1.498 1.943 0 O-C-N 121.416 -0.803 . . . . 0.45 110.919 -179.149 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.675 ' HD2' HG22 ' A' ' 44' ' ' THR . 55.1 Cg_endo -95.12 132.5 0.56 Allowed 'Trans proline' 0 C--N 1.319 -0.979 0 C-N-CA 121.823 1.682 . . . . 0.57 110.421 178.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 35.8 m -90.24 99.35 12.39 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.067 -1.021 . . . . 0.34 109.202 179.019 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.73 ' HA ' HG12 ' A' ' 58' ' ' VAL . 12.4 p -76.63 135.18 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.544 -0.722 . . . . 0.33 111.495 -178.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.426 ' HE2' ' HB3' ' A' ' 57' ' ' SER . 0.2 OUTLIER -142.71 150.78 55.02 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.789 -0.569 . . . . 0.74 109.817 179.096 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -80.4 80.04 3.15 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 O-C-N 123.982 1.517 . . . . 0.51 110.616 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.54 -47.1 13.53 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.312 -0.867 . . . . 0.92 109.999 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.559 ' HB3' ' HB3' ' A' ' 55' ' ' TYR . 0.6 OUTLIER -105.46 156.42 18.22 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.447 -0.783 . . . . 0.79 110.142 179.582 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.52 150.18 20.51 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.49 -0.756 . . . . 0.94 110.439 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.41 -136.78 12.92 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.653 -1.379 . . . . 0.53 109.653 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -98.55 72.65 2.04 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.468 -1.019 . . . . 0.61 109.974 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.559 ' HB3' ' HB3' ' A' ' 51' ' ' SER . 16.3 t80 -146.36 128.8 15.93 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.416 -0.802 . . . . 0.57 110.38 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 4.0 m170 -120.62 126.04 49.27 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.561 -0.712 . . . . 0.7 109.974 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.426 ' HB3' ' HE2' ' A' ' 48' ' ' LYS . 38.9 m -109.7 110.88 22.05 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.403 -0.811 . . . . 0.4 109.593 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.73 HG12 ' HA ' ' A' ' 47' ' ' VAL . 3.6 m -119.74 151.34 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.21 -0.931 . . . . 0.25 110.931 -179.313 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.566 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 79.3 p -117.8 118.08 31.06 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.478 -0.764 . . . . 0.32 109.422 179.347 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.693 ' CD1' HG13 ' A' ' 31' ' ' VAL . 9.1 tt -93.17 130.68 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.33 -0.856 . . . . 0.28 110.922 -179.012 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 97.2 m -86.15 129.91 34.7 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 109.101 -0.703 . . . . 0.35 109.101 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.434 HD11 HD13 ' A' ' 60' ' ' ILE . 91.0 mt -141.65 96.6 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.103 -0.998 . . . . 0.3 110.848 -179.344 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.467 ' HA ' ' HA ' ' A' ' 14' ' ' PRO . 2.0 t30 -82.31 93.94 7.25 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.039 -1.038 . . . . 0.46 109.353 178.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -117.45 140.21 49.89 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.598 -0.689 . . . . 0.26 110.319 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.558 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 33.8 p -69.74 -15.37 63.13 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.546 -0.722 . . . . 0.35 110.653 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -130.53 157.98 41.2 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.399 -0.813 . . . . 0.43 109.901 179.466 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.2 tt -89.99 -3.23 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.29 -0.881 . . . . 0.55 111.093 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -74.38 -43.68 55.42 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.106 -0.996 . . . . 0.42 110.487 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.461 ' CG ' ' HB3' ' A' ' 38' ' ' HIS . 0.6 OUTLIER -67.01 -47.0 72.79 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.531 -0.73 . . . . 0.58 110.848 -179.682 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.704 HG21 ' CB ' ' A' ' 15' ' ' PHE . 8.9 p -62.24 -31.13 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 121.446 -0.784 . . . . 0.3 110.699 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -66.76 -46.89 73.93 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.326 -0.859 . . . . 0.52 109.224 178.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.447 HG22 ' OE1' ' A' ' 76' ' ' GLU . 7.0 m -61.32 -34.38 75.16 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.679 -0.638 . . . . 0.41 109.464 178.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.453 HD11 ' CG ' ' A' ' 38' ' ' HIS . 2.1 mp -65.64 -39.11 91.08 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.515 -0.741 . . . . 0.37 109.914 179.202 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.48 ' HB2' HG21 ' A' ' 86' ' ' VAL . 0.0 OUTLIER -63.12 -48.94 76.37 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.625 -0.672 . . . . 0.43 109.779 179.419 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -71.26 -26.24 62.81 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.423 -0.798 . . . . 0.62 110.883 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.733 ' CB ' HG21 ' A' ' 34' ' ' VAL . 23.2 mt-10 -73.49 -50.18 22.88 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.216 -0.927 . . . . 0.39 110.07 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.695 ' HA ' ' HG2' ' A' ' 30' ' ' GLN . 1.5 pp -76.17 -25.73 55.52 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.282 -0.886 . . . . 0.34 110.023 178.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -101.39 40.74 2.32 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.307 -1.517 . . . . 0.31 109.307 179.261 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.05 4.12 39.44 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.384 -1.068 . . . . 0.81 110.842 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.0 mp -62.04 145.85 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.334 -0.854 . . . . 0.35 110.116 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -60.96 -30.29 70.16 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.407 -0.808 . . . . 0.74 110.302 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -61.35 171.09 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.616 -0.678 . . . . 0.41 110.611 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 78.9 t -63.67 118.16 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.43 -0.794 . . . . 0.41 110.288 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.35 158.67 27.74 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.675 -0.641 . . . . 0.7 110.369 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.549 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 1.1 ttp -157.76 158.53 35.46 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.511 -0.743 . . . . 0.88 109.786 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.48 HG21 ' HB2' ' A' ' 74' ' ' TYR . 9.1 p -135.46 147.17 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.378 -0.826 . . . . 0.32 110.628 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.408 ' CD2' ' HA ' ' A' ' 17' ' ' TYR . 35.8 mt . . . . . 0 N--CA 1.5 2.061 0 CA-C-O 118.693 -0.67 . . . . 0.47 110.466 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 N--CA 1.495 1.816 0 N-CA-C 109.989 -0.374 . . . . 0.33000000000000002 109.989 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -69.44 114.64 3.72 Favored 'Trans proline' 0 C--N 1.313 -1.312 0 O-C-N 123.861 1.453 . . . . 0.35999999999999999 110.979 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.526 ' CE2' ' HB3' ' A' ' 64' ' ' ALA . 15.7 m-85 -102.53 101.13 11.28 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.694 -0.629 . . . . 0.33000000000000002 110.222 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.4 m -75.5 93.04 2.93 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.631 -0.877 . . . . 0.37 108.631 178.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -110.75 159.25 17.8 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.468 -0.77 . . . . 0.38 110.752 -178.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.546 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -134.82 101.25 4.85 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.348 -0.612 . . . . 0.40000000000000002 109.348 179.766 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 1.062 HG11 HD11 ' A' ' 77' ' ' LEU . 3.5 t -79.68 95.62 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.477 -0.764 . . . . 0.28000000000000003 109.59 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.541 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 43.9 mtm -97.73 142.0 30.05 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.538 -0.726 . . . . 0.56000000000000005 110.178 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 166.42 -147.69 12.46 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.586 -1.406 . . . . 0.31 109.586 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.509 ' HG3' HG21 ' A' ' 82' ' ' ILE . 0.0 OUTLIER -75.8 151.1 37.59 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.326 -1.102 . . . . 0.69999999999999996 110.106 179.816 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.6 105.04 2.98 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.564 -0.71 . . . . 0.35999999999999999 110.31 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.522 HD13 ' HD2' ' A' ' 25' ' ' PRO . 2.6 mm? -111.13 129.69 23.74 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.592 -0.693 . . . . 0.56000000000000005 109.761 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.522 ' HD2' HD13 ' A' ' 24' ' ' LEU . 43.3 Cg_endo -70.49 -30.5 18.81 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 O-C-N 123.701 1.369 . . . . 0.40999999999999998 110.606 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -83.6 -2.81 56.9 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.463 -0.773 . . . . 0.64000000000000001 110.791 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.52 HD21 HG21 ' A' ' 58' ' ' VAL . 0.8 OUTLIER -58.48 -52.62 64.85 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.043 -1.035 . . . . 0.81999999999999995 110.284 179.997 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.499 HG12 ' HG2' ' A' ' 45' ' ' PRO . 35.8 m -62.23 -33.2 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.48 -0.762 . . . . 0.34999999999999998 110.467 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -67.45 -46.26 73.59 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.511 -0.743 . . . . 0.48999999999999999 109.937 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.734 ' O ' HG12 ' A' ' 34' ' ' VAL . 3.2 tp60 -72.24 -34.32 68.2 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.446 -0.784 . . . . 0.53000000000000003 110.328 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.807 HG22 HD12 ' A' ' 60' ' ' ILE . 2.8 t -60.41 -53.21 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.561 -0.712 . . . . 0.26000000000000001 110.432 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.444 ' HA ' HG12 ' A' ' 35' ' ' VAL . 9.9 p -70.81 -31.47 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 121.329 -0.857 . . . . 0.28999999999999998 110.846 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.73 -46.27 54.39 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.301 -0.874 . . . . 0.52000000000000002 110.932 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.849 HG21 ' CB ' ' A' ' 76' ' ' GLU . 7.6 p -75.51 -30.28 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.247 -0.908 . . . . 0.25 111.048 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.67 HG11 ' HB2' ' A' ' 43' ' ' TYR . 4.0 p -75.2 -30.75 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.045 -1.034 . . . . 0.26000000000000001 110.209 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -79.04 -42.0 27.52 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.383 -0.823 . . . . 0.57999999999999996 110.32 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.9 mtm180 -62.87 -30.06 71.23 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.269 -0.895 . . . . 2.5099999999999998 111.053 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.743 ' CG ' HD11 ' A' ' 73' ' ' LEU . 68.6 m-70 -97.5 -41.05 8.36 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.342 -0.849 . . . . 0.51000000000000001 110.72 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -120.8 145.56 41.58 Favored Pre-proline 0 N--CA 1.497 1.922 0 O-C-N 121.439 -0.788 . . . . 0.29999999999999999 110.019 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.96 142.53 51.77 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 O-C-N 123.598 1.315 . . . . 0.40000000000000002 110.985 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 98.09 147.76 22.74 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.724 -1.35 . . . . 0.35999999999999999 109.724 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -94.48 139.9 30.53 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.573 -0.957 . . . . 0.66000000000000003 109.949 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.67 ' HB2' HG11 ' A' ' 35' ' ' VAL . 76.5 m-85 -131.81 164.41 26.09 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.444 -0.785 . . . . 0.45000000000000001 110.67 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.431 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 0.5 OUTLIER -142.79 158.14 60.16 Favored Pre-proline 0 N--CA 1.498 1.935 0 O-C-N 121.424 -0.798 . . . . 0.55000000000000004 111.713 -179.314 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.688 ' HG3' HG21 ' A' ' 31' ' ' VAL . 55.2 Cg_endo -96.69 120.58 0.19 Allowed 'Trans proline' 0 C--N 1.317 -1.119 0 C-N-CA 122.382 2.055 . . . . 0.51000000000000001 110.258 179.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.522 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 27.6 m -81.41 99.48 8.74 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.021 -1.049 . . . . 0.32000000000000001 109.397 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.666 HG23 HG12 ' A' ' 58' ' ' VAL . 10.8 p -75.89 144.35 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.419 -0.801 . . . . 0.34000000000000002 111.469 -178.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 O-C-N 121.834 -0.541 . . . . 0.55000000000000004 109.665 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 41.3 t80 . . . . . 0 N--CA 1.497 1.894 0 CA-C-O 121.074 0.464 . . . . 0.90000000000000002 109.797 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -130.35 142.26 50.54 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.281 -0.887 . . . . 0.64000000000000001 111.311 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.541 ' HA ' ' HA ' ' A' ' 20' ' ' MET . 16.0 m -110.51 117.23 32.99 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.705 -0.85 . . . . 0.35999999999999999 108.705 179.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.666 HG12 HG23 ' A' ' 47' ' ' VAL . 2.8 m -110.09 150.78 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.187 -0.946 . . . . 0.26000000000000001 111.829 -178.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.484 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 0.3 OUTLIER -104.41 104.6 14.5 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.396 -0.965 . . . . 1.0 108.396 178.476 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.807 HD12 HG22 ' A' ' 31' ' ' VAL . 14.5 tt -93.1 130.73 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.305 -0.872 . . . . 0.28000000000000003 111.849 -178.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.523 ' O ' ' HB3' ' A' ' 43' ' ' TYR . 37.7 m -96.44 133.91 40.27 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.633 -0.877 . . . . 0.33000000000000002 108.633 178.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.511 HG23 HG23 ' A' ' 35' ' ' VAL . 32.3 mt -144.14 139.39 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 120.939 -1.1 . . . . 0.26000000000000001 111.137 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -112.63 57.21 0.66 Allowed 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.877 0.846 . . . . 0.35999999999999999 109.161 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.642 ' HB1' ' HB3' ' A' ' 69' ' ' GLN . . . -67.21 130.74 44.06 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.965 -1.085 . . . . 0.25 110.22 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 32.8 p -70.08 -7.57 42.4 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.868 -0.52 . . . . 0.29999999999999999 111.053 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.743 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 13.1 t-80 -129.75 157.89 40.92 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.198 -0.939 . . . . 0.38 110.104 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.492 ' O ' HG12 ' A' ' 70' ' ' VAL . 16.0 mm -69.7 -51.4 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.413 -0.805 . . . . 0.55000000000000004 110.504 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.42 ' HB2' ' CE1' ' A' ' 66' ' ' HIS . 1.7 mt-10 -71.58 -14.69 62.16 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.472 -0.768 . . . . 1.1499999999999999 111.647 -179.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.743 ' HB2' ' HB3' ' A' ' 66' ' ' HIS . 39.4 tt0 -62.09 -46.0 91.02 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.013 -1.055 . . . . 0.42999999999999999 110.306 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.492 HG12 ' O ' ' A' ' 67' ' ' ILE . 5.8 p -60.73 -27.22 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 121.158 -0.964 . . . . 0.33000000000000002 110.609 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -67.82 -50.24 57.86 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.298 -0.876 . . . . 0.83999999999999997 109.856 179.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.9 p -63.5 -37.33 86.9 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.512 -0.742 . . . . 0.37 109.597 179.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.743 HD11 ' CG ' ' A' ' 38' ' ' HIS . 5.5 mp -60.03 -39.96 87.69 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.538 -0.726 . . . . 0.52000000000000002 109.561 178.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.627 ' CD1' ' HB ' ' A' ' 86' ' ' VAL . 0.6 OUTLIER -63.03 -45.79 90.61 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.531 -0.73 . . . . 0.45000000000000001 109.084 178.654 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -60.7 -37.67 82.43 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.56 -0.713 . . . . 0.67000000000000004 109.943 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.849 ' CB ' HG21 ' A' ' 34' ' ' VAL . 0.3 OUTLIER -63.26 -41.38 99.03 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.516 -0.74 . . . . 0.56999999999999995 110.566 179.801 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 1.062 HD11 HG11 ' A' ' 19' ' ' VAL . 0.3 OUTLIER -84.47 -28.59 26.68 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.382 -0.824 . . . . 0.32000000000000001 110.557 179.818 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.536 ' N ' ' HG ' ' A' ' 77' ' ' LEU . . . -107.08 58.98 0.4 Allowed Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.806 -1.317 . . . . 0.26000000000000001 109.806 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.12 4.17 26.56 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.606 -0.938 . . . . 0.46000000000000002 110.389 178.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.448 HG22 ' H ' ' A' ' 82' ' ' ILE . 2.2 mp -63.4 152.65 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.383 -0.823 . . . . 0.47999999999999998 110.125 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -69.74 -11.87 61.19 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.333 -0.854 . . . . 0.79000000000000004 111.063 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.52 HG22 ' H ' ' A' ' 83' ' ' VAL . 22.3 mm -82.94 175.23 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.134 -0.979 . . . . 0.46999999999999997 109.903 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.52 ' H ' HG22 ' A' ' 82' ' ' ILE . 76.0 t -63.16 112.04 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.373 -0.829 . . . . 0.51000000000000001 111.395 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.96 136.76 54.94 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 109.109 -0.7 . . . . 1.02 109.109 178.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.46 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 2.6 ttt -151.3 161.57 42.46 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.12 -0.987 . . . . 2.3599999999999999 110.724 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.627 ' HB ' ' CD1' ' A' ' 74' ' ' TYR . 8.1 p -141.71 153.04 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.431 -0.793 . . . . 0.29999999999999999 110.565 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.546 ' HB3' ' HB2' ' A' ' 18' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.496 1.835 0 CA-C-O 117.944 -1.027 . . . . 0.32000000000000001 109.705 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.1 t . . . . . 0 N--CA 1.494 1.774 0 N-CA-C 110.306 -0.257 . . . . 0.33000000000000002 110.306 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.31 125.68 11.57 Favored 'Trans proline' 0 C--N 1.313 -1.301 0 O-C-N 123.925 1.487 . . . . 0.40000000000000002 110.483 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.577 ' HB2' HG23 ' A' ' 62' ' ' ILE . 29.5 m-85 -105.91 99.31 8.91 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.535 -0.728 . . . . 0.33000000000000002 110.355 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.1 m -76.93 92.72 3.69 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.072 -1.084 . . . . 0.42999999999999999 108.072 178.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.478 ' O ' HG22 ' A' ' 60' ' ' ILE . 3.0 m-85 -99.86 107.33 19.32 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.434 -0.792 . . . . 0.29999999999999999 110.723 -178.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 0.1 OUTLIER -82.07 88.79 6.41 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.524 -0.735 . . . . 0.34000000000000002 109.292 179.547 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 1.034 HG11 HD11 ' A' ' 77' ' ' LEU . 21.3 t -79.95 95.02 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.537 -0.727 . . . . 0.28999999999999998 109.617 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.8 ttt -107.96 125.91 52.07 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.573 -0.704 . . . . 1.1100000000000001 110.431 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.486 ' HA3' ' HD3' ' A' ' 84' ' ' ARG . . . -153.82 -160.24 9.64 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.28 -1.528 . . . . 0.26000000000000001 109.28 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.433 ' HB2' HG23 ' A' ' 82' ' ' ILE . 0.0 OUTLIER -67.02 168.06 10.69 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.38 -1.07 . . . . 1.04 110.253 179.73 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.413 ' O ' HD22 ' A' ' 24' ' ' LEU . . . -63.76 103.62 0.58 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.408 -0.808 . . . . 0.35999999999999999 110.417 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.761 HD13 ' HD2' ' A' ' 25' ' ' PRO . 0.5 OUTLIER -125.1 123.03 25.39 Favored Pre-proline 0 N--CA 1.496 1.835 0 O-C-N 121.469 -0.769 . . . . 0.41999999999999998 110.32 -179.706 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.761 ' HD2' HD13 ' A' ' 24' ' ' LEU . 46.3 Cg_endo -73.04 -22.41 19.51 Favored 'Trans proline' 0 N--CA 1.489 1.227 0 O-C-N 123.892 1.47 . . . . 0.48999999999999999 111.163 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.606 ' HG2' HD12 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -78.49 -0.67 30.36 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.307 -0.87 . . . . 0.56000000000000005 111.524 -179.985 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.571 HD11 ' NH1' ' A' ' 84' ' ' ARG . 9.3 mt -53.64 -58.44 7.19 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.19 -0.944 . . . . 0.34999999999999998 110.871 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.441 ' HA ' ' HG3' ' A' ' 45' ' ' PRO . 8.9 p -64.9 -30.35 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.429 -0.794 . . . . 0.34999999999999998 111.177 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.4 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 13.6 m-20 -67.08 -56.44 10.03 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.317 -0.865 . . . . 0.46999999999999997 110.649 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.669 ' O ' HG12 ' A' ' 34' ' ' VAL . 0.7 OUTLIER -68.98 -38.02 79.09 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.327 -0.858 . . . . 1.03 110.846 -179.898 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.611 HG22 HD22 ' A' ' 77' ' ' LEU . 3.2 t -57.63 -54.52 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.398 -0.814 . . . . 0.27000000000000002 110.596 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.3 p -66.09 -34.16 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.329 -0.857 . . . . 0.35999999999999999 111.284 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' A' ' 29' ' ' ASP . 0.3 OUTLIER -73.88 -52.77 11.9 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.094 -1.004 . . . . 1.26 111.06 -179.681 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.832 HG21 ' CB ' ' A' ' 76' ' ' GLU . 8.0 p -68.26 -27.26 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.3 -0.875 . . . . 0.35999999999999999 111.34 -179.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.805 HG23 HD12 ' A' ' 62' ' ' ILE . 2.9 p -79.92 -34.14 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.01 -1.056 . . . . 0.35999999999999999 110.703 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -80.92 -23.71 38.7 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.058 -1.027 . . . . 1.1699999999999999 110.585 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 31.7 mtm180 -76.59 -43.8 37.1 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.318 -0.864 . . . . 1.3500000000000001 110.793 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.598 ' CB ' HD11 ' A' ' 73' ' ' LEU . 90.1 m-70 -93.19 -45.65 7.77 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.365 -0.834 . . . . 1.49 110.843 -179.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.562 ' HB3' ' O ' ' A' ' 35' ' ' VAL . . . -91.92 148.84 37.83 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 121.337 -0.852 . . . . 0.55000000000000004 110.072 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.02 140.28 34.39 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 O-C-N 123.884 1.465 . . . . 0.75 110.572 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.96 154.45 9.41 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.729 -1.348 . . . . 0.48999999999999999 109.729 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.94 143.56 26.68 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.399 -1.06 . . . . 0.66000000000000003 110.002 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.52 ' HB2' HG11 ' A' ' 35' ' ' VAL . 51.0 m-85 -127.65 172.73 10.51 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.516 -0.74 . . . . 0.45000000000000001 110.517 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.804 HG22 ' HD2' ' A' ' 45' ' ' PRO . 1.0 OUTLIER -142.23 154.38 64.24 Favored Pre-proline 0 N--CA 1.497 1.9 0 O-C-N 121.43 -0.794 . . . . 0.60999999999999999 110.82 -179.433 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.804 ' HD2' HG22 ' A' ' 44' ' ' THR . 53.4 Cg_endo -93.91 164.39 2.16 Favored 'Trans proline' 0 C--N 1.317 -1.11 0 C-N-CA 121.69 1.593 . . . . 0.46999999999999997 110.354 179.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.476 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 22.7 m -120.28 95.98 4.96 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.688 -0.856 . . . . 0.34000000000000002 108.688 178.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.401 HG23 HG23 ' A' ' 58' ' ' VAL . 9.9 p -75.78 143.8 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.538 -0.726 . . . . 0.35999999999999999 111.239 -178.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.438 ' HB2' ' HB3' ' A' ' 57' ' ' SER . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.671 0 O-C-N 121.722 -0.612 . . . . 0.44 110.102 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 121.075 0.464 . . . . 0.52000000000000002 109.96 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -111.1 129.83 55.8 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.54 -0.725 . . . . 0.63 110.483 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.438 ' HB3' ' HB2' ' A' ' 48' ' ' LYS . 0.4 OUTLIER -97.56 99.31 10.7 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.522 -0.736 . . . . 0.33000000000000002 109.451 179.341 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.631 HG13 ' HB2' ' A' ' 45' ' ' PRO . 1.0 OUTLIER -103.81 120.93 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.394 -0.816 . . . . 0.28000000000000003 110.746 -179.216 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.493 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 11.6 t -100.92 114.49 28.41 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.452 -0.78 . . . . 0.40999999999999998 109.114 178.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.553 ' CD1' HG13 ' A' ' 31' ' ' VAL . 11.2 tt -93.47 132.7 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.268 -0.895 . . . . 0.32000000000000001 111.344 -178.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.466 ' O ' ' HB3' ' A' ' 43' ' ' TYR . 22.7 m -99.03 135.52 40.31 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.808 -0.812 . . . . 0.40999999999999998 108.808 178.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.805 HD12 HG23 ' A' ' 35' ' ' VAL . 3.1 tt -162.37 131.75 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.128 -0.983 . . . . 0.44 111.003 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -105.28 101.19 10.75 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.407 -0.808 . . . . 0.57999999999999996 109.359 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -115.72 146.56 41.78 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.427 -0.795 . . . . 0.29999999999999999 110.64 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 47.3 p -79.35 -2.87 43.58 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.661 -0.649 . . . . 0.44 111.136 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.541 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 8.6 t-160 -129.81 147.4 51.58 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.189 -0.944 . . . . 0.64000000000000001 110.746 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.509 ' O ' HG12 ' A' ' 70' ' ' VAL . 0.8 OUTLIER -78.95 -41.42 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.638 -0.664 . . . . 0.76000000000000001 109.843 179.292 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -65.47 -32.5 74.14 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.472 -0.767 . . . . 0.52000000000000002 110.661 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.541 ' HB2' ' HB3' ' A' ' 66' ' ' HIS . 0.6 OUTLIER -59.91 -55.81 29.53 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.361 -0.837 . . . . 0.57999999999999996 110.531 -179.936 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.573 HG21 ' HB3' ' A' ' 15' ' ' PHE . 13.3 p -61.16 -29.89 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.351 -0.843 . . . . 0.27000000000000002 110.452 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -67.69 -43.85 79.13 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.229 -0.919 . . . . 0.46999999999999997 109.365 178.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 54.7 m -60.52 -38.63 85.02 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.604 -0.685 . . . . 0.34999999999999998 109.168 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.711 ' HG ' HG22 ' A' ' 34' ' ' VAL . 7.7 mp -63.71 -38.39 90.92 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.68 -0.638 . . . . 0.40999999999999998 109.777 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.618 ' CD1' ' HB ' ' A' ' 86' ' ' VAL . 0.2 OUTLIER -59.3 -47.92 83.56 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 108.973 -0.751 . . . . 0.64000000000000001 108.973 178.693 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.14 -31.29 72.41 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.606 -0.684 . . . . 0.55000000000000004 110.214 179.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.832 ' CB ' HG21 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -66.14 -51.38 58.4 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.442 -0.787 . . . . 0.66000000000000003 110.236 179.501 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 1.034 HD11 HG11 ' A' ' 19' ' ' VAL . 0.4 OUTLIER -76.43 -25.41 54.4 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.431 -0.793 . . . . 0.28000000000000003 110.536 179.685 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.651 ' HA2' ' HG2' ' A' ' 84' ' ' ARG . . . -101.11 39.23 2.81 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 110.051 -1.22 . . . . 0.27000000000000002 110.051 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.62 4.23 45.64 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.521 -0.988 . . . . 1.97 110.635 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.7 mp -60.14 153.03 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.303 -0.873 . . . . 0.37 110.064 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.5 -27.79 67.87 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.479 -0.763 . . . . 1.3 109.932 179.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.512 HG21 HD23 ' A' ' 24' ' ' LEU . 0.9 OUTLIER -68.26 171.99 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.526 -0.734 . . . . 0.51000000000000001 110.179 179.36 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.418 ' N ' HG23 ' A' ' 82' ' ' ILE . 97.5 t -81.5 110.8 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.294 -0.879 . . . . 0.60999999999999999 110.639 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.764 ' HD2' HG12 ' A' ' 19' ' ' VAL . 8.3 tpp180 -121.59 131.85 54.35 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.689 -0.632 . . . . 0.44 109.802 179.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.514 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 6.0 mtm -129.82 171.41 12.73 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.382 -0.823 . . . . 1.3100000000000001 110.516 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.692 HG23 HG22 ' A' ' 19' ' ' VAL . 8.8 p -138.62 156.03 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.548 -0.72 . . . . 0.28999999999999998 110.619 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.432 ' HA ' HD22 ' A' ' 87' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.5 2.029 0 CA-C-O 118.81 -0.614 . . . . 0.54000000000000004 110.398 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.2 t . . . . . 0 N--CA 1.495 1.82 0 N-CA-C 110.244 -0.28 . . . . 0.37 110.244 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.43 117.82 5.35 Favored 'Trans proline' 0 C--N 1.315 -1.212 0 O-C-N 123.893 1.47 . . . . 0.39000000000000001 110.811 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.665 ' HB2' ' HB ' ' A' ' 62' ' ' ILE . 16.7 m-85 -103.29 99.67 9.53 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.589 -0.694 . . . . 0.29999999999999999 110.429 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.9 m -75.56 92.94 2.95 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.504 -0.925 . . . . 0.34000000000000002 108.504 178.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.532 ' HD2' HG21 ' A' ' 86' ' ' VAL . 3.4 m-85 -102.72 108.0 19.1 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.343 -0.848 . . . . 0.32000000000000001 110.9 -178.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.551 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 0.0 OUTLIER -78.3 89.72 4.34 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.532 -0.73 . . . . 0.78000000000000003 109.296 179.404 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 1.054 HG11 HD11 ' A' ' 77' ' ' LEU . 24.8 t -78.57 96.5 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.487 -0.758 . . . . 0.29999999999999999 109.906 -179.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.582 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 1.0 OUTLIER -97.21 149.71 21.72 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.541 -0.724 . . . . 1.1799999999999999 110.124 -179.772 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 170.21 -151.44 16.61 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.848 -1.301 . . . . 0.34000000000000002 109.848 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -79.38 151.45 30.95 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.545 -0.973 . . . . 0.73999999999999999 110.327 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.21 96.99 4.02 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.604 -0.685 . . . . 0.32000000000000001 110.199 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.408 HD13 HG21 ' A' ' 82' ' ' ILE . 0.1 OUTLIER -127.4 155.53 76.45 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.469 -0.769 . . . . 0.69999999999999996 110.45 -179.823 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.56 -22.96 20.46 Favored 'Trans proline' 0 C--N 1.314 -1.263 0 O-C-N 123.927 1.488 . . . . 0.53000000000000003 110.803 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -70.32 -18.09 63.08 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.337 -0.852 . . . . 0.57999999999999996 111.035 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.472 ' HA ' HD13 ' A' ' 27' ' ' LEU . 1.7 mm? -57.87 -66.28 0.5 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.305 -0.872 . . . . 0.46000000000000002 110.414 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.5 p -62.99 -29.5 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.449 -0.782 . . . . 0.39000000000000001 110.965 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -64.59 -57.66 8.5 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.338 -0.851 . . . . 0.46000000000000002 110.324 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.641 ' O ' HG12 ' A' ' 34' ' ' VAL . 4.9 tp60 -69.33 -30.32 68.33 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.353 -0.842 . . . . 0.91000000000000003 110.821 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.987 HG22 HD12 ' A' ' 60' ' ' ILE . 2.3 t -59.79 -54.52 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.248 -0.907 . . . . 0.23999999999999999 110.242 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.418 ' O ' ' HG2' ' A' ' 36' ' ' GLN . 9.5 p -70.77 -32.74 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.339 -0.85 . . . . 0.32000000000000001 111.15 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.406 ' HA ' ' HG2' ' A' ' 36' ' ' GLN . 0.8 OUTLIER -73.58 -51.42 16.96 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.204 -0.935 . . . . 0.62 110.756 -179.885 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.695 HG21 ' HB2' ' A' ' 76' ' ' GLU . 4.0 p -66.71 -29.22 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.467 -0.771 . . . . 0.27000000000000002 111.213 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.506 ' CG2' HD13 ' A' ' 62' ' ' ILE . 4.7 p -80.09 -31.93 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.035 -1.041 . . . . 0.28000000000000003 110.711 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.492 ' HG3' ' N ' ' A' ' 37' ' ' ARG . 1.6 pt20 -82.42 -21.91 35.54 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.055 -1.028 . . . . 1.1699999999999999 110.685 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.492 ' N ' ' HG3' ' A' ' 36' ' ' GLN . 26.9 mtm180 -79.24 -41.84 27.29 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.278 -0.889 . . . . 0.72999999999999998 110.704 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.658 ' HB2' HD11 ' A' ' 73' ' ' LEU . 93.7 m-70 -95.9 -43.62 7.75 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.391 -0.818 . . . . 0.45000000000000001 110.683 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.496 ' HB3' ' O ' ' A' ' 35' ' ' VAL . . . -98.01 150.64 36.96 Favored Pre-proline 0 N--CA 1.497 1.894 0 O-C-N 121.324 -0.86 . . . . 0.27000000000000002 109.924 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.36 140.09 29.88 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.678 1.357 . . . . 0.29999999999999999 110.673 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.63 154.02 14.18 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 110.045 -1.222 . . . . 0.40000000000000002 110.045 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -95.07 148.32 22.48 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.466 -1.02 . . . . 0.45000000000000001 109.914 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.449 ' HB2' HG11 ' A' ' 35' ' ' VAL . 67.7 m-85 -135.1 175.9 9.16 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.467 -0.771 . . . . 0.5 110.723 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.613 HG22 ' HD2' ' A' ' 45' ' ' PRO . 0.2 OUTLIER -142.7 158.06 60.61 Favored Pre-proline 0 N--CA 1.498 1.95 0 O-C-N 121.398 -0.814 . . . . 0.62 111.239 -178.973 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.613 ' HD2' HG22 ' A' ' 44' ' ' THR . 54.4 Cg_endo -96.24 118.26 0.18 Allowed 'Trans proline' 0 C--N 1.318 -1.029 0 C-N-CA 122.121 1.881 . . . . 0.28000000000000003 110.431 179.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.511 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 31.9 m -76.24 104.71 6.9 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.086 -1.009 . . . . 0.38 109.283 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.548 HG23 HG12 ' A' ' 58' ' ' VAL . 14.3 p -76.2 142.58 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.411 -0.806 . . . . 0.35999999999999999 111.656 -178.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.408 ' HD2' HG22 ' A' ' 46' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.721 0 O-C-N 121.755 -0.591 . . . . 0.80000000000000004 109.787 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 33.3 t80 . . . . . 0 N--CA 1.497 1.908 0 CA-C-O 121.063 0.459 . . . . 0.69999999999999996 109.845 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 2.6 m170 -117.27 135.69 53.64 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.428 -0.795 . . . . 0.78000000000000003 110.904 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.582 ' HA ' ' HA ' ' A' ' 20' ' ' MET . 26.8 m -108.64 102.54 11.59 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 109.139 -0.689 . . . . 0.40999999999999998 109.139 179.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.548 HG12 HG23 ' A' ' 47' ' ' VAL . 3.1 m -103.65 146.79 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.306 -0.871 . . . . 0.31 110.834 -179.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.551 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 7.3 t -108.98 114.15 27.66 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.852 -0.796 . . . . 0.46999999999999997 108.852 179.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.987 HD12 HG22 ' A' ' 31' ' ' VAL . 8.8 tt -93.08 132.77 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.269 -0.894 . . . . 0.29999999999999999 111.763 -178.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 56.2 m -86.7 117.4 25.43 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.565 -0.902 . . . . 0.34999999999999998 108.565 178.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.682 HG21 HG23 ' A' ' 70' ' ' VAL . 38.3 mm -114.29 132.93 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.068 -1.02 . . . . 0.40000000000000002 111.048 -178.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.418 ' HB2' ' CZ ' ' A' ' 43' ' ' TYR . 3.6 t30 -108.18 62.1 0.61 Allowed 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.521 0.677 . . . . 0.39000000000000001 109.216 178.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.852 ' HB1' ' HB3' ' A' ' 69' ' ' GLN . . . -91.67 133.83 35.24 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.306 -0.871 . . . . 0.25 110.686 -179.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 31.8 p -70.67 -17.83 62.84 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.608 -0.682 . . . . 0.40000000000000002 110.691 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -129.84 159.88 35.22 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.332 -0.855 . . . . 0.48999999999999999 110.127 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.2 tt -74.62 -17.01 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.378 -0.826 . . . . 0.80000000000000004 110.783 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.9 -30.22 40.04 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.188 -0.945 . . . . 0.83999999999999997 110.25 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.852 ' HB3' ' HB1' ' A' ' 64' ' ' ALA . 0.4 OUTLIER -65.64 -47.97 73.77 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.395 -0.815 . . . . 0.48999999999999999 110.271 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.682 HG23 HG21 ' A' ' 62' ' ' ILE . 13.7 p -67.44 -28.82 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.367 -0.833 . . . . 0.28999999999999998 110.294 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.16 -52.94 56.57 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.354 -0.841 . . . . 0.83999999999999997 109.536 179.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.5 p -63.23 -35.66 81.05 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.503 -0.748 . . . . 0.34999999999999998 109.487 179.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.658 HD11 ' HB2' ' A' ' 38' ' ' HIS . 3.6 mp -60.9 -39.58 89.84 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.634 -0.666 . . . . 0.34999999999999998 109.557 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.59 ' CD1' ' HB ' ' A' ' 86' ' ' VAL . 0.3 OUTLIER -63.91 -48.69 75.6 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 109.143 -0.688 . . . . 0.59999999999999998 109.143 178.761 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.76 -36.71 83.95 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.549 -0.719 . . . . 0.68000000000000005 110.2 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.695 ' HB2' HG21 ' A' ' 34' ' ' VAL . 23.5 mt-10 -65.04 -47.38 77.6 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.586 -0.696 . . . . 0.33000000000000002 110.459 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 1.054 HD11 HG11 ' A' ' 19' ' ' VAL . 0.3 OUTLIER -76.84 -29.11 55.76 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.246 -0.909 . . . . 0.32000000000000001 110.433 179.718 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.477 ' N ' ' HG ' ' A' ' 77' ' ' LEU . . . -102.36 48.19 1.08 Allowed Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.503 -1.439 . . . . 0.25 109.503 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.9 ttmt -106.46 4.0 27.85 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.47 -1.017 . . . . 1.6599999999999999 110.808 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.0 mp -69.57 153.13 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.218 -0.926 . . . . 0.35999999999999999 110.105 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.12 -26.45 68.31 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.399 -0.813 . . . . 1.3799999999999999 110.239 179.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.453 HG23 ' N ' ' A' ' 83' ' ' VAL . 1.0 OUTLIER -64.13 174.72 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.606 -0.684 . . . . 0.46000000000000002 110.583 179.671 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.453 ' N ' HG23 ' A' ' 82' ' ' ILE . 75.4 t -63.71 117.49 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.392 -0.818 . . . . 0.38 110.546 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.94 132.81 54.74 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.728 -0.607 . . . . 0.77000000000000002 110.049 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.526 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -154.22 160.54 41.89 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.215 -0.928 . . . . 1.7 110.318 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.641 HG23 HG22 ' A' ' 19' ' ' VAL . 8.2 p -141.48 157.23 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.406 -0.809 . . . . 0.26000000000000001 110.763 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.49 HD11 ' CZ ' ' A' ' 17' ' ' TYR . 77.4 mt . . . . . 0 N--CA 1.501 2.08 0 CA-C-O 117.674 -1.155 . . . . 0.47999999999999998 110.554 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.7 t . . . . . 0 N--CA 1.495 1.784 0 N-CA-C 110.227 -0.286 . . . . 0.40000000000000002 110.227 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.94 122.56 8.92 Favored 'Trans proline' 0 C--N 1.315 -1.197 0 O-C-N 123.83 1.437 . . . . 0.40000000000000002 110.883 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.491 ' HB2' HG23 ' A' ' 62' ' ' ILE . 20.3 m-85 -106.38 99.78 9.34 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.652 -0.655 . . . . 0.34000000000000002 110.281 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.1 p -73.64 99.22 3.03 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.248 -1.019 . . . . 0.33000000000000002 108.248 178.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -113.91 159.54 19.77 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.384 -0.822 . . . . 0.33000000000000002 111.031 -178.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.703 ' HD2' HD22 ' A' ' 87' ' ' LEU . 0.7 OUTLIER -137.35 102.46 4.8 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.822 -0.807 . . . . 0.66000000000000003 108.822 179.204 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 1.005 HG11 HD11 ' A' ' 77' ' ' LEU . 15.6 t -81.14 99.74 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 CA-C-O 121.463 0.649 . . . . 0.26000000000000001 110.193 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.413 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 35.7 mtt -94.77 155.01 17.01 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.479 -0.763 . . . . 1.2 109.961 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 157.5 -150.12 20.98 Favored Glycine 0 N--CA 1.497 2.722 0 N-CA-C 110.194 -1.163 . . . . 0.34000000000000002 110.194 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.422 ' O ' HD23 ' A' ' 24' ' ' LEU . 1.1 tm0? -76.93 160.81 28.89 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.51 -0.994 . . . . 0.73999999999999999 110.642 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -86.43 92.28 8.79 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.628 -0.67 . . . . 0.46999999999999997 110.053 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.422 HD23 ' O ' ' A' ' 22' ' ' GLN . 0.7 OUTLIER -127.59 150.31 72.62 Favored Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 121.504 -0.748 . . . . 0.41999999999999998 110.386 179.924 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -71.86 -24.06 21.56 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 O-C-N 123.861 1.453 . . . . 0.42999999999999999 111.461 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.82 -18.31 64.8 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.216 -0.927 . . . . 0.59999999999999998 111.044 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.459 HD22 HG21 ' A' ' 58' ' ' VAL . 0.7 OUTLIER -60.8 -63.18 1.39 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.225 -0.922 . . . . 0.68999999999999995 110.365 -179.956 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.726 HG23 ' HD2' ' A' ' 45' ' ' PRO . 8.6 p -65.38 -31.58 54.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.421 -0.799 . . . . 0.34999999999999998 110.63 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -63.4 -53.71 48.16 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.339 -0.851 . . . . 0.51000000000000001 110.188 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.725 ' O ' HG12 ' A' ' 34' ' ' VAL . 1.1 tp-100 -68.55 -34.87 76.6 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.426 -0.796 . . . . 0.80000000000000004 110.658 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.768 HG22 HD22 ' A' ' 77' ' ' LEU . 2.7 t -57.28 -46.94 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.342 -0.849 . . . . 0.29999999999999999 109.997 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 77.4 t -71.17 -37.25 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.493 -0.754 . . . . 0.39000000000000001 110.681 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.43 -54.32 11.05 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.181 -0.95 . . . . 1.03 110.839 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.779 HG21 ' CB ' ' A' ' 76' ' ' GLU . 9.9 p -62.79 -33.02 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.43 -0.794 . . . . 0.34999999999999998 111.395 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.654 HG21 ' HB2' ' A' ' 43' ' ' TYR . 3.2 p -77.21 -29.61 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.032 -1.043 . . . . 0.40000000000000002 110.343 179.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -74.26 -35.19 63.77 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.235 -0.916 . . . . 1.0800000000000001 109.977 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.48 -23.87 61.1 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.493 -0.755 . . . . 1.4099999999999999 110.811 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.419 ' CD2' HD11 ' A' ' 73' ' ' LEU . 0.3 OUTLIER -101.51 -46.0 5.12 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.206 -0.934 . . . . 0.59999999999999998 110.546 -179.905 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -103.15 151.09 38.44 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.484 -0.76 . . . . 0.54000000000000004 109.841 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -69.94 -41.26 4.2 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 O-C-N 123.857 1.451 . . . . 0.75 111.115 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -85.81 145.24 20.77 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.634 -1.386 . . . . 0.51000000000000001 109.634 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.9 152.03 27.0 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.446 -1.032 . . . . 0.80000000000000004 109.962 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.654 ' HB2' HG21 ' A' ' 35' ' ' VAL . 45.2 m-85 -136.9 159.79 40.82 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.529 -0.732 . . . . 0.40999999999999998 110.573 -179.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.495 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 22.8 m -142.32 151.51 58.35 Favored Pre-proline 0 N--CA 1.499 1.984 0 O-C-N 121.445 -0.784 . . . . 0.35999999999999999 111.301 -179.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.726 ' HD2' HG23 ' A' ' 28' ' ' VAL . 54.1 Cg_endo -96.51 135.84 0.5 Allowed 'Trans proline' 0 C--N 1.32 -0.958 0 C-N-CA 122.03 1.82 . . . . 0.47999999999999998 110.508 178.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.511 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 32.1 m -95.03 108.43 20.5 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.16 -0.963 . . . . 0.40000000000000002 109.17 179.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.739 HG23 HG12 ' A' ' 58' ' ' VAL . 7.7 p -75.9 141.58 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.444 -0.785 . . . . 0.42999999999999999 111.54 -178.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.7 mtmp? . . . . . 0 N--CA 1.495 1.782 0 O-C-N 121.885 -0.509 . . . . 0.98999999999999999 109.905 179.611 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 30.2 t80 . . . . . 0 N--CA 1.497 1.904 0 CA-C-O 121.137 0.494 . . . . 0.60999999999999999 110.111 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 1.2 m170 -125.06 145.26 50.0 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.281 -0.887 . . . . 1.01 111.333 -179.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.413 ' HA ' ' HA ' ' A' ' 20' ' ' MET . 14.0 t -119.22 106.09 12.0 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.54 -0.911 . . . . 0.35999999999999999 108.54 178.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.739 HG12 HG23 ' A' ' 47' ' ' VAL . 2.1 m -103.29 146.4 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.272 -0.892 . . . . 0.32000000000000001 111.176 -178.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.609 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 16.9 p -103.89 110.67 22.89 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.64 -0.874 . . . . 0.34000000000000002 108.64 178.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.621 ' HA ' ' HA ' ' A' ' 45' ' ' PRO . 13.8 tt -93.12 128.34 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 CA-C-O 121.902 0.858 . . . . 0.35999999999999999 111.459 -178.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.491 ' O ' ' HB3' ' A' ' 43' ' ' TYR . 22.5 m -97.18 126.83 42.62 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.193 -1.04 . . . . 0.39000000000000001 108.193 178.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.491 HG23 ' HB2' ' A' ' 15' ' ' PHE . 11.0 tt -153.9 141.03 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.124 -0.985 . . . . 0.63 111.466 -178.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -117.22 102.99 9.74 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.723 -0.843 . . . . 0.67000000000000004 108.723 178.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.727 ' HB1' ' HB3' ' A' ' 69' ' ' GLN . . . -109.86 141.01 43.17 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.485 -0.759 . . . . 0.34000000000000002 111.312 -178.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.2 p -74.29 -5.23 40.95 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.788 -0.57 . . . . 0.53000000000000003 111.269 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.735 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 49.5 t60 -129.73 146.54 51.49 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.969 -1.082 . . . . 0.54000000000000004 110.188 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -67.64 -30.01 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.52 -0.738 . . . . 1.04 110.749 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.05 -11.66 43.49 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.274 -0.891 . . . . 0.93000000000000005 111.068 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.735 ' HB2' ' HB3' ' A' ' 66' ' ' HIS . 8.8 tt0 -61.52 -46.54 89.54 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.22 -0.925 . . . . 0.85999999999999999 109.874 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.1 p -70.48 -28.92 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.638 -0.664 . . . . 0.37 110.01 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.99 -50.06 45.35 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.485 -0.759 . . . . 0.56000000000000005 109.604 179.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.6 p -61.81 -40.78 96.43 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.527 -0.733 . . . . 0.32000000000000001 109.51 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.452 ' HG ' HG22 ' A' ' 34' ' ' VAL . 2.8 mp -60.45 -37.59 81.44 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.682 -0.636 . . . . 0.40000000000000002 109.694 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.541 ' CD1' ' HB ' ' A' ' 86' ' ' VAL . 0.4 OUTLIER -62.97 -45.03 94.36 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.564 -0.71 . . . . 0.56999999999999995 109.179 178.662 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.46 -36.15 79.61 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.498 -0.751 . . . . 0.40000000000000002 109.988 179.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.779 ' CB ' HG21 ' A' ' 34' ' ' VAL . 0.5 OUTLIER -67.55 -49.07 65.01 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.544 -0.722 . . . . 0.47999999999999998 110.279 179.497 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 1.005 HD11 HG11 ' A' ' 19' ' ' VAL . 0.3 OUTLIER -72.62 -27.23 62.02 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.423 -0.798 . . . . 0.28999999999999998 110.533 179.622 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.466 ' N ' ' HG ' ' A' ' 77' ' ' LEU . . . -107.44 38.96 3.07 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.678 -1.369 . . . . 0.31 109.678 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.91 4.09 54.54 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.31 -1.112 . . . . 1.04 110.732 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.4 mp -72.17 155.07 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.321 -0.862 . . . . 0.52000000000000002 109.982 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -68.71 -15.78 63.62 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.41 -0.806 . . . . 0.91000000000000003 110.235 178.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.472 HG22 ' N ' ' A' ' 83' ' ' VAL . 49.7 mm -71.33 170.14 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.544 -0.723 . . . . 0.71999999999999997 109.985 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.472 ' N ' HG22 ' A' ' 82' ' ' ILE . 76.1 t -62.42 115.06 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.342 -0.849 . . . . 0.51000000000000001 110.818 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -121.19 140.74 51.61 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.857 -0.527 . . . . 0.83999999999999997 109.595 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.1 mtp -158.54 154.05 26.05 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.062 -1.024 . . . . 1.4399999999999999 110.29 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.573 HG23 HG22 ' A' ' 19' ' ' VAL . 5.9 p -142.5 157.44 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.32 -0.863 . . . . 0.32000000000000001 110.801 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.703 HD22 ' HD2' ' A' ' 18' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.497 1.899 0 CA-C-O 117.955 -1.022 . . . . 0.40000000000000002 109.878 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.0 t . . . . . 0 N--CA 1.495 1.802 0 CA-C-O 120.559 0.219 . . . . 0.31 110.455 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -71.65 127.23 12.89 Favored 'Trans proline' 0 C--N 1.315 -1.213 0 O-C-N 123.911 1.48 . . . . 0.29999999999999999 110.389 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.629 ' HB3' HG21 ' A' ' 70' ' ' VAL . 23.1 m-85 -108.5 99.69 9.05 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.482 -0.761 . . . . 0.37 110.467 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.5 m -74.18 92.9 2.25 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.169 -1.049 . . . . 0.38 108.169 178.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.563 ' O ' HG22 ' A' ' 60' ' ' ILE . 3.0 m-85 -105.09 106.69 17.3 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.379 -0.826 . . . . 0.34999999999999998 110.897 -178.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.571 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 0.0 OUTLIER -79.27 92.49 5.14 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.533 -0.729 . . . . 1.1799999999999999 109.532 179.525 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.952 HG11 HD11 ' A' ' 77' ' ' LEU . 15.7 t -79.02 96.09 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.462 -0.774 . . . . 0.28999999999999998 109.516 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.662 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 44.4 ttp -98.05 148.71 23.24 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.601 -0.687 . . . . 0.93000000000000005 110.295 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 166.83 -152.35 21.17 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.664 -1.374 . . . . 0.26000000000000001 109.664 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.431 ' HG2' HG21 ' A' ' 82' ' ' ILE . 20.7 tp60 -74.01 138.9 44.39 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.423 -1.045 . . . . 1.3400000000000001 110.394 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.35 115.24 7.56 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.665 -0.647 . . . . 0.38 110.378 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.612 ' HB2' HD12 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -131.86 150.91 77.5 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.623 -0.673 . . . . 0.77000000000000002 110.2 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -73.0 -24.87 16.89 Favored 'Trans proline' 0 C--N 1.313 -1.335 0 O-C-N 123.839 1.442 . . . . 0.55000000000000004 111.079 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.15 -7.32 58.1 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.244 -0.91 . . . . 0.81000000000000005 111.643 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.612 HD12 ' HB2' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -59.85 -60.03 4.48 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.033 -1.042 . . . . 1.21 110.374 -179.665 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.2 p -62.97 -31.36 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 121.439 -0.788 . . . . 0.56999999999999995 110.567 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -68.32 -56.42 8.65 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.372 -0.83 . . . . 0.46999999999999997 109.913 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.702 ' O ' HG12 ' A' ' 34' ' ' VAL . 0.1 OUTLIER -63.19 -38.62 91.9 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.338 -0.851 . . . . 1.0600000000000001 110.269 179.524 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.881 HG22 HD12 ' A' ' 60' ' ' ILE . 2.4 t -56.57 -52.0 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.542 -0.723 . . . . 0.31 110.216 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 40.1 t -63.68 -40.88 90.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.47 -0.769 . . . . 0.34000000000000002 111.244 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.13 -50.77 29.93 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.309 -0.869 . . . . 0.62 111.134 -179.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.844 HG21 ' CB ' ' A' ' 76' ' ' GLU . 8.9 p -69.1 -28.05 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.485 -0.759 . . . . 0.26000000000000001 111.521 -179.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.593 HG11 ' HB2' ' A' ' 43' ' ' TYR . 1.9 p -83.21 -27.05 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.034 -1.041 . . . . 0.29999999999999999 110.784 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -78.89 -39.7 34.27 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.235 -0.915 . . . . 0.55000000000000004 110.429 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 14.4 ptt180 -69.56 -20.1 63.67 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.344 -0.847 . . . . 1.0 111.33 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.567 ' HB2' HD11 ' A' ' 73' ' ' LEU . 1.8 m-70 -106.16 -45.77 4.23 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.15 -0.969 . . . . 0.87 110.768 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -103.68 149.84 37.52 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.401 -0.812 . . . . 0.41999999999999998 109.997 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.33 140.4 36.88 Favored 'Trans proline' 0 C--N 1.314 -1.241 0 O-C-N 123.802 1.422 . . . . 0.56999999999999995 110.636 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.06 172.92 49.25 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.706 -1.357 . . . . 0.56000000000000005 109.706 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -100.99 144.69 29.62 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.439 -1.036 . . . . 0.56999999999999995 110.338 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.593 ' HB2' HG11 ' A' ' 35' ' ' VAL . 83.5 m-85 -129.08 165.46 21.18 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.509 -0.745 . . . . 0.40999999999999998 110.325 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.542 HG22 ' HD2' ' A' ' 45' ' ' PRO . 0.2 OUTLIER -142.57 156.79 63.21 Favored Pre-proline 0 N--CA 1.499 1.992 0 O-C-N 121.371 -0.831 . . . . 0.70999999999999996 111.165 -179.417 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.542 ' HD2' HG22 ' A' ' 44' ' ' THR . 53.2 Cg_endo -96.54 132.78 0.41 Allowed 'Trans proline' 0 C--N 1.32 -0.952 0 C-N-CA 122.233 1.955 . . . . 0.53000000000000003 110.292 178.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.473 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 36.2 m -93.89 92.11 7.24 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.955 -1.09 . . . . 0.40000000000000002 109.502 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.688 HG23 HG12 ' A' ' 58' ' ' VAL . 11.3 p -76.55 140.69 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.474 -0.766 . . . . 0.28999999999999998 111.638 -178.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.1 ptpt . . . . . 0 N--CA 1.493 1.715 0 O-C-N 121.785 -0.572 . . . . 1.5700000000000001 109.498 179.089 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 23.0 t80 . . . . . 0 N--CA 1.498 1.926 0 CA-C-O 121.181 0.515 . . . . 0.47999999999999998 110.021 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.528 ' HD2' HG22 ' A' ' 47' ' ' VAL . 1.6 m80 -130.16 148.14 51.97 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.373 -0.829 . . . . 0.45000000000000001 111.174 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.662 ' HA ' ' HA ' ' A' ' 20' ' ' MET . 89.3 p -113.34 126.12 55.03 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 109.155 -0.683 . . . . 0.37 109.155 179.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.688 HG12 HG23 ' A' ' 47' ' ' VAL . 1.5 m -116.59 141.37 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.241 -0.912 . . . . 0.34999999999999998 111.116 -178.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.571 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 1.3 t -103.08 106.41 16.92 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.387 -0.821 . . . . 0.72999999999999998 108.87 178.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.881 HD12 HG22 ' A' ' 31' ' ' VAL . 6.2 tt -93.7 132.1 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.273 -0.892 . . . . 0.34000000000000002 111.264 -178.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.465 ' O ' ' HB3' ' A' ' 43' ' ' TYR . 85.9 m -87.12 127.79 35.12 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 108.635 -0.876 . . . . 0.42999999999999999 108.635 178.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.606 HD11 HD13 ' A' ' 60' ' ' ILE . 44.5 mt -137.85 103.36 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 120.995 -1.065 . . . . 0.28999999999999998 111.176 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -85.08 80.51 9.23 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.298 -0.876 . . . . 0.44 109.17 178.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -101.74 136.74 41.07 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.515 -0.741 . . . . 0.23000000000000001 110.311 -179.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 39.9 p -68.8 -14.8 63.26 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.45 -0.781 . . . . 0.35999999999999999 111.063 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -130.85 159.74 36.47 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.246 -0.909 . . . . 0.47999999999999998 110.764 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 8.4 tp -76.5 -27.15 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.532 -0.73 . . . . 0.40000000000000002 110.367 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.32 -26.9 63.04 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.203 -0.936 . . . . 0.64000000000000001 110.558 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.461 ' O ' HD13 ' A' ' 73' ' ' LEU . 28.3 mt-30 -63.84 -53.46 50.41 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.393 -0.817 . . . . 1.73 110.231 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.629 HG21 ' HB3' ' A' ' 15' ' ' PHE . 7.4 p -65.73 -27.59 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.662 -0.649 . . . . 0.27000000000000002 110.441 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.18 -48.31 73.89 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.316 -0.865 . . . . 0.46000000000000002 109.286 178.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 82.7 m -64.36 -34.59 78.52 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.741 -0.599 . . . . 0.38 109.436 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.567 HD11 ' HB2' ' A' ' 38' ' ' HIS . 5.2 mp -63.14 -40.29 97.14 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.67 -0.644 . . . . 0.28000000000000003 109.714 179.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.642 ' CD1' ' HB ' ' A' ' 86' ' ' VAL . 0.7 OUTLIER -64.77 -43.86 91.9 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.604 -0.685 . . . . 0.40999999999999998 109.457 178.886 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -65.98 -32.87 74.6 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.474 -0.766 . . . . 0.75 110.735 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.844 ' CB ' HG21 ' A' ' 34' ' ' VAL . 0.3 OUTLIER -70.49 -55.52 8.76 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.333 -0.854 . . . . 0.51000000000000001 110.378 179.972 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.952 HD11 HG11 ' A' ' 19' ' ' VAL . 0.3 OUTLIER -70.27 -28.19 65.02 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.361 -0.837 . . . . 0.28999999999999998 110.199 179.677 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.514 ' N ' ' HG ' ' A' ' 77' ' ' LEU . . . -107.59 55.78 0.51 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.428 -1.469 . . . . 0.22 109.428 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -106.07 4.18 28.95 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.702 -0.881 . . . . 1.53 110.6 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.695 HG22 ' H ' ' A' ' 82' ' ' ILE . 2.7 mp -63.44 145.05 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.35 -0.844 . . . . 0.45000000000000001 110.195 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.73 -5.93 41.08 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.509 -0.744 . . . . 1.6200000000000001 111.603 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.695 ' H ' HG22 ' A' ' 80' ' ' ILE . 47.3 mm -80.77 -106.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.031 -1.043 . . . . 0.55000000000000004 109.887 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 63.5 t -123.93 112.16 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 120.915 -1.116 . . . . 0.46999999999999997 110.389 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.06 122.02 38.31 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.37 0.605 . . . . 0.67000000000000004 109.727 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.545 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 1.3 ttm -146.88 158.6 43.96 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.25 -0.906 . . . . 2.5299999999999998 110.174 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.642 ' HB ' ' CD1' ' A' ' 74' ' ' TYR . 9.8 p -141.45 154.13 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.429 -0.795 . . . . 0.32000000000000001 110.837 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.499 1.989 0 CA-C-O 118.823 -0.608 . . . . 0.65000000000000002 110.407 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.5 t . . . . . 0 N--CA 1.496 1.836 0 CA-C-O 120.612 0.244 . . . . 0.39000000000000001 110.459 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.66 129.6 14.79 Favored 'Trans proline' 0 C--N 1.314 -1.261 0 O-C-N 123.879 1.462 . . . . 0.35999999999999999 110.637 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.675 ' HB3' HG21 ' A' ' 70' ' ' VAL . 31.1 m-85 -109.6 99.7 8.86 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.596 -0.69 . . . . 0.39000000000000001 110.217 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.2 m -73.95 92.58 2.12 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.257 -1.016 . . . . 0.38 108.257 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.581 ' O ' HG22 ' A' ' 60' ' ' ILE . 2.9 m-85 -103.55 103.74 13.72 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.461 -0.774 . . . . 0.38 110.949 -178.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.616 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 0.1 OUTLIER -82.3 97.45 8.31 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.344 -0.847 . . . . 3.1299999999999999 109.741 179.404 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.982 HG11 HD11 ' A' ' 77' ' ' LEU . 15.9 t -79.95 96.89 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.427 -0.795 . . . . 0.28000000000000003 109.37 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 60.2 mtm -101.36 127.3 48.05 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.571 -0.705 . . . . 0.62 110.254 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -157.15 -158.81 9.12 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.875 -1.29 . . . . 0.33000000000000002 109.875 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.451 ' HB2' ' CG2' ' A' ' 82' ' ' ILE . 0.0 OUTLIER -68.78 177.49 2.53 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.364 -1.08 . . . . 1.1799999999999999 110.559 -179.979 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.43 ' HA ' ' CG ' ' A' ' 56' ' ' HIS . . . -79.4 91.03 5.04 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.427 -0.796 . . . . 0.35999999999999999 110.459 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.585 ' O ' HD23 ' A' ' 27' ' ' LEU . 1.0 OUTLIER -133.81 132.29 21.48 Favored Pre-proline 0 N--CA 1.496 1.847 0 O-C-N 121.397 -0.814 . . . . 0.37 110.249 179.664 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -76.43 -4.19 14.73 Favored 'Trans proline' 0 N--CA 1.489 1.216 0 O-C-N 123.702 1.369 . . . . 0.53000000000000003 112.057 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -80.14 -5.84 56.7 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 120.968 -1.082 . . . . 0.62 111.466 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.639 HD13 HG11 ' A' ' 58' ' ' VAL . 4.1 pp -66.13 -38.23 87.63 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.932 -1.105 . . . . 0.38 111.083 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.629 ' N ' HD12 ' A' ' 27' ' ' LEU . 9.8 p -76.53 -29.83 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.256 -0.902 . . . . 0.32000000000000001 110.855 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -69.27 -53.84 17.73 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.365 -0.834 . . . . 0.39000000000000001 110.116 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.686 ' O ' HG12 ' A' ' 34' ' ' VAL . 0.6 OUTLIER -67.66 -38.78 84.25 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.34 -0.85 . . . . 0.63 110.75 179.911 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.737 ' CG1' HD13 ' A' ' 60' ' ' ILE . 2.8 t -59.39 -56.87 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.362 -0.836 . . . . 0.27000000000000002 110.615 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.7 p -62.79 -33.71 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 121.292 -0.88 . . . . 0.31 111.549 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.85 -55.91 5.32 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.043 -1.036 . . . . 0.42999999999999999 110.823 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.884 HG21 ' HB2' ' A' ' 76' ' ' GLU . 6.2 p -65.53 -23.97 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.34 -0.85 . . . . 0.28000000000000003 111.512 -179.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.581 HG11 ' HB2' ' A' ' 43' ' ' TYR . 1.8 p -86.0 -32.52 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 120.922 -1.111 . . . . 0.28999999999999998 111.078 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -78.73 -26.92 44.78 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.966 -1.084 . . . . 0.45000000000000001 110.558 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.86 -39.51 35.03 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.276 -0.89 . . . . 0.65000000000000002 110.609 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.675 ' HB2' HD11 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -86.69 -45.54 10.88 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.35 -0.844 . . . . 0.39000000000000001 110.571 -179.878 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -100.69 152.15 37.77 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.434 -0.791 . . . . 0.29999999999999999 109.993 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.42 140.58 36.92 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 O-C-N 123.844 1.444 . . . . 0.40999999999999998 110.584 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.22 162.41 26.2 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.749 -1.341 . . . . 0.52000000000000002 109.749 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.05 143.62 27.71 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.426 -1.043 . . . . 0.41999999999999998 110.088 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.581 ' HB2' HG11 ' A' ' 35' ' ' VAL . 82.8 m-85 -125.79 166.37 16.96 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.493 -0.754 . . . . 0.41999999999999998 110.448 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.61 HG22 ' HD2' ' A' ' 45' ' ' PRO . 3.9 m -140.76 152.36 65.58 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.408 -0.808 . . . . 0.35999999999999999 111.083 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.61 ' HD2' HG22 ' A' ' 44' ' ' THR . 54.6 Cg_endo -96.06 123.42 0.27 Allowed 'Trans proline' 0 C--N 1.319 -0.999 0 C-N-CA 122.125 1.884 . . . . 0.22 110.545 179.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.53 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 58.6 m -75.3 92.72 2.79 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.213 -0.929 . . . . 0.31 108.779 178.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.76 HG23 HG12 ' A' ' 58' ' ' VAL . 8.3 p -80.75 139.38 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 CA-C-O 121.863 0.84 . . . . 0.33000000000000002 112.406 -178.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.464 ' HG2' ' O ' ' A' ' 57' ' ' SER . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.695 0 N-CA-C 108.709 -0.848 . . . . 0.64000000000000001 108.709 178.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 16.0 t80 . . . . . 0 N--CA 1.497 1.879 0 CA-C-O 121.144 0.497 . . . . 0.82999999999999996 110.351 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.43 ' CG ' ' HA ' ' A' ' 23' ' ' ALA . 5.4 m170 -116.27 123.76 48.49 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.558 -0.713 . . . . 0.73999999999999999 110.317 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.464 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 26.0 m -108.7 119.88 40.82 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.435 -0.791 . . . . 0.38 108.913 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.76 HG12 HG23 ' A' ' 47' ' ' VAL . 1.7 m -124.81 151.62 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 120.957 -1.089 . . . . 0.29999999999999999 111.221 -178.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.616 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 6.4 t -118.82 105.86 11.95 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.586 -0.696 . . . . 0.63 109.155 179.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.737 HD13 ' CG1' ' A' ' 31' ' ' VAL . 2.5 tp -93.29 129.93 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.238 -0.914 . . . . 0.25 111.07 -179.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.436 ' O ' ' HB3' ' A' ' 43' ' ' TYR . 49.5 m -85.44 121.92 28.84 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.855 -0.794 . . . . 0.32000000000000001 108.855 178.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.504 HG21 HG23 ' A' ' 70' ' ' VAL . 68.2 mt -127.82 109.25 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 120.939 -1.101 . . . . 0.42999999999999999 110.986 -178.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -90.7 92.96 9.04 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.418 -0.801 . . . . 0.62 109.576 179.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.426 ' HB1' ' HB3' ' A' ' 69' ' ' GLN . . . -117.79 139.38 51.15 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.53 -0.731 . . . . 0.25 110.39 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 34.5 p -74.86 -13.0 60.51 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.502 -0.749 . . . . 0.32000000000000001 110.729 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -129.14 148.15 51.06 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.338 -0.851 . . . . 0.41999999999999998 110.311 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -72.87 -21.7 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.511 -0.743 . . . . 0.78000000000000003 110.763 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.18 -23.86 57.76 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.144 -0.973 . . . . 0.5 110.844 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.426 ' HB3' ' HB1' ' A' ' 64' ' ' ALA . 0.2 OUTLIER -71.21 -50.45 32.94 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.296 -0.877 . . . . 0.52000000000000002 110.268 -179.99 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.675 HG21 ' HB3' ' A' ' 15' ' ' PHE . 8.1 p -65.81 -31.52 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.56 -0.712 . . . . 0.26000000000000001 110.339 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.4 -47.22 77.04 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.361 -0.837 . . . . 0.46999999999999997 109.343 178.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.402 HG22 ' OE1' ' A' ' 76' ' ' GLU . 93.4 m -62.47 -34.7 77.35 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.705 -0.622 . . . . 0.38 109.498 178.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.675 HD11 ' HB2' ' A' ' 38' ' ' HIS . 2.0 mp -61.96 -41.02 97.51 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.583 -0.698 . . . . 0.34999999999999998 109.593 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.539 ' CD1' ' HB ' ' A' ' 86' ' ' VAL . 2.7 t80 -64.64 -40.47 95.51 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.597 -0.689 . . . . 0.38 109.323 178.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.57 -38.49 87.7 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.379 -0.826 . . . . 0.40999999999999998 110.254 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.884 ' HB2' HG21 ' A' ' 34' ' ' VAL . 0.4 OUTLIER -71.12 -50.73 30.46 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.483 -0.76 . . . . 0.46999999999999997 110.721 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.982 HD11 HG11 ' A' ' 19' ' ' VAL . 0.2 OUTLIER -72.01 -27.71 62.91 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.316 -0.865 . . . . 0.28000000000000003 110.574 179.944 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.494 ' N ' ' HG ' ' A' ' 77' ' ' LEU . . . -100.84 38.13 3.28 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.646 -1.382 . . . . 0.28000000000000003 109.646 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.54 3.72 27.36 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.545 -0.974 . . . . 0.55000000000000004 110.815 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.0 mt -67.36 155.91 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.15 -0.969 . . . . 0.34000000000000002 109.911 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -62.25 -25.0 67.58 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.349 -0.844 . . . . 0.5 110.005 179.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.451 ' CG2' ' HB2' ' A' ' 22' ' ' GLN . 49.7 mm -73.54 163.89 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.555 -0.716 . . . . 0.39000000000000001 109.92 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 92.2 t -71.6 106.28 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.409 -0.807 . . . . 0.46000000000000002 110.843 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.415 ' HG2' ' HA2' ' A' ' 78' ' ' GLY . 1.4 tpm_? -121.99 114.03 20.4 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.598 -0.689 . . . . 0.40000000000000002 109.585 179.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.51 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -120.65 170.54 9.33 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.296 -0.877 . . . . 1.6299999999999999 110.38 -179.713 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.56 HG23 HG22 ' A' ' 19' ' ' VAL . 4.7 p -138.16 155.21 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.472 -0.768 . . . . 0.32000000000000001 110.629 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.498 1.937 0 CA-C-O 117.738 -1.125 . . . . 0.64000000000000001 110.43 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.5 t . . . . . 0 N--CA 1.496 1.835 0 N-CA-C 110.037 -0.357 . . . . 0.42999999999999999 110.037 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -71.98 125.22 10.75 Favored 'Trans proline' 0 C--N 1.314 -1.282 0 O-C-N 123.869 1.458 . . . . 0.37 111.19 -179.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.661 ' HB3' HG21 ' A' ' 70' ' ' VAL . 23.4 m-85 -110.35 99.31 8.36 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.591 -0.693 . . . . 0.31 110.249 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.482 HG22 ' HD2' ' A' ' 18' ' ' LYS . 24.4 m -78.99 92.32 4.94 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.21 -1.033 . . . . 0.35999999999999999 108.21 178.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -99.66 107.91 20.14 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.496 -0.752 . . . . 0.34999999999999998 110.768 -178.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.644 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 0.0 OUTLIER -87.56 89.7 8.09 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.592 -0.693 . . . . 1.77 109.944 179.825 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.847 HG11 HD11 ' A' ' 77' ' ' LEU . 2.4 m -82.34 110.35 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.36 -0.837 . . . . 0.28000000000000003 109.828 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 53.9 mtt -109.36 157.34 18.99 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.611 -0.681 . . . . 0.73999999999999999 110.282 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 169.36 -164.04 37.62 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 109.986 -1.246 . . . . 0.41999999999999998 109.986 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -69.59 150.85 46.64 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.53 -0.982 . . . . 1.6899999999999999 110.017 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.429 ' HA ' ' CD2' ' A' ' 56' ' ' HIS . . . -53.74 111.7 0.78 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.583 -0.698 . . . . 0.45000000000000001 110.548 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.7 mt -132.21 129.72 21.75 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.585 -0.697 . . . . 1.0800000000000001 110.395 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.65 -21.65 18.91 Favored 'Trans proline' 0 C--N 1.315 -1.231 0 O-C-N 123.849 1.447 . . . . 0.71999999999999997 111.171 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -81.33 -4.25 55.08 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.271 -0.893 . . . . 1.46 111.298 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.98 -58.34 8.27 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.991 -1.068 . . . . 0.59999999999999998 110.332 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.505 HG12 ' HG2' ' A' ' 45' ' ' PRO . 36.0 m -62.22 -29.67 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 O-C-N 121.497 -0.752 . . . . 0.38 111.042 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.417 ' O ' HG12 ' A' ' 32' ' ' VAL . 31.9 t70 -70.22 -53.26 17.77 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.286 -0.884 . . . . 0.52000000000000002 110.427 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.704 ' O ' HG12 ' A' ' 34' ' ' VAL . 0.2 OUTLIER -69.17 -35.8 76.68 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.326 -0.859 . . . . 1.4099999999999999 110.352 179.6 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.743 ' CG1' HD13 ' A' ' 60' ' ' ILE . 3.8 t -61.81 -51.47 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.574 -0.704 . . . . 0.34999999999999998 110.562 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.417 HG12 ' O ' ' A' ' 29' ' ' ASP . 6.1 p -67.03 -32.63 58.77 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.232 -0.917 . . . . 0.28999999999999998 111.223 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.417 ' O ' ' HG2' ' A' ' 36' ' ' GLN . 0.1 OUTLIER -75.63 -50.93 14.02 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.079 -1.013 . . . . 1.0800000000000001 110.509 179.806 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.815 HG21 ' CB ' ' A' ' 76' ' ' GLU . 9.9 p -67.69 -30.37 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.366 -0.834 . . . . 0.28000000000000003 110.898 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.607 HG23 ' CG1' ' A' ' 62' ' ' ILE . 2.3 p -76.64 -38.2 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.073 -1.017 . . . . 0.28000000000000003 110.352 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.417 ' HG2' ' O ' ' A' ' 33' ' ' GLU . 7.4 pt20 -74.05 -22.45 59.53 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.054 -1.029 . . . . 0.51000000000000001 109.946 179.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.0 mtp-105 -68.48 -49.24 61.24 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.415 -0.803 . . . . 0.77000000000000002 110.154 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.626 ' HB2' HD11 ' A' ' 73' ' ' LEU . 2.0 m-70 -84.54 -45.78 12.25 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.39 -0.819 . . . . 0.34000000000000002 110.498 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.509 ' HB3' ' O ' ' A' ' 35' ' ' VAL . . . -76.83 153.79 83.11 Favored Pre-proline 0 N--CA 1.497 1.897 0 O-C-N 121.351 -0.843 . . . . 0.27000000000000002 110.068 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -69.06 -34.54 16.68 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.922 1.485 . . . . 0.48999999999999999 111.395 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -108.86 -178.61 21.57 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 110.063 -1.215 . . . . 0.38 110.063 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.14 148.68 22.8 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.553 -0.969 . . . . 0.52000000000000002 109.648 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.473 ' HB2' HG11 ' A' ' 35' ' ' VAL . 98.0 m-85 -135.4 172.84 12.43 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.409 -0.807 . . . . 0.39000000000000001 111.188 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.685 HG22 ' HD2' ' A' ' 45' ' ' PRO . 0.3 OUTLIER -142.39 156.53 63.89 Favored Pre-proline 0 N--CA 1.496 1.851 0 O-C-N 121.613 -0.68 . . . . 0.47999999999999998 110.513 -179.64 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.685 ' HD2' HG22 ' A' ' 44' ' ' THR . 52.6 Cg_endo -94.64 121.94 0.34 Allowed 'Trans proline' 0 C--N 1.317 -1.125 0 C-N-CA 121.986 1.79 . . . . 0.33000000000000002 110.229 179.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 74.2 m -80.44 101.4 9.02 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.079 -1.013 . . . . 0.40999999999999998 109.572 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.665 ' CB ' HG12 ' A' ' 58' ' ' VAL . 12.1 p -76.52 141.2 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.408 -0.807 . . . . 0.37 111.525 -179.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.487 ' HE2' ' HB3' ' A' ' 57' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.729 0 O-C-N 121.752 -0.593 . . . . 0.88 109.691 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 14.9 t80 . . . . . 0 N--CA 1.495 1.793 0 CA-C-O 121.17 0.51 . . . . 1.2 110.231 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.429 ' CD2' ' HA ' ' A' ' 23' ' ' ALA . 0.6 OUTLIER -142.25 146.71 35.44 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.506 -0.746 . . . . 0.44 110.31 179.824 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.487 ' HB3' ' HE2' ' A' ' 48' ' ' LYS . 37.5 m -119.69 114.22 21.85 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.282 -0.886 . . . . 0.35999999999999999 109.719 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.665 HG12 ' CB ' ' A' ' 47' ' ' VAL . 3.1 m -114.07 146.76 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.136 -0.977 . . . . 0.31 110.952 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.644 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 45.5 t -112.97 111.1 21.6 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.687 -0.633 . . . . 0.42999999999999999 109.43 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.743 HD13 ' CG1' ' A' ' 31' ' ' VAL . 2.2 tp -92.74 129.79 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 C-N-CA 119.773 -0.771 . . . . 0.26000000000000001 111.042 -179.15 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 82.7 m -82.34 137.83 34.67 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.934 -0.765 . . . . 0.32000000000000001 108.934 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.607 ' CG1' HG23 ' A' ' 35' ' ' VAL . 2.3 mt -136.95 139.54 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.105 -0.997 . . . . 0.39000000000000001 111.017 -179.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -117.99 69.55 0.78 Allowed 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 121.457 0.646 . . . . 0.45000000000000001 109.299 179.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.606 ' HB1' ' HB2' ' A' ' 69' ' ' GLN . . . -99.59 135.78 40.5 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.489 -0.757 . . . . 0.28000000000000003 110.269 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 58.0 p -73.73 -13.05 60.9 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.492 -0.755 . . . . 0.34999999999999998 110.847 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 8.7 t60 -129.47 157.16 42.78 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.249 -0.907 . . . . 0.56999999999999995 110.76 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.14 -24.88 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.534 -0.729 . . . . 1.0600000000000001 110.43 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -70.96 -31.26 67.77 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.319 -0.863 . . . . 0.94999999999999996 110.278 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.606 ' HB2' ' HB1' ' A' ' 64' ' ' ALA . 57.1 mt-30 -63.06 -52.74 61.59 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.472 -0.768 . . . . 0.42999999999999999 110.025 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.661 HG21 ' HB3' ' A' ' 15' ' ' PHE . 7.7 p -69.31 -26.98 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.371 -0.831 . . . . 0.33000000000000002 110.222 179.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.95 -52.27 64.72 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.345 -0.847 . . . . 0.70999999999999996 109.229 178.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.5 p -63.83 -35.75 81.65 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.474 -0.767 . . . . 0.34000000000000002 109.239 178.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.626 HD11 ' HB2' ' A' ' 38' ' ' HIS . 3.7 mp -57.3 -42.2 81.3 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.541 -0.724 . . . . 0.28999999999999998 109.693 178.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.461 ' CD1' ' HB ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -65.03 -44.22 89.82 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 109.102 -0.703 . . . . 0.47999999999999998 109.102 178.766 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -65.71 -33.84 76.81 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.548 -0.72 . . . . 0.63 110.616 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.815 ' CB ' HG21 ' A' ' 34' ' ' VAL . 0.2 OUTLIER -70.31 -54.3 13.19 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.452 -0.78 . . . . 0.44 110.629 -179.897 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.847 HD11 HG11 ' A' ' 19' ' ' VAL . 0.9 OUTLIER -73.13 -24.67 60.63 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.309 -0.87 . . . . 0.32000000000000001 110.177 179.588 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -103.68 43.67 1.63 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.492 -1.443 . . . . 0.34000000000000002 109.492 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.13 3.89 28.5 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.435 -1.038 . . . . 0.81000000000000005 110.842 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.612 HG22 ' H ' ' A' ' 82' ' ' ILE . 2.2 mp -65.3 144.89 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.26 -0.9 . . . . 0.45000000000000001 110.292 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.8 -20.87 66.03 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.332 -0.855 . . . . 1.48 110.322 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.612 ' H ' HG22 ' A' ' 80' ' ' ILE . 40.4 mm -70.46 170.13 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.431 -0.793 . . . . 0.51000000000000001 109.87 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.473 ' N ' HG22 ' A' ' 82' ' ' ILE . 75.3 t -62.32 112.75 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.335 -0.853 . . . . 0.46999999999999997 110.544 -179.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.31 161.64 21.67 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.733 -0.605 . . . . 1.1799999999999999 110.113 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.488 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 1.7 ttp -157.72 160.19 37.65 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.401 -0.812 . . . . 1.1299999999999999 109.882 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.538 ' HA ' ' HA ' ' A' ' 19' ' ' VAL . 11.3 p -134.1 146.46 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.32 -0.863 . . . . 0.33000000000000002 110.524 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 34.8 mt . . . . . 0 N--CA 1.5 2.063 0 CA-C-O 117.646 -1.169 . . . . 0.51000000000000001 110.488 -179.807 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.5 t . . . . . 0 N--CA 1.495 1.81 0 CA-C-O 120.611 0.243 . . . . 0.35999999999999999 110.54 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.17 129.54 15.23 Favored 'Trans proline' 0 C--N 1.315 -1.199 0 O-C-N 123.917 1.483 . . . . 0.44 110.334 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.571 ' HB3' HG21 ' A' ' 70' ' ' VAL . 32.8 m-85 -108.29 100.76 10.03 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.595 -0.69 . . . . 0.33000000000000002 110.32 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.9 m -74.19 92.26 2.2 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.407 -0.96 . . . . 0.39000000000000001 108.407 178.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.599 ' O ' HG22 ' A' ' 60' ' ' ILE . 3.3 m-85 -102.8 104.41 14.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.441 -0.787 . . . . 0.34999999999999998 110.611 -178.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.605 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 0.0 OUTLIER -78.99 93.47 5.1 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.573 -0.704 . . . . 2.0 109.484 179.605 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 1.004 HG11 HD11 ' A' ' 77' ' ' LEU . 24.8 t -78.36 95.3 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.463 -0.773 . . . . 0.26000000000000001 109.15 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.454 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 53.7 mtt -97.71 153.57 18.16 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.577 -0.702 . . . . 1.02 110.535 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 168.4 -151.94 19.37 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.877 -1.289 . . . . 0.31 109.877 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.565 ' HA ' ' HA ' ' A' ' 55' ' ' TYR . 5.9 mt-30 -78.19 170.26 16.91 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.458 -1.025 . . . . 1.1299999999999999 110.414 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.434 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -78.0 101.33 6.85 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.29 -0.881 . . . . 0.42999999999999999 109.816 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.526 ' HG ' ' HD2' ' A' ' 25' ' ' PRO . 1.0 OUTLIER -130.33 136.37 28.89 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.49 -0.756 . . . . 1.1399999999999999 110.548 -179.404 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.526 ' HD2' ' HG ' ' A' ' 24' ' ' LEU . 47.3 Cg_endo -72.92 -20.48 22.18 Favored 'Trans proline' 0 C--N 1.316 -1.181 0 O-C-N 123.822 1.433 . . . . 0.48999999999999999 110.997 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -72.07 -13.74 61.67 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.351 -0.843 . . . . 0.68999999999999995 111.213 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.8 mt -56.83 -64.01 1.01 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.213 -0.929 . . . . 0.53000000000000003 110.577 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.6 p -60.94 -30.84 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 O-C-N 121.388 -0.82 . . . . 0.29999999999999999 111.021 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -64.35 -62.39 1.63 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.395 -0.816 . . . . 0.51000000000000001 110.389 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.681 ' O ' HG12 ' A' ' 34' ' ' VAL . 5.5 tp60 -64.35 -32.53 74.18 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.354 -0.841 . . . . 0.59999999999999998 110.724 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.706 HG22 HD12 ' A' ' 60' ' ' ILE . 2.3 t -59.03 -56.67 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.269 -0.894 . . . . 0.26000000000000001 110.346 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.402 ' HA ' HG12 ' A' ' 35' ' ' VAL . 8.6 p -68.49 -28.36 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.381 -0.824 . . . . 0.31 111.548 -179.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.417 ' O ' ' HG2' ' A' ' 36' ' ' GLN . 1.0 OUTLIER -76.02 -55.97 5.1 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.031 -1.043 . . . . 0.52000000000000002 110.773 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.834 HG21 ' CB ' ' A' ' 76' ' ' GLU . 5.7 p -66.93 -25.8 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.428 -0.795 . . . . 0.27000000000000002 111.339 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.64 HG11 ' HB2' ' A' ' 43' ' ' TYR . 2.4 p -82.64 -35.02 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.013 -1.055 . . . . 0.25 110.828 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.417 ' HG2' ' O ' ' A' ' 33' ' ' GLU . 13.8 pt20 -76.73 -25.98 54.13 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.066 -1.021 . . . . 0.52000000000000002 110.2 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 25.7 mtm-85 -75.96 -39.7 55.45 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.267 -0.896 . . . . 1.29 110.533 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.754 ' HB2' HD11 ' A' ' 73' ' ' LEU . 0.5 OUTLIER -90.26 -45.71 8.89 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.285 -0.884 . . . . 0.65000000000000002 110.691 -179.818 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -98.52 150.95 37.22 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.56 -0.713 . . . . 0.28999999999999998 110.149 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -71.3 140.72 37.6 Favored 'Trans proline' 0 C--N 1.313 -1.302 0 O-C-N 123.823 1.433 . . . . 0.40999999999999998 110.385 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.83 164.77 32.29 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.597 -1.401 . . . . 0.54000000000000004 109.597 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -99.98 139.56 35.47 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.376 -1.073 . . . . 0.51000000000000001 110.117 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.64 ' HB2' HG11 ' A' ' 35' ' ' VAL . 93.0 m-85 -119.21 170.59 8.95 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.527 -0.733 . . . . 0.37 110.541 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.666 HG22 ' HD2' ' A' ' 45' ' ' PRO . 0.2 OUTLIER -142.44 153.91 62.97 Favored Pre-proline 0 N--CA 1.498 1.974 0 O-C-N 121.423 -0.798 . . . . 0.45000000000000001 110.836 -179.136 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.666 ' HD2' HG22 ' A' ' 44' ' ' THR . 52.6 Cg_endo -96.36 121.16 0.22 Allowed 'Trans proline' 0 C--N 1.321 -0.9 0 C-N-CA 122.015 1.81 . . . . 0.28999999999999998 110.104 178.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 53.2 m -78.81 97.6 6.0 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.129 -0.982 . . . . 0.35999999999999999 109.686 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.648 HG23 HG12 ' A' ' 58' ' ' VAL . 11.5 p -76.53 139.22 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.515 -0.74 . . . . 0.42999999999999999 111.479 -179.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.3 pttt . . . . . 0 N--CA 1.494 1.772 0 O-C-N 121.684 -0.635 . . . . 1.97 109.884 179.199 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.565 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 17.6 m-85 . . . . . 0 N--CA 1.496 1.83 0 CA-C-O 121.129 0.49 . . . . 1.0800000000000001 110.394 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.434 ' HB2' ' HA ' ' A' ' 23' ' ' ALA . 0.2 OUTLIER -137.5 142.44 41.49 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.561 -0.712 . . . . 0.91000000000000003 110.417 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.454 ' HA ' ' HA ' ' A' ' 20' ' ' MET . 17.1 m -116.87 107.84 15.1 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.601 -0.687 . . . . 0.33000000000000002 109.445 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.648 HG12 HG23 ' A' ' 47' ' ' VAL . 3.1 m -108.23 149.8 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.336 -0.853 . . . . 0.33000000000000002 110.85 -179.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.605 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 9.1 t -114.76 110.08 19.18 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.938 -0.764 . . . . 0.5 108.938 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.706 HD12 HG22 ' A' ' 31' ' ' VAL . 6.6 tt -92.43 131.06 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.228 -0.92 . . . . 0.31 111.423 -178.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.406 ' O ' ' HB3' ' A' ' 43' ' ' TYR . 91.9 m -86.13 130.21 34.6 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.684 -0.858 . . . . 0.35999999999999999 108.684 178.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.577 HD11 HD13 ' A' ' 60' ' ' ILE . 59.3 mt -139.75 99.16 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.004 -1.06 . . . . 0.32000000000000001 111.086 -179.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -84.02 97.97 9.58 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.277 -0.889 . . . . 0.37 108.925 178.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -119.05 138.79 52.61 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.533 -0.729 . . . . 0.23999999999999999 111.19 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 37.8 p -74.23 -9.93 59.1 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.619 -0.676 . . . . 0.37 110.475 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.449 ' HD2' ' HB2' ' A' ' 68' ' ' GLU . 6.7 t60 -129.51 156.97 43.29 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.398 -0.814 . . . . 0.59999999999999998 110.201 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.421 ' O ' HG12 ' A' ' 70' ' ' VAL . 0.8 OUTLIER -82.37 -22.66 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.476 -0.765 . . . . 0.81999999999999995 111.075 179.895 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.449 ' HB2' ' HD2' ' A' ' 66' ' ' HIS . 39.5 mt-10 -77.33 -30.27 53.92 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.057 -1.027 . . . . 0.96999999999999997 110.928 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.509 ' O ' HD13 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -61.74 -44.58 96.63 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.3 -0.875 . . . . 0.54000000000000004 110.214 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.571 HG21 ' HB3' ' A' ' 15' ' ' PHE . 9.2 p -71.77 -29.31 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.234 -0.917 . . . . 0.29999999999999999 110.238 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.83 -47.5 74.81 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.31 -0.869 . . . . 0.68000000000000005 109.32 179.036 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.532 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . 17.9 p -65.36 -35.17 80.16 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.654 -0.654 . . . . 0.33000000000000002 109.466 178.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.754 HD11 ' HB2' ' A' ' 38' ' ' HIS . 3.8 mp -61.86 -37.23 83.72 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.367 -0.833 . . . . 0.28000000000000003 109.942 179.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.549 ' CD1' ' HB ' ' A' ' 86' ' ' VAL . 0.8 OUTLIER -67.74 -52.78 33.46 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.386 -0.821 . . . . 0.58999999999999997 109.715 179.28 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.532 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 10.6 pt-20 -63.04 -28.03 69.81 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.375 -0.828 . . . . 0.64000000000000001 110.705 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.834 ' CB ' HG21 ' A' ' 34' ' ' VAL . 0.1 OUTLIER -71.29 -48.05 53.15 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.277 -0.889 . . . . 0.44 110.003 179.454 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 1.004 HD11 HG11 ' A' ' 19' ' ' VAL . 0.3 OUTLIER -76.94 -28.09 55.1 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.468 -0.77 . . . . 0.33000000000000002 110.198 179.519 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.638 ' HA2' ' HG2' ' A' ' 84' ' ' ARG . . . -103.49 44.96 1.39 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.701 -1.36 . . . . 0.32000000000000001 109.701 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.1 3.83 36.39 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.626 -0.926 . . . . 0.87 110.778 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.614 HD12 ' HG2' ' A' ' 84' ' ' ARG . 1.7 mp -73.87 154.87 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.276 -0.89 . . . . 0.39000000000000001 110.03 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.0 -19.91 66.01 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.442 -0.786 . . . . 1.45 110.638 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.465 HG22 ' HB2' ' A' ' 22' ' ' GLN . 51.9 mm -70.19 169.27 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.395 -0.815 . . . . 0.5 109.985 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.457 ' N ' HG22 ' A' ' 82' ' ' ILE . 90.3 t -62.47 104.6 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.439 -0.788 . . . . 0.41999999999999998 110.445 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.638 ' HG2' ' HA2' ' A' ' 78' ' ' GLY . 0.1 OUTLIER -121.82 112.61 18.57 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.692 -0.484 . . . . 0.54000000000000004 109.692 179.911 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.518 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 0.2 OUTLIER -135.5 166.37 23.36 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.287 -0.883 . . . . 1.3100000000000001 110.419 -179.611 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.557 HG23 HG22 ' A' ' 19' ' ' VAL . 5.1 p -139.2 157.06 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.393 -0.817 . . . . 0.27000000000000002 110.583 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.499 2.003 0 CA-C-O 118.843 -0.599 . . . . 0.47999999999999998 110.459 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.4 t . . . . . 0 N--CA 1.496 1.833 0 CA-C-O 120.551 0.215 . . . . 0.37 110.441 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.69 123.47 9.04 Favored 'Trans proline' 0 C--N 1.314 -1.238 0 O-C-N 123.864 1.455 . . . . 0.34000000000000002 110.49 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.646 ' HB2' HG23 ' A' ' 62' ' ' ILE . 21.8 m-85 -104.42 99.47 9.17 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.508 -0.745 . . . . 0.34000000000000002 110.587 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.8 m -75.7 93.35 3.09 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.085 -1.079 . . . . 0.42999999999999999 108.085 178.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.57 ' O ' HG22 ' A' ' 60' ' ' ILE . 2.7 m-85 -101.91 109.74 21.56 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.306 -0.871 . . . . 0.33000000000000002 111.306 -178.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.597 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 0.0 OUTLIER -81.66 91.15 6.38 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.533 -0.729 . . . . 1.1699999999999999 109.331 179.06 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 1.083 HG11 HD11 ' A' ' 77' ' ' LEU . 38.4 t -79.25 96.96 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.666 -0.646 . . . . 0.29999999999999999 109.955 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.429 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 58.6 mtm -102.17 148.4 25.46 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.405 -0.81 . . . . 0.65000000000000002 110.028 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.443 ' HA3' ' O ' ' A' ' 83' ' ' VAL . . . 166.77 -142.35 7.55 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 110.035 -1.226 . . . . 0.22 110.035 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.622 ' HG3' HG21 ' A' ' 82' ' ' ILE . 0.0 OUTLIER -66.25 153.93 41.23 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.523 -0.987 . . . . 0.44 110.57 -179.934 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -96.58 99.1 10.76 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.568 -0.708 . . . . 0.33000000000000002 110.232 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -128.71 155.82 78.55 Favored Pre-proline 0 N--CA 1.498 1.946 0 O-C-N 121.479 -0.763 . . . . 0.38 110.546 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -72.56 -24.58 18.66 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 O-C-N 123.879 1.463 . . . . 0.42999999999999999 111.367 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.27 -5.62 45.57 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.182 -0.948 . . . . 0.56999999999999995 111.291 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.509 ' CD2' HG21 ' A' ' 58' ' ' VAL . 0.3 OUTLIER -61.14 -55.66 29.83 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.107 -0.995 . . . . 1.0 110.266 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.614 HG12 ' HG2' ' A' ' 45' ' ' PRO . 26.8 m -66.99 -29.48 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.426 -0.796 . . . . 0.37 110.69 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -66.83 -53.42 32.88 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.364 -0.835 . . . . 0.41999999999999998 110.33 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.726 ' O ' HG12 ' A' ' 34' ' ' VAL . 0.3 OUTLIER -68.29 -34.29 75.89 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.25 -0.906 . . . . 1.4199999999999999 110.376 179.594 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.622 HG22 HD22 ' A' ' 77' ' ' LEU . 2.7 t -57.58 -56.09 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.405 -0.81 . . . . 0.25 110.268 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.8 p -66.81 -32.98 60.45 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.352 -0.842 . . . . 0.34000000000000002 111.266 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.19 -54.93 7.21 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.14 -0.975 . . . . 0.84999999999999998 110.772 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.893 HG21 ' CB ' ' A' ' 76' ' ' GLU . 8.2 p -66.66 -29.68 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 121.412 -0.805 . . . . 0.27000000000000002 111.153 -179.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.726 HG11 ' HB2' ' A' ' 43' ' ' TYR . 2.4 p -78.08 -30.66 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.058 -1.026 . . . . 0.33000000000000002 110.304 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -73.67 -38.32 64.97 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.201 -0.937 . . . . 0.67000000000000004 110.063 179.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.27 -25.14 65.91 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.526 -0.734 . . . . 1.45 111.199 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.446 ' CD2' HD11 ' A' ' 73' ' ' LEU . 1.1 m-70 -103.39 -45.62 4.82 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.291 -0.881 . . . . 1.0 110.792 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -106.65 149.51 38.49 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.424 -0.798 . . . . 0.47999999999999998 110.173 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -71.53 142.4 40.31 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 O-C-N 123.858 1.452 . . . . 0.69999999999999996 110.652 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.21 156.26 21.25 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.751 -1.34 . . . . 0.46000000000000002 109.751 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -89.97 140.49 29.58 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.463 -1.021 . . . . 0.55000000000000004 110.127 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.726 ' HB2' HG11 ' A' ' 35' ' ' VAL . 67.8 m-85 -121.76 169.07 11.11 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.556 -0.715 . . . . 0.34000000000000002 110.39 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.695 HG22 ' HD2' ' A' ' 45' ' ' PRO . 2.0 m -142.4 153.19 62.24 Favored Pre-proline 0 N--CA 1.497 1.92 0 O-C-N 121.374 -0.829 . . . . 0.54000000000000004 110.912 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.695 ' HD2' HG22 ' A' ' 44' ' ' THR . 54.3 Cg_endo -95.94 125.06 0.31 Allowed 'Trans proline' 0 C--N 1.32 -0.957 0 C-N-CA 122.022 1.814 . . . . 0.45000000000000001 110.389 178.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 55.5 m -83.04 94.39 7.78 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.09 -1.006 . . . . 0.48999999999999999 109.468 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.674 HG23 HG12 ' A' ' 58' ' ' VAL . 14.1 p -76.76 141.66 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.453 -0.779 . . . . 0.45000000000000001 111.543 -178.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.43 ' HG2' ' O ' ' A' ' 57' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.777 0 O-C-N 121.724 -0.61 . . . . 0.56999999999999995 109.732 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 13.3 t80 . . . . . 0 N--CA 1.495 1.81 0 CA-C-O 121.168 0.509 . . . . 0.5 110.131 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -132.59 140.53 48.28 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.504 -0.747 . . . . 0.68999999999999995 110.383 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.43 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 28.9 m -108.0 108.93 20.27 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.649 -0.657 . . . . 0.34000000000000002 109.387 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.674 HG12 HG23 ' A' ' 47' ' ' VAL . 2.9 m -109.86 152.75 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.143 -0.973 . . . . 0.39000000000000001 110.858 -179.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.597 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 1.7 t -116.59 111.27 19.65 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.613 -0.884 . . . . 0.73999999999999999 108.613 178.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.599 ' CD1' HG13 ' A' ' 31' ' ' VAL . 10.5 tt -92.21 127.9 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.218 -0.926 . . . . 0.40000000000000002 111.296 -178.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.481 ' O ' ' HB3' ' A' ' 43' ' ' TYR . 65.9 m -90.91 141.16 29.12 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 109.047 -0.723 . . . . 0.42999999999999999 109.047 179.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.646 HD12 HG23 ' A' ' 35' ' ' VAL . 7.8 tt -162.54 141.76 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.012 -1.055 . . . . 0.42999999999999999 110.998 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -108.0 87.56 2.53 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.509 -0.744 . . . . 0.68999999999999995 109.317 178.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.442 ' HB3' ' CD2' ' A' ' 15' ' ' PHE . . . -106.63 136.73 45.91 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.46 -0.775 . . . . 0.33000000000000002 110.524 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.2 p -66.98 -23.47 65.95 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.489 -0.757 . . . . 0.45000000000000001 110.843 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -131.47 157.88 42.34 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.193 -0.942 . . . . 0.56999999999999995 110.525 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.2 tt -75.73 -19.1 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.459 -0.776 . . . . 0.42999999999999999 110.676 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.43 -35.42 79.22 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.243 -0.911 . . . . 0.44 110.403 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -65.21 -48.94 71.61 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.457 -0.777 . . . . 0.88 110.351 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.557 HG23 HG21 ' A' ' 62' ' ' ILE . 8.0 p -70.23 -25.23 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.448 -0.782 . . . . 0.27000000000000002 110.485 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -68.7 -50.5 50.35 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.195 -0.94 . . . . 0.39000000000000001 109.584 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 20.6 p -61.47 -40.01 92.97 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 109.028 -0.73 . . . . 0.38 109.028 178.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.536 HD23 HD12 ' A' ' 62' ' ' ILE . 3.1 mp -59.65 -39.07 83.16 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.665 -0.647 . . . . 0.31 109.709 178.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.66 ' CD1' ' HB ' ' A' ' 86' ' ' VAL . 0.2 OUTLIER -60.36 -44.98 95.06 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.977 -0.749 . . . . 0.44 108.977 178.653 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -69.07 -33.21 73.19 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.59 -0.693 . . . . 1.22 110.322 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.893 ' CB ' HG21 ' A' ' 34' ' ' VAL . 0.3 OUTLIER -64.74 -50.0 68.6 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.464 -0.773 . . . . 0.41999999999999998 109.883 179.48 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 1.083 HD11 HG11 ' A' ' 19' ' ' VAL . 0.4 OUTLIER -78.25 -26.57 47.32 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.42 -0.8 . . . . 0.31 109.698 178.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.501 ' N ' ' HG ' ' A' ' 77' ' ' LEU . . . -105.94 56.25 0.52 Allowed Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.367 -1.493 . . . . 0.26000000000000001 109.367 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.18 4.31 28.83 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.643 -0.916 . . . . 1.4399999999999999 110.573 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.9 mp -60.06 155.27 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.404 -0.81 . . . . 0.42999999999999999 110.094 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.99 -3.93 53.35 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.205 -0.935 . . . . 1.26 111.547 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.622 HG21 ' HG3' ' A' ' 22' ' ' GLN . 39.2 mm -84.71 -104.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.105 -0.997 . . . . 0.37 109.975 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.443 ' O ' ' HA3' ' A' ' 21' ' ' GLY . 84.7 t -124.32 118.73 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 120.943 -1.098 . . . . 0.33000000000000002 110.263 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.33 113.63 19.66 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.517 -0.739 . . . . 1.1299999999999999 109.488 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.476 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 3.1 mtm -139.95 157.12 46.19 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.361 -0.837 . . . . 0.70999999999999996 110.179 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.66 ' HB ' ' CD1' ' A' ' 74' ' ' TYR . 8.1 p -141.74 152.88 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.362 -0.837 . . . . 0.27000000000000002 110.787 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.413 ' HA ' HD22 ' A' ' 87' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.5 2.042 0 CA-C-O 117.52 -1.229 . . . . 0.64000000000000001 110.558 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.6 t . . . . . 0 N--CA 1.496 1.826 0 N-CA-C 110.41 -0.218 . . . . 0.34000000000000002 110.41 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -71.27 126.44 12.32 Favored 'Trans proline' 0 C--N 1.315 -1.188 0 O-C-N 123.997 1.525 . . . . 0.37 110.306 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.623 ' HB2' HG23 ' A' ' 62' ' ' ILE . 25.0 m-85 -107.01 99.75 9.29 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.557 -0.714 . . . . 0.35999999999999999 110.451 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.7 m -78.2 92.68 4.48 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.3 -1.0 . . . . 0.38 108.3 178.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.473 ' O ' HG22 ' A' ' 60' ' ' ILE . 3.4 m-85 -100.53 105.9 17.37 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.535 -0.728 . . . . 0.37 110.959 -178.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.586 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 0.0 OUTLIER -80.8 91.77 5.98 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.351 -0.843 . . . . 1.3400000000000001 109.358 179.341 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 1.081 HG11 HD11 ' A' ' 77' ' ' LEU . 21.9 t -78.58 95.9 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.462 -0.774 . . . . 0.28000000000000003 109.736 -179.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 7.1 ttt -100.68 151.85 21.16 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.55 -0.719 . . . . 1.45 110.052 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 171.47 -165.08 38.02 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.95 -1.26 . . . . 0.29999999999999999 109.95 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.462 ' HB3' HG21 ' A' ' 82' ' ' ILE . 4.5 tt0 -71.38 154.58 41.46 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.501 -0.999 . . . . 1.51 110.142 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.46 109.65 0.29 Allowed 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.747 -0.595 . . . . 0.53000000000000003 110.707 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.589 HD13 ' HD2' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -129.35 114.71 18.4 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.574 -0.704 . . . . 0.70999999999999996 110.112 -179.602 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.589 ' HD2' HD13 ' A' ' 24' ' ' LEU . 44.0 Cg_endo -71.67 -26.0 20.04 Favored 'Trans proline' 0 N--CA 1.49 1.293 0 O-C-N 123.828 1.436 . . . . 0.46999999999999997 111.108 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -81.92 -6.42 59.09 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.216 -0.927 . . . . 0.68000000000000005 111.193 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.626 HD23 HG21 ' A' ' 58' ' ' VAL . 0.3 OUTLIER -60.8 -50.29 74.05 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.985 -1.072 . . . . 0.68000000000000005 110.512 -179.88 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.441 HG23 ' HD2' ' A' ' 45' ' ' PRO . 8.9 p -65.67 -34.08 67.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.392 -0.818 . . . . 0.33000000000000002 110.349 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -66.68 -46.79 74.52 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.338 -0.851 . . . . 0.62 109.812 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.682 ' O ' HG12 ' A' ' 34' ' ' VAL . 3.3 tp60 -72.14 -30.79 65.37 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.476 -0.765 . . . . 1.1799999999999999 110.252 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.627 HG22 HD22 ' A' ' 77' ' ' LEU . 2.3 t -62.79 -46.26 96.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.412 -0.805 . . . . 0.26000000000000001 110.277 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.8 p -76.12 -35.06 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.36 -0.838 . . . . 0.28999999999999998 111.583 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.575 ' CG ' ' HA ' ' A' ' 30' ' ' GLN . 0.5 OUTLIER -76.74 -35.17 57.93 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.709 -1.244 . . . . 0.52000000000000002 110.867 -179.733 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.843 HG21 ' CB ' ' A' ' 76' ' ' GLU . 6.9 p -78.43 -34.02 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.017 -1.052 . . . . 0.27000000000000002 110.014 179.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.95 HG23 HD12 ' A' ' 62' ' ' ILE . 3.9 p -74.01 -31.52 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.271 -0.893 . . . . 0.38 109.607 178.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -75.59 -35.05 60.67 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.323 -0.861 . . . . 1.6200000000000001 109.649 178.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 28.1 mtm180 -66.42 -24.41 66.45 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.485 -0.759 . . . . 0.83999999999999997 110.788 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.533 ' CD2' HD11 ' A' ' 73' ' ' LEU . 4.0 m-70 -104.96 -45.77 4.46 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.216 -0.927 . . . . 0.89000000000000001 110.742 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -96.0 153.64 39.13 Favored Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.428 -0.795 . . . . 0.55000000000000004 109.886 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -69.03 -39.5 7.82 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 O-C-N 123.859 1.452 . . . . 0.93000000000000005 111.317 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -95.1 146.83 18.37 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.871 -1.292 . . . . 0.46000000000000002 109.871 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -77.96 159.97 28.5 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.454 -1.027 . . . . 0.62 109.936 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.57 ' HB2' HG21 ' A' ' 35' ' ' VAL . 40.5 m-85 -143.32 167.51 22.0 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.455 -0.778 . . . . 0.41999999999999998 110.717 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.772 HG22 ' HD2' ' A' ' 45' ' ' PRO . 2.0 m -142.33 155.51 64.47 Favored Pre-proline 0 N--CA 1.499 1.989 0 O-C-N 121.47 -0.769 . . . . 0.41999999999999998 110.99 -179.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.772 ' HD2' HG22 ' A' ' 44' ' ' THR . 51.5 Cg_endo -95.95 137.62 0.67 Allowed 'Trans proline' 0 C--N 1.321 -0.881 0 C-N-CA 121.97 1.78 . . . . 0.56000000000000005 110.447 179.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.462 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 72.4 m -95.6 100.73 12.43 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.217 -0.927 . . . . 0.44 109.463 179.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.635 ' CB ' HG12 ' A' ' 58' ' ' VAL . 13.2 p -76.19 141.56 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.413 -0.805 . . . . 0.38 111.485 -179.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.517 ' HE2' ' HB3' ' A' ' 57' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.765 0 N-CA-C 109.479 -0.563 . . . . 0.70999999999999996 109.479 179.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 1.6 t80 . . . . . 0 N--CA 1.495 1.79 0 CA-C-O 121.191 0.519 . . . . 0.89000000000000001 110.536 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.43 ' CE1' HD22 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -145.13 152.55 40.22 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.492 -0.755 . . . . 0.41999999999999998 110.503 179.809 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.517 ' HB3' ' HE2' ' A' ' 48' ' ' LYS . 0.8 OUTLIER -124.47 110.05 14.02 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.397 -0.814 . . . . 1.01 109.758 -179.962 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.635 HG12 ' CB ' ' A' ' 47' ' ' VAL . 2.5 m -109.85 147.66 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.122 -0.986 . . . . 0.33000000000000002 110.711 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.586 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 1.0 OUTLIER -115.24 114.73 25.61 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.965 -0.754 . . . . 0.82999999999999996 108.965 179.209 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.607 ' CD1' HG13 ' A' ' 31' ' ' VAL . 3.9 tt -92.18 128.4 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.232 -0.917 . . . . 0.40000000000000002 110.843 -178.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.404 ' O ' ' HB3' ' A' ' 43' ' ' TYR . 26.3 m -93.88 135.09 35.56 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.707 -0.849 . . . . 0.41999999999999998 108.707 179.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.95 HD12 HG23 ' A' ' 35' ' ' VAL . 3.9 tt -162.46 118.61 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.171 -0.956 . . . . 0.35999999999999999 111.165 -179.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -92.45 100.19 12.79 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.474 -0.766 . . . . 0.53000000000000003 109.005 178.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -115.01 139.55 49.76 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.509 -0.745 . . . . 0.31 110.99 -178.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 47.6 p -73.47 -6.63 47.62 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.559 -0.713 . . . . 0.44 110.817 179.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 20.8 m80 -129.4 136.31 49.8 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.322 -0.862 . . . . 1.1799999999999999 110.433 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.4 tt -72.11 -24.0 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.483 -0.761 . . . . 0.73999999999999999 109.699 178.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.14 -32.9 61.47 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.411 -0.806 . . . . 0.52000000000000002 110.412 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -60.96 -47.78 84.87 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.477 -0.764 . . . . 0.65000000000000002 110.277 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.576 HG21 ' HB3' ' A' ' 15' ' ' PHE . 11.2 p -71.85 -27.49 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.43 -0.794 . . . . 0.32000000000000001 110.377 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -71.36 -44.67 64.58 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.16 -0.962 . . . . 0.45000000000000001 109.132 178.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 95.4 m -63.11 -37.61 87.87 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 109.03 -0.73 . . . . 0.40999999999999998 109.03 178.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.544 HD21 ' HA ' ' A' ' 35' ' ' VAL . 2.7 mp -62.96 -39.19 93.9 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.716 -0.615 . . . . 0.34000000000000002 109.559 178.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.587 ' CD1' ' HB ' ' A' ' 86' ' ' VAL . 0.5 OUTLIER -60.37 -44.93 95.15 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.519 -0.738 . . . . 0.62 109.068 178.497 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.47 -35.46 80.53 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.587 -0.696 . . . . 0.82999999999999996 110.525 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.843 ' CB ' HG21 ' A' ' 34' ' ' VAL . 0.2 OUTLIER -69.46 -51.68 33.9 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.48 -0.763 . . . . 0.46999999999999997 110.421 179.886 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 1.081 HD11 HG11 ' A' ' 19' ' ' VAL . 0.4 OUTLIER -69.38 -28.4 66.15 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.377 -0.827 . . . . 0.29999999999999999 110.335 179.729 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.476 ' N ' ' HG ' ' A' ' 77' ' ' LEU . . . -107.42 42.9 1.81 Allowed Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.609 -1.397 . . . . 0.33000000000000002 109.609 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.7 4.32 51.91 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.342 -1.093 . . . . 0.72999999999999998 110.694 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.402 ' H ' HD12 ' A' ' 80' ' ' ILE . 1.6 mp -69.25 153.21 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.248 -0.907 . . . . 0.42999999999999999 110.268 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -68.24 -17.47 64.31 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.481 -0.762 . . . . 0.57999999999999996 110.312 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.483 HG22 ' N ' ' A' ' 83' ' ' VAL . 51.8 mm -70.75 170.12 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.547 -0.72 . . . . 0.53000000000000003 110.043 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.483 ' N ' HG22 ' A' ' 82' ' ' ILE . 78.4 t -62.4 114.9 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.37 -0.831 . . . . 0.57999999999999996 110.596 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 5.4 ppt_? -121.42 143.57 49.15 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.86 -0.525 . . . . 1.21 110.117 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.47 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 1.6 ttp -156.42 159.04 38.34 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.166 -0.959 . . . . 0.88 110.486 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.695 HG23 HG22 ' A' ' 19' ' ' VAL . 9.2 p -141.02 156.61 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.44 -0.787 . . . . 0.27000000000000002 110.301 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.46 HD11 ' CZ ' ' A' ' 17' ' ' TYR . 67.3 mt . . . . . 0 N--CA 1.502 2.136 0 CA-C-O 117.655 -1.164 . . . . 0.52000000000000002 110.206 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.1 t . . . . . 0 N--CA 1.495 1.788 0 CA-C-O 120.614 0.245 . . . . 0.34000000000000002 110.48 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -72.4 125.93 11.16 Favored 'Trans proline' 0 C--N 1.315 -1.222 0 O-C-N 123.862 1.454 . . . . 0.34999999999999998 110.398 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.5 ' HB2' HG23 ' A' ' 62' ' ' ILE . 23.9 m-85 -106.16 99.6 9.18 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.556 -0.715 . . . . 0.32000000000000001 110.632 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.4 m -76.06 92.88 3.22 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 107.982 -1.118 . . . . 0.42999999999999999 107.982 178.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.532 ' O ' HG22 ' A' ' 60' ' ' ILE . 2.6 m-85 -100.1 109.47 21.77 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.397 -0.815 . . . . 0.42999999999999999 111.327 -177.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.543 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 0.1 OUTLIER -81.26 90.45 6.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.592 -0.693 . . . . 0.93000000000000005 109.402 179.156 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.996 HG11 HD11 ' A' ' 77' ' ' LEU . 32.1 t -79.64 98.07 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.623 -0.673 . . . . 0.34000000000000002 109.945 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.435 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 36.7 mtm -106.15 147.55 28.89 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.575 -0.703 . . . . 0.67000000000000004 110.085 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.418 ' HA3' ' O ' ' A' ' 83' ' ' VAL . . . 170.14 -141.5 6.63 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.088 -1.205 . . . . 0.26000000000000001 110.088 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.747 ' HG3' HG21 ' A' ' 82' ' ' ILE . 0.0 OUTLIER -66.04 154.33 39.81 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.547 -0.973 . . . . 0.60999999999999999 110.626 -179.817 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.576 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -93.08 97.93 11.0 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.491 -0.756 . . . . 0.34000000000000002 110.305 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -130.44 154.23 81.53 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.523 -0.736 . . . . 0.40999999999999998 110.49 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.03 -19.94 22.44 Favored 'Trans proline' 0 C--N 1.313 -1.316 0 O-C-N 124.041 1.548 . . . . 0.42999999999999999 111.477 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -75.98 -5.08 44.64 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.084 -1.01 . . . . 0.56999999999999995 111.358 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.4 mt -60.35 -59.92 4.63 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.067 -1.021 . . . . 0.62 110.219 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.604 HG12 ' HG2' ' A' ' 45' ' ' PRO . 33.6 m -64.99 -29.96 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.436 -0.79 . . . . 0.34999999999999998 110.796 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -67.28 -55.06 15.5 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.395 -0.816 . . . . 0.48999999999999999 110.229 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.72 ' O ' HG12 ' A' ' 34' ' ' VAL . 16.0 tp60 -67.1 -34.85 78.51 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.319 -0.863 . . . . 0.68999999999999995 110.643 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.842 HG22 HD22 ' A' ' 77' ' ' LEU . 3.0 t -59.06 -57.78 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.409 -0.807 . . . . 0.25 110.366 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.428 ' HA ' HG12 ' A' ' 35' ' ' VAL . 9.8 p -64.37 -33.07 60.36 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.323 -0.86 . . . . 0.31 111.424 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.6 -55.01 8.59 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.134 -0.979 . . . . 0.63 110.913 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.897 HG21 ' CB ' ' A' ' 76' ' ' GLU . 10.0 p -68.58 -27.58 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.407 -0.808 . . . . 0.28999999999999998 111.481 -179.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.887 HG23 HD12 ' A' ' 62' ' ' ILE . 2.4 p -80.64 -28.94 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.028 -1.045 . . . . 0.38 110.732 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -79.59 -40.96 28.15 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.264 -0.897 . . . . 1.27 110.143 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.3 mtm180 -66.62 -22.85 66.11 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.39 -0.819 . . . . 2.5 111.299 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.672 ' CG ' HD11 ' A' ' 73' ' ' LEU . 39.4 m-70 -105.23 -45.79 4.4 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.208 -0.933 . . . . 1.3200000000000001 110.667 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -106.72 143.41 26.98 Favored Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 121.438 -0.789 . . . . 0.58999999999999997 110.247 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -72.12 144.81 42.96 Favored 'Trans proline' 0 C--N 1.314 -1.27 0 O-C-N 123.827 1.435 . . . . 0.79000000000000004 110.786 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 91.66 148.35 21.9 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.532 -1.427 . . . . 0.5 109.532 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -82.01 134.27 35.35 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.531 -0.982 . . . . 1.22 110.113 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.652 ' HB2' HG11 ' A' ' 35' ' ' VAL . 38.8 m-85 -123.95 157.49 34.22 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.623 -0.673 . . . . 0.40999999999999998 110.402 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.732 HG22 ' HD2' ' A' ' 45' ' ' PRO . 1.4 m -142.36 153.38 62.59 Favored Pre-proline 0 N--CA 1.498 1.937 0 O-C-N 121.515 -0.741 . . . . 0.59999999999999998 110.955 -179.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.732 ' HD2' HG22 ' A' ' 44' ' ' THR . 55.3 Cg_endo -95.27 133.15 0.56 Allowed 'Trans proline' 0 C--N 1.32 -0.962 0 C-N-CA 121.898 1.732 . . . . 0.53000000000000003 110.579 179.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.452 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 51.5 m -89.93 93.99 9.63 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.187 -0.945 . . . . 0.39000000000000001 109.289 179.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.645 ' CB ' HG12 ' A' ' 58' ' ' VAL . 14.4 p -76.46 137.26 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.498 -0.752 . . . . 0.39000000000000001 111.589 -178.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.448 ' HE2' ' HB3' ' A' ' 57' ' ' SER . 0.5 OUTLIER . . . . . 0 N--CA 1.494 1.733 0 O-C-N 121.728 -0.608 . . . . 0.87 109.833 179.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 14.6 t80 . . . . . 0 N--CA 1.493 1.724 0 CA-C-O 121.156 0.503 . . . . 0.53000000000000003 110.178 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.576 ' HB2' ' HA ' ' A' ' 23' ' ' ALA . 0.1 OUTLIER -129.73 137.03 50.35 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.495 -0.753 . . . . 0.89000000000000001 110.29 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.448 ' HB3' ' HE2' ' A' ' 48' ' ' LYS . 6.1 m -110.18 105.46 14.54 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.598 -0.689 . . . . 0.35999999999999999 109.392 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.645 HG12 ' CB ' ' A' ' 47' ' ' VAL . 2.8 m -108.36 147.57 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.219 -0.926 . . . . 0.37 110.84 -179.267 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.543 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 8.6 t -112.1 112.16 23.58 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.403 -0.81 . . . . 0.45000000000000001 108.843 179.117 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.636 ' CD1' HG13 ' A' ' 31' ' ' VAL . 9.6 tt -92.33 126.86 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.217 -0.927 . . . . 0.33000000000000002 111.265 -178.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.412 ' O ' ' HB3' ' A' ' 43' ' ' TYR . 19.1 m -91.72 136.06 33.42 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.944 -0.762 . . . . 0.42999999999999999 108.944 179.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.887 HD12 HG23 ' A' ' 35' ' ' VAL . 5.9 tt -162.5 131.27 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.276 -0.89 . . . . 0.42999999999999999 110.72 -179.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -99.68 98.18 9.05 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.358 -0.838 . . . . 0.52000000000000002 109.698 179.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -113.67 139.69 48.84 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.451 -0.781 . . . . 0.26000000000000001 110.227 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 33.9 p -66.54 -22.64 66.16 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.465 -0.772 . . . . 0.34999999999999998 110.864 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -131.64 157.65 43.15 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.146 -0.971 . . . . 0.56999999999999995 110.8 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.3 tt -79.9 -16.75 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.529 -0.732 . . . . 0.40999999999999998 110.407 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.14 -33.09 71.37 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.125 -0.985 . . . . 0.46000000000000002 110.124 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.449 ' O ' HD13 ' A' ' 73' ' ' LEU . 0.0 OUTLIER -68.12 -48.75 64.59 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.353 -0.842 . . . . 1.24 110.053 179.549 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.464 HG23 HG21 ' A' ' 62' ' ' ILE . 7.6 p -69.25 -25.02 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.387 -0.821 . . . . 0.33000000000000002 110.262 179.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -69.02 -51.04 43.33 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.252 -0.905 . . . . 0.40999999999999998 109.529 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 20.1 p -62.02 -38.26 87.98 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.526 -0.734 . . . . 0.37 109.284 178.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.672 HD11 ' CG ' ' A' ' 38' ' ' HIS . 5.4 mp -61.33 -40.3 93.73 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 109.304 -0.628 . . . . 0.37 109.304 178.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.642 ' CD1' ' HB ' ' A' ' 86' ' ' VAL . 0.1 OUTLIER -59.16 -42.81 91.63 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.858 -0.793 . . . . 0.55000000000000004 108.858 178.387 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -68.5 -34.94 76.78 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.565 -0.709 . . . . 1.3500000000000001 110.336 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.897 ' CB ' HG21 ' A' ' 34' ' ' VAL . 0.3 OUTLIER -62.99 -48.59 78.17 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.488 -0.758 . . . . 0.48999999999999999 110.03 179.482 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.996 HD11 HG11 ' A' ' 19' ' ' VAL . 0.3 OUTLIER -79.38 -29.42 42.09 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.45 -0.781 . . . . 0.29999999999999999 110.132 179.387 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.502 ' N ' ' HG ' ' A' ' 77' ' ' LEU . . . -102.59 56.36 0.64 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.266 -1.533 . . . . 0.26000000000000001 109.266 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.3 tttt -106.22 4.59 29.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.698 -0.883 . . . . 1.6100000000000001 110.774 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.468 HG22 ' H ' ' A' ' 82' ' ' ILE . 2.5 mp -59.78 154.99 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.335 -0.853 . . . . 0.45000000000000001 110.111 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.16 -4.55 55.74 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.285 -0.884 . . . . 1.52 111.505 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.747 HG21 ' HG3' ' A' ' 22' ' ' GLN . 48.9 mm -85.52 -103.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 120.921 -1.112 . . . . 0.47999999999999998 110.175 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.432 HG23 HG22 ' A' ' 82' ' ' ILE . 88.3 t -123.99 118.75 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 120.822 -1.174 . . . . 0.40000000000000002 110.298 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.47 111.24 16.59 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.614 -0.679 . . . . 0.96999999999999997 109.543 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.509 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 0.4 OUTLIER -136.73 154.93 50.45 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.36 -0.838 . . . . 0.78000000000000003 110.392 -179.812 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.642 ' HB ' ' CD1' ' A' ' 74' ' ' TYR . 8.0 p -141.81 151.29 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.445 -0.784 . . . . 0.34999999999999998 110.572 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.427 HD22 ' HA ' ' A' ' 87' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.5 2.067 0 CA-C-O 117.545 -1.217 . . . . 0.52000000000000002 110.474 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.2 t . . . . . 0 N--CA 1.495 1.804 0 N-CA-C 110.438 -0.208 . . . . 0.31 110.438 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.73 120.26 6.57 Favored 'Trans proline' 0 C--N 1.315 -1.227 0 O-C-N 123.897 1.472 . . . . 0.34000000000000002 110.311 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.521 ' HB2' HG23 ' A' ' 62' ' ' ILE . 18.3 m-85 -102.88 99.71 9.64 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.568 -0.707 . . . . 0.33000000000000002 110.606 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.7 p -74.45 101.15 4.04 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.545 -0.909 . . . . 0.28000000000000003 108.545 178.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -114.77 160.04 19.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.395 -0.816 . . . . 0.37 111.024 -178.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.684 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 7.6 mttt -135.97 99.18 4.08 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.099 -0.704 . . . . 2.0600000000000001 109.099 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.988 HG11 HD11 ' A' ' 77' ' ' LEU . 10.2 t -79.76 98.31 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.445 -0.784 . . . . 0.26000000000000001 109.399 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 63.0 mtm -106.66 157.77 17.45 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.32 -0.862 . . . . 0.69999999999999996 110.298 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 164.2 -160.59 33.58 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 110.089 -1.204 . . . . 0.28999999999999998 110.089 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.418 ' HB3' ' CG2' ' A' ' 82' ' ' ILE . 0.0 OUTLIER -70.27 156.48 39.21 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.496 -1.003 . . . . 1.51 110.085 179.868 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -48.4 110.13 0.31 Allowed 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.776 -0.578 . . . . 0.51000000000000001 110.814 -179.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.472 HD13 ' HD2' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -130.51 110.99 16.34 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.554 -0.716 . . . . 0.52000000000000002 109.966 -179.872 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.472 ' HD2' HD13 ' A' ' 24' ' ' LEU . 44.9 Cg_endo -72.6 -30.48 11.95 Favored 'Trans proline' 0 C--N 1.315 -1.209 0 O-C-N 123.914 1.481 . . . . 0.54000000000000004 111.05 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -77.5 -7.12 55.75 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.228 -0.92 . . . . 0.68999999999999995 111.291 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.469 ' O ' HG23 ' A' ' 31' ' ' VAL . 0.3 OUTLIER -58.24 -55.14 38.89 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.947 -1.095 . . . . 0.64000000000000001 110.308 -179.952 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.552 HG23 ' HD2' ' A' ' 45' ' ' PRO . 11.9 p -61.04 -34.9 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 121.461 -0.774 . . . . 0.32000000000000001 110.559 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.441 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 10.1 m-20 -64.23 -49.46 71.84 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.479 -0.763 . . . . 0.53000000000000003 110.125 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.73 ' O ' HG12 ' A' ' 34' ' ' VAL . 13.3 tp60 -71.64 -31.74 67.18 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.477 -0.764 . . . . 0.55000000000000004 110.517 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.702 HG22 HD22 ' A' ' 77' ' ' LEU . 7.3 t -58.71 -52.48 59.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.324 -0.86 . . . . 0.23999999999999999 110.043 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.431 ' HA ' HG12 ' A' ' 35' ' ' VAL . 8.9 p -73.32 -30.54 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.414 -0.804 . . . . 0.33000000000000002 111.198 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.441 ' HB2' ' O ' ' A' ' 29' ' ' ASP . 0.8 OUTLIER -73.64 -50.48 20.83 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.045 -1.034 . . . . 0.55000000000000004 110.484 179.958 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.757 HG21 ' CB ' ' A' ' 76' ' ' GLU . 9.8 p -67.45 -32.41 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.426 -0.796 . . . . 0.34000000000000002 110.706 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.555 HG21 ' HB2' ' A' ' 43' ' ' TYR . 2.5 p -77.17 -27.45 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.046 -1.034 . . . . 0.34000000000000002 110.02 179.112 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -74.18 -36.29 64.04 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.293 -0.88 . . . . 0.75 109.602 178.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 52.7 mtm180 -73.1 -25.82 61.01 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.478 -0.764 . . . . 0.89000000000000001 110.758 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.767 ' CG ' HD11 ' A' ' 73' ' ' LEU . 43.0 m-70 -98.39 -45.8 6.01 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.368 -0.833 . . . . 0.67000000000000004 110.715 -179.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -102.8 151.84 38.39 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 121.481 -0.762 . . . . 0.63 109.975 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -69.83 -41.1 4.47 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.855 1.45 . . . . 1.0700000000000001 110.895 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -86.45 144.79 20.01 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.494 -1.442 . . . . 0.46000000000000002 109.494 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.08 149.06 29.36 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.37 -1.076 . . . . 0.59999999999999998 110.047 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.555 ' HB2' HG21 ' A' ' 35' ' ' VAL . 42.3 m-85 -132.43 161.13 34.46 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.572 -0.705 . . . . 0.47999999999999998 110.762 -179.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.67 HG22 ' HD2' ' A' ' 45' ' ' PRO . 3.7 m -142.6 153.49 61.91 Favored Pre-proline 0 N--CA 1.499 2.01 0 O-C-N 121.484 -0.76 . . . . 0.39000000000000001 111.016 -179.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.67 ' HD2' HG22 ' A' ' 44' ' ' THR . 51.9 Cg_endo -95.1 148.75 1.59 Allowed 'Trans proline' 0 C--N 1.319 -0.997 0 C-N-CA 121.832 1.688 . . . . 0.55000000000000004 110.479 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.522 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 56.9 m -106.81 96.84 6.72 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.174 -0.954 . . . . 0.39000000000000001 109.142 179.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.586 HG23 HG12 ' A' ' 58' ' ' VAL . 12.4 p -75.49 139.38 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.364 -0.835 . . . . 0.32000000000000001 111.771 -178.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.758 0 N-CA-C 109.69 -0.485 . . . . 0.93000000000000005 109.69 179.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 22.3 t80 . . . . . 0 N--CA 1.497 1.885 0 CA-C-O 121.097 0.475 . . . . 0.81999999999999995 110.169 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 4.1 p-80 -145.45 147.32 32.08 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.478 -0.764 . . . . 0.38 110.54 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.8 m -125.81 117.71 23.98 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.389 -0.819 . . . . 0.34999999999999998 109.524 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.586 HG12 HG23 ' A' ' 47' ' ' VAL . 1.3 m -115.04 139.64 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.188 -0.945 . . . . 0.27000000000000002 111.388 -179.17 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.54 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 7.5 t -95.64 108.0 20.24 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.352 -0.981 . . . . 0.60999999999999999 108.352 178.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.573 ' HA ' ' HA ' ' A' ' 45' ' ' PRO . 12.1 tt -92.4 125.79 44.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.256 -0.902 . . . . 0.34999999999999998 111.208 -178.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.48 ' O ' ' HB3' ' A' ' 43' ' ' TYR . 98.5 m -93.03 135.51 34.14 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.364 -0.976 . . . . 0.40999999999999998 108.364 178.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.521 HG23 ' HB2' ' A' ' 15' ' ' PHE . 12.6 tt -160.46 145.18 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.076 -1.015 . . . . 0.38 111.059 -179.203 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -121.62 111.13 16.83 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.62 -0.675 . . . . 0.41999999999999998 109.305 179.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.453 ' HB1' ' HB3' ' A' ' 69' ' ' GLN . . . -121.46 141.47 50.98 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.47 -0.769 . . . . 0.26000000000000001 110.762 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 26.1 p -77.33 -4.5 45.42 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.506 -0.746 . . . . 0.32000000000000001 111.219 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.651 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 62.1 t60 -130.37 150.32 51.65 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.216 -0.927 . . . . 0.48999999999999999 110.191 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.439 ' O ' HG12 ' A' ' 70' ' ' VAL . 7.5 mm -70.67 -48.39 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 121.47 -0.769 . . . . 0.48999999999999999 110.087 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.55 -18.46 65.38 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.454 -0.779 . . . . 0.75 111.236 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.651 ' HB2' ' HB3' ' A' ' 66' ' ' HIS . 0.3 OUTLIER -59.11 -58.87 6.75 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.263 -0.898 . . . . 1.1200000000000001 110.405 179.901 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.439 HG12 ' O ' ' A' ' 67' ' ' ILE . 8.0 p -59.57 -26.98 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.416 -0.803 . . . . 0.31 110.924 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.23 -45.66 62.8 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.265 -0.897 . . . . 0.81999999999999995 109.668 179.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 67.5 m -62.39 -41.17 98.44 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.573 -0.705 . . . . 0.34000000000000002 109.728 179.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.767 HD11 ' CG ' ' A' ' 38' ' ' HIS . 4.7 mp -65.08 -36.39 84.18 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.636 -0.665 . . . . 0.55000000000000004 110.047 179.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.627 ' CD1' ' HB ' ' A' ' 86' ' ' VAL . 0.3 OUTLIER -61.32 -46.09 91.74 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.46 -0.775 . . . . 0.52000000000000002 109.105 178.837 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.56 -33.82 76.8 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.522 -0.736 . . . . 1.1699999999999999 109.887 179.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.757 ' CB ' HG21 ' A' ' 34' ' ' VAL . 28.1 mt-10 -65.03 -43.47 92.31 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.411 -0.805 . . . . 0.37 109.889 179.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.988 HD11 HG11 ' A' ' 19' ' ' VAL . 0.4 OUTLIER -80.73 -29.68 36.33 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.358 -0.839 . . . . 0.27000000000000002 109.964 178.943 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.509 ' N ' ' HG ' ' A' ' 77' ' ' LEU . . . -105.26 54.32 0.61 Allowed Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.475 -1.45 . . . . 0.29999999999999999 109.475 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.97 4.12 29.11 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.567 -0.961 . . . . 0.94999999999999996 110.563 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.411 HD12 ' H ' ' A' ' 80' ' ' ILE . 1.7 mp -68.6 154.46 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.34 -0.85 . . . . 0.33000000000000002 110.175 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -66.16 -20.67 66.21 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.361 -0.837 . . . . 0.72999999999999998 110.155 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.44 HG22 ' N ' ' A' ' 83' ' ' VAL . 43.3 mm -68.91 166.75 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.422 -0.798 . . . . 0.38 109.895 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.44 ' N ' HG22 ' A' ' 82' ' ' ILE . 76.6 t -62.47 114.39 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.287 -0.883 . . . . 0.46999999999999997 110.779 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.25 137.16 54.81 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.774 -0.579 . . . . 1.22 109.615 179.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.424 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 2.7 mtm -151.92 160.21 43.58 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.158 -0.964 . . . . 1.49 110.523 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.627 ' HB ' ' CD1' ' A' ' 74' ' ' TYR . 5.4 p -142.14 155.23 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.463 -0.773 . . . . 0.31 110.378 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.684 ' HB3' ' HB2' ' A' ' 18' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.494 1.764 0 CA-C-O 117.896 -1.05 . . . . 0.34000000000000002 109.824 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.9 t . . . . . 0 N--CA 1.495 1.782 0 N-CA-C 110.172 -0.307 . . . . 0.34000000000000002 110.172 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -72.37 129.88 15.48 Favored 'Trans proline' 0 C--N 1.314 -1.277 0 O-C-N 123.939 1.494 . . . . 0.37 110.631 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.692 ' HB3' HG21 ' A' ' 70' ' ' VAL . 33.9 m-85 -112.01 100.89 9.24 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.583 -0.698 . . . . 0.35999999999999999 110.022 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 16.5 m -73.52 92.96 1.94 Allowed 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 108.497 -0.927 . . . . 0.42999999999999999 108.497 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.598 ' O ' HG22 ' A' ' 60' ' ' ILE . 3.3 m-85 -103.82 102.16 11.98 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.464 -0.773 . . . . 0.34999999999999998 110.858 -178.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.649 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 0.0 OUTLIER -77.77 89.19 4.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.671 -0.643 . . . . 1.3400000000000001 109.89 179.805 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.779 HG23 HG13 ' A' ' 58' ' ' VAL . 1.2 m -82.51 108.22 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 C-N-CA 119.358 -0.937 . . . . 0.27000000000000002 109.413 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.1 mtp -108.05 151.72 25.46 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.553 -0.717 . . . . 0.95999999999999996 110.567 -179.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 178.28 -159.81 25.51 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.82 -1.312 . . . . 0.34000000000000002 109.82 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.537 ' HA ' ' HA ' ' A' ' 55' ' ' TYR . 0.9 OUTLIER -70.44 -179.8 2.21 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.426 -1.044 . . . . 0.85999999999999999 110.503 179.973 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.61 100.01 2.2 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.392 -0.817 . . . . 0.47999999999999998 110.126 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.421 ' O ' HD23 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -122.94 108.56 32.53 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.516 -0.74 . . . . 0.90000000000000002 109.923 -179.773 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.402 ' HD2' HD13 ' A' ' 24' ' ' LEU . 44.0 Cg_endo -69.91 -15.44 36.54 Favored 'Trans proline' 0 N--CA 1.491 1.354 0 O-C-N 123.805 1.424 . . . . 0.63 111.588 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -83.09 -0.41 48.93 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.201 -0.937 . . . . 1.1200000000000001 111.476 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.687 HD13 HG21 ' A' ' 58' ' ' VAL . 3.1 pp -58.84 -35.11 72.37 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.906 -1.121 . . . . 0.60999999999999999 110.906 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.451 ' N ' HD12 ' A' ' 27' ' ' LEU . 9.8 p -75.35 -32.9 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.066 -1.021 . . . . 0.40000000000000002 110.557 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -64.77 -48.75 73.39 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.442 -0.786 . . . . 0.63 110.085 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.7 ' HG2' ' HA ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -72.92 -37.3 67.25 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.474 -0.766 . . . . 1.04 110.698 179.937 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.995 HG22 HD12 ' A' ' 60' ' ' ILE . 4.2 t -57.11 -47.09 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.31 -0.869 . . . . 0.26000000000000001 110.885 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.2 p -76.33 -37.19 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.251 -0.905 . . . . 0.34000000000000002 111.577 -179.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.529 ' CG ' ' HA ' ' A' ' 30' ' ' GLN . 0.2 OUTLIER -75.94 -31.37 59.05 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.828 -1.17 . . . . 0.56000000000000005 110.912 -179.869 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.681 HG21 ' HB2' ' A' ' 76' ' ' GLU . 5.4 p -79.98 -35.02 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.092 -1.005 . . . . 0.23999999999999999 110.14 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.565 HG21 ' HB2' ' A' ' 43' ' ' TYR . 9.7 p -73.99 -29.94 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.181 -0.95 . . . . 0.31 109.446 178.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -77.08 -36.39 55.81 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.435 -0.791 . . . . 0.76000000000000001 109.997 179.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.7 mtp-105 -65.92 -27.09 67.93 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.42 -0.8 . . . . 0.91000000000000003 111.085 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.509 ' CD2' HD11 ' A' ' 73' ' ' LEU . 17.3 m-70 -105.16 -45.86 4.4 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.334 -0.853 . . . . 0.48999999999999999 110.599 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -100.21 150.14 36.65 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.509 -0.745 . . . . 0.38 109.808 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -70.04 -38.46 7.16 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.759 1.4 . . . . 0.59999999999999998 111.15 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -85.78 145.3 20.82 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.918 -1.273 . . . . 0.42999999999999999 109.918 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.83 150.08 22.39 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.523 -0.987 . . . . 0.52000000000000002 109.864 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.565 ' HB2' HG21 ' A' ' 35' ' ' VAL . 51.9 m-85 -135.9 178.86 6.72 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.495 -0.753 . . . . 0.39000000000000001 110.779 -179.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.839 HG22 ' HD2' ' A' ' 45' ' ' PRO . 0.2 OUTLIER -141.0 157.0 68.18 Favored Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 121.476 -0.765 . . . . 0.47999999999999998 110.847 -179.064 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.839 ' HD2' HG22 ' A' ' 44' ' ' THR . 51.7 Cg_endo -93.75 163.27 2.26 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 C-N-CA 121.784 1.656 . . . . 0.40999999999999998 110.366 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.494 ' C ' HG23 ' A' ' 58' ' ' VAL . 44.6 m -127.34 88.79 2.85 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.341 -0.85 . . . . 0.39000000000000001 109.063 178.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.475 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 11.4 p -83.11 142.74 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.401 -0.812 . . . . 0.34000000000000002 111.651 -178.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.671 0 O-C-N 121.698 -0.626 . . . . 0.72999999999999998 109.841 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.537 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 15.0 t80 . . . . . 0 N--CA 1.494 1.761 0 CA-C-O 121.164 0.507 . . . . 0.91000000000000003 110.183 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -139.57 136.91 34.92 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.589 -0.694 . . . . 0.88 110.469 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.3 m -108.67 120.66 43.13 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.64 -0.663 . . . . 0.38 109.318 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.779 HG13 HG23 ' A' ' 19' ' ' VAL . 3.2 p -127.01 145.27 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.257 -0.902 . . . . 0.23999999999999999 111.485 -178.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.649 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 66.5 p -111.79 118.07 34.56 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.636 -0.665 . . . . 0.34999999999999998 109.51 179.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.995 HD12 HG22 ' A' ' 31' ' ' VAL . 7.0 tt -94.55 134.5 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.436 -0.79 . . . . 0.32000000000000001 111.249 -179.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 52.9 m -89.19 114.37 25.67 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.58 -0.896 . . . . 0.37 108.58 178.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.608 HD11 HD11 ' A' ' 60' ' ' ILE . 32.3 mm -122.42 99.32 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.171 -0.956 . . . . 0.34000000000000002 111.299 -178.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -88.59 86.25 6.97 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.108 -0.995 . . . . 0.45000000000000001 108.703 178.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.719 ' HB1' ' HB3' ' A' ' 69' ' ' GLN . . . -102.84 140.14 37.51 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.605 -0.685 . . . . 0.23999999999999999 111.042 -178.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 32.9 p -75.86 -6.84 52.71 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.667 -0.646 . . . . 0.38 110.981 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.421 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 4.2 t-160 -129.73 158.59 38.97 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.265 -0.897 . . . . 0.45000000000000001 110.454 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.461 ' O ' HG12 ' A' ' 70' ' ' VAL . 1.8 mt -73.68 -46.92 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.588 -0.695 . . . . 0.80000000000000004 109.851 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.5 -21.28 66.63 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.495 -0.753 . . . . 0.72999999999999998 110.998 179.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.719 ' HB3' ' HB1' ' A' ' 64' ' ' ALA . 9.9 tt0 -61.04 -52.6 64.28 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.238 -0.914 . . . . 0.38 110.44 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.692 HG21 ' HB3' ' A' ' 15' ' ' PHE . 7.4 p -69.73 -27.42 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.335 -0.853 . . . . 0.29999999999999999 110.332 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.56 -52.7 59.92 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.275 -0.89 . . . . 0.92000000000000004 109.533 179.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.8 p -62.65 -37.35 86.04 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.541 -0.724 . . . . 0.37 109.298 178.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.509 HD11 ' CD2' ' A' ' 38' ' ' HIS . 2.0 mp -61.85 -39.77 93.01 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.666 -0.646 . . . . 0.29999999999999999 110.021 179.207 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.49 ' CD1' ' C ' ' A' ' 74' ' ' TYR . 0.0 OUTLIER -63.51 -45.97 88.21 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.552 -0.718 . . . . 0.46000000000000002 109.332 179.02 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -70.12 -30.04 67.13 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.542 -0.724 . . . . 0.73999999999999999 110.722 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.681 ' HB2' HG21 ' A' ' 34' ' ' VAL . 23.4 mt-10 -71.65 -51.39 23.34 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.377 -0.827 . . . . 0.42999999999999999 110.362 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.7 ' HA ' ' HG2' ' A' ' 30' ' ' GLN . 0.7 OUTLIER -71.54 -29.69 65.04 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.279 -0.888 . . . . 0.28999999999999998 109.951 179.236 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.473 ' N ' ' HG ' ' A' ' 77' ' ' LEU . . . -102.61 46.03 1.28 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.362 -1.495 . . . . 0.23999999999999999 109.362 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.76 3.92 29.38 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.533 -0.981 . . . . 1.48 110.998 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.592 HG22 ' H ' ' A' ' 82' ' ' ILE . 2.3 mp -60.96 145.88 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.288 -0.883 . . . . 0.44 110.159 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -63.57 -21.19 66.21 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.474 -0.766 . . . . 0.81999999999999995 110.525 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.592 ' H ' HG22 ' A' ' 80' ' ' ILE . 38.2 mm -71.59 172.4 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.405 -0.81 . . . . 0.5 109.83 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.469 ' N ' HG22 ' A' ' 82' ' ' ILE . 68.9 t -62.29 113.7 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.248 -0.908 . . . . 0.5 110.766 -179.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.87 154.26 37.31 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.782 -0.574 . . . . 1.01 110.368 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.516 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 4.4 ttp -156.18 159.86 39.35 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.336 -0.852 . . . . 0.65000000000000002 110.012 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.623 ' HA ' ' HA ' ' A' ' 19' ' ' VAL . 9.8 p -131.87 149.15 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 121.307 -0.871 . . . . 0.34000000000000002 110.891 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.463 ' CD2' ' HA ' ' A' ' 17' ' ' TYR . 37.6 mt . . . . . 0 N--CA 1.501 2.092 0 CA-C-O 117.653 -1.165 . . . . 0.45000000000000001 110.664 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 N--CA 1.497 1.885 0 N-CA-C 110.34 -0.244 . . . . 0.44 110.34 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.93 119.75 6.24 Favored 'Trans proline' 0 C--N 1.314 -1.283 0 O-C-N 123.915 1.481 . . . . 0.44 110.634 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.683 ' HB2' ' HB ' ' A' ' 62' ' ' ILE . 15.6 m-85 -103.62 99.8 9.61 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.638 -0.664 . . . . 0.39000000000000001 110.231 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.9 m -75.03 96.05 3.13 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.395 -0.816 . . . . 0.38 108.843 179.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.459 ' HD2' HG21 ' A' ' 86' ' ' VAL . 4.6 m-85 -108.63 115.07 29.41 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.244 -0.91 . . . . 0.40000000000000002 110.848 -178.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.528 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 0.8 OUTLIER -83.64 91.04 7.37 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.478 -0.764 . . . . 0.90000000000000002 109.5 179.452 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.946 HG11 HD11 ' A' ' 77' ' ' LEU . 11.0 t -79.3 95.4 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.51 -0.744 . . . . 0.66000000000000003 109.645 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.486 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 34.5 mtm -101.58 136.02 42.11 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.461 -0.774 . . . . 0.96999999999999997 110.15 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -172.25 -156.97 13.04 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.565 -1.414 . . . . 0.37 109.565 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.594 ' HG2' HG21 ' A' ' 82' ' ' ILE . 3.3 tp60 -67.68 168.79 10.61 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.458 -1.024 . . . . 0.58999999999999997 110.486 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -90.0 97.85 11.43 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.426 -0.796 . . . . 0.41999999999999998 109.969 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.441 ' CD1' ' HB3' ' A' ' 26' ' ' GLU . 0.8 OUTLIER -130.13 154.45 81.32 Favored Pre-proline 0 N--CA 1.498 1.939 0 O-C-N 121.562 -0.711 . . . . 0.40000000000000002 110.645 -179.837 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -73.06 -26.7 14.76 Favored 'Trans proline' 0 N--CA 1.49 1.316 0 O-C-N 123.877 1.461 . . . . 0.46999999999999997 111.68 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.441 ' HB3' ' CD1' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -68.82 -11.61 60.62 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.135 -0.978 . . . . 0.62 111.258 -179.804 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.417 HD22 HG21 ' A' ' 58' ' ' VAL . 0.7 OUTLIER -59.14 -64.61 0.88 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.124 -0.985 . . . . 0.81000000000000005 110.441 -179.867 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.585 HG12 ' HG2' ' A' ' 45' ' ' PRO . 26.9 m -66.77 -29.81 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 O-C-N 121.396 -0.815 . . . . 0.56999999999999995 110.956 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -65.23 -56.63 11.69 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.314 -0.867 . . . . 0.67000000000000004 110.051 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.655 ' O ' HG12 ' A' ' 34' ' ' VAL . 7.8 tp60 -68.3 -31.55 71.06 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.494 -0.754 . . . . 0.60999999999999999 110.586 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.882 HG22 HD12 ' A' ' 60' ' ' ILE . 2.4 t -58.2 -52.33 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.37 -0.831 . . . . 0.31 110.368 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.7 p -73.49 -32.53 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.303 -0.873 . . . . 0.34999999999999998 111.385 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.69 -49.05 27.66 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.029 -1.044 . . . . 1.1799999999999999 110.777 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.79 HG21 ' HB2' ' A' ' 76' ' ' GLU . 4.6 p -68.79 -34.05 62.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.457 -0.777 . . . . 0.28999999999999998 111.012 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.564 HG11 ' HB2' ' A' ' 43' ' ' TYR . 4.7 p -74.16 -31.16 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.007 -1.058 . . . . 0.31 110.051 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -73.31 -34.03 65.48 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.269 -0.894 . . . . 1.3600000000000001 109.754 178.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.3 mtt180 -68.96 -33.75 74.22 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.447 -0.783 . . . . 2.0 111.345 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.586 ' HB2' HD11 ' A' ' 73' ' ' LEU . 24.6 m-70 -99.1 -45.81 5.79 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.081 -1.012 . . . . 0.62 110.781 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -101.74 150.28 37.2 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 121.449 -0.782 . . . . 0.41999999999999998 110.28 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.55 141.18 34.2 Favored 'Trans proline' 0 C--N 1.314 -1.281 0 O-C-N 123.803 1.423 . . . . 0.67000000000000004 110.762 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.55 165.23 36.41 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.71 -1.356 . . . . 0.54000000000000004 109.71 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -99.01 145.45 27.06 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.411 -1.052 . . . . 0.62 110.21 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.564 ' HB2' HG11 ' A' ' 35' ' ' VAL . 78.2 m-85 -129.26 167.11 18.16 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.524 -0.735 . . . . 0.42999999999999999 110.108 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.778 HG22 ' HD2' ' A' ' 45' ' ' PRO . 0.2 OUTLIER -140.12 157.61 68.72 Favored Pre-proline 0 N--CA 1.498 1.973 0 O-C-N 121.233 -0.917 . . . . 0.70999999999999996 111.552 -178.55 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.778 ' HD2' HG22 ' A' ' 44' ' ' THR . 54.8 Cg_endo -96.56 141.74 0.8 Allowed 'Trans proline' 0 C--N 1.319 -0.997 0 C-N-CA 122.131 1.887 . . . . 0.58999999999999997 110.395 179.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.479 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 45.2 m -95.64 93.66 7.27 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.21 -0.931 . . . . 0.40999999999999998 109.051 178.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.762 HG23 HG12 ' A' ' 58' ' ' VAL . 11.0 p -76.06 138.24 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.473 -0.767 . . . . 0.37 111.598 -178.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.722 0 O-C-N 121.868 -0.52 . . . . 1.0900000000000001 109.705 179.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 22.2 t80 . . . . . 0 N--CA 1.494 1.764 0 CA-C-O 121.195 0.522 . . . . 0.84999999999999998 109.905 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -132.72 139.09 47.46 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.431 -0.793 . . . . 0.58999999999999997 110.497 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.486 ' HA ' ' HA ' ' A' ' 20' ' ' MET . 57.7 m -107.89 116.22 31.56 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.605 -0.685 . . . . 0.34000000000000002 109.476 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.762 HG12 HG23 ' A' ' 47' ' ' VAL . 1.7 m -115.5 143.3 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.27 -0.894 . . . . 0.35999999999999999 111.13 -179.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.528 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 13.4 m -104.56 108.28 19.64 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.753 -0.832 . . . . 0.71999999999999997 108.753 178.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.882 HD12 HG22 ' A' ' 31' ' ' VAL . 6.4 tt -92.84 132.13 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.326 -0.859 . . . . 0.34000000000000002 111.556 -178.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.428 HG23 ' O ' ' A' ' 61' ' ' THR . 13.2 t -87.69 125.12 34.21 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.755 -0.832 . . . . 0.32000000000000001 108.755 178.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.683 ' HB ' ' HB2' ' A' ' 15' ' ' PHE . 45.4 mm -121.37 125.0 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.217 -0.927 . . . . 0.46999999999999997 110.998 -178.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -101.94 64.01 0.94 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.411 -0.806 . . . . 0.62 109.21 178.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.707 ' HB1' ' HB2' ' A' ' 69' ' ' GLN . . . -94.68 132.86 38.97 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.353 -0.842 . . . . 0.28999999999999998 110.355 -179.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 41.3 p -67.7 -22.66 65.26 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.603 -0.685 . . . . 0.44 110.613 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -130.42 160.28 34.51 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.411 -0.805 . . . . 1.03 110.139 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.432 ' O ' HG12 ' A' ' 70' ' ' VAL . 0.9 OUTLIER -72.06 -16.86 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.412 -0.805 . . . . 0.89000000000000001 110.681 179.604 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.1 -33.89 72.44 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.089 -1.007 . . . . 0.84999999999999998 110.399 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.707 ' HB2' ' HB1' ' A' ' 64' ' ' ALA . 8.5 mt-30 -66.35 -48.29 70.7 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.464 -0.772 . . . . 0.88 110.381 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.584 HG23 HG21 ' A' ' 62' ' ' ILE . 8.1 p -68.34 -25.89 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.387 -0.821 . . . . 0.34000000000000002 110.561 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -67.71 -51.28 51.38 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.207 -0.933 . . . . 0.52000000000000002 109.544 179.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.2 p -65.01 -34.95 79.66 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.532 -0.73 . . . . 0.41999999999999998 109.578 178.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.586 HD11 ' HB2' ' A' ' 38' ' ' HIS . 2.9 mp -60.62 -41.74 95.47 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.548 -0.72 . . . . 0.31 109.844 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.54 ' CD1' ' HB ' ' A' ' 86' ' ' VAL . 2.0 t80 -65.15 -44.31 89.01 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.476 -0.765 . . . . 1.04 109.487 178.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.22 -37.4 83.55 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.521 -0.737 . . . . 0.92000000000000004 110.53 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.79 ' HB2' HG21 ' A' ' 34' ' ' VAL . 26.5 mt-10 -69.01 -49.88 53.78 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.449 -0.782 . . . . 0.45000000000000001 110.483 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.946 HD11 HG11 ' A' ' 19' ' ' VAL . 0.3 OUTLIER -74.09 -28.98 61.63 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.352 -0.842 . . . . 0.41999999999999998 110.3 179.633 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.481 ' N ' ' HG ' ' A' ' 77' ' ' LEU . . . -104.09 49.43 0.93 Allowed Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.314 -1.514 . . . . 0.31 109.314 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -106.16 3.97 28.51 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.705 -0.88 . . . . 0.82999999999999996 110.791 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.507 HG22 HG12 ' A' ' 82' ' ' ILE . 2.3 mp -61.1 157.27 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.323 -0.86 . . . . 0.39000000000000001 110.328 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.32 -4.12 40.4 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.131 -0.981 . . . . 1.1499999999999999 111.83 -179.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.594 HG21 ' HG2' ' A' ' 22' ' ' GLN . 17.8 mm -86.68 -125.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 120.962 -1.086 . . . . 0.46000000000000002 110.402 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 98.9 t -119.51 117.2 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 120.711 -1.243 . . . . 0.37 110.485 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.493 ' HD2' ' HB ' ' A' ' 80' ' ' ILE . 0.0 OUTLIER -122.49 131.65 53.96 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.656 -0.653 . . . . 0.63 110.283 179.779 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.541 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 1.8 ttp -143.05 158.56 43.49 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.413 -0.804 . . . . 1.1699999999999999 109.683 179.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.633 HG23 HG22 ' A' ' 19' ' ' VAL . 9.8 p -141.62 152.21 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.294 -0.879 . . . . 0.46000000000000002 111.026 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.501 2.078 0 CA-C-O 117.54 -1.219 . . . . 0.51000000000000001 110.482 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.2 t . . . . . 0 N--CA 1.495 1.785 0 CA-C-O 120.604 0.24 . . . . 0.33000000000000002 110.633 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.467 ' HA ' ' HA ' ' A' ' 63' ' ' ASN . 46.2 Cg_endo -72.7 125.5 10.6 Favored 'Trans proline' 0 C--N 1.314 -1.248 0 O-C-N 123.94 1.495 . . . . 0.34000000000000002 110.449 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.704 ' CB ' HG21 ' A' ' 70' ' ' VAL . 32.9 m-85 -103.14 99.45 9.32 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.558 -0.714 . . . . 0.35999999999999999 110.215 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.9 m -78.23 91.94 4.43 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.299 -1.0 . . . . 0.37 108.299 178.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.408 ' HA ' ' CD2' ' A' ' 87' ' ' LEU . 3.1 m-85 -97.6 104.37 16.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.573 -0.704 . . . . 0.40999999999999998 110.352 -178.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.566 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 0.0 OUTLIER -78.22 89.12 4.28 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.693 -0.629 . . . . 1.8700000000000001 110.202 179.905 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.673 HG23 HG23 ' A' ' 58' ' ' VAL . 1.0 OUTLIER -83.89 101.67 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.308 -0.87 . . . . 0.23000000000000001 109.397 179.337 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.407 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 36.8 mtm -109.44 151.43 26.69 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.588 -0.695 . . . . 1.01 110.254 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -177.67 -154.89 12.85 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.847 -1.301 . . . . 0.31 109.847 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.88 167.27 11.83 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.468 -1.019 . . . . 0.68000000000000005 110.353 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.29 102.61 1.42 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.37 -0.831 . . . . 0.33000000000000002 110.255 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.727 ' O ' HD23 ' A' ' 27' ' ' LEU . 0.5 OUTLIER -129.55 120.48 19.77 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.499 -0.751 . . . . 0.90000000000000002 110.091 -179.785 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -71.9 -14.91 29.68 Favored 'Trans proline' 0 N--CA 1.49 1.323 0 O-C-N 123.871 1.458 . . . . 0.53000000000000003 111.465 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -82.28 -0.33 45.0 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.111 -0.993 . . . . 0.73999999999999999 111.456 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.727 HD23 ' O ' ' A' ' 24' ' ' LEU . 3.5 pp -57.87 -36.51 72.47 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 120.969 -1.082 . . . . 0.46000000000000002 111.045 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.9 p -79.36 -30.91 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.161 -0.962 . . . . 0.39000000000000001 110.497 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -66.72 -50.92 61.25 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.403 -0.81 . . . . 0.40999999999999998 109.891 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.695 ' HG2' ' HA ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -68.81 -45.25 71.73 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.261 -0.9 . . . . 1.05 110.525 179.765 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.693 HG13 ' CD1' ' A' ' 60' ' ' ILE . 2.9 t -53.76 -54.05 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.442 -0.786 . . . . 0.23999999999999999 111.172 -179.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.9 p -66.77 -35.65 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 121.185 -0.947 . . . . 0.32000000000000001 111.63 -179.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -73.8 -51.06 17.62 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.059 -1.026 . . . . 0.5 110.896 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.733 HG21 ' CB ' ' A' ' 76' ' ' GLU . 9.5 p -66.25 -31.7 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.403 -0.81 . . . . 0.33000000000000002 111.162 -179.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.468 HG11 ' HB2' ' A' ' 43' ' ' TYR . 1.6 p -79.59 -28.23 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.145 -0.972 . . . . 0.31 110.634 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -75.98 -37.76 58.2 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.226 -0.922 . . . . 0.78000000000000003 110.524 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 13.3 mtm180 -71.87 -23.11 61.46 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.332 -0.855 . . . . 2.5499999999999998 110.93 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.528 ' CD2' HD11 ' A' ' 73' ' ' LEU . 19.8 m-70 -99.6 -45.78 5.67 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.298 -0.877 . . . . 0.51000000000000001 110.392 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -92.17 153.57 43.13 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.405 -0.809 . . . . 0.44 109.695 179.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -68.05 -36.74 16.54 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 O-C-N 123.752 1.396 . . . . 0.71999999999999997 111.082 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -101.74 163.89 17.47 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 109.517 -1.433 . . . . 0.46999999999999997 109.517 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -88.55 154.63 20.19 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.354 -1.086 . . . . 0.66000000000000003 109.885 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.468 ' HB2' HG11 ' A' ' 35' ' ' VAL . 75.3 m-85 -137.65 172.77 12.46 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.471 -0.768 . . . . 0.46999999999999997 110.641 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.675 HG22 ' HD2' ' A' ' 45' ' ' PRO . 4.2 m -142.27 154.0 63.65 Favored Pre-proline 0 N--CA 1.498 1.943 0 O-C-N 121.416 -0.803 . . . . 0.45000000000000001 110.919 -179.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.675 ' HD2' HG22 ' A' ' 44' ' ' THR . 55.1 Cg_endo -95.12 132.5 0.56 Allowed 'Trans proline' 0 C--N 1.319 -0.979 0 C-N-CA 121.823 1.682 . . . . 0.56999999999999995 110.421 178.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 35.8 m -90.24 99.35 12.39 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.067 -1.021 . . . . 0.34000000000000002 109.202 179.019 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.73 ' HA ' HG12 ' A' ' 58' ' ' VAL . 12.4 p -76.63 135.18 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.544 -0.722 . . . . 0.33000000000000002 111.495 -178.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.426 ' HE2' ' HB3' ' A' ' 57' ' ' SER . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.802 0 O-C-N 121.789 -0.569 . . . . 0.73999999999999999 109.817 179.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 16.3 t80 . . . . . 0 N--CA 1.494 1.761 0 CA-C-O 121.139 0.495 . . . . 0.56999999999999995 110.38 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 4.0 m170 -120.62 126.04 49.27 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.561 -0.712 . . . . 0.69999999999999996 109.974 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.426 ' HB3' ' HE2' ' A' ' 48' ' ' LYS . 38.9 m -109.7 110.88 22.05 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.403 -0.811 . . . . 0.40000000000000002 109.593 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.73 HG12 ' HA ' ' A' ' 47' ' ' VAL . 3.6 m -119.74 151.34 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.21 -0.931 . . . . 0.25 110.931 -179.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.566 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 79.3 p -117.8 118.08 31.06 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.478 -0.764 . . . . 0.32000000000000001 109.422 179.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.693 ' CD1' HG13 ' A' ' 31' ' ' VAL . 9.1 tt -93.17 130.68 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.33 -0.856 . . . . 0.28000000000000003 110.922 -179.012 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 97.2 m -86.15 129.91 34.7 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 109.101 -0.703 . . . . 0.34999999999999998 109.101 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.434 HD11 HD13 ' A' ' 60' ' ' ILE . 91.0 mt -141.65 96.6 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.103 -0.998 . . . . 0.29999999999999999 110.848 -179.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.467 ' HA ' ' HA ' ' A' ' 14' ' ' PRO . 2.0 t30 -82.31 93.94 7.25 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.039 -1.038 . . . . 0.46000000000000002 109.353 178.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -117.45 140.21 49.89 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.598 -0.689 . . . . 0.26000000000000001 110.319 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 33.8 p -69.74 -15.37 63.13 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.546 -0.722 . . . . 0.34999999999999998 110.653 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -130.53 157.98 41.2 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.399 -0.813 . . . . 0.42999999999999999 109.901 179.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.2 tt -89.99 -3.23 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.29 -0.881 . . . . 0.55000000000000004 111.093 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -74.38 -43.68 55.42 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.106 -0.996 . . . . 0.41999999999999998 110.487 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.461 ' CG ' ' HB3' ' A' ' 38' ' ' HIS . 0.6 OUTLIER -67.01 -47.0 72.79 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.531 -0.73 . . . . 0.57999999999999996 110.848 -179.682 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.704 HG21 ' CB ' ' A' ' 15' ' ' PHE . 8.9 p -62.24 -31.13 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 121.446 -0.784 . . . . 0.29999999999999999 110.699 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -66.76 -46.89 73.93 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.326 -0.859 . . . . 0.52000000000000002 109.224 178.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.447 HG22 ' OE1' ' A' ' 76' ' ' GLU . 7.0 m -61.32 -34.38 75.16 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.679 -0.638 . . . . 0.40999999999999998 109.464 178.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.528 HD11 ' CD2' ' A' ' 38' ' ' HIS . 2.1 mp -65.64 -39.11 91.08 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.515 -0.741 . . . . 0.37 109.914 179.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.48 ' HB2' HG21 ' A' ' 86' ' ' VAL . 0.0 OUTLIER -63.12 -48.94 76.37 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.625 -0.672 . . . . 0.42999999999999999 109.779 179.419 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -71.26 -26.24 62.81 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.423 -0.798 . . . . 0.62 110.883 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.733 ' CB ' HG21 ' A' ' 34' ' ' VAL . 23.2 mt-10 -73.49 -50.18 22.88 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.216 -0.927 . . . . 0.39000000000000001 110.07 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.695 ' HA ' ' HG2' ' A' ' 30' ' ' GLN . 1.5 pp -76.17 -25.73 55.52 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.282 -0.886 . . . . 0.34000000000000002 110.023 178.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -101.39 40.74 2.32 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.307 -1.517 . . . . 0.31 109.307 179.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.05 4.12 39.44 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.384 -1.068 . . . . 0.81000000000000005 110.842 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.0 mp -62.04 145.85 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.334 -0.854 . . . . 0.34999999999999998 110.116 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -60.96 -30.29 70.16 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.407 -0.808 . . . . 0.73999999999999999 110.302 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -61.35 171.09 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.616 -0.678 . . . . 0.40999999999999998 110.611 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 78.9 t -63.67 118.16 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.43 -0.794 . . . . 0.40999999999999998 110.288 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.35 158.67 27.74 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.675 -0.641 . . . . 0.69999999999999996 110.369 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.549 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 1.1 ttp -157.76 158.53 35.46 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.511 -0.743 . . . . 0.88 109.786 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.48 HG21 ' HB2' ' A' ' 74' ' ' TYR . 9.1 p -135.46 147.17 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.378 -0.826 . . . . 0.32000000000000001 110.628 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.408 ' CD2' ' HA ' ' A' ' 17' ' ' TYR . 35.8 mt . . . . . 0 N--CA 1.5 2.061 0 CA-C-O 118.693 -0.67 . . . . 0.46999999999999997 110.466 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.653 ' HB3' ' HB3' ' A' ' 7' ' ' GLU . 2.4 mtm . . . . . 0 N--CA 1.496 1.831 0 CA-C-O 121.225 0.535 . . . . 2.02 110.556 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.89 89.48 1.97 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.486 -0.759 . . . . 2.75 110.033 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 27.0 p -120.62 -5.71 9.73 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.465 -0.772 . . . . 0.69999999999999996 111.326 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.35 41.92 28.4 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.172 -0.955 . . . . 2.2200000000000002 110.769 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -163.8 -55.22 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.546 -0.721 . . . . 1.23 110.086 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -113.35 -21.17 11.05 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.38 -0.825 . . . . 0.95999999999999996 110.931 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.653 ' HB3' ' HB3' ' A' ' 1' ' ' MET . 0.6 OUTLIER -157.11 141.68 16.67 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.158 -0.964 . . . . 0.55000000000000004 110.822 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.3 tt -158.2 -55.92 0.07 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.583 -0.698 . . . . 0.94999999999999996 110.269 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.669 HD12 ' CB ' ' A' ' 11' ' ' PHE . 0.6 OUTLIER -89.04 -13.96 37.51 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.693 -0.629 . . . . 0.37 111.178 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 55.03 52.17 12.27 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.354 -0.841 . . . . 0.55000000000000004 111.183 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.669 ' CB ' HD12 ' A' ' 9' ' ' LEU . 13.4 t80 -139.87 111.39 7.4 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.441 -0.787 . . . . 1.24 109.425 179.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.463 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 43.4 Cg_endo -69.89 107.54 1.91 Allowed 'Trans proline' 0 C--N 1.314 -1.264 0 O-C-N 123.884 1.465 . . . . 0.31 110.911 -179.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.9 t -110.44 146.02 33.43 Favored Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 121.66 -0.65 . . . . 0.33000000000000002 109.989 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -69.44 114.64 3.72 Favored 'Trans proline' 0 C--N 1.313 -1.312 0 O-C-N 123.861 1.453 . . . . 0.35999999999999999 110.979 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.526 ' CE2' ' HB3' ' A' ' 64' ' ' ALA . 15.7 m-85 -102.53 101.13 11.28 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.694 -0.629 . . . . 0.33000000000000002 110.222 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.4 m -75.5 93.04 2.93 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.631 -0.877 . . . . 0.37 108.631 178.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -110.75 159.25 17.8 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.468 -0.77 . . . . 0.38 110.752 -178.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.546 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -134.82 101.25 4.85 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.348 -0.612 . . . . 0.40000000000000002 109.348 179.766 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 1.062 HG11 HD11 ' A' ' 77' ' ' LEU . 3.5 t -79.68 95.62 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.477 -0.764 . . . . 0.28000000000000003 109.59 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.541 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 43.9 mtm -97.73 142.0 30.05 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.538 -0.726 . . . . 0.56000000000000005 110.178 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 166.42 -147.69 12.46 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.586 -1.406 . . . . 0.31 109.586 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.509 ' HG3' HG21 ' A' ' 82' ' ' ILE . 0.0 OUTLIER -75.8 151.1 37.59 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.326 -1.102 . . . . 0.69999999999999996 110.106 179.816 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.6 105.04 2.98 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.564 -0.71 . . . . 0.35999999999999999 110.31 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.522 HD13 ' HD2' ' A' ' 25' ' ' PRO . 2.6 mm? -111.13 129.69 23.74 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.592 -0.693 . . . . 0.56000000000000005 109.761 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.522 ' HD2' HD13 ' A' ' 24' ' ' LEU . 43.3 Cg_endo -70.49 -30.5 18.81 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 O-C-N 123.701 1.369 . . . . 0.40999999999999998 110.606 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -83.6 -2.81 56.9 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.463 -0.773 . . . . 0.64000000000000001 110.791 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.52 HD21 HG21 ' A' ' 58' ' ' VAL . 0.8 OUTLIER -58.48 -52.62 64.85 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.043 -1.035 . . . . 0.81999999999999995 110.284 179.997 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.499 HG12 ' HG2' ' A' ' 45' ' ' PRO . 35.8 m -62.23 -33.2 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.48 -0.762 . . . . 0.34999999999999998 110.467 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -67.45 -46.26 73.59 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.511 -0.743 . . . . 0.48999999999999999 109.937 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.734 ' O ' HG12 ' A' ' 34' ' ' VAL . 3.2 tp60 -72.24 -34.32 68.2 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.446 -0.784 . . . . 0.53000000000000003 110.328 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.807 HG22 HD12 ' A' ' 60' ' ' ILE . 2.8 t -60.41 -53.21 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.561 -0.712 . . . . 0.26000000000000001 110.432 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.444 ' HA ' HG12 ' A' ' 35' ' ' VAL . 9.9 p -70.81 -31.47 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 121.329 -0.857 . . . . 0.28999999999999998 110.846 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.73 -46.27 54.39 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.301 -0.874 . . . . 0.52000000000000002 110.932 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.849 HG21 ' CB ' ' A' ' 76' ' ' GLU . 7.6 p -75.51 -30.28 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.247 -0.908 . . . . 0.25 111.048 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.67 HG11 ' HB2' ' A' ' 43' ' ' TYR . 4.0 p -75.2 -30.75 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.045 -1.034 . . . . 0.26000000000000001 110.209 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -79.04 -42.0 27.52 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.383 -0.823 . . . . 0.57999999999999996 110.32 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.9 mtm180 -62.87 -30.06 71.23 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.269 -0.895 . . . . 2.5099999999999998 111.053 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.743 ' CG ' HD11 ' A' ' 73' ' ' LEU . 68.6 m-70 -97.5 -41.05 8.36 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.342 -0.849 . . . . 0.51000000000000001 110.72 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -120.8 145.56 41.58 Favored Pre-proline 0 N--CA 1.497 1.922 0 O-C-N 121.439 -0.788 . . . . 0.29999999999999999 110.019 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.96 142.53 51.77 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 O-C-N 123.598 1.315 . . . . 0.40000000000000002 110.985 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 98.09 147.76 22.74 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.724 -1.35 . . . . 0.35999999999999999 109.724 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -94.48 139.9 30.53 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.573 -0.957 . . . . 0.66000000000000003 109.949 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.67 ' HB2' HG11 ' A' ' 35' ' ' VAL . 76.5 m-85 -131.81 164.41 26.09 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.444 -0.785 . . . . 0.45000000000000001 110.67 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.431 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 0.5 OUTLIER -142.79 158.14 60.16 Favored Pre-proline 0 N--CA 1.498 1.935 0 O-C-N 121.424 -0.798 . . . . 0.55000000000000004 111.713 -179.314 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.688 ' HG3' HG21 ' A' ' 31' ' ' VAL . 55.2 Cg_endo -96.69 120.58 0.19 Allowed 'Trans proline' 0 C--N 1.317 -1.119 0 C-N-CA 122.382 2.055 . . . . 0.51000000000000001 110.258 179.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.522 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 27.6 m -81.41 99.48 8.74 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.021 -1.049 . . . . 0.32000000000000001 109.397 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.666 HG23 HG12 ' A' ' 58' ' ' VAL . 10.8 p -75.89 144.35 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.419 -0.801 . . . . 0.34000000000000002 111.469 -178.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.41 147.28 42.56 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.834 -0.541 . . . . 0.55000000000000004 109.665 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.66 97.73 0.73 Allowed 'Trans proline' 0 C--N 1.314 -1.265 0 O-C-N 123.767 1.404 . . . . 0.54000000000000004 110.307 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.1 t -86.33 -50.04 7.22 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.561 -0.712 . . . . 0.95999999999999996 110.998 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.41 -52.15 1.62 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.134 -0.979 . . . . 1.23 111.204 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 10.2 tttt -150.35 179.56 8.03 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.304 -0.872 . . . . 2.7999999999999998 110.306 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.78 -27.94 73.48 Favored Glycine 0 N--CA 1.497 2.716 0 N-CA-C 109.355 -1.498 . . . . 0.48999999999999999 109.355 179.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -74.43 -31.74 62.4 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.505 -0.997 . . . . 0.78000000000000003 110.547 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -111.27 123.83 51.01 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.35 -0.844 . . . . 0.90000000000000002 109.797 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -130.35 142.26 50.54 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.281 -0.887 . . . . 0.64000000000000001 111.311 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.541 ' HA ' ' HA ' ' A' ' 20' ' ' MET . 16.0 m -110.51 117.23 32.99 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.705 -0.85 . . . . 0.35999999999999999 108.705 179.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.666 HG12 HG23 ' A' ' 47' ' ' VAL . 2.8 m -110.09 150.78 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.187 -0.946 . . . . 0.26000000000000001 111.829 -178.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.484 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 0.3 OUTLIER -104.41 104.6 14.5 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.396 -0.965 . . . . 1.0 108.396 178.476 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.807 HD12 HG22 ' A' ' 31' ' ' VAL . 14.5 tt -93.1 130.73 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.305 -0.872 . . . . 0.28000000000000003 111.849 -178.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.523 ' O ' ' HB3' ' A' ' 43' ' ' TYR . 37.7 m -96.44 133.91 40.27 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.633 -0.877 . . . . 0.33000000000000002 108.633 178.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.511 HG23 HG23 ' A' ' 35' ' ' VAL . 32.3 mt -144.14 139.39 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 120.939 -1.1 . . . . 0.26000000000000001 111.137 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -112.63 57.21 0.66 Allowed 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.877 0.846 . . . . 0.35999999999999999 109.161 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.642 ' HB1' ' HB3' ' A' ' 69' ' ' GLN . . . -67.21 130.74 44.06 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.965 -1.085 . . . . 0.25 110.22 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 32.8 p -70.08 -7.57 42.4 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.868 -0.52 . . . . 0.29999999999999999 111.053 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.743 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 13.1 t-80 -129.75 157.89 40.92 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.198 -0.939 . . . . 0.38 110.104 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.492 ' O ' HG12 ' A' ' 70' ' ' VAL . 16.0 mm -69.7 -51.4 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.413 -0.805 . . . . 0.55000000000000004 110.504 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.42 ' HB2' ' CE1' ' A' ' 66' ' ' HIS . 1.7 mt-10 -71.58 -14.69 62.16 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.472 -0.768 . . . . 1.1499999999999999 111.647 -179.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.743 ' HB2' ' HB3' ' A' ' 66' ' ' HIS . 39.4 tt0 -62.09 -46.0 91.02 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.013 -1.055 . . . . 0.42999999999999999 110.306 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.492 HG12 ' O ' ' A' ' 67' ' ' ILE . 5.8 p -60.73 -27.22 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 121.158 -0.964 . . . . 0.33000000000000002 110.609 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -67.82 -50.24 57.86 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.298 -0.876 . . . . 0.83999999999999997 109.856 179.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.9 p -63.5 -37.33 86.9 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.512 -0.742 . . . . 0.37 109.597 179.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.743 HD11 ' CG ' ' A' ' 38' ' ' HIS . 5.5 mp -60.03 -39.96 87.69 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.538 -0.726 . . . . 0.52000000000000002 109.561 178.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.627 ' CD1' ' HB ' ' A' ' 86' ' ' VAL . 0.6 OUTLIER -63.03 -45.79 90.61 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.531 -0.73 . . . . 0.45000000000000001 109.084 178.654 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -60.7 -37.67 82.43 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.56 -0.713 . . . . 0.67000000000000004 109.943 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.849 ' CB ' HG21 ' A' ' 34' ' ' VAL . 0.3 OUTLIER -63.26 -41.38 99.03 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.516 -0.74 . . . . 0.56999999999999995 110.566 179.801 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 1.062 HD11 HG11 ' A' ' 19' ' ' VAL . 0.3 OUTLIER -84.47 -28.59 26.68 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.382 -0.824 . . . . 0.32000000000000001 110.557 179.818 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.536 ' N ' ' HG ' ' A' ' 77' ' ' LEU . . . -107.08 58.98 0.4 Allowed Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.806 -1.317 . . . . 0.26000000000000001 109.806 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.12 4.17 26.56 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.606 -0.938 . . . . 0.46000000000000002 110.389 178.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.448 HG22 ' H ' ' A' ' 82' ' ' ILE . 2.2 mp -63.4 152.65 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.383 -0.823 . . . . 0.47999999999999998 110.125 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -69.74 -11.87 61.19 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.333 -0.854 . . . . 0.79000000000000004 111.063 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.52 HG22 ' H ' ' A' ' 83' ' ' VAL . 22.3 mm -82.94 175.23 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.134 -0.979 . . . . 0.46999999999999997 109.903 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.52 ' H ' HG22 ' A' ' 82' ' ' ILE . 76.0 t -63.16 112.04 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.373 -0.829 . . . . 0.51000000000000001 111.395 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.96 136.76 54.94 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 109.109 -0.7 . . . . 1.02 109.109 178.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.46 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 2.6 ttt -151.3 161.57 42.46 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.12 -0.987 . . . . 2.3599999999999999 110.724 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.627 ' HB ' ' CD1' ' A' ' 74' ' ' TYR . 8.1 p -141.71 153.04 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.431 -0.793 . . . . 0.29999999999999999 110.565 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.546 ' HB3' ' HB2' ' A' ' 18' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.496 1.835 0 CA-C-O 117.944 -1.027 . . . . 0.32000000000000001 109.705 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.805 0 CA-C-O 121.022 0.439 . . . . 1.8 110.28 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.419 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -137.04 -57.38 0.72 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.422 -0.799 . . . . 1.3500000000000001 110.125 179.729 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 28.5 p -84.87 -175.11 5.63 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.533 -0.729 . . . . 1.0700000000000001 110.276 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.16 71.48 0.56 Allowed 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.526 0.679 . . . . 2.4199999999999999 110.21 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.07 82.68 1.85 Allowed 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.5 0.667 . . . . 1.3999999999999999 109.408 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -97.45 -24.52 15.56 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.492 -0.755 . . . . 2.1499999999999999 110.461 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.487 ' HG2' ' CG ' ' A' ' 66' ' ' HIS . 0.0 OUTLIER 64.59 99.63 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.68 -0.637 . . . . 0.76000000000000001 110.413 -179.906 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -124.37 22.43 8.49 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.456 -0.778 . . . . 1.46 110.463 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.462 ' O ' ' HB2' ' A' ' 10' ' ' GLU . 3.7 mp -123.52 -48.49 1.93 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.445 -0.784 . . . . 0.69999999999999996 109.939 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 9' ' ' LEU . 3.7 mp0 61.14 31.82 19.63 Favored 'General case' 0 N--CA 1.5 2.037 0 CA-C-O 121.112 0.482 . . . . 0.66000000000000003 110.698 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.481 ' O ' ' HA ' ' A' ' 65' ' ' THR . 29.8 m-85 -111.63 109.07 55.93 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.42 -0.8 . . . . 1.1499999999999999 109.395 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.506 ' HB3' HG22 ' A' ' 65' ' ' THR . 44.0 Cg_endo -70.37 110.26 2.63 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 O-C-N 124.019 1.536 . . . . 0.45000000000000001 110.684 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.1 t -132.29 146.29 60.95 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.663 -0.648 . . . . 0.33000000000000002 110.306 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.31 125.68 11.57 Favored 'Trans proline' 0 C--N 1.313 -1.301 0 O-C-N 123.925 1.487 . . . . 0.40000000000000002 110.483 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.577 ' HB2' HG23 ' A' ' 62' ' ' ILE . 29.5 m-85 -105.91 99.31 8.91 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.535 -0.728 . . . . 0.33000000000000002 110.355 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.1 m -76.93 92.72 3.69 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.072 -1.084 . . . . 0.42999999999999999 108.072 178.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.478 ' O ' HG22 ' A' ' 60' ' ' ILE . 3.0 m-85 -99.86 107.33 19.32 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.434 -0.792 . . . . 0.29999999999999999 110.723 -178.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 0.1 OUTLIER -82.07 88.79 6.41 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.524 -0.735 . . . . 0.34000000000000002 109.292 179.547 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 1.034 HG11 HD11 ' A' ' 77' ' ' LEU . 21.3 t -79.95 95.02 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.537 -0.727 . . . . 0.28999999999999998 109.617 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.8 ttt -107.96 125.91 52.07 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.573 -0.704 . . . . 1.1100000000000001 110.431 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.486 ' HA3' ' HD3' ' A' ' 84' ' ' ARG . . . -153.82 -160.24 9.64 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.28 -1.528 . . . . 0.26000000000000001 109.28 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.433 ' HB2' HG23 ' A' ' 82' ' ' ILE . 0.0 OUTLIER -67.02 168.06 10.69 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.38 -1.07 . . . . 1.04 110.253 179.73 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.413 ' O ' HD22 ' A' ' 24' ' ' LEU . . . -63.76 103.62 0.58 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.408 -0.808 . . . . 0.35999999999999999 110.417 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.761 HD13 ' HD2' ' A' ' 25' ' ' PRO . 0.5 OUTLIER -125.1 123.03 25.39 Favored Pre-proline 0 N--CA 1.496 1.835 0 O-C-N 121.469 -0.769 . . . . 0.41999999999999998 110.32 -179.706 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.761 ' HD2' HD13 ' A' ' 24' ' ' LEU . 46.3 Cg_endo -73.04 -22.41 19.51 Favored 'Trans proline' 0 N--CA 1.489 1.227 0 O-C-N 123.892 1.47 . . . . 0.48999999999999999 111.163 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.606 ' HG2' HD12 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -78.49 -0.67 30.36 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.307 -0.87 . . . . 0.56000000000000005 111.524 -179.985 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.571 HD11 ' NH1' ' A' ' 84' ' ' ARG . 9.3 mt -53.64 -58.44 7.19 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.19 -0.944 . . . . 0.34999999999999998 110.871 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.441 ' HA ' ' HG3' ' A' ' 45' ' ' PRO . 8.9 p -64.9 -30.35 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.429 -0.794 . . . . 0.34999999999999998 111.177 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.4 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 13.6 m-20 -67.08 -56.44 10.03 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.317 -0.865 . . . . 0.46999999999999997 110.649 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.669 ' O ' HG12 ' A' ' 34' ' ' VAL . 0.7 OUTLIER -68.98 -38.02 79.09 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.327 -0.858 . . . . 1.03 110.846 -179.898 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.611 HG22 HD22 ' A' ' 77' ' ' LEU . 3.2 t -57.63 -54.52 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.398 -0.814 . . . . 0.27000000000000002 110.596 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.3 p -66.09 -34.16 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.329 -0.857 . . . . 0.35999999999999999 111.284 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' A' ' 29' ' ' ASP . 0.3 OUTLIER -73.88 -52.77 11.9 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.094 -1.004 . . . . 1.26 111.06 -179.681 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.832 HG21 ' CB ' ' A' ' 76' ' ' GLU . 8.0 p -68.26 -27.26 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.3 -0.875 . . . . 0.35999999999999999 111.34 -179.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.805 HG23 HD12 ' A' ' 62' ' ' ILE . 2.9 p -79.92 -34.14 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.01 -1.056 . . . . 0.35999999999999999 110.703 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -80.92 -23.71 38.7 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.058 -1.027 . . . . 1.1699999999999999 110.585 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 31.7 mtm180 -76.59 -43.8 37.1 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.318 -0.864 . . . . 1.3500000000000001 110.793 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.598 ' CB ' HD11 ' A' ' 73' ' ' LEU . 90.1 m-70 -93.19 -45.65 7.77 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.365 -0.834 . . . . 1.49 110.843 -179.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.562 ' HB3' ' O ' ' A' ' 35' ' ' VAL . . . -91.92 148.84 37.83 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 121.337 -0.852 . . . . 0.55000000000000004 110.072 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.02 140.28 34.39 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 O-C-N 123.884 1.465 . . . . 0.75 110.572 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.96 154.45 9.41 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.729 -1.348 . . . . 0.48999999999999999 109.729 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.94 143.56 26.68 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.399 -1.06 . . . . 0.66000000000000003 110.002 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.52 ' HB2' HG11 ' A' ' 35' ' ' VAL . 51.0 m-85 -127.65 172.73 10.51 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.516 -0.74 . . . . 0.45000000000000001 110.517 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.804 HG22 ' HD2' ' A' ' 45' ' ' PRO . 1.0 OUTLIER -142.23 154.38 64.24 Favored Pre-proline 0 N--CA 1.497 1.9 0 O-C-N 121.43 -0.794 . . . . 0.60999999999999999 110.82 -179.433 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.804 ' HD2' HG22 ' A' ' 44' ' ' THR . 53.4 Cg_endo -93.91 164.39 2.16 Favored 'Trans proline' 0 C--N 1.317 -1.11 0 C-N-CA 121.69 1.593 . . . . 0.46999999999999997 110.354 179.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.476 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 22.7 m -120.28 95.98 4.96 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.688 -0.856 . . . . 0.34000000000000002 108.688 178.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.401 HG23 HG23 ' A' ' 58' ' ' VAL . 9.9 p -75.78 143.8 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.538 -0.726 . . . . 0.35999999999999999 111.239 -178.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.438 ' HB2' ' HB3' ' A' ' 57' ' ' SER . 0.8 OUTLIER -135.76 106.19 9.82 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.722 -0.612 . . . . 0.44 110.102 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -76.7 -18.81 14.93 Favored 'Trans proline' 0 C--N 1.315 -1.235 0 O-C-N 124.115 1.587 . . . . 0.56000000000000005 110.916 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 88.1 p -60.66 -24.39 65.55 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.403 -0.81 . . . . 0.68000000000000005 111.129 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 28.9 m -63.25 -56.11 19.28 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.292 -0.88 . . . . 0.77000000000000002 110.322 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.403 ' HB3' ' HB2' ' A' ' 55' ' ' TYR . 0.0 OUTLIER -152.49 166.26 32.53 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.475 -0.765 . . . . 1.9399999999999999 110.578 -179.929 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.52 -51.66 5.91 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.737 -1.345 . . . . 0.68000000000000005 109.737 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -93.57 14.32 19.24 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.445 -1.032 . . . . 0.78000000000000003 111.068 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.403 ' HB2' ' HB3' ' A' ' 52' ' ' LYS . 0.2 OUTLIER -132.26 129.75 40.01 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.209 -0.932 . . . . 0.52000000000000002 109.96 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -111.1 129.83 55.8 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.54 -0.725 . . . . 0.63 110.483 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.438 ' HB3' ' HB2' ' A' ' 48' ' ' LYS . 0.4 OUTLIER -97.56 99.31 10.7 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.522 -0.736 . . . . 0.33000000000000002 109.451 179.341 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.631 HG13 ' HB2' ' A' ' 45' ' ' PRO . 1.0 OUTLIER -103.81 120.93 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.394 -0.816 . . . . 0.28000000000000003 110.746 -179.216 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.493 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 11.6 t -100.92 114.49 28.41 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.452 -0.78 . . . . 0.40999999999999998 109.114 178.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.553 ' CD1' HG13 ' A' ' 31' ' ' VAL . 11.2 tt -93.47 132.7 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.268 -0.895 . . . . 0.32000000000000001 111.344 -178.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.466 ' O ' ' HB3' ' A' ' 43' ' ' TYR . 22.7 m -99.03 135.52 40.31 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.808 -0.812 . . . . 0.40999999999999998 108.808 178.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.805 HD12 HG23 ' A' ' 35' ' ' VAL . 3.1 tt -162.37 131.75 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.128 -0.983 . . . . 0.44 111.003 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -105.28 101.19 10.75 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.407 -0.808 . . . . 0.57999999999999996 109.359 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -115.72 146.56 41.78 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.427 -0.795 . . . . 0.29999999999999999 110.64 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.506 HG22 ' HB3' ' A' ' 12' ' ' PRO . 47.3 p -79.35 -2.87 43.58 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.661 -0.649 . . . . 0.44 111.136 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.541 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 8.6 t-160 -129.81 147.4 51.58 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.189 -0.944 . . . . 0.64000000000000001 110.746 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.509 ' O ' HG12 ' A' ' 70' ' ' VAL . 0.8 OUTLIER -78.95 -41.42 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.638 -0.664 . . . . 0.76000000000000001 109.843 179.292 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -65.47 -32.5 74.14 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.472 -0.767 . . . . 0.52000000000000002 110.661 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.541 ' HB2' ' HB3' ' A' ' 66' ' ' HIS . 0.6 OUTLIER -59.91 -55.81 29.53 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.361 -0.837 . . . . 0.57999999999999996 110.531 -179.936 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.573 HG21 ' HB3' ' A' ' 15' ' ' PHE . 13.3 p -61.16 -29.89 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.351 -0.843 . . . . 0.27000000000000002 110.452 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -67.69 -43.85 79.13 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.229 -0.919 . . . . 0.46999999999999997 109.365 178.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.419 ' HA ' ' HG2' ' A' ' 2' ' ' LYS . 54.7 m -60.52 -38.63 85.02 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.604 -0.685 . . . . 0.34999999999999998 109.168 178.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.711 ' HG ' HG22 ' A' ' 34' ' ' VAL . 7.7 mp -63.71 -38.39 90.92 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.68 -0.638 . . . . 0.40999999999999998 109.777 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.618 ' CD1' ' HB ' ' A' ' 86' ' ' VAL . 0.2 OUTLIER -59.3 -47.92 83.56 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 108.973 -0.751 . . . . 0.64000000000000001 108.973 178.693 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.14 -31.29 72.41 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.606 -0.684 . . . . 0.55000000000000004 110.214 179.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.832 ' CB ' HG21 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -66.14 -51.38 58.4 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.442 -0.787 . . . . 0.66000000000000003 110.236 179.501 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 1.034 HD11 HG11 ' A' ' 19' ' ' VAL . 0.4 OUTLIER -76.43 -25.41 54.4 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.431 -0.793 . . . . 0.28000000000000003 110.536 179.685 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.651 ' HA2' ' HG2' ' A' ' 84' ' ' ARG . . . -101.11 39.23 2.81 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 110.051 -1.22 . . . . 0.27000000000000002 110.051 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.62 4.23 45.64 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.521 -0.988 . . . . 1.97 110.635 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.7 mp -60.14 153.03 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.303 -0.873 . . . . 0.37 110.064 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.5 -27.79 67.87 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.479 -0.763 . . . . 1.3 109.932 179.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.512 HG21 HD23 ' A' ' 24' ' ' LEU . 0.9 OUTLIER -68.26 171.99 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.526 -0.734 . . . . 0.51000000000000001 110.179 179.36 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.418 ' N ' HG23 ' A' ' 82' ' ' ILE . 97.5 t -81.5 110.8 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.294 -0.879 . . . . 0.60999999999999999 110.639 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.764 ' HD2' HG12 ' A' ' 19' ' ' VAL . 8.3 tpp180 -121.59 131.85 54.35 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.689 -0.632 . . . . 0.44 109.802 179.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.514 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 6.0 mtm -129.82 171.41 12.73 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.382 -0.823 . . . . 1.3100000000000001 110.516 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.692 HG23 HG22 ' A' ' 19' ' ' VAL . 8.8 p -138.62 156.03 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.548 -0.72 . . . . 0.28999999999999998 110.619 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.432 ' HA ' HD22 ' A' ' 87' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.5 2.029 0 CA-C-O 118.81 -0.614 . . . . 0.54000000000000004 110.398 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.496 1.851 0 CA-C-O 121.014 0.435 . . . . 2.4300000000000002 110.299 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.427 ' HE2' ' HA ' ' A' ' 7' ' ' GLU . 0.1 OUTLIER -67.49 144.09 55.86 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.544 -0.723 . . . . 0.92000000000000004 110.546 -179.836 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.7 m 53.11 42.48 32.19 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-O 121.072 0.463 . . . . 0.55000000000000004 111.13 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 14.2 tttt -168.24 -67.34 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.114 -0.991 . . . . 0.97999999999999998 110.065 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.419 HD11 ' HA ' ' A' ' 38' ' ' HIS . 0.2 OUTLIER -106.57 -46.68 3.94 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.232 -0.918 . . . . 0.95999999999999996 109.949 179.338 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -120.62 112.56 19.05 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.516 -0.74 . . . . 1.78 109.816 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.427 ' HA ' ' HE2' ' A' ' 2' ' ' LYS . 0.8 OUTLIER -144.18 -164.48 1.91 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.38 -0.825 . . . . 0.89000000000000001 110.76 -179.617 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.411 ' HA ' HD13 ' A' ' 8' ' ' LEU . 0.8 OUTLIER -77.73 -32.3 52.73 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.294 -0.879 . . . . 1.05 110.864 -179.531 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.5 mp -74.12 -58.45 3.29 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.356 -0.84 . . . . 0.93000000000000005 109.987 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 56.87 37.47 28.82 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.77 -0.581 . . . . 0.91000000000000003 111.153 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.444 ' O ' ' HA ' ' A' ' 65' ' ' THR . 87.4 t80 -105.44 109.25 62.99 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.298 -0.876 . . . . 0.73999999999999999 109.687 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.615 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 45.6 Cg_endo -70.64 108.63 2.29 Favored 'Trans proline' 0 C--N 1.314 -1.265 0 O-C-N 123.861 1.453 . . . . 0.37 110.798 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.2 t -110.35 144.06 29.36 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.494 -0.754 . . . . 0.37 110.244 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.43 117.82 5.35 Favored 'Trans proline' 0 C--N 1.315 -1.212 0 O-C-N 123.893 1.47 . . . . 0.39000000000000001 110.811 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.665 ' HB2' ' HB ' ' A' ' 62' ' ' ILE . 16.7 m-85 -103.29 99.67 9.53 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.589 -0.694 . . . . 0.29999999999999999 110.429 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.9 m -75.56 92.94 2.95 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.504 -0.925 . . . . 0.34000000000000002 108.504 178.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.532 ' HD2' HG21 ' A' ' 86' ' ' VAL . 3.4 m-85 -102.72 108.0 19.1 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.343 -0.848 . . . . 0.32000000000000001 110.9 -178.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.551 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 0.0 OUTLIER -78.3 89.72 4.34 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.532 -0.73 . . . . 0.78000000000000003 109.296 179.404 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 1.054 HG11 HD11 ' A' ' 77' ' ' LEU . 24.8 t -78.57 96.5 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.487 -0.758 . . . . 0.29999999999999999 109.906 -179.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.582 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 1.0 OUTLIER -97.21 149.71 21.72 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.541 -0.724 . . . . 1.1799999999999999 110.124 -179.772 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 170.21 -151.44 16.61 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.848 -1.301 . . . . 0.34000000000000002 109.848 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -79.38 151.45 30.95 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.545 -0.973 . . . . 0.73999999999999999 110.327 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.21 96.99 4.02 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.604 -0.685 . . . . 0.32000000000000001 110.199 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.408 HD13 HG21 ' A' ' 82' ' ' ILE . 0.1 OUTLIER -127.4 155.53 76.45 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.469 -0.769 . . . . 0.69999999999999996 110.45 -179.823 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.56 -22.96 20.46 Favored 'Trans proline' 0 C--N 1.314 -1.263 0 O-C-N 123.927 1.488 . . . . 0.53000000000000003 110.803 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -70.32 -18.09 63.08 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.337 -0.852 . . . . 0.57999999999999996 111.035 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.472 ' HA ' HD13 ' A' ' 27' ' ' LEU . 1.7 mm? -57.87 -66.28 0.5 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.305 -0.872 . . . . 0.46000000000000002 110.414 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.5 p -62.99 -29.5 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.449 -0.782 . . . . 0.39000000000000001 110.965 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -64.59 -57.66 8.5 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.338 -0.851 . . . . 0.46000000000000002 110.324 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.641 ' O ' HG12 ' A' ' 34' ' ' VAL . 4.9 tp60 -69.33 -30.32 68.33 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.353 -0.842 . . . . 0.91000000000000003 110.821 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.987 HG22 HD12 ' A' ' 60' ' ' ILE . 2.3 t -59.79 -54.52 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.248 -0.907 . . . . 0.23999999999999999 110.242 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.418 ' O ' ' HG2' ' A' ' 36' ' ' GLN . 9.5 p -70.77 -32.74 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.339 -0.85 . . . . 0.32000000000000001 111.15 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.406 ' HA ' ' HG2' ' A' ' 36' ' ' GLN . 0.8 OUTLIER -73.58 -51.42 16.96 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.204 -0.935 . . . . 0.62 110.756 -179.885 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.695 HG21 ' HB2' ' A' ' 76' ' ' GLU . 4.0 p -66.71 -29.22 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.467 -0.771 . . . . 0.27000000000000002 111.213 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.506 ' CG2' HD13 ' A' ' 62' ' ' ILE . 4.7 p -80.09 -31.93 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.035 -1.041 . . . . 0.28000000000000003 110.711 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.492 ' HG3' ' N ' ' A' ' 37' ' ' ARG . 1.6 pt20 -82.42 -21.91 35.54 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.055 -1.028 . . . . 1.1699999999999999 110.685 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.492 ' N ' ' HG3' ' A' ' 36' ' ' GLN . 26.9 mtm180 -79.24 -41.84 27.29 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.278 -0.889 . . . . 0.72999999999999998 110.704 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.658 ' HB2' HD11 ' A' ' 73' ' ' LEU . 93.7 m-70 -95.9 -43.62 7.75 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.391 -0.818 . . . . 0.45000000000000001 110.683 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.496 ' HB3' ' O ' ' A' ' 35' ' ' VAL . . . -98.01 150.64 36.96 Favored Pre-proline 0 N--CA 1.497 1.894 0 O-C-N 121.324 -0.86 . . . . 0.27000000000000002 109.924 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.36 140.09 29.88 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.678 1.357 . . . . 0.29999999999999999 110.673 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.63 154.02 14.18 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 110.045 -1.222 . . . . 0.40000000000000002 110.045 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -95.07 148.32 22.48 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.466 -1.02 . . . . 0.45000000000000001 109.914 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.449 ' HB2' HG11 ' A' ' 35' ' ' VAL . 67.7 m-85 -135.1 175.9 9.16 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.467 -0.771 . . . . 0.5 110.723 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.613 HG22 ' HD2' ' A' ' 45' ' ' PRO . 0.2 OUTLIER -142.7 158.06 60.61 Favored Pre-proline 0 N--CA 1.498 1.95 0 O-C-N 121.398 -0.814 . . . . 0.62 111.239 -178.973 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.613 ' HD2' HG22 ' A' ' 44' ' ' THR . 54.4 Cg_endo -96.24 118.26 0.18 Allowed 'Trans proline' 0 C--N 1.318 -1.029 0 C-N-CA 122.121 1.881 . . . . 0.28000000000000003 110.431 179.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.511 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 31.9 m -76.24 104.71 6.9 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.086 -1.009 . . . . 0.38 109.283 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.548 HG23 HG12 ' A' ' 58' ' ' VAL . 14.3 p -76.2 142.58 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.411 -0.806 . . . . 0.35999999999999999 111.656 -178.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.408 ' HD2' HG22 ' A' ' 46' ' ' THR . 0.0 OUTLIER -142.91 135.96 13.88 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.755 -0.591 . . . . 0.80000000000000004 109.787 179.784 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.78 101.48 1.31 Allowed 'Trans proline' 0 C--N 1.316 -1.177 0 O-C-N 123.763 1.402 . . . . 0.54000000000000004 110.071 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -87.58 -51.03 6.13 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.405 -0.81 . . . . 0.98999999999999999 110.931 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.8 m -119.73 -57.44 1.97 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.339 -0.851 . . . . 0.93000000000000005 110.801 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.79 -179.43 6.79 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.355 -0.841 . . . . 1.6799999999999999 110.388 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.53 -32.45 71.35 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.542 -1.423 . . . . 0.39000000000000001 109.542 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -63.81 -34.99 79.16 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.631 -0.923 . . . . 1.28 110.781 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -109.01 119.3 39.14 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.222 -0.924 . . . . 0.69999999999999996 109.845 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 2.6 m170 -117.27 135.69 53.64 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.428 -0.795 . . . . 0.78000000000000003 110.904 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.582 ' HA ' ' HA ' ' A' ' 20' ' ' MET . 26.8 m -108.64 102.54 11.59 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 109.139 -0.689 . . . . 0.40999999999999998 109.139 179.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.548 HG12 HG23 ' A' ' 47' ' ' VAL . 3.1 m -103.65 146.79 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.306 -0.871 . . . . 0.31 110.834 -179.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.551 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 7.3 t -108.98 114.15 27.66 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.852 -0.796 . . . . 0.46999999999999997 108.852 179.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.987 HD12 HG22 ' A' ' 31' ' ' VAL . 8.8 tt -93.08 132.77 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.269 -0.894 . . . . 0.29999999999999999 111.763 -178.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 56.2 m -86.7 117.4 25.43 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.565 -0.902 . . . . 0.34999999999999998 108.565 178.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.682 HG21 HG23 ' A' ' 70' ' ' VAL . 38.3 mm -114.29 132.93 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.068 -1.02 . . . . 0.40000000000000002 111.048 -178.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.418 ' HB2' ' CZ ' ' A' ' 43' ' ' TYR . 3.6 t30 -108.18 62.1 0.61 Allowed 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.521 0.677 . . . . 0.39000000000000001 109.216 178.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.852 ' HB1' ' HB3' ' A' ' 69' ' ' GLN . . . -91.67 133.83 35.24 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.306 -0.871 . . . . 0.25 110.686 -179.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.615 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 31.8 p -70.67 -17.83 62.84 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.608 -0.682 . . . . 0.40000000000000002 110.691 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -129.84 159.88 35.22 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.332 -0.855 . . . . 0.48999999999999999 110.127 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.2 tt -74.62 -17.01 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.378 -0.826 . . . . 0.80000000000000004 110.783 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.9 -30.22 40.04 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.188 -0.945 . . . . 0.83999999999999997 110.25 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.852 ' HB3' ' HB1' ' A' ' 64' ' ' ALA . 0.4 OUTLIER -65.64 -47.97 73.77 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.395 -0.815 . . . . 0.48999999999999999 110.271 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.682 HG23 HG21 ' A' ' 62' ' ' ILE . 13.7 p -67.44 -28.82 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.367 -0.833 . . . . 0.28999999999999998 110.294 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.16 -52.94 56.57 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.354 -0.841 . . . . 0.83999999999999997 109.536 179.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.5 p -63.23 -35.66 81.05 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.503 -0.748 . . . . 0.34999999999999998 109.487 179.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.658 HD11 ' HB2' ' A' ' 38' ' ' HIS . 3.6 mp -60.9 -39.58 89.84 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.634 -0.666 . . . . 0.34999999999999998 109.557 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.59 ' CD1' ' HB ' ' A' ' 86' ' ' VAL . 0.3 OUTLIER -63.91 -48.69 75.6 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 109.143 -0.688 . . . . 0.59999999999999998 109.143 178.761 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.76 -36.71 83.95 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.549 -0.719 . . . . 0.68000000000000005 110.2 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.695 ' HB2' HG21 ' A' ' 34' ' ' VAL . 23.5 mt-10 -65.04 -47.38 77.6 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.586 -0.696 . . . . 0.33000000000000002 110.459 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 1.054 HD11 HG11 ' A' ' 19' ' ' VAL . 0.3 OUTLIER -76.84 -29.11 55.76 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.246 -0.909 . . . . 0.32000000000000001 110.433 179.718 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.477 ' N ' ' HG ' ' A' ' 77' ' ' LEU . . . -102.36 48.19 1.08 Allowed Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.503 -1.439 . . . . 0.25 109.503 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.9 ttmt -106.46 4.0 27.85 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.47 -1.017 . . . . 1.6599999999999999 110.808 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.0 mp -69.57 153.13 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.218 -0.926 . . . . 0.35999999999999999 110.105 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.12 -26.45 68.31 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.399 -0.813 . . . . 1.3799999999999999 110.239 179.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.453 HG23 ' N ' ' A' ' 83' ' ' VAL . 1.0 OUTLIER -64.13 174.72 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.606 -0.684 . . . . 0.46000000000000002 110.583 179.671 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.453 ' N ' HG23 ' A' ' 82' ' ' ILE . 75.4 t -63.71 117.49 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.392 -0.818 . . . . 0.38 110.546 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.94 132.81 54.74 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.728 -0.607 . . . . 0.77000000000000002 110.049 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.526 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -154.22 160.54 41.89 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.215 -0.928 . . . . 1.7 110.318 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.641 HG23 HG22 ' A' ' 19' ' ' VAL . 8.2 p -141.48 157.23 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.406 -0.809 . . . . 0.26000000000000001 110.763 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.49 HD11 ' CZ ' ' A' ' 17' ' ' TYR . 77.4 mt . . . . . 0 N--CA 1.501 2.08 0 CA-C-O 117.674 -1.155 . . . . 0.47999999999999998 110.554 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.0 ttt . . . . . 0 N--CA 1.493 1.718 0 CA-C-O 121.249 0.547 . . . . 1.75 110.525 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.7 ptmt -134.64 169.79 16.79 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.517 -0.739 . . . . 1.46 110.35 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.8 t -65.85 150.98 47.72 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.427 -0.796 . . . . 0.69999999999999996 110.422 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.22 -48.28 0.92 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.387 -0.821 . . . . 0.83999999999999997 110.689 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.82 171.17 16.71 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.373 -0.829 . . . . 1.1899999999999999 110.463 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -118.47 -48.54 2.5 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.533 -0.729 . . . . 1.54 110.408 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -158.06 144.22 17.34 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.376 -0.827 . . . . 0.71999999999999997 110.712 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -159.22 -60.23 0.07 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.557 -0.714 . . . . 1.0600000000000001 110.475 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.602 HD12 ' HB3' ' A' ' 11' ' ' PHE . 0.6 OUTLIER -77.77 -24.89 48.83 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.435 -0.791 . . . . 0.68999999999999995 110.856 179.867 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 56.07 45.67 23.13 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.536 -0.728 . . . . 0.80000000000000004 111.638 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.602 ' HB3' HD12 ' A' ' 9' ' ' LEU . 53.9 t80 -117.53 109.5 41.81 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.38 -0.825 . . . . 0.66000000000000003 109.095 178.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.578 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 44.5 Cg_endo -70.14 112.29 3.11 Favored 'Trans proline' 0 C--N 1.313 -1.303 0 O-C-N 123.897 1.472 . . . . 0.48999999999999999 110.741 -179.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.7 t -132.89 145.28 56.41 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 121.731 -0.606 . . . . 0.40000000000000002 110.227 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.94 122.56 8.92 Favored 'Trans proline' 0 C--N 1.315 -1.197 0 O-C-N 123.83 1.437 . . . . 0.40000000000000002 110.883 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.491 ' HB2' HG23 ' A' ' 62' ' ' ILE . 20.3 m-85 -106.38 99.78 9.34 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.652 -0.655 . . . . 0.34000000000000002 110.281 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.1 p -73.64 99.22 3.03 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.248 -1.019 . . . . 0.33000000000000002 108.248 178.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -113.91 159.54 19.77 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.384 -0.822 . . . . 0.33000000000000002 111.031 -178.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.703 ' HD2' HD22 ' A' ' 87' ' ' LEU . 0.7 OUTLIER -137.35 102.46 4.8 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.822 -0.807 . . . . 0.66000000000000003 108.822 179.204 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 1.005 HG11 HD11 ' A' ' 77' ' ' LEU . 15.6 t -81.14 99.74 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 CA-C-O 121.463 0.649 . . . . 0.26000000000000001 110.193 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.413 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 35.7 mtt -94.77 155.01 17.01 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.479 -0.763 . . . . 1.2 109.961 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 157.5 -150.12 20.98 Favored Glycine 0 N--CA 1.497 2.722 0 N-CA-C 110.194 -1.163 . . . . 0.34000000000000002 110.194 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.422 ' O ' HD23 ' A' ' 24' ' ' LEU . 1.1 tm0? -76.93 160.81 28.89 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.51 -0.994 . . . . 0.73999999999999999 110.642 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -86.43 92.28 8.79 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.628 -0.67 . . . . 0.46999999999999997 110.053 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.422 HD23 ' O ' ' A' ' 22' ' ' GLN . 0.7 OUTLIER -127.59 150.31 72.62 Favored Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 121.504 -0.748 . . . . 0.41999999999999998 110.386 179.924 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -71.86 -24.06 21.56 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 O-C-N 123.861 1.453 . . . . 0.42999999999999999 111.461 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.82 -18.31 64.8 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.216 -0.927 . . . . 0.59999999999999998 111.044 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.459 HD22 HG21 ' A' ' 58' ' ' VAL . 0.7 OUTLIER -60.8 -63.18 1.39 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.225 -0.922 . . . . 0.68999999999999995 110.365 -179.956 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.726 HG23 ' HD2' ' A' ' 45' ' ' PRO . 8.6 p -65.38 -31.58 54.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.421 -0.799 . . . . 0.34999999999999998 110.63 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -63.4 -53.71 48.16 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.339 -0.851 . . . . 0.51000000000000001 110.188 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.725 ' O ' HG12 ' A' ' 34' ' ' VAL . 1.1 tp-100 -68.55 -34.87 76.6 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.426 -0.796 . . . . 0.80000000000000004 110.658 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.768 HG22 HD22 ' A' ' 77' ' ' LEU . 2.7 t -57.28 -46.94 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.342 -0.849 . . . . 0.29999999999999999 109.997 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 77.4 t -71.17 -37.25 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.493 -0.754 . . . . 0.39000000000000001 110.681 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.43 -54.32 11.05 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.181 -0.95 . . . . 1.03 110.839 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.779 HG21 ' CB ' ' A' ' 76' ' ' GLU . 9.9 p -62.79 -33.02 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.43 -0.794 . . . . 0.34999999999999998 111.395 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.654 HG21 ' HB2' ' A' ' 43' ' ' TYR . 3.2 p -77.21 -29.61 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.032 -1.043 . . . . 0.40000000000000002 110.343 179.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -74.26 -35.19 63.77 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.235 -0.916 . . . . 1.0800000000000001 109.977 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.48 -23.87 61.1 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.493 -0.755 . . . . 1.4099999999999999 110.811 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.419 ' CD2' HD11 ' A' ' 73' ' ' LEU . 0.3 OUTLIER -101.51 -46.0 5.12 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.206 -0.934 . . . . 0.59999999999999998 110.546 -179.905 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -103.15 151.09 38.44 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.484 -0.76 . . . . 0.54000000000000004 109.841 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -69.94 -41.26 4.2 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 O-C-N 123.857 1.451 . . . . 0.75 111.115 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -85.81 145.24 20.77 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.634 -1.386 . . . . 0.51000000000000001 109.634 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.9 152.03 27.0 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.446 -1.032 . . . . 0.80000000000000004 109.962 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.654 ' HB2' HG21 ' A' ' 35' ' ' VAL . 45.2 m-85 -136.9 159.79 40.82 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.529 -0.732 . . . . 0.40999999999999998 110.573 -179.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.495 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 22.8 m -142.32 151.51 58.35 Favored Pre-proline 0 N--CA 1.499 1.984 0 O-C-N 121.445 -0.784 . . . . 0.35999999999999999 111.301 -179.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.726 ' HD2' HG23 ' A' ' 28' ' ' VAL . 54.1 Cg_endo -96.51 135.84 0.5 Allowed 'Trans proline' 0 C--N 1.32 -0.958 0 C-N-CA 122.03 1.82 . . . . 0.47999999999999998 110.508 178.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.511 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 32.1 m -95.03 108.43 20.5 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.16 -0.963 . . . . 0.40000000000000002 109.17 179.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.739 HG23 HG12 ' A' ' 58' ' ' VAL . 7.7 p -75.9 141.58 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.444 -0.785 . . . . 0.42999999999999999 111.54 -178.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.7 mtmp? -140.09 149.19 57.58 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.885 -0.509 . . . . 0.98999999999999999 109.905 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.99 100.14 1.17 Allowed 'Trans proline' 0 C--N 1.315 -1.212 0 O-C-N 123.747 1.393 . . . . 0.51000000000000001 109.825 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.4 ' HB3' ' HB3' ' A' ' 57' ' ' SER . 20.9 p -89.83 -49.12 6.81 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.552 -0.717 . . . . 0.56999999999999995 111.165 -179.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.5 m -123.94 -60.32 1.45 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.309 -0.87 . . . . 1.1299999999999999 110.563 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -144.87 179.82 7.08 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.394 -0.816 . . . . 1.73 110.563 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.16 -31.57 79.65 Favored Glycine 0 N--CA 1.496 2.653 0 N-CA-C 109.862 -1.295 . . . . 0.57999999999999996 109.862 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -71.45 -35.19 70.8 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.483 -1.01 . . . . 0.87 110.952 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -105.36 127.4 52.95 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.142 -0.974 . . . . 0.60999999999999999 110.111 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 1.2 m170 -125.06 145.26 50.0 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.281 -0.887 . . . . 1.01 111.333 -179.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.413 ' HA ' ' HA ' ' A' ' 20' ' ' MET . 14.0 t -119.22 106.09 12.0 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.54 -0.911 . . . . 0.35999999999999999 108.54 178.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.739 HG12 HG23 ' A' ' 47' ' ' VAL . 2.1 m -103.29 146.4 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.272 -0.892 . . . . 0.32000000000000001 111.176 -178.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.609 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 16.9 p -103.89 110.67 22.89 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.64 -0.874 . . . . 0.34000000000000002 108.64 178.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.621 ' HA ' ' HA ' ' A' ' 45' ' ' PRO . 13.8 tt -93.12 128.34 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 CA-C-O 121.902 0.858 . . . . 0.35999999999999999 111.459 -178.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.491 ' O ' ' HB3' ' A' ' 43' ' ' TYR . 22.5 m -97.18 126.83 42.62 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.193 -1.04 . . . . 0.39000000000000001 108.193 178.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.491 HG23 ' HB2' ' A' ' 15' ' ' PHE . 11.0 tt -153.9 141.03 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.124 -0.985 . . . . 0.63 111.466 -178.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -117.22 102.99 9.74 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.723 -0.843 . . . . 0.67000000000000004 108.723 178.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.727 ' HB1' ' HB3' ' A' ' 69' ' ' GLN . . . -109.86 141.01 43.17 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.485 -0.759 . . . . 0.34000000000000002 111.312 -178.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.578 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 13.2 p -74.29 -5.23 40.95 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.788 -0.57 . . . . 0.53000000000000003 111.269 179.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.735 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 49.5 t60 -129.73 146.54 51.49 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.969 -1.082 . . . . 0.54000000000000004 110.188 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -67.64 -30.01 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.52 -0.738 . . . . 1.04 110.749 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.05 -11.66 43.49 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.274 -0.891 . . . . 0.93000000000000005 111.068 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.735 ' HB2' ' HB3' ' A' ' 66' ' ' HIS . 8.8 tt0 -61.52 -46.54 89.54 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.22 -0.925 . . . . 0.85999999999999999 109.874 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.1 p -70.48 -28.92 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.638 -0.664 . . . . 0.37 110.01 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.99 -50.06 45.35 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.485 -0.759 . . . . 0.56000000000000005 109.604 179.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.6 p -61.81 -40.78 96.43 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.527 -0.733 . . . . 0.32000000000000001 109.51 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.452 ' HG ' HG22 ' A' ' 34' ' ' VAL . 2.8 mp -60.45 -37.59 81.44 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.682 -0.636 . . . . 0.40000000000000002 109.694 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.541 ' CD1' ' HB ' ' A' ' 86' ' ' VAL . 0.4 OUTLIER -62.97 -45.03 94.36 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.564 -0.71 . . . . 0.56999999999999995 109.179 178.662 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.46 -36.15 79.61 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.498 -0.751 . . . . 0.40000000000000002 109.988 179.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.779 ' CB ' HG21 ' A' ' 34' ' ' VAL . 0.5 OUTLIER -67.55 -49.07 65.01 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.544 -0.722 . . . . 0.47999999999999998 110.279 179.497 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 1.005 HD11 HG11 ' A' ' 19' ' ' VAL . 0.3 OUTLIER -72.62 -27.23 62.02 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.423 -0.798 . . . . 0.28999999999999998 110.533 179.622 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.466 ' N ' ' HG ' ' A' ' 77' ' ' LEU . . . -107.44 38.96 3.07 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.678 -1.369 . . . . 0.31 109.678 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.91 4.09 54.54 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.31 -1.112 . . . . 1.04 110.732 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.4 mp -72.17 155.07 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.321 -0.862 . . . . 0.52000000000000002 109.982 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -68.71 -15.78 63.62 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.41 -0.806 . . . . 0.91000000000000003 110.235 178.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.472 HG22 ' N ' ' A' ' 83' ' ' VAL . 49.7 mm -71.33 170.14 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.544 -0.723 . . . . 0.71999999999999997 109.985 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.472 ' N ' HG22 ' A' ' 82' ' ' ILE . 76.1 t -62.42 115.06 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.342 -0.849 . . . . 0.51000000000000001 110.818 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -121.19 140.74 51.61 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.857 -0.527 . . . . 0.83999999999999997 109.595 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.1 mtp -158.54 154.05 26.05 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.062 -1.024 . . . . 1.4399999999999999 110.29 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.573 HG23 HG22 ' A' ' 19' ' ' VAL . 5.9 p -142.5 157.44 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.32 -0.863 . . . . 0.32000000000000001 110.801 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.703 HD22 ' HD2' ' A' ' 18' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.497 1.899 0 CA-C-O 117.955 -1.022 . . . . 0.40000000000000002 109.878 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 ttt . . . . . 0 N--CA 1.496 1.845 0 CA-C-O 121.074 0.464 . . . . 1.72 110.368 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.558 ' HG3' ' HB ' ' A' ' 67' ' ' ILE . 0.0 OUTLIER -89.09 63.21 6.56 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.429 -0.795 . . . . 0.53000000000000003 110.271 179.962 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 10.7 p -136.58 -56.54 0.74 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.405 -0.809 . . . . 0.53000000000000003 109.89 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.33 49.0 0.83 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.594 -0.691 . . . . 1.4099999999999999 109.979 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.454 HD13 ' HA ' ' A' ' 5' ' ' LEU . 1.4 mm? -108.85 161.91 14.69 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.351 -0.843 . . . . 0.75 110.669 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -133.9 129.49 36.43 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.541 -0.725 . . . . 1.74 109.923 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 51.91 61.83 3.01 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-O 121.421 0.629 . . . . 1.99 110.679 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -146.04 -42.97 0.2 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.264 -0.898 . . . . 0.88 110.901 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.5 mp -88.58 -53.26 4.73 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.352 -0.842 . . . . 0.45000000000000001 110.589 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 56.88 32.64 21.81 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.708 -0.62 . . . . 0.72999999999999998 110.662 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.506 ' O ' ' HA ' ' A' ' 65' ' ' THR . 92.2 t80 -111.74 118.8 46.09 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.35 -0.844 . . . . 0.65000000000000002 109.762 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.617 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 43.4 Cg_endo -69.67 108.43 2.06 Favored 'Trans proline' 0 C--N 1.315 -1.208 0 O-C-N 123.854 1.449 . . . . 0.38 110.686 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.0 t -129.58 143.79 50.36 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.608 -0.682 . . . . 0.31 110.455 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -71.65 127.23 12.89 Favored 'Trans proline' 0 C--N 1.315 -1.213 0 O-C-N 123.911 1.48 . . . . 0.29999999999999999 110.389 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.629 ' HB3' HG21 ' A' ' 70' ' ' VAL . 23.1 m-85 -108.5 99.69 9.05 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.482 -0.761 . . . . 0.37 110.467 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.5 m -74.18 92.9 2.25 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.169 -1.049 . . . . 0.38 108.169 178.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.563 ' O ' HG22 ' A' ' 60' ' ' ILE . 3.0 m-85 -105.09 106.69 17.3 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.379 -0.826 . . . . 0.34999999999999998 110.897 -178.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.571 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 0.0 OUTLIER -79.27 92.49 5.14 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.533 -0.729 . . . . 1.1799999999999999 109.532 179.525 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.952 HG11 HD11 ' A' ' 77' ' ' LEU . 15.7 t -79.02 96.09 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.462 -0.774 . . . . 0.28999999999999998 109.516 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.662 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 44.4 ttp -98.05 148.71 23.24 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.601 -0.687 . . . . 0.93000000000000005 110.295 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 166.83 -152.35 21.17 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.664 -1.374 . . . . 0.26000000000000001 109.664 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.431 ' HG2' HG21 ' A' ' 82' ' ' ILE . 20.7 tp60 -74.01 138.9 44.39 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.423 -1.045 . . . . 1.3400000000000001 110.394 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.35 115.24 7.56 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.665 -0.647 . . . . 0.38 110.378 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.612 ' HB2' HD12 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -131.86 150.91 77.5 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.623 -0.673 . . . . 0.77000000000000002 110.2 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -73.0 -24.87 16.89 Favored 'Trans proline' 0 C--N 1.313 -1.335 0 O-C-N 123.839 1.442 . . . . 0.55000000000000004 111.079 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.15 -7.32 58.1 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.244 -0.91 . . . . 0.81000000000000005 111.643 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.612 HD12 ' HB2' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -59.85 -60.03 4.48 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.033 -1.042 . . . . 1.21 110.374 -179.665 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.2 p -62.97 -31.36 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 121.439 -0.788 . . . . 0.56999999999999995 110.567 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -68.32 -56.42 8.65 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.372 -0.83 . . . . 0.46999999999999997 109.913 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.702 ' O ' HG12 ' A' ' 34' ' ' VAL . 0.1 OUTLIER -63.19 -38.62 91.9 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.338 -0.851 . . . . 1.0600000000000001 110.269 179.524 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.881 HG22 HD12 ' A' ' 60' ' ' ILE . 2.4 t -56.57 -52.0 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.542 -0.723 . . . . 0.31 110.216 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 40.1 t -63.68 -40.88 90.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.47 -0.769 . . . . 0.34000000000000002 111.244 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.13 -50.77 29.93 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.309 -0.869 . . . . 0.62 111.134 -179.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.844 HG21 ' CB ' ' A' ' 76' ' ' GLU . 8.9 p -69.1 -28.05 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.485 -0.759 . . . . 0.26000000000000001 111.521 -179.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.593 HG11 ' HB2' ' A' ' 43' ' ' TYR . 1.9 p -83.21 -27.05 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.034 -1.041 . . . . 0.29999999999999999 110.784 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -78.89 -39.7 34.27 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.235 -0.915 . . . . 0.55000000000000004 110.429 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 14.4 ptt180 -69.56 -20.1 63.67 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.344 -0.847 . . . . 1.0 111.33 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.567 ' HB2' HD11 ' A' ' 73' ' ' LEU . 1.8 m-70 -106.16 -45.77 4.23 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.15 -0.969 . . . . 0.87 110.768 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -103.68 149.84 37.52 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.401 -0.812 . . . . 0.41999999999999998 109.997 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.33 140.4 36.88 Favored 'Trans proline' 0 C--N 1.314 -1.241 0 O-C-N 123.802 1.422 . . . . 0.56999999999999995 110.636 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.06 172.92 49.25 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.706 -1.357 . . . . 0.56000000000000005 109.706 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -100.99 144.69 29.62 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.439 -1.036 . . . . 0.56999999999999995 110.338 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.593 ' HB2' HG11 ' A' ' 35' ' ' VAL . 83.5 m-85 -129.08 165.46 21.18 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.509 -0.745 . . . . 0.40999999999999998 110.325 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.542 HG22 ' HD2' ' A' ' 45' ' ' PRO . 0.2 OUTLIER -142.57 156.79 63.21 Favored Pre-proline 0 N--CA 1.499 1.992 0 O-C-N 121.371 -0.831 . . . . 0.70999999999999996 111.165 -179.417 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.542 ' HD2' HG22 ' A' ' 44' ' ' THR . 53.2 Cg_endo -96.54 132.78 0.41 Allowed 'Trans proline' 0 C--N 1.32 -0.952 0 C-N-CA 122.233 1.955 . . . . 0.53000000000000003 110.292 178.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.473 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 36.2 m -93.89 92.11 7.24 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.955 -1.09 . . . . 0.40000000000000002 109.502 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.688 HG23 HG12 ' A' ' 58' ' ' VAL . 11.3 p -76.55 140.69 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.474 -0.766 . . . . 0.28999999999999998 111.638 -178.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.1 ptpt -142.32 154.9 64.58 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.785 -0.572 . . . . 1.5700000000000001 109.498 179.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -71.36 99.61 0.93 Allowed 'Trans proline' 0 C--N 1.313 -1.331 0 O-C-N 123.845 1.445 . . . . 0.48999999999999999 110.209 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.5 p -89.94 -47.17 8.04 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.547 -0.72 . . . . 0.60999999999999999 110.955 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.24 -52.44 1.74 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.252 -0.905 . . . . 1.1799999999999999 110.872 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.3 mttt -151.2 176.79 10.86 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.399 -0.813 . . . . 2.2999999999999998 110.34 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.429 ' HA2' ' HE1' ' A' ' 56' ' ' HIS . . . -64.42 -28.42 73.08 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.309 -1.516 . . . . 0.47999999999999998 109.309 178.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -78.89 -28.57 44.08 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.475 -1.014 . . . . 1.3500000000000001 110.552 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -111.35 118.1 34.93 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.359 -0.838 . . . . 0.47999999999999998 110.021 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.528 ' HD2' HG22 ' A' ' 47' ' ' VAL . 1.6 m80 -130.16 148.14 51.97 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.373 -0.829 . . . . 0.45000000000000001 111.174 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.662 ' HA ' ' HA ' ' A' ' 20' ' ' MET . 89.3 p -113.34 126.12 55.03 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 109.155 -0.683 . . . . 0.37 109.155 179.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.688 HG12 HG23 ' A' ' 47' ' ' VAL . 1.5 m -116.59 141.37 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.241 -0.912 . . . . 0.34999999999999998 111.116 -178.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.571 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 1.3 t -103.08 106.41 16.92 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.387 -0.821 . . . . 0.72999999999999998 108.87 178.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.881 HD12 HG22 ' A' ' 31' ' ' VAL . 6.2 tt -93.7 132.1 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.273 -0.892 . . . . 0.34000000000000002 111.264 -178.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.465 ' O ' ' HB3' ' A' ' 43' ' ' TYR . 85.9 m -87.12 127.79 35.12 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 108.635 -0.876 . . . . 0.42999999999999999 108.635 178.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.606 HD11 HD13 ' A' ' 60' ' ' ILE . 44.5 mt -137.85 103.36 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 120.995 -1.065 . . . . 0.28999999999999998 111.176 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -85.08 80.51 9.23 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.298 -0.876 . . . . 0.44 109.17 178.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -101.74 136.74 41.07 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.515 -0.741 . . . . 0.23000000000000001 110.311 -179.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.617 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 39.9 p -68.8 -14.8 63.26 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.45 -0.781 . . . . 0.35999999999999999 111.063 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -130.85 159.74 36.47 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.246 -0.909 . . . . 0.47999999999999998 110.764 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.558 ' HB ' ' HG3' ' A' ' 2' ' ' LYS . 8.4 tp -76.5 -27.15 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.532 -0.73 . . . . 0.40000000000000002 110.367 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.32 -26.9 63.04 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.203 -0.936 . . . . 0.64000000000000001 110.558 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.461 ' O ' HD13 ' A' ' 73' ' ' LEU . 28.3 mt-30 -63.84 -53.46 50.41 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.393 -0.817 . . . . 1.73 110.231 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.629 HG21 ' HB3' ' A' ' 15' ' ' PHE . 7.4 p -65.73 -27.59 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.662 -0.649 . . . . 0.27000000000000002 110.441 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.18 -48.31 73.89 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.316 -0.865 . . . . 0.46000000000000002 109.286 178.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 82.7 m -64.36 -34.59 78.52 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.741 -0.599 . . . . 0.38 109.436 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.567 HD11 ' HB2' ' A' ' 38' ' ' HIS . 5.2 mp -63.14 -40.29 97.14 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.67 -0.644 . . . . 0.28000000000000003 109.714 179.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.642 ' CD1' ' HB ' ' A' ' 86' ' ' VAL . 0.7 OUTLIER -64.77 -43.86 91.9 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.604 -0.685 . . . . 0.40999999999999998 109.457 178.886 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -65.98 -32.87 74.6 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.474 -0.766 . . . . 0.75 110.735 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.844 ' CB ' HG21 ' A' ' 34' ' ' VAL . 0.3 OUTLIER -70.49 -55.52 8.76 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.333 -0.854 . . . . 0.51000000000000001 110.378 179.972 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.952 HD11 HG11 ' A' ' 19' ' ' VAL . 0.3 OUTLIER -70.27 -28.19 65.02 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.361 -0.837 . . . . 0.28999999999999998 110.199 179.677 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.514 ' N ' ' HG ' ' A' ' 77' ' ' LEU . . . -107.59 55.78 0.51 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.428 -1.469 . . . . 0.22 109.428 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -106.07 4.18 28.95 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.702 -0.881 . . . . 1.53 110.6 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.695 HG22 ' H ' ' A' ' 82' ' ' ILE . 2.7 mp -63.44 145.05 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.35 -0.844 . . . . 0.45000000000000001 110.195 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.73 -5.93 41.08 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.509 -0.744 . . . . 1.6200000000000001 111.603 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.695 ' H ' HG22 ' A' ' 80' ' ' ILE . 47.3 mm -80.77 -106.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.031 -1.043 . . . . 0.55000000000000004 109.887 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 63.5 t -123.93 112.16 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 120.915 -1.116 . . . . 0.46999999999999997 110.389 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.06 122.02 38.31 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.37 0.605 . . . . 0.67000000000000004 109.727 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.545 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 1.3 ttm -146.88 158.6 43.96 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.25 -0.906 . . . . 2.5299999999999998 110.174 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.642 ' HB ' ' CD1' ' A' ' 74' ' ' TYR . 9.8 p -141.45 154.13 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.429 -0.795 . . . . 0.32000000000000001 110.837 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.499 1.989 0 CA-C-O 118.823 -0.608 . . . . 0.65000000000000002 110.407 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.769 0 CA-C-O 120.874 0.369 . . . . 2.77 110.586 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.05 -62.87 1.44 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.301 -0.874 . . . . 1.1000000000000001 109.83 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 57.6 m -138.83 84.95 2.04 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.493 -0.754 . . . . 1.1399999999999999 109.602 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.71 -54.91 0.61 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.445 -0.784 . . . . 1.0800000000000001 110.498 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.637 HD11 ' HG3' ' A' ' 69' ' ' GLN . 0.2 OUTLIER 52.54 55.19 9.44 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.701 -0.624 . . . . 1.1200000000000001 110.303 -179.666 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -102.14 73.14 1.35 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.399 -0.813 . . . . 1.1499999999999999 109.937 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -105.39 155.69 18.89 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.553 -0.717 . . . . 0.54000000000000004 110.224 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.419 ' HA ' HD13 ' A' ' 8' ' ' LEU . 0.6 OUTLIER -81.91 -41.84 20.35 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.388 -0.82 . . . . 0.84999999999999998 109.487 179.367 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -94.37 -30.38 14.53 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.75 -0.594 . . . . 0.52000000000000002 110.345 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 46.27 67.43 0.76 Allowed 'General case' 0 N--CA 1.499 2.01 0 CA-C-O 121.509 0.671 . . . . 0.59999999999999998 110.877 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.409 ' O ' ' HA ' ' A' ' 65' ' ' THR . 87.4 t80 -94.93 125.26 51.56 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.482 -0.761 . . . . 0.56000000000000005 110.039 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.568 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 43.4 Cg_endo -70.79 112.05 3.17 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 O-C-N 124.051 1.553 . . . . 0.31 110.424 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.5 t -121.5 141.56 33.71 Favored Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 121.556 -0.715 . . . . 0.39000000000000001 110.459 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.66 129.6 14.79 Favored 'Trans proline' 0 C--N 1.314 -1.261 0 O-C-N 123.879 1.462 . . . . 0.35999999999999999 110.637 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.675 ' HB3' HG21 ' A' ' 70' ' ' VAL . 31.1 m-85 -109.6 99.7 8.86 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.596 -0.69 . . . . 0.39000000000000001 110.217 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.2 m -73.95 92.58 2.12 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.257 -1.016 . . . . 0.38 108.257 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.581 ' O ' HG22 ' A' ' 60' ' ' ILE . 2.9 m-85 -103.55 103.74 13.72 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.461 -0.774 . . . . 0.38 110.949 -178.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.616 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 0.1 OUTLIER -82.3 97.45 8.31 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.344 -0.847 . . . . 3.1299999999999999 109.741 179.404 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.982 HG11 HD11 ' A' ' 77' ' ' LEU . 15.9 t -79.95 96.89 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.427 -0.795 . . . . 0.28000000000000003 109.37 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 60.2 mtm -101.36 127.3 48.05 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.571 -0.705 . . . . 0.62 110.254 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -157.15 -158.81 9.12 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.875 -1.29 . . . . 0.33000000000000002 109.875 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.451 ' HB2' ' CG2' ' A' ' 82' ' ' ILE . 0.0 OUTLIER -68.78 177.49 2.53 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.364 -1.08 . . . . 1.1799999999999999 110.559 -179.979 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.43 ' HA ' ' CG ' ' A' ' 56' ' ' HIS . . . -79.4 91.03 5.04 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.427 -0.796 . . . . 0.35999999999999999 110.459 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.585 ' O ' HD23 ' A' ' 27' ' ' LEU . 1.0 OUTLIER -133.81 132.29 21.48 Favored Pre-proline 0 N--CA 1.496 1.847 0 O-C-N 121.397 -0.814 . . . . 0.37 110.249 179.664 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -76.43 -4.19 14.73 Favored 'Trans proline' 0 N--CA 1.489 1.216 0 O-C-N 123.702 1.369 . . . . 0.53000000000000003 112.057 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -80.14 -5.84 56.7 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 120.968 -1.082 . . . . 0.62 111.466 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.639 HD13 HG11 ' A' ' 58' ' ' VAL . 4.1 pp -66.13 -38.23 87.63 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.932 -1.105 . . . . 0.38 111.083 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.629 ' N ' HD12 ' A' ' 27' ' ' LEU . 9.8 p -76.53 -29.83 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.256 -0.902 . . . . 0.32000000000000001 110.855 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -69.27 -53.84 17.73 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.365 -0.834 . . . . 0.39000000000000001 110.116 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.686 ' O ' HG12 ' A' ' 34' ' ' VAL . 0.6 OUTLIER -67.66 -38.78 84.25 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.34 -0.85 . . . . 0.63 110.75 179.911 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.737 ' CG1' HD13 ' A' ' 60' ' ' ILE . 2.8 t -59.39 -56.87 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.362 -0.836 . . . . 0.27000000000000002 110.615 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.7 p -62.79 -33.71 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 121.292 -0.88 . . . . 0.31 111.549 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.85 -55.91 5.32 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.043 -1.036 . . . . 0.42999999999999999 110.823 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.884 HG21 ' HB2' ' A' ' 76' ' ' GLU . 6.2 p -65.53 -23.97 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.34 -0.85 . . . . 0.28000000000000003 111.512 -179.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.581 HG11 ' HB2' ' A' ' 43' ' ' TYR . 1.8 p -86.0 -32.52 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 120.922 -1.111 . . . . 0.28999999999999998 111.078 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -78.73 -26.92 44.78 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.966 -1.084 . . . . 0.45000000000000001 110.558 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.86 -39.51 35.03 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.276 -0.89 . . . . 0.65000000000000002 110.609 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.675 ' HB2' HD11 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -86.69 -45.54 10.88 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.35 -0.844 . . . . 0.39000000000000001 110.571 -179.878 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -100.69 152.15 37.77 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.434 -0.791 . . . . 0.29999999999999999 109.993 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.42 140.58 36.92 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 O-C-N 123.844 1.444 . . . . 0.40999999999999998 110.584 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.22 162.41 26.2 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.749 -1.341 . . . . 0.52000000000000002 109.749 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.05 143.62 27.71 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.426 -1.043 . . . . 0.41999999999999998 110.088 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.581 ' HB2' HG11 ' A' ' 35' ' ' VAL . 82.8 m-85 -125.79 166.37 16.96 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.493 -0.754 . . . . 0.41999999999999998 110.448 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.61 HG22 ' HD2' ' A' ' 45' ' ' PRO . 3.9 m -140.76 152.36 65.58 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.408 -0.808 . . . . 0.35999999999999999 111.083 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.61 ' HD2' HG22 ' A' ' 44' ' ' THR . 54.6 Cg_endo -96.06 123.42 0.27 Allowed 'Trans proline' 0 C--N 1.319 -0.999 0 C-N-CA 122.125 1.884 . . . . 0.22 110.545 179.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.53 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 58.6 m -75.3 92.72 2.79 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.213 -0.929 . . . . 0.31 108.779 178.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.76 HG23 HG12 ' A' ' 58' ' ' VAL . 8.3 p -80.75 139.38 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 CA-C-O 121.863 0.84 . . . . 0.33000000000000002 112.406 -178.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.464 ' HG2' ' O ' ' A' ' 57' ' ' SER . 0.2 OUTLIER -142.57 109.39 5.67 Favored Pre-proline 0 N--CA 1.493 1.695 0 N-CA-C 108.709 -0.848 . . . . 0.64000000000000001 108.709 178.198 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -77.09 126.44 8.62 Favored 'Trans proline' 0 C--N 1.315 -1.191 0 O-C-N 123.766 1.403 . . . . 0.46999999999999997 111.021 -178.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 31.1 p -77.25 -44.95 28.04 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.444 -0.785 . . . . 0.60999999999999999 109.802 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -122.86 -165.66 1.34 Allowed 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 109.347 -0.612 . . . . 1.1599999999999999 109.347 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.63 118.31 31.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.265 -0.897 . . . . 2.9100000000000001 109.589 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 50.18 33.21 22.37 Favored Glycine 0 N--CA 1.497 2.762 0 N-CA-C 110.596 -1.002 . . . . 0.51000000000000001 110.596 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -108.22 -65.93 1.08 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.277 -1.131 . . . . 1.6100000000000001 110.817 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -142.5 136.97 29.9 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.51 -0.744 . . . . 0.82999999999999996 110.351 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.43 ' CG ' ' HA ' ' A' ' 23' ' ' ALA . 5.4 m170 -116.27 123.76 48.49 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.558 -0.713 . . . . 0.73999999999999999 110.317 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.464 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 26.0 m -108.7 119.88 40.82 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.435 -0.791 . . . . 0.38 108.913 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.76 HG12 HG23 ' A' ' 47' ' ' VAL . 1.7 m -124.81 151.62 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 120.957 -1.089 . . . . 0.29999999999999999 111.221 -178.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.616 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 6.4 t -118.82 105.86 11.95 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.586 -0.696 . . . . 0.63 109.155 179.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.737 HD13 ' CG1' ' A' ' 31' ' ' VAL . 2.5 tp -93.29 129.93 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.238 -0.914 . . . . 0.25 111.07 -179.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.436 ' O ' ' HB3' ' A' ' 43' ' ' TYR . 49.5 m -85.44 121.92 28.84 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.855 -0.794 . . . . 0.32000000000000001 108.855 178.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.504 HG21 HG23 ' A' ' 70' ' ' VAL . 68.2 mt -127.82 109.25 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 120.939 -1.101 . . . . 0.42999999999999999 110.986 -178.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -90.7 92.96 9.04 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.418 -0.801 . . . . 0.62 109.576 179.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.426 ' HB1' ' HB3' ' A' ' 69' ' ' GLN . . . -117.79 139.38 51.15 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.53 -0.731 . . . . 0.25 110.39 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.568 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 34.5 p -74.86 -13.0 60.51 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.502 -0.749 . . . . 0.32000000000000001 110.729 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -129.14 148.15 51.06 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.338 -0.851 . . . . 0.41999999999999998 110.311 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -72.87 -21.7 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.511 -0.743 . . . . 0.78000000000000003 110.763 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.18 -23.86 57.76 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.144 -0.973 . . . . 0.5 110.844 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.637 ' HG3' HD11 ' A' ' 5' ' ' LEU . 0.2 OUTLIER -71.21 -50.45 32.94 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.296 -0.877 . . . . 0.52000000000000002 110.268 -179.99 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.675 HG21 ' HB3' ' A' ' 15' ' ' PHE . 8.1 p -65.81 -31.52 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.56 -0.712 . . . . 0.26000000000000001 110.339 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.4 -47.22 77.04 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.361 -0.837 . . . . 0.46999999999999997 109.343 178.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.402 HG22 ' OE1' ' A' ' 76' ' ' GLU . 93.4 m -62.47 -34.7 77.35 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.705 -0.622 . . . . 0.38 109.498 178.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.675 HD11 ' HB2' ' A' ' 38' ' ' HIS . 2.0 mp -61.96 -41.02 97.51 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.583 -0.698 . . . . 0.34999999999999998 109.593 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.539 ' CD1' ' HB ' ' A' ' 86' ' ' VAL . 2.7 t80 -64.64 -40.47 95.51 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.597 -0.689 . . . . 0.38 109.323 178.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.57 -38.49 87.7 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.379 -0.826 . . . . 0.40999999999999998 110.254 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.884 ' HB2' HG21 ' A' ' 34' ' ' VAL . 0.4 OUTLIER -71.12 -50.73 30.46 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.483 -0.76 . . . . 0.46999999999999997 110.721 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.982 HD11 HG11 ' A' ' 19' ' ' VAL . 0.2 OUTLIER -72.01 -27.71 62.91 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.316 -0.865 . . . . 0.28000000000000003 110.574 179.944 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.494 ' N ' ' HG ' ' A' ' 77' ' ' LEU . . . -100.84 38.13 3.28 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.646 -1.382 . . . . 0.28000000000000003 109.646 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.54 3.72 27.36 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.545 -0.974 . . . . 0.55000000000000004 110.815 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.0 mt -67.36 155.91 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.15 -0.969 . . . . 0.34000000000000002 109.911 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -62.25 -25.0 67.58 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.349 -0.844 . . . . 0.5 110.005 179.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.451 ' CG2' ' HB2' ' A' ' 22' ' ' GLN . 49.7 mm -73.54 163.89 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.555 -0.716 . . . . 0.39000000000000001 109.92 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 92.2 t -71.6 106.28 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.409 -0.807 . . . . 0.46000000000000002 110.843 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.415 ' HG2' ' HA2' ' A' ' 78' ' ' GLY . 1.4 tpm_? -121.99 114.03 20.4 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.598 -0.689 . . . . 0.40000000000000002 109.585 179.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.51 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -120.65 170.54 9.33 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.296 -0.877 . . . . 1.6299999999999999 110.38 -179.713 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.56 HG23 HG22 ' A' ' 19' ' ' VAL . 4.7 p -138.16 155.21 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.472 -0.768 . . . . 0.32000000000000001 110.629 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.498 1.937 0 CA-C-O 117.738 -1.125 . . . . 0.64000000000000001 110.43 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.5 mtt . . . . . 0 N--CA 1.495 1.812 0 CA-C-O 121.223 0.535 . . . . 1.3500000000000001 110.372 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -162.61 -170.38 2.39 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.47 -0.769 . . . . 1.75 110.007 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 85.1 m -111.51 -53.1 2.74 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.359 -0.838 . . . . 0.54000000000000004 110.045 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.6 tptt -145.68 158.35 43.86 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.381 -0.825 . . . . 0.58999999999999997 110.069 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.45 ' O ' ' HB2' ' A' ' 6' ' ' ASN . 0.9 OUTLIER -102.01 12.94 36.07 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.418 -0.801 . . . . 0.75 110.734 179.8 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' ' 5' ' ' LEU . 22.5 m-80 62.25 -79.2 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.808 -0.557 . . . . 1.52 111.41 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.415 ' HB2' ' O ' ' A' ' 6' ' ' ASN . 1.2 mt-10 62.96 176.37 0.15 Allowed 'General case' 0 N--CA 1.506 2.359 0 O-C-N 121.468 -0.77 . . . . 0.60999999999999999 110.965 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -98.07 -33.2 11.26 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.436 -0.79 . . . . 1.28 110.039 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.2 mp -98.39 -41.88 7.61 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.424 -0.798 . . . . 0.73999999999999999 110.008 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 58.65 60.09 2.66 Favored 'General case' 0 N--CA 1.5 2.025 0 CA-C-O 121.505 0.669 . . . . 0.53000000000000003 110.208 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.448 ' O ' ' HA ' ' A' ' 65' ' ' THR . 84.9 t80 -95.63 113.51 62.02 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.488 -0.757 . . . . 0.93999999999999995 109.705 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.616 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 44.7 Cg_endo -70.62 116.66 4.75 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 O-C-N 124.021 1.537 . . . . 0.38 110.949 -179.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.5 t -119.51 142.94 33.6 Favored Pre-proline 0 N--CA 1.496 1.835 0 O-C-N 121.687 -0.633 . . . . 0.42999999999999999 110.037 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -71.98 125.22 10.75 Favored 'Trans proline' 0 C--N 1.314 -1.282 0 O-C-N 123.869 1.458 . . . . 0.37 111.19 -179.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.661 ' HB3' HG21 ' A' ' 70' ' ' VAL . 23.4 m-85 -110.35 99.31 8.36 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.591 -0.693 . . . . 0.31 110.249 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.482 HG22 ' HD2' ' A' ' 18' ' ' LYS . 24.4 m -78.99 92.32 4.94 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.21 -1.033 . . . . 0.35999999999999999 108.21 178.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -99.66 107.91 20.14 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.496 -0.752 . . . . 0.34999999999999998 110.768 -178.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.644 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 0.0 OUTLIER -87.56 89.7 8.09 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.592 -0.693 . . . . 1.77 109.944 179.825 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.847 HG11 HD11 ' A' ' 77' ' ' LEU . 2.4 m -82.34 110.35 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.36 -0.837 . . . . 0.28000000000000003 109.828 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 53.9 mtt -109.36 157.34 18.99 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.611 -0.681 . . . . 0.73999999999999999 110.282 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 169.36 -164.04 37.62 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 109.986 -1.246 . . . . 0.41999999999999998 109.986 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -69.59 150.85 46.64 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.53 -0.982 . . . . 1.6899999999999999 110.017 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.476 ' HB3' ' ND2' ' A' ' 54' ' ' ASN . . . -53.74 111.7 0.78 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.583 -0.698 . . . . 0.45000000000000001 110.548 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.7 mt -132.21 129.72 21.75 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.585 -0.697 . . . . 1.0800000000000001 110.395 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.65 -21.65 18.91 Favored 'Trans proline' 0 C--N 1.315 -1.231 0 O-C-N 123.849 1.447 . . . . 0.71999999999999997 111.171 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -81.33 -4.25 55.08 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.271 -0.893 . . . . 1.46 111.298 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.98 -58.34 8.27 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.991 -1.068 . . . . 0.59999999999999998 110.332 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.505 HG12 ' HG2' ' A' ' 45' ' ' PRO . 36.0 m -62.22 -29.67 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 O-C-N 121.497 -0.752 . . . . 0.38 111.042 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.417 ' O ' HG12 ' A' ' 32' ' ' VAL . 31.9 t70 -70.22 -53.26 17.77 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.286 -0.884 . . . . 0.52000000000000002 110.427 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.704 ' O ' HG12 ' A' ' 34' ' ' VAL . 0.2 OUTLIER -69.17 -35.8 76.68 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.326 -0.859 . . . . 1.4099999999999999 110.352 179.6 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.743 ' CG1' HD13 ' A' ' 60' ' ' ILE . 3.8 t -61.81 -51.47 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.574 -0.704 . . . . 0.34999999999999998 110.562 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.417 HG12 ' O ' ' A' ' 29' ' ' ASP . 6.1 p -67.03 -32.63 58.77 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.232 -0.917 . . . . 0.28999999999999998 111.223 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.417 ' O ' ' HG2' ' A' ' 36' ' ' GLN . 0.1 OUTLIER -75.63 -50.93 14.02 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.079 -1.013 . . . . 1.0800000000000001 110.509 179.806 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.815 HG21 ' CB ' ' A' ' 76' ' ' GLU . 9.9 p -67.69 -30.37 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.366 -0.834 . . . . 0.28000000000000003 110.898 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.607 HG23 ' CG1' ' A' ' 62' ' ' ILE . 2.3 p -76.64 -38.2 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.073 -1.017 . . . . 0.28000000000000003 110.352 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.417 ' HG2' ' O ' ' A' ' 33' ' ' GLU . 7.4 pt20 -74.05 -22.45 59.53 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.054 -1.029 . . . . 0.51000000000000001 109.946 179.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.0 mtp-105 -68.48 -49.24 61.24 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.415 -0.803 . . . . 0.77000000000000002 110.154 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.626 ' HB2' HD11 ' A' ' 73' ' ' LEU . 2.0 m-70 -84.54 -45.78 12.25 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.39 -0.819 . . . . 0.34000000000000002 110.498 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.509 ' HB3' ' O ' ' A' ' 35' ' ' VAL . . . -76.83 153.79 83.11 Favored Pre-proline 0 N--CA 1.497 1.897 0 O-C-N 121.351 -0.843 . . . . 0.27000000000000002 110.068 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -69.06 -34.54 16.68 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.922 1.485 . . . . 0.48999999999999999 111.395 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -108.86 -178.61 21.57 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 110.063 -1.215 . . . . 0.38 110.063 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.14 148.68 22.8 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.553 -0.969 . . . . 0.52000000000000002 109.648 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.473 ' HB2' HG11 ' A' ' 35' ' ' VAL . 98.0 m-85 -135.4 172.84 12.43 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.409 -0.807 . . . . 0.39000000000000001 111.188 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.685 HG22 ' HD2' ' A' ' 45' ' ' PRO . 0.3 OUTLIER -142.39 156.53 63.89 Favored Pre-proline 0 N--CA 1.496 1.851 0 O-C-N 121.613 -0.68 . . . . 0.47999999999999998 110.513 -179.64 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.685 ' HD2' HG22 ' A' ' 44' ' ' THR . 52.6 Cg_endo -94.64 121.94 0.34 Allowed 'Trans proline' 0 C--N 1.317 -1.125 0 C-N-CA 121.986 1.79 . . . . 0.33000000000000002 110.229 179.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 74.2 m -80.44 101.4 9.02 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.079 -1.013 . . . . 0.40999999999999998 109.572 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.665 ' CB ' HG12 ' A' ' 58' ' ' VAL . 12.1 p -76.52 141.2 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.408 -0.807 . . . . 0.37 111.525 -179.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.487 ' HE2' ' HB3' ' A' ' 57' ' ' SER . 0.1 OUTLIER -142.27 149.55 52.05 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.752 -0.593 . . . . 0.88 109.691 179.215 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -75.85 88.46 1.31 Allowed 'Trans proline' 0 C--N 1.314 -1.267 0 O-C-N 124.03 1.542 . . . . 0.68999999999999995 110.649 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.3 m -93.23 -44.83 8.14 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.49 -0.757 . . . . 0.82999999999999996 109.968 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.504 ' HB3' ' HB3' ' A' ' 55' ' ' TYR . 0.1 OUTLIER -112.85 161.12 17.31 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.531 -0.731 . . . . 1.21 110.092 179.651 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.42 158.25 15.52 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.363 -0.835 . . . . 2.0800000000000001 110.54 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.93 -138.28 13.98 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.68 -1.368 . . . . 0.75 109.68 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.476 ' ND2' ' HB3' ' A' ' 23' ' ' ALA . 2.9 t30 -98.07 67.43 1.91 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.452 -1.028 . . . . 0.95999999999999996 109.945 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.504 ' HB3' ' HB3' ' A' ' 51' ' ' SER . 14.9 t80 -145.47 139.4 26.82 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.445 -0.784 . . . . 1.2 110.231 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.429 ' CD2' ' HA ' ' A' ' 23' ' ' ALA . 0.6 OUTLIER -142.25 146.71 35.44 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.506 -0.746 . . . . 0.44 110.31 179.824 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.487 ' HB3' ' HE2' ' A' ' 48' ' ' LYS . 37.5 m -119.69 114.22 21.85 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.282 -0.886 . . . . 0.35999999999999999 109.719 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.665 HG12 ' CB ' ' A' ' 47' ' ' VAL . 3.1 m -114.07 146.76 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.136 -0.977 . . . . 0.31 110.952 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.644 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 45.5 t -112.97 111.1 21.6 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.687 -0.633 . . . . 0.42999999999999999 109.43 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.743 HD13 ' CG1' ' A' ' 31' ' ' VAL . 2.2 tp -92.74 129.79 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 C-N-CA 119.773 -0.771 . . . . 0.26000000000000001 111.042 -179.15 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 82.7 m -82.34 137.83 34.67 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.934 -0.765 . . . . 0.32000000000000001 108.934 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.607 ' CG1' HG23 ' A' ' 35' ' ' VAL . 2.3 mt -136.95 139.54 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.105 -0.997 . . . . 0.39000000000000001 111.017 -179.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -117.99 69.55 0.78 Allowed 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 121.457 0.646 . . . . 0.45000000000000001 109.299 179.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.606 ' HB1' ' HB2' ' A' ' 69' ' ' GLN . . . -99.59 135.78 40.5 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.489 -0.757 . . . . 0.28000000000000003 110.269 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.616 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 58.0 p -73.73 -13.05 60.9 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.492 -0.755 . . . . 0.34999999999999998 110.847 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 8.7 t60 -129.47 157.16 42.78 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.249 -0.907 . . . . 0.56999999999999995 110.76 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.14 -24.88 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.534 -0.729 . . . . 1.0600000000000001 110.43 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -70.96 -31.26 67.77 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.319 -0.863 . . . . 0.94999999999999996 110.278 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.606 ' HB2' ' HB1' ' A' ' 64' ' ' ALA . 57.1 mt-30 -63.06 -52.74 61.59 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.472 -0.768 . . . . 0.42999999999999999 110.025 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.661 HG21 ' HB3' ' A' ' 15' ' ' PHE . 7.7 p -69.31 -26.98 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.371 -0.831 . . . . 0.33000000000000002 110.222 179.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.95 -52.27 64.72 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.345 -0.847 . . . . 0.70999999999999996 109.229 178.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.5 p -63.83 -35.75 81.65 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.474 -0.767 . . . . 0.34000000000000002 109.239 178.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.626 HD11 ' HB2' ' A' ' 38' ' ' HIS . 3.7 mp -57.3 -42.2 81.3 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.541 -0.724 . . . . 0.28999999999999998 109.693 178.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.461 ' CD1' ' HB ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -65.03 -44.22 89.82 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 109.102 -0.703 . . . . 0.47999999999999998 109.102 178.766 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -65.71 -33.84 76.81 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.548 -0.72 . . . . 0.63 110.616 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.815 ' CB ' HG21 ' A' ' 34' ' ' VAL . 0.2 OUTLIER -70.31 -54.3 13.19 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.452 -0.78 . . . . 0.44 110.629 -179.897 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.847 HD11 HG11 ' A' ' 19' ' ' VAL . 0.9 OUTLIER -73.13 -24.67 60.63 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.309 -0.87 . . . . 0.32000000000000001 110.177 179.588 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -103.68 43.67 1.63 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.492 -1.443 . . . . 0.34000000000000002 109.492 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.13 3.89 28.5 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.435 -1.038 . . . . 0.81000000000000005 110.842 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.612 HG22 ' H ' ' A' ' 82' ' ' ILE . 2.2 mp -65.3 144.89 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.26 -0.9 . . . . 0.45000000000000001 110.292 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.8 -20.87 66.03 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.332 -0.855 . . . . 1.48 110.322 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.612 ' H ' HG22 ' A' ' 80' ' ' ILE . 40.4 mm -70.46 170.13 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.431 -0.793 . . . . 0.51000000000000001 109.87 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.473 ' N ' HG22 ' A' ' 82' ' ' ILE . 75.3 t -62.32 112.75 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.335 -0.853 . . . . 0.46999999999999997 110.544 -179.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.31 161.64 21.67 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.733 -0.605 . . . . 1.1799999999999999 110.113 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.488 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 1.7 ttp -157.72 160.19 37.65 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.401 -0.812 . . . . 1.1299999999999999 109.882 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.538 ' HA ' ' HA ' ' A' ' 19' ' ' VAL . 11.3 p -134.1 146.46 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.32 -0.863 . . . . 0.33000000000000002 110.524 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 34.8 mt . . . . . 0 N--CA 1.5 2.063 0 CA-C-O 117.646 -1.169 . . . . 0.51000000000000001 110.488 -179.807 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.406 ' SD ' ' HB3' ' A' ' 71' ' ' GLU . 9.8 ptm . . . . . 0 N--CA 1.497 1.891 0 CA-C-O 121.312 0.577 . . . . 1.02 111.173 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.82 170.6 9.76 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.648 -0.657 . . . . 3.46 110.866 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.419 ' O ' ' C ' ' A' ' 4' ' ' LYS . 26.4 p -129.3 -52.17 1.19 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.457 -0.777 . . . . 0.64000000000000001 110.79 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.419 ' C ' ' O ' ' A' ' 3' ' ' THR . 5.6 ptmt 33.54 68.62 0.16 Allowed 'General case' 0 N--CA 1.509 2.496 0 CA-C-O 121.587 0.708 . . . . 1.0700000000000001 111.236 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.498 HD21 ' HG3' ' A' ' 69' ' ' GLN . 0.4 OUTLIER -69.0 151.83 46.01 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.444 -0.785 . . . . 0.92000000000000004 111.062 -179.461 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.414 ' HA ' ' HG3' ' A' ' 10' ' ' GLU . 0.5 OUTLIER 51.61 61.43 3.23 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.333 0.587 . . . . 1.0800000000000001 111.178 179.487 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -129.02 -57.19 1.17 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.306 -0.871 . . . . 0.63 110.021 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -110.11 -35.92 5.98 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.648 -0.658 . . . . 1.0800000000000001 110.413 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.4 mp -96.05 -56.15 2.74 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.401 -0.812 . . . . 0.97999999999999998 110.331 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.414 ' HG3' ' HA ' ' A' ' 6' ' ' ASN . 3.2 mt-10 54.77 33.71 20.21 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.801 -0.562 . . . . 0.73999999999999999 110.803 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.479 ' O ' ' HA ' ' A' ' 65' ' ' THR . 69.7 t80 -121.66 114.41 31.39 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.329 -0.857 . . . . 0.81999999999999995 109.8 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.507 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 44.3 Cg_endo -70.3 108.94 2.29 Favored 'Trans proline' 0 C--N 1.314 -1.272 0 O-C-N 123.911 1.479 . . . . 0.33000000000000002 110.51 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.5 t -129.65 142.43 45.27 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.658 -0.651 . . . . 0.35999999999999999 110.54 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.17 129.54 15.23 Favored 'Trans proline' 0 C--N 1.315 -1.199 0 O-C-N 123.917 1.483 . . . . 0.44 110.334 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.571 ' HB3' HG21 ' A' ' 70' ' ' VAL . 32.8 m-85 -108.29 100.76 10.03 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.595 -0.69 . . . . 0.33000000000000002 110.32 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.9 m -74.19 92.26 2.2 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.407 -0.96 . . . . 0.39000000000000001 108.407 178.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.599 ' O ' HG22 ' A' ' 60' ' ' ILE . 3.3 m-85 -102.8 104.41 14.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.441 -0.787 . . . . 0.34999999999999998 110.611 -178.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.605 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 0.0 OUTLIER -78.99 93.47 5.1 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.573 -0.704 . . . . 2.0 109.484 179.605 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 1.004 HG11 HD11 ' A' ' 77' ' ' LEU . 24.8 t -78.36 95.3 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.463 -0.773 . . . . 0.26000000000000001 109.15 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.454 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 53.7 mtt -97.71 153.57 18.16 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.577 -0.702 . . . . 1.02 110.535 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 168.4 -151.94 19.37 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.877 -1.289 . . . . 0.31 109.877 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.565 ' HA ' ' HA ' ' A' ' 55' ' ' TYR . 5.9 mt-30 -78.19 170.26 16.91 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.458 -1.025 . . . . 1.1299999999999999 110.414 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.434 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -78.0 101.33 6.85 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.29 -0.881 . . . . 0.42999999999999999 109.816 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.526 ' HG ' ' HD2' ' A' ' 25' ' ' PRO . 1.0 OUTLIER -130.33 136.37 28.89 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.49 -0.756 . . . . 1.1399999999999999 110.548 -179.404 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.526 ' HD2' ' HG ' ' A' ' 24' ' ' LEU . 47.3 Cg_endo -72.92 -20.48 22.18 Favored 'Trans proline' 0 C--N 1.316 -1.181 0 O-C-N 123.822 1.433 . . . . 0.48999999999999999 110.997 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -72.07 -13.74 61.67 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.351 -0.843 . . . . 0.68999999999999995 111.213 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.8 mt -56.83 -64.01 1.01 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.213 -0.929 . . . . 0.53000000000000003 110.577 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.6 p -60.94 -30.84 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 O-C-N 121.388 -0.82 . . . . 0.29999999999999999 111.021 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -64.35 -62.39 1.63 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.395 -0.816 . . . . 0.51000000000000001 110.389 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.681 ' O ' HG12 ' A' ' 34' ' ' VAL . 5.5 tp60 -64.35 -32.53 74.18 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.354 -0.841 . . . . 0.59999999999999998 110.724 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.706 HG22 HD12 ' A' ' 60' ' ' ILE . 2.3 t -59.03 -56.67 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.269 -0.894 . . . . 0.26000000000000001 110.346 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.402 ' HA ' HG12 ' A' ' 35' ' ' VAL . 8.6 p -68.49 -28.36 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.381 -0.824 . . . . 0.31 111.548 -179.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.417 ' O ' ' HG2' ' A' ' 36' ' ' GLN . 1.0 OUTLIER -76.02 -55.97 5.1 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.031 -1.043 . . . . 0.52000000000000002 110.773 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.834 HG21 ' CB ' ' A' ' 76' ' ' GLU . 5.7 p -66.93 -25.8 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.428 -0.795 . . . . 0.27000000000000002 111.339 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.64 HG11 ' HB2' ' A' ' 43' ' ' TYR . 2.4 p -82.64 -35.02 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.013 -1.055 . . . . 0.25 110.828 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.417 ' HG2' ' O ' ' A' ' 33' ' ' GLU . 13.8 pt20 -76.73 -25.98 54.13 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.066 -1.021 . . . . 0.52000000000000002 110.2 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 25.7 mtm-85 -75.96 -39.7 55.45 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.267 -0.896 . . . . 1.29 110.533 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.754 ' HB2' HD11 ' A' ' 73' ' ' LEU . 0.5 OUTLIER -90.26 -45.71 8.89 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.285 -0.884 . . . . 0.65000000000000002 110.691 -179.818 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -98.52 150.95 37.22 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.56 -0.713 . . . . 0.28999999999999998 110.149 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -71.3 140.72 37.6 Favored 'Trans proline' 0 C--N 1.313 -1.302 0 O-C-N 123.823 1.433 . . . . 0.40999999999999998 110.385 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.83 164.77 32.29 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.597 -1.401 . . . . 0.54000000000000004 109.597 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -99.98 139.56 35.47 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.376 -1.073 . . . . 0.51000000000000001 110.117 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.64 ' HB2' HG11 ' A' ' 35' ' ' VAL . 93.0 m-85 -119.21 170.59 8.95 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.527 -0.733 . . . . 0.37 110.541 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.666 HG22 ' HD2' ' A' ' 45' ' ' PRO . 0.2 OUTLIER -142.44 153.91 62.97 Favored Pre-proline 0 N--CA 1.498 1.974 0 O-C-N 121.423 -0.798 . . . . 0.45000000000000001 110.836 -179.136 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.666 ' HD2' HG22 ' A' ' 44' ' ' THR . 52.6 Cg_endo -96.36 121.16 0.22 Allowed 'Trans proline' 0 C--N 1.321 -0.9 0 C-N-CA 122.015 1.81 . . . . 0.28999999999999998 110.104 178.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 53.2 m -78.81 97.6 6.0 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.129 -0.982 . . . . 0.35999999999999999 109.686 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.648 HG23 HG12 ' A' ' 58' ' ' VAL . 11.5 p -76.53 139.22 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.515 -0.74 . . . . 0.42999999999999999 111.479 -179.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.3 pttt -142.53 152.53 60.33 Favored Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.684 -0.635 . . . . 1.97 109.884 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -77.16 81.49 2.6 Favored 'Trans proline' 0 C--N 1.313 -1.308 0 O-C-N 123.934 1.492 . . . . 0.67000000000000004 110.49 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.478 ' HB2' ' HB2' ' A' ' 57' ' ' SER . 0.4 OUTLIER -90.15 -46.55 8.38 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.424 -0.797 . . . . 1.0 110.07 179.829 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.442 ' HB3' ' CB ' ' A' ' 55' ' ' TYR . 0.1 OUTLIER -102.73 166.23 10.61 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.45 -0.781 . . . . 1.3600000000000001 110.202 179.767 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.39 160.07 14.74 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.422 -0.799 . . . . 1.6599999999999999 110.586 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.44 -136.24 13.75 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.563 -1.415 . . . . 0.79000000000000004 109.563 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -99.23 64.88 1.39 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.578 -0.954 . . . . 0.93000000000000005 110.01 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.565 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 17.6 m-85 -139.0 139.27 37.82 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.494 -0.754 . . . . 1.0800000000000001 110.394 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.434 ' HB2' ' HA ' ' A' ' 23' ' ' ALA . 0.2 OUTLIER -137.5 142.44 41.49 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.561 -0.712 . . . . 0.91000000000000003 110.417 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.478 ' HB2' ' HB2' ' A' ' 50' ' ' SER . 17.1 m -116.87 107.84 15.1 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.601 -0.687 . . . . 0.33000000000000002 109.445 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.648 HG12 HG23 ' A' ' 47' ' ' VAL . 3.1 m -108.23 149.8 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.336 -0.853 . . . . 0.33000000000000002 110.85 -179.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.605 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 9.1 t -114.76 110.08 19.18 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.938 -0.764 . . . . 0.5 108.938 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.706 HD12 HG22 ' A' ' 31' ' ' VAL . 6.6 tt -92.43 131.06 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.228 -0.92 . . . . 0.31 111.423 -178.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.406 ' O ' ' HB3' ' A' ' 43' ' ' TYR . 91.9 m -86.13 130.21 34.6 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.684 -0.858 . . . . 0.35999999999999999 108.684 178.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.577 HD11 HD13 ' A' ' 60' ' ' ILE . 59.3 mt -139.75 99.16 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.004 -1.06 . . . . 0.32000000000000001 111.086 -179.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -84.02 97.97 9.58 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.277 -0.889 . . . . 0.37 108.925 178.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -119.05 138.79 52.61 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.533 -0.729 . . . . 0.23999999999999999 111.19 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.507 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 37.8 p -74.23 -9.93 59.1 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.619 -0.676 . . . . 0.37 110.475 179.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.449 ' HD2' ' HB2' ' A' ' 68' ' ' GLU . 6.7 t60 -129.51 156.97 43.29 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.398 -0.814 . . . . 0.59999999999999998 110.201 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.421 ' O ' HG12 ' A' ' 70' ' ' VAL . 0.8 OUTLIER -82.37 -22.66 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.476 -0.765 . . . . 0.81999999999999995 111.075 179.895 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.449 ' HB2' ' HD2' ' A' ' 66' ' ' HIS . 39.5 mt-10 -77.33 -30.27 53.92 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.057 -1.027 . . . . 0.96999999999999997 110.928 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.509 ' O ' HD13 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -61.74 -44.58 96.63 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.3 -0.875 . . . . 0.54000000000000004 110.214 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.571 HG21 ' HB3' ' A' ' 15' ' ' PHE . 9.2 p -71.77 -29.31 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.234 -0.917 . . . . 0.29999999999999999 110.238 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.406 ' HB3' ' SD ' ' A' ' 1' ' ' MET . 0.1 OUTLIER -65.83 -47.5 74.81 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.31 -0.869 . . . . 0.68000000000000005 109.32 179.036 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.532 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . 17.9 p -65.36 -35.17 80.16 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.654 -0.654 . . . . 0.33000000000000002 109.466 178.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.754 HD11 ' HB2' ' A' ' 38' ' ' HIS . 3.8 mp -61.86 -37.23 83.72 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.367 -0.833 . . . . 0.28000000000000003 109.942 179.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.549 ' CD1' ' HB ' ' A' ' 86' ' ' VAL . 0.8 OUTLIER -67.74 -52.78 33.46 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.386 -0.821 . . . . 0.58999999999999997 109.715 179.28 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.532 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 10.6 pt-20 -63.04 -28.03 69.81 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.375 -0.828 . . . . 0.64000000000000001 110.705 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.834 ' CB ' HG21 ' A' ' 34' ' ' VAL . 0.1 OUTLIER -71.29 -48.05 53.15 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.277 -0.889 . . . . 0.44 110.003 179.454 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 1.004 HD11 HG11 ' A' ' 19' ' ' VAL . 0.3 OUTLIER -76.94 -28.09 55.1 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.468 -0.77 . . . . 0.33000000000000002 110.198 179.519 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.638 ' HA2' ' HG2' ' A' ' 84' ' ' ARG . . . -103.49 44.96 1.39 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.701 -1.36 . . . . 0.32000000000000001 109.701 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.1 3.83 36.39 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.626 -0.926 . . . . 0.87 110.778 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.614 HD12 ' HG2' ' A' ' 84' ' ' ARG . 1.7 mp -73.87 154.87 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.276 -0.89 . . . . 0.39000000000000001 110.03 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.0 -19.91 66.01 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.442 -0.786 . . . . 1.45 110.638 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.465 HG22 ' HB2' ' A' ' 22' ' ' GLN . 51.9 mm -70.19 169.27 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.395 -0.815 . . . . 0.5 109.985 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.457 ' N ' HG22 ' A' ' 82' ' ' ILE . 90.3 t -62.47 104.6 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.439 -0.788 . . . . 0.41999999999999998 110.445 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.638 ' HG2' ' HA2' ' A' ' 78' ' ' GLY . 0.1 OUTLIER -121.82 112.61 18.57 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.692 -0.484 . . . . 0.54000000000000004 109.692 179.911 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.518 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 0.2 OUTLIER -135.5 166.37 23.36 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.287 -0.883 . . . . 1.3100000000000001 110.419 -179.611 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.557 HG23 HG22 ' A' ' 19' ' ' VAL . 5.1 p -139.2 157.06 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.393 -0.817 . . . . 0.27000000000000002 110.583 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.499 2.003 0 CA-C-O 118.843 -0.599 . . . . 0.47999999999999998 110.459 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.795 0 CA-C-O 120.981 0.419 . . . . 1.5800000000000001 110.767 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? 65.36 106.58 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.161 0 CA-C-O 121.431 0.634 . . . . 1.8300000000000001 110.718 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 87.4 m -97.74 140.04 32.72 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.54 -0.725 . . . . 0.75 109.883 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -138.26 128.13 25.35 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.572 -0.705 . . . . 0.77000000000000002 110.408 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.647 HD13 HD11 ' A' ' 9' ' ' LEU . 0.5 OUTLIER 56.4 -172.06 0.08 Allowed 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 121.296 0.57 . . . . 1.46 111.148 -179.886 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -136.42 78.23 1.7 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.435 -0.791 . . . . 1.8700000000000001 110.271 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 52.05 58.18 5.71 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.701 -0.625 . . . . 0.65000000000000002 110.798 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.9 mt -113.3 -44.18 3.27 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.378 -0.826 . . . . 0.89000000000000001 110.275 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.647 HD11 HD13 ' A' ' 5' ' ' LEU . 1.4 mp -81.18 -48.13 12.51 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.347 -0.846 . . . . 1.0900000000000001 109.936 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 60.38 50.26 6.22 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.341 0.591 . . . . 0.95999999999999996 111.082 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.514 ' O ' ' HA ' ' A' ' 65' ' ' THR . 7.3 m-85 -96.55 117.32 66.13 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 121.371 -0.831 . . . . 1.04 109.001 178.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.651 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 42.6 Cg_endo -68.13 106.17 1.32 Allowed 'Trans proline' 0 C--N 1.313 -1.312 0 O-C-N 123.779 1.41 . . . . 0.5 111.107 -178.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.4 t -129.15 146.75 62.07 Favored Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 121.84 -0.537 . . . . 0.37 110.441 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.69 123.47 9.04 Favored 'Trans proline' 0 C--N 1.314 -1.238 0 O-C-N 123.864 1.455 . . . . 0.34000000000000002 110.49 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.646 ' HB2' HG23 ' A' ' 62' ' ' ILE . 21.8 m-85 -104.42 99.47 9.17 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.508 -0.745 . . . . 0.34000000000000002 110.587 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.8 m -75.7 93.35 3.09 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.085 -1.079 . . . . 0.42999999999999999 108.085 178.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.57 ' O ' HG22 ' A' ' 60' ' ' ILE . 2.7 m-85 -101.91 109.74 21.56 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.306 -0.871 . . . . 0.33000000000000002 111.306 -178.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.597 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 0.0 OUTLIER -81.66 91.15 6.38 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.533 -0.729 . . . . 1.1699999999999999 109.331 179.06 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 1.083 HG11 HD11 ' A' ' 77' ' ' LEU . 38.4 t -79.25 96.96 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.666 -0.646 . . . . 0.29999999999999999 109.955 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.429 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 58.6 mtm -102.17 148.4 25.46 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.405 -0.81 . . . . 0.65000000000000002 110.028 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.443 ' HA3' ' O ' ' A' ' 83' ' ' VAL . . . 166.77 -142.35 7.55 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 110.035 -1.226 . . . . 0.22 110.035 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.622 ' HG3' HG21 ' A' ' 82' ' ' ILE . 0.0 OUTLIER -66.25 153.93 41.23 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.523 -0.987 . . . . 0.44 110.57 -179.934 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -96.58 99.1 10.76 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.568 -0.708 . . . . 0.33000000000000002 110.232 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -128.71 155.82 78.55 Favored Pre-proline 0 N--CA 1.498 1.946 0 O-C-N 121.479 -0.763 . . . . 0.38 110.546 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -72.56 -24.58 18.66 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 O-C-N 123.879 1.463 . . . . 0.42999999999999999 111.367 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.27 -5.62 45.57 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.182 -0.948 . . . . 0.56999999999999995 111.291 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.509 ' CD2' HG21 ' A' ' 58' ' ' VAL . 0.3 OUTLIER -61.14 -55.66 29.83 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.107 -0.995 . . . . 1.0 110.266 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.614 HG12 ' HG2' ' A' ' 45' ' ' PRO . 26.8 m -66.99 -29.48 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.426 -0.796 . . . . 0.37 110.69 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -66.83 -53.42 32.88 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.364 -0.835 . . . . 0.41999999999999998 110.33 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.726 ' O ' HG12 ' A' ' 34' ' ' VAL . 0.3 OUTLIER -68.29 -34.29 75.89 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.25 -0.906 . . . . 1.4199999999999999 110.376 179.594 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.622 HG22 HD22 ' A' ' 77' ' ' LEU . 2.7 t -57.58 -56.09 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.405 -0.81 . . . . 0.25 110.268 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.8 p -66.81 -32.98 60.45 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.352 -0.842 . . . . 0.34000000000000002 111.266 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.19 -54.93 7.21 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.14 -0.975 . . . . 0.84999999999999998 110.772 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.893 HG21 ' CB ' ' A' ' 76' ' ' GLU . 8.2 p -66.66 -29.68 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 121.412 -0.805 . . . . 0.27000000000000002 111.153 -179.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.726 HG11 ' HB2' ' A' ' 43' ' ' TYR . 2.4 p -78.08 -30.66 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.058 -1.026 . . . . 0.33000000000000002 110.304 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -73.67 -38.32 64.97 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.201 -0.937 . . . . 0.67000000000000004 110.063 179.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.27 -25.14 65.91 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.526 -0.734 . . . . 1.45 111.199 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.446 ' CD2' HD11 ' A' ' 73' ' ' LEU . 1.1 m-70 -103.39 -45.62 4.82 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.291 -0.881 . . . . 1.0 110.792 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -106.65 149.51 38.49 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.424 -0.798 . . . . 0.47999999999999998 110.173 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -71.53 142.4 40.31 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 O-C-N 123.858 1.452 . . . . 0.69999999999999996 110.652 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.21 156.26 21.25 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.751 -1.34 . . . . 0.46000000000000002 109.751 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -89.97 140.49 29.58 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.463 -1.021 . . . . 0.55000000000000004 110.127 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.726 ' HB2' HG11 ' A' ' 35' ' ' VAL . 67.8 m-85 -121.76 169.07 11.11 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.556 -0.715 . . . . 0.34000000000000002 110.39 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.695 HG22 ' HD2' ' A' ' 45' ' ' PRO . 2.0 m -142.4 153.19 62.24 Favored Pre-proline 0 N--CA 1.497 1.92 0 O-C-N 121.374 -0.829 . . . . 0.54000000000000004 110.912 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.695 ' HD2' HG22 ' A' ' 44' ' ' THR . 54.3 Cg_endo -95.94 125.06 0.31 Allowed 'Trans proline' 0 C--N 1.32 -0.957 0 C-N-CA 122.022 1.814 . . . . 0.45000000000000001 110.389 178.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 55.5 m -83.04 94.39 7.78 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.09 -1.006 . . . . 0.48999999999999999 109.468 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.674 HG23 HG12 ' A' ' 58' ' ' VAL . 14.1 p -76.76 141.66 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.453 -0.779 . . . . 0.45000000000000001 111.543 -178.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.43 ' HG2' ' O ' ' A' ' 57' ' ' SER . 0.1 OUTLIER -142.46 149.62 51.65 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.724 -0.61 . . . . 0.56999999999999995 109.732 179.293 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -75.04 84.63 1.64 Allowed 'Trans proline' 0 C--N 1.315 -1.197 0 O-C-N 123.9 1.474 . . . . 0.66000000000000003 110.472 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -91.18 -46.47 8.07 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.484 -0.76 . . . . 1.05 109.964 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 13.9 m -110.21 163.27 13.79 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.542 -0.724 . . . . 0.66000000000000003 110.188 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.56 158.99 15.18 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.462 -0.774 . . . . 1.5800000000000001 110.265 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.52 -135.78 12.76 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.579 -1.408 . . . . 0.57999999999999996 109.579 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -103.37 57.76 0.75 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.414 -1.051 . . . . 1.23 110.199 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -135.4 130.21 34.51 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.376 -0.827 . . . . 0.5 110.131 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -132.59 140.53 48.28 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.504 -0.747 . . . . 0.68999999999999995 110.383 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.43 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 28.9 m -108.0 108.93 20.27 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.649 -0.657 . . . . 0.34000000000000002 109.387 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.674 HG12 HG23 ' A' ' 47' ' ' VAL . 2.9 m -109.86 152.75 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.143 -0.973 . . . . 0.39000000000000001 110.858 -179.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.597 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 1.7 t -116.59 111.27 19.65 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.613 -0.884 . . . . 0.73999999999999999 108.613 178.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.599 ' CD1' HG13 ' A' ' 31' ' ' VAL . 10.5 tt -92.21 127.9 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.218 -0.926 . . . . 0.40000000000000002 111.296 -178.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.481 ' O ' ' HB3' ' A' ' 43' ' ' TYR . 65.9 m -90.91 141.16 29.12 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 109.047 -0.723 . . . . 0.42999999999999999 109.047 179.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.646 HD12 HG23 ' A' ' 35' ' ' VAL . 7.8 tt -162.54 141.76 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.012 -1.055 . . . . 0.42999999999999999 110.998 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -108.0 87.56 2.53 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.509 -0.744 . . . . 0.68999999999999995 109.317 178.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.442 ' HB3' ' CD2' ' A' ' 15' ' ' PHE . . . -106.63 136.73 45.91 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.46 -0.775 . . . . 0.33000000000000002 110.524 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.651 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 40.2 p -66.98 -23.47 65.95 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.489 -0.757 . . . . 0.45000000000000001 110.843 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -131.47 157.88 42.34 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.193 -0.942 . . . . 0.56999999999999995 110.525 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.2 tt -75.73 -19.1 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.459 -0.776 . . . . 0.42999999999999999 110.676 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.43 -35.42 79.22 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.243 -0.911 . . . . 0.44 110.403 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -65.21 -48.94 71.61 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.457 -0.777 . . . . 0.88 110.351 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.557 HG23 HG21 ' A' ' 62' ' ' ILE . 8.0 p -70.23 -25.23 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.448 -0.782 . . . . 0.27000000000000002 110.485 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -68.7 -50.5 50.35 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.195 -0.94 . . . . 0.39000000000000001 109.584 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 20.6 p -61.47 -40.01 92.97 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 109.028 -0.73 . . . . 0.38 109.028 178.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.536 HD23 HD12 ' A' ' 62' ' ' ILE . 3.1 mp -59.65 -39.07 83.16 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.665 -0.647 . . . . 0.31 109.709 178.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.66 ' CD1' ' HB ' ' A' ' 86' ' ' VAL . 0.2 OUTLIER -60.36 -44.98 95.06 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.977 -0.749 . . . . 0.44 108.977 178.653 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -69.07 -33.21 73.19 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.59 -0.693 . . . . 1.22 110.322 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.893 ' CB ' HG21 ' A' ' 34' ' ' VAL . 0.3 OUTLIER -64.74 -50.0 68.6 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.464 -0.773 . . . . 0.41999999999999998 109.883 179.48 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 1.083 HD11 HG11 ' A' ' 19' ' ' VAL . 0.4 OUTLIER -78.25 -26.57 47.32 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.42 -0.8 . . . . 0.31 109.698 178.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.501 ' N ' ' HG ' ' A' ' 77' ' ' LEU . . . -105.94 56.25 0.52 Allowed Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.367 -1.493 . . . . 0.26000000000000001 109.367 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.18 4.31 28.83 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.643 -0.916 . . . . 1.4399999999999999 110.573 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.9 mp -60.06 155.27 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.404 -0.81 . . . . 0.42999999999999999 110.094 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.99 -3.93 53.35 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.205 -0.935 . . . . 1.26 111.547 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.622 HG21 ' HG3' ' A' ' 22' ' ' GLN . 39.2 mm -84.71 -104.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.105 -0.997 . . . . 0.37 109.975 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.443 ' O ' ' HA3' ' A' ' 21' ' ' GLY . 84.7 t -124.32 118.73 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 120.943 -1.098 . . . . 0.33000000000000002 110.263 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.33 113.63 19.66 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.517 -0.739 . . . . 1.1299999999999999 109.488 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.476 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 3.1 mtm -139.95 157.12 46.19 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.361 -0.837 . . . . 0.70999999999999996 110.179 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.66 ' HB ' ' CD1' ' A' ' 74' ' ' TYR . 8.1 p -141.74 152.88 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.362 -0.837 . . . . 0.27000000000000002 110.787 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.413 ' HA ' HD22 ' A' ' 87' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.5 2.042 0 CA-C-O 117.52 -1.229 . . . . 0.64000000000000001 110.558 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.123 0.487 . . . . 1.3700000000000001 110.216 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.8 mtmp? -110.09 123.36 49.57 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.539 -0.726 . . . . 0.90000000000000002 109.832 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 16.7 p -70.05 -51.26 33.45 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.316 -0.865 . . . . 0.78000000000000003 109.997 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.05 30.55 2.47 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.615 -0.678 . . . . 0.97999999999999998 110.175 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.44 142.45 43.68 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.334 -0.854 . . . . 1.4299999999999999 110.399 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -72.21 163.26 28.24 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.461 -0.774 . . . . 1.3500000000000001 110.509 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -143.26 171.8 13.61 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.405 -0.81 . . . . 0.68999999999999995 110.703 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.421 HD13 ' HA ' ' A' ' 8' ' ' LEU . 0.4 OUTLIER -114.31 56.68 0.71 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.495 -0.753 . . . . 1.3100000000000001 110.215 179.875 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.8 mp -115.88 -57.27 2.24 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.347 -0.846 . . . . 1.01 109.887 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 55.9 39.3 30.63 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.808 -0.558 . . . . 0.91000000000000003 110.554 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.479 ' O ' ' HA ' ' A' ' 65' ' ' THR . 73.6 t80 -109.66 119.33 48.14 Favored Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 121.386 -0.821 . . . . 0.81999999999999995 109.767 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.508 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 43.9 Cg_endo -70.41 111.36 2.92 Favored 'Trans proline' 0 C--N 1.314 -1.277 0 O-C-N 123.951 1.501 . . . . 0.42999999999999999 110.539 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.6 t -136.62 144.55 47.6 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 121.587 -0.695 . . . . 0.34000000000000002 110.41 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -71.27 126.44 12.32 Favored 'Trans proline' 0 C--N 1.315 -1.188 0 O-C-N 123.997 1.525 . . . . 0.37 110.306 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.623 ' HB2' HG23 ' A' ' 62' ' ' ILE . 25.0 m-85 -107.01 99.75 9.29 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.557 -0.714 . . . . 0.35999999999999999 110.451 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.7 m -78.2 92.68 4.48 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.3 -1.0 . . . . 0.38 108.3 178.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.473 ' O ' HG22 ' A' ' 60' ' ' ILE . 3.4 m-85 -100.53 105.9 17.37 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.535 -0.728 . . . . 0.37 110.959 -178.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.586 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 0.0 OUTLIER -80.8 91.77 5.98 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.351 -0.843 . . . . 1.3400000000000001 109.358 179.341 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 1.081 HG11 HD11 ' A' ' 77' ' ' LEU . 21.9 t -78.58 95.9 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.462 -0.774 . . . . 0.28000000000000003 109.736 -179.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 7.1 ttt -100.68 151.85 21.16 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.55 -0.719 . . . . 1.45 110.052 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 171.47 -165.08 38.02 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.95 -1.26 . . . . 0.29999999999999999 109.95 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.462 ' HB3' HG21 ' A' ' 82' ' ' ILE . 4.5 tt0 -71.38 154.58 41.46 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.501 -0.999 . . . . 1.51 110.142 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.46 109.65 0.29 Allowed 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.747 -0.595 . . . . 0.53000000000000003 110.707 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.589 HD13 ' HD2' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -129.35 114.71 18.4 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.574 -0.704 . . . . 0.70999999999999996 110.112 -179.602 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.589 ' HD2' HD13 ' A' ' 24' ' ' LEU . 44.0 Cg_endo -71.67 -26.0 20.04 Favored 'Trans proline' 0 N--CA 1.49 1.293 0 O-C-N 123.828 1.436 . . . . 0.46999999999999997 111.108 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -81.92 -6.42 59.09 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.216 -0.927 . . . . 0.68000000000000005 111.193 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.626 HD23 HG21 ' A' ' 58' ' ' VAL . 0.3 OUTLIER -60.8 -50.29 74.05 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.985 -1.072 . . . . 0.68000000000000005 110.512 -179.88 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.441 HG23 ' HD2' ' A' ' 45' ' ' PRO . 8.9 p -65.67 -34.08 67.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.392 -0.818 . . . . 0.33000000000000002 110.349 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -66.68 -46.79 74.52 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.338 -0.851 . . . . 0.62 109.812 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.682 ' O ' HG12 ' A' ' 34' ' ' VAL . 3.3 tp60 -72.14 -30.79 65.37 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.476 -0.765 . . . . 1.1799999999999999 110.252 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.627 HG22 HD22 ' A' ' 77' ' ' LEU . 2.3 t -62.79 -46.26 96.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.412 -0.805 . . . . 0.26000000000000001 110.277 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.8 p -76.12 -35.06 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.36 -0.838 . . . . 0.28999999999999998 111.583 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.575 ' CG ' ' HA ' ' A' ' 30' ' ' GLN . 0.5 OUTLIER -76.74 -35.17 57.93 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.709 -1.244 . . . . 0.52000000000000002 110.867 -179.733 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.843 HG21 ' CB ' ' A' ' 76' ' ' GLU . 6.9 p -78.43 -34.02 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.017 -1.052 . . . . 0.27000000000000002 110.014 179.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.95 HG23 HD12 ' A' ' 62' ' ' ILE . 3.9 p -74.01 -31.52 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.271 -0.893 . . . . 0.38 109.607 178.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -75.59 -35.05 60.67 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.323 -0.861 . . . . 1.6200000000000001 109.649 178.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 28.1 mtm180 -66.42 -24.41 66.45 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.485 -0.759 . . . . 0.83999999999999997 110.788 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.533 ' CD2' HD11 ' A' ' 73' ' ' LEU . 4.0 m-70 -104.96 -45.77 4.46 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.216 -0.927 . . . . 0.89000000000000001 110.742 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -96.0 153.64 39.13 Favored Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.428 -0.795 . . . . 0.55000000000000004 109.886 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -69.03 -39.5 7.82 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 O-C-N 123.859 1.452 . . . . 0.93000000000000005 111.317 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -95.1 146.83 18.37 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.871 -1.292 . . . . 0.46000000000000002 109.871 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -77.96 159.97 28.5 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.454 -1.027 . . . . 0.62 109.936 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.57 ' HB2' HG21 ' A' ' 35' ' ' VAL . 40.5 m-85 -143.32 167.51 22.0 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.455 -0.778 . . . . 0.41999999999999998 110.717 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.772 HG22 ' HD2' ' A' ' 45' ' ' PRO . 2.0 m -142.33 155.51 64.47 Favored Pre-proline 0 N--CA 1.499 1.989 0 O-C-N 121.47 -0.769 . . . . 0.41999999999999998 110.99 -179.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.772 ' HD2' HG22 ' A' ' 44' ' ' THR . 51.5 Cg_endo -95.95 137.62 0.67 Allowed 'Trans proline' 0 C--N 1.321 -0.881 0 C-N-CA 121.97 1.78 . . . . 0.56000000000000005 110.447 179.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.462 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 72.4 m -95.6 100.73 12.43 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.217 -0.927 . . . . 0.44 109.463 179.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.635 ' CB ' HG12 ' A' ' 58' ' ' VAL . 13.2 p -76.19 141.56 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.413 -0.805 . . . . 0.38 111.485 -179.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.517 ' HE2' ' HB3' ' A' ' 57' ' ' SER . 0.1 OUTLIER -142.06 151.96 60.38 Favored Pre-proline 0 N--CA 1.494 1.765 0 N-CA-C 109.479 -0.563 . . . . 0.70999999999999996 109.479 179.039 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -75.09 85.19 1.56 Allowed 'Trans proline' 0 C--N 1.313 -1.324 0 O-C-N 124.01 1.532 . . . . 0.5 110.959 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.529 ' HB2' ' HB2' ' A' ' 57' ' ' SER . 1.2 m -91.21 -47.95 7.22 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.496 -0.752 . . . . 0.93000000000000005 109.606 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.413 ' HB2' ' HB3' ' A' ' 55' ' ' TYR . 4.0 m -109.57 159.26 17.24 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.628 -0.67 . . . . 0.57999999999999996 110.028 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.98 160.92 14.0 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.393 -0.817 . . . . 1.29 110.466 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.66 -133.81 11.96 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.549 -1.42 . . . . 0.56999999999999995 109.549 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -100.93 64.66 1.07 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.511 -0.994 . . . . 1.52 109.883 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.413 ' HB3' ' HB2' ' A' ' 51' ' ' SER . 1.6 t80 -145.06 144.79 31.16 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.346 -0.846 . . . . 0.89000000000000001 110.536 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.43 ' CE1' HD22 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -145.13 152.55 40.22 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.492 -0.755 . . . . 0.41999999999999998 110.503 179.809 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.529 ' HB2' ' HB2' ' A' ' 50' ' ' SER . 0.8 OUTLIER -124.47 110.05 14.02 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.397 -0.814 . . . . 1.01 109.758 -179.962 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.635 HG12 ' CB ' ' A' ' 47' ' ' VAL . 2.5 m -109.85 147.66 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.122 -0.986 . . . . 0.33000000000000002 110.711 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.586 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 1.0 OUTLIER -115.24 114.73 25.61 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.965 -0.754 . . . . 0.82999999999999996 108.965 179.209 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.607 ' CD1' HG13 ' A' ' 31' ' ' VAL . 3.9 tt -92.18 128.4 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.232 -0.917 . . . . 0.40000000000000002 110.843 -178.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.404 ' O ' ' HB3' ' A' ' 43' ' ' TYR . 26.3 m -93.88 135.09 35.56 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.707 -0.849 . . . . 0.41999999999999998 108.707 179.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.95 HD12 HG23 ' A' ' 35' ' ' VAL . 3.9 tt -162.46 118.61 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.171 -0.956 . . . . 0.35999999999999999 111.165 -179.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -92.45 100.19 12.79 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.474 -0.766 . . . . 0.53000000000000003 109.005 178.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -115.01 139.55 49.76 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.509 -0.745 . . . . 0.31 110.99 -178.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.508 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 47.6 p -73.47 -6.63 47.62 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.559 -0.713 . . . . 0.44 110.817 179.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 20.8 m80 -129.4 136.31 49.8 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.322 -0.862 . . . . 1.1799999999999999 110.433 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.4 tt -72.11 -24.0 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.483 -0.761 . . . . 0.73999999999999999 109.699 178.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.14 -32.9 61.47 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.411 -0.806 . . . . 0.52000000000000002 110.412 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -60.96 -47.78 84.87 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.477 -0.764 . . . . 0.65000000000000002 110.277 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.576 HG21 ' HB3' ' A' ' 15' ' ' PHE . 11.2 p -71.85 -27.49 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.43 -0.794 . . . . 0.32000000000000001 110.377 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -71.36 -44.67 64.58 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.16 -0.962 . . . . 0.45000000000000001 109.132 178.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 95.4 m -63.11 -37.61 87.87 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 109.03 -0.73 . . . . 0.40999999999999998 109.03 178.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.544 HD21 ' HA ' ' A' ' 35' ' ' VAL . 2.7 mp -62.96 -39.19 93.9 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.716 -0.615 . . . . 0.34000000000000002 109.559 178.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.587 ' CD1' ' HB ' ' A' ' 86' ' ' VAL . 0.5 OUTLIER -60.37 -44.93 95.15 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.519 -0.738 . . . . 0.62 109.068 178.497 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.47 -35.46 80.53 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.587 -0.696 . . . . 0.82999999999999996 110.525 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.843 ' CB ' HG21 ' A' ' 34' ' ' VAL . 0.2 OUTLIER -69.46 -51.68 33.9 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.48 -0.763 . . . . 0.46999999999999997 110.421 179.886 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 1.081 HD11 HG11 ' A' ' 19' ' ' VAL . 0.4 OUTLIER -69.38 -28.4 66.15 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.377 -0.827 . . . . 0.29999999999999999 110.335 179.729 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.476 ' N ' ' HG ' ' A' ' 77' ' ' LEU . . . -107.42 42.9 1.81 Allowed Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.609 -1.397 . . . . 0.33000000000000002 109.609 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.7 4.32 51.91 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.342 -1.093 . . . . 0.72999999999999998 110.694 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.402 ' H ' HD12 ' A' ' 80' ' ' ILE . 1.6 mp -69.25 153.21 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.248 -0.907 . . . . 0.42999999999999999 110.268 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -68.24 -17.47 64.31 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.481 -0.762 . . . . 0.57999999999999996 110.312 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.483 HG22 ' N ' ' A' ' 83' ' ' VAL . 51.8 mm -70.75 170.12 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.547 -0.72 . . . . 0.53000000000000003 110.043 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.483 ' N ' HG22 ' A' ' 82' ' ' ILE . 78.4 t -62.4 114.9 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.37 -0.831 . . . . 0.57999999999999996 110.596 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 5.4 ppt_? -121.42 143.57 49.15 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.86 -0.525 . . . . 1.21 110.117 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.47 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 1.6 ttp -156.42 159.04 38.34 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.166 -0.959 . . . . 0.88 110.486 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.695 HG23 HG22 ' A' ' 19' ' ' VAL . 9.2 p -141.02 156.61 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.44 -0.787 . . . . 0.27000000000000002 110.301 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.46 HD11 ' CZ ' ' A' ' 17' ' ' TYR . 67.3 mt . . . . . 0 N--CA 1.502 2.136 0 CA-C-O 117.655 -1.164 . . . . 0.52000000000000002 110.206 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mtt . . . . . 0 N--CA 1.494 1.754 0 CA-C-O 121.126 0.488 . . . . 2.3300000000000001 110.925 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.46 111.95 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.128 0 CA-C-O 121.353 0.597 . . . . 1.26 110.819 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 91.3 m -103.13 142.87 33.41 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.471 -0.768 . . . . 0.68000000000000005 109.667 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.511 ' HE3' ' CE1' ' A' ' 66' ' ' HIS . 0.0 OUTLIER -132.46 119.22 20.32 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.425 -0.797 . . . . 1.05 110.48 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.44 HD13 HD11 ' A' ' 9' ' ' LEU . 0.8 OUTLIER 53.36 -165.52 0.08 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.763 -0.586 . . . . 1.01 110.896 -179.855 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -135.51 86.0 2.21 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.347 -0.846 . . . . 1.6100000000000001 110.029 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 51.68 59.6 4.45 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.738 -0.601 . . . . 1.1299999999999999 110.749 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.59 -47.87 2.61 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.35 -0.844 . . . . 1.1899999999999999 110.48 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.44 HD11 HD13 ' A' ' 5' ' ' LEU . 1.8 mp -77.19 -50.07 13.76 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.418 -0.801 . . . . 0.82999999999999996 110.02 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 58.82 47.47 12.59 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.161 0.505 . . . . 0.95999999999999996 111.113 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.502 ' O ' ' HA ' ' A' ' 65' ' ' THR . 85.8 t80 -95.51 119.97 64.4 Favored Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 121.381 -0.824 . . . . 0.94999999999999996 109.128 179.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.654 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 42.6 Cg_endo -68.55 106.62 1.47 Allowed 'Trans proline' 0 C--N 1.315 -1.23 0 O-C-N 123.703 1.37 . . . . 0.39000000000000001 110.906 -178.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.1 t -131.88 146.59 62.41 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.851 -0.531 . . . . 0.34000000000000002 110.48 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -72.4 125.93 11.16 Favored 'Trans proline' 0 C--N 1.315 -1.222 0 O-C-N 123.862 1.454 . . . . 0.34999999999999998 110.398 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.5 ' HB2' HG23 ' A' ' 62' ' ' ILE . 23.9 m-85 -106.16 99.6 9.18 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.556 -0.715 . . . . 0.32000000000000001 110.632 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.4 m -76.06 92.88 3.22 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 107.982 -1.118 . . . . 0.42999999999999999 107.982 178.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.532 ' O ' HG22 ' A' ' 60' ' ' ILE . 2.6 m-85 -100.1 109.47 21.77 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.397 -0.815 . . . . 0.42999999999999999 111.327 -177.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.543 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 0.1 OUTLIER -81.26 90.45 6.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.592 -0.693 . . . . 0.93000000000000005 109.402 179.156 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.996 HG11 HD11 ' A' ' 77' ' ' LEU . 32.1 t -79.64 98.07 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.623 -0.673 . . . . 0.34000000000000002 109.945 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.435 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 36.7 mtm -106.15 147.55 28.89 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.575 -0.703 . . . . 0.67000000000000004 110.085 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.418 ' HA3' ' O ' ' A' ' 83' ' ' VAL . . . 170.14 -141.5 6.63 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.088 -1.205 . . . . 0.26000000000000001 110.088 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.747 ' HG3' HG21 ' A' ' 82' ' ' ILE . 0.0 OUTLIER -66.04 154.33 39.81 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.547 -0.973 . . . . 0.60999999999999999 110.626 -179.817 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.576 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -93.08 97.93 11.0 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.491 -0.756 . . . . 0.34000000000000002 110.305 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -130.44 154.23 81.53 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.523 -0.736 . . . . 0.40999999999999998 110.49 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.03 -19.94 22.44 Favored 'Trans proline' 0 C--N 1.313 -1.316 0 O-C-N 124.041 1.548 . . . . 0.42999999999999999 111.477 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -75.98 -5.08 44.64 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.084 -1.01 . . . . 0.56999999999999995 111.358 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.4 mt -60.35 -59.92 4.63 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.067 -1.021 . . . . 0.62 110.219 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.604 HG12 ' HG2' ' A' ' 45' ' ' PRO . 33.6 m -64.99 -29.96 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.436 -0.79 . . . . 0.34999999999999998 110.796 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -67.28 -55.06 15.5 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.395 -0.816 . . . . 0.48999999999999999 110.229 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.72 ' O ' HG12 ' A' ' 34' ' ' VAL . 16.0 tp60 -67.1 -34.85 78.51 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.319 -0.863 . . . . 0.68999999999999995 110.643 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.842 HG22 HD22 ' A' ' 77' ' ' LEU . 3.0 t -59.06 -57.78 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.409 -0.807 . . . . 0.25 110.366 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.428 ' HA ' HG12 ' A' ' 35' ' ' VAL . 9.8 p -64.37 -33.07 60.36 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.323 -0.86 . . . . 0.31 111.424 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.6 -55.01 8.59 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.134 -0.979 . . . . 0.63 110.913 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.897 HG21 ' CB ' ' A' ' 76' ' ' GLU . 10.0 p -68.58 -27.58 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.407 -0.808 . . . . 0.28999999999999998 111.481 -179.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.887 HG23 HD12 ' A' ' 62' ' ' ILE . 2.4 p -80.64 -28.94 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.028 -1.045 . . . . 0.38 110.732 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -79.59 -40.96 28.15 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.264 -0.897 . . . . 1.27 110.143 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.3 mtm180 -66.62 -22.85 66.11 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.39 -0.819 . . . . 2.5 111.299 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.672 ' CG ' HD11 ' A' ' 73' ' ' LEU . 39.4 m-70 -105.23 -45.79 4.4 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.208 -0.933 . . . . 1.3200000000000001 110.667 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -106.72 143.41 26.98 Favored Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 121.438 -0.789 . . . . 0.58999999999999997 110.247 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -72.12 144.81 42.96 Favored 'Trans proline' 0 C--N 1.314 -1.27 0 O-C-N 123.827 1.435 . . . . 0.79000000000000004 110.786 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 91.66 148.35 21.9 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.532 -1.427 . . . . 0.5 109.532 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -82.01 134.27 35.35 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.531 -0.982 . . . . 1.22 110.113 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.652 ' HB2' HG11 ' A' ' 35' ' ' VAL . 38.8 m-85 -123.95 157.49 34.22 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.623 -0.673 . . . . 0.40999999999999998 110.402 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.732 HG22 ' HD2' ' A' ' 45' ' ' PRO . 1.4 m -142.36 153.38 62.59 Favored Pre-proline 0 N--CA 1.498 1.937 0 O-C-N 121.515 -0.741 . . . . 0.59999999999999998 110.955 -179.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.732 ' HD2' HG22 ' A' ' 44' ' ' THR . 55.3 Cg_endo -95.27 133.15 0.56 Allowed 'Trans proline' 0 C--N 1.32 -0.962 0 C-N-CA 121.898 1.732 . . . . 0.53000000000000003 110.579 179.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.452 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 51.5 m -89.93 93.99 9.63 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.187 -0.945 . . . . 0.39000000000000001 109.289 179.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.645 ' CB ' HG12 ' A' ' 58' ' ' VAL . 14.4 p -76.46 137.26 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.498 -0.752 . . . . 0.39000000000000001 111.589 -178.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.448 ' HE2' ' HB3' ' A' ' 57' ' ' SER . 0.5 OUTLIER -142.47 149.8 52.28 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.728 -0.608 . . . . 0.87 109.833 179.247 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -76.1 84.84 1.74 Allowed 'Trans proline' 0 C--N 1.314 -1.272 0 O-C-N 123.872 1.459 . . . . 0.55000000000000004 110.578 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.0 -45.65 9.04 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.363 -0.835 . . . . 1.0 109.817 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.403 ' HB2' ' CD1' ' A' ' 55' ' ' TYR . 0.4 OUTLIER -106.82 167.93 9.53 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.473 -0.767 . . . . 0.93999999999999995 110.218 179.573 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.62 158.25 16.07 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.401 -0.812 . . . . 1.55 110.44 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.88 -137.38 13.73 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.554 -1.418 . . . . 0.59999999999999998 109.554 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -100.62 63.84 1.09 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.596 -0.944 . . . . 1.3799999999999999 110.217 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.403 ' CD1' ' HB2' ' A' ' 51' ' ' SER . 14.6 t80 -137.99 130.87 29.93 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.492 -0.755 . . . . 0.53000000000000003 110.178 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.576 ' HB2' ' HA ' ' A' ' 23' ' ' ALA . 0.1 OUTLIER -129.73 137.03 50.35 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.495 -0.753 . . . . 0.89000000000000001 110.29 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.448 ' HB3' ' HE2' ' A' ' 48' ' ' LYS . 6.1 m -110.18 105.46 14.54 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.598 -0.689 . . . . 0.35999999999999999 109.392 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.645 HG12 ' CB ' ' A' ' 47' ' ' VAL . 2.8 m -108.36 147.57 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.219 -0.926 . . . . 0.37 110.84 -179.267 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.543 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 8.6 t -112.1 112.16 23.58 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.403 -0.81 . . . . 0.45000000000000001 108.843 179.117 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.636 ' CD1' HG13 ' A' ' 31' ' ' VAL . 9.6 tt -92.33 126.86 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.217 -0.927 . . . . 0.33000000000000002 111.265 -178.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.412 ' O ' ' HB3' ' A' ' 43' ' ' TYR . 19.1 m -91.72 136.06 33.42 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.944 -0.762 . . . . 0.42999999999999999 108.944 179.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.887 HD12 HG23 ' A' ' 35' ' ' VAL . 5.9 tt -162.5 131.27 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.276 -0.89 . . . . 0.42999999999999999 110.72 -179.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -99.68 98.18 9.05 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.358 -0.838 . . . . 0.52000000000000002 109.698 179.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -113.67 139.69 48.84 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.451 -0.781 . . . . 0.26000000000000001 110.227 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.654 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 33.9 p -66.54 -22.64 66.16 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.465 -0.772 . . . . 0.34999999999999998 110.864 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.511 ' CE1' ' HE3' ' A' ' 4' ' ' LYS . 1.2 t60 -131.64 157.65 43.15 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.146 -0.971 . . . . 0.56999999999999995 110.8 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.3 tt -79.9 -16.75 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.529 -0.732 . . . . 0.40999999999999998 110.407 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.14 -33.09 71.37 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.125 -0.985 . . . . 0.46000000000000002 110.124 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.449 ' O ' HD13 ' A' ' 73' ' ' LEU . 0.0 OUTLIER -68.12 -48.75 64.59 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.353 -0.842 . . . . 1.24 110.053 179.549 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.464 HG23 HG21 ' A' ' 62' ' ' ILE . 7.6 p -69.25 -25.02 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.387 -0.821 . . . . 0.33000000000000002 110.262 179.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -69.02 -51.04 43.33 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.252 -0.905 . . . . 0.40999999999999998 109.529 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 20.1 p -62.02 -38.26 87.98 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.526 -0.734 . . . . 0.37 109.284 178.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.672 HD11 ' CG ' ' A' ' 38' ' ' HIS . 5.4 mp -61.33 -40.3 93.73 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 109.304 -0.628 . . . . 0.37 109.304 178.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.642 ' CD1' ' HB ' ' A' ' 86' ' ' VAL . 0.1 OUTLIER -59.16 -42.81 91.63 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.858 -0.793 . . . . 0.55000000000000004 108.858 178.387 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -68.5 -34.94 76.78 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.565 -0.709 . . . . 1.3500000000000001 110.336 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.897 ' CB ' HG21 ' A' ' 34' ' ' VAL . 0.3 OUTLIER -62.99 -48.59 78.17 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.488 -0.758 . . . . 0.48999999999999999 110.03 179.482 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.996 HD11 HG11 ' A' ' 19' ' ' VAL . 0.3 OUTLIER -79.38 -29.42 42.09 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.45 -0.781 . . . . 0.29999999999999999 110.132 179.387 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.502 ' N ' ' HG ' ' A' ' 77' ' ' LEU . . . -102.59 56.36 0.64 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.266 -1.533 . . . . 0.26000000000000001 109.266 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.3 tttt -106.22 4.59 29.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.698 -0.883 . . . . 1.6100000000000001 110.774 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.468 HG22 ' H ' ' A' ' 82' ' ' ILE . 2.5 mp -59.78 154.99 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.335 -0.853 . . . . 0.45000000000000001 110.111 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.16 -4.55 55.74 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.285 -0.884 . . . . 1.52 111.505 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.747 HG21 ' HG3' ' A' ' 22' ' ' GLN . 48.9 mm -85.52 -103.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 120.921 -1.112 . . . . 0.47999999999999998 110.175 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.432 HG23 HG22 ' A' ' 82' ' ' ILE . 88.3 t -123.99 118.75 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 120.822 -1.174 . . . . 0.40000000000000002 110.298 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.47 111.24 16.59 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.614 -0.679 . . . . 0.96999999999999997 109.543 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.509 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 0.4 OUTLIER -136.73 154.93 50.45 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.36 -0.838 . . . . 0.78000000000000003 110.392 -179.812 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.642 ' HB ' ' CD1' ' A' ' 74' ' ' TYR . 8.0 p -141.81 151.29 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.445 -0.784 . . . . 0.34999999999999998 110.572 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.427 HD22 ' HA ' ' A' ' 87' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.5 2.067 0 CA-C-O 117.545 -1.217 . . . . 0.52000000000000002 110.474 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.758 0 CA-C-O 121.149 0.5 . . . . 1.28 110.118 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.401 ' HG2' HG21 ' A' ' 13' ' ' THR . 0.2 OUTLIER -116.03 -173.13 2.3 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.475 -0.766 . . . . 1.04 110.502 -179.674 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.8 t -136.05 164.02 28.98 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.426 -0.796 . . . . 0.78000000000000003 110.303 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.07 112.26 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.236 0 CA-C-O 121.34 0.591 . . . . 1.4199999999999999 110.542 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.426 ' HA ' ' HB ' ' A' ' 67' ' ' ILE . 1.5 pp -73.7 137.05 43.82 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.49 -0.756 . . . . 0.97999999999999998 110.69 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -144.75 137.0 26.17 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.433 -0.792 . . . . 0.93000000000000005 110.52 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -104.62 -3.16 24.12 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.385 -0.822 . . . . 1.03 111.051 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.4 HD13 ' HA ' ' A' ' 8' ' ' LEU . 0.5 OUTLIER -90.35 -36.42 14.65 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.117 -0.989 . . . . 1.26 110.364 -179.974 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.7 mp -89.19 -48.32 7.46 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.406 -0.809 . . . . 0.81999999999999995 109.89 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 53.92 67.11 1.06 Allowed 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.595 0.712 . . . . 0.69999999999999996 110.549 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.453 ' O ' ' HA ' ' A' ' 65' ' ' THR . 82.8 t80 -95.58 124.2 53.73 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.479 -0.763 . . . . 0.78000000000000003 109.865 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.541 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 44.2 Cg_endo -70.78 112.35 3.24 Favored 'Trans proline' 0 C--N 1.315 -1.232 0 O-C-N 123.996 1.524 . . . . 0.31 110.434 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.401 HG21 ' HG2' ' A' ' 2' ' ' LYS . 11.2 t -124.87 145.72 50.88 Favored Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 121.608 -0.683 . . . . 0.31 110.438 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.73 120.26 6.57 Favored 'Trans proline' 0 C--N 1.315 -1.227 0 O-C-N 123.897 1.472 . . . . 0.34000000000000002 110.311 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.521 ' HB2' HG23 ' A' ' 62' ' ' ILE . 18.3 m-85 -102.88 99.71 9.64 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.568 -0.707 . . . . 0.33000000000000002 110.606 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.7 p -74.45 101.15 4.04 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.545 -0.909 . . . . 0.28000000000000003 108.545 178.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -114.77 160.04 19.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.395 -0.816 . . . . 0.37 111.024 -178.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.684 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 7.6 mttt -135.97 99.18 4.08 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.099 -0.704 . . . . 2.0600000000000001 109.099 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.988 HG11 HD11 ' A' ' 77' ' ' LEU . 10.2 t -79.76 98.31 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.445 -0.784 . . . . 0.26000000000000001 109.399 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 63.0 mtm -106.66 157.77 17.45 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.32 -0.862 . . . . 0.69999999999999996 110.298 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 164.2 -160.59 33.58 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 110.089 -1.204 . . . . 0.28999999999999998 110.089 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.418 ' HB3' ' CG2' ' A' ' 82' ' ' ILE . 0.0 OUTLIER -70.27 156.48 39.21 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.496 -1.003 . . . . 1.51 110.085 179.868 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -48.4 110.13 0.31 Allowed 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.776 -0.578 . . . . 0.51000000000000001 110.814 -179.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.472 HD13 ' HD2' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -130.51 110.99 16.34 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.554 -0.716 . . . . 0.52000000000000002 109.966 -179.872 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.472 ' HD2' HD13 ' A' ' 24' ' ' LEU . 44.9 Cg_endo -72.6 -30.48 11.95 Favored 'Trans proline' 0 C--N 1.315 -1.209 0 O-C-N 123.914 1.481 . . . . 0.54000000000000004 111.05 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -77.5 -7.12 55.75 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.228 -0.92 . . . . 0.68999999999999995 111.291 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.469 ' O ' HG23 ' A' ' 31' ' ' VAL . 0.3 OUTLIER -58.24 -55.14 38.89 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.947 -1.095 . . . . 0.64000000000000001 110.308 -179.952 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.552 HG23 ' HD2' ' A' ' 45' ' ' PRO . 11.9 p -61.04 -34.9 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 121.461 -0.774 . . . . 0.32000000000000001 110.559 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.441 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 10.1 m-20 -64.23 -49.46 71.84 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.479 -0.763 . . . . 0.53000000000000003 110.125 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.73 ' O ' HG12 ' A' ' 34' ' ' VAL . 13.3 tp60 -71.64 -31.74 67.18 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.477 -0.764 . . . . 0.55000000000000004 110.517 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.702 HG22 HD22 ' A' ' 77' ' ' LEU . 7.3 t -58.71 -52.48 59.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.324 -0.86 . . . . 0.23999999999999999 110.043 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.431 ' HA ' HG12 ' A' ' 35' ' ' VAL . 8.9 p -73.32 -30.54 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.414 -0.804 . . . . 0.33000000000000002 111.198 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.441 ' HB2' ' O ' ' A' ' 29' ' ' ASP . 0.8 OUTLIER -73.64 -50.48 20.83 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.045 -1.034 . . . . 0.55000000000000004 110.484 179.958 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.757 HG21 ' CB ' ' A' ' 76' ' ' GLU . 9.8 p -67.45 -32.41 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.426 -0.796 . . . . 0.34000000000000002 110.706 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.555 HG21 ' HB2' ' A' ' 43' ' ' TYR . 2.5 p -77.17 -27.45 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.046 -1.034 . . . . 0.34000000000000002 110.02 179.112 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -74.18 -36.29 64.04 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.293 -0.88 . . . . 0.75 109.602 178.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 52.7 mtm180 -73.1 -25.82 61.01 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.478 -0.764 . . . . 0.89000000000000001 110.758 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.767 ' CG ' HD11 ' A' ' 73' ' ' LEU . 43.0 m-70 -98.39 -45.8 6.01 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.368 -0.833 . . . . 0.67000000000000004 110.715 -179.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -102.8 151.84 38.39 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 121.481 -0.762 . . . . 0.63 109.975 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -69.83 -41.1 4.47 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.855 1.45 . . . . 1.0700000000000001 110.895 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -86.45 144.79 20.01 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.494 -1.442 . . . . 0.46000000000000002 109.494 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.08 149.06 29.36 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.37 -1.076 . . . . 0.59999999999999998 110.047 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.555 ' HB2' HG21 ' A' ' 35' ' ' VAL . 42.3 m-85 -132.43 161.13 34.46 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.572 -0.705 . . . . 0.47999999999999998 110.762 -179.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.67 HG22 ' HD2' ' A' ' 45' ' ' PRO . 3.7 m -142.6 153.49 61.91 Favored Pre-proline 0 N--CA 1.499 2.01 0 O-C-N 121.484 -0.76 . . . . 0.39000000000000001 111.016 -179.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.67 ' HD2' HG22 ' A' ' 44' ' ' THR . 51.9 Cg_endo -95.1 148.75 1.59 Allowed 'Trans proline' 0 C--N 1.319 -0.997 0 C-N-CA 121.832 1.688 . . . . 0.55000000000000004 110.479 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.522 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 56.9 m -106.81 96.84 6.72 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.174 -0.954 . . . . 0.39000000000000001 109.142 179.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.586 HG23 HG12 ' A' ' 58' ' ' VAL . 12.4 p -75.49 139.38 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.364 -0.835 . . . . 0.32000000000000001 111.771 -178.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.59 153.98 62.57 Favored Pre-proline 0 N--CA 1.494 1.758 0 N-CA-C 109.69 -0.485 . . . . 0.93000000000000005 109.69 179.338 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -76.19 85.5 1.66 Allowed 'Trans proline' 0 C--N 1.314 -1.254 0 O-C-N 124.07 1.563 . . . . 0.52000000000000002 110.536 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.6 m -87.51 -49.98 6.83 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.407 -0.808 . . . . 1.0 109.967 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.604 ' HB3' ' HB3' ' A' ' 55' ' ' TYR . 1.0 OUTLIER -106.93 162.75 13.55 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.512 -0.742 . . . . 0.94999999999999996 110.076 179.738 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.45 154.55 17.21 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.336 -0.853 . . . . 1.71 110.604 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.13 -134.37 11.65 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.742 -1.343 . . . . 0.59999999999999998 109.742 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -103.37 60.19 0.76 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.633 -0.922 . . . . 0.80000000000000004 110.308 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.604 ' HB3' ' HB3' ' A' ' 51' ' ' SER . 22.3 t80 -135.77 147.75 48.5 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.401 -0.812 . . . . 0.81999999999999995 110.169 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 4.1 p-80 -145.45 147.32 32.08 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.478 -0.764 . . . . 0.38 110.54 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.8 m -125.81 117.71 23.98 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.389 -0.819 . . . . 0.34999999999999998 109.524 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.586 HG12 HG23 ' A' ' 47' ' ' VAL . 1.3 m -115.04 139.64 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.188 -0.945 . . . . 0.27000000000000002 111.388 -179.17 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.54 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 7.5 t -95.64 108.0 20.24 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.352 -0.981 . . . . 0.60999999999999999 108.352 178.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.573 ' HA ' ' HA ' ' A' ' 45' ' ' PRO . 12.1 tt -92.4 125.79 44.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.256 -0.902 . . . . 0.34999999999999998 111.208 -178.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.48 ' O ' ' HB3' ' A' ' 43' ' ' TYR . 98.5 m -93.03 135.51 34.14 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.364 -0.976 . . . . 0.40999999999999998 108.364 178.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.521 HG23 ' HB2' ' A' ' 15' ' ' PHE . 12.6 tt -160.46 145.18 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.076 -1.015 . . . . 0.38 111.059 -179.203 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -121.62 111.13 16.83 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.62 -0.675 . . . . 0.41999999999999998 109.305 179.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.453 ' HB1' ' HB3' ' A' ' 69' ' ' GLN . . . -121.46 141.47 50.98 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.47 -0.769 . . . . 0.26000000000000001 110.762 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 26.1 p -77.33 -4.5 45.42 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.506 -0.746 . . . . 0.32000000000000001 111.219 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.651 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 62.1 t60 -130.37 150.32 51.65 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.216 -0.927 . . . . 0.48999999999999999 110.191 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.439 ' O ' HG12 ' A' ' 70' ' ' VAL . 7.5 mm -70.67 -48.39 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 121.47 -0.769 . . . . 0.48999999999999999 110.087 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.55 -18.46 65.38 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.454 -0.779 . . . . 0.75 111.236 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.651 ' HB2' ' HB3' ' A' ' 66' ' ' HIS . 0.3 OUTLIER -59.11 -58.87 6.75 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.263 -0.898 . . . . 1.1200000000000001 110.405 179.901 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.439 HG12 ' O ' ' A' ' 67' ' ' ILE . 8.0 p -59.57 -26.98 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.416 -0.803 . . . . 0.31 110.924 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.23 -45.66 62.8 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.265 -0.897 . . . . 0.81999999999999995 109.668 179.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 67.5 m -62.39 -41.17 98.44 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.573 -0.705 . . . . 0.34000000000000002 109.728 179.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.767 HD11 ' CG ' ' A' ' 38' ' ' HIS . 4.7 mp -65.08 -36.39 84.18 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.636 -0.665 . . . . 0.55000000000000004 110.047 179.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.627 ' CD1' ' HB ' ' A' ' 86' ' ' VAL . 0.3 OUTLIER -61.32 -46.09 91.74 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.46 -0.775 . . . . 0.52000000000000002 109.105 178.837 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.56 -33.82 76.8 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.522 -0.736 . . . . 1.1699999999999999 109.887 179.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.757 ' CB ' HG21 ' A' ' 34' ' ' VAL . 28.1 mt-10 -65.03 -43.47 92.31 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.411 -0.805 . . . . 0.37 109.889 179.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.988 HD11 HG11 ' A' ' 19' ' ' VAL . 0.4 OUTLIER -80.73 -29.68 36.33 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.358 -0.839 . . . . 0.27000000000000002 109.964 178.943 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.509 ' N ' ' HG ' ' A' ' 77' ' ' LEU . . . -105.26 54.32 0.61 Allowed Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.475 -1.45 . . . . 0.29999999999999999 109.475 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.97 4.12 29.11 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.567 -0.961 . . . . 0.94999999999999996 110.563 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.411 HD12 ' H ' ' A' ' 80' ' ' ILE . 1.7 mp -68.6 154.46 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.34 -0.85 . . . . 0.33000000000000002 110.175 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -66.16 -20.67 66.21 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.361 -0.837 . . . . 0.72999999999999998 110.155 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.44 HG22 ' N ' ' A' ' 83' ' ' VAL . 43.3 mm -68.91 166.75 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.422 -0.798 . . . . 0.38 109.895 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.44 ' N ' HG22 ' A' ' 82' ' ' ILE . 76.6 t -62.47 114.39 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.287 -0.883 . . . . 0.46999999999999997 110.779 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.25 137.16 54.81 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.774 -0.579 . . . . 1.22 109.615 179.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.424 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 2.7 mtm -151.92 160.21 43.58 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.158 -0.964 . . . . 1.49 110.523 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.627 ' HB ' ' CD1' ' A' ' 74' ' ' TYR . 5.4 p -142.14 155.23 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.463 -0.773 . . . . 0.31 110.378 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.684 ' HB3' ' HB2' ' A' ' 18' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.494 1.764 0 CA-C-O 117.896 -1.05 . . . . 0.34000000000000002 109.824 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.816 0 N-CA-C 110.081 -0.34 . . . . 1.77 110.081 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.67 144.1 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.194 0 CA-C-O 121.494 0.664 . . . . 0.78000000000000003 111.15 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.462 HG23 ' O ' ' A' ' 38' ' ' HIS . 24.0 m -138.96 -62.94 0.54 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.212 -0.93 . . . . 0.51000000000000001 110.361 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.11 148.52 29.76 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.315 -0.866 . . . . 0.88 110.733 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.78 -165.76 1.33 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.442 -0.786 . . . . 1.1599999999999999 110.314 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -59.7 117.47 4.99 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.276 -0.89 . . . . 1.6699999999999999 110.504 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.16 153.87 26.47 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.668 -0.645 . . . . 0.67000000000000004 110.607 -179.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.51 38.14 4.08 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.561 -0.712 . . . . 0.94999999999999996 110.237 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.7 mp -128.27 -62.61 1.04 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.252 -0.905 . . . . 0.72999999999999998 110.011 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 55.56 52.58 10.89 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.673 -0.642 . . . . 0.58999999999999997 110.791 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.424 ' O ' ' HA ' ' A' ' 65' ' ' THR . 72.9 t80 -95.54 112.47 59.03 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.316 -0.865 . . . . 0.84999999999999998 109.551 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.6 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 44.0 Cg_endo -70.63 108.77 2.32 Favored 'Trans proline' 0 C--N 1.314 -1.243 0 O-C-N 123.994 1.523 . . . . 0.35999999999999999 110.557 -179.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.9 t -128.06 142.4 44.32 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.669 -0.644 . . . . 0.34000000000000002 110.172 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -72.37 129.88 15.48 Favored 'Trans proline' 0 C--N 1.314 -1.277 0 O-C-N 123.939 1.494 . . . . 0.37 110.631 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.692 ' HB3' HG21 ' A' ' 70' ' ' VAL . 33.9 m-85 -112.01 100.89 9.24 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.583 -0.698 . . . . 0.35999999999999999 110.022 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 16.5 m -73.52 92.96 1.94 Allowed 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 108.497 -0.927 . . . . 0.42999999999999999 108.497 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.598 ' O ' HG22 ' A' ' 60' ' ' ILE . 3.3 m-85 -103.82 102.16 11.98 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.464 -0.773 . . . . 0.34999999999999998 110.858 -178.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.649 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 0.0 OUTLIER -77.77 89.19 4.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.671 -0.643 . . . . 1.3400000000000001 109.89 179.805 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.779 HG23 HG13 ' A' ' 58' ' ' VAL . 1.2 m -82.51 108.22 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 C-N-CA 119.358 -0.937 . . . . 0.27000000000000002 109.413 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.1 mtp -108.05 151.72 25.46 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.553 -0.717 . . . . 0.95999999999999996 110.567 -179.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 178.28 -159.81 25.51 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.82 -1.312 . . . . 0.34000000000000002 109.82 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.537 ' HA ' ' HA ' ' A' ' 55' ' ' TYR . 0.9 OUTLIER -70.44 -179.8 2.21 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.426 -1.044 . . . . 0.85999999999999999 110.503 179.973 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.61 100.01 2.2 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.392 -0.817 . . . . 0.47999999999999998 110.126 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.421 ' O ' HD23 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -122.94 108.56 32.53 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.516 -0.74 . . . . 0.90000000000000002 109.923 -179.773 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.402 ' HD2' HD13 ' A' ' 24' ' ' LEU . 44.0 Cg_endo -69.91 -15.44 36.54 Favored 'Trans proline' 0 N--CA 1.491 1.354 0 O-C-N 123.805 1.424 . . . . 0.63 111.588 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -83.09 -0.41 48.93 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.201 -0.937 . . . . 1.1200000000000001 111.476 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.687 HD13 HG21 ' A' ' 58' ' ' VAL . 3.1 pp -58.84 -35.11 72.37 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.906 -1.121 . . . . 0.60999999999999999 110.906 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.451 ' N ' HD12 ' A' ' 27' ' ' LEU . 9.8 p -75.35 -32.9 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.066 -1.021 . . . . 0.40000000000000002 110.557 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -64.77 -48.75 73.39 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.442 -0.786 . . . . 0.63 110.085 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.7 ' HG2' ' HA ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -72.92 -37.3 67.25 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.474 -0.766 . . . . 1.04 110.698 179.937 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.995 HG22 HD12 ' A' ' 60' ' ' ILE . 4.2 t -57.11 -47.09 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.31 -0.869 . . . . 0.26000000000000001 110.885 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.2 p -76.33 -37.19 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.251 -0.905 . . . . 0.34000000000000002 111.577 -179.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.529 ' CG ' ' HA ' ' A' ' 30' ' ' GLN . 0.2 OUTLIER -75.94 -31.37 59.05 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.828 -1.17 . . . . 0.56000000000000005 110.912 -179.869 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.681 HG21 ' HB2' ' A' ' 76' ' ' GLU . 5.4 p -79.98 -35.02 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.092 -1.005 . . . . 0.23999999999999999 110.14 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.565 HG21 ' HB2' ' A' ' 43' ' ' TYR . 9.7 p -73.99 -29.94 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.181 -0.95 . . . . 0.31 109.446 178.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -77.08 -36.39 55.81 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.435 -0.791 . . . . 0.76000000000000001 109.997 179.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.7 mtp-105 -65.92 -27.09 67.93 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.42 -0.8 . . . . 0.91000000000000003 111.085 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.509 ' CD2' HD11 ' A' ' 73' ' ' LEU . 17.3 m-70 -105.16 -45.86 4.4 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.334 -0.853 . . . . 0.48999999999999999 110.599 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -100.21 150.14 36.65 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.509 -0.745 . . . . 0.38 109.808 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -70.04 -38.46 7.16 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.759 1.4 . . . . 0.59999999999999998 111.15 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -85.78 145.3 20.82 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.918 -1.273 . . . . 0.42999999999999999 109.918 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.83 150.08 22.39 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.523 -0.987 . . . . 0.52000000000000002 109.864 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.565 ' HB2' HG21 ' A' ' 35' ' ' VAL . 51.9 m-85 -135.9 178.86 6.72 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.495 -0.753 . . . . 0.39000000000000001 110.779 -179.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.839 HG22 ' HD2' ' A' ' 45' ' ' PRO . 0.2 OUTLIER -141.0 157.0 68.18 Favored Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 121.476 -0.765 . . . . 0.47999999999999998 110.847 -179.064 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.839 ' HD2' HG22 ' A' ' 44' ' ' THR . 51.7 Cg_endo -93.75 163.27 2.26 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 C-N-CA 121.784 1.656 . . . . 0.40999999999999998 110.366 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.494 ' C ' HG23 ' A' ' 58' ' ' VAL . 44.6 m -127.34 88.79 2.85 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.341 -0.85 . . . . 0.39000000000000001 109.063 178.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.475 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 11.4 p -83.11 142.74 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.401 -0.812 . . . . 0.34000000000000002 111.651 -178.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.99 152.54 58.84 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.698 -0.626 . . . . 0.72999999999999998 109.841 179.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -75.33 82.9 1.96 Allowed 'Trans proline' 0 C--N 1.314 -1.268 0 O-C-N 123.845 1.445 . . . . 0.55000000000000004 110.411 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.5 m -88.02 -43.95 11.35 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.477 -0.764 . . . . 0.84999999999999998 110.089 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -102.74 166.18 10.64 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.595 -0.69 . . . . 0.96999999999999997 110.292 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.16 155.81 17.54 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.412 -0.805 . . . . 1.8999999999999999 110.48 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.33 -136.27 13.03 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.63 -1.388 . . . . 0.60999999999999999 109.63 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -102.17 63.52 0.9 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.574 -0.957 . . . . 0.62 110.172 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.537 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 15.0 t80 -140.99 139.44 34.2 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.395 -0.816 . . . . 0.91000000000000003 110.183 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -139.57 136.91 34.92 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.589 -0.694 . . . . 0.88 110.469 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.3 m -108.67 120.66 43.13 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.64 -0.663 . . . . 0.38 109.318 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.779 HG13 HG23 ' A' ' 19' ' ' VAL . 3.2 p -127.01 145.27 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.257 -0.902 . . . . 0.23999999999999999 111.485 -178.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.649 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 66.5 p -111.79 118.07 34.56 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.636 -0.665 . . . . 0.34999999999999998 109.51 179.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.995 HD12 HG22 ' A' ' 31' ' ' VAL . 7.0 tt -94.55 134.5 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.436 -0.79 . . . . 0.32000000000000001 111.249 -179.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 52.9 m -89.19 114.37 25.67 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.58 -0.896 . . . . 0.37 108.58 178.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.608 HD11 HD11 ' A' ' 60' ' ' ILE . 32.3 mm -122.42 99.32 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.171 -0.956 . . . . 0.34000000000000002 111.299 -178.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -88.59 86.25 6.97 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.108 -0.995 . . . . 0.45000000000000001 108.703 178.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.719 ' HB1' ' HB3' ' A' ' 69' ' ' GLN . . . -102.84 140.14 37.51 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.605 -0.685 . . . . 0.23999999999999999 111.042 -178.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.6 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 32.9 p -75.86 -6.84 52.71 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.667 -0.646 . . . . 0.38 110.981 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.421 ' HB3' ' HB2' ' A' ' 69' ' ' GLN . 4.2 t-160 -129.73 158.59 38.97 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.265 -0.897 . . . . 0.45000000000000001 110.454 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.461 ' O ' HG12 ' A' ' 70' ' ' VAL . 1.8 mt -73.68 -46.92 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.588 -0.695 . . . . 0.80000000000000004 109.851 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.5 -21.28 66.63 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.495 -0.753 . . . . 0.72999999999999998 110.998 179.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.719 ' HB3' ' HB1' ' A' ' 64' ' ' ALA . 9.9 tt0 -61.04 -52.6 64.28 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.238 -0.914 . . . . 0.38 110.44 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.692 HG21 ' HB3' ' A' ' 15' ' ' PHE . 7.4 p -69.73 -27.42 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.335 -0.853 . . . . 0.29999999999999999 110.332 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.56 -52.7 59.92 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.275 -0.89 . . . . 0.92000000000000004 109.533 179.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.8 p -62.65 -37.35 86.04 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.541 -0.724 . . . . 0.37 109.298 178.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.509 HD11 ' CD2' ' A' ' 38' ' ' HIS . 2.0 mp -61.85 -39.77 93.01 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.666 -0.646 . . . . 0.29999999999999999 110.021 179.207 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.49 ' CD1' ' C ' ' A' ' 74' ' ' TYR . 0.0 OUTLIER -63.51 -45.97 88.21 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.552 -0.718 . . . . 0.46000000000000002 109.332 179.02 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -70.12 -30.04 67.13 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.542 -0.724 . . . . 0.73999999999999999 110.722 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.681 ' HB2' HG21 ' A' ' 34' ' ' VAL . 23.4 mt-10 -71.65 -51.39 23.34 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.377 -0.827 . . . . 0.42999999999999999 110.362 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.7 ' HA ' ' HG2' ' A' ' 30' ' ' GLN . 0.7 OUTLIER -71.54 -29.69 65.04 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.279 -0.888 . . . . 0.28999999999999998 109.951 179.236 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.473 ' N ' ' HG ' ' A' ' 77' ' ' LEU . . . -102.61 46.03 1.28 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.362 -1.495 . . . . 0.23999999999999999 109.362 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.76 3.92 29.38 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.533 -0.981 . . . . 1.48 110.998 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.592 HG22 ' H ' ' A' ' 82' ' ' ILE . 2.3 mp -60.96 145.88 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.288 -0.883 . . . . 0.44 110.159 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -63.57 -21.19 66.21 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.474 -0.766 . . . . 0.81999999999999995 110.525 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.592 ' H ' HG22 ' A' ' 80' ' ' ILE . 38.2 mm -71.59 172.4 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.405 -0.81 . . . . 0.5 109.83 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.469 ' N ' HG22 ' A' ' 82' ' ' ILE . 68.9 t -62.29 113.7 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.248 -0.908 . . . . 0.5 110.766 -179.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.87 154.26 37.31 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.782 -0.574 . . . . 1.01 110.368 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.516 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 4.4 ttp -156.18 159.86 39.35 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.336 -0.852 . . . . 0.65000000000000002 110.012 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.623 ' HA ' ' HA ' ' A' ' 19' ' ' VAL . 9.8 p -131.87 149.15 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 121.307 -0.871 . . . . 0.34000000000000002 110.891 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.463 ' CD2' ' HA ' ' A' ' 17' ' ' TYR . 37.6 mt . . . . . 0 N--CA 1.501 2.092 0 CA-C-O 117.653 -1.165 . . . . 0.45000000000000001 110.664 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.739 0 CA-C-O 121.021 0.439 . . . . 2.29 110.456 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 66.89 105.61 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.075 0 CA-C-O 121.598 0.713 . . . . 1.95 110.401 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.508 HG23 ' CG ' ' A' ' 68' ' ' GLU . 26.6 m -75.58 132.66 40.82 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.569 -0.707 . . . . 0.73999999999999999 109.711 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.18 142.37 35.93 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.526 -0.734 . . . . 1.1699999999999999 110.646 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.597 HD23 HD13 ' A' ' 8' ' ' LEU . 0.4 OUTLIER 56.62 -171.65 0.08 Allowed 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.371 0.605 . . . . 1.6000000000000001 110.941 -179.785 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -135.58 66.48 1.51 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.41 -0.806 . . . . 1.55 109.84 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 52.16 58.22 5.65 Favored 'General case' 0 N--CA 1.499 1.975 0 CA-C-O 121.39 0.614 . . . . 0.70999999999999996 110.856 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.597 HD13 HD23 ' A' ' 5' ' ' LEU . 0.1 OUTLIER -99.09 -37.73 9.22 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.343 -0.848 . . . . 1.1599999999999999 110.369 179.847 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.5 mp -76.38 -46.07 29.0 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.386 -0.821 . . . . 0.93999999999999995 110.058 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 62.96 34.84 13.74 Favored 'General case' 0 N--CA 1.501 2.098 0 CA-C-O 121.167 0.508 . . . . 0.73999999999999999 110.684 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.525 ' O ' ' HA ' ' A' ' 65' ' ' THR . 91.0 t80 -98.71 118.0 63.69 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.327 -0.858 . . . . 0.81999999999999995 109.281 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.637 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 43.5 Cg_endo -69.29 107.49 1.78 Allowed 'Trans proline' 0 C--N 1.313 -1.291 0 O-C-N 123.874 1.46 . . . . 0.42999999999999999 110.776 -179.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.8 t -115.71 143.9 31.55 Favored Pre-proline 0 N--CA 1.497 1.885 0 C-N-CA 120.138 -0.625 . . . . 0.44 110.34 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.93 119.75 6.24 Favored 'Trans proline' 0 C--N 1.314 -1.283 0 O-C-N 123.915 1.481 . . . . 0.44 110.634 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.683 ' HB2' ' HB ' ' A' ' 62' ' ' ILE . 15.6 m-85 -103.62 99.8 9.61 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.638 -0.664 . . . . 0.39000000000000001 110.231 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.9 m -75.03 96.05 3.13 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.395 -0.816 . . . . 0.38 108.843 179.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.459 ' HD2' HG21 ' A' ' 86' ' ' VAL . 4.6 m-85 -108.63 115.07 29.41 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.244 -0.91 . . . . 0.40000000000000002 110.848 -178.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.528 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 0.8 OUTLIER -83.64 91.04 7.37 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.478 -0.764 . . . . 0.90000000000000002 109.5 179.452 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.946 HG11 HD11 ' A' ' 77' ' ' LEU . 11.0 t -79.3 95.4 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.51 -0.744 . . . . 0.66000000000000003 109.645 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.486 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 34.5 mtm -101.58 136.02 42.11 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.461 -0.774 . . . . 0.96999999999999997 110.15 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -172.25 -156.97 13.04 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.565 -1.414 . . . . 0.37 109.565 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.594 ' HG2' HG21 ' A' ' 82' ' ' ILE . 3.3 tp60 -67.68 168.79 10.61 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.458 -1.024 . . . . 0.58999999999999997 110.486 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -90.0 97.85 11.43 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.426 -0.796 . . . . 0.41999999999999998 109.969 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.441 ' CD1' ' HB3' ' A' ' 26' ' ' GLU . 0.8 OUTLIER -130.13 154.45 81.32 Favored Pre-proline 0 N--CA 1.498 1.939 0 O-C-N 121.562 -0.711 . . . . 0.40000000000000002 110.645 -179.837 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -73.06 -26.7 14.76 Favored 'Trans proline' 0 N--CA 1.49 1.316 0 O-C-N 123.877 1.461 . . . . 0.46999999999999997 111.68 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.441 ' HB3' ' CD1' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -68.82 -11.61 60.62 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.135 -0.978 . . . . 0.62 111.258 -179.804 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.417 HD22 HG21 ' A' ' 58' ' ' VAL . 0.7 OUTLIER -59.14 -64.61 0.88 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.124 -0.985 . . . . 0.81000000000000005 110.441 -179.867 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.585 HG12 ' HG2' ' A' ' 45' ' ' PRO . 26.9 m -66.77 -29.81 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 O-C-N 121.396 -0.815 . . . . 0.56999999999999995 110.956 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -65.23 -56.63 11.69 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.314 -0.867 . . . . 0.67000000000000004 110.051 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.655 ' O ' HG12 ' A' ' 34' ' ' VAL . 7.8 tp60 -68.3 -31.55 71.06 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.494 -0.754 . . . . 0.60999999999999999 110.586 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.882 HG22 HD12 ' A' ' 60' ' ' ILE . 2.4 t -58.2 -52.33 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.37 -0.831 . . . . 0.31 110.368 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.7 p -73.49 -32.53 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.303 -0.873 . . . . 0.34999999999999998 111.385 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.69 -49.05 27.66 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.029 -1.044 . . . . 1.1799999999999999 110.777 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.79 HG21 ' HB2' ' A' ' 76' ' ' GLU . 4.6 p -68.79 -34.05 62.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.457 -0.777 . . . . 0.28999999999999998 111.012 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.564 HG11 ' HB2' ' A' ' 43' ' ' TYR . 4.7 p -74.16 -31.16 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.007 -1.058 . . . . 0.31 110.051 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -73.31 -34.03 65.48 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.269 -0.894 . . . . 1.3600000000000001 109.754 178.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.3 mtt180 -68.96 -33.75 74.22 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.447 -0.783 . . . . 2.0 111.345 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.586 ' HB2' HD11 ' A' ' 73' ' ' LEU . 24.6 m-70 -99.1 -45.81 5.79 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.081 -1.012 . . . . 0.62 110.781 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -101.74 150.28 37.2 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 121.449 -0.782 . . . . 0.41999999999999998 110.28 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.55 141.18 34.2 Favored 'Trans proline' 0 C--N 1.314 -1.281 0 O-C-N 123.803 1.423 . . . . 0.67000000000000004 110.762 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.55 165.23 36.41 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.71 -1.356 . . . . 0.54000000000000004 109.71 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -99.01 145.45 27.06 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.411 -1.052 . . . . 0.62 110.21 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.564 ' HB2' HG11 ' A' ' 35' ' ' VAL . 78.2 m-85 -129.26 167.11 18.16 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.524 -0.735 . . . . 0.42999999999999999 110.108 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.778 HG22 ' HD2' ' A' ' 45' ' ' PRO . 0.2 OUTLIER -140.12 157.61 68.72 Favored Pre-proline 0 N--CA 1.498 1.973 0 O-C-N 121.233 -0.917 . . . . 0.70999999999999996 111.552 -178.55 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.778 ' HD2' HG22 ' A' ' 44' ' ' THR . 54.8 Cg_endo -96.56 141.74 0.8 Allowed 'Trans proline' 0 C--N 1.319 -0.997 0 C-N-CA 122.131 1.887 . . . . 0.58999999999999997 110.395 179.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.479 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 45.2 m -95.64 93.66 7.27 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.21 -0.931 . . . . 0.40999999999999998 109.051 178.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.762 HG23 HG12 ' A' ' 58' ' ' VAL . 11.0 p -76.06 138.24 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.473 -0.767 . . . . 0.37 111.598 -178.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.61 150.52 54.41 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.868 -0.52 . . . . 1.0900000000000001 109.705 179.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -74.97 83.79 1.76 Allowed 'Trans proline' 0 C--N 1.314 -1.288 0 O-C-N 123.858 1.451 . . . . 0.54000000000000004 110.392 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -91.6 -46.9 7.69 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.431 -0.793 . . . . 1.0600000000000001 110.059 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.589 ' HB3' ' HB3' ' A' ' 55' ' ' TYR . 3.5 t -102.82 170.74 7.81 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.487 -0.758 . . . . 1.1699999999999999 110.266 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.94 163.21 12.4 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.376 -0.828 . . . . 1.96 110.531 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 86.8 -139.84 16.68 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.692 -1.363 . . . . 0.70999999999999996 109.692 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -100.7 58.06 0.92 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.528 -0.984 . . . . 0.68999999999999995 110.215 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.589 ' HB3' ' HB3' ' A' ' 51' ' ' SER . 22.2 t80 -133.2 132.58 41.71 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.356 -0.84 . . . . 0.84999999999999998 109.905 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -132.72 139.09 47.46 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.431 -0.793 . . . . 0.58999999999999997 110.497 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.486 ' HA ' ' HA ' ' A' ' 20' ' ' MET . 57.7 m -107.89 116.22 31.56 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.605 -0.685 . . . . 0.34000000000000002 109.476 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.762 HG12 HG23 ' A' ' 47' ' ' VAL . 1.7 m -115.5 143.3 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.27 -0.894 . . . . 0.35999999999999999 111.13 -179.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.528 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 13.4 m -104.56 108.28 19.64 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.753 -0.832 . . . . 0.71999999999999997 108.753 178.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.882 HD12 HG22 ' A' ' 31' ' ' VAL . 6.4 tt -92.84 132.13 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.326 -0.859 . . . . 0.34000000000000002 111.556 -178.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.428 HG23 ' O ' ' A' ' 61' ' ' THR . 13.2 t -87.69 125.12 34.21 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.755 -0.832 . . . . 0.32000000000000001 108.755 178.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.683 ' HB ' ' HB2' ' A' ' 15' ' ' PHE . 45.4 mm -121.37 125.0 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.217 -0.927 . . . . 0.46999999999999997 110.998 -178.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -101.94 64.01 0.94 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.411 -0.806 . . . . 0.62 109.21 178.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.707 ' HB1' ' HB2' ' A' ' 69' ' ' GLN . . . -94.68 132.86 38.97 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.353 -0.842 . . . . 0.28999999999999998 110.355 -179.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.637 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 41.3 p -67.7 -22.66 65.26 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.603 -0.685 . . . . 0.44 110.613 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -130.42 160.28 34.51 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.411 -0.805 . . . . 1.03 110.139 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.432 ' O ' HG12 ' A' ' 70' ' ' VAL . 0.9 OUTLIER -72.06 -16.86 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.412 -0.805 . . . . 0.89000000000000001 110.681 179.604 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.508 ' CG ' HG23 ' A' ' 3' ' ' THR . 0.3 OUTLIER -70.1 -33.89 72.44 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.089 -1.007 . . . . 0.84999999999999998 110.399 179.499 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.707 ' HB2' ' HB1' ' A' ' 64' ' ' ALA . 8.5 mt-30 -66.35 -48.29 70.7 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.464 -0.772 . . . . 0.88 110.381 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.584 HG23 HG21 ' A' ' 62' ' ' ILE . 8.1 p -68.34 -25.89 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.387 -0.821 . . . . 0.34000000000000002 110.561 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -67.71 -51.28 51.38 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.207 -0.933 . . . . 0.52000000000000002 109.544 179.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.2 p -65.01 -34.95 79.66 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.532 -0.73 . . . . 0.41999999999999998 109.578 178.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.586 HD11 ' HB2' ' A' ' 38' ' ' HIS . 2.9 mp -60.62 -41.74 95.47 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.548 -0.72 . . . . 0.31 109.844 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.54 ' CD1' ' HB ' ' A' ' 86' ' ' VAL . 2.0 t80 -65.15 -44.31 89.01 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.476 -0.765 . . . . 1.04 109.487 178.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.22 -37.4 83.55 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.521 -0.737 . . . . 0.92000000000000004 110.53 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.79 ' HB2' HG21 ' A' ' 34' ' ' VAL . 26.5 mt-10 -69.01 -49.88 53.78 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.449 -0.782 . . . . 0.45000000000000001 110.483 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.946 HD11 HG11 ' A' ' 19' ' ' VAL . 0.3 OUTLIER -74.09 -28.98 61.63 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.352 -0.842 . . . . 0.41999999999999998 110.3 179.633 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.481 ' N ' ' HG ' ' A' ' 77' ' ' LEU . . . -104.09 49.43 0.93 Allowed Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.314 -1.514 . . . . 0.31 109.314 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -106.16 3.97 28.51 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.705 -0.88 . . . . 0.82999999999999996 110.791 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.507 HG22 HG12 ' A' ' 82' ' ' ILE . 2.3 mp -61.1 157.27 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.323 -0.86 . . . . 0.39000000000000001 110.328 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.32 -4.12 40.4 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.131 -0.981 . . . . 1.1499999999999999 111.83 -179.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.594 HG21 ' HG2' ' A' ' 22' ' ' GLN . 17.8 mm -86.68 -125.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 120.962 -1.086 . . . . 0.46000000000000002 110.402 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 98.9 t -119.51 117.2 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 120.711 -1.243 . . . . 0.37 110.485 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.493 ' HD2' ' HB ' ' A' ' 80' ' ' ILE . 0.0 OUTLIER -122.49 131.65 53.96 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.656 -0.653 . . . . 0.63 110.283 179.779 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.541 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 1.8 ttp -143.05 158.56 43.49 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.413 -0.804 . . . . 1.1699999999999999 109.683 179.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.633 HG23 HG22 ' A' ' 19' ' ' VAL . 9.8 p -141.62 152.21 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.294 -0.879 . . . . 0.46000000000000002 111.026 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.501 2.078 0 CA-C-O 117.54 -1.219 . . . . 0.51000000000000001 110.482 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.807 0 CA-C-O 120.856 0.36 . . . . 0.75 110.519 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.75 80.48 8.83 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.216 -0.928 . . . . 1.5600000000000001 110.451 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 24.7 p -119.92 132.27 55.48 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.563 -0.711 . . . . 0.91000000000000003 109.998 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.1 mttp 59.9 -82.26 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.24 0 O-C-N 122.065 -0.397 . . . . 3.2799999999999998 110.748 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -93.55 -160.6 0.77 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.976 -1.077 . . . . 1.5900000000000001 110.353 179.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -62.56 -55.27 28.82 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.445 -0.784 . . . . 1.3799999999999999 109.779 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -146.78 121.03 9.54 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.591 -0.693 . . . . 0.59999999999999998 110.103 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -102.23 -34.67 9.15 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.661 -0.649 . . . . 0.81000000000000005 110.235 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.3 mp -83.79 -50.35 8.2 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.517 -0.739 . . . . 0.57999999999999996 110.241 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 59.48 42.42 17.71 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-O 121.227 0.537 . . . . 0.54000000000000004 110.648 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.52 ' O ' ' HA ' ' A' ' 65' ' ' THR . 90.1 t80 -96.73 131.52 27.9 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.347 -0.846 . . . . 0.69999999999999996 109.673 179.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.558 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 43.4 Cg_endo -69.5 107.29 1.77 Allowed 'Trans proline' 0 C--N 1.315 -1.203 0 O-C-N 123.909 1.479 . . . . 0.39000000000000001 110.41 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.2 t -129.18 142.31 44.76 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.643 -0.661 . . . . 0.33000000000000002 110.633 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.467 ' HA ' ' HA ' ' A' ' 63' ' ' ASN . 46.2 Cg_endo -72.7 125.5 10.6 Favored 'Trans proline' 0 C--N 1.314 -1.248 0 O-C-N 123.94 1.495 . . . . 0.34000000000000002 110.449 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.704 ' CB ' HG21 ' A' ' 70' ' ' VAL . 32.9 m-85 -103.14 99.45 9.32 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.558 -0.714 . . . . 0.35999999999999999 110.215 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.9 m -78.23 91.94 4.43 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.299 -1.0 . . . . 0.37 108.299 178.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.408 ' HA ' ' CD2' ' A' ' 87' ' ' LEU . 3.1 m-85 -97.6 104.37 16.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.573 -0.704 . . . . 0.40999999999999998 110.352 -178.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.566 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 0.0 OUTLIER -78.22 89.12 4.28 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.693 -0.629 . . . . 1.8700000000000001 110.202 179.905 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.673 HG23 HG23 ' A' ' 58' ' ' VAL . 1.0 OUTLIER -83.89 101.67 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.308 -0.87 . . . . 0.23000000000000001 109.397 179.337 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.407 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 36.8 mtm -109.44 151.43 26.69 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.588 -0.695 . . . . 1.01 110.254 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -177.67 -154.89 12.85 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.847 -1.301 . . . . 0.31 109.847 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.88 167.27 11.83 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.468 -1.019 . . . . 0.68000000000000005 110.353 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.29 102.61 1.42 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.37 -0.831 . . . . 0.33000000000000002 110.255 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.727 ' O ' HD23 ' A' ' 27' ' ' LEU . 0.5 OUTLIER -129.55 120.48 19.77 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.499 -0.751 . . . . 0.90000000000000002 110.091 -179.785 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -71.9 -14.91 29.68 Favored 'Trans proline' 0 N--CA 1.49 1.323 0 O-C-N 123.871 1.458 . . . . 0.53000000000000003 111.465 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -82.28 -0.33 45.0 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.111 -0.993 . . . . 0.73999999999999999 111.456 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.727 HD23 ' O ' ' A' ' 24' ' ' LEU . 3.5 pp -57.87 -36.51 72.47 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 120.969 -1.082 . . . . 0.46000000000000002 111.045 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.9 p -79.36 -30.91 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.161 -0.962 . . . . 0.39000000000000001 110.497 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -66.72 -50.92 61.25 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.403 -0.81 . . . . 0.40999999999999998 109.891 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.695 ' HG2' ' HA ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -68.81 -45.25 71.73 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.261 -0.9 . . . . 1.05 110.525 179.765 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.693 HG13 ' CD1' ' A' ' 60' ' ' ILE . 2.9 t -53.76 -54.05 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.442 -0.786 . . . . 0.23999999999999999 111.172 -179.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.9 p -66.77 -35.65 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 121.185 -0.947 . . . . 0.32000000000000001 111.63 -179.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -73.8 -51.06 17.62 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.059 -1.026 . . . . 0.5 110.896 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.733 HG21 ' CB ' ' A' ' 76' ' ' GLU . 9.5 p -66.25 -31.7 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.403 -0.81 . . . . 0.33000000000000002 111.162 -179.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.468 HG11 ' HB2' ' A' ' 43' ' ' TYR . 1.6 p -79.59 -28.23 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.145 -0.972 . . . . 0.31 110.634 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -75.98 -37.76 58.2 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.226 -0.922 . . . . 0.78000000000000003 110.524 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 13.3 mtm180 -71.87 -23.11 61.46 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.332 -0.855 . . . . 2.5499999999999998 110.93 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.528 ' CD2' HD11 ' A' ' 73' ' ' LEU . 19.8 m-70 -99.6 -45.78 5.67 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.298 -0.877 . . . . 0.51000000000000001 110.392 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -92.17 153.57 43.13 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.405 -0.809 . . . . 0.44 109.695 179.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -68.05 -36.74 16.54 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 O-C-N 123.752 1.396 . . . . 0.71999999999999997 111.082 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -101.74 163.89 17.47 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 109.517 -1.433 . . . . 0.46999999999999997 109.517 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -88.55 154.63 20.19 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.354 -1.086 . . . . 0.66000000000000003 109.885 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.468 ' HB2' HG11 ' A' ' 35' ' ' VAL . 75.3 m-85 -137.65 172.77 12.46 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.471 -0.768 . . . . 0.46999999999999997 110.641 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.675 HG22 ' HD2' ' A' ' 45' ' ' PRO . 4.2 m -142.27 154.0 63.65 Favored Pre-proline 0 N--CA 1.498 1.943 0 O-C-N 121.416 -0.803 . . . . 0.45000000000000001 110.919 -179.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.675 ' HD2' HG22 ' A' ' 44' ' ' THR . 55.1 Cg_endo -95.12 132.5 0.56 Allowed 'Trans proline' 0 C--N 1.319 -0.979 0 C-N-CA 121.823 1.682 . . . . 0.56999999999999995 110.421 178.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 35.8 m -90.24 99.35 12.39 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.067 -1.021 . . . . 0.34000000000000002 109.202 179.019 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.73 ' HA ' HG12 ' A' ' 58' ' ' VAL . 12.4 p -76.63 135.18 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.544 -0.722 . . . . 0.33000000000000002 111.495 -178.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.426 ' HE2' ' HB3' ' A' ' 57' ' ' SER . 0.2 OUTLIER -142.71 150.78 55.02 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.789 -0.569 . . . . 0.73999999999999999 109.817 179.096 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -80.4 80.04 3.15 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 O-C-N 123.982 1.517 . . . . 0.51000000000000001 110.616 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.54 -47.1 13.53 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.312 -0.867 . . . . 0.92000000000000004 109.999 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.559 ' HB3' ' HB3' ' A' ' 55' ' ' TYR . 0.6 OUTLIER -105.46 156.42 18.22 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.447 -0.783 . . . . 0.79000000000000004 110.142 179.582 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.52 150.18 20.51 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.49 -0.756 . . . . 0.93999999999999995 110.439 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.41 -136.78 12.92 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.653 -1.379 . . . . 0.53000000000000003 109.653 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -98.55 72.65 2.04 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.468 -1.019 . . . . 0.60999999999999999 109.974 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.559 ' HB3' ' HB3' ' A' ' 51' ' ' SER . 16.3 t80 -146.36 128.8 15.93 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.416 -0.802 . . . . 0.56999999999999995 110.38 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 4.0 m170 -120.62 126.04 49.27 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.561 -0.712 . . . . 0.69999999999999996 109.974 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.426 ' HB3' ' HE2' ' A' ' 48' ' ' LYS . 38.9 m -109.7 110.88 22.05 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.403 -0.811 . . . . 0.40000000000000002 109.593 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.73 HG12 ' HA ' ' A' ' 47' ' ' VAL . 3.6 m -119.74 151.34 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.21 -0.931 . . . . 0.25 110.931 -179.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.566 ' HA ' ' HA ' ' A' ' 18' ' ' LYS . 79.3 p -117.8 118.08 31.06 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.478 -0.764 . . . . 0.32000000000000001 109.422 179.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.693 ' CD1' HG13 ' A' ' 31' ' ' VAL . 9.1 tt -93.17 130.68 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.33 -0.856 . . . . 0.28000000000000003 110.922 -179.012 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 97.2 m -86.15 129.91 34.7 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 109.101 -0.703 . . . . 0.34999999999999998 109.101 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.434 HD11 HD13 ' A' ' 60' ' ' ILE . 91.0 mt -141.65 96.6 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.103 -0.998 . . . . 0.29999999999999999 110.848 -179.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.467 ' HA ' ' HA ' ' A' ' 14' ' ' PRO . 2.0 t30 -82.31 93.94 7.25 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.039 -1.038 . . . . 0.46000000000000002 109.353 178.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -117.45 140.21 49.89 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.598 -0.689 . . . . 0.26000000000000001 110.319 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.558 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 33.8 p -69.74 -15.37 63.13 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.546 -0.722 . . . . 0.34999999999999998 110.653 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -130.53 157.98 41.2 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.399 -0.813 . . . . 0.42999999999999999 109.901 179.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.2 tt -89.99 -3.23 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.29 -0.881 . . . . 0.55000000000000004 111.093 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -74.38 -43.68 55.42 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.106 -0.996 . . . . 0.41999999999999998 110.487 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.461 ' CG ' ' HB3' ' A' ' 38' ' ' HIS . 0.6 OUTLIER -67.01 -47.0 72.79 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.531 -0.73 . . . . 0.57999999999999996 110.848 -179.682 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.704 HG21 ' CB ' ' A' ' 15' ' ' PHE . 8.9 p -62.24 -31.13 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 121.446 -0.784 . . . . 0.29999999999999999 110.699 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -66.76 -46.89 73.93 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.326 -0.859 . . . . 0.52000000000000002 109.224 178.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.447 HG22 ' OE1' ' A' ' 76' ' ' GLU . 7.0 m -61.32 -34.38 75.16 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.679 -0.638 . . . . 0.40999999999999998 109.464 178.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.528 HD11 ' CD2' ' A' ' 38' ' ' HIS . 2.1 mp -65.64 -39.11 91.08 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.515 -0.741 . . . . 0.37 109.914 179.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.48 ' HB2' HG21 ' A' ' 86' ' ' VAL . 0.0 OUTLIER -63.12 -48.94 76.37 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.625 -0.672 . . . . 0.42999999999999999 109.779 179.419 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -71.26 -26.24 62.81 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.423 -0.798 . . . . 0.62 110.883 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.733 ' CB ' HG21 ' A' ' 34' ' ' VAL . 23.2 mt-10 -73.49 -50.18 22.88 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.216 -0.927 . . . . 0.39000000000000001 110.07 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.695 ' HA ' ' HG2' ' A' ' 30' ' ' GLN . 1.5 pp -76.17 -25.73 55.52 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.282 -0.886 . . . . 0.34000000000000002 110.023 178.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -101.39 40.74 2.32 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.307 -1.517 . . . . 0.31 109.307 179.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.05 4.12 39.44 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.384 -1.068 . . . . 0.81000000000000005 110.842 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.0 mp -62.04 145.85 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.334 -0.854 . . . . 0.34999999999999998 110.116 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -60.96 -30.29 70.16 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.407 -0.808 . . . . 0.73999999999999999 110.302 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -61.35 171.09 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.616 -0.678 . . . . 0.40999999999999998 110.611 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 78.9 t -63.67 118.16 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.43 -0.794 . . . . 0.40999999999999998 110.288 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.35 158.67 27.74 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.675 -0.641 . . . . 0.69999999999999996 110.369 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.549 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 1.1 ttp -157.76 158.53 35.46 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.511 -0.743 . . . . 0.88 109.786 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.48 HG21 ' HB2' ' A' ' 74' ' ' TYR . 9.1 p -135.46 147.17 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.378 -0.826 . . . . 0.32000000000000001 110.628 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.408 ' CD2' ' HA ' ' A' ' 17' ' ' TYR . 35.8 mt . . . . . 0 N--CA 1.5 2.061 0 CA-C-O 118.693 -0.67 . . . . 0.46999999999999997 110.466 -179.948 . . . . . . . . 1 1 . 1 stop_ save_